RESULT_COUNT: 2176,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
TEVA,TEVA:US,BBG000C0CD58,3-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-21 03:34:00 +0000,https://finance.yahoo.com/news/3-day-deadline-khang-khang-033400207.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 20, 2017 / Khang & Khang LLP (the ''Firm'') announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (''Teva'' or the''Company'') (NYSE: ..."
TEVA,TEVA:US,BBG000C0CD58,"DEADLINE MONDAY: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-10-20 13:35:00 +0000,https://finance.yahoo.com/news/deadline-monday-levi-korsinsky-llp-133500521.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 20, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,DEADLINE MONDAY: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-10-19 21:30:00 +0000,https://finance.yahoo.com/news/deadline-monday-lundin-law-pc-213000031.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 19, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,Bernard Horn Comments on Teva Pharmaceutical,2017-10-19 17:44:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GCjocEXurMU/bernard-horn-comments-on-teva-pharmaceutical-cm862149,TEVA Bernard Horn Trades Portfolio shareholder commentary Premium Members This article first appeared on GuruFocus This article first appeared
TEVA,TEVA:US,BBG000C0CD58,"EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-10-19 15:32:00 +0000,https://finance.yahoo.com/news/equity-alert-law-offices-vincent-153200189.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 19, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Will Highlight New Data on Its MS Program at 7th joint ECTRIMS-ACTRIMS Meeting,2017-10-19 13:50:18 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-135018981.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that new data on its multiple sclerosis (MS) program, including COPAXONE® (glatiramer acetate injection), a product for relapsing forms of MS, and laquinimod, an investigational MS therapy, will be highlighted in 11 presentations at the 7th Joint Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) in Paris, October 25-28, 2017.  “New data from Teva’s MS program further contributes to the scientific understanding of treating a complex disease like MS,” said Michael Hayden, MD, PhD, President of Global R&D and Chief Scientific Officer at Teva."
TEVA,TEVA:US,BBG000C0CD58,Teva Submits BLA to FDA for Migraine Candidate Fremanezumab,2017-10-19 13:20:01 +0000,https://finance.yahoo.com/news/teva-submits-bla-fda-migraine-132001127.html?.tsrc=rss,"Teva Pharma (TEVA) submits BLA seeking approval for its pipeline candidate, Fremanezumab, as a preventive treatment for migraine in the United States."
TEVA,TEVA:US,BBG000C0CD58,"Zacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna",2017-10-19 13:19:01 +0000,https://finance.yahoo.com/news/zacks-market-edge-highlights-gilead-131901931.html?.tsrc=rss,"Zacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna"
TEVA,TEVA:US,BBG000C0CD58,"Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi",2017-10-19 13:00:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-acorda-130001205.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi"
TEVA,TEVA:US,BBG000C0CD58,Teva to Highlight New Data in Multiple Sclerosis at Joint ECTRIMS – ACTRIMS Congress in Paris,2017-10-19 12:00:00 +0000,https://finance.yahoo.com/news/teva-highlight-data-multiple-sclerosis-120000150.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today announced that new data on its multiple sclerosis program, including COPAXONE® , a product for relapsing forms of MS, and laquinimod, an investigational MS therapy, will be highlighted in 11 presentations at the 7th Joint Congress of the European Committee for Treatment and Research in Multiple Sclerosis and Americas Committee for Treatment and Research in ..."
TEVA,TEVA:US,BBG000C0CD58,3 Value Stocks for Retirees,2017-10-19 11:51:00 +0000,https://finance.yahoo.com/news/3-value-stocks-retirees-115100793.html?.tsrc=rss,"With retirees living longer than ever, these value stocks offer an opportunity to really grow your nest egg."
TEVA,TEVA:US,BBG000C0CD58,"Pricing Pressure, Competition Remain Headwinds for Pharma Stocks",2017-10-18 23:52:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BGPaJqXj1kA/pricing-pressure-competition-remain-headwinds-for-pharma-stocks-cm861689,While the drug pricing issue no longer remains a major headwind for pharma and biotech stocks it will nevertheless remain a headline risk until the Trump administration comes out with a policy for controlling drug prices The sector previously a Wall Street favorite was hit hard by
TEVA,TEVA:US,BBG000C0CD58,"Why SUPERVALU, Synchronoss Technologies, and Allergan Slumped Today",2017-10-18 20:30:00 +0000,https://finance.yahoo.com/news/why-supervalu-synchronoss-technologies-allergan-203000996.html?.tsrc=rss,"Even as the market climbed, these stocks lagged behind. Find out why."
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited,2017-10-18 19:22:26 +0000,https://finance.yahoo.com/news/investor-alert-goldberg-law-pc-192226711.html?.tsrc=rss,"LOS ANGELES, Oct. 18, 2017-- Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited for violations ..."
TEVA,TEVA:US,BBG000C0CD58,TEVA Reminder Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd.,2017-10-18 19:02:00 +0000,https://finance.yahoo.com/news/teva-reminder-deadline-alert-law-190200903.html?.tsrc=rss,"Law Offices of Howard G. Smith reminds investors of the October 23, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Teva Pharmaceutical Industries Ltd."
TEVA,TEVA:US,BBG000C0CD58,APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-18 18:55:00 +0000,https://finance.yahoo.com/news/approaching-deadline-khang-khang-llp-185500203.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 18, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ..."
TEVA,TEVA:US,BBG000C0CD58,Shares of large generic drugmakers fall,2017-10-18 16:28:04 +0000,http://finance.yahoo.com/r/2a18e210-a5f2-3b38-bc87-59bb9ec6fe6a/Story.aspx?guid=29CAEBDB-DDCF-40C4-AC04-DEE89204768F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of several large generic drugmakers fell in Wednesday midday trade. Mylan NV shares dropped 2.7%, Teva Pharmaceutical Industries Ltd. shares dropped 2.1% , Taro Pharmaceutical Industries Ltd. shares ..."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 – TEVA",2017-10-18 16:19:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-161900286.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 18, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,Where to Find Value in Healthcare Stocks,2017-10-18 01:49:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9DmGD-JRjCw/where-to-find-value-in-healthcare-stocks-cm861075,0 45 Emerging Biotech Market Is It Time To Invest 6 10 Is Large Cap Biotech a Value Trap 160 Gilead Biogen and Bluebird 12 00 Generic Drug Companies Teva Valeant and AbbVie 15 50 Managed Healthcare Sector The Effects Of
TEVA,TEVA:US,BBG000C0CD58,"Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall",2017-10-17 23:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aE36nyCQKmQ/allergan-agn-loses-restasis-patent-lawsuit-shares-fall-cm861054,Allergan plc AGN announced that a Texas federal district court invalidated four of the six patents covering Restasis Allergan s second bestselling drug This potentially opens the doors for early generic competition Shares of the company fell almost 3 5 in response on Monday The company
TEVA,TEVA:US,BBG000C0CD58,Where to Find Value in Healthcare Stocks,2017-10-17 23:33:11 +0000,https://finance.yahoo.com/news/where-value-healthcare-stocks-233311502.html?.tsrc=rss,"The Biotech stocks have been on a big run in 2017, but that doesn&apos;t mean there aren&apos;t some healthcare values still out there."
TEVA,TEVA:US,BBG000C0CD58,How Allergan's 'Public Relations Backlash' Deepened This Week,2017-10-17 20:50:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MS0e4TAnYTc/how-allergans-public-relations-backlash-deepened-this-week-cm860847,Allergan AGN was already facing a public relations backlash after transferring patent rights for its Restasis eye medication to a Native American tribe when a judge on Monday then invalidated four of those patents ibd display video id 2326965 width 50 float
TEVA,TEVA:US,BBG000C0CD58,DEADLINE ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-10-17 18:02:00 +0000,https://finance.yahoo.com/news/deadline-alert-lundin-law-pc-180200309.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 17, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen",2017-10-17 15:56:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z_aPJlshdXE/zacks-industry-outlook-highlights-gilead-teva-pfizer-and-amgen-cm860679,For Immediate Release Chicago IL October 17 2017 Today Zacks Equity Research discusses the Industry Pharmaceuticals Part 1 including Gilead 160 Nasdaq GILD 160 Free Report Teva NYSE TEVA Free Report Pfizer NYSE PFE Free Report and
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Healthcare Stocks,2017-10-17 15:51:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVL2vNb4zjM/3-dividend-healthcare-stocks-cm860621,Healthcare stocks have been extremely fertile ground for dividend investors over the last few years thanks in large part to the aging global population that s presently driving a surge in demand for medical products and healthcare services Best of all this rising tide is showing
TEVA,TEVA:US,BBG000C0CD58,"TEVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-10-17 14:21:00 +0000,https://finance.yahoo.com/news/teva-investor-alert-law-offices-142100821.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 17, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania ..."
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Healthcare Stocks,2017-10-17 14:00:00 +0000,https://finance.yahoo.com/news/3-dividend-healthcare-stocks-140000927.html?.tsrc=rss,"If you&apos;re on the hunt for outstanding healthcare dividend stocks, Allergan, Bristol-Myers Squibb, and McKesson need to be on your radar."
TEVA,TEVA:US,BBG000C0CD58,Incoming Teva Pharm CEO Schultz to start by month end -newspaper,2017-10-17 13:47:08 +0000,https://finance.yahoo.com/news/incoming-teva-pharm-ceo-schultz-134708583.html?.tsrc=rss,"Kare Schultz will start his  new post as chief executive of Israel's Teva Pharmaceutical  Industries by the end of October, the Calcalist  financial newspaper reported on Tuesday.  A Teva spokesman, asked about the Israeli news  report, said the company does not comment on market rumours.  Teva poached Schultz from Denmark's Lundbeck in  September, handing the drugs industry veteran the urgent task of  convincing investors of the struggling Israeli firm's future."
TEVA,TEVA:US,BBG000C0CD58,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen",2017-10-17 13:44:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-gilead-134401197.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen"
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Oct 17, 2017 :  GSK, IPXL, NFLX, MU, MS, FCX, SNCR, BAC, QQQ, CS, TEVA, NEWS",2017-10-17 12:55:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cxPqGZA7VwA/pre-market-most-active-for-oct-17-2017-gsk-ipxl-nflx-mu-ms-fcx-sncr-bac-qqq-cs-teva-news-cm860471,The NASDAQ 100 Pre Market Indicator is down 06 to 6 114 47 The total Pre Market volume is currently 4 917 773 shares traded The following are the most active stocks for the pre market session GlaxoSmithKline PLC GSK is 0 0376 at 40 82 with 792 000 shares
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Submits Biologics License Application to the FDA for Migraine Treatment,2017-10-17 12:33:32 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-123332124.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for fremanezumab, an anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibody for the preventive treatment of migraine.  TEVA Chief Scientific Officer Michael Hayden commented, ""The BLA submission for fremanezumab marks a very important milestone for the migraine community [...] There have been few therapeutic innovations for migraine patients in over 25 years. If approved, fremanezumab will be among the first to enter the market in a new class of drugs for the preventive treatment of migraine."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Submission of Biologics License Application for Fremanezumab to the U.S. FDA,2017-10-17 12:00:00 +0000,https://finance.yahoo.com/news/teva-announces-submission-biologics-license-120000663.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application to the U.S. Food and Drug Administration for fremanezumab, an anti-calcitonin gene-related peptide monoclonal antibody for the preventive treatment of migraine."
TEVA,TEVA:US,BBG000C0CD58,Allergan Tanks After Judge Invalidates Restasis Patents,2017-10-16 21:17:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/byGTOw3jPuk/allergan-tanks-after-judge-invalidates-restasis-patents-cm860268,Allergan AGN stock tanked Monday after a federal judge invalidated patents covering eye drug Restasis in a dispute pitting Allergan against a group of generic drugmakers led by Teva Pharmaceutical TEVA and Mylan MYL ibd display video id
TEVA,TEVA:US,BBG000C0CD58,Allergan Tanks After Judge Invalidates Restasis Patents,2017-10-16 20:42:31 +0000,http://finance.yahoo.com/r/6c6efe6a-0b42-36c5-89c9-988233aabccd/allergan-tanks-after-judge-reportedly-invalidates-restasis-patents?src=A00220&yptr=yahoo&.tsrc=rss,Allergan tanked Monday after a federal judge invalidated patents covering eye-drug Restasis.
TEVA,TEVA:US,BBG000C0CD58,EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-16 19:20:00 +0000,https://finance.yahoo.com/news/equity-alert-khang-khang-llp-192000137.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 16, 2017 / Khang & Khang LLP (the ''Firm'') announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (''Teva'' or the ''Company'') (NYSE: ..."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-10-16 15:01:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-150100842.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 16, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Oct 16, 2017 :  F, EXEL, GSK, VALE, NVO, BAC, JD, MNKD, TEVA, AAPL, MU, XT",2017-10-16 12:55:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fQcGC3YCL_0/pre-market-most-active-for-oct-16-2017-f-exel-gsk-vale-nvo-bac-jd-mnkd-teva-aapl-mu-xt-cm859997,The NASDAQ 100 Pre Market Indicator is up 12 88 to 6 105 33 The total Pre Market volume is currently 6 077 323 shares traded The following are the most active stocks for the pre market session Ford Motor Company F is 0 08 at 11 97 with 1 260 112 shares traded F
TEVA,TEVA:US,BBG000C0CD58,"DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Teva Pharmaceutical Industries Limited to Contact the Firm",2017-10-14 13:10:00 +0000,https://finance.yahoo.com/news/deadline-alert-brower-piven-reminds-131000688.html?.tsrc=rss,"The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Teva Pharmaceutical Industries Limited  American Depository Shares and/or shares on the Tel Aviv Stock Exchange between November 15, 2016 and August 2, 2017, inclusive ..."
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER REMINDER: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-10-14 03:52:00 +0000,https://finance.yahoo.com/news/shareholder-reminder-lundin-law-pc-035200723.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 13, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - (TEVA)",2017-10-14 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-former-025000038.html?.tsrc=rss,"NEW ORLEANS, Oct. 13, 2017-- Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 23, 2017 to file lead plaintiff ..."
TEVA,TEVA:US,BBG000C0CD58,"PG&E, Teva Pharmaceuticals Dive into Friday’s 52-Week Low Club",2017-10-13 20:04:41 +0000,https://finance.yahoo.com/news/pg-e-teva-pharmaceuticals-dive-200441702.html?.tsrc=rss,"PG&E, Teva Pharmaceuticals, Vipshop, and 3D Systems all posted new 52-week lows Friday."
TEVA,TEVA:US,BBG000C0CD58,A New FDA Approval Sends Small Cap Flexion Soaring,2017-10-13 07:15:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lBtv9GtH38o/a-new-fda-approval-sends-small-cap-flexion-soaring-cm859179,This week small cap biotech company Flexion NASDAQ FLXN received its first FDA approval for Zilretta a 160 non opioid sustained release 160 steroid injection for knee pain In this week s episode of Industry Focus Healthcare analysts Kristine Harjes
TEVA,TEVA:US,BBG000C0CD58,Why Do Companies Pay Dividends?,2017-10-13 06:14:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mIFju7XCPnQ/why-do-companies-pay-dividends-cm859174,In this edition of Industry Focus host Michael Douglass and Fool contributor Matt Frankel discuss dividends They agree that dividends can be important features of a stock to income investors and an established track record of paying dividends can be an excellent way for a company
TEVA,TEVA:US,BBG000C0CD58,A New FDA Approval Sends Small Cap Flexion Soaring,2017-10-13 05:15:00 +0000,https://finance.yahoo.com/news/fda-approval-sends-small-cap-051500529.html?.tsrc=rss,"Flexion&apos;s non-opioid pain management drug has huge potential, and it&apos;s looking to expand into more indications."
TEVA,TEVA:US,BBG000C0CD58,Why Do Companies Pay Dividends?,2017-10-13 04:35:00 +0000,https://finance.yahoo.com/news/why-companies-pay-dividends-043500574.html?.tsrc=rss,"There are some good reasons to pay dividends, but it’s not the right move for all companies."
TEVA,TEVA:US,BBG000C0CD58,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Teva Pharmaceutical Industries Ltd. To Contact The Firm",2017-10-12 21:23:00 +0000,https://finance.yahoo.com/news/lead-plaintiff-deadline-alert-faruqi-212300911.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 12, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teva Pharmaceutical Industries Ltd. (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,"JC Penney, General Electric Topple Into Thursday’s 52-Week Low Club",2017-10-12 20:04:02 +0000,https://finance.yahoo.com/news/j-c-penney-general-electric-200402464.html?.tsrc=rss,"General Electric, Rite Aid, J.C. Penney, and Teva all posted new 52-week lows with high volume on Thursday."
TEVA,TEVA:US,BBG000C0CD58,BDSI settles patent litigation with generic giant Teva,2017-10-12 18:30:11 +0000,http://finance.yahoo.com/r/cd70bb4d-34e6-34ab-9989-801fbd65b7a3/bdsi-settles-patent-litigation-with-generic-giant.html?ana=yahoo&yptr=yahoo&.tsrc=rss,BDSI further said that additional terms of the settlement agreement are confidential and that the agreement is subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice.  A Teva spokeswoman confirmed the settlement agreement and launch date.
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-11 21:09:00 +0000,https://finance.yahoo.com/news/investor-alert-khang-khang-llp-210900701.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 11, 2017 / Khang & Khang LLP (the ''Firm'') announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (''Teva'' or the ''Company'') (NYSE: ..."
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceutical Industries Ltd. Investors and Encourages Investors to Contact the Firm (TEVA),2017-10-11 18:45:00 +0000,https://finance.yahoo.com/news/investor-alert-law-offices-howard-184500684.html?.tsrc=rss,"Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Teva Pharmaceutical Industries Ltd. securities between November 15, 2016 and August 2, 2017, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,"The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Teva Pharmaceutical Industries Ltd. Shareholders and a Lead Plaintiff Deadline of October 23, 2017 (TEVA)",2017-10-11 15:37:00 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-153700377.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 11, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) who ..."
TEVA,TEVA:US,BBG000C0CD58,Mylan Gets Complete Response Letter For Biosimilar Neulasta,2017-10-11 15:17:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JvzU_WYOZCc/mylan-gets-complete-response-letter-for-biosimilar-neulasta-cm858108,Mylan N V MYL suffered a setback following the FDA s Complete Response Letter CRL for the company s Biologics License Application BLA for MYL 1401H a proposed biosimilar of Amgen s Inc AMGN Neulasta The CRL relates to the pending update of the BLA with certain CMC data from
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Run for Cover From Major Pharma,2017-10-11 14:55:22 +0000,https://finance.yahoo.com/news/short-sellers-run-cover-major-145522682.html?.tsrc=rss,"The September 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased."
TEVA,TEVA:US,BBG000C0CD58,"Capital Allocation: Buybacks, Dividends, and More",2017-10-11 14:12:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JYCh2Bjug2c/capital-allocation-buybacks-dividends-and-more-cm857976,In this episode of Industry Focus Financials host Michael Douglass and Fool com contributor Matt Frankel discuss the ways companies can choose to use their capital including share buybacks dividends organic growth and mergers and acquisitions When is each one a good
TEVA,TEVA:US,BBG000C0CD58,Mylan Deals a Blow to Teva Pharmaceutical,2017-10-11 13:15:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YdBrYm_IM_U/mylan-deals-a-blow-to-teva-pharmaceutical-cm857951,Generic drugmakers Mylan NASDAQ MYL and Teva Pharmaceutical NYSE TEVA 160 usually deal blows to brand name drug manufacturers not each other but that changed last week when the Food and Drug Administration approved Mylan s generic version of Teva Pharmaceutical
TEVA,TEVA:US,BBG000C0CD58,Mylan Deals a Blow to Teva Pharmaceutical,2017-10-11 11:20:00 +0000,https://finance.yahoo.com/news/mylan-deals-blow-teva-pharmaceutical-112000788.html?.tsrc=rss,Mylan&apos;s latest drug approval could take a big chunk out of Teva Pharmaceutical&apos;s revenue.
TEVA,TEVA:US,BBG000C0CD58,UPCOMING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-10-10 17:50:00 +0000,https://finance.yahoo.com/news/upcoming-deadline-lundin-law-pc-175000480.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 10, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva to Report Third Quarter 2017 Financial Results on November 2, 2017",2017-10-10 17:43:00 +0000,https://finance.yahoo.com/news/teva-report-third-quarter-2017-174300682.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. announced today that it will release its third quarter 2017 financial results on Thursday, November 2, 2017 at 7:00 a.m. ET."
TEVA,TEVA:US,BBG000C0CD58,[$$] CVC Picks Former Allergan Executive to Run Women's Drug Portfolio,2017-10-10 17:00:30 +0000,http://finance.yahoo.com/r/0906733e-8484-34a5-8c01-64439d2622be/cvc-picks-former-allergan-executive-to-run-womens-drug-portfolio-1507654827?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Anish Mehta oversaw the $40.5 billion sale of Allergan’s generics business in 2016.
TEVA,TEVA:US,BBG000C0CD58,"TEVA EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-10-10 15:07:00 +0000,https://finance.yahoo.com/news/teva-equity-alert-law-offices-150700670.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 10, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania ..."
TEVA,TEVA:US,BBG000C0CD58,"$50,000 Per Year in Prescription Drugs? You Likely Know Someone Who Used at Least That Much",2017-10-10 11:52:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t-rnuaPQfiU/50000-per-year-in-prescription-drugs-you-likely-know-someone-who-used-at-least-that-much-cm857333,For most Americans 50 000 is a lot of money Six out of 10 households in the U S have make less than that amount per year based on adjusted gross income But for a growing number of Americans that s how much or more was spent on their prescription medications last
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-09 17:31:00 +0000,https://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-173100352.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 9, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ..."
TEVA,TEVA:US,BBG000C0CD58,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-10-09 14:25:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-142500285.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 9, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,"Forget Teva (TEVA), Buy These 5 Drug Stocks Instead",2017-10-09 14:20:02 +0000,https://finance.yahoo.com/news/forget-teva-teva-buy-5-142002954.html?.tsrc=rss,"With another challenge cropping up for Teva (TEVA) in the form of earlier-than-expected generic competition for the 40 mg dose of Copaxone, here is a look at 5 drug stocks that look better-positioned."
TEVA,TEVA:US,BBG000C0CD58,Stocks That Fell to 3-Year Lows in the Week of Oct. 6,2017-10-08 20:29:51 +0000,https://finance.yahoo.com/news/stocks-fell-3-lows-week-202951167.html?.tsrc=rss,"BT Group PLC (BT), Cardinal Health Inc. (CAH), Teva Pharmaceutical Industries Ltd (TEVA), and Chipotle Mexican Grill Inc. (CMG) have declined to their respective three-year lows."
TEVA,TEVA:US,BBG000C0CD58,DEADLINE APPROACHING: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-10-07 17:45:00 +0000,https://finance.yahoo.com/news/deadline-approaching-lundin-law-pc-174500774.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 7, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,3 Drug Stocks That Soared This Week: Are They Buys?,2017-10-07 15:51:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/swCDo7pKBbM/3-drug-stocks-that-soared-this-week-are-they-buys-cm856672,Most investors would be quite happy to get a 20 return over the course of a year Of course happy wouldn t begin to describe the feeling of getting an even better return than that in just a week But that s just what three drug stocks did over the last five days with two of
TEVA,TEVA:US,BBG000C0CD58,3 Drug Stocks That Soared This Week: Are They Buys?,2017-10-07 14:34:00 +0000,http://finance.yahoo.com/r/9be837b9-d261-3c5e-bae1-e1bff690b417/3-drug-stocks-that-soared-this-week-are-they-buys.aspx?yptr=yahoo&.tsrc=rss,"Endocyte, MannKind, and Mylan have bounced back from big losses earlier this year. But can their momentum continue?"
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT: ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - (TEVA)",2017-10-07 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-claimsfiler-025000036.html?.tsrc=rss,"ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 23, 2017 to file lead plaintiff applications in a securities class action lawsuit against Teva Pharmaceutical Industries Limited , if they purchased the Company’s American Depository Shares and/or shares on the Tel Aviv Stock Exchange between November 15, 2016 and August 2, 2017, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Not His Cup of Teva; Recommended Reading: Best of Kass,2017-10-06 23:00:00 +0000,http://finance.yahoo.com/r/91c20eea-6501-3e98-bd64-26b2b24b7ff1/not-his-cup-of-teva-recommended-reading-best-of-kass.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"In highlights from this week's trading diary and posts, Kass discusses Teva and offers some recommended reading."
TEVA,TEVA:US,BBG000C0CD58,Motorola Solutions leading the IQ100,2017-10-06 19:32:00 +0000,https://finance.yahoo.com/video/motorola-solutions-leading-iq100-193200349.html?.tsrc=rss,"The CNBC IQ100 index is beating the broader market over one year up 22%. Today's leaders include Motorola Solutions, Teva Pharma, GM, Metlife and Prudential."
TEVA,TEVA:US,BBG000C0CD58,Is Allergan plc a Bargain After a $7.6 Billion Dip in September?,2017-10-06 16:45:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g_-pQcEu8t4/is-allergan-plc-a-bargain-after-a-76-billion-dip-in-september-cm856329,What happened According to data from S amp P Global Market Intelligence Botox maker Allergan NYSE AGN shed 10 of its value which equates to approximately 7 6 billion of its market cap last month This sizable drop appears to be the result of two
TEVA,TEVA:US,BBG000C0CD58,"IEFA, NXPI, TEVA, CHKP: ETF Inflow Alert",2017-10-06 16:41:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EqcTRPljNmE/iefa-nxpi-teva-chkp-etf-inflow-alert-cm856265,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 1 2 billion dollar inflow that s a 3 3 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Is Allergan plc a Bargain After a $7.6 Billion Dip in September?,2017-10-06 15:00:00 +0000,http://finance.yahoo.com/r/7a43aead-17e3-3ee3-8fc4-c9d3bf8c17e5/is-allergan-plc-a-bargain-after-a-76-billion-dip-i.aspx?yptr=yahoo&.tsrc=rss,Allergan continues to be a victim of Teva&apos;s downfall.
TEVA,TEVA:US,BBG000C0CD58,Lilly Wins Favorable Ruling From U.S. PTO in Alimta Dispute,2017-10-06 14:45:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/anQgQDkKhIA/lilly-wins-favorable-ruling-from-us-pto-in-alimta-dispute-cm856174,Eli Lilly amp Company LLY announced that it has received a favorable ruling from the U S Patent and Trademark Office PTO in a dispute related to the vitamin regimen patent on its key cancer drug Alimta pemetrexed disodium In an inter partes review IPR ruling the U S PTO
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Mylan Up, Teva Down on Copaxone News, Lawmakers Question Allergan Deal",2017-10-06 13:07:01 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mylan-teva-130701395.html?.tsrc=rss,The FDA approval of Mylan&apos;s (MYL) generic version of Teva&apos;s Copaxone was the main news this week. Allergan was also in the headlines related to its deal with the Saint Regis Mohawk Tribe.
TEVA,TEVA:US,BBG000C0CD58,Lilly Wins Favorable Ruling From U.S. PTO in Alimta Dispute,2017-10-06 12:50:12 +0000,https://finance.yahoo.com/news/lilly-wins-favorable-ruling-u-125012937.html?.tsrc=rss,"Lilly (LLY) has received a favorable ruling from the U.S. PTO in a dispute related to vitamin regimen patent on its key cancer drug, Alimta."
TEVA,TEVA:US,BBG000C0CD58,Mylan's FDA Approval Isn't All That: Wells Fargo,2017-10-05 21:44:00 +0000,http://finance.yahoo.com/r/df7513b0-5870-33e7-b263-0beaf0d40a2b/mylans-fda-approval-isnt-all-wells-fargo?partner=YahooSA&yptr=yahoo&.tsrc=rss,"While Mylan's 17% rally this week is 'a little bit exaggerated,' a 'key win' could boost EPS."
TEVA,TEVA:US,BBG000C0CD58,Teva's Copaxone faces generic competition in Europe after U.S. hit,2017-10-05 18:04:00 +0000,https://finance.yahoo.com/news/tevas-copaxone-faces-generic-competition-180400959.html?.tsrc=rss,"Teva's blockbuster  multiple sclerosis treatment Copaxone will face additional  generic competition in Europe, just two days after Mylan NV  won U.S. approval to sell  cheaper versions of the  medicine in the world's largest market.  Mylan's European partner, Synthon, and Alvogen said on  Thursday they had received decentralized European approval for a  40 milligram dose of glatiramer acetate, as Copaxone is known  generically.  Nearly 20 percent of total sales for Teva Pharmaceutical  Industries comes from branded Copaxone."
TEVA,TEVA:US,BBG000C0CD58,Teva Down as Mylan's Copaxone 40 mg Generic Arrives Early,2017-10-05 17:50:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xwWDsqxMNvA/teva-down-as-mylans-copaxone-40-mg-generic-arrives-early-cm855904,Shares of Teva Pharmaceutical Industries Limited TEVA declined almost 15 on Wednesday after Mylan N V MYL after hours on Tuesday announced the FDA approval of its generic version of a 40 mg thrice weekly formulation of the former s blockbuster multiple sclerosis drug Copaxone The FDA
TEVA,TEVA:US,BBG000C0CD58,"Celgene Is Not a Sell, Jim Cramer Rebuts Analysts' Call",2017-10-05 17:06:00 +0000,http://finance.yahoo.com/r/10e6e443-ac1f-3f99-b979-5eecd34833b7/celgene-not-a-sell-jim-cramer-rebuts-analysts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Morgan Stanley analysts downgraded shares of Celgene over concerns of generic drug pressures. Those concerns are not warranted just yet and Celgene is not a sell, Jim Cramer reasoned."
TEVA,TEVA:US,BBG000C0CD58,Teva Investors Concerned Debt Could Be Cut to Junk Rating,2017-10-05 16:12:00 +0000,http://finance.yahoo.com/r/95dad99b-8bb2-3e83-a30e-d5799d2c7158/teva-investors-concerned-debt-could-be-cut-to-junk-rating.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Teva's enormous debt load is getting heavier by the second, Evercore ISI says."
TEVA,TEVA:US,BBG000C0CD58,Teva Down as Mylan&apos;s Copaxone 40 mg Generic Arrives Early,2017-10-05 15:16:03 +0000,https://finance.yahoo.com/news/teva-down-mylan-apos-copaxone-151603348.html?.tsrc=rss,"Teva&apos;s (TEVA) shares plunged after Mylan announced an earlier-than-expected launch of its generic version of the 40-mg thrice-weekly formulation of its blockbuster multiple sclerosis drug, Copaxone."
TEVA,TEVA:US,BBG000C0CD58,Mylan: S&P 500’s Top Gainer on October 4,2017-10-05 14:40:19 +0000,http://finance.yahoo.com/r/247e6883-978e-3953-9706-762de782e4e8/mylan-inc-sp-500s-top-gainer-october-4?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Mylan, which is one of the leading global pharmaceutical companies in the world, was the S&P 500's top gainer on October 4."
TEVA,TEVA:US,BBG000C0CD58,Wall Street Sees Cautiously Higher Open Amid Data,2017-10-05 13:47:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JoQ4pHP4A6Q/wall-street-sees-cautiously-higher-open-amid-data-cm855620,U S stocks were set for a moderately higher open on Thursday as traders evaluated several readings on the U S economy U S stocks were set for a moderately higher open on Thursday as traders evaluated several readings on the U S economy Oil prices edged higher with global benchmark Brent
TEVA,TEVA:US,BBG000C0CD58,"Thursday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Netflix, Inc. (NFLX) and JPMorgan Chase & Co. (JPM)",2017-10-05 13:35:37 +0000,https://finance.yahoo.com/news/thursday-vital-data-teva-pharmaceutical-133537727.html?.tsrc=rss,"U.S. stock futures are trading flat to higher this morning, with Wall Street drifting bullish ahead of a flurry of Federal Reserve speeches and tomorrow&#8217;s September jobs data. What&#8217;s more, traders will also be keeping a close eye on the release of minutes from the latest European Central Bank policy meeting."
TEVA,TEVA:US,BBG000C0CD58,"Teva Announces tomy’s Award Winner at Oncology Satellite Symposium During the 7th International Symposium on Acute Promyelocytic Leukemia (APL) in Rome, Italy",2017-10-05 13:18:00 +0000,https://finance.yahoo.com/news/teva-announces-tomy-award-winner-131800153.html?.tsrc=rss,"Teva Pharmaceuticals Europe BV, announced the winner of the tomy’s at the 7th International Symposium on Acute Promyelocytic Leukemia in Rome, Italy last week."
TEVA,TEVA:US,BBG000C0CD58,U.S. Futures Point to Narrow Gains Ahead of Data,2017-10-05 13:07:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GPXfLlC45pg/us-futures-point-to-narrow-gains-ahead-of-data-cm855558,U S stock futures were trading flat to narrow gains as traders looked ahead to the release of several readings on the U S economy U S stock futures were trading flat to narrow gains as traders looked ahead to the release of several readings on the U S economy Oil prices edged higher
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Oct 5, 2017 :  LYG, MTDR, TROX, RIGL, CDNA, COLL, ECYT, INO, CATB, TEVA, SHOP, MFGP",2017-10-05 12:57:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HEn7glNRMWY/pre-market-most-active-for-oct-5-2017-lyg-mtdr-trox-rigl-cdna-coll-ecyt-ino-catb-teva-shop-mfgp-cm855554,The NASDAQ 100 Pre Market Indicator is up 14 65 to 6 013 49 The total Pre Market volume is currently 6 003 533 shares traded The following are the most active stocks for the pre market session Lloyds Banking Group Plc LYG is 0 05 at 3 59 with 1 538 800 shares
TEVA,TEVA:US,BBG000C0CD58,Mylan Rises on FDA Approval of Generic MS Drug,2017-10-05 12:47:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aD5P9pXFn7s/mylan-rises-on-fda-approval-of-generic-ms-drug-cm855550,The S amp P 500 Nasdaq and Dow Jones opened lower on Wednesday after registering record highs the past several days but soon reversed The S P 500 Nasdaq and Dow Jones opened lower on Wednesday after registering record highs the past several days but soon reversed Mylan N V MYL s
TEVA,TEVA:US,BBG000C0CD58,"Mylan’s surprise generic win sends Teva, Momenta shares plunging",2017-10-05 12:39:53 +0000,http://finance.yahoo.com/r/816c75b0-81e4-3677-bfcd-6a24a39bfd1c/Story.aspx?guid=A5298B36-A8FB-11E7-8976-8EC638BF7118&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The multiple sclerosis drug Copaxone brought in $4 billion last year for Teva, and generic competition wasn’t expected until at least 2018."
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Mylan,2017-10-05 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000296.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 5, 2017 / Traders had a big reason to celebrate Mylan on Wednesday after the drug's generic version of Teva's Copaxone was approved by the FDA. Generic competition for ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] Even Tougher Choices Ahead for Teva After FDA Shocker,2017-10-05 04:33:59 +0000,http://finance.yahoo.com/r/017797bc-88d3-3d4a-97f0-1a4f31286440/even-tougher-choices-ahead-for-teva-after-fda-shocker-1507124924?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,A surprise move from the Food and Drug Administration means that a recovery for Teva Pharmaceutical Industries just got much more difficult.
TEVA,TEVA:US,BBG000C0CD58,"Mylan surges, Teva slumps after FDA approves Copaxone copy",2017-10-05 04:28:51 +0000,https://finance.yahoo.com/news/mylan-surges-teva-slumps-fda-042851573.html?.tsrc=rss,Mylan NV's long-awaited U.S. approval for its generic version of rival Teva's blockbuster multiple sclerosis treatment Copaxone drove Mylan's shares up around 18 percent on Wednesday while Teva shares plunged.  The approval late on Tuesday by the U.S. Food and Drug Administration came earlier than both companies had expected.  It was issued a day after the health regulator said it would introduce measures to speed to market generic versions of complex drugs like Copaxone to help address the rising cost of pharmaceuticals.
TEVA,TEVA:US,BBG000C0CD58,Cramer Remix: My mea culpa on DexCom and where it’s heade...,2017-10-04 23:19:00 +0000,https://finance.yahoo.com/video/cramer-remix-mea-culpa-dexcom-231900660.html?.tsrc=rss,Jim Cramer analyzes the huge drop in DexCom and whether he thinks the stock could rebound.
TEVA,TEVA:US,BBG000C0CD58,Cramer's lightning round: Why my charitable trust sold it...,2017-10-04 23:03:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-why-charitable-230300115.html?.tsrc=rss,"Jim Cramer shares his take on callers' favorite stocks at lightning speed, including one at risk of being &quot;Amazon-ed.&quot;"
TEVA,TEVA:US,BBG000C0CD58,What Happened in the Stock Market Today,2017-10-04 22:49:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6lPbI_0pbrg/what-happened-in-the-stock-market-today-cm855460,Stocks were little changed on Wednesday with advancing and declining issues about equal in number but the Dow Jones Industrial Average DJINDICES DJI 160 and the S amp P 500 SNPINDEX GSPC 160 again closed in record territory Today s stock
TEVA,TEVA:US,BBG000C0CD58,Shopify Drops After Citron Note; Verizon Is Protected From Yahoo Drama -- ICYMI,2017-10-04 22:37:00 +0000,http://finance.yahoo.com/r/c385ffff-5163-3843-be88-39e1a580958c/shopify-discounted-after-citron-note-how-verizon-is-protected-from-yahoo-drama.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Wednesday, Oct. 4."
TEVA,TEVA:US,BBG000C0CD58,What Happened in the Stock Market Today,2017-10-04 21:02:00 +0000,http://finance.yahoo.com/r/bab0e31a-072a-31b2-bd0f-0acd25c0288b/what-happened-in-the-stock-market-today.aspx?yptr=yahoo&.tsrc=rss,"On a day the indexes set records, Mylan won a big drug approval and Office Depot announced an acquisition."
TEVA,TEVA:US,BBG000C0CD58,The Hot Stock: My Oh Mylan!,2017-10-04 20:52:00 +0000,http://finance.yahoo.com/r/20aca632-de8d-3be2-8639-e2a7c168bab7/the-hot-stock-my-oh-mylan-1507150372?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Mylan (MYL) shot to the top of the S&P 500 today after the FDA approved its generic version of Teva Pharmaceutical Industries (TEVA) multiple-sclerosis drug Copaxone.  Mylan gained 16% to $37.80 today, while the S&P 500 advanced 0.1% to 2537.74.  Teva dropped 15% to $16.08."
TEVA,TEVA:US,BBG000C0CD58,"How Mylan's MS-Generic Approval Caused Teva, Momenta To Plunge",2017-10-04 20:32:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RJnO4osjttc/how-mylans-ms-generic-approval-caused-teva-momenta-to-plunge-cm855303,Never count out Mylan MYL an analyst said Wednesday after the Food and Drug Administration approved its generic versions of Teva Pharmaceutical s TEVA Copaxone a multiple sclerosis drug 160 setting shares of the two companies on vastly divergent
TEVA,TEVA:US,BBG000C0CD58,"Teva Dealt Another Blow With Latest Generic From Mylan, Outlook Remains Bleak",2017-10-04 20:14:00 +0000,http://finance.yahoo.com/r/a6a4d10d-0967-3d42-8f46-c49d8ef1d914/teva-dealt-another-blow-with-latest-generic-from-mylan.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Shares of the Israeli pharma company were trading down after Mylan said the Food and Drug Administration had approved a generic version of Teva's top-selling multiple sclerosis drug, Copaxone."
TEVA,TEVA:US,BBG000C0CD58,"How Mylan&apos;s MS-Generic Approval Caused Teva, Momenta To Plunge",2017-10-04 20:11:23 +0000,http://finance.yahoo.com/r/9a253306-8f9d-37cf-9280-59d6bf351019/how-mylans-ms-generic-approval-caused-teva-momenta-to-plunge?src=A00220&yptr=yahoo&.tsrc=rss,"Never count out Mylan, an analyst said Wednesday, after the FDA approved its generic versions of Teva&apos;s Copaxone."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd -- Moody's says approvals of generic versions of Copaxone are a credit positive for Mylan and a credit negative for Teva,2017-10-04 19:30:06 +0000,http://finance.yahoo.com/r/e7341ac3-4369-3934-ae57-dec2a09fb759/viewresearchdoc.aspx?docid=PR_373599&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20171004_PR_373599&yptr=yahoo&.tsrc=rss,"Announcement: Moody's says approvals of generic versions of Copaxone are a credit positive for Mylan and a credit negative for Teva. Global Credit Research- 04 Oct 2017. New York, October 04, 2017-- Moody's ..."
TEVA,TEVA:US,BBG000C0CD58,"Mylan And Teva And Copaxone, Explained",2017-10-04 18:35:02 +0000,https://finance.yahoo.com/news/mylan-teva-copaxone-explained-183502486.html?.tsrc=rss,Mylan N.V. (NASDAQ: MYL ) announced Tuesday that the FDA has approved its Abbreviated New Drug Application for the first generic for Copaxone. Mylan shares were up 19 percent to $38.75. Wells Fargo raised ...
TEVA,TEVA:US,BBG000C0CD58,"Mylan surges, Teva slumps after FDA approves Copaxone copy",2017-10-04 18:34:54 +0000,https://finance.yahoo.com/news/mylan-surges-generic-tevas-copaxone-104317321.html?.tsrc=rss,"The approval late on Tuesday by the U.S. Food and Drug Administration came earlier than both companies had expected.  It was issued a day after the health regulator said it would introduce measures to speed to market generic versions of complex drugs like Copaxone to help address the rising cost of pharmaceuticals.  Copaxone is the leading MS therapy worldwide as well as Teva's best-selling drug, generating more than $4 billion in revenue for the Israeli drugmaker last year."
TEVA,TEVA:US,BBG000C0CD58,A Generic Drug Face-Off Sends Mylan Soaring 19%,2017-10-04 18:33:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nCUCKUKHHkQ/a-generic-drug-face-off-sends-mylan-soaring-19-cm855361,What happened After the Food and Drug Administration surprisingly gave a green light to the company s Copaxone knockoff shares in Mylan Inc NASDAQ MYL 160 are surging 19 5 higher today at 11 30 a m EDT So what Teva Pharmaceutical NYSE TEVA received
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-04 18:18:00 +0000,https://finance.yahoo.com/news/important-equity-alert-khang-khang-181800138.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 4, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ..."
TEVA,TEVA:US,BBG000C0CD58,Don't Be in a Hurry to Buy Teva Stock,2017-10-04 18:15:00 +0000,http://finance.yahoo.com/r/b55df307-5b61-3ded-8df0-093b9a63418a/dont-be-hurry-buy-teva-stock?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Trying to catch a falling knife is not a healthy activity.
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval,2017-10-04 17:34:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kodlL4tWFfA/teva-shares-plummet-after-mylans-copaxone-generic-gets-fda-approval-cm855313,Shares of Teva Pharmaceuticals TEVA opened more than 13 lower on Wednesday plunging close to their 52 week low in the process The struggling Israeli pharma firm which has faced significant pressure to reduce its debt load is sliding once again this time because of a brand new
TEVA,TEVA:US,BBG000C0CD58,Mylan move is a bit exaggerated after FDA drug approval: ...,2017-10-04 17:26:00 +0000,https://finance.yahoo.com/video/mylan-move-bit-exaggerated-fda-172600075.html?.tsrc=rss,"CNBC's Meg Tirrell speaks with David Maris, Wells Fargo Securities senior analyst, about the generic competition between Mylan and Teva after Mylan gets approval for a generic MS drug."
TEVA,TEVA:US,BBG000C0CD58,Mylan N.V. (MYL) Stock Gets Massive Boost From Generic MS Drug Approval,2017-10-04 17:21:42 +0000,https://finance.yahoo.com/news/mylan-n-v-myl-stock-172142517.html?.tsrc=rss,The generic drug that Mylan N.C. got approval for is Glatiramer Acetate Injection 40 mg/mL for 3-times-a-week injection.  This is a generic version of Teva Pharmaceutical Industries Ltd (ADR)’s (NYSE:TEVA) Copaxone.  Approval from the U.S. Food and Drug Administration (FDA) means that Mylan N.V. can now sell the generic drug to customers.
TEVA,TEVA:US,BBG000C0CD58,Mylan Rises on FDA Approval of Generic MS Drug,2017-10-04 17:03:18 +0000,https://finance.yahoo.com/news/mylan-rises-fda-approval-generic-170318609.html?.tsrc=rss,Teva falls as Copaxone now has competition
TEVA,TEVA:US,BBG000C0CD58,FDA approves Mylan generic MS treatment,2017-10-04 16:39:00 +0000,https://finance.yahoo.com/video/fda-approves-mylan-generic-ms-163900358.html?.tsrc=rss,CNBC's Meg Tirrell reports on Mylan soaring after FDA approves their generic multiple sclerosis treatment as Teva shares sinks. The “Fast Money Halftime Report” traders weigh in.
TEVA,TEVA:US,BBG000C0CD58,Today&apos;s charts: Mylan shares soar on FDA approval; Amazon hit with $295M fine; Netflix shares gain,2017-10-04 16:32:21 +0000,https://finance.yahoo.com/news/todays-charts-mylan-shares-soar-fda-approval-amazon-hit-295m-fine-netflix-shares-gain-163221979.html?.tsrc=rss,"Mylan (MYL) shares are getting a boost after the FDA approved its generic version of Teva Pharmaceutical’s (TEVA) blockbuster drug for multiple sclerosis.  In a statement, Mylan CEO Heather Bresch said the approval of the treatment, called Copaxone, marks “another significant milestone for our company” and proves its ability to bring “complex and difficult-to-manufacture products to market.” Shares of Mylan were up 19.1% as of 12:30 p.m. ET, while Teva’s stock was trading down 13.5%."
TEVA,TEVA:US,BBG000C0CD58,A Generic Drug Face-Off Sends Mylan Soaring 19%,2017-10-04 16:28:00 +0000,http://finance.yahoo.com/r/aa11c84e-e198-340d-a2a4-a807fea7ed57/a-generic-drug-face-off-sends-mylan-soaring-19.aspx?yptr=yahoo&.tsrc=rss,The surprising FDA approval of Mylan&apos;s generic version of Teva Pharmaceutical&apos;s top-selling multiple sclerosis drug Copaxone is sending shares higher today.
TEVA,TEVA:US,BBG000C0CD58,Mylan Is Now Worth $4 Billion More Because the FDA Approved This Generic Drug,2017-10-04 16:04:00 +0000,http://finance.yahoo.com/r/14547e47-a0f4-344c-ad1d-5dd70b2f1e59/mylan-gains-after-fda-drug-approval.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Mylan's win with the FDA is fixing a busted price trajectory for shares. Take a look at the chart.
TEVA,TEVA:US,BBG000C0CD58,"Mylan's Generic Copaxone Arrives, Teva Sales To Take A Hit",2017-10-04 15:40:36 +0000,https://finance.yahoo.com/news/mylans-generic-copaxone-arrives-teva-154036275.html?.tsrc=rss,The FDA dealt yet another blow to struggling Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ) investors by approving rival Mylan N.V. (NASDAQ: MYL )’s generic version of Teva’s Copaxone multiple ...
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Plummet After Mylan&apos;s Copaxone Generic Gets FDA Approval,2017-10-04 15:40:03 +0000,https://finance.yahoo.com/news/teva-shares-plummet-mylan-apos-154003466.html?.tsrc=rss,"Shares of Teva Pharmaceuticals (TEVA) opened more than 13% lower on Wednesday, plunging close to their 52-week low in the process. The struggling Israeli pharma firm, which has faced significant pressure to reduce its debt load, is sliding once again--this time because of a brand new competitor."
TEVA,TEVA:US,BBG000C0CD58,Allergan's Botox Gets FDA Nod for Forehead Line Treatment,2017-10-04 15:36:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zEQs0CtzZpk/allergans-botox-gets-fda-nod-for-forehead-line-treatment-cm855190,Allergan plc AGN announced that the FDA has approved its Botox Cosmetic product for a third indication temporary improvement of moderate to severe forehead lines in appearance associated with frontalis muscle activity in adults So far this year Allergan s share price has slipped 0
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Gets FDA Approval for Generic Copaxone 40mg,2017-10-04 15:35:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H6Rl-TaeMDA/mylan-myl-gets-fda-approval-for-generic-copaxone-40mg-cm855170,Mylan N V MYL announced that the FDA has approved Abbreviated New Drug Applications ANDAs for the generic version of Teva Pharmaceutical Industries Limited s TEVA multiple sclerosis MS drug Copaxone glatiramer acetate 40 mg mL thrice weekly Notably this is the first generic
TEVA,TEVA:US,BBG000C0CD58,Mylan Stock Surges on FDA Approval of Generic Version of Teva's Copaxone,2017-10-04 15:32:00 +0000,http://finance.yahoo.com/r/dbe044d2-0168-31d9-99db-bfeaf8306f27/mylan-stock-surges-on-fda-approval-of-copaxone.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Conversely, shares of Teva were sinking over 15% in pre-market trading on Wednesday, following Copaxone's approval."
TEVA,TEVA:US,BBG000C0CD58,"The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Teva Pharmaceutical Industries Ltd. Shareholders and a Lead Plaintiff Deadline of October 23, 2017 (TEVA)",2017-10-04 15:21:00 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-152100475.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 4, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) who ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] US FDA approves generic competitor of Teva blockbuster drug,2017-10-04 15:15:45 +0000,"http://finance.yahoo.com/r/febca0b3-b9f2-36f8-91b0-bd0039528b9c/ed76de04-a90d-11e7-93c5-648314d2c72c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The US drugs watchdog has given the green light to a copycat version of Teva's multiple sclerosis injection, underscoring its efforts to bring down drug prices by speeding up the approval of generic medicines. ..."
TEVA,TEVA:US,BBG000C0CD58,"Tesla revs higher, PepsiCo falls, Mylan soars",2017-10-04 14:58:00 +0000,https://finance.yahoo.com/news/tesla-revs-higher-pepsico-falls-mylan-soars-145800515.html?.tsrc=rss,"Tesla, PepsiCo, Verizon, Ford, Mylan and Teva Pharmaceutical are among the stocks to watch."
TEVA,TEVA:US,BBG000C0CD58,Teva shares down 13% following FDA approval of generic Copaxone,2017-10-04 14:55:07 +0000,http://finance.yahoo.com/r/3538a77a-f795-397e-a608-e493007f8b7c/teva-shares-down-13-following-fda-approval-of.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd.' stock price was trading down 13 percent Wednesday morning after the Food and Drug Administration granted marketing approval to a generic version of Teva’s multiple sclerosis drug Copaxone.  The generic drug was developed by Mylan of Canonsburg.  Dr. Yitzhak Peterburg, Teva’s interim president and CEO, said the company has planned for the eventual introduction of a generic competitor for Copaxone."
TEVA,TEVA:US,BBG000C0CD58,[$$] Even Tougher Choices Ahead for Teva After FDA Shocker,2017-10-04 14:43:13 +0000,http://finance.yahoo.com/r/017797bc-88d3-3d4a-97f0-1a4f31286440/even-tougher-choices-ahead-for-teva-after-fda-shocker-1507124924?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,A surprise move from the Food and Drug Administration means that a recovery for Teva Pharmaceutical Industries just got much more difficult.
TEVA,TEVA:US,BBG000C0CD58,Mylan Soars After FDA Approval for Generic Copaxone --Biotech Movers,2017-10-04 14:24:00 +0000,http://finance.yahoo.com/r/5739da54-60a9-39af-bb3b-508242173ee9/mylan-soars-after-fda-approval-generic-copaxone-biotech-movers?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The pharmaceutical company on Oct. 3 said the FDA has approved its generic version of Teva's multiple sclerosis drug Copaxone.
TEVA,TEVA:US,BBG000C0CD58,The FDA just approved a 'complex generic drug' and it's sending one stock soaring and another crashing,2017-10-04 13:56:36 +0000,https://finance.yahoo.com/news/fda-just-approved-complex-generic-135636920.html?.tsrc=rss,"The FDA on Tuesday approved a generic version of Copaxone, a drug that treats multiple sclerosis..."
TEVA,TEVA:US,BBG000C0CD58,"Teva: Yes, There's a Bright Side",2017-10-04 13:55:00 +0000,http://finance.yahoo.com/r/86deb186-3948-39e3-8f94-ec6373c8aa74/teva-yes-theres-a-bright-side-1507125318?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Teva Pharmaceutical Industries (TEVA) are tumbling today after the FDA approved Mylan's (MYL) generic version of Copaxone. But is there an upside in the downside? It's hard to see one. Teva has ...
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Gets FDA Approval for Generic Copaxone 40mg,2017-10-04 13:33:01 +0000,https://finance.yahoo.com/news/mylan-myl-gets-fda-approval-133301119.html?.tsrc=rss,Mylan N.V. (MYL) gets a boost with the FDA&apos;s approval of the generic version of multiple sclerosis drug Copaxone.
TEVA,TEVA:US,BBG000C0CD58,Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mL,2017-10-04 13:26:00 +0000,https://finance.yahoo.com/news/teva-comments-anticipated-risk-u-132600012.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today commented that any launch by Mylan of a generic version of COPAXONE® 40mg/ml prior to final resolution of the pending patent appeals and other patent litigation should be considered an “at-risk” launch, which could subject Mylan to significant damages among other remedies."
TEVA,TEVA:US,BBG000C0CD58,Why Is Teva Falling? Competition,2017-10-04 13:10:38 +0000,https://finance.yahoo.com/news/why-teva-falling-competition-131038303.html?.tsrc=rss,Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ) were under heavy selling pressure Wednesday morning after the U.S. Food and Drug Administration granted approval for a rival product. The ...
TEVA,TEVA:US,BBG000C0CD58,"Health Care Sector Update for 10/04/2017: CTMX,AMGN,MYL,TEVA,RIGL",2017-10-04 13:10:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hg1dqNz3O7U/health-care-sector-update-for-10042017-ctmxamgnmyltevarigl-cm855032,Top Health Care StocksTop Health Care Stocks JNJ 0 08 JNJ 0 08 PFE 0 61 PFE 0 61 ABT 0 47 ABT 0 47 MRK 0 05 MRK 0 05 AMGN 0 00 AMGN 0 00 Health care stocks still were flat Wednesday morning with the NYSE Health Care Index unchanged following a 0 1 rise during Tuesday s
TEVA,TEVA:US,BBG000C0CD58,"Mylan surges, Teva slumps after FDA okays Copaxone copy",2017-10-04 13:08:43 +0000,https://finance.yahoo.com/news/mylan-surges-generic-tevas-copaxone-104859376.html?.tsrc=rss,"The surprise approval came a day after the health regulator said it would introduce a slew of measures to speed to market generic versions of complex drugs in an effort to address the rising cost of pharmaceuticals.  U.S. listed shares of Israel-based Teva sank 13.7 percent in response while Mylan was the top gainer on the S&P 500 before the opening bell.  The FDA approved both doses - 20 mg and 40 mg - of Mylan's version of Copaxone, which generated global sales of $1.02 billion for Teva in the second quarter of this year."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Oct 4, 2017 :  TEVA, MYL, CATB, AEG, ECYT, FOLD, SAN, QQQ, F, MNKD, BBVA, NVS",2017-10-04 12:59:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mzO5iVVGQjA/pre-market-most-active-for-oct-4-2017-teva-myl-catb-aeg-ecyt-fold-san-qqq-f-mnkd-bbva-nvs-cm855030,The NASDAQ 100 Pre Market Indicator is down 4 47 to 5 990 59 The total Pre Market volume is currently 8 154 709 shares traded The following are the most active stocks for the pre market session Teva Pharmaceutical Industries Limited TEVA is 2 56 at 16 26
TEVA,TEVA:US,BBG000C0CD58,"Morning Movers: Mylan Soars, Teva Tumbles, PepsiCo Drops",2017-10-04 12:48:00 +0000,http://finance.yahoo.com/r/f06fb141-a00f-3bdf-9ba7-a8f5bd8ddb34/morning-movers-mylan-soars-teva-tumbles-pepsico-drops-1507121302?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a lower open this morning after hitting new highs on Monday and Tuesday, as oil prices fell and Treasury yields dipped. The ADP jobs report disappointed, likely due to the impact of ..."
TEVA,TEVA:US,BBG000C0CD58,Mylan Shares Surge After MS Treatment Gets FDA Approval,2017-10-04 10:39:00 +0000,http://finance.yahoo.com/r/b79c5cb3-a95b-3605-a8ec-5128ffe67132/mylan-shares-surge-after-ms-treatment-gets-fda-approval?partner=YahooSA&yptr=yahoo&.tsrc=rss,"News that Mylan’s generic version of Teva’s MS drug won FDA approval sent its shares, and those of its Indian manufacturing partner, soaring."
TEVA,TEVA:US,BBG000C0CD58,Mylan jumps 15% premarket after FDA OK for MS drug,2017-10-04 10:32:48 +0000,http://finance.yahoo.com/r/90b83b4e-c845-35e3-a803-53ca1a44a9d3/Story.aspx?guid=BF24768E-8414-4B51-BDF5-AB0D7B475304&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Shares in Mylan NV rose 15% in premarket action after the maker of generic drugs late Tuesday announced that the Food and Drug Administration had approved its generic versions for Teva Pharmaceutical Industries ...
TEVA,TEVA:US,BBG000C0CD58,Mylan Surges After FDA Approves Copy of Teva's Blockbuster Drug,2017-10-04 06:50:11 +0000,http://finance.yahoo.com/r/3d9e5cc3-2373-350e-903b-abf7cb2abe05/mylan-gets-approval-for-copy-of-teva-s-multiple-sclerosis-drug?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Mylan NV shares rose as much as 19 percent Wednesday after the company won U.S. regulators’ approval for the first generic copies of Teva Pharmaceutical Industries Ltd.’s best-selling multiple-sclerosis ...
TEVA,TEVA:US,BBG000C0CD58,Why This Biotech Suffered A 2-Day Headache On Rare-Disease Trial,2017-10-03 20:54:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yawyer5s1Cc/why-this-biotech-suffered-a-2-day-headache-on-rare-disease-trial-cm854795,Biohaven Pharmaceuticals BHVN continued its two day free fall Tuesday after its rare disease drug failed in a trial 160 prompting at least two analysts to downgrade the stock ibd display video id 2326102 width 50 float left autostart true By the closing bell on the
TEVA,TEVA:US,BBG000C0CD58,DEADLINE ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-03 19:42:00 +0000,https://finance.yahoo.com/news/deadline-alert-lundin-law-pc-194200129.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / October 3, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,2 Clear-Cut Reasons Teva Pharmaceutical Industries Tacked on $1.3 Billion in Market Cap in September,2017-10-03 16:55:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ImSO9jYoVP8/2-clear-cut-reasons-teva-pharmaceutical-industries-tacked-on-13-billion-in-market-cap-in-september-cm854647,What happened Shares of Teva Pharmaceutical Industries NYSE TEVA an Israeli based developer of branded and generic drugs gained more than 8 during September totaling 1 3 billion in market cap according to data from S amp P Global Market Intelligence A key hiring and
TEVA,TEVA:US,BBG000C0CD58,2 Clear-Cut Reasons Teva Pharmaceutical Industries Tacked on $1.3 Billion in Market Cap in September,2017-10-03 15:28:00 +0000,http://finance.yahoo.com/r/b03302f6-4bb0-3824-901d-93c49eae33ab/2-clear-cut-reasons-teva-pharmaceutical-industries.aspx?yptr=yahoo&.tsrc=rss,Teva takes baby steps to address its debt and path forward.
TEVA,TEVA:US,BBG000C0CD58,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-10-03 15:04:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-150400964.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 3, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Oct 3, 2017 :  ECYT, BRCD, ERIC, RIGL, GSK, TTS, ZGNX, BAC, GM, TEVA, BABA, MFGP",2017-10-03 12:55:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l_kLMMC7Cbg/pre-market-most-active-for-oct-3-2017-ecyt-brcd-eric-rigl-gsk-tts-zgnx-bac-gm-teva-baba-mfgp-cm854375,The NASDAQ 100 Pre Market Indicator is up 1 59 to 5 983 51 The total Pre Market volume is currently 2 054 180 shares traded The following are the most active stocks for the pre market session Endocyte Inc ECYT is 2 27 at 5 90 with 4 111 676 shares traded
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-10-02 20:13:00 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-201300488.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / October 2, 2017 / Khang & Khang LLP (the ""Firm"") announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ..."
TEVA,TEVA:US,BBG000C0CD58,6 Reasons I've Been Aggressively Buying Teva Pharmaceutical Industries,2017-10-02 14:49:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/phDl8FosW6I/6-reasons-ive-been-aggressively-buying-teva-pharmaceutical-industries-cm853846,Israeli based Teva Pharmaceutical Industries NYSE TEVA has had quite a run of bad luck Like really really bad luck Its share price has been cut by roughly three quarters in less than two years as a confluence of factors have weighed on its core businesses and made its
TEVA,TEVA:US,BBG000C0CD58,"TEVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-10-02 14:42:00 +0000,https://finance.yahoo.com/news/teva-shareholder-alert-law-offices-144200144.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 2, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania ..."
TEVA,TEVA:US,BBG000C0CD58,6 Reasons I&apos;ve Been Aggressively Buying Teva Pharmaceutical Industries,2017-10-02 13:33:00 +0000,http://finance.yahoo.com/r/c7da0601-dde3-3da4-a021-b6b71e83d2de/6-reasons-ive-been-aggressively-buying-teva-pharma.aspx?yptr=yahoo&.tsrc=rss,"Aside from being exceptionally cheap relative to its peers, Teva has five other catalysts working in its favor that Wall Street may be overlooking."
TEVA,TEVA:US,BBG000C0CD58,UPCOMING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-09-30 03:36:00 +0000,https://finance.yahoo.com/news/upcoming-deadline-lundin-law-pc-033600576.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 29, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses In Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited",2017-09-30 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-former-025000151.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 23, 2017 to file lead plaintiff applications in a securities class action lawsuit against Teva Pharmaceutical Industries Limited , if they purchased the Company’s American Depository Shares and/or shares on the Tel Aviv Stock Exchange between November 15, ..."
TEVA,TEVA:US,BBG000C0CD58,How Does Investing In Teva Pharmaceutical Industries Limited (TEVA) Impact Your Portfolio?,2017-09-29 12:22:09 +0000,https://finance.yahoo.com/news/does-investing-teva-pharmaceutical-industries-122209106.html?.tsrc=rss,"For Teva Pharmaceutical Industries Limited’s (NYSE:TEVA) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. TEVA isRead More..."
TEVA,TEVA:US,BBG000C0CD58,"Noteworthy ETF Inflows: IEFA, NXPI, TEVA, CHKP",2017-09-28 16:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zuExHOJg_Hk/noteworthy-etf-inflows-iefa-nxpi-teva-chkp-cm852614,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 456 1 million dollar inflow that s a 1 3 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-09-28 16:10:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-161000654.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 28, 2017 :  ERIC, ZYNE, RAD, BBRY, DXCM, EXA, ITCI, DB, SAN, TEVA, NKE, BAC",2017-09-28 12:59:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TwQSVmhYr9M/pre-market-most-active-for-sep-28-2017-eric-zyne-rad-bbry-dxcm-exa-itci-db-san-teva-nke-bac-cm852369,The NASDAQ 100 Pre Market Indicator is down 5 16 to 5 932 63 The total Pre Market volume is currently 8 345 631 shares traded The following are the most active stocks for the pre market session Ericsson ERIC is unchanged at 5 66 with 1 856 837 shares traded
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-09-27 21:00:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-khang-khang-210000847.html?.tsrc=rss,"IRVINE, Calif., Sept. 27, 2017-- Khang & Khang LLP announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited. Investors who purchased or otherwise acquired shares from ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Runs Out Of Buyers After Changes In C-Suite,2017-09-27 18:37:08 +0000,https://finance.yahoo.com/news/teva-runs-buyers-changes-c-183708099.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ) shareholders have had an extremely volatile couple of months. After an August guidance and dividend cut sent the stock tumbling from a July high of ...
TEVA,TEVA:US,BBG000C0CD58,Big Pharma Is Getting Hit With a Huge Wave of Opioid Suits,2017-09-27 17:00:14 +0000,https://finance.yahoo.com/news/big-pharma-getting-hit-huge-170014394.html?.tsrc=rss,This could be the pharma&apos;s Big Tobacco moment.
TEVA,TEVA:US,BBG000C0CD58,Impax Generic Division Progresses Well Amid Pricing Pressure,2017-09-27 16:00:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RkXd46I3Q3M/impax-generic-division-progresses-well-amid-pricing-pressure-cm851892,On Sep 26 we issued an updated research report on Impax Laboratories Inc IPXL Impaxis a biopharmaceutical company focused on the development of obesity treatments and is based in Hayward CA Impax s anaphylaxis treatment epinephrine auto injector has shown notable growth in sales
TEVA,TEVA:US,BBG000C0CD58,Teva Reintroduces Generic Depo-Provera Injection in U.S.,2017-09-27 15:59:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XJ7OhFCSw-A/teva-reintroduces-generic-depo-provera-injection-in-us-cm851858,Teva Pharmaceutical Industries Ltd TEVA announced the reintroduction of the generic equivalent to Depo Prover Contraceptive Injection medroxyprogesterone acetate injectable suspension USP 150 mg mL in the United States indicated for the prevention of pregnancy With the reintroduction
TEVA,TEVA:US,BBG000C0CD58,"The Klein Law Firm Reminds Investors of Commencement of a Class Action Commenced on Behalf of Teva Pharmaceutical Industries Ltd. Shareholders and a Lead Plaintiff Deadline of October 23, 2017 (TEVA)",2017-09-27 14:21:59 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-142159952.html?.tsrc=rss,"NEW YORK, Sept. 27, 2017-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd. who purchased American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Reintroduces Generic Depo-Provera Injection in U.S.,2017-09-27 13:35:01 +0000,https://finance.yahoo.com/news/teva-reintroduces-generic-depo-provera-133501721.html?.tsrc=rss,Teva (TEVA) announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection 150 mg/mL in the United States.
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Interest Piles On,2017-09-27 13:00:13 +0000,https://finance.yahoo.com/news/major-pharma-short-interest-piles-130013970.html?.tsrc=rss,"The September 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased."
TEVA,TEVA:US,BBG000C0CD58,Here's How to Find the Best Dividend Stocks,2017-09-27 11:54:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ErSuyi3RBA0/heres-how-to-find-the-best-dividend-stocks-cm851505,Owning stocks that pay dividends can be an incredibly profitable part of your investing strategy but not every dividend stock is created equal If you want to find the best dividend stocks you need to look for ones that have this handful of key
TEVA,TEVA:US,BBG000C0CD58,Here&apos;s How to Find the Best Dividend Stocks,2017-09-27 10:02:00 +0000,http://finance.yahoo.com/r/a5b55012-8763-3845-bf3c-1890b9c9eab3/heres-how-to-find-the-best-dividend-stocks.aspx?yptr=yahoo&.tsrc=rss,Five key factors help the greatest dividend stocks stand out from all the rest.
TEVA,TEVA:US,BBG000C0CD58,"Allergan Authorizes New $2B Share Buyback Plan, Stock Up",2017-09-26 22:52:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DVSo_5KAkiE/allergan-authorizes-new-2b-share-buyback-plan-stock-up-cm851413,In an effort to reward shareholders the board of directors of Allergan plc AZN has sanctioned a new stock repurchase program thereby allowing the company to buy back shares worth up to 2 billion The company also reiterated its commitment to increase quarterly cash dividend annually
TEVA,TEVA:US,BBG000C0CD58,APPROACHING DEADLINE: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-09-26 22:05:47 +0000,https://finance.yahoo.com/news/approaching-deadline-lundin-law-pc-220547685.html?.tsrc=rss,"LOS ANGELES, Sept. 26, 2017-- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited regarding possible violations of federal securities ..."
TEVA,TEVA:US,BBG000C0CD58,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 19:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rAwfgjO4Ips/is-teva-pharmaceutical-teva-stock-worth-the-risk-cm851359,InvestorPlace Stock Market News Stock Advice amp Trading Tips Those who do not learn from history are doomed to repeat it That feels awfully applicable when talking about 160 Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA Source Open Grid
TEVA,TEVA:US,BBG000C0CD58,Is Teva Pharmaceutical (TEVA) Stock Worth the Risk?,2017-09-26 15:25:20 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-teva-stock-worth-152520894.html?.tsrc=rss,"This highly levered, acquisition-focused growth story has come crashing down recently.  It is eerily similar to when the highly-levered, acquisition-focused growth story of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) fell apart not too long ago.  As we all know, VRX stock went bust and hasn’t recovered."
TEVA,TEVA:US,BBG000C0CD58,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-09-26 15:07:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-150700586.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 26, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,Caveat Emptor When Buying High-Yield Drug Stocks,2017-09-26 13:54:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L2o7W8NSZUI/caveat-emptor-when-buying-high-yield-drug-stocks-cm850892,Income investors seemingly have hundreds of stocks to choose from that currently pay a dividend The telecom and utility sectors often generate some of the most robust payouts for investors with FactSet Research data from the third quarter of 2016 showing that sector aggregate yield
TEVA,TEVA:US,BBG000C0CD58,The Creative Ways Drugmakers Are Delaying Generics,2017-09-26 13:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xhR22eTo6Bs/the-creative-ways-drugmakers-are-delaying-generics-cm850856,Drugmakers are increasingly embracing new tactics to protect billions of dollars in sales from generic competition These strategies often involve patent trials but that s not the only way companies are waylaying generic drugmakers In this clip from The Motley Fool s
TEVA,TEVA:US,BBG000C0CD58,The Creative Ways Drugmakers Are Delaying Generics,2017-09-26 12:39:37 +0000,http://finance.yahoo.com/r/9c2daa8a-6530-38d5-b127-1110b5bb5169/the-creative-ways-drugmakers-are-delaying-generics.aspx?yptr=yahoo&.tsrc=rss,Biopharma companies are using court battles and reformulations to prevent generic-drug makers from capturing sales.
TEVA,TEVA:US,BBG000C0CD58,EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-25 19:57:00 +0000,https://finance.yahoo.com/news/equity-alert-khang-khang-llp-195700187.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 25, 2017 / Khang & Khang LLP (the ''Firm'') announces a securities class action lawsuit against Teva Pharmaceutical Industries Limited (''Teva'' or the ''Company'') ..."
TEVA,TEVA:US,BBG000C0CD58,"INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited (NYSE: TEVA) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",2017-09-25 19:07:53 +0000,https://finance.yahoo.com/news/investor-alert-brower-piven-encourages-190753741.html?.tsrc=rss,"STEVENSON, Md., Sept. 25, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Reintroduction of Generic Depo-Provera® in the United States,2017-09-25 18:29:00 +0000,https://finance.yahoo.com/news/teva-announces-reintroduction-generic-depo-182900717.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the reintroduction of the generic equivalent to Depo-Provera®1 Contraceptive Injection 150 mg/mL, in the United States."
TEVA,TEVA:US,BBG000C0CD58,"TEVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-09-25 15:19:51 +0000,https://finance.yahoo.com/news/teva-investor-alert-law-offices-151951195.html?.tsrc=rss,"NEW YORK, Sept. 25, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf ..."
TEVA,TEVA:US,BBG000C0CD58,3 Top Stocks on Sale This Fall,2017-09-25 12:49:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9lvwpI5Rfh4/3-top-stocks-on-sale-this-fall-cm850235,Cue the pumpkin spiced everything because fall is officially here Along with the coming of fall we ve also witnessed a pretty steady stream of new highs for the stock market with all three indexes recently notching all time record closes Nonetheless we head into fall with a number
TEVA,TEVA:US,BBG000C0CD58,3 Top Stocks on Sale This Fall,2017-09-25 11:34:00 +0000,http://finance.yahoo.com/r/809c4c5c-2eb4-3436-96d7-d32cfcb725ef/3-top-stocks-on-sale-this-fall.aspx?yptr=yahoo&.tsrc=rss,"Long-term investors take note, because bargains abound."
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - (TEVA)",2017-09-23 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-claimsfiler-025000444.html?.tsrc=rss,"NEW ORLEANS , Sept. 22, 2017 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 23, 2017 to file lead plaintiff applications in a securities ..."
TEVA,TEVA:US,BBG000C0CD58,Generic Drug Makers Face Pricing Issues That Other Pharmas Don&apos;t,2017-09-22 17:25:18 +0000,http://finance.yahoo.com/r/e8943a6d-0fb4-3cd7-b343-b04496d4bf70/generic-drug-makers-face-pricing-issues-unlike-other-pharma-companies?src=A00220&yptr=yahoo&.tsrc=rss,"Everyone knows high prescription drug prices are a problem, but except for pharma stockholders, few people may realize that price cuts are rippling through the generic side of the industry."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : August 29th, 2017 (record date) : By the numbers : September 21, 2017",2017-09-21 20:18:27 +0000,http://finance.yahoo.com/r/94457cdb-3d68-3f51-9cb6-b728aeb4d729/teva-pharmaceutical-industries-ltd-teva-us-dividend-analysis-august-29th-2017-record-date-by-the-numbers-september-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Our analysis is based on comparing Teva Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Sanofi Sponsored ADR, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Takeda Pharmaceutical Co. Ltd. Sponsored ADR and ... Read more
<b>(Read more...)</b>"
TEVA,TEVA:US,BBG000C0CD58,EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-09-21 17:44:00 +0000,https://finance.yahoo.com/news/equity-alert-lundin-law-pc-174400381.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 21, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceutical Industries Ltd. Investors and Encourages Investors to Contact the Firm (TEVA),2017-09-21 17:30:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-announces-filing-173000618.html?.tsrc=rss,"Glancy Prongay & Murray LLP  announces that a class action lawsuit has been filed on behalf of investors who purchased Teva Pharmaceutical Industries Ltd. securities between November 15, 2016 and August 2, 2017, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,"Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 23rd Lead Plaintiff Deadline in Class Action Against Teva Pharmaceutical Industries Ltd. (TEVA)",2017-09-21 15:20:00 +0000,https://finance.yahoo.com/news/scott-scott-attorneys-law-llp-152000476.html?.tsrc=rss,"NEW YORK , Sept. 21, 2017 /PRNewswire/ -- Scott+Scott, Attorneys at Law, LLP (""Scott+Scott""), a national shareholder and consumer rights litigation firm, reminds investors that October 23rd is ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Pharmaceutical Stock Could Double,2017-09-21 11:37:00 +0000,http://finance.yahoo.com/r/947894e4-f696-3b4e-8d54-b7ee35174d57/teva-pharmaceutical-stock-could-double-1505993839?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries’ business has undergone significant turmoil over the past two years, as its stock price clearly indicates.  Teva (TEVA) was originally founded in 1901 as a wholesale drug distributor in modern-day Israel.  By 2015, Teva was the world’s largest generic pharmaceutical manufacturer."
TEVA,TEVA:US,BBG000C0CD58,Our 5 Top Picks For A Booming Marijuana Market,2017-09-20 23:30:00 +0000,https://finance.yahoo.com/news/5-top-picks-booming-marijuana-233000408.html?.tsrc=rss,"The marijuana market is growing fast in North-America and while legal cannabis is still in its infancy, the potential for growth is mouthwatering"
TEVA,TEVA:US,BBG000C0CD58,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Teva Pharmaceutical Industries Ltd. To Contact The Firm",2017-09-20 21:30:00 +0000,https://finance.yahoo.com/news/lead-plaintiff-deadline-alert-faruqi-213000835.html?.tsrc=rss,"NEW YORK, Sept. 20, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teva Pharmaceutical Industries Ltd. (""Teva"" or the ""Company"") (TEVA) of the October 23, 2017 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.  If you invested in Teva American Depositary Shares (""ADSs"") on the New York Stock Exchange (""NYSE"") between November 15, 2016 and August 2, 2017 and would like to discuss your legal rights, click here: www.faruqilaw.com/TEVA.  There is no cost or obligation to you."
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-20 21:14:00 +0000,https://finance.yahoo.com/news/investor-alert-khang-khang-llp-211400793.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 20, 2017 / Khang & Khang LLP (the ""Firm"") announces the filing of a securities class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,Teva/Nuvelution to Speed Up Development of Austedo in US,2017-09-20 16:41:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8aYMDPKwaA/tevanuvelution-to-speed-up-development-of-austedo-in-us-cm848460,Teva Pharmaceutical Industries Ltd TEVA announced a partnership deal with Nuvelution Pharma Inc to accelerate development of Austedo deutetrabenazine tablets for the treatment of tics associated with Tourette syndrome TS in pediatric patients in the United States Per the
TEVA,TEVA:US,BBG000C0CD58,"Noteworthy ETF Inflows: IEFA, NXPI, CHKP, TEVA",2017-09-20 16:39:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/roedRaelMGM/noteworthy-etf-inflows-iefa-nxpi-chkp-teva-cm848459,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 538 1 million dollar inflow that s a 1 5 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 – TEVA",2017-09-20 15:56:14 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-155614607.html?.tsrc=rss,"NEW YORK, Sept. 20, 2017-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired American Depositary Shares of Teva Pharmaceutical ..."
TEVA,TEVA:US,BBG000C0CD58,Teva/Nuvelution to Speed Up Development of Austedo in US,2017-09-20 14:36:02 +0000,https://finance.yahoo.com/news/teva-nuvelution-speed-development-austedo-143602797.html?.tsrc=rss,Teva Pharma (TEVA) and Nuvelution inked a deal to accelerate the development of Austedo (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome.
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 20, 2017 :  NBRV, FWONK, BBBY, ALNY, CHU, RAD, DB, MU, WDC, TEVA, S, BBU",2017-09-20 12:55:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yWhqoW4N1iE/pre-market-most-active-for-sep-20-2017-nbrv-fwonk-bbby-alny-chu-rad-db-mu-wdc-teva-s-bbu-cm848219,The NASDAQ 100 Pre Market Indicator is down 4 19 to 5 986 89 The total Pre Market volume is currently 3 161 824 shares traded The following are the most active stocks for the pre market session Nabriva Therapeutics plc NBRV is 0 47 at 8 72 with 791 213 shares
TEVA,TEVA:US,BBG000C0CD58,[$$] States Push Ahead With Investigation Into Opioid Painkillers,2017-09-20 04:24:26 +0000,http://finance.yahoo.com/r/79f81d8a-6e69-3374-b5e2-9a873df2893e/states-push-ahead-with-investigation-into-opioid-painkillers-1505858722?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction have demanded fresh documents from drugmakers and distributors.
TEVA,TEVA:US,BBG000C0CD58,[$$] States Push Ahead With Investigation Into Opioid Painkillers,2017-09-19 22:05:26 +0000,http://finance.yahoo.com/r/79f81d8a-6e69-3374-b5e2-9a873df2893e/states-push-ahead-with-investigation-into-opioid-painkillers-1505858722?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,A bipartisan group of states investigating the opioid painkiller industry and the causes of widespread addiction have demanded fresh documents from drugmakers and distributors.
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-09-19 20:36:00 +0000,https://finance.yahoo.com/news/shareholder-alert-lundin-law-pc-203600348.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 19, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited (''Teva'' or ..."
TEVA,TEVA:US,BBG000C0CD58,State attorneys general subpoena opioid makers and dealer...,2017-09-19 16:22:00 +0000,https://finance.yahoo.com/video/state-attorneys-general-subpoena-opioid-162200859.html?.tsrc=rss,CNBC's Sue Herera reports on the companies state Attornies General are subpoenaing for the opioid investigation.
TEVA,TEVA:US,BBG000C0CD58,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-09-19 16:05:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-160500800.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 19, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Teva Pharmaceutical Industries Limited to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit",2017-09-19 15:39:00 +0000,https://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-153900260.html?.tsrc=rss,"The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Teva Pharmaceutical Industries Limited  American Depository Shares and/or shares on the Tel Aviv Stock Exchange between November 15, 2016 and August 2, 2017, inclusive ..."
TEVA,TEVA:US,BBG000C0CD58,A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd (TEVA) Stock,2017-09-19 15:37:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oDGiISfggvc/a-new-ceo-only-emboldens-the-case-for-teva-pharmaceutical-industries-ltd-teva-stock-cm847811,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock is off 160 more than 50 so far this year For most stocks that isn t the time to jump in but TEVA is not like most stocks Source Open Grid
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Teva Pharmaceutical Industries Ltd. Investors (TEVA),2017-09-19 14:30:00 +0000,https://finance.yahoo.com/news/investor-alert-law-offices-howard-143000237.html?.tsrc=rss,Law Offices of Howard G. Smith continues its investigation on behalf of Teva Pharmaceutical Industries Ltd. investors concerning the Company and its officers’ possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,Teva shares rise on debt covenant amendments,2017-09-19 14:06:12 +0000,http://finance.yahoo.com/r/40d4c336-cbd7-3ec1-8673-059b60fcc533/Story.aspx?guid=55504990-9D36-11E7-BD9C-A3E0D18A370A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The generic drugmaker said the changes will give it “greater flexibility.”
TEVA,TEVA:US,BBG000C0CD58,Teva and Nuvelution Pharma Partner to Accelerate Development of AUSTEDO® (deutetrabenazine) Tablets for Use in Tourette Syndrome in the United States,2017-09-19 14:00:00 +0000,https://finance.yahoo.com/news/teva-nuvelution-pharma-partner-accelerate-140000616.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. and Nuvelution Pharma, Inc. today announced their partnership to develop AUSTEDO® tablets for the treatment of tics associated with Tourette syndrome in pediatric patients in the United States."
TEVA,TEVA:US,BBG000C0CD58,Teva shares rise 2% on debt covenant amendments,2017-09-19 12:25:37 +0000,http://finance.yahoo.com/r/2a4fd79f-9451-3843-a58b-301035719914/Story.aspx?guid=C69FE89C-5925-49F1-B292-56B8AE3B7BB2&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. shares rose 2.3% in premarket trade Tuesday after the company announced it has made amendments to its U.S. dollar and Japanese yen term loan and revolving credit facilities, ..."
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Trending Tickers: Nutanix and Teva Pharmaceutical,2017-09-19 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000627.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 19, 2017 / U.S. markets reached record highs Monday as financial stocks rallied with the latest Federal Reserve meeting on the horizon. The Dow Jones Industrial Average ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Completes Amendment to Credit Facilities,2017-09-19 11:30:00 +0000,https://finance.yahoo.com/news/teva-completes-amendment-credit-facilities-113000156.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced amendments to its USD and JPY term loan and revolving credit facilities, providing Teva greater flexibility in its financial leverage ratio covenants."
TEVA,TEVA:US,BBG000C0CD58,A New CEO Only Emboldens the Case for Teva Pharmaceutical Industries Ltd (TEVA) Stock,2017-09-19 11:00:29 +0000,https://finance.yahoo.com/news/ceo-only-emboldens-case-teva-110029733.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock is off more than 50% so far this year.  This is one of the leading generic drug producers in the world.  Unfortunately, U.S. courts changed the dynamic by allowing more generics competition sooner than TEVA counted on."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Sells Slate of Women’s Health Products in Debt-Reducing Moves,2017-09-19 04:51:47 +0000,http://finance.yahoo.com/r/b43e1926-2c46-370a-8b01-dafabee7ead7/teva-sells-slate-of-womens-health-products-in-debt-reducing-moves-1505744912?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. will sell the remaining assets in its specialty global women’s health business for $1.38 billion, the company’s latest move to grapple with high debt."
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, Pier 1 Imports, and Kinross Gold Slumped Today",2017-09-18 21:36:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cab50FNofUs/why-teva-pharmaceutical-industries-pier-1-imports-and-kinross-gold-slumped-today-cm847394,Monday was an overall positive day for the stock market through major benchmarks saw different reactions to events during the trading session The Dow Jones Industrials posted solid gains to set another record but moves for broader market benchmarks weren t quite as
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, Pier 1 Imports, and Kinross Gold Slumped Today",2017-09-18 20:30:00 +0000,http://finance.yahoo.com/r/5d033323-0486-3e28-bd00-330796c54649/why-teva-pharmaceutical-industries-pier-1-imports.aspx?yptr=yahoo&.tsrc=rss,"Despite good gains from some market benchmarks, these stocks dropped. Find out why."
TEVA,TEVA:US,BBG000C0CD58,S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed,2017-09-18 20:07:00 +0000,http://finance.yahoo.com/r/61998881-7430-37fc-9b82-03767afac5c4/s-p-500-and-dow-score-records-with-wall-street-upbeat-ahead-of-fed.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The S&P 500 and Dow score new records. Here's where stocks settled on Monday.
TEVA,TEVA:US,BBG000C0CD58,S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed,2017-09-18 18:37:00 +0000,http://finance.yahoo.com/r/5c8ff856-9612-32f4-809f-aa4b5a86eedd/sp500-record-fed-meeting.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks aim for new records. Here's where stocks are trading at the session midway mark on Monday.
TEVA,TEVA:US,BBG000C0CD58,$1.38 billion payday: Teva signs 2 deals for remaining women's health assets,2017-09-18 17:50:11 +0000,http://finance.yahoo.com/r/cf9d7d22-cd70-3ba2-8480-09bd3a021bd2/pharma-teva-sells-ovaleap-zoely-planb-seasonique.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. said Monday it has entered into two agreements to sell the remaining assets of its specialty global women’s health business for $1.38 billion.  In one deal, CVC Capital Partners Fund VI will acquire a portfolio of products within Teva's global women’s health business across contraception, fertility, menopause and osteoporosis for $703 million in cash.  The portfolio of products, which is marketed and sold outside of the U.S., includes the fertility treatment Ovaleap, the oral contraceptives Zoely and Seasonique, and the osteoporisis drug Actonel."
TEVA,TEVA:US,BBG000C0CD58,Teva: When Bold Action Just Isn't Possible,2017-09-18 17:04:00 +0000,http://finance.yahoo.com/r/5d0a251d-f398-3117-9f4f-8732e58847d0/teva-when-bold-action-just-isnt-possible-1505754241?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When bad things happen to a company, it's easy to fall back clichés like ""bold action is necessary"" when talking about solutions.  Teva, of course, has a plethora of issues ranging from its massive debt load, pressures on generics, and a generic Copaxone perhaps coming to market from Mylan (MYL) or another company.  It did solve its leadership issue by finally getting around to filling its vacant CEO slot, but RBC's Randall Stanicky and Ashley Ryu contend that there are ""few bold or aggressive strategic outs"" for Teva."
TEVA,TEVA:US,BBG000C0CD58,Why Allergan Could Be A $300 Stock,2017-09-18 16:37:00 +0000,http://finance.yahoo.com/r/6d88979d-42fa-3467-845b-4b3058505b60/why-allergan-could-be-a-300-stock-1505752669?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Allergan (AGN) are rising today after J.P. Morgan analyst Chris Schott said the drug maker’s stock could climb more than 30% in the next year.  Allergan’s share price has fallen more than 12% since it hit a 52-week high of $256.80 in late July.  Overall, we believe several controversies (most notably the timing of generic Restasis competition) have taken focus away from a highly attractive core franchise at Allergan and as we look out to 2018, we see an increasingly compelling setup for AGN shares with both pipeline optionality and a strong SOTP valuation argument."
TEVA,TEVA:US,BBG000C0CD58,[$$] CVC Buys $703 Million Women's Drug Portfolio from Teva,2017-09-18 16:29:18 +0000,http://finance.yahoo.com/r/16771c06-2e49-375b-911b-25161327b346/cvc-buys-703-million-womens-drug-portfolio-from-teva-1505752156?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,The deal was struck from CVC’s sixth fund.
TEVA,TEVA:US,BBG000C0CD58,"TEVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-09-18 15:32:00 +0000,https://finance.yahoo.com/news/teva-shareholder-alert-law-offices-153200379.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 18, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of ..."
TEVA,TEVA:US,BBG000C0CD58,New Initiative Creates Scalable Solutions to Improve Care of Patients with Multiple Chronic Conditions,2017-09-18 15:30:00 +0000,https://finance.yahoo.com/news/initiative-creates-scalable-solutions-improve-153000702.html?.tsrc=rss,"Today, two leading private sector groups announced a partnership to create scalable solutions to improve patient and health system care for Multiple Chronic Conditions."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Sells Slate of Women's Health Products,2017-09-18 14:38:21 +0000,http://finance.yahoo.com/r/b43e1926-2c46-370a-8b01-dafabee7ead7/teva-sells-slate-of-womens-health-products-in-debt-reducing-moves-1505744912?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. will sell the remaining assets in its specialty global women’s health business for $1.38 billion, the company’s latest move to grapple with high debt."
TEVA,TEVA:US,BBG000C0CD58,Valeant Pharmaceuticals: Is A New Drug Approval On The Horizon?,2017-09-18 14:33:00 +0000,http://finance.yahoo.com/r/a9b50ab9-fec9-381e-9ea0-d0b89cb98683/valeant-pharmaceuticals-is-a-new-drug-approval-on-the-horizon-1505745193?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"H.C. Wainwright’s Raghuram Selvaraju predicts that Valeant Pharmaceuticals (VRX) could receive FDA approval this week for its experimental glaucoma drug Vyzulta.  For those who are not familiar with the situation, in July 2016, Valeant announced that it had received a complete response letter from the FDA regarding Vyzulta.  The letter highlighted concerns about Bausch & Lomb’s manufacturing facility in Tampa."
TEVA,TEVA:US,BBG000C0CD58,Dow and S&P 500 Reach New Intraday Highs With Markets in Good Mood Ahead of Fed,2017-09-18 14:17:00 +0000,http://finance.yahoo.com/r/cae05db6-81e9-31bd-8e31-d06a9dd2f0a6/dow-and-s-p-500-trade-above-record-closes-in-fed-decision-week.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks aim for new records. Here's where stocks are trading at the market open on Monday.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma to sell more women's health assets for $1.38 bln,2017-09-18 12:57:39 +0000,https://finance.yahoo.com/news/teva-pharma-sell-more-womens-125739871.html?.tsrc=rss,"Teva Pharmaceutical Industries  Ltd  said on Monday it would sell the  remaining assets in its specialty women's health business for  $1.38 billion in two separate transactions.  Israel-based Teva will use proceeds from these sales, along  with those from its recently announced sale of contraceptive  brand Paragard, to repay debt, the company said.  CVC Capital Partners Fund VI will pay $703 million in cash  for a portfolio in Teva's global women’s health business  including contraception, fertility, menopause and osteoporosis  products, Teva said."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 18, 2017 :  RAD, NOK, NBRV, OA, TEVA, ALR, NVDA, SKM, TVIX, QQQ, USLV, AAPL",2017-09-18 12:55:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/409RG-W8lhQ/pre-market-most-active-for-sep-18-2017-rad-nok-nbrv-oa-teva-alr-nvda-skm-tvix-qqq-uslv-aapl-cm846929,The NASDAQ 100 Pre Market Indicator is up 11 24 to 5 999 24 The total Pre Market volume is currently 5 356 971 shares traded The following are the most active stocks for the pre market session Rite Aid Corporation RAD is 0 1 at 2 73 with 1 304 445 shares traded RAD
TEVA,TEVA:US,BBG000C0CD58,Teva sells its remaining women's health assets for $1.4 billion,2017-09-18 12:18:36 +0000,http://finance.yahoo.com/r/43e737df-20d9-33a1-9f97-5ef40ac4e919/Story.aspx?guid=4A963AED-AC13-4D8E-B936-DFA1973847A0&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. said Monday it has agreed to sell its specialty global women's health business assets for $1.38 billion. The drug maker plans to use the proceeds of the sale, combined ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Sale of Remaining Assets in Specialty Global Women’s Health Portfolio for $1.38 Billion,2017-09-18 12:07:00 +0000,https://finance.yahoo.com/news/teva-announces-sale-remaining-assets-120700090.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced it has entered into two agreements to sell the remaining assets of its specialty global women’s health business for $1.38 billion."
TEVA,TEVA:US,BBG000C0CD58,Teva To Sell Remaining Assets In Specialty Global Women's Health For $1.38 Bln,2017-09-18 08:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yi9V3U-2mbA/teva-to-sell-remaining-assets-in-specialty-global-womens-health-for-138-bln-20170918-00543,Teva To Sell Remaining Assets In Specialty Global Women's Health For $1.38 Bln
TEVA,TEVA:US,BBG000C0CD58,"Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?",2017-09-16 16:35:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u53HUED6s14/halozyme-inovalon-and-teva-soared-this-week-can-they-go-higher-cm846722,Many healthcare stocks muddled along over the past week That wasn t the case though for three stocks of companies operating in very different parts of the healthcare spectrum Shares of Halozyme Therapeutics NASDAQ HALO Inovalon Holdings NASDAQ INOV and
TEVA,TEVA:US,BBG000C0CD58,"Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?",2017-09-16 14:47:00 +0000,http://finance.yahoo.com/r/1d856052-bb96-3c0c-98c3-8d02fbb0dc0c/halozyme-inovalon-and-teva-soared-this-week-can-th.aspx?yptr=yahoo&.tsrc=rss,Prospects for two of this week&apos;s big healthcare winners look great. But it&apos;s a different story for one of them.
TEVA,TEVA:US,BBG000C0CD58,Teva's New CEO Brings This Secret Weapon,2017-09-16 11:00:00 +0000,http://finance.yahoo.com/r/ea474d91-9ba2-3681-9b5c-5a30eda9757b/teva-s-new-ceo-brings-his-past-turnaround-experience.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Israel-based drugmaker on Monday tapped Kare Schultz as its new CEO. Schultz, who hails from Denmark-based Lundbeck, succeeds Dr. Yitzhak Peterburg, who has served as interim CEO since February."
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-16 03:24:00 +0000,https://finance.yahoo.com/news/shareholder-alert-khang-khang-llp-032400703.html?.tsrc=rss,"IRVINE, CA / ACCESSWIRE / September 15, 2017 / Khang & Khang LLP (the ""Firm"") announces the filing of a securities class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited (TEVA)",2017-09-16 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-former-025000982.html?.tsrc=rss,"NEW ORLEANS , Sept. 15, 2017 /PRNewswire/ -- Kahn Swick & Foti, LLC (""KSF"") and KSF partner, the former Attorney General of Louisiana , Charles C. Foti, Jr. , remind investors that they have ..."
TEVA,TEVA:US,BBG000C0CD58,"INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA",2017-09-15 15:24:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-152400898.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 15, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,Behind TEVA’s Women’s Health Products after 1H17,2017-09-15 14:37:13 +0000,http://finance.yahoo.com/r/aedfaca3-8171-3730-9855-59dd067b0fa1/behind-tevas-womens-health-products-after-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Teva Pharmaceutical's (TEVA) women’s health business reported revenues of ~$239 million, or ~5% higher YoY (year-over-year)."
TEVA,TEVA:US,BBG000C0CD58,Why New Generic Products Could Boost TEVA’s Revenue Growth,2017-09-15 13:07:33 +0000,http://finance.yahoo.com/r/c8276737-a1db-317d-b140-72f5ce069f9c/why-new-generic-products-could-boost-tevas-revenue-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, Teva Pharmaceutical (TEVA) launched the generic version of Eli Lilly’s (LLY) Axiron."
TEVA,TEVA:US,BBG000C0CD58,The Latest on TEVA’s Oncology Business,2017-09-15 11:36:18 +0000,http://finance.yahoo.com/r/7655bd45-6359-3f2f-9cef-1b43c1bd45a8/the-latest-on-tevas-oncology-business?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Teva Pharmaceutical's (TEVA) oncology business generated revenues of ~$550 million, or ~9% lower YoY (year-over-year)."
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO",2017-09-15 10:52:10 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-achillion-slumps-105210457.html?.tsrc=rss,Key highlights this week include Teva&apos;s (TEVA) CEO announcement and the FDA approval of the first cancer biosimilar.
TEVA,TEVA:US,BBG000C0CD58,Indivior Unit Files Lawsuits In U.S. To Protect SUBOXONE Film Patent,2017-09-15 02:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7gUbQ94f5Pc/indivior-unit-files-lawsuits-in-us-to-protect-suboxone-film-patent-20170915-00060,Indivior Unit Files Lawsuits In U.S. To Protect SUBOXONE Film Patent
TEVA,TEVA:US,BBG000C0CD58,Go Long Teva Pharmaceuticals Industries Ltd (ADR) (TEVA) Stock With Less Speculation,2017-09-14 20:38:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vEP_rBjWA80/go-long-teva-pharmaceuticals-industries-ltd-adr-teva-stock-with-less-speculation-cm845988,InvestorPlace Stock Market News Stock Advice amp Trading Tips A long term pain prescription looks to finally be filled both on and off the chart for Teva Pharmaceuticals Industries Ltd ADR NYSE TEVA But for investors who are interested in
TEVA,TEVA:US,BBG000C0CD58,Company under fire for opioid marketing files patent suit,2017-09-14 17:55:26 +0000,https://finance.yahoo.com/news/company-under-fire-opioid-marketing-175526540.html?.tsrc=rss,An Arizona-based pharmaceutical company targeted in lawsuits and criminal investigations over its marketing of a highly addictive painkiller has filed a related patent-infringement lawsuit against a rival ...
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm,2017-09-14 17:19:00 +0000,https://finance.yahoo.com/news/investor-alert-lundin-law-pc-171900507.html?.tsrc=rss,"LOS ANGELES, CA / ACCESSWIRE / September 14, 2017 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,Is It Too Late To Buy Teva Pharmaceutical Industries Limited (TEVA)?,2017-09-14 16:13:10 +0000,https://finance.yahoo.com/news/too-buy-teva-pharmaceutical-industries-161310161.html?.tsrc=rss,Let’s talk about the popular Teva Pharmaceutical Industries Limited (NYSE:TEVA). The company’s shares See our latest analysis for TEVA Is TEVA still cheap? Great news for investors – TEVA isRead More...
TEVA,TEVA:US,BBG000C0CD58,Go Long Teva Pharmaceuticals Industries Ltd (ADR) (TEVA) Stock With Less Speculation,2017-09-14 16:08:19 +0000,https://finance.yahoo.com/news/long-teva-pharmaceuticals-industries-ltd-160819789.html?.tsrc=rss,A long-term pain prescription looks to finally be filled both on and off the chart for Teva Pharmaceuticals Industries Ltd (ADR) (NYSE:TEVA).  It has been a busy week in TEVA stock.  It’s also finally one where bullish investors have been offered some promising developments after a couple punishing years marked by scandal and poor business decisions pummeled shares to 15-year lows this past month.
TEVA,TEVA:US,BBG000C0CD58,"The Klein Law Firm Reminds Investors of a Class Action Commenced on Behalf of Teva Pharmaceutical Industries Ltd. Shareholders and a Lead Plaintiff Deadline of October 23, 2017",2017-09-14 15:57:00 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-155700689.html?.tsrc=rss,"The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd. who purchased American Depositary Shares between November 15, 2016 and August 2, 2017."
TEVA,TEVA:US,BBG000C0CD58,Analysts Forecast 10% Upside For PPH,2017-09-14 14:41:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rlcJRUpqdFE/analysts-forecast-10-upside-for-pph-cm845600,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
TEVA,TEVA:US,BBG000C0CD58,How TEVA’s Respiratory Franchise Is Positioned after 1H17,2017-09-14 14:37:30 +0000,http://finance.yahoo.com/r/10f69519-fbf6-3f68-bfe5-322c65826d44/how-tevas-respiratory-franchise-is-positioned-after-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Teva Pharmaceutical's (TEVA) respiratory franchise reported revenues of ~$626 million, or ~8% lower YoY (year-over-year)."
TEVA,TEVA:US,BBG000C0CD58,How TEVA’s CNS Drugs Performed in 1H17,2017-09-14 13:07:39 +0000,http://finance.yahoo.com/r/5bf27bf2-7ad8-384f-9028-2d88add0c602/how-tevas-cns-drugs-performed-in-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Teva Pharmaceutical's (TEVA) CNS (central nervous system) business generated revenues of ~$2.3 billion, or ~16% lower YoY (year-over-year)."
TEVA,TEVA:US,BBG000C0CD58,Teva to Present Data for AUSTEDO® (deutetrabenazine) Tablets and Other Research at the 2017 Psych Congress,2017-09-14 12:00:00 +0000,https://finance.yahoo.com/news/teva-present-data-austedo-deutetrabenazine-120000996.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today announced the presentation of 12 posters at the upcoming 2017 Psych Congress, September 16-19 in New Orleans, Louisiana."
TEVA,TEVA:US,BBG000C0CD58,TEVA Depends on This for Revenue Growth,2017-09-14 11:39:36 +0000,http://finance.yahoo.com/r/f3ba13bc-81fd-31ce-8ea5-7b8e53f93cf6/teva-depends-on-this-for-revenue-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Teva Pharmaceutical's (TEVA) Copaxone reported revenues of ~$2.1 billion, or ~7% lower YoY (year-over-year)."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-13 20:42:15 +0000,https://finance.yahoo.com/news/important-equity-alert-khang-khang-204215249.html?.tsrc=rss,"IRVINE, Calif., Sept. 13, 2017-- Khang & Khang LLP announces the filing of a securities class action lawsuit against Teva Pharmaceutical Industries Limited. Investors who purchased or otherwise acquired ..."
TEVA,TEVA:US,BBG000C0CD58,Teva to sell women's health assets to CVC Capital Partners - Report,2017-09-13 20:32:38 +0000,https://finance.yahoo.com/news/teva-sell-womens-health-assets-203238550.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd  is close to a deal to sell its women's health  assets outside the United States to private equity firm CVC  Capital Partners, the Fly reported, citing Bloomberg.  The assets could be valued at about $800 million, according  to the Bloomberg report.  Israel-based Teva, the world's largest maker of generic  drugs, has been looking at divestures to help pare its $35  billion debt pile."
TEVA,TEVA:US,BBG000C0CD58,CVC Nears Deal for Teva’s European Women's Health Assets,2017-09-13 18:07:04 +0000,http://finance.yahoo.com/r/468bf148-2391-3c3e-85fb-e3820e9242a7/cvc-is-said-near-deal-for-teva-s-european-women-s-health-assets?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Buyout firm CVC Capital Partners is nearing an agreement to buy Teva Pharmaceutical Industries Ltd.’s women’s health assets outside the U.S., according to people familiar with the matter."
TEVA,TEVA:US,BBG000C0CD58,"TEVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-09-13 16:44:00 +0000,https://finance.yahoo.com/news/teva-investor-alert-law-offices-164400908.html?.tsrc=rss,The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased Teva Pharmaceutical Industries Ltd.
TEVA,TEVA:US,BBG000C0CD58,"Company News For Sep 13, 2017",2017-09-13 16:39:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OxxM4hh9K58/company-news-for-sep-13-2017-cm845175,Shares of Teva Pharmaceuticals Industries Ltd TEVA surged almost 7 after the company entered into an agreement with Cooper Cos COO to sell them its Pargard IUD product for 1 1 billion Western Digital Corp s WDC shares rose 1 6 after it agreed to purchase Toshiba s
TEVA,TEVA:US,BBG000C0CD58,Teva's Leukemia Drug sNDA Granted Priority Review by the FDA,2017-09-13 16:38:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FBf2MHWxRlA/tevas-leukemia-drug-snda-granted-priority-review-by-the-fda-cm845159,Teva Pharmaceutical Industries Ltd TEVA announced that the FDA has accepted the supplemental New Drug Application sNDA for Trisenox on a priority review basis The company is looking to expand the label of Trisenox to include its use in combination with all trans retinoic acid for
TEVA,TEVA:US,BBG000C0CD58,"IEFA, NXPI, CHKP, TEVA: Large Inflows Detected at ETF",2017-09-13 16:36:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mfh3AtoC-qE/iefa-nxpi-chkp-teva-large-inflows-detected-at-etf-cm845158,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 828 8 million dollar inflow that s a 2 4 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Teva&apos;s Leukemia Drug sNDA Granted Priority Review by the FDA,2017-09-13 14:51:02 +0000,https://finance.yahoo.com/news/teva-apos-leukemia-drug-snda-145102555.html?.tsrc=rss,Teva Pharmaceutical&apos;s (TEVA) sNDA for label expansion of Trisenox as first-line treatment of acute promyelocytic leukemia has been accepted by the FDA under priority review.
TEVA,TEVA:US,BBG000C0CD58,"Company News For Sep 13, 2017",2017-09-13 14:39:02 +0000,https://finance.yahoo.com/news/company-news-sep-13-2017-143902171.html?.tsrc=rss,"Companies in the news are: TEVA,WDC,AMZN,LMNR"
TEVA,TEVA:US,BBG000C0CD58,How TEVA’s Generic Medicines Franchise Is Positioned after 1H17,2017-09-13 14:37:47 +0000,http://finance.yahoo.com/r/769e6ae8-1cc0-3459-9460-25331e774c15/how-tevas-generic-medicines-franchise-is-positioned-after-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Teva Pharmaceutical's (TEVA) generic medicines business generated revenues of ~$6.1 billion, or ~22% higher YoY (year-over-year)."
TEVA,TEVA:US,BBG000C0CD58,"A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides",2017-09-13 13:14:40 +0000,https://finance.yahoo.com/news/look-tevas-paragard-iud-asset-131440865.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA ) said Tuesday it has agreed to sell its Paragard IUD product to Cooper Companies Inc (NYSE: COO ) in a $1.1 billion cash deal. Teva also confirmed ...
TEVA,TEVA:US,BBG000C0CD58,Inside Teva Pharmaceutical’s 1H17 Performance,2017-09-13 13:08:53 +0000,http://finance.yahoo.com/r/b89c740d-1de8-3173-ac7c-5e7cfcb5ad37/inside-teva-pharmaceuticals-1h17-performance?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Teva Pharmaceutical (TEVA) reported revenues of ~$21.9 billion, or ~11% higher on a YoY (year-over-year) basis."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 13, 2017 :  AGNC, WDAY, FOLD, MU, AAPL, TEVA, AZN, TVIX, SKM, BCRX, BAC, JWN",2017-09-13 12:54:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CDTq6EOPX_o/pre-market-most-active-for-sep-13-2017-agnc-wday-fold-mu-aapl-teva-azn-tvix-skm-bcrx-bac-jwn-cm844799,The NASDAQ 100 Pre Market Indicator is down 5 72 to 5 989 92 The total Pre Market volume is currently 6 359 847 shares traded The following are the most active stocks for the pre market session AGNC Investment Corp AGNC is 0 65 at 20 85 with 6 377 490 shares
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Interest Surges,2017-09-13 12:40:34 +0000,https://finance.yahoo.com/news/major-pharma-short-interest-surges-124034340.html?.tsrc=rss,"The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased."
TEVA,TEVA:US,BBG000C0CD58,Regeneron's Dupixent Takes Another Step Toward Blockbuster Status,2017-09-13 12:36:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Fn8nLbfBIk/regenerons-dupixent-takes-another-step-toward-blockbuster-status-cm844767,Regeneron Pharmaceuticals NASDAQ REGN unveiled phase 3 study data for its autoimmune disease drug Dupixent earlier this week that show it is effective in treating asthma The success has management planning to file for Dupixent s approval in asthma patients soon and that
TEVA,TEVA:US,BBG000C0CD58,3 PR Scandals Creating Intriguing Buying Opportunities,2017-09-13 12:36:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_LjvOK23180/3-pr-scandals-creating-intriguing-buying-opportunities-cm844765,If you re an investor arguably the last thing you want or expect to see from any of the companies you own is a scandal or public relations nightmare But let s face the facts It happens from time to time Usually when a company or its management team is alleged of wrongdoing
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical on the Street: Analysts’ Recommendations in September,2017-09-13 11:41:04 +0000,http://finance.yahoo.com/r/406f03bd-ce6c-3b92-a009-6e113ba53e7a/teva-pharmaceutical-on-the-street-analysts-recommendations-in-september?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, the FDA approved Teva Pharmaceutical's (TEVA) Austedo for the treatment of adult individuals with tardive dyskinesia."
TEVA,TEVA:US,BBG000C0CD58,3 PR Scandals Creating Intriguing Buying Opportunities,2017-09-13 11:23:00 +0000,http://finance.yahoo.com/r/ff0b2417-8624-3679-9577-f0275a576c5d/3-pr-scandals-creating-intriguing-buying-opportuni.aspx?yptr=yahoo&.tsrc=rss,"Despite dealing with cringe-worthy public relations flubs, recent weakness in these stocks could be your chance to buy in at a cheap price."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-12 22:15:37 +0000,https://finance.yahoo.com/news/important-equity-alert-lundin-law-221537767.html?.tsrc=rss,"LOS ANGELES, Sept. 12, 2017-- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited regarding possible violations of federal ..."
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Teva Pharmaceutical Industries Ltd. Investors (TEVA),2017-09-12 21:44:00 +0000,https://finance.yahoo.com/news/investor-alert-law-offices-howard-214400722.html?.tsrc=rss,Law Offices of Howard G. Smith announces an investigation on behalf of Teva Pharmaceutical Industries Ltd. investors concerning the Company and its officers’ possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,Teva's New CEO Brings No Relief: Generic Drugmakers to Dump,2017-09-12 21:37:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HktdhAhOZkw/tevas-new-ceo-brings-no-relief-generic-drugmakers-to-dump-cm844604,Teva Pharmaceutical Industries Limited TEVA on Monday announced that it has hired H Lundbeck s HLUYY chief Kåre Schultz as its new CEO The appointment ended Teva s more than six month long search for a permanent CEO after Erez Vigodman stepped down in February this year Israel based Teva
TEVA,TEVA:US,BBG000C0CD58,Teva&apos;s New CEO Brings No Relief: Generic Drugmakers to Dump,2017-09-12 19:33:07 +0000,https://finance.yahoo.com/news/teva-apos-ceo-brings-no-193307197.html?.tsrc=rss,"The New CEO appointment at Teva (TEVA has once again shifted focus to the Generic Drug industry, which is presently facing several challenges."
TEVA,TEVA:US,BBG000C0CD58,"Tuesday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Snap Inc (SNAP) and Tesla Inc (TSLA)",2017-09-12 18:35:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sO1x_yK1ooI/tuesdays-vital-data-teva-pharmaceutical-industries-ltd-adr-teva-snap-inc-snap-and-tesla-inc-tsla-cm844533,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading higher again this morning as the North Korea hurricane relief rally continues Technology will be in focus today as traders count down to the release of Apple Inc s
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharma showing strong gains, IQ100 up 22%",2017-09-12 17:11:00 +0000,https://finance.yahoo.com/video/teva-pharma-showing-strong-gains-171100840.html?.tsrc=rss,"The CNBC IQ100 index beating the broader market over one year up 22%. Among today's top gainers Teva Pharma, DowDupont, Micron, International Paper and Pfizer."
TEVA,TEVA:US,BBG000C0CD58,"Company News For Sep 12, 2017",2017-09-12 16:39:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t60zBhtaJgc/company-news-for-sep-12-2017-cm844435,Shares of Teva Pharmaceutical Industries Ltd TEVA surged 19 4 after the company announced Kare Schultz as its new chief executive officer Bristol Myers Squibb Co s BMY shares increased 0 2 after the company reported positive results from studies conducted on its
TEVA,TEVA:US,BBG000C0CD58,"GOVT, IDEV: Big ETF Inflows",2017-09-12 16:35:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdZrkKBE3aI/govt-idev-big-etf-inflows-cm844375,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares U S Treasury Bond ETF GOVT which added 2 400 000 units or a 1 2 increase week over week And on a percentage change basis the ETF with
TEVA,TEVA:US,BBG000C0CD58,"EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017",2017-09-12 16:34:00 +0000,https://finance.yahoo.com/news/equity-alert-levi-korsinsky-llp-163400545.html?.tsrc=rss,"The following statement is being issued by Levi & Korsinsky, LLP:"
TEVA,TEVA:US,BBG000C0CD58,$1.1B deal: Teva sells Paragard in 'important step' for stakeholders,2017-09-12 16:30:11 +0000,http://finance.yahoo.com/r/10ce6eae-a2b7-34b1-baf5-cf8c75c473af/teva-sells-paragard-birth-control-coopersurgical.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. entered into a definitive agreement to sell its Paragard contraceptive device to CooperSurgical for $1.1 billion.  Paragard, a product within Teva's global women’s health business, is a copper-releasing device that is placed in the uterus to prevent pregnancy for up to 10 years.  The deal with CooperSurgical of Trumbull, Conn., includes Teva’s manufacturing facility in Buffalo, N.Y., which produces the Paragard product exclusively."
TEVA,TEVA:US,BBG000C0CD58,Cooper Companies Buys Teva's PARAGARD Intrauterine Platform,2017-09-12 14:42:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HUq5xe3RJ-U/cooper-companies-buys-tevas-paragard-intrauterine-platform-cm844289,Cooper Companies Inc COO recently signed an asset purchase agreement to acquire the flagship contraception platform of Israel based Teva Pharmaceutical Industries TEVA PARAGARD Intrauterine Device This 1 1 billion cash transaction will bolster Cooper Companies CooperSurgical
TEVA,TEVA:US,BBG000C0CD58,"Company News For Sep 12, 2017",2017-09-12 14:17:02 +0000,https://finance.yahoo.com/news/company-news-sep-12-2017-141702659.html?.tsrc=rss,"Companies in the news are: TEVA,BMY,EFX,FB"
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Teva Pharmaceutical Industries Ltd. (TEVA) & Lead Plaintiff Deadline October 23, 2017",2017-09-12 14:17:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141700343.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 12, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,"With New CEO In Place, Focus For Teva Pharma Turns To 'Execution'",2017-09-12 14:11:04 +0000,https://finance.yahoo.com/news/ceo-place-focus-teva-pharma-141104816.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA )’s having a big week , and it’s only Tuesday. The drug manufacturer’s stock popped as much as 24 percent Monday after the board appointed Kåre Schultz ..."
TEVA,TEVA:US,BBG000C0CD58,"Tuesday’s Vital Data: Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Snap Inc (SNAP) and Tesla Inc (TSLA)",2017-09-12 14:04:03 +0000,https://finance.yahoo.com/news/tuesday-vital-data-teva-pharmaceutical-140403524.html?.tsrc=rss,"U.S. stock futures are trading higher again this morning, as the North Korea/hurricane relief rally continues.  Technology will be in focus today, as traders count down to the release of Apple Inc.’s (NASDAQ:AAPL) newest iPhone.  Options traders have been call-heavy on AAPL stock leading up to the event."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Has a Long Road Back,2017-09-12 13:56:00 +0000,http://finance.yahoo.com/r/227f749a-c97f-3af7-b993-03a31f4cb7b4/teva-pharmaceutical-has-long-road-back?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Damage on TEVA's charts is significant.
TEVA,TEVA:US,BBG000C0CD58,Wall Street Set to Open in Green Territory as Traders Assess Irma Impact,2017-09-12 13:55:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/djtDJpNUQGs/wall-street-set-to-open-in-green-territory-as-traders-assess-irma-impact-cm844236,U S stocks were set to open in green territory Tuesday on signs of relief that damages caused by Hurricane Irma will probably be less than what had been feared U S stocks were set to open in green territory Tuesday on signs of relief that damages caused by Hurricane Irma will probably be
TEVA,TEVA:US,BBG000C0CD58,"Stocks Open Higher; S&P 500 Aces New Record, DowDuPont Breaks Out",2017-09-12 13:39:33 +0000,http://finance.yahoo.com/r/45762cf8-e978-39f6-ac5d-07ade5398109/stock-futures-climb-as-dow-jones-fang-names-eye-buy-points?src=A00220&yptr=yahoo&.tsrc=rss,"Stocks pulsed higher at Tuesday&apos;s open, as investors awaited a new iPhone launch expected later this morning."
TEVA,TEVA:US,BBG000C0CD58,Valeant Pharmaceuticals Intl Inc (VRX) Stock Is STILL Too Ugly to Buy,2017-09-12 13:14:35 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-131435634.html?.tsrc=rss,"There’s no doubt that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has made some progress so far this year.  Bankruptcy risk seemed material for Valeant stock as recently as earlier this year.  Under CEO Joe Papa, however, VRX stock has at least has bought itself some time."
TEVA,TEVA:US,BBG000C0CD58,U.S. Futures Set for Higher Open as Traders Assess Irma Impact,2017-09-12 12:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XoccGzLgu6M/us-futures-set-for-higher-open-as-traders-assess-irma-impact-cm844167,U S stock futures moved higher Tuesday on signs of relief that damages caused by Hurricane Irma will probably be less than what had been feared U S stock futures moved higher Tuesday on signs of relief that damages caused by Hurricane Irma will probably be less than what had been feared
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 12, 2017 :  TEVA, AEG, SAGE, AAPL, TVIX, MT, NOK, AZN, CS, MRNS, ICPT, KWEB",2017-09-12 12:54:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gSYdKhZjtfw/pre-market-most-active-for-sep-12-2017-teva-aeg-sage-aapl-tvix-mt-nok-azn-cs-mrns-icpt-kweb-cm844183,The NASDAQ 100 Pre Market Indicator is up 18 28 to 5 998 81 The total Pre Market volume is currently 6 935 694 shares traded The following are the most active stocks for the pre market session Teva Pharmaceutical Industries Limited TEVA is 1 37 at 19 87 with 3 155
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Marinus Pharmaceuticals and Teva Pharmaceutical Industries,2017-09-12 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000721.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 12, 2017 / Marinus Pharmaceuticals and Teva both got a big boost in trading price yesterday for different reasons. Teva has finally found a new CEO and announced the ..."
TEVA,TEVA:US,BBG000C0CD58,Cooper Companies Buys Teva&apos;s PARAGARD Intrauterine Platform,2017-09-12 12:02:12 +0000,https://finance.yahoo.com/news/cooper-companies-buys-teva-apos-120212065.html?.tsrc=rss,Cooper Companies (COO) latest development is expected to fortify its foothold in the contraceptive device market. Margins are likely to improve within one year of the deal closure.
TEVA,TEVA:US,BBG000C0CD58,Teva Receives FDA Priority Review for First Line Use of TRISENOX® (arsenic trioxide) in Patients with Low to Intermediate Risk Acute Promyelocytic Leukemia (APL),2017-09-12 12:00:00 +0000,https://finance.yahoo.com/news/teva-receives-fda-priority-review-120000915.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. announced today the U.S. Food and Drug Administration has accepted for review the company’s supplemental New Drug Application for the use of TRISENOX®  injection in combination with all-trans retinoic acid for induction of remission and consolidation in patients with newly diagnosed low or intermediate risk acute promyelocytic leukemia whose APL is characterized ...
TEVA,TEVA:US,BBG000C0CD58,Featured Company News - Teva Pharmaceuticals Presents Outcome Measure Results from Phase-III Clinical Trials for the Potential of Fremanezumab to Treat Migraine Patients,2017-09-12 11:20:00 +0000,https://finance.yahoo.com/news/featured-company-news-teva-pharmaceuticals-112000059.html?.tsrc=rss,"Research Desk Line-up: MEI Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Teva ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Surges Once Again on $1.1 Billion Sale and New CEO,2017-09-12 09:43:00 +0000,http://finance.yahoo.com/r/6f165ac2-8463-3891-9635-5d38fcdca2f7/teva-surges-once-again-on-1-1-billion-sale-and-new-ceo.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Teva's New York-listed shares were up 7.63% in premarket trading, indicated to open at $19.90"
TEVA,TEVA:US,BBG000C0CD58,[$$] Now Comes the Hard Part at Teva,2017-09-12 04:41:15 +0000,http://finance.yahoo.com/r/1fcd523a-3370-373e-a05d-97bba79471f1/now-comes-the-hard-part-at-teva-1505153889?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Investors love Teva’s new CEO, but falling generic drug prices and high debt will weigh on shares."
TEVA,TEVA:US,BBG000C0CD58,Teva Appoints New Chief Executive After Months of Speculation,2017-09-12 04:41:08 +0000,http://finance.yahoo.com/r/329b265d-ca23-30e6-b266-9d5e3dc30e8c/teva-names-kare-schultz-as-new-chief-executive-1505115189?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries named Kare Schultz as its new chief executive, ending months of speculation over who will lead the Israeli drug company."
TEVA,TEVA:US,BBG000C0CD58,[$$] New Teva chief must tackle 'tough decisions' on jobs,2017-09-12 04:03:07 +0000,"http://finance.yahoo.com/r/d8a755db-93bd-3bef-8f7f-d43362f6a020/b109e198-973b-11e7-a652-cde3f882dd7b,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Teva's newly appointed chief executive should not avoid ""tough decisions"" such as domestic job cuts as he seeks to revive the flagging Israeli drugmaker, the company's chairman has said. The ..."
TEVA,TEVA:US,BBG000C0CD58,"Keep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted",2017-09-12 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2ukkrom-ueg/keep-close-watch-on-aldx-today-abbv-just-hit-another-high-fennec-uplisted-20170912-00079,"Keep Close Watch On ALDX Today, ABBV Just Hit Another High, Fennec Uplisted"
TEVA,TEVA:US,BBG000C0CD58,Teva to Sell ParaGard for $1.1 Billion to Reduce Debt,2017-09-12 01:55:58 +0000,http://finance.yahoo.com/r/989d3e9b-b599-3439-828e-a4eb92fc6448/teva-to-sell-paragard-for-1-1-billion-in-move-to-reduce-debt?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Teva Pharmaceutical Industries Ltd. agreed to sell its ParaGard intrauterine contraceptive device business to Cooper Cos. for $1.1 billion as the world’s largest maker of generic drugs works to reduce ...
TEVA,TEVA:US,BBG000C0CD58,Cooper Companies To Buy PARAGARD IUD From Teva For $1.1 Bln In Cash,2017-09-12 00:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WjQujTYvexc/cooper-companies-to-buy-paragard-iud-from-teva-for-11-bln-in-cash-20170912-00010,Cooper Companies To Buy PARAGARD IUD From Teva For $1.1 Bln In Cash
TEVA,TEVA:US,BBG000C0CD58,PRESS DIGEST- Financial Times - Sept 12,2017-09-11 23:27:21 +0000,https://finance.yahoo.com/news/press-digest-financial-times-sept-232721800.html?.tsrc=rss,The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines Teva sells Paragard contraceptive business for $1.1 bln ...
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, MercadoLibre, and XL Group Jumped Today",2017-09-11 22:36:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vj--Gn0_bbc/why-teva-pharmaceutical-industries-mercadolibre-and-xl-group-jumped-today-cm844020,The stock market soared on Monday with major benchmarks finishing higher by 1 or more following a weekend that featured somewhat less devastation than many had feared Hurricane Irma spent most of the weekend working its way toward and up the Florida coast but a change in its
TEVA,TEVA:US,BBG000C0CD58,Teva to sell contraceptive brand Paragard in $1.1 bln deal,2017-09-11 22:19:38 +0000,https://finance.yahoo.com/news/teva-sell-contraceptive-brand-paragard-221938592.html?.tsrc=rss,"Teva Pharmaceutical Industries  , on Monday agreed to sell its contraceptive  brand Paragard to a unit of Cooper Cos for $1.1 billion,  on a day the struggling Israeli drugmaker named industry veteran  Kare Schultz as CEO.  The sale of the business is the first step in the planned  divestment of non-core assets and the proceeds would be used to  repay term loan debt, Teva said.  Saddled with about $35 billion in debt, Teva has speeded up  plans to divest non-core assets, Reuters reported last month,  citing sources."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Soars on New CEO News,2017-09-11 21:35:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t7X6uLEr5lw/teva-pharmaceutical-industries-ltd-adr-teva-stock-soars-on-new-ceo-news-cm844014,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock was flying high today following news of a new CEO Source Open Grid Scheduler Modified Kare Schultz will be taking over the position of president
TEVA,TEVA:US,BBG000C0CD58,UPDATE 1-Teva to sell contraceptive brand Paragard in $1.1 bln deal,2017-09-11 21:34:48 +0000,https://finance.yahoo.com/news/teva-sell-contraceptive-brand-paragard-204954234.html?.tsrc=rss,"Teva Pharmaceutical Industries  , said it has agreed to sell Paragard, its  intrauterine copper contraceptive brand, to a unit of Cooper Cos  in a $1.1 billion cash deal.  The sale of the business is the first step in the planned  divestment of non-core assets and the proceeds would be used to  repay term loan debt, Teva said on Monday.  The deal with CooperSurgical includes the Isarel-based drug  maker's manufacturing facility in Buffalo, NY, which produces  Paragard exclusively."
TEVA,TEVA:US,BBG000C0CD58,Teva Rockets After Hiring Former Novo Nordisk Exec As CEO,2017-09-11 20:49:21 +0000,http://finance.yahoo.com/r/26f1c4c1-7d66-31d4-8851-4db902d96ac4/teva-rockets-after-hiring-former-novo-nordisk-exec-as-ceo?src=A00220&yptr=yahoo&.tsrc=rss,"Teva rocketed Monday after announcing a former Novo Nordisk executive will take the helm at Teva, just seven months after its last full-time CEO resigned."
TEVA,TEVA:US,BBG000C0CD58,[$$] Now Comes the Hard Part at Teva,2017-09-11 20:48:15 +0000,http://finance.yahoo.com/r/1fcd523a-3370-373e-a05d-97bba79471f1/now-comes-the-hard-part-at-teva-1505153889?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Investors love Teva’s new CEO, but falling generic drug prices and high debt will weigh on shares."
TEVA,TEVA:US,BBG000C0CD58,Cooper Cos. buys Teva IUD line for $1.1 billion,2017-09-11 20:31:12 +0000,http://finance.yahoo.com/r/489ec4b4-714a-3467-bff0-03a89f03aa9b/Story.aspx?guid=AB0EBBD2-94C5-437E-A93B-00D3B96B668A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Teva Pharmaceuticals Industries Ltd. said late Monday it is selling its Paragard IUD product to Cooper Cos. for $1.1 billion cash. Paraguard had sales of about $168 million for the 12 months ending June ...
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, MercadoLibre, and XL Group Jumped Today",2017-09-11 20:30:00 +0000,http://finance.yahoo.com/r/03ca2b3b-1b94-35cf-a8bb-b9b18f512b24/why-teva-pharmaceutical-industries-mercadolibre-an.aspx?yptr=yahoo&.tsrc=rss,These stocks helped lift the market higher. Find out why.
TEVA,TEVA:US,BBG000C0CD58,Teva’s stock rockets to biggest gain since 1984,2017-09-11 20:20:44 +0000,http://finance.yahoo.com/r/13fdbccf-e0b5-3280-bf1c-a51c1c75e439/Story.aspx?guid=B46EA5CC-971C-11E7-ABA1-F483FF5F3E4E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Teva’s stock soars to best one-day performance in 33 years as investors cheer the naming of its new CEO.
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Sale of PARAGARD® (intrauterine copper contraceptive) to CooperSurgical,2017-09-11 20:15:00 +0000,https://finance.yahoo.com/news/teva-announces-sale-paragard-intrauterine-201500290.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced it has entered into a definitive agreement under which CooperSurgical will acquire PARAGARD® , a product within its global Women’s Health business, in a $1.1 billion cash transaction."
TEVA,TEVA:US,BBG000C0CD58,The Cooper Companies Announces Definitive Agreement to Acquire PARAGARD® IUD From Teva,2017-09-11 20:15:00 +0000,https://finance.yahoo.com/news/cooper-companies-announces-definitive-agreement-201500008.html?.tsrc=rss,"PLEASANTON, Calif., Sept. 11, 2017-- The Cooper Companies, Inc. today announced it has entered into a definitive asset purchase agreement with Teva Pharmaceutical Industries Ltd. to acquire the global ..."
TEVA,TEVA:US,BBG000C0CD58,"Health Care Sector Update for 09/11/2017: TEVA,MRNS,PLSE",2017-09-11 20:14:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5LrgGEJL6x4/health-care-sector-update-for-09112017-tevamrnsplse-cm843975,Top Health Care StocksTop Health Care Stocks JNJ 1 63 JNJ 1 63 PFE 0 65 PFE 0 65 ABT 0 79 ABT 0 79 MRK 1 38 MRK 1 38 AMGN 3 12 AMGN 3 12 Health care stocks were trending higher with the NYSE Health Care Index gaining more than 0 8 while shares of health care companies in
TEVA,TEVA:US,BBG000C0CD58,"A Look At Kare Schultz, The New CEO In Charge Of Teva",2017-09-11 19:59:51 +0000,https://finance.yahoo.com/news/look-kare-schultz-ceo-charge-195951558.html?.tsrc=rss,"Kare Schultz, a veteran pharmaceutical executive with a background in restructuring, was a big hit with investors after the 56-year-old Dane was chosen as CEO of Teva Pharmaceutical Industries Ltd (ADR) ..."
TEVA,TEVA:US,BBG000C0CD58,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Alamos Gold Shares Slide,2017-09-11 19:44:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OyeWqQVTgUo/mid-afternoon-market-update-crude-oil-up-over-1-alamos-gold-shares-slide-cm843974,Toward the end of trading Monday the Dow traded up 1 17 percent to 22 053 72 while the NASDAQ climbed 1 13 percent to 6 431 89 The S amp P also rose gaining 1 04 percent to 2 486 91 Leading and Lagging Sectors Monday afternoon the financial shares surged 1 43 percent
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd. (ADR) Is Soaring,2017-09-11 19:35:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gdkKAuU7YX8/why-teva-pharmaceutical-industries-ltd-adr-is-soaring-cm843937,What happened After announcing that it has officially filled its vacant CEO seat Teva Pharmaceutical Industries NYSE TEVA a pharma company primarily focused on generic drugs jumped 18 as of 1 45 p m EDT on Monday So what Teva announced today that it has hired
TEVA,TEVA:US,BBG000C0CD58,Why Did Teva Pharmaceuticals Stock Soar Today?,2017-09-11 18:36:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Od2xZxsBFFc/why-did-teva-pharmaceuticals-stock-soar-today-cm843915,Shares of Teva Pharmaceuticals TEVA opened more than 15 higher on Monday after the struggling drugmaker picked H Lundbeck HLUYY chief Kare Schultz to fill its long vacant CEO role Schultz who has been at the helm of H Lundbeck since May 2015 is set to take over at Teva a generics
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Appoints New Chief Executive After Months of Speculation,2017-09-11 18:21:35 +0000,http://finance.yahoo.com/r/329b265d-ca23-30e6-b266-9d5e3dc30e8c/teva-names-kare-schultz-as-new-chief-executive-1505115189?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries named Kare Schultz as its new chief executive, ending months of speculation over who will lead the Israeli drug company."
TEVA,TEVA:US,BBG000C0CD58,"Teva, finally, names CEO",2017-09-11 18:15:07 +0000,http://finance.yahoo.com/r/6d4555ba-5a4a-38e1-a218-12121af979bf/teva-names-schultz-ceo-peterberg.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd., after a lengthy search, named Kåre Schultz as the generic drug company's new president and CEO.  Schultz will succeed Dr. Yitzhak Peterburg, who will continue to serve as interim-CEO until Schultz, who will be relocating to the company's headquarters in Israel, starts.  A nearly 30-year veteran of the pharmaceutical industry, Schultz most recently served as the president and CEO of H. Lundbeck A/S. Prior to that, he chief operating officer of Novo Nordis."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-11 18:06:00 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-180600935.html?.tsrc=rss,"IRVINE, Calif. , Sept. 11, 2017 /PRNewswire/ -- Khang & Khang LLP (the ""Firm"") announces the filing of a securities class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd. (ADR) Is Soaring,2017-09-11 17:58:00 +0000,http://finance.yahoo.com/r/5b05c439-c66f-30c7-83b8-a090ffe4f674/why-teva-pharmaceutical-industries-ltd-adr-is-soar.aspx?yptr=yahoo&.tsrc=rss,Shares jump after the company announces that it has finally filled a key executive position.
TEVA,TEVA:US,BBG000C0CD58,Unusual activity on two tech giants,2017-09-11 17:51:00 +0000,https://finance.yahoo.com/video/unusual-activity-two-tech-giants-175100361.html?.tsrc=rss,The options activity shows these stocks will move.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Soars on New CEO News,2017-09-11 17:16:11 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-171611954.html?.tsrc=rss,"Kare Schultz will be taking over the position of president and CEO at Teva Pharmaceutical Industries Ltd (ADR).  This will have him replacing Dr. Yitzhak Peterburg, who has been serving the company as its Interim CEO.  Kare Schultz was chosen as the new CEO of Teva Pharmaceutical Industries Ltd (ADR) by its Board of Directors."
TEVA,TEVA:US,BBG000C0CD58,Teva's CEO News Is Encouraging,2017-09-11 17:05:00 +0000,https://finance.yahoo.com/news/tevas-ceo-news-encouraging-170500393.html?.tsrc=rss,"Kare Schultz's familiarity in branded drug markets lead the firm to take on more product development risk longer-term, with purchases of earlier-stage products and more dramatic asset sales."
TEVA,TEVA:US,BBG000C0CD58,Here's Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August,2017-09-11 16:37:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-KhpcxG0fo/heres-why-allergan-stock-might-be-an-incredible-bargain-after-dropping-99-in-august-cm843806,What happened Despite a stronger than expected second quarter earnings report Allergan s NYSE AGN two month long rally came to an abrupt halt in August with the stock losing 9 9 of its value according to data from S amp P Global Market Intelligence The
TEVA,TEVA:US,BBG000C0CD58,New Teva CEO Just Added Nearly 13% to Company's Market Cap Without Even Starting,2017-09-11 16:17:00 +0000,http://finance.yahoo.com/r/5ac83f25-cb39-385f-aa3f-fe671c8c5458/teva-spikes-on-new-ceo.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The world's biggest generic drug maker Monday named Kare Schultz as president and CEO, ending months of speculation about who would replace former head Erez Vigodman, who left the company in February for ..."
TEVA,TEVA:US,BBG000C0CD58,Why Did Teva Pharmaceuticals Stock Soar Today?,2017-09-11 15:59:03 +0000,https://finance.yahoo.com/news/why-did-teva-pharmaceuticals-stock-155903197.html?.tsrc=rss,Shares of Teva Pharmaceuticals (TEVA) opened more than 15% higher on Monday after the struggling drugmaker picked H. Lundbeck (HLUYY) chief Kare Schultz to fill its long-vacant CEO role.
TEVA,TEVA:US,BBG000C0CD58,"The Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Teva Pharmaceutical Industries Ltd. Shareholders and a Lead Plaintiff Deadline of October 23, 2017",2017-09-11 15:58:00 +0000,https://finance.yahoo.com/news/klein-law-firm-notifies-investors-155800955.html?.tsrc=rss,"The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd. who purchased American Depositary Shares between November 15, 2016 and August 2, 2017."
TEVA,TEVA:US,BBG000C0CD58,Drugmaker Teva hires new CEO to restore its health,2017-09-11 15:53:57 +0000,https://www.yahoo.com/news/drugmaker-teva-hires-ceo-restore-155357431.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd names H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, as it struggles with heavy debts and fierce competition for its generic drugs in the United States. Amy Pollock reports"
TEVA,TEVA:US,BBG000C0CD58,Mid-Morning Market Update: Markets Open Higher; Teva Pharmaceutical Names Kaare Schultz As CEO,2017-09-11 15:39:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cLMFIZR913g/mid-morning-market-update-markets-open-higher-teva-pharmaceutical-names-kaare-schultz-as-ceo-cm843801,Following the market opening Monday the Dow traded up 0 96 percent to 22 007 68 while the NASDAQ climbed 1 23 percent to 6 438 15 The S amp P also rose gaining 0 88 percent to 2 483 07 Leading and Lagging Sectors Monday morning the technology shares surged 1 39
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva poaches chief from Danish drugmaker Lundbeck,2017-09-11 15:21:34 +0000,"http://finance.yahoo.com/r/a5972ac0-f08d-3abc-8282-cc722d6f9e38/85b139fa-9700-11e7-b83c-9588e51488a0,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Teva has appointed Kare Schultz from Danish drugmaker Lundbeck to be its new chief executive, ending a seven month search which saw the Israeli pharmaceuticals company linked with AstraZeneca's Pascal ..."
TEVA,TEVA:US,BBG000C0CD58,Here&apos;s Why Allergan Stock Might Be an Incredible Bargain After Dropping 9.9% in August,2017-09-11 15:00:00 +0000,http://finance.yahoo.com/r/0b9c515c-4b97-3ac1-bbed-4e355977a68b/heres-why-allergan-stock-might-be-an-incredible-ba.aspx?yptr=yahoo&.tsrc=rss,"Allergan&apos;s stock fell in sympathy with Teva Pharmaceutical Industries in August, but it may now be a bargain as a result."
TEVA,TEVA:US,BBG000C0CD58,Can a New CEO Turn Around Teva?,2017-09-11 14:50:52 +0000,https://finance.yahoo.com/news/ceo-turn-around-teva-145052415.html?.tsrc=rss,"Often companies that lose their way or face adversity may need a change at the top. Teva Pharmaceutical seems to be the perfect example, and with its change investors are sending the shares much higher...."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical: Talk About a Good Hire!,2017-09-11 14:47:00 +0000,http://finance.yahoo.com/r/786bd1fa-9738-37d8-a453-fc4fd8a86746/teva-pharmaceutical-talk-about-a-good-hire-1505141266?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"If Teva Pharmaceutical Industries (TEVA) last earnings report did anything, it confirmed that the company really needed to finally get around to hiring a new CEO.  Remember, Teva CEO Erez Vigodman  stepped down in February, and the company began a search for a new chief executive while Yitzhak Peterburg served as interim CEO.  During that period, Teva cut its earnings guidance, and slashed its dividend, causing its shares to tumble."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva/Lundbeck: healer dealer,2017-09-11 14:43:09 +0000,"http://finance.yahoo.com/r/d794f878-6fd8-331e-8005-5898ff103ddd/ada3eed2-96ef-11e7-a652-cde3f882dd7b,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Teva needs strong medicine, and quick. Its charts are dire. The Israeli generic drugmaker's shares recently touched 15-year lows. The price-to-earnings ratio is less than half its 10-year average. Yet, ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Hires Kare Schultz as CEO: Is a Recovery in the Cards?,2017-09-11 13:54:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xzDlSaj_2n4/teva-hires-kare-schultz-as-ceo-is-a-recovery-in-the-cards-cm843648,Teva Pharmaceutical Industries Limited TEVA announced the appointment of Kåre Schultz as president and chief executive officer CEO thus ending the Israeli generic maker s more than six month long search for a permanent CEO Share rose more than 12 in pre market trading on Monday
TEVA,TEVA:US,BBG000C0CD58,"Wall Street Set for Higher Open as North Korean Tensions Subside, Hurricane Irma Weakens",2017-09-11 13:50:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PQE2kEaiaIQ/wall-street-set-for-higher-open-as-north-korean-tensions-subside-hurricane-irma-weakens-cm843564,U S stocks were poised for a higher open Monday tracking similar gains in Asian markets over easing tensions in the Korean peninsula and with Hurricane Irma making a landfall in Florida weaker than anticipated U S stocks were poised for a higher open Monday tracking similar gains in
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd ADR (TEVA) Names Kare Schultz As CEO,2017-09-11 13:50:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5thBSL0Fgcs/teva-pharmaceutical-industries-ltd-adr-teva-names-kare-schultz-as-ceo-cm843586,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA named Kåre Schultz to become the president and CEO according to a company press release today TEVA stock was up more than 12 in pre market trading at 5 30 a m in New
TEVA,TEVA:US,BBG000C0CD58,Morning Movers: Teva Soars on CEO; MGM Drops,2017-09-11 13:03:00 +0000,http://finance.yahoo.com/r/905dee4e-0972-3475-9aa8-23e409ee6de7/morning-movers-teva-soars-on-ceo-mgm-drops-1505134728?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for  higher open as Hurricane Irma appears to have done less damage than expected, while the U.S. dollar is rallying after China said it would stop trying to support its currency. S&P 500 futures ..."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 11, 2017 :  TEVA, AZN, MRNS, BAC, TVIX, QQQ, AAPL, SNAP, USLV, ACHN, UN, MFGP",2017-09-11 12:59:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/axZgdf0hGRA/pre-market-most-active-for-sep-11-2017-teva-azn-mrns-bac-tvix-qqq-aapl-snap-uslv-achn-un-mfgp-cm843520,The NASDAQ 100 Pre Market Indicator is up 25 79 to 5 939 16 The total Pre Market volume is currently 7 550 196 shares traded The following are the most active stocks for the pre market session Teva Pharmaceutical Industries Limited TEVA is 1 81 at 17 31 with 2 781
TEVA,TEVA:US,BBG000C0CD58,Allergan's Patent Loophole Could Be a Huge Gift for Pfizer,2017-09-11 12:51:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83hKfVQuGsY/allergans-patent-loophole-could-be-a-huge-gift-for-pfizer-cm843496,The tribe has spoken On Friday Allergan NYSE AGN announced that the Saint Regis Mohawk Tribe now owns all patents for blockbuster dry eye disease drug Restatis Both parties should win from the deal The tribe will receive millions of dollars upfront and in annual
TEVA,TEVA:US,BBG000C0CD58,"U.S. Futures Point North as Tensions in North Korea Subside, Hurricane Irma Weakens",2017-09-11 12:50:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4JJujFsal3U/us-futures-point-north-as-tensions-in-north-korea-subside-hurricane-irma-weakens-cm843507,U S stock futures rallied on Monday tracking similar gains in Asian markets over easing tensions in the Korean peninsula and with Hurricane Irma making a landfall in Florida weaker than anticipated U S stock futures rallied on Monday tracking similar gains in Asian markets over easing
TEVA,TEVA:US,BBG000C0CD58,Teva Hires Kare Schultz as CEO: Is a Recovery in the Cards?,2017-09-11 12:17:12 +0000,https://finance.yahoo.com/news/teva-hires-kare-schultz-ceo-121712059.html?.tsrc=rss,Teva Pharmaceutical (TEVA) announced the appointment of H. Lundbeck&apos;s Kare Schultz as President and Chief Executive Officer (CEO).
TEVA,TEVA:US,BBG000C0CD58,[$$] The Morning Risk Report: Equifax Breach Could Spur New Round of Training,2017-09-11 11:17:24 +0000,http://finance.yahoo.com/r/99bd7c85-eecc-3e9e-9f6b-8123ae0ad3fd/the-morning-risk-report-equifax-breach-could-spur-new-round-of-training-1505128642?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,The size and scope of the Equifax breach could serve as a wake-up call to companies that haven’t taken very seriously the cybersecurity training of their employees.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd ADR (TEVA) Names Kare Schultz As CEO,2017-09-11 09:47:03 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-094703263.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd ADR (NYSE:TEVA) named Kåre Schultz to become the president and CEO, according to a company press release today.  Schultz is viewed as a seasoned veteran in the healthcare industry, with more than 30 years experience in global pharmaceutical and healthcare companies."
TEVA,TEVA:US,BBG000C0CD58,Future Teva CEO Seeks to 'Formulate Clear Strategy',2017-09-11 09:18:26 +0000,https://finance.yahoo.com/video/future-teva-ceo-seeks-formulate-091826042.html?.tsrc=rss,"Sep.11 -- Kaare Schultz, outgoing chief executive officer at H. Lundbeck A/S, discusses his move to Teva Pharmaceuticals Industries Ltd. to lead the world's largest maker of generic drugs. He speaks with Bloomberg's Francine Lacqua on &quot;Bloomberg Surveillance.&quot;"
TEVA,TEVA:US,BBG000C0CD58,Israel's Teva Pharma appoints Lundbeck's Kare Schultz as CEO,2017-09-11 07:39:20 +0000,https://finance.yahoo.com/news/israels-teva-pharma-appoints-lundbecks-073920664.html?.tsrc=rss,"Teva Pharmaceutical  Industries Ltd named H Lundbeck A/S Chief  Executive Kare Schultz as its new CEO and president on Monday,  as it struggles with heavy debts and fierce competition for its  generic drugs in the United States.  Israel-based Teva's shares, which plunged after the company  issued poor second-quarter results last month, rose 8 percent in  early trade in Tel Aviv.  Schultz will succeed Yitzhak Peterburg, who will continue as  Teva's interim CEO until Schultz takes over."
TEVA,TEVA:US,BBG000C0CD58,Israel's Teva Pharma appoints H Lundbeck's Kare Schultz as CEO,2017-09-11 06:31:31 +0000,https://finance.yahoo.com/news/israels-teva-pharma-appoints-h-063131655.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd named H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, the Israel-based drugmaker said on Monday. Schultz will succeed Yitzhak Peterburg, who ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Picks Lundbeck's Schultz to Revive Israeli Drugmaker,2017-09-11 06:19:48 +0000,http://finance.yahoo.com/r/169e48de-fd3e-382d-945b-213bcc56e20a/teva-names-lundbeck-s-schultz-as-ceo-to-revive-drugmaker?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. named H. Lundbeck A/S’s Kaare Schultz as its new chief executive officer, ending a seven-month search for a new leader to revive sales and reduce debt at the world’s ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Names Kåre Schultz as President and Chief Executive Officer,2017-09-11 06:04:00 +0000,https://finance.yahoo.com/news/teva-names-k-schultz-president-060400628.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. today announced that its Board of Directors has named Kåre Schultz to become the Company’s President and Chief Executive Officer.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Names KÃ¥re Schultz President & CEO - Quick Facts,2017-09-11 02:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B9NSc4xhaSE/teva-pharma-names-k%C3%A3re-schultz-president--ceo---quick-facts-20170911-00079,Teva Pharma Names KÃ¥re Schultz President & CEO - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,3 Reasons to Buy Allergan plc Stock Right Now,2017-09-10 13:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4BM1mBJiGts/3-reasons-to-buy-allergan-plc-stock-right-now-cm843382,Allergan NYSE AGN is one of the most underappreciated big pharma stocks on the market right now That s the thought that occurred to me as I listened to Brent Saunders Allergan s CEO speak at the Wells Fargo Healthcare Conference on Thursday One thing s for sure
TEVA,TEVA:US,BBG000C0CD58,Does Teva's Terrible Tumble Make Its Stock a Buy?,2017-09-10 10:49:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lYsBYUUyfis/does-tevas-terrible-tumble-make-its-stock-a-buy-cm843365,Disappointing financial results a dividend cut and reduced guidance have caused Teva Pharmaceutical Industries NYSE TEVA shares to lose half their value in the past month Can a restructuring help management reduce debt and kick start shares or is this company s share price on
TEVA,TEVA:US,BBG000C0CD58,Does Teva&apos;s Terrible Tumble Make Its Stock a Buy?,2017-09-10 09:30:00 +0000,http://finance.yahoo.com/r/dd69f7e2-77b6-3d65-b87b-dd09c3193fa2/does-tevas-terrible-tumble-make-its-stock-a-buy.aspx?yptr=yahoo&.tsrc=rss,"We&apos;ve seen this movie before: spend a lot of money on acquisitions, get heavily indebted, and the next thing you know…"
TEVA,TEVA:US,BBG000C0CD58,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 20:28:04 +0000,https://finance.yahoo.com/news/pharmaceuticals-spend-lobbying-influence-trump-202804898.html?.tsrc=rss,"Pharmaceuticals need a palliative in the age of Donald Trump. Even before taking office, the president threatened the industry’s profit model with a commitment to lower treatment prices. He accused drugmakers ..."
TEVA,TEVA:US,BBG000C0CD58,These 3 Stocks Have Gotten Sliced in Half This Year,2017-09-09 15:50:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pwxcps5H0hY/these-3-stocks-have-gotten-sliced-in-half-this-year-cm843313,The stock market has held up well in 2017 extending the bull market into its ninth year and producing solid performance for long term investors Even in the best of markets some stocks won t participate and company specific problems often send shares sharply lower regardless of what
TEVA,TEVA:US,BBG000C0CD58,These 3 Stocks Have Gotten Sliced in Half This Year,2017-09-09 14:31:00 +0000,http://finance.yahoo.com/r/63473532-e724-30e7-97e6-3d5ce8647410/these-3-stocks-have-gotten-sliced-in-half-this-yea.aspx?yptr=yahoo&.tsrc=rss,Find out what&apos;s behind the drops for these companies.
TEVA,TEVA:US,BBG000C0CD58,Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine,2017-09-09 12:00:00 +0000,https://finance.yahoo.com/news/teva-showcases-data-demonstrating-potential-120000035.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., has presented new data evaluating fremanezumab, an investigational treatment for the prevention of migraine, at the 18th Congress of the International Headache Society in Vancouver, Canada."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-09 03:54:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-lundin-law-035400555.html?.tsrc=rss,"LOS ANGELES , Sept. 8, 2017 /PRNewswire/ --  Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or ..."
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - (TEVA)",2017-09-09 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-claimsfiler-025000860.html?.tsrc=rss,"NEW ORLEANS, Sept. 08, 2017-- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 23, 2017 to file lead plaintiff applications in a securities class action ..."
TEVA,TEVA:US,BBG000C0CD58,TEVA LOSS NOTICE: Rosen Law Firm Reminds Teva Pharmaceutical Industries Ltd. Investors of Important Deadline in Class Action – TEVA,2017-09-08 22:43:00 +0000,https://finance.yahoo.com/news/teva-loss-notice-rosen-law-224300894.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teva Pharmaceutical Industries Ltd. from November 15, 2016 through August 2, 2017, inclusive of the important October 23, 2017 deadline in the class action."
TEVA,TEVA:US,BBG000C0CD58,"TEVA EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-09-08 18:20:00 +0000,https://finance.yahoo.com/news/teva-equity-alert-law-offices-182000043.html?.tsrc=rss,The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased Teva Pharmaceutical Industries Ltd.
TEVA,TEVA:US,BBG000C0CD58,A Perfect Storm Cut Teva Pharmaceutical Industries's Stock in Half in August,2017-09-08 14:54:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ytQprwUVH40/a-perfect-storm-cut-teva-pharmaceutical-industriess-stock-in-half-in-august-cm842862,What happened Shares of Teva Pharmaceutical Industries NYSE TEVA an Israeli based developer of branded and generic drugs imploded in August and lost 51 of its market cap according to data from S amp P Global Market Intelligence While a perfect storm of
TEVA,TEVA:US,BBG000C0CD58,A Perfect Storm Cut Teva Pharmaceutical Industries&apos;s Stock in Half in August,2017-09-08 13:36:00 +0000,http://finance.yahoo.com/r/d1bb597c-aaa2-33fd-941d-04ee12c86151/a-perfect-storm-cut-teva-pharmaceutical-industries.aspx?yptr=yahoo&.tsrc=rss,"Teva has a long, but potentially promising, road ahead."
TEVA,TEVA:US,BBG000C0CD58,EQUITY ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited,2017-09-07 23:16:00 +0000,https://finance.yahoo.com/news/equity-alert-goldberg-law-pc-231600366.html?.tsrc=rss,"LOS ANGELES , Sept. 7, 2017 /PRNewswire/ --  Goldberg Law PC , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited ..."
TEVA,TEVA:US,BBG000C0CD58,Are These Healthcare Stocks Top Takeover Targets?,2017-09-07 22:51:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yblKEdUGXY8/are-these-healthcare-stocks-top-takeover-targets-cm842641,Following Gilead Sciences NASDAQ GILD decision to buy 160 Kite Pharma NASDAQ KITE for 11 9 billion in cash we couldn t help but wonder what other healthcare stocks could be takeover targets too In this episode of The Motley Fool s Industry Focus
TEVA,TEVA:US,BBG000C0CD58,"TEVA INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Teva Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of October 23, 2017",2017-09-07 21:17:42 +0000,https://finance.yahoo.com/news/teva-investor-alert-law-offices-211742016.html?.tsrc=rss,"NEW YORK, Sept. 07, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf ..."
TEVA,TEVA:US,BBG000C0CD58,Are These Healthcare Stocks Top Takeover Targets?,2017-09-07 21:10:00 +0000,http://finance.yahoo.com/r/d40d0cac-b80e-31ea-8f8f-6ff649b83d38/are-these-healthcare-stocks-top-takeover-targets.aspx?yptr=yahoo&.tsrc=rss,"Big-cap biopharma could come knocking if Juno Therapeutics’ next-generation CAR-T is safer than its competitors, and Medtronic&apos;s already investing billions in Mazor Robotics, a maker of surgical robots."
TEVA,TEVA:US,BBG000C0CD58,"The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Teva Pharmaceutical Industries Ltd. Shareholders and a Lead Plaintiff Deadline of October 23, 2017 (TEVA)",2017-09-07 18:19:07 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-181907269.html?.tsrc=rss,"NEW YORK, Sept. 07, 2017-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd. who purchased American Depositary Shares ..."
TEVA,TEVA:US,BBG000C0CD58,Amgen/AstraZeneca Asthma Candidate Tezepelumab Shows Promise,2017-09-07 16:51:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tpAgI1yDMH0/amgenastrazeneca-asthma-candidate-tezepelumab-shows-promise-cm842337,Amgen Inc 160 AMGN and AstraZeneca plc AZN announced that their pipeline candidate tezepelumab reduced annual asthma exacerbation rate AAER a measure of deterioration of asthma in PATHWAY study in patients with severe uncontrolled asthma Tezepelumab an anti thymic
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-06 19:51:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-khang-khang-195100271.html?.tsrc=rss,"Khang & Khang LLP announces the filing of a securities class action lawsuit against Teva Pharmaceutical Industries Limited . Investors who purchased or otherwise acquired shares between November 15, 2016 and August 2, 2017, inclusive , are encouraged to contact the Firm in advance of the October 23, 2017 lead plaintiff motion deadline."
TEVA,TEVA:US,BBG000C0CD58,"INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Teva Pharmaceutical Industries Ltd. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017",2017-09-06 18:42:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-184200230.html?.tsrc=rss,"The following statement is being issued by Levi & Korsinsky, LLP:"
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited (NYSE: TEVA) To Contact Brower Piven Before The Lead Plaintiff Deadline",2017-09-06 17:58:49 +0000,https://finance.yahoo.com/news/shareholder-alert-brower-piven-notifies-175849355.html?.tsrc=rss,"STEVENSON, Md., Sept. 06, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-06 17:49:00 +0000,https://finance.yahoo.com/news/important-investor-alert-lundin-law-174900261.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws between November 15, 2016 and August 2, 2017, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Novartis' (NVS) MS Drug Gilenya Positive in Long-Term Study,2017-09-06 16:54:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WfIumkgNKjU/novartis-nvs-ms-drug-gilenya-positive-in-long-term-study-cm841759,Novartis AG NVS announced positive top line results from the phase III study PARADIGMS The study evaluated the safety and efficacy of oral once daily Gilenya in children and adolescents aged 10 17 with multiple sclerosis MS The flexible duration up to two years double
TEVA,TEVA:US,BBG000C0CD58,Glancy Prongay & Murray LLP Continues Investigation on Behalf of Teva Pharmaceutical Industries Ltd. Investors,2017-09-06 14:30:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-llp-continues-143000436.html?.tsrc=rss,Glancy Prongay & Murray LLP continues its investigation on behalf of Teva Pharmaceutical Industries Ltd. investors concerning the Company and its officers’ possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,Teva To Present New Asthma and COPD Data at the 2017 European Respiratory Society (ERS) International Congress,2017-09-06 12:00:00 +0000,https://finance.yahoo.com/news/teva-present-asthma-copd-data-120000976.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced that ten company-sponsored abstracts will be presented at the 2017 European Respiratory Society International Congress in Milan, Italy on September 9-13, 2017."
TEVA,TEVA:US,BBG000C0CD58,The 10 Highest Dividend Yielding Stocks,2017-09-06 11:49:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M07KQNMHbVs/the-10-highest-dividend-yielding-stocks-cm841382,So you re looking for some high yielding dividend paying stocks for your portfolio you say What That 0 01 interest rate on your Chase checking account just isn t doing the trick for you If that s the case you ve come to the right place Today I m going to run down the
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited,2017-09-05 17:57:00 +0000,https://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-175700496.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited for violations of §§10 and 20 of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 – TEVA",2017-09-05 16:20:22 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-162022439.html?.tsrc=rss,"NEW YORK, Sept. 05, 2017-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired American Depositary Shares of Teva Pharmaceutical ..."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 5, 2017 :  INSM, COL, TVIX, ING, DB, BAC, UTX, CLLS, TEVA, XIV, AAPL, QQQ",2017-09-05 12:59:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/npVkS-5TmF0/pre-market-most-active-for-sep-5-2017-insm-col-tvix-ing-db-bac-utx-clls-teva-xiv-aapl-qqq-cm840893,The NASDAQ 100 Pre Market Indicator is down 12 64 to 5 975 26 The total Pre Market volume is currently 5 289 167 shares traded The following are the most active stocks for the pre market session Insmed Inc INSM is 14 76 at 27 05 with 1 194 101 shares traded
TEVA,TEVA:US,BBG000C0CD58,Teva to Present Fremanezumab Data on Migraine Prevention at the 18th Congress of the International Headache Society,2017-09-05 12:00:00 +0000,https://finance.yahoo.com/news/teva-present-fremanezumab-data-migraine-120000084.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced that 12 scientific abstracts and two platform presentations evaluating fremanezumab will be presented at the 18th Congress of the International Headache Society in Vancouver, Canada from September 7-10, 2017."
TEVA,TEVA:US,BBG000C0CD58,Here's the Best Dividend Stock in Big Pharma,2017-09-03 12:49:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oyf-OUR12Pk/heres-the-best-dividend-stock-in-big-pharma-cm840633,Dividends make a huge impact on your overall investing returns They can also provide solid income during your retirement years Historically big pharma stocks have been a great place for investors to turn to for high yields and reliable income But which big pharma stock is the
TEVA,TEVA:US,BBG000C0CD58,"FORTHCOMING DEADLINES: J&W Announces Class Action Suits against Forterra, Inc., Foundation Medicine, Inc., Teva Pharmaceutical Industries Limited and Dr. Reddys Laboratories Limited; Investors Encouraged to Contact Firm",2017-09-02 17:10:00 +0000,https://finance.yahoo.com/news/forthcoming-deadlines-j-w-announces-171000228.html?.tsrc=rss,"Johnson & Weaver, LLP (J&W) reminds investors that a class action case was filed against Forterra, Inc. (FRTA) (""Forterra"") for purchasers of the stock between October 19, 2016 and May 12, 2017 or traceable to the Company's Initial Public Offering (""IPO"").  The complaint alleges that the Registration Statement used to conduct the IPO contained inaccurate statements and omitted facts necessary to make other statements made therein not misleading."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2017-09-02 03:52:00 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-035200778.html?.tsrc=rss,"Khang & Khang LLP announces the filing of a securities class action lawsuit against Teva Pharmaceutical Industries Limited . Investors who purchased or otherwise acquired shares between November 15, 2016 and August 2, 2017, inclusive , are encouraged to contact the Firm in advance of the October 23, 2017 lead plaintiff motion deadline."
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited (TEVA)",2017-09-02 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-former-025000138.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 23, 2017 to file lead plaintiff applications in a securities ..."
TEVA,TEVA:US,BBG000C0CD58,"Stull, Stull & Brody Reminds Investors of Class Action Lawsuit on Behalf of Employee Benefit Plan Purchasers of American Depository Shares of Teva Pharmaceutical Industries Limited",2017-09-01 23:00:00 +0000,https://finance.yahoo.com/news/stull-stull-brody-reminds-investors-230000900.html?.tsrc=rss,"NEW YORK, Sept. 01, 2017-- Stull, Stull & Brody reminds investors that a class action lawsuit was commenced in the United States District Court for the Southern District of Ohio on behalf of purchasers ..."
TEVA,TEVA:US,BBG000C0CD58,Parkinson's Now a Hot Therapeutic Area: What's Up Lately?,2017-09-01 21:49:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UlPon7i0Jjs/parkinsons-now-a-hot-therapeutic-area-whats-up-lately-cm840483,Parkinson s disease PD is a progressive degenerative neurological movement disorder resulting from the loss of dopamine producing brain cells The disease mainly progresses with age It is the second most common neurodegenerative disease after Alzheimer s An estimated seven to 10
TEVA,TEVA:US,BBG000C0CD58,"After Hours Most Active for Sep 1, 2017 :  QQQ, TEVA, GE, BAC, TOT, MSFT, CPN, PGR, MU, INTC, TLT, CSX",2017-09-01 20:58:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-cMuXjXsHfs/after-hours-most-active-for-sep-1-2017-qqq-teva-ge-bac-tot-msft-cpn-pgr-mu-intc-tlt-csx-cm840490,The NASDAQ 100 After Hours Indicator is up 24 to 5 988 14 The total After hours volume is currently 30 742 196 shares traded The following are the most active stocks for the after hours session PowerShares QQQ Trust Series 1 QQQ is 0 01 at 145 99 with 2 167
TEVA,TEVA:US,BBG000C0CD58,Glancy Prongay & Murray LLP Commences Investigation on Behalf of Teva Pharmaceutical Industries Ltd. Investors,2017-09-01 17:30:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-173000543.html?.tsrc=rss,Glancy Prongay & Murray LLP announces an investigation on behalf of Teva Pharmaceutical Industries Ltd. investors concerning the Company and its officers’ possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,"EFV, JDST: Big ETF Inflows",2017-09-01 16:54:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ALO7Wgn41t0/efv-jdst-big-etf-inflows-cm840351,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares MSCI EAFE Value ETF which added 7 600 000 units or a 7 6 increase week over week Among the largest underlying components of EFV in morning trading
TEVA,TEVA:US,BBG000C0CD58,The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Teva Pharmaceutical Industries Limited,2017-09-01 15:53:00 +0000,https://finance.yahoo.com/news/klein-law-firm-reminds-investors-155300554.html?.tsrc=rss,The Klein Law Firm announces the commencement of an investigation of Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Sep 1, 2017 :  BAC, APVO, AMBA, DB, TVIX, TLT, NTNX, QQQ, TEVA, BP, PANW, ING",2017-09-01 12:58:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/996n0iavn-M/pre-market-most-active-for-sep-1-2017-bac-apvo-amba-db-tvix-tlt-ntnx-qqq-teva-bp-panw-ing-cm840115,The NASDAQ 100 Pre Market Indicator is up 10 84 to 5 999 44 The total Pre Market volume is currently 4 340 892 shares traded The following are the most active stocks for the pre market session Bank of America Corporation BAC is 0 08 at 23 81 with 515 724
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update",2017-09-01 11:57:11 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-novartis-car-115711976.html?.tsrc=rss,"It was a landmark week for the pharmaceutical sector and the medical community with the FDA approving Novartis&apos; (NVS) Kymriah, the first CAR-T cell treatment to be approved in the United States."
TEVA,TEVA:US,BBG000C0CD58,"ETFs with exposure to Teva Pharmaceutical Industries Ltd. : September 1, 2017",2017-09-01 01:29:35 +0000,http://finance.yahoo.com/r/d7a1d252-c022-3ed6-9410-2f6ac2ec8146/etfs-with-exposure-to-teva-pharmaceutical-industries-ltd-september-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Teva Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TEVA-US. Comparing the performance and risk of Teva Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, Shoe Carnival, and Hasbro Jumped Today",2017-08-31 22:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XOKQnpit5vk/why-teva-pharmaceutical-industries-shoe-carnival-and-hasbro-jumped-today-cm840001,The major benchmarks all moved higher Thursday with the Nasdaq Composite 160 producing the biggest gains The growing devastation left in the wake of Hurricane Harvey still dominated the news The White House announced that it would tap the U S emergency oil reserves as the U S
TEVA,TEVA:US,BBG000C0CD58,"After Hours Most Active for Aug 31, 2017 :  DOW, DD, SBAC, BAC, QQQ, MSFT, TEVA, PFE, GE, AMAT, GILD, INTC",2017-08-31 20:58:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q4d1DzcEtNI/after-hours-most-active-for-aug-31-2017-dow-dd-sbac-bac-qqq-msft-teva-pfe-ge-amat-gild-intc-cm839965,The NASDAQ 100 After Hours Indicator is down 63 to 5 987 97 The total After hours volume is currently 66 675 731 shares traded The following are the most active stocks for the after hours session Dow Chemical Company The DOW is unchanged at 66 65 with 12 912
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, Shoe Carnival, and Hasbro Jumped Today",2017-08-31 20:56:31 +0000,http://finance.yahoo.com/r/cddbf295-1dc0-3c56-89ea-184855f78a60/why-teva-pharmaceutical-industries-shoe-carnival-a.aspx?yptr=yahoo&.tsrc=rss,These stocks helped lead the market higher. Find out why.
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited and Encourages Investors With Losses to Contact the Firm,2017-08-31 19:59:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-lundin-law-195900355.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws November 15, 2016 and August 2, 2017, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Teva Austedo Gets FDA Nod for Label Expansion in Dyskinesia,2017-08-31 17:50:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-EBAYM8Ghco/teva-austedo-gets-fda-nod-for-label-expansion-in-dyskinesia-cm839851,Teva Pharmaceutical Industries Ltd TEVA announced that the FDA has approved a label expansion for its drug Austedo With the latest FDA approval Austedo s label has been expanded to include treatment of tardive dyskinesia a debilitating and often irreversible movement disorder We
TEVA,TEVA:US,BBG000C0CD58,The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Teva Pharmaceutical Industries Limited (TEVA),2017-08-31 16:27:00 +0000,https://finance.yahoo.com/news/klein-law-firm-notifies-investors-162700862.html?.tsrc=rss,The Klein Law Firm announces the commencement of an investigation of Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,Teva Austedo Gets FDA Nod for Label Expansion in Dyskinesia,2017-08-31 15:15:03 +0000,https://finance.yahoo.com/news/teva-austedo-gets-fda-nod-151503074.html?.tsrc=rss,Teva Pharmaceutical (TEVA) announced that the FDA has approved the label expansion of Austedo to include tardive dyskinesia in adults. Shares are up since announcement.
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 31, 2017 :  CIEN, QQQ, TKC, FCAU, CTRP, TEVA, OTIC, MOMO, DB, BAC, TVIX, ERIC",2017-08-31 12:58:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BSBi4-PNXJo/pre-market-most-active-for-aug-31-2017-cien-qqq-tkc-fcau-ctrp-teva-otic-momo-db-bac-tvix-eric-cm839554,The NASDAQ 100 Pre Market Indicator is up 8 67 to 5 941 57 The total Pre Market volume is currently 3 999 910 shares traded The following are the most active stocks for the pre market session Ciena Corporation CIEN is 1 36 at 22 91 with 643 847 shares traded
TEVA,TEVA:US,BBG000C0CD58,"AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears",2017-08-31 02:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bBxkaP_xFs8/amgns-endeavor-awaits-verdict-nvs-scripts-history-otic-is-not-music-to-ears-20170831-00080,"AMGN's Endeavor Awaits Verdict, NVS Scripts History, OTIC Is Not Music To Ears"
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited,2017-08-30 23:33:00 +0000,https://finance.yahoo.com/news/investor-alert-goldberg-law-pc-233300323.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited for violations of §§10 and 20 of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S."
TEVA,TEVA:US,BBG000C0CD58,Teva : FDA Oks AUSTEDO Tablets For Treatment Of Tardive Dyskinesia In Adults,2017-08-30 22:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R3IBcvj9kP0/teva--fda-oks-austedo-tablets-for-treatment-of-tardive-dyskinesia-in-adults-20170830-01269,Teva : FDA Oks AUSTEDO Tablets For Treatment Of Tardive Dyskinesia In Adults
TEVA,TEVA:US,BBG000C0CD58,Teva Announces FDA Approval of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in Adults,2017-08-30 19:53:00 +0000,https://finance.yahoo.com/news/teva-announces-fda-approval-austedo-195300729.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AUSTEDO® tablets for the treatment of tardive dyskinesia in adults.
TEVA,TEVA:US,BBG000C0CD58,TEVA SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Teva Pharmaceutical Industries Limited (TEVA),2017-08-30 19:08:00 +0000,https://finance.yahoo.com/news/teva-shareholder-alert-law-offices-190800419.html?.tsrc=rss,The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Teva Pharmaceutical Industries Limited violated federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,"Scott+Scott, Attorneys at Law, LLP Announces Filing of Securities Class Action Against Teva Pharmaceutical Industries Ltd. (TEVA)",2017-08-30 18:21:00 +0000,https://finance.yahoo.com/news/scott-scott-attorneys-law-llp-182100387.html?.tsrc=rss,"Scott+Scott, Attorneys at Law, LLP , a national shareholder and consumer rights litigation firm, announces that a securities class action has been filed against Teva Pharmaceutical Industries Ltd."
TEVA,TEVA:US,BBG000C0CD58,5 Dividends I’d Pay to Short (and Probably Will),2017-08-30 14:51:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JDQJz-vPeAA/5-dividends-id-pay-to-short-and-probably-will-cm839050,By Brett Owens Let s talk about five big payouts that are so flimsy they re just asking for the ultimate sign of dividend disrespect Paying money to short them It s one thing to turn down a decent yield in today s 2 world It s another to be willing to pay
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 30, 2017 :  OTIC, NMR, BAC, TVIX, AAPL, BABA, QQQ, DY, CHS, TEVA, SQQQ, ADI",2017-08-30 12:58:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DvxfmlyV_X4/pre-market-most-active-for-aug-30-2017-otic-nmr-bac-tvix-aapl-baba-qqq-dy-chs-teva-sqqq-adi-cm838998,The NASDAQ 100 Pre Market Indicator is up 12 51 to 5 874 65 The total Pre Market volume is currently 5 008 195 shares traded The following are the most active stocks for the pre market session Otonomy Inc OTIC is 17 at 3 80 with 6 536 060 shares traded As
TEVA,TEVA:US,BBG000C0CD58,10 High-Risk Stocks to Buy for Massive Rewards,2017-08-29 23:48:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pVoFR9ML6Tw/10-high-risk-stocks-to-buy-for-massive-rewards-cm838906,InvestorPlace Stock Market News Stock Advice amp Trading Tips Slow and steady wins the race as the old adage goes But slow and steady can be a bit boring Investors looking for stocks to buy as a rule should focus on high quality and preferably lower risk issues Source
TEVA,TEVA:US,BBG000C0CD58,Robbins Arroyo LLP: Teva Pharmaceutical Industries Ltd. (TEVA) Misled Shareholders According to a Recently Filed Class Action,2017-08-29 21:10:00 +0000,https://finance.yahoo.com/news/robbins-arroyo-llp-teva-pharmaceutical-211000738.html?.tsrc=rss,Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Teva Pharmaceutical Industries Ltd. for failing to disclose and actively concealing the negative impact of the acquisition and integration of Actavis Generics on the company's financial results and business prospects.
TEVA,TEVA:US,BBG000C0CD58,TEVA INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Teva Pharmaceutical Industries Limited,2017-08-29 20:42:00 +0000,https://finance.yahoo.com/news/teva-investor-alert-law-offices-204200260.html?.tsrc=rss,The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Teva Pharmaceutical Industries Limited violated federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,"The Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Teva Pharmaceutical Industries Ltd. Shareholders and a Lead Plaintiff Deadline of October 23, 2017 (TEVA)",2017-08-29 20:12:00 +0000,https://finance.yahoo.com/news/klein-law-firm-notifies-investors-201200409.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 29, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) who ..."
TEVA,TEVA:US,BBG000C0CD58,"LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Teva Pharmaceutical Industries Ltd. To Contact The Firm",2017-08-29 19:05:51 +0000,https://finance.yahoo.com/news/lead-plaintiff-deadline-alert-faruqi-190551086.html?.tsrc=rss,"NEW YORK, Aug. 29, 2017-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teva Pharmaceutical Industries Ltd. of the October 23, 2017 deadline to seek the role of lead ..."
TEVA,TEVA:US,BBG000C0CD58,Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic,2017-08-29 14:23:55 +0000,https://finance.yahoo.com/news/battered-teva-pharmaceutical-industries-ltd-142355186.html?.tsrc=rss,"All is not well for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  Teva bought Allergan’s generic drug business for $40.5 billion, which put severe pressure on its balance sheet.  One year ago, Teva had nearly $7 billion in cash and just $10.9 billion in debt."
TEVA,TEVA:US,BBG000C0CD58,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd.,2017-08-28 19:07:00 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-190700048.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Teva Pharmaceutical Industries Ltd. from November 15, 2016 through August 2, 2017, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 28, 2017",2017-08-28 16:43:34 +0000,http://finance.yahoo.com/r/22d6da02-5d74-30d8-acad-faa6f4ec45e0/teva-pharmaceutical-industries-ltd-teva-us-earnings-analysis-q2-2017-by-the-numbers-august-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Teva Pharmaceutical Industries Ltd. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Teva Pharmaceutical Industries Ltd. – Mylan N.V., Sanofi Sponsored ADR, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Pfizer Inc., Valeant Pharmaceuticals International ... Read more
<b>(Read more...)</b>"
TEVA,TEVA:US,BBG000C0CD58,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Teva Pharmaceutical Industries Ltd.",2017-08-28 16:40:00 +0000,https://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-164000088.html?.tsrc=rss,Levi & Korsinsky announces it has commenced an investigation of Teva Pharmaceutical Industries Ltd. concerning possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Holzer & Holzer Announces a Class Action Lawsuit Filed on Behalf of Investors in Teva,2017-08-28 16:09:00 +0000,https://finance.yahoo.com/news/investor-alert-holzer-holzer-announces-160900659.html?.tsrc=rss,"Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Teva Pharmaceutical Industries Ltd. American Depositary Shares on the New York Stock Exchange and/or common stock on the Tel Aviv Stock Exchange between November 15, 2016 and August 2, 2017."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Teva Pharmaceutical Industries Ltd. (TEVA) & Lead Plaintiff Deadline: October 23, 2017",2017-08-28 14:31:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-143100272.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 28, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,Biotech Stocks To Watch And Pharma Industry News,2017-08-28 14:08:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
TEVA,TEVA:US,BBG000C0CD58,"TEVA PHARMACEUTICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited- (TEVA)",2017-08-26 02:50:00 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-shareholder-alert-former-025000049.html?.tsrc=rss,"NEW ORLEANS, Aug. 25, 2017-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 23, 2017 to file lead ..."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Teva Pharmaceutical Industries Ltd. (TEVA) & Lead Plaintiff Deadline: October 23, 2017",2017-08-25 22:04:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-220400294.html?.tsrc=rss,"NEW YORK , Aug. 25, 2017 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. ..."
TEVA,TEVA:US,BBG000C0CD58,"[$$] Down With Teva, Up With Portola",2017-08-25 15:03:00 +0000,http://finance.yahoo.com/r/6bc072d8-ca41-30d8-a1c9-8f3db749bb3f/down-with-teva-up-with-portola-1503673394?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  Ahead of an expected uptick in pharmaceuticals news flow next month, we make several rating and target price changes as we look towards year-end 2017 and first-half 2018.  Conversely, we upgrade Portola Pharmaceuticals (PTLA) to Outperform from Neutral, while maintaining our $70 target price ahead of the Bevyxxa launch and likely AndexXa approval, and upgrade Corvus Pharmaceuticals (CRVS) to Neutral from Underperform, and increase our target price to $14 from $12 ahead of additional CPI-444 data at SITC."
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Run for Cover From Major Pharma,2017-08-25 13:55:52 +0000,https://finance.yahoo.com/news/short-sellers-run-cover-major-135552519.html?.tsrc=rss,"The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks dropped."
TEVA,TEVA:US,BBG000C0CD58,"Teva Has No Hope, Analyst Hints",2017-08-24 20:13:00 +0000,http://finance.yahoo.com/r/627ea481-d36b-3b7f-91d6-dd107b6d674b/credit-suisse-joins-teva-bears-predicts-stock-will-tumble-21.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Teva's challenges aren't 'fading anytime soon,' Credit Suisse says."
TEVA,TEVA:US,BBG000C0CD58,Big earnings movers & health care in the blitz,2017-08-24 17:34:00 +0000,https://finance.yahoo.com/video/big-earnings-movers-health-care-173400630.html?.tsrc=rss,The &quot;Halftime Report&quot; traders take investors through some of the day's biggest movers.
TEVA,TEVA:US,BBG000C0CD58,The Market In 5 Minutes,2017-08-24 14:01:33 +0000,https://finance.yahoo.com/news/market-5-minutes-140133755.html?.tsrc=rss,"IN THE NEWS Benzinga Salesforce.com, inc. (NYSE: CRM ) hit a new all-time high of $94.63 Wednesday after the company managed to report a top and bottom-line beat in its second-quarter earnings. With the ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for August 25, 2017",2017-08-24 13:18:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hA1yJjRGf1M/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-august-25-2017-cm836404,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on August 25 2017 A cash dividend payment of 0 072 per share is scheduled to be paid on September 14 2017 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 24, 2017 :  WFM, FCAU, NOK, SNE, ANF, TVIX, TEVA, DLTR, SNAP, USLV, OCLR, XIV",2017-08-24 12:58:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jTZAxq0MS40/pre-market-most-active-for-aug-24-2017-wfm-fcau-nok-sne-anf-tvix-teva-dltr-snap-uslv-oclr-xiv-cm836389,The NASDAQ 100 Pre Market Indicator is up 14 52 to 5 866 3 The total Pre Market volume is currently 6 673 212 shares traded The following are the most active stocks for the pre market session Whole Foods Market Inc WFM is 0 28 at 41 96 with 1 394 926 shares
TEVA,TEVA:US,BBG000C0CD58,Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much,2017-08-23 21:38:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S2vukS9Itr8/heres-the-simple-reason-why-multiple-sclerosis-drugs-cost-so-much-cm836219,Two members of the U S House of Representatives Committee on Oversight and Government Reform want to know why the prices of multiple sclerosis MS drugs are so high Rep 160 Elijah Cummings D Md and Rep Peter Welch D Vt have sent letters to seven drugmakers including
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Teva Pharmaceutical Industries Limited",2017-08-23 19:53:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-195300680.html?.tsrc=rss,Levi & Korsinsky announces it has commenced an investigation of Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,Here&apos;s the Simple Reason Why Multiple Sclerosis Drugs Cost So Much,2017-08-23 19:42:00 +0000,http://finance.yahoo.com/r/843de9e1-1673-3c66-ada0-7b593133212b/heres-the-simple-reason-why-multiple-sclerosis-dru.aspx?yptr=yahoo&.tsrc=rss,"It&apos;s not just Biogen, Teva, and other drugmakers. It&apos;s the entire system."
TEVA,TEVA:US,BBG000C0CD58,"Kaufman, Coren & Ress, P.C. Files Class Action Lawsuit Against Teva Pharmaceutical Industries Ltd. (TEVA)",2017-08-23 14:45:00 +0000,https://finance.yahoo.com/news/kaufman-coren-ress-p-c-144500198.html?.tsrc=rss,"PHILADELPHIA , Aug. 23, 2017 /PRNewswire/ -- Kaufman, Coren & Ress, P.C. announces that it filed a class action lawsuit in the U.S. District Court, Eastern District of Pennsylvania , 17-CV- 003743, on ..."
TEVA,TEVA:US,BBG000C0CD58,The Difficulties of Cloning a CEO,2017-08-23 04:01:06 +0000,http://finance.yahoo.com/r/431a2ded-b533-3bc2-b025-5f13cdc1eb3f/the-difficulties-of-cloning-a-ceo?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Teva Pharmaceutical is a generic manufacturer with a particular problem: It can’t find a leader or a strategy—­at least not in Israel.
TEVA,TEVA:US,BBG000C0CD58,"Teva Women's Health Unit Attracts Interest of Church & Dwight, Cooper",2017-08-22 11:41:56 +0000,http://finance.yahoo.com/r/7389e494-24c1-30b4-9026-8d1a44e8087c/teva-women-s-health-unit-is-said-to-draw-church-dwight-cooper?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd.’s women’s health unit is drawing interest from Church & Dwight Co. and Cooper Cos., people familiar with the matter said, as the troubled Israeli drugmaker sells assets ..."
TEVA,TEVA:US,BBG000C0CD58,One of the 33 Great Minds of Investing,2017-08-21 21:59:03 +0000,https://finance.yahoo.com/news/one-33-great-minds-investing-215903791.html?.tsrc=rss,"Frances Chou was covered in William Green’s book, 'The Great Minds of Investing,' but nagging questions remain"
TEVA,TEVA:US,BBG000C0CD58,UPDATE: Shire: There Goes the CFO!,2017-08-21 17:29:00 +0000,http://finance.yahoo.com/r/d4c50bf4-b72a-331f-938c-1658457eaca3/shire-there-goes-the-cfo-1503329044?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Update: I spoke with Shire (SHPG) CFO Jeff Poulton about his decision to leave, and he was quick to dispel any concerns that his departure was about anything except his desire to pursue a new opportunity.  Poulton also said that calling Shire a specialty-pharmaceutical company is a misnomer, as an overwhelming percentage of revenue now comes from its orphan drug business, a point raised by analyst Evercore ISI analyst Josh Schimmer, who wrote that Shire has ""biotech cash flows with a spec pharma valuation"" in a note last week.  Shares of Shire have fallen 4% to $139.71 at 1:26 p.m. today."
TEVA,TEVA:US,BBG000C0CD58,Teva Must Clear Three Big Hurdles to Reclaim Its Perch,2017-08-21 13:42:00 +0000,http://finance.yahoo.com/r/328259a6-cae8-330a-820c-b53e11e0ec78/teva-must-clear-three-big-hurdles-to-reclaim-its-perch.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Analysts are most critical about Teva's plan to cut $5 billion in debt by the end of the year.
TEVA,TEVA:US,BBG000C0CD58,4 “Safe” Dividends That are Anything But,2017-08-21 13:37:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qIdTvsMPNpY/4-safe-dividends-that-are-anything-but-cm834550,By Brett Owens Don t take any stated yields for granted these days The financial news has been flooded with dividend cuts lately with Teva Pharmaceutical TEVA and Mattel MAT taking the hatchet to their payouts and telecom Windstream WIN dropping
TEVA,TEVA:US,BBG000C0CD58,Teva launches latest generic - shares higher in response,2017-08-18 22:15:00 +0000,https://finance.yahoo.com/news/teva-launches-latest-generic-shares-221500890.html?.tsrc=rss,"Investing.com - Teva Pharma Industries Ltd ADR (NYSE:TEVA) has launched its generic version of Eli Lilly&apos;s Axiron topical solution CIII, in the U.S. Axiron is I used to treat adult men with low or no testosterone. The U.S. market is worth approximately $247 million, according to IMS."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Exclusive Launch of Generic Axiron® in the United States,2017-08-18 17:37:00 +0000,https://finance.yahoo.com/news/teva-announces-exclusive-launch-generic-173700207.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the launch of generic Axiron®1 topical solution CIII, 30 mg/1.5 mL, in the U.S."
TEVA,TEVA:US,BBG000C0CD58,3 Stocks That Are Absurdly Cheap Right Now,2017-08-18 12:46:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yHDo94f-i8I/3-stocks-that-are-absurdly-cheap-right-now-cm833735,One sound investing strategy is to buy shares of troubled companies that are trading on the cheap with the goal of selling them at a later date when their fortunes have turned around However the key to making this strategy work is to buy companies that are temporarily going
TEVA,TEVA:US,BBG000C0CD58,3 Stocks That Are Absurdly Cheap Right Now,2017-08-18 11:15:00 +0000,http://finance.yahoo.com/r/1d5a0221-0cde-3801-846b-e55503595352/3-stocks-that-are-absurdly-cheap-right-now.aspx?yptr=yahoo&.tsrc=rss,"Carrols Restaurant Group, GameStop, and TEVA Pharmaceuticals are all trading at a discount, but are any of them worth buying?"
TEVA,TEVA:US,BBG000C0CD58,Here&apos;s Why Horizon Pharma Gained as Much as 13.1% Today,2017-08-17 19:50:00 +0000,http://finance.yahoo.com/r/93d32b30-3ab4-3a56-bd18-5fc931356a11/heres-why-horizon-pharma-gained-as-much-as-131-tod.aspx?yptr=yahoo&.tsrc=rss,The biopharma successfully staved off a generic challenger for its most important drug.
TEVA,TEVA:US,BBG000C0CD58,Buy the Capitulation in Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock,2017-08-17 18:38:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tNn-fKjYrs8/buy-the-capitulation-in-teva-pharmaceutical-industries-ltd-adr-teva-stock-cm833517,InvestorPlace Stock Market News Stock Advice amp Trading Tips Don t buy the pain meds Citi is prescribing in Teva Pharmaceutical Industries Ltd ADR NYSE TEVA In our view it s too late to fill that order and this is a better occasion to take on
TEVA,TEVA:US,BBG000C0CD58,Buy the Capitulation in Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock,2017-08-17 13:57:26 +0000,https://finance.yahoo.com/news/buy-capitulation-teva-pharmaceutical-industries-135726619.html?.tsrc=rss,"Don’t buy the pain meds Citi is prescribing in Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  In our view, it’s too late to fill that order and this is a better occasion to take on a pick-me-up, contrarian position in TEVA with a bullish short-term options play.  Apologies are a rare bird with analysts on Wall Street, and for that I almost want to tip the hat for Citi’s actions in TEVA stock."
TEVA,TEVA:US,BBG000C0CD58,Valeant: Hard to Ignore the Positive Developments?,2017-08-17 13:38:00 +0000,http://finance.yahoo.com/r/7894c281-019d-356c-a149-886f399daec9/valeant-hard-to-ignore-the-positive-developments-1502977102?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) have tumbled 14% in August as concerns about generic drugs following Teva Pharmaceutical Industries' (TEVA) earnings sparked a specialty-pharmaceutical stock selloff.  Valeant, however, is trying to make back some of those losses this week, with the stock up more than 2% today after the company announced that it was close to fixing problems at a Bausch & Lomb plant.  While this might seem like a minor piece of news, it has big implications for Valeant's stock."
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Pluristem Therapeutics,2017-08-17 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000487.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 17, 2017 / While it was a good day for one Israeli company, it was a bad day for another. Israeli-based Teva saw its shares fall yesterday after a significant price target ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] Generic drugmakers feel pinch as prices crumble,2017-08-17 10:52:33 +0000,"http://finance.yahoo.com/r/07b8d9d3-aae7-3617-a2fb-d5e9353ad1db/b27cee6e-8221-11e7-a4ce-15b2513cb3ff,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","If a company makes money by copying the inventions of others, is it entitled to skim a thick layer of cream off the top? That is the question on the lips of investors in generic drugmakers, after a torrid ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva Stock Tumbles Again, Citi Downgrades, Says 'We Have Been Wrong'",2017-08-16 20:39:00 +0000,http://finance.yahoo.com/r/ce30034c-3418-36ea-85dd-4ef55b34ac54/teva-stock-tumbles-again-citi-downgrades-says-we-have-been-wrong.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Citigroup cut its rating for the struggling generic drug maker to 'neutral'.
TEVA,TEVA:US,BBG000C0CD58,"Why Transocean LTD (RIG), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Hertz Global Holdings, Inc (HTZ) Are 3 of Today’s Worst Stocks",2017-08-16 20:35:55 +0000,https://finance.yahoo.com/news/why-transocean-ltd-rig-teva-203555084.html?.tsrc=rss,"A small gain still would have been better than the results Hertz Global Holdings, Inc (NYSE:HTZ), Transocean LTD (NYSE:RIG) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) achieved on Wednesday, however.  Just when it looked as if Teva Pharmaceutical shares were going to turn things around and start to claw their way higher again — after getting thumped following a miserable quarterly report — the rug gets pulled out from underneath it.  TEVA stock fell 2.7% on Wednesday, moving back within easy reach of new multi-year lows hit last week."
TEVA,TEVA:US,BBG000C0CD58,Bottom-Fish for Exxon Mobil Corporation (XOM) Stock and Get Paid,2017-08-16 16:34:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tCC6aHjX2DQ/bottom-fish-for-exxon-mobil-corporation-xom-stock-and-get-paid-cm832879,InvestorPlace Stock Market News Stock Advice amp Trading Tips Exxon Mobil Corporation NYSE XOM shares closed Tuesday at a fresh 52 week low of 78 04 XOM stock has been dead money for six months but the past week s slip finally pushed it into oversold territory again
TEVA,TEVA:US,BBG000C0CD58,Israel's Teva seeks partners for new drugs to relieve pressure,2017-08-16 14:18:02 +0000,https://finance.yahoo.com/news/israels-teva-seeks-partners-drugs-132334553.html?.tsrc=rss,"JERUSALEM/LONDON/FRANKFURT, Aug 16 (Reuters) - Teva  Pharmaceutical Industries  is looking to team  up with other drugmakers to fund some of its development  pipeline as it struggles with debts and expiring patents.  ""We are looking for partners ... a series of partners."
TEVA,TEVA:US,BBG000C0CD58,The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak,2017-08-16 14:16:55 +0000,https://finance.yahoo.com/news/bull-case-valeant-pharmaceuticals-intl-141655890.html?.tsrc=rss,"Giving credit where credit is due, I do think Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock looks stronger than it did just a couple of quarters ago.  VRX stock has still declined 1.5% so far this year, but the narrative surrounding the company has certainly changed.  On the Q2 conference call, Valeant management made a big deal of the fact that 73% of Q2 revenue came from Bausch & Lomb and the Salix business."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 16, 2017 :  TGT, FCAU, TEVA, NEFF, URBN, BABA, YY, FGEN, AAPL, TVIX, SNAP, QQQ",2017-08-16 12:54:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JbKCeiwMiU4/pre-market-most-active-for-aug-16-2017-tgt-fcau-teva-neff-urbn-baba-yy-fgen-aapl-tvix-snap-qqq-cm832621,The NASDAQ 100 Pre Market Indicator is up 9 02 to 5 916 75 The total Pre Market volume is currently 3 658 568 shares traded The following are the most active stocks for the pre market session Target Corporation TGT is 2 1 at 56 45 with 635 807 shares traded
TEVA,TEVA:US,BBG000C0CD58,"Francis Chou Buys Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries, ...",2017-08-16 11:35:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MSH49BM1TEw/francis-chou-buys-valeant-pharmaceuticals-international-inc-teva-pharmaceutical-industries-cm832584,Francis Chou Added Positions VRX TEVA Reduced Positions NOK C Added Positions VRX TEVA Added Positions VRX TEVA Reduced Positions NOK C Reduced Positions NOK C For the details of Francis Chou s
TEVA,TEVA:US,BBG000C0CD58,Israel's Teva seeks partners to fund some drug development,2017-08-16 08:34:00 +0000,https://finance.yahoo.com/news/israels-teva-seeks-partners-fund-083400561.html?.tsrc=rss,"Teva Pharmaceutical Industries  said on Wednesday it was looking into a  series of partnerships to fund some projects in its drug  development pipeline, as the drugmaker seeks to pay down more  than $5 billion of debt this year."
TEVA,TEVA:US,BBG000C0CD58,Cramer's lightning round: Don't touch this pharma play,2017-08-15 22:58:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-dont-touch-225800106.html?.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks, including that of one controversial pharmaceutical company."
TEVA,TEVA:US,BBG000C0CD58,"Health Care Sector Update for 08/15/2017: TEVA,CGIX,FMS,MYL,NVS",2017-08-15 20:36:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h9uY_SAfW-4/health-care-sector-update-for-08152017-tevacgixfmsmylnvs-cm832442,Top Health Care StocksTop Health Care Stocks JNJ 0 07 JNJ 0 07 PFE 0 26 PFE 0 26 ABT 0 51 ABT 0 51 MRK 0 28 MRK 0 28 AMGN 0 26 AMGN 0 26 Health care stocks were putting up narrow gains Tuesday with the NYSE Health Care Index climbing almost 0 3 while shares of health care
TEVA,TEVA:US,BBG000C0CD58,"Teva Falls Hard, Loses Title as Israel's Biggest Firm",2017-08-15 16:07:00 +0000,http://finance.yahoo.com/r/8ac31e12-2544-3a6d-8499-494006096ac5/teva-falls-hard-loses-title-as-israel-s-biggest-firm.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva just isn't 'the people's stock' it used to be.
TEVA,TEVA:US,BBG000C0CD58,The Prescription For Generic Drugs ETF,2017-08-15 12:39:13 +0000,https://finance.yahoo.com/news/prescription-generic-drugs-etf-123913710.html?.tsrc=rss,"The health care sector, the third-largest sector weight in the S&P 500, is bouncing back in an impressive fashion this year after posting its first annual loss last year since 2008. While diversified health ..."
TEVA,TEVA:US,BBG000C0CD58,Perrigo: Still A Hard Pill To Swallow,2017-08-14 20:12:00 +0000,http://finance.yahoo.com/r/9238a8f3-48fc-3ea7-a1a4-f27cbed2056c/perrigo-still-a-hard-pill-to-swallow-1502740712?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Perrigo (PRGO) got a big lift off last week’s second quarter financial results.  The stock price had a 16% one-day surge after the drug maker posted quarterly financial results that beat estimates and raised its guidance.  It offered a stark contradiction to other specialty drug makers, namely the dismal results posted earlier this month by Teva Pharmaceutical Industries (TEVA)."
TEVA,TEVA:US,BBG000C0CD58,Teva Cedes Spot as Israel's Biggest Firm in Blow to Prestige,2017-08-14 15:21:45 +0000,http://finance.yahoo.com/r/1dba8d47-1128-3a8e-a0a8-e9ae7031ba68/teva-loses-spot-atop-israel-s-stock-market-in-blow-to-prestige?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Teva Pharmaceutical Industries Ltd. lost its position atop Israel’s corporate hierarchy for the first time in 15 years in yet another sign of the precipitous decline in fortunes at the world’s biggest ...
TEVA,TEVA:US,BBG000C0CD58,Jim Cramer Says Allergan Shares Are 'Just Too Cheap',2017-08-14 13:38:00 +0000,http://finance.yahoo.com/r/a2df6c4c-ef58-32fc-ae75-3ca7335e9106/jim-cramer-says-allergan-shares-are-just-too-cheap.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stockpicker may boost his charitable trust's AGN stake.
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 14, 2017 :  JD, QQQ, XIV, TVIX, BAC, SNAP, BABA, TEVA, NVDA, AAPL, AU, NEFF",2017-08-14 12:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OKkgW8Wf7QE/pre-market-most-active-for-aug-14-2017-jd-qqq-xiv-tvix-bac-snap-baba-teva-nvda-aapl-au-neff-cm831515,The NASDAQ 100 Pre Market Indicator is up 28 68 to 5 860 21 The total Pre Market volume is currently 3 540 743 shares traded The following are the most active stocks for the pre market session JD com Inc JD is 0 83 at 45 07 with 2 951 550 shares traded
TEVA,TEVA:US,BBG000C0CD58,[$$] Two Ways to Cut Your Teva Losses,2017-08-12 04:00:00 +0000,http://finance.yahoo.com/r/0aac733c-afaf-3fbb-a9f1-6f8c77ed72d1/two-ways-to-cut-your-teva-losses-1502510438?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceuticals has thrice sinned against investors.  The generic-drug maker recently reported weak earnings, offered dour financial guidance, and cut its dividend by 75%, moves that have severed whatever sliver of trust remained between management and investors.  The transgressions are reason to dump the stock, which has fallen from $53.80 to $17.19 in the past year, but some investors are trapped in the rubble."
TEVA,TEVA:US,BBG000C0CD58,Street Has No Mercy For Teva Following Dividend Cut,2017-08-11 17:30:44 +0000,https://finance.yahoo.com/news/street-no-mercy-teva-following-173044726.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA )'s management recently made the difficult decision to slash the company’s 6.5-percent dividend by 75 percent, lowering the stock’s yield to just 1.2 ..."
TEVA,TEVA:US,BBG000C0CD58,"Impax Laboratories (IPXL) Q2 Earnings Beat, Revenues Up Y/Y",2017-08-11 15:37:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Frd-e64pEXY/impax-laboratories-ipxl-q2-earnings-beat-revenues-up-yy-cm830947,Impax Laboratories Inc s IPXL shares have risen almost 10 since it announced robust results on Aug 9 The company reported second quarter 2017 adjusted earnings of 18 cents per share beating the Zacks Consensus Estimate of 14 cents However earnings were down 14 3 from 21 cents in
TEVA,TEVA:US,BBG000C0CD58,"Forget Teva (TEVA), Buy These 4 Drug Stocks Instead",2017-08-11 14:38:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hkSo-GedxMk/forget-teva-teva-buy-these-4-drug-stocks-instead-cm830870,It s not been a good quarter for Israel based generic drug maker Teva Pharmaceutical Industries Limited TEVA Teva missed on both second quarter earnings and revenues and lowered its outlook for 2017 The company s shares are down significantly following the release of disappointing
TEVA,TEVA:US,BBG000C0CD58,Valeant: Three Steps to a Recovery?,2017-08-11 13:59:00 +0000,http://finance.yahoo.com/r/ef93b6ad-4030-3c3d-957b-671c90d943b3/valeant-three-steps-to-a-recovery-1502459959?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Ever since Teva Pharmaceuticals Industries (TEVA) reported its terrible earnings, specialty pharmaceutical companies have been under pressure--and Valeant Pharmaceuticals International (VRX) has been no ..."
TEVA,TEVA:US,BBG000C0CD58,"Impax Laboratories (IPXL) Q2 Earnings Beat, Revenues Up Y/Y",2017-08-11 13:11:01 +0000,https://finance.yahoo.com/news/impax-laboratories-ipxl-q2-earnings-131101248.html?.tsrc=rss,Impax Laboratories (IPXL) reported positive second-quarter results with earnings and sales both beating estimates. The company has strengthened its generic portfolio with additional approvals during the quarter.
TEVA,TEVA:US,BBG000C0CD58,"Forget Teva (TEVA), Buy These 4 Drug Stocks Instead",2017-08-11 12:42:12 +0000,https://finance.yahoo.com/news/forget-teva-teva-buy-4-124212412.html?.tsrc=rss,"With generic drugmakers like Teva (TEVA) under pressure, here is a look at four drug stocks that look well-positioned."
TEVA,TEVA:US,BBG000C0CD58,SolarEdge (SEDG) and Teva (TEVA) are Blowouts!,2017-08-10 23:35:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JhvlLPK0Z1U/solaredge-sedg-and-teva-teva-are-blowouts-cm830622,SolarEdge SEDG has reported back to back big beats the most recent one was a blowout 160 Brian Bolan notes that revenue guidance was much better than expected and there is an indication that margins might surprise to the upside as well 160 Brian kills us at the end of the segment with
TEVA,TEVA:US,BBG000C0CD58,SolarEdge (SEDG) and Teva (TEVA) are Blowouts!,2017-08-10 21:43:09 +0000,https://finance.yahoo.com/news/solaredge-sedg-teva-teva-blowouts-214309175.html?.tsrc=rss,One stock is being blown off the books and one had a blow out earnings report.
TEVA,TEVA:US,BBG000C0CD58,"The generic drug market ‘is at risk now’ from deflation, trade group says",2017-08-10 20:14:39 +0000,https://finance.yahoo.com/news/generic-drug-market-risk-now-201439311.html?.tsrc=rss,"An imbalance in supply and demand is the cause of recent pain in the generics industry, said the head of the industry&apos;s trade group."
TEVA,TEVA:US,BBG000C0CD58,"The generic drug market ‘is at risk now’ from deflation, trade group says",2017-08-10 20:14:39 +0000,http://finance.yahoo.com/r/f10b74cf-d7f0-36ad-a980-8bd6a49dbb1f/104645952?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104645952&yptr=yahoo&.tsrc=rss,"An imbalance in supply and demand is the cause of recent pain in the generics industry, said the head of the industry's trade group."
TEVA,TEVA:US,BBG000C0CD58,3 Covered Calls for Long-Term Buy-and-Hold Stocks,2017-08-10 19:37:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BuhJhOmT64E/3-covered-calls-for-long-term-buy-and-hold-stocks-cm830494,InvestorPlace Stock Market News Stock Advice amp Trading Tips Covered calls are options trades that have a lot of utility They can generate additional monthly income which is how I utilize them in my stock advisory newsletter The Liberty Portfolio They can also be used to hedge
TEVA,TEVA:US,BBG000C0CD58,Here's why competitiveness in generic drug market is at r...,2017-08-10 17:47:00 +0000,https://finance.yahoo.com/video/heres-why-competitiveness-generic-drug-174700686.html?.tsrc=rss,"CNBC's Meg Tirrell speaks with Chip Davis, Association for Accessible Medicines president, about generic drugs facing pricing pressures."
TEVA,TEVA:US,BBG000C0CD58,"Noteworthy ETF Inflows: IEFA, TEVA, CHKP, MLCO",2017-08-10 16:34:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ozCJy_xnEeA/noteworthy-etf-inflows-iefa-teva-chkp-mlco-cm830243,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 150 0 million dollar inflow that s a 0 5 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Why Perrigo is Soaring,2017-08-10 15:22:00 +0000,http://finance.yahoo.com/r/1e02bbba-2dae-3ca2-901a-7bc85edd56f7/why-perrigo-is-soaring-1502378575?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"On a day like today, when the entire stock market is under pressure, you must have done something right to see your stock jump more than 10%.  Perrigo reported an adjusted profit of $1.22 a share, beating forecasts for 92 cents, on sales of $1.24 billion, topping estimates of $1.18 billion.  Perrigo also said it expects to report earnings between $4.46 and $4.70 a share in 2017, ahead of the Street consensus for $4.28."
TEVA,TEVA:US,BBG000C0CD58,Generic Drug Makers: The Worst Is Yet To Come,2017-08-10 13:56:00 +0000,http://finance.yahoo.com/r/ebf48ec2-f783-3cbd-8df1-b472b4bf0b83/generic-drug-makers-the-worst-is-yet-to-come-1502373407?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Generic drug makers like Teva Pharmaceuticals (TEVA) and Mylan (MYL) reported disappointing earnings this quarter, telegraphing the headwinds the sector faces.  Not according to RBC Capital Markets' Randall Stanicky and Ashley Ryu. They write that they think pressure on sector EBITDA will persist, with leverage for many pushing up on covenants, leaving elevated risk.  While they write that full capitulation has already come (average 2018 EPS estimates are down 44% in the past 18 months), investors are focused on stabilization now, a process that will take time."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 10, 2017 :  M, QQQ, GLPG, KSS, CBI, TEVA, APRN, JCP, TVIX, XIV, AAPL, OPK",2017-08-10 12:53:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/18KHV2Fn1f4/pre-market-most-active-for-aug-10-2017-m-qqq-glpg-kss-cbi-teva-aprn-jcp-tvix-xiv-aapl-opk-cm829997,The NASDAQ 100 Pre Market Indicator is down 16 4 to 5 902 99 The total Pre Market volume is currently 5 780 422 shares traded The following are the most active stocks for the pre market session Macy s Inc M is 0 57 at 23 60 with 1 220 786 shares traded
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Hike Bets in Major Pharma,2017-08-10 12:40:22 +0000,https://finance.yahoo.com/news/short-sellers-hike-bets-major-124022255.html?.tsrc=rss,"The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased."
TEVA,TEVA:US,BBG000C0CD58,Israel's Stock Market Is Having a Disastrous Week,2017-08-10 12:18:00 +0000,http://finance.yahoo.com/r/29c0ad2d-87d6-3000-b98d-87d198cac156/israel-s-stock-market-is-having-a-disastrous-week.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva's not the only one struggling to stay afloat in Israel.
TEVA,TEVA:US,BBG000C0CD58,"Fed Up With Paying the Price for Teva's Woes, Workers Dig In",2017-08-10 04:00:00 +0000,http://finance.yahoo.com/r/0045b83c-80eb-34c0-80c6-0ad422850cdd/fed-up-with-paying-the-price-for-teva-s-troubles-workers-dig-in?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"White banners with red-and-black Hebrew letters saying ""We won’t be the victims” hang in the parking lot, lobby and hallways of the Teva Pharmaceutical Industries Ltd. factory at Kfar Saba, on the ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva Plunges to 10-Year Low, Credit Rating in Jeopardy",2017-08-09 23:35:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S6-RxKPsHN0/teva-plunges-to-10-year-low-credit-rating-in-jeopardy-cm829875,Shares of Teva Pharmaceuticals TEVA a favorite for investors chasing large dividend yields fell more than 4 4 and hit a 10 year intraday low on Wednesday Just says after the company reported sluggish Q2 earnings investors are continuing to ditch the stock amid reports that Teva
TEVA,TEVA:US,BBG000C0CD58,Valeant and Teva Share Similar Ambitions With Similar Pitfalls,2017-08-09 22:36:00 +0000,http://finance.yahoo.com/r/a6119dd3-137d-3652-aa9b-9199a7bbbcf9/valeant-and-teva-share-similar-ambitions-with-similar-pitfalls.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Wed., Aug. 9."
TEVA,TEVA:US,BBG000C0CD58,"Teva Plunges to 10-Year Low, Credit Rating in Jeopardy",2017-08-09 21:21:09 +0000,https://finance.yahoo.com/news/teva-plunges-10-low-credit-212109342.html?.tsrc=rss,"Shares of Teva Pharmaceuticals (TEVA), a favorite for investors chasing large dividend yields, fell more than 4.4%--and hit a 10-year intraday low--on Wednesday."
TEVA,TEVA:US,BBG000C0CD58,Mylan stock bounces back from early losses after CEO blames FDA for drug delays,2017-08-09 21:13:21 +0000,http://finance.yahoo.com/r/15f47d4a-e8cb-30ac-afb4-2088ced76850/104643358?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104643358&yptr=yahoo&.tsrc=rss,CEO Heather Bresch clarified on a call with investors that delaying Advair's launch to 2018 was due to the Food and Drug Administration reorganizing.
TEVA,TEVA:US,BBG000C0CD58,Mylan’s double whammy: It’s getting hurt by both fast FDA approvals and too-slow ones,2017-08-09 20:10:09 +0000,http://finance.yahoo.com/r/5f11c4a4-4b51-385f-8892-ec26fa299367/Story.aspx?guid=796FD6B6-7D0A-11E7-B6FC-D20F5D7C6FEC&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The company pushed major product launches, including those of two highly-anticipated generic drugs, into its 2018 financial guidance."
TEVA,TEVA:US,BBG000C0CD58,Mylan to defer 2 major U.S. drug launches to 2018,2017-08-09 19:14:00 +0000,https://finance.yahoo.com/video/mylan-defer-2-major-u-191400599.html?.tsrc=rss,CNBC's Meg Tirrell reports Mylan shares are under pressure after reporting weaker than expected earnings.
TEVA,TEVA:US,BBG000C0CD58,Teva Ramping Up Asset Sales to Preserve Credit Rating,2017-08-09 16:00:00 +0000,http://finance.yahoo.com/r/dd560b1e-8992-31af-8b52-a19954b14519/teva-ramping-up-asset-sales-to-preserve-credit-rating.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Moody's kept Teva as investment grade because it remains the largest generic drug company in the world and still has strong cash flow.
TEVA,TEVA:US,BBG000C0CD58,Drugmaker Teva looks to sell Medis business to help cut debt,2017-08-09 14:02:05 +0000,https://finance.yahoo.com/news/drugmaker-teva-looks-sell-medis-140205661.html?.tsrc=rss,"Teva Pharmaceutical Industries  , the world's largest generic drugmaker, said on  Wednesday it was looking for a buyer for its Medis business as  it sells assets to pare down its debt burden.  Teva, which last week reported a drop in  second-quarter results and cut its outlook and dividend,  acquired Iceland-based Medis as part of its acquisition of  Actavis last year.  ""Teva is looking at every opportunity to focus our business  and streamline operations, processes and structure,"" Teva said  in an emailed statement to Reuters."
TEVA,TEVA:US,BBG000C0CD58,Teva just showed investors the big risk in chasing dividend yields,2017-08-09 12:54:58 +0000,http://finance.yahoo.com/r/5bbb2acf-0fc4-3953-a549-13521c244586/Story.aspx?guid=CED6592A-7C5D-11E7-BE68-A3304057D7D4&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Other stocks are vulnerable too, says Nigam Arora."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 9, 2017 :  MYL, TEVA, MPLX, EPD, TVIX, QQQ, BAC, EEP, VNTV, TLT, FOSL, CG",2017-08-09 12:53:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WJyPu6DGK-s/pre-market-most-active-for-aug-9-2017-myl-teva-mplx-epd-tvix-qqq-bac-eep-vntv-tlt-fosl-cg-cm829264,The NASDAQ 100 Pre Market Indicator is down 36 25 to 5 890 1 The total Pre Market volume is currently 11 842 696 shares traded The following are the most active stocks for the pre market session Mylan N V MYL is 2 3 at 29 49 with 1 827 645 shares traded RTT
TEVA,TEVA:US,BBG000C0CD58,Teva shares surge 2.2% after Mylan says it will delay generic Copaxone launch to 2018,2017-08-09 12:30:46 +0000,http://finance.yahoo.com/r/c94095e1-248b-3b7d-b97d-29b158aa8a1f/Story.aspx?guid=0E24B1B4-B894-49BB-90C7-B12E90B505E0&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Teva Pharmaceutical Industries Ltd. shares surged 2.2% in premarket trade Wednesday after Mylan NV said it plans to defer its generic Copaxone launch to its 2018 financial guidance. The multiple sclerosis ...
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm says looking to sell off Medis business,2017-08-09 12:12:25 +0000,https://finance.yahoo.com/news/teva-pharm-says-looking-sell-121225754.html?.tsrc=rss,"Teva Pharmaceutical Industries , the world's largest generic drugmaker, said on Wednesday that it would seek to divest its Medis business that it acquired with its purchase of Actavis. Israel-based Teva, ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva Ramps Up Sales With Medis, Respiratory Units",2017-08-09 11:28:04 +0000,http://finance.yahoo.com/r/4cea67d9-9648-3e53-9867-1fd0acba724b/teva-is-said-to-ramp-up-asset-sales-with-medis-respiratory-unit?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. is ramping up asset sales as the troubled Israeli drug maker works to preserve its credit rating and cut debt, people familiar with the matter said."
TEVA,TEVA:US,BBG000C0CD58,Teva Sinks 40% as It Loses Top Rating from 5 Firms,2017-08-08 21:58:00 +0000,http://finance.yahoo.com/r/b8858027-bb35-38c7-a12e-336f73bb479f/teva-sinks-40-it-loses-top-rating-5-firms?partner=YahooSA&yptr=yahoo&.tsrc=rss,Analysts indicate that the Israeli pharmaceutical giant faces long-term challenges in the US.
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical and Under Armour Are Looking So Unhealthy,2017-08-08 21:36:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kAUy5vi1l_o/why-teva-pharmaceutical-and-under-armour-are-looking-so-unhealthy-cm829066,In this segment from Motley Fool Money host Chris Hill Million Dollar Portfolio s Jason Moser Total Income s Ron Gross and Supernova and Rule Breakers David Kretzmann first consider the confluence of ugliness that came together last week for
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical and Under Armour Are Looking So Unhealthy,2017-08-08 19:54:23 +0000,http://finance.yahoo.com/r/8f2c5079-a443-37f3-ba4a-fb9aedff2e01/why-teva-pharmaceutical-and-under-armour-are-looki.aspx?yptr=yahoo&.tsrc=rss,"The world&apos;s top generic-drug maker just suffered through a week that saw the market trim its value by about one-third. Meanwhile, the athletic gear upstart is down by half in the past year."
TEVA,TEVA:US,BBG000C0CD58,[$$] Valeant/Teva: lost summer,2017-08-08 19:15:05 +0000,"http://finance.yahoo.com/r/7de55247-d77c-381c-9a8c-0737a7a35ffa/31996cae-7c55-11e7-9108-edda0bcbc928,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","The summer of 2015 seems like a long time ago for the once-rollicking drugmaking luminaries. The first to crumble was Valeant Pharmaceuticals, a vehicle for buying smaller drugmakers and jacking up treatment ..."
TEVA,TEVA:US,BBG000C0CD58,Israeli Officials Ask Teva to Delay Planned Job Cuts,2017-08-08 16:15:00 +0000,http://finance.yahoo.com/r/d0648c4f-66ae-3e95-8ad3-0a53fe39d062/israeli-officials-ask-teva-to-delay-planned-job-cuts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva receives special tax benefits from Israel.
TEVA,TEVA:US,BBG000C0CD58,"Company News For August 08, 2017",2017-08-08 15:43:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9dx2A9hu-n8/company-news-for-august-08-2017-cm828767,160 160 160 160 160 160 160 160 Shares of Tyson Foods Inc TSN surged 5 7 after third quarter net sales increased 4 8 to 9 85 billion beating the Zacks Consensus Estimate of 9 48 billion 160 160 160 160 160 160 160 160 Shares of Rockwell Collins Inc
TEVA,TEVA:US,BBG000C0CD58,"Tuesday’s Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX)",2017-08-08 13:40:57 +0000,https://finance.yahoo.com/news/tuesday-vital-data-apple-inc-134057802.html?.tsrc=rss,"U.S. stock futures are trading lower this morning, as Wall Street eyes a rally in crude oil amid another influx of corporate earnings.  At last check, futures on the Dow Jones Industrial Average were down 0.08%, Nasdaq-100 futures were off by 0.23% and S&P 500 futures were lagging by 0.14%.  Turning to Monday’s options activity, Apple Inc. (NASDAQ:AAPL) CEO Tim Cook reportedly met with India’s Prime Minister recently to talk iPhone production and the company just bought India-based Eros Group’s entire content library of movies and music."
TEVA,TEVA:US,BBG000C0CD58,"Company News For August 08, 2017",2017-08-08 13:35:01 +0000,https://finance.yahoo.com/news/company-news-august-08-2017-133501353.html?.tsrc=rss,"Companies in the news are: TSN,COL,UTX,TEVA,NXTM"
TEVA,TEVA:US,BBG000C0CD58,"With Teva Down 20%, Blaming FDA Policies",2017-08-08 13:30:00 +0000,http://finance.yahoo.com/r/c6ddff08-fd85-3ef4-bdc4-82ece7d4d561/teva-down-20-blaming-fda-policies?partner=YahooSA&yptr=yahoo&.tsrc=rss,The Israeli pharmaceutical giant blames a $6.1B write down in Q2 on increased competition in the US.
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 8, 2017 :  VRX, ENDP, TEVA, ABB, FGEN, QQQ, INVA, CAR, KORS, NVDA, HTZ, PAGP",2017-08-08 12:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/um4N-O5f0N0/pre-market-most-active-for-aug-8-2017-vrx-endp-teva-abb-fgen-qqq-inva-car-kors-nvda-htz-pagp-cm828565,The NASDAQ 100 Pre Market Indicator is down 1 37 to 5 933 36 The total Pre Market volume is currently 7 622 229 shares traded The following are the most active stocks for the pre market session Valeant Pharmaceuticals International Inc VRX is 1 37 at 16 74
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals,2017-08-08 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000548.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Valeant Pharmaceuticals had a positive day in the green yesterday, despite Teva Pharmaceuticals shares plummeting. It was just last week that Valeant saw its ..."
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, Intrepid Potash, and Ensco Slumped Today",2017-08-07 21:35:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IiBnoLveDBQ/why-teva-pharmaceutical-industries-intrepid-potash-and-ensco-slumped-today-cm828359,Monday was another good day for stocks as major benchmarks continued their slow but steady ascent Without much in the way of market moving news on the geopolitical or macroeconomic fronts investors largely focused on individual companies especially in the wake of numerous
TEVA,TEVA:US,BBG000C0CD58,3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping?,2017-08-07 21:35:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V7kTi3Bd36c/3-stocks-hitting-52-week-lows-time-to-go-bargain-shopping-cm828356,There s an old saying that a rising tide lifts all boats That s true but only if the boats don t have holes in them With the S amp P 500 index hitting an all time high recently most stocks are performing quite well Not all of them though A few are sinking like leaky
TEVA,TEVA:US,BBG000C0CD58,"Multnomah County seeks $250M from Purdue, other opioid manufacturers",2017-08-07 21:06:57 +0000,http://finance.yahoo.com/r/3e9ee5a3-16fc-3050-b356-0d989770a88c/multnomah-county-seeks-250m-from-purdue-other.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Multnomah County is the latest local government to sue Purdue Pharma and 22 other opioid manufacturers.  The suit, which seeks $250 million in damages, was filed late last week, days after the Multnomah County Board of Commissioners declared the oversupply of prescription opioids a public nuisance.  “As a matter of common sense and medical evidence, long-term use of opioids — drugs that can kill you or commit you to a lifetime of addictions — does not improve function or quality of life,” the 118-page complaint filed in Multnomah County Circuit Court reads."
TEVA,TEVA:US,BBG000C0CD58,"After Hours Most Active for Aug 7, 2017 :  AN, F, FCN, BAC, TEVA, C",2017-08-07 21:03:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xpMAj-D65rE/after-hours-most-active-for-aug-7-2017-an-f-fcn-bac-teva-c-cm828381,The NASDAQ 100 After Hours Indicator is down 1 66 to 5 933 07 The total After hours volume is currently 40 325 892 shares traded The following are the most active stocks for the after hours session AutoNation Inc AN is unchanged at 40 34 with 6 619 256
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Intrepid Potash, Inc. (IPI) and Marathon Oil Corporation (MRO) Are 3 of Today’s Worst Stocks",2017-08-07 20:39:31 +0000,https://finance.yahoo.com/news/why-teva-pharmaceutical-industries-ltd-203931702.html?.tsrc=rss,"Intrepid Potash, Inc. (NYSE:IPI), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Marathon Oil Corporation (NYSE:MRO) were doomed from the start of today’s trading.  In terms of total market cap lost and total volume traded though, it was Marathon Oil that did the most damage to the most shareholders, losing 4.2% of its value on significant volume."
TEVA,TEVA:US,BBG000C0CD58,3 Stocks Hitting 52-Week Lows: Time to Go Bargain Shopping?,2017-08-07 20:21:00 +0000,http://finance.yahoo.com/r/c031165a-2da9-36b6-9408-4caaa4dd89fb/3-stocks-hitting-52-week-lows-time-to-go-bargain-s.aspx?yptr=yahoo&.tsrc=rss,"Endologix, Lannett, and Teva stocks are sinking while the overall market is rising. Are they bargains or busts?"
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries, Intrepid Potash, and Ensco Slumped Today",2017-08-07 20:20:00 +0000,http://finance.yahoo.com/r/afa47765-2259-3fdb-94e0-ab7ca3c56a32/why-teva-pharmaceutical-industries-intrepid-potash.aspx?yptr=yahoo&.tsrc=rss,"Despite a stronger market, these stocks fell. Find out why."
TEVA,TEVA:US,BBG000C0CD58,Mylan Is at Risk From These Insurmountable Sector Headwinds,2017-08-07 20:06:00 +0000,http://finance.yahoo.com/r/6a7b77db-fb50-39a2-9784-a4ebe681a9aa/analyst-maintains-near-term-cautious-stance-on-mylan.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,RBC Capital analyst Randall Stanicky thinks Mylan is not immune to the broader challenges facing the generic drug industry.
TEVA,TEVA:US,BBG000C0CD58,"Teva: Another Day, Another Downgrade",2017-08-07 19:10:00 +0000,http://finance.yahoo.com/r/81459483-8f82-3e66-a1ca-07538ad6cd24/teva-another-day-another-downgrade-1502133031?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"On Thursday, Teva Pharmaceutical Industries (TEVA) tumbled more than 20% after reporting dreadful earnings and cutting its dividend.  On Friday, Teva had its rating cut by four analysts, all of whom had rated the stock Outperform before the downgrade.  Today, Morgan Stanley analyst David Risinger and team cut their rating on Teva too, but at least they had it rate Equal Weight before downgrading it to Underweight."
TEVA,TEVA:US,BBG000C0CD58,How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback,2017-08-07 18:35:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Hi3m5b93Wo/how-valeant-pharmaceuticals-intl-inc-vrx-stock-can-make-a-comeback-cm828300,InvestorPlace Stock Market News Stock Advice amp Trading Tips There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc 160 NYSE VRX stock ahead of its second quarter fiscal 2017 earnings results before Tuesday s opening bell For example VRX stock
TEVA,TEVA:US,BBG000C0CD58,"Advanced Micro Devices, Inc. (AMD) Stock Needs Another Home Run",2017-08-07 18:34:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nRXEJREzj2w/advanced-micro-devices-inc-amd-stock-needs-another-home-run-cm828294,InvestorPlace Stock Market News Stock Advice amp Trading Tips Unveiling the latest generation of high end graphics cards should ve been a knockout punch for Advanced Micro Devices Inc NASDAQ AMD in its long competitive struggle with Nvidia Corporation 160 NASDAQ
TEVA,TEVA:US,BBG000C0CD58,"Monday’s Vital Data: Tesla Inc (TSLA), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Snap Inc (SNAP)",2017-08-07 17:35:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NvBerLVCuIo/mondays-vital-data-tesla-inc-tsla-teva-pharmaceutical-industries-ltd-adr-teva-and-snap-inc-snap-cm828256,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are headed higher this morning with Wall Street looking toward a positive start as Friday s non farm payrolls data spills over Last week the Dow Jones Industrial Average logged
TEVA,TEVA:US,BBG000C0CD58,Teva’s stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more,2017-08-07 17:18:19 +0000,http://finance.yahoo.com/r/4239bc35-2df6-349d-b6c7-41d2b5d945b8/Story.aspx?guid=87BF4B26-7B88-11E7-961F-F4B810E967A1&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Teva’s corporate troubles have been exacerbated by wider generic drug industry challenges.
TEVA,TEVA:US,BBG000C0CD58,"Teva's Crash Is Just Getting Started, Here Comes a 55% Bear Raid",2017-08-07 17:17:00 +0000,https://finance.yahoo.com/news/video-teva-could-plunge-another-143900921.html?.tsrc=rss,Morgan Stanley doesn't have much confidence in Teva Pharmaceutical.
TEVA,TEVA:US,BBG000C0CD58,Teva Just Got One of the Latest Stock Downgrades by an Investment Bank Maybe Ever,2017-08-07 16:14:00 +0000,http://finance.yahoo.com/r/211b8686-6ead-3f12-9319-38a890e1af2d/teva-stock-tumbles-again-on-morgan-stanley-downgrade.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"It's a long road to recovery for Teva, Morgan Stanley says."
TEVA,TEVA:US,BBG000C0CD58,Teva Is Still Being Pounded After Horrific Week,2017-08-07 16:12:00 +0000,http://finance.yahoo.com/r/541333cc-06f1-3f3a-94e5-e12609926469/teva-drops-in-premarket-trading-after-tumultuous-trading-in-israel.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,It's not looking good for Teva
TEVA,TEVA:US,BBG000C0CD58,Teva's stock keeps plunging on heavy volume after Morgan Stanley downgrade,2017-08-07 16:10:35 +0000,http://finance.yahoo.com/r/2f2366f9-de52-3391-a23a-92da34c84a38/Story.aspx?guid=48585A05-4D75-461C-832A-39BFBA92933A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Teva Pharmaceutical Industries Ltd. tumbled 8% in morning trade Monday on heavy volume, putting them on track to close at a 14-year low, as Morgan Stanley turned bearish on the generic drug maker ..."
TEVA,TEVA:US,BBG000C0CD58,"Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing",2017-08-07 15:55:01 +0000,https://finance.yahoo.com/news/every-generation-drug-people-dealing-155501149.html?.tsrc=rss,"The state of Ohio sues pharmaceutical companies for pushing painkillers. Missouri cops carry opioid antidotes in their cars. Judges everywhere play doctor, forcing abusers to choose between anti-addiction ..."
TEVA,TEVA:US,BBG000C0CD58,Generic Drug Stocks Take a Hit: Here's Why,2017-08-07 15:43:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KMqEPQwxUDY/generic-drug-stocks-take-a-hit-heres-why-cm828109,It s been a tough week for generic drugmakers which saw their shares tumbling following the release of disappointing second quarter results from Israel based Teva Pharmaceutical Industries Limited TEVA Teva not only missed on earnings and revenue expectations the company also slashed its
TEVA,TEVA:US,BBG000C0CD58,"VIVUS (VVUS) Q2 Loss In Line with Estimates, Sales Down Y/Y",2017-08-07 15:42:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iWnoPyx_WCc/vivus-vvus-q2-loss-in-line-with-estimates-sales-down-yy-cm828081,VIVUS Inc VVUS reported a loss of 13 cents per share in the second quarter of 2017 which was wider than a loss of 11 cents in the year ago period However the loss was in line with the Zacks Consensus Estimate VIVUS Inc Price Consensus and EPS
TEVA,TEVA:US,BBG000C0CD58,Valeant: Why Teva's Blowup Could Be Good News,2017-08-07 14:04:00 +0000,http://finance.yahoo.com/r/b4f3385c-827b-387d-9322-6996cfd39741/valeant-why-tevas-blowup-could-be-good-news-1502114661?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last week, Valeant Pharmaceuticals International (VRX) tumbled 10% but for once it had nothing to do with anything Valeant did.  Instead, it fell after Teva Pharmaceutical Industries (TEVA) announced god-awful earnings and guidance due to pressure in its generics business, pressures that were then extrapolated to just about every specialty-pharmaceutical company, including Valeant.  Valeant is scheduled to report earnings tomorrow, and last week's plunge creates an interesting setup going into the print: Was last week's pain enough to tamp down the reaction to bad news?"
TEVA,TEVA:US,BBG000C0CD58,How Valeant Pharmaceuticals Intl Inc (VRX) Stock Can Make a Comeback,2017-08-07 13:53:37 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-135337338.html?.tsrc=rss,"There are tons of reason to be skeptical about Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock ahead of its second-quarter fiscal 2017 earnings results before Tuesday’s opening bell.  The embattled drugmaker continues to make operational improvements, including divesting various non-core assets to lower debts.  Since falling to a 52-week low of $8.31 on April 24, Valeant stock has skyrocketed as much as 118%, reaching $18.17 on July 25."
TEVA,TEVA:US,BBG000C0CD58,Generic Drug Stocks Take a Hit: Here&apos;s Why,2017-08-07 13:14:01 +0000,https://finance.yahoo.com/news/generic-drug-stocks-hit-apos-131401847.html?.tsrc=rss,"As generic drug pricing concerns loom large, Teva (TEVA) and other players in the generic market saw their shares tumble last week."
TEVA,TEVA:US,BBG000C0CD58,"Monday’s Vital Data: Tesla Inc (TSLA), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Snap Inc (SNAP)",2017-08-07 13:08:02 +0000,https://finance.yahoo.com/news/monday-vital-data-tesla-inc-130802290.html?.tsrc=rss,"U.S. stock futures are headed higher this morning, with Wall Street looking toward a positive start as Friday’s non-farm payrolls data spills over.  Last week, the Dow Jones Industrial Average logged its ninth-straight daily gain, its longest winning streak since February.  At last check, futures on the Dow Jones Industrial Average were up 0.12%, Nasdaq-100 futures had added 0.16% and S&P 500 futures were lagging with a gain of 0.09%."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 7, 2017 :  NXTM, ERIC, TEVA, ZYNE, HZNP, MYL, QQQ, SNAP, BAC, AKS, BABA, CLF",2017-08-07 12:53:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DRwYrZm3WZ0/pre-market-most-active-for-aug-7-2017-nxtm-eric-teva-zyne-hznp-myl-qqq-snap-bac-aks-baba-clf-cm827935,The NASDAQ 100 Pre Market Indicator is up 7 71 to 5 907 62 The total Pre Market volume is currently 3 488 683 shares traded The following are the most active stocks for the pre market session NxStage Medical Inc NXTM is 6 34 at 29 48 with 3 714 105
TEVA,TEVA:US,BBG000C0CD58,"Morning Movers: Tyson Jumps, Horizon Soars, Teva Tumbles",2017-08-07 12:43:00 +0000,http://finance.yahoo.com/r/bf1de2a4-55e6-38fc-b5b7-a71328181ee9/morning-movers-tyson-jumps-horizon-soars-teva-tumbles-1502109831?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks look set for a higher open, with the Dow Jones Industrial Average on pace for a ninth-consecutive record high. S&P 500 futures have risen 0.1%, while Dow Jones Industrial Average futures have advanced ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceuticals Had a Very Bad Day, in a Very Bad Year",2017-08-07 12:37:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8t1LokvYjmk/teva-pharmaceuticals-had-a-very-bad-day-in-a-very-bad-year-cm827900,In this Market Foolery 160 podcast segment host Chris Hill and Motley Fool One s Bill Mann consider how much worse Teva Pharmaceutical Industries NYSE TEVA 160 looks presently after a second quarter report that featured weak sales low profits a 75 dividend
TEVA,TEVA:US,BBG000C0CD58,Teva Announces FDA Approval of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol,2017-08-07 12:00:00 +0000,https://finance.yahoo.com/news/teva-announces-fda-approval-qvar-120000813.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved QVAR® RediHaler™ inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma as a prophylactic therapy in patients 4 years of age and older."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceuticals Had a Very Bad Day, in a Very Bad Year",2017-08-07 11:13:00 +0000,http://finance.yahoo.com/r/0ccc7bea-5342-3ba8-a5bd-53ab80c1ef7d/teva-pharmaceuticals-had-a-very-bad-day-in-a-very.aspx?yptr=yahoo&.tsrc=rss,The generic drugmaker lost 20% of its market cap last Thursday after a quarterly report that was heavy on bearish news.
TEVA,TEVA:US,BBG000C0CD58,Teva: FDA Approves QVAR RediHaler Inhalation Aerosol - Quick Facts,2017-08-07 08:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ze8r0fK-8A8/teva-fda-approves-qvar-redihaler-inhalation-aerosol--quick-facts-20170807-00496,Teva: FDA Approves QVAR RediHaler Inhalation Aerosol - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,Teva's Trouble Was Predicted. Path to Recovery Not as Clear,2017-08-07 04:00:29 +0000,http://finance.yahoo.com/r/8f8c9c20-b6b5-38e8-b4c1-cf25119723f3/teva-s-trouble-was-predicted-its-path-to-recovery-not-as-clear?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,You can’t say investors weren’t warned.
TEVA,TEVA:US,BBG000C0CD58,"The generic drug bloodbath continues for a second day, with Teva leading the way",2017-08-06 14:36:41 +0000,http://finance.yahoo.com/r/17c805ac-c869-35e9-b432-5f4bb60ef96d/Story.aspx?guid=1CBA9F06-784A-11E7-8BAC-51224A647843&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Generic drug prices have been going down, and the trend isn’t expected to go away soon."
TEVA,TEVA:US,BBG000C0CD58,"Tesla Speeds Ahead, While Teva Hits the Skids",2017-08-05 22:58:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j4Or6RY8ihw/tesla-speeds-ahead-while-teva-hits-the-skids-cm827751,On this Market Foolery podcast host Chris Hill and Motley Fool One s Bill Mann 160 discuss two very different companies with two wildly different places in the market today As electric car innovator Tesla NASDAQ TSLA begins to deliver its long awaited Model 3
TEVA,TEVA:US,BBG000C0CD58,"Tesla Speeds Ahead, While Teva Hits the Skids",2017-08-05 21:00:00 +0000,http://finance.yahoo.com/r/195ceed3-dca2-37bd-8424-19db48845745/tesla-speeds-ahead-while-teva-hits-the-skids.aspx?yptr=yahoo&.tsrc=rss,"For the electric-car maker, outperformance in Q2 was just the prologue to the real challenge. For the generic-drug maker, the news just keeps getting worse."
TEVA,TEVA:US,BBG000C0CD58,Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter,2017-08-05 18:58:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_J-lUtP6izo/vanguard-health-care-fund-gains-4-international-stocks-in-2nd-quarter-cm827740,Vanguard Health Care Fund Trades Portfolio portfolio manager Jean Hynes invested in four international health care companies during the second quarter Her new holdings are in Sysmex Corp TSE 6869 Terumo Corp TSE 4543 WuXi Biologics Cayman Inc HKSE 02269 and Idorsia
TEVA,TEVA:US,BBG000C0CD58,How You Can Beat the Still Astronomical Prices for Prescription Drugs,2017-08-05 14:26:00 +0000,http://finance.yahoo.com/r/c0bc418f-913c-3e65-9acc-56f65d4eaccf/how-consumers-can-beat-the-costs-of-prescription-drugs.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The prices of generic drugs are declining as more of them are becoming available on the market along with pressure from major retail pharmacies.
TEVA,TEVA:US,BBG000C0CD58,"Teva, Mylan Seen to Stay on M&A Sidelines",2017-08-05 12:27:00 +0000,http://finance.yahoo.com/r/0e62b320-e863-3291-8e5f-b7964880206c/teva-mylan-seen-to-stay-on-m-amp-a-sidelines.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Teva is 'in no shape' to be making acquisitions while Mylan is 'still pretty leveraged,' says Oppenheimer analyst Derek Archila."
TEVA,TEVA:US,BBG000C0CD58,"Falling U.S. Generic Drug Prices Hurt Manufacturers, Wholesalers",2017-08-05 03:45:26 +0000,http://finance.yahoo.com/r/c4b31cc4-b7fc-354d-ae58-d19aeb092ce8/falling-u-s-generic-drug-prices-hurt-manufacturers-wholesalers-1501877062?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"U.S. generic-drug prices are falling at the fastest rate in years, eating into the profits of pharmaceutical wholesalers and manufacturers alike and erasing billions of dollars of their market value in ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva May Need to Pay Up to Lure a CEO Able to Reverse Its Fortunes,2017-08-05 03:44:20 +0000,http://finance.yahoo.com/r/74d6a074-2c11-3ca4-950d-7720d0de81b0/teva-may-need-to-pay-up-to-lure-a-ceo-able-to-reverse-its-fortunes-1501857088?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Troubled Israeli drugmaker Teva, which for months has been unsuccessfully searching for a new chief executive, may be forced to open its wallet wide to lure a candidate to help reverse its fortunes."
TEVA,TEVA:US,BBG000C0CD58,Netflix Crusade Against Movie Theaters May Take Longer Than Expected -ICYMI Friday,2017-08-04 23:30:00 +0000,http://finance.yahoo.com/r/4cc906e8-11c3-3dcf-8bb0-23bd5f79162f/netflix-crusade-against-movie-theaters-may-take-longer-than-expected-icymi-friday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Friday, Aug. 4"
TEVA,TEVA:US,BBG000C0CD58,"Falling U.S. Generic Drug Prices Hurt Manufacturers, Wholesalers",2017-08-04 22:22:43 +0000,http://finance.yahoo.com/r/c4b31cc4-b7fc-354d-ae58-d19aeb092ce8/falling-u-s-generic-drug-prices-hurt-manufacturers-wholesalers-1501877062?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"U.S. generic-drug prices are falling at the fastest rate in years, eating into the profits of pharmaceutical wholesalers and manufacturers alike and erasing billions of dollars of their market value in ..."
TEVA,TEVA:US,BBG000C0CD58,"3 Big Stock Charts for Friday: GoPro Inc (GPRO), Valeant Pharmaceuticals Intl Inc (VRX) and Microchip Technology Inc. (MCHP)",2017-08-04 22:01:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fAToxN_xvq8/3-big-stock-charts-for-friday-gopro-inc-gpro-valeant-pharmaceuticals-intl-inc-vrx-and-microchip-technology-inc-mchp-cm827605,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market is trying to make a move back towards its highs for the last day of the week as light earnings reporting and no headline risk are allowing investors to push stocks higher on lighter volume There are
TEVA,TEVA:US,BBG000C0CD58,Teva's Massive Debt Load Just Became an Even Bigger Issue,2017-08-04 21:10:00 +0000,http://finance.yahoo.com/r/d4fb36e0-042f-3d1c-b251-862320514f3d/teva-s-massive-debt-load-just-became-an-even-bigger-issue.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,It is just not going to get better anytime soon.
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Are Getting Obliterated Again After Vicious Investment Bank Downgrades,2017-08-04 21:06:00 +0000,http://finance.yahoo.com/r/f2cc6cbd-a95e-3a07-af28-1b1bf0a0462d/teva-is-cut-after-three-strikes-at-credit-suisse.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva's stock is crumbling as another analyst slams it with a downgrade.
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Stock Fell for a Second Straight Day,2017-08-04 20:00:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-NrsQOMZXTY/why-teva-pharmaceutical-industries-stock-fell-for-a-second-straight-day-cm827487,What happened Shares of Teva Pharmaceutical Industries NYSE TEVA 160 are down 9 8 as 1 15 p m EDT after dropping by an even greater amount yesterday following disappointing second quarter results and lowered guidance Today s sinking stock price seems to be due to
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Not a Falling Knife, It’s a Guillotine",2017-08-04 19:02:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hNtbTvkoEXk/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-not-a-falling-knife-its-a-guillotine-cm827499,InvestorPlace Stock Market News Stock Advice amp Trading Tips Fundamentally I am not here to argue for value in Teva Pharmaceutical Industries Ltd ADR NYSE TEVA It is expensive on a fundamental basis Furthermore it s facing operational challenges and competition
TEVA,TEVA:US,BBG000C0CD58,"Teva Shares Get CRUSHED Again and Earn This Unwanted Distinction, Jim Cramer Says",2017-08-04 18:27:00 +0000,http://finance.yahoo.com/r/82354980-437e-3975-882c-3614e6c81a12/teva-shares-get-pounded-and-earn-this-unwanted-distinction-jim-cramer-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva gets rocked.
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Stock Fell for a Second Straight Day,2017-08-04 18:20:28 +0000,http://finance.yahoo.com/r/92fd4107-9e40-3c03-85de-b5c9ebb9642b/why-teva-pharmaceutical-industries-ltd-fell-for-a.aspx?yptr=yahoo&.tsrc=rss,Analyst downgrades are sinking shares of the generic-drug maker.
TEVA,TEVA:US,BBG000C0CD58,Analysts Still Like Allergan,2017-08-04 18:12:49 +0000,https://finance.yahoo.com/news/analysts-still-allergan-181249687.html?.tsrc=rss,"Following Allergan plc Ordinary Shares (NYSE: AGN ) second-quarter results , UBS still likes the company. Analyst Marc Goodman said, despite the beat-and-raise quarter, investors are skeptical concerning ..."
TEVA,TEVA:US,BBG000C0CD58,"3 Big Stock Charts for Friday: GoPro Inc (GPRO), Valeant Pharmaceuticals Intl Inc (VRX) and Microchip Technology Inc. (MCHP)",2017-08-04 17:40:54 +0000,https://finance.yahoo.com/news/3-big-stock-charts-friday-174054340.html?.tsrc=rss,"Today’s three big stock charts look at the charts for GoPro Inc (NASDAQ:GPRO), Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Microchip Technology Inc. (NASDAQ:MCHP) as these companies are making moves that put them in the top five for each of their indices.  Leave it to GoPro to figure out a way to pull a good quarter off.  The 20% rally in GPRO shares has catapulted the stock above its 50- and 200-day moving averages, both of which have been trending lower."
TEVA,TEVA:US,BBG000C0CD58,"Teva: Three Strikes, We're Out!",2017-08-04 17:25:00 +0000,http://finance.yahoo.com/r/ff704ca8-4fff-350b-8f78-235f91af09e6/teva-three-strikes-were-out-1501867544?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Yesterday, Teva Pharmaceutical Industries (TEVA) missed earnings forecasts, cut its full-year guidance and slashed its dividend, too, causing its shares to tumble 24%. So what does it do for an encore? ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Will Bounce Big Soon for Traders: Chart,2017-08-04 16:40:00 +0000,http://finance.yahoo.com/r/6e5a1fd1-58e5-3284-a686-9cdb5157d0fa/teva-pharmaceutical-will-bounce-big-soon-for-traders-chart.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Shares of TEVA have hit an extreme oversold reading, a big bounce is coming soon for traders."
TEVA,TEVA:US,BBG000C0CD58,Teva Loses Another Bull; Credit Suisse Downgrades,2017-08-04 16:16:40 +0000,https://finance.yahoo.com/news/teva-loses-another-bull-credit-161640103.html?.tsrc=rss,Five analysts have downgraded Teva Pharmaceuticals Industries Ltd (ADR) (NYSE: TEVA ) since it reported its second-quarter earnings on Thursday before the market opened. Credit Suisse’s Vamil Diva is one ...
TEVA,TEVA:US,BBG000C0CD58,"Teva Q2 Earnings Lag, '17 View & Dividend Cut, Stock Slumps",2017-08-04 16:05:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DlQMZMjR9Ms/teva-q2-earnings-lag-17-view-dividend-cut-stock-slumps-cm827296,Teva Pharmaceutical Industries Limited TEVA reported second quarter 2017 earnings of 99 cents per share including equity compensation expenses which missed the Zacks Consensus Estimate of 1 06 per share by 6 6 The year ago adjusted earnings were 1 22 per share Revenues of 5 69
TEVA,TEVA:US,BBG000C0CD58,"IEUR, IDEV: Big ETF Inflows",2017-08-04 16:03:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XSgMvQ1keQw/ieur-idev-big-etf-inflows-cm827272,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI Europe ETF IEUR which added 4 400 000 units or a 7 3 increase week over week Among the largest underlying components of IEUR in
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva May Need to Pay Up to Lure a CEO Able to Reverse its Fortunes,2017-08-04 15:15:33 +0000,http://finance.yahoo.com/r/74d6a074-2c11-3ca4-950d-7720d0de81b0/teva-may-need-to-pay-up-to-lure-a-ceo-able-to-reverse-its-fortunes-1501857088?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Troubled Israeli drugmaker Teva, which for months has been unsuccessfully searching for a new chief executive, may be forced to open its wallet wide to lure a candidate to help reverse its fortunes."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Not a Falling Knife, It’s a Guillotine",2017-08-04 14:40:55 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-144055959.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
TEVA,TEVA:US,BBG000C0CD58,"P&G, Valeant Exemplify Wall Street's 'Overboarded' Problem; Musk Must Raise Funds",2017-08-04 14:38:00 +0000,http://finance.yahoo.com/r/fdeeb988-1a22-3c5d-b761-1bbedc955759/p-amp-g-valeant-exemplify-wall-street-s-overboarded-problem-musk-must-raise-funds-icymi-thursday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Thursday, Aug. 3."
TEVA,TEVA:US,BBG000C0CD58,"Teva Q2 Earnings Lag, &apos;17 View & Dividend Cut, Stock Slumps",2017-08-04 13:57:01 +0000,https://finance.yahoo.com/news/teva-q2-earnings-lag-apos-135701083.html?.tsrc=rss,Teva Pharmaceutical Industries Limited&apos;s (TEVA) Q2 earnings and missed expectations. It also slashed its 2017 earnings and sales outlook and cut its dividend by 75%.
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Mixed 2Q Results from Pfizer, Bristol-Myers Announces IO Deals",2017-08-04 12:47:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mixed-2q-124712684.html?.tsrc=rss,Pfizer&apos;s (PFE) results were mixed while Teva had a dismal quarter with the company missing estimates as well as cutting its outlook and guidance.
TEVA,TEVA:US,BBG000C0CD58,The Market In 5 Minutes,2017-08-04 12:32:20 +0000,https://finance.yahoo.com/news/market-5-minutes-123220688.html?.tsrc=rss,"IN THE NEWS Benzinga Macau has staged a dramatic comeback, and major casino stocks are reflecting this. An anti-corruption crackdown by the Chinese government posed an initial threat to the region, but ..."
TEVA,TEVA:US,BBG000C0CD58,"Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Regeneron Pharmaceuticals, Inc.",2017-08-04 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000345.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 4, 2017 / Teva's shares hit a 13 year low on Thursday after reporting a miss in its second quarter earnings report, as well as a lowered outlook and a dividend cut. Regeneron ..."
TEVA,TEVA:US,BBG000C0CD58,"Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals",2017-08-04 11:00:00 +0000,https://finance.yahoo.com/news/wal-mart-walgreens-cvs-turn-110000760.html?.tsrc=rss,"The largest U.S. retail pharmacies,  including Wal-Mart Stores Inc and Walgreens Boots  Alliance Inc, are wielding more leverage when buying  generic drugs, accelerating a decline in prices likely to affect  drug companies for some time, industry experts said on Thursday.  The extent of the shift became clearer this week, when  wholesale drug distributors Cardinal Health Inc and  AmerisourceBergen Corp, as well as top global generic  drugmaker Teva Pharmaceutical Industries Ltd, warned  of generic price declines of as much as 9 percent through the  end of the year.  On Thursday, Teva fell 24  percent, while rival Mylan NV dropped 6 percent and  AmerisourceBergen fell 10 percent."
TEVA,TEVA:US,BBG000C0CD58,[$$] No Cure in Sight for Teva,2017-08-04 04:20:04 +0000,http://finance.yahoo.com/r/9b08e21b-e70c-31b8-bd0f-4b3a0e0cd0a4/no-cure-in-sight-for-teva-1501770864?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Don’t be fooled by the low valuation. Teva Pharmaceutical Industries is a dangerous stock to own.
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Pharmaceutical’s Stock Tumbles on Outlook,2017-08-04 04:17:18 +0000,http://finance.yahoo.com/r/3b951cfb-0707-3d04-865b-6338fc60066e/generic-competition-roils-teva-1501773117?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"The world’s biggest seller of generic drugs lost a quarter of its market value Thursday as concerns mounted about the future of the company, which has no chief executive and is struggling under the weight ..."
TEVA,TEVA:US,BBG000C0CD58,"Elon Musk Reveals Tons of People Have Canceled Tesla Model 3 Orders, Proving Several Key Things",2017-08-04 00:05:00 +0000,http://finance.yahoo.com/r/fbbf5cfb-559d-33c1-a44a-4234fc08e092/tesla-ceo-elon-musk-will-not-solve-world-hunger-and-save-humanity.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Tesla is absurd.
TEVA,TEVA:US,BBG000C0CD58,"Wal-Mart, Walgreens, CVS turn up the heat on generic drugmaker deals",2017-08-03 23:57:55 +0000,https://finance.yahoo.com/news/wal-mart-walgreens-cvs-turn-233102156.html?.tsrc=rss,"The extent of the shift became clearer this week, when wholesale drug distributors Cardinal Health Inc and AmerisourceBergen Corp, as well as top global generic drugmaker Teva Pharmaceutical Industries Ltd, warned of generic price declines of as much as 9 percent through the end of the year.  On Thursday, Teva fell 24 percent, while rival Mylan NV dropped 6 percent and AmerisourceBergen fell 10 percent."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Hits 13-Year Low,2017-08-03 23:01:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sFy_A5oXNGQ/teva-pharmaceutical-industries-ltd-adr-teva-stock-hits-13-year-low-cm826954,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s no denying that today s earnings report is not good news for Israel based Teva Pharmaceutical Industries Ltd ADR NYSE TEVA the world s largest generic drug maker and the largest company in
TEVA,TEVA:US,BBG000C0CD58,What Happened in the Stock Market Today,2017-08-03 23:00:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p_JpB2YNBPU/what-happened-in-the-stock-market-today-cm826913,Most stocks fell Thursday but the Dow Jones Industrial Average DJINDICES DJI 160 set another record while the S amp P 500 SNPINDEX GSPC 160 posted a small decline Today s stock market Index Percentage Change Point
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Finance Netherlands II BV -- Moody's downgrades Teva's ratings to Baa3 from Baa2; outlook negative,2017-08-03 22:12:06 +0000,http://finance.yahoo.com/r/ad79db03-aa35-3b36-a7b4-4fd7da7c6140/viewresearchdoc.aspx?docid=PR_370853&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170803_PR_370853&yptr=yahoo&.tsrc=rss,"Rating Action: Moody's downgrades Teva's ratings to Baa3 from Baa2; outlook negative. Global Credit Research- 03 Aug 2017. New York, August 03, 2017-- Moody's Investors Service, downgraded the senior unsecured ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Plunge After 2017 Outlook Cut Amid Slowing U.S. Growth,2017-08-03 22:05:00 +0000,http://finance.yahoo.com/r/e7706e02-0c07-3f4b-8025-8b88a9c0d300/teva-shares-plunge-after-2017-outlook-cut-amid-slowing-u-s-growth.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva plunges the most since 1998.
TEVA,TEVA:US,BBG000C0CD58,"Momenta Pharmaceuticals, Inc. Treads Water in the Second Quarter",2017-08-03 22:01:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qz-CTOCQpl4/momenta-pharmaceuticals-inc-treads-water-in-the-second-quarter-cm826891,Momenta Pharmaceuticals NASDAQ MNTA continued to tread water in the second quarter waiting for approval by the U S Food and Drug Administration of its copycat of the three times weekly version of Copaxone Teva Pharmaceutical s NYSE TEVA drug for multiple sclerosis
TEVA,TEVA:US,BBG000C0CD58,The Biggest Loser: AmerisourceBergen Tumbles 10%,2017-08-03 21:45:00 +0000,http://finance.yahoo.com/r/8b9e849c-04e2-33c4-aa46-adc9ef3dd4fb/the-biggest-loser-amerisourcebergen-tumbles-10-1501796743?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"AmerisourceBergen (ABC) tumbled to the bottom of the S&P 500 today after Teva Pharmaceutical Industries (TEVA) cited pressures in its generic business for its earnings miss, hitting stock that has anything ..."
TEVA,TEVA:US,BBG000C0CD58,What Happened in the Stock Market Today,2017-08-03 21:06:00 +0000,http://finance.yahoo.com/r/14c83d37-426e-3396-bbfc-2fcf57fdce96/what-happened-in-the-stock-market-today.aspx?yptr=yahoo&.tsrc=rss,"On a mixed day for indexes, investors embraced Tesla&apos;s quarterly report and soundly rejected Teva Pharmaceuticals&apos;."
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Fell Today,2017-08-03 21:02:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AUKJ-wPJASA/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-fell-today-cm826896,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA shares fell today as the company posted its earnings results The drugmaker reported a profit of 1 02 per share
TEVA,TEVA:US,BBG000C0CD58,"Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA), 3D Systems Corporation (DDD) and Centurylink Inc (CTL) Are 3 of Today’s Worst Stocks",2017-08-03 20:38:16 +0000,https://finance.yahoo.com/news/why-teva-pharmaceutical-industries-ltd-203816483.html?.tsrc=rss,"Despite the rocky start to Thursday’s trading, the bulls made a respectable recovery effort.  The bears had no problem making decisions on 3D Systems Corporation (NYSE:DDD), Centurylink Inc (NYSE:CTL) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) today though.  The short version of a long story: On Thursday, Teva Pharmaceutical shares fell a whopping 24% following the release of second-quarter results that were down due to increased competition in the U.S. generic drug space."
TEVA,TEVA:US,BBG000C0CD58,[$$] No Cure in Sight for Teva,2017-08-03 20:22:01 +0000,http://finance.yahoo.com/r/9b08e21b-e70c-31b8-bd0f-4b3a0e0cd0a4/no-cure-in-sight-for-teva-1501770864?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Don’t be fooled by the low valuation. Teva Pharmaceutical Industries is a dangerous stock to own.
TEVA,TEVA:US,BBG000C0CD58,Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone,2017-08-03 20:01:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GmUb1OO_gqU/heres-why-teva-pharmaceutical-industries-ltd-adr-is-sinking-like-a-stone-cm826768,What happened In response to reporting rough second quarter results shares of Teva Pharmaceutical Industries NYSE TEVA a leading provider of generic drugs dropped 24 as of 1 15 p m EDT on Thursday So what Here s a review of the key takeaways from the company
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Crashes To 13-Year Low On &apos;Very Tough Quarter&apos;,2017-08-03 20:00:04 +0000,http://finance.yahoo.com/r/dfd374fa-3cb9-3f8c-a567-95c7f8f9f9b6/teva-pharmaceutical-misses-on-q2-earnings-cuts-guidance-stock-dives?src=A00220&yptr=yahoo&.tsrc=rss,"The generics drug giant reported weaker-than-expected earnings and sales, cutting its quarterly dividend and its full-year earnings target."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Slashes Dividend, Shares Fall 24%",2017-08-03 19:26:00 +0000,http://finance.yahoo.com/r/30b5fa7c-7879-3c01-8eb6-789cb2016d08/teva-pharmaceutical-slashes-dividend-shares-fall-24-1501788396?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Generic drugmaker Teva Pharmaceutical Industries (TEVA) took a pounding from investors after it slashed its dividend by 75%.  Teva currently has an interim chief executive in place.  Investors clearly would like to see a new CEO take over.
TEVA,TEVA:US,BBG000C0CD58,Teva Shows the Flip Side of Leverage,2017-08-03 19:08:38 +0000,http://finance.yahoo.com/r/9a486a23-c51b-322a-9c35-82fbd6a2c9d7/teva-shows-the-flip-side-of-rapidly-growing-leverage?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,The weight of debt can shift in a hurry.
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical swings to 2Q loss, slashes outlook",2017-08-03 18:37:45 +0000,http://finance.yahoo.com/r/266766c5-812d-369b-92b7-ded485b759e1/teva-pharmaceutical-swings-2q-loss-slashes-outlook-150424476.html?.tsrc=rss,NEW YORK (AP) — Shares of Teva Pharmaceutical Industries Inc. slid after the drugmaker reported it swung to a second-quarter loss and slashed its outlook as competition in the U.S. cuts into revenue.
TEVA,TEVA:US,BBG000C0CD58,Here&apos;s Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone,2017-08-03 18:35:00 +0000,http://finance.yahoo.com/r/3142e620-ea78-312f-a47a-b29b8d77030f/heres-why-teva-pharmaceuticals-industries-ltd-adr.aspx?yptr=yahoo&.tsrc=rss,Shares plunge after the company reports dreadful second-quarter results and slashes its dividend payment.
TEVA,TEVA:US,BBG000C0CD58,"S&P 500 and Nasdaq Are Solidly Lower, While the Dow Holds Out Hope for Another Record",2017-08-03 18:29:00 +0000,http://finance.yahoo.com/r/ed2087a9-f5ee-3ee0-80cb-b61044c203e3/dow-clings-to-gains-but-rest-of-market-slides.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks are mixed Thursday.
TEVA,TEVA:US,BBG000C0CD58,2 factors driving the generics market: Wells Fargo Securi...,2017-08-03 18:09:00 +0000,https://finance.yahoo.com/video/2-factors-driving-generics-market-180900847.html?.tsrc=rss,"David Maris, Wells Fargo Securities, discusses the outlook for generic drug companies in the pharmaceutical sector."
TEVA,TEVA:US,BBG000C0CD58,Teva: Hire a CEO…Please!!!,2017-08-03 17:44:00 +0000,http://finance.yahoo.com/r/5e3490d4-6033-3e00-9f51-84f1715f44eb/teva-hire-a-ceoplease-1501782259?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Teva Pharmaceutical Industries (TEVA), which is being led by an interim CEO, are tanking today after the specialty-pharmaceutical company missed earnings forecasts, slashed its guidance and approved a dividend cut.  Teva reported a profit of $1.02 a share, missing forecasts for $1.06, on sales of $5.7 billion, missing forecasts for $5.72 billion.  Teva said it would earn between $4.30 and $4.50 during 2017, below expectations for $4.74."
TEVA,TEVA:US,BBG000C0CD58,Mid-Day Market Update: Stamps.com Surges On Earnings Beat; Aerohive Shares Plunge,2017-08-03 17:28:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s5pFiUsp8us/mid-day-market-update-stampscom-surges-on-earnings-beat-aerohive-shares-plunge-cm826709,Midway through trading Thursday the Dow traded down 0 01 percent to 22 014 84 while the NASDAQ declined 0 25 percent to 6 346 80 The S amp P also fell dropping 0 21 percent to 2 472 27 Leading and Lagging Sectors On Thursday the non cyclical consumer goods amp services
TEVA,TEVA:US,BBG000C0CD58,Teva Downgraded As Analyst Casts Doubt On Turnaround Story,2017-08-03 17:19:36 +0000,https://finance.yahoo.com/news/teva-downgraded-analyst-casts-doubt-171936310.html?.tsrc=rss,"Based on the nearly 25-percent decline in Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA )'s stock price on Thursday, some investors and analysts have legitimate concerns over the company's earnings ..."
TEVA,TEVA:US,BBG000C0CD58,Teva plummets on earnings,2017-08-03 17:08:00 +0000,https://finance.yahoo.com/video/teva-plummets-earnings-170800958.html?.tsrc=rss,CNBC's Meg Tirrell reports on Teva's stock plummeting in response to their earnings report.
TEVA,TEVA:US,BBG000C0CD58,"Allergan (AGN) Q2 Earnings & Sales Top, Restasis Sales Down",2017-08-03 17:02:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TbIf27IsIbQ/allergan-agn-q2-earnings-sales-top-restasis-sales-down-cm826643,Allergan plc s AGN second quarter 2017 earnings came in at 4 02 per share beating the Zacks Consensus Estimate of 3 95 by 1 8 Earnings rose 20 year over year driven by higher revenues and operating profits Revenues came in at 4 01 billion up 8 8 from the year ago period and beat
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter,2017-08-03 17:01:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LqEO3NSL3hc/teva-pharmaceutical-industries-ltd-slashes-full-year-outlook-after-disappointing-second-quarter-cm826591,Buying the Actavis Generics business from Allergan NYSE AGN made the difference for Teva Pharmaceutical Industries Ltd NYSE TEVA when it reported first quarter results in May That deal boosted Teva s revenue and earnings Teva announced its second quarter results
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries is Oversold,2017-08-03 17:00:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dMR51D1jJRU/teva-pharmaceutical-industries-is-oversold-cm826609,The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics strong fundamentals and a valuation that looks inexpensive
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva's $6bn loss complicates search for a chief,2017-08-03 16:43:30 +0000,"http://finance.yahoo.com/r/04712054-e8f4-3b69-ab42-eeef64db9ced/dee408f6-784f-11e7-90c0-90a9d1bc9691,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Teva's share price tumbled 18 per cent on Thursday after the Israeli drugs group reported a $6bn loss, slashed its dividend and said it would not rush a protracted search for a chief executive. Underscoring ..."
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Fell Today,2017-08-03 16:35:40 +0000,https://finance.yahoo.com/news/why-teva-pharmaceutical-industries-ltd-163540104.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares fell today as the company posted its earnings results.  The Food and Drug Administration has approved more generic drugs lately, and the prices for these medications has been lower.  This has boosted sales for some companies, but Teva has been hurt by the fact that it’s making less money per product."
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers,2017-08-03 15:46:00 +0000,http://finance.yahoo.com/r/cc476b2e-c6bd-3460-bbde-1dedcdf099f4/teva-fall-out-takes-big-bite-of-generic-makers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva said weak U.S. markets and the ongoing political turmoil in Venezuela weighed on the company's second quarter performance.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter,2017-08-03 15:41:00 +0000,http://finance.yahoo.com/r/794b6d02-4db4-37bd-a062-59e3fe7ed50f/teva-pharmaceutical-industries-ltd-slashes-full-ye.aspx?yptr=yahoo&.tsrc=rss,The big generic and specialty drugmaker struggled in the second quarter due to challenges for its U.S. generics business and Venezuelan uncertainty.
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Hit by Increased Competition in U.S. Generics,2017-08-03 15:33:18 +0000,http://finance.yahoo.com/r/3b951cfb-0707-3d04-865b-6338fc60066e/generic-competition-roils-teva-1501773117?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Teva warned of the rapid deterioration of its U.S. generics business, prompting the Israel-based drugmaker to look at cutting costs and considering divestitures."
TEVA,TEVA:US,BBG000C0CD58,"Some of Today's Worst Performing Stocks: Teva, Cheesecake Factory, 3D Systems",2017-08-03 15:08:00 +0000,http://finance.yahoo.com/r/60ed681c-6b34-3cd3-8da1-0dd2cbf0bf66/teva-cheesecake-factory-and-3d-systems-are-some-of-today-s-worst-stocks.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A number of stocks were trading lower on Thursday.
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical swings to 2Q loss, slashes outlook",2017-08-03 15:04:27 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-swings-2q-loss-slashes-outlook-150424476.html?.tsrc=rss,"Shares of Teva Pharmaceutical Industries Inc. slid after the drugmaker reported it swung to a second-quarter loss and slashed its outlook as competition in the U.S. cuts into revenue. The stock fell $5.52, ..."
TEVA,TEVA:US,BBG000C0CD58,AmerisourceBergen stock plummets 9% alongside other companies affected by negative generic price trends,2017-08-03 14:59:16 +0000,http://finance.yahoo.com/r/581fcbfc-56aa-3729-8e41-83e618a8bf4f/Story.aspx?guid=7FBD8C4E-285B-4719-999D-D9954BAFF643&siteid=yhoof2&yptr=yahoo&.tsrc=rss,AmerisourceBergen Corp. shares plummeted 9% in extremely heavy morning trade Thursday after the company reported third-quarter profit beat but revenue miss. Shares of the drug distributor fell alongside ...
TEVA,TEVA:US,BBG000C0CD58,'Boring' Valeant Poised for Q2 Beat,2017-08-03 14:51:00 +0000,http://finance.yahoo.com/r/eafe8a78-2ac7-3cd7-bd2e-750b7b85cbf8/boring-valeant-poised-for-q2-beat.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals will report second quarter earnings results next Tuesday, August 8."
TEVA,TEVA:US,BBG000C0CD58,"Teva's Quarter: Earnings Miss, Guidance Cut, Dividend Devastated",2017-08-03 14:29:21 +0000,https://finance.yahoo.com/news/tevas-quarter-earnings-miss-guidance-142921389.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA )'s earnings report brought mostly bad news for investors, which resulted in an 18-percent plunge in the stock Thursday morning. But not all analysts ..."
TEVA,TEVA:US,BBG000C0CD58,"Dow Tries to Hold in the Green, but Rest of Market Slides",2017-08-03 14:15:00 +0000,http://finance.yahoo.com/r/5ad454e3-7dc6-3e94-982f-cb615adc57f7/stock-market-hits-pause-after-dow-s-string-of-record-highs.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks are mixed Thursday.
TEVA,TEVA:US,BBG000C0CD58,Tesla CEO Elon Musk Will Not Solve World Hunger and Save Humanity,2017-08-03 14:15:00 +0000,http://finance.yahoo.com/r/d1f5e703-e2c2-3944-9304-b1e51f13d127/tesla-ceo-elon-musk-will-not-solve-world-hunger-and-save-humanity?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Tesla is absurd.
TEVA,TEVA:US,BBG000C0CD58,Valeant: Why Boring is Better,2017-08-03 14:10:00 +0000,http://finance.yahoo.com/r/ac4f3fcd-7be7-304c-aec2-9612010f089a/valeant-why-boring-is-better-1501769403?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Valeant Pharmaceuticals International (VRX) are falling today--likely because Teva Pharmaceutical Industries (TEVA) is tanking after releasing its earnings--but one team of analysts expects no ...
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical reports big drop in profits, slashes dividend",2017-08-03 14:04:45 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-reports-big-drop-134838142.html?.tsrc=rss,"Israeli drugs group Teva  Pharmaceutical Industries reported a steeper than  expected drop in second-quarter earnings on Thursday, due to  weaker prices in the United States, and cut its interim dividend  by 75 percent.  On a conference call with analysts Teva officials offered  little in the way of hope for a turnaround, saying the company  expects the fall in generic drug prices to accelerate in the  second half of 2017 and on into 2018.  ""The board understands our shareholders' disappointments,""  said Chairman Sol Barer."
TEVA,TEVA:US,BBG000C0CD58,Teva stock plummets 18% after rough quarter in US generic drug market,2017-08-03 13:53:34 +0000,http://finance.yahoo.com/r/cf0a4e54-a64d-3004-aedf-e83d04853dac/104630113?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104630113&yptr=yahoo&.tsrc=rss,Interim CEO Yitzhak Peterburg blamed Teva's recent poor performance on a saturation of the U.S. generic drug market.
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Posting Steep Loss On Disappointing Results, Guidance",2017-08-03 13:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8jITyl4NLUI/teva-pharmaceutical-posting-steep-loss-on-disappointing-results-guidance-20170803-01648,"Teva Pharmaceutical Posting Steep Loss On Disappointing Results, Guidance"
TEVA,TEVA:US,BBG000C0CD58,Wall Street Sees Mixed Open Amid Last Big Wave of Earnings Season; Jobless Claims Fall,2017-08-03 13:39:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bNt5hH3llhI/wall-street-sees-mixed-open-amid-last-big-wave-of-earnings-season-jobless-claims-fall-cm826359,U S stocks were set for a narrowly mixed open on Thursday a day after the Dow reached a new record as traders evaluated the last big wave of corporate earnings for the season and key readings on the U S economy U S stocks were set for a narrowly mixed open on Thursday a day after the
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Q2 Earnings and Sales Miss, Shares Up",2017-08-03 13:05:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KNEywO1D6ZE/teva-teva-q2-earnings-and-sales-miss-shares-up-cm826329,Israel based 160 Teva Pharmaceutical Industries Ltd TEVA is a global pharmaceutical company with a strong presence in the generics as well as branded markets The company s branded products include Copaxone multiple sclerosis MS Azilect Parkinson s disease and respiratory products
TEVA,TEVA:US,BBG000C0CD58,US Futures Narrowly Mixed Amid Last Big Wave of Earnings Season,2017-08-03 13:02:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IBGRBzz2NBk/us-futures-narrowly-mixed-amid-last-big-wave-of-earnings-season-cm826283,U S stock futures were narrowly mixed on Thursday a day after the Dow reached a new record as traders evaluated the last big wave of corporate earnings for the season and looked ahead to some key readings on the U S economy U S stock futures were narrowly mixed on Thursday a day after the
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Aug 3, 2017 :  TEVA, CHK, TSLA, MYL, COMM, FIT, AZN, SPLS, CHGG, USLV, FBP, SHPG",2017-08-03 13:01:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X4XuzxRlcUs/pre-market-most-active-for-aug-3-2017-teva-chk-tsla-myl-comm-fit-azn-spls-chgg-uslv-fbp-shpg-cm826285,The NASDAQ 100 Pre Market Indicator is up 2 86 to 5 917 09 The total Pre Market volume is currently 11 394 721 shares traded The following are the most active stocks for the pre market session Teva Pharmaceutical Industries Limited TEVA is 4 65 at 26 60 with 7 022
TEVA,TEVA:US,BBG000C0CD58,"Early movers: YUM, DISH, AET, TEVA, REGN, TSLA, FIT, WYN, SQ & more",2017-08-03 12:03:11 +0000,http://finance.yahoo.com/r/28a499f3-ea7f-325c-bb69-994f0e79e139/104630000?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104630000&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
TEVA,TEVA:US,BBG000C0CD58,Teva's stock plunges on heavy volume after profit miss and slashed outlook,2017-08-03 11:55:26 +0000,http://finance.yahoo.com/r/b46f7de8-2436-3e43-8bc6-80931a7e2646/Story.aspx?guid=6F7E2BE7-3F68-46B3-B1C0-CE6953EF625E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Teva Pharmaceuticals Industries Ltd. plunged 10.4% in active premarket trade Thursday, after the drug maker missed fiscal second-quarter profit expectations and slashed its full-year outlook. ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Q2 Earnings and Sales Miss, Shares Up",2017-08-03 11:54:11 +0000,https://finance.yahoo.com/news/teva-teva-q2-earnings-sales-115411731.html?.tsrc=rss,Teva Pharmaceutical (TEVA) second quarter earnings and revenue missed estimates. The company has also lowered its earnings and revenue guidance for 2017.
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical reports big drop in profits, cuts dividend",2017-08-03 11:29:30 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-reports-big-drop-112930741.html?.tsrc=rss,"Israeli drugs group Teva  Pharmaceutical Industrial Industries reported a  steeper than expected 18.4 percent drop in second-quarter  earnings on Thursday, due to weaker prices in the United States,  and cut its interim dividend by 75 percent.  Teva, the world's largest generics drugmaker, said  it earned $1.02 per share excluding one-off items in the second  quarter, down from $1.25 a share in the same period last year.  It cut the quarterly dividend payout to $0.085 per ordinary  share from $0.34."
TEVA,TEVA:US,BBG000C0CD58,Teva's Challenges Mount With Weaker Outlook Amid CEO Search,2017-08-03 10:51:42 +0000,http://finance.yahoo.com/r/2dcc4e7a-cc66-36c2-8724-88e7e26ba9b3/israel-s-teva-cuts-profit-forecast-again-pares-dividend-payment?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Teva Pharmaceutical Industries Ltd.’s search for a new chief executive probably just got a little tougher after the world’s biggest maker of generic medicines pared its profit forecast for a second time ...
TEVA,TEVA:US,BBG000C0CD58,Teva Reports Second Quarter 2017 Financial Results,2017-08-03 10:30:00 +0000,https://finance.yahoo.com/news/teva-reports-second-quarter-2017-103000375.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2017."
TEVA,TEVA:US,BBG000C0CD58,Teva to proceed with Rimsa breach of contract suit after ruling,2017-08-03 09:57:52 +0000,https://finance.yahoo.com/news/teva-proceed-rimsa-breach-contract-095752024.html?.tsrc=rss,"Teva Pharmaceutical Industries (TEVA.TA) said on Thursday it would continue to pursue a breach of contract suit against the former owners of its Rimsa plant in Mexico after a New York judge rejected Teva's claim of fraud.  Israel-based Teva (TEVA.N), the world's largest generic drugmaker, bought the Rimsa plant in 2016 in a $2.3 billion deal, only to shut it down immediately, saying the operation was overrun by improprieties.  Rimsa's previous owners, the Espinosa family, deny this, and the two sides have been locked in a legal battle."
TEVA,TEVA:US,BBG000C0CD58,Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call,2017-08-03 09:00:00 +0000,https://finance.yahoo.com/news/investor-network-teva-pharmaceutical-industries-090000669.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Teva Pharmaceutical Industries Limited Sponsored ADR (NYSE: TEVA ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, ..."
TEVA,TEVA:US,BBG000C0CD58,Harel Insurance Investments & Financial Services Ltd. ...,2017-08-03 07:54:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y6eQ4urMLAg/harel-insurance-investments-financial-services-ltd-cm826204,Harel Insurance Investments Financial Services Ltd New Purchases BHI XLRE SPLV MNKD BSCJ RDS B XBI CAR BP AXP Added Positions XLP IBB IYF XLE SPY VCIT EFA CIU QQQ VCSH Reduced Positions GM IYG F AAPL XLV OPK XLK FXI INTC
TEVA,TEVA:US,BBG000C0CD58,Teva Cuts 2017 Outlook; Stock Down,2017-08-03 06:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nSo6-DUCY4I/teva-cuts-2017-outlook-stock-down-20170803-00477,Teva Cuts 2017 Outlook; Stock Down
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Limited Reveals 15% Fall In Q2 Earnings,2017-08-03 06:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QCOJ3n97jyQ/teva-pharmaceutical-industries-limited-reveals-15-fall-in-q2-earnings-20170803-00433,Teva Pharmaceutical Industries Limited Reveals 15% Fall In Q2 Earnings
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Q2 17 Earnings Conference Call At 7:30 AM ET,2017-08-03 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_l7K91NQsEQ/teva-pharmaceutical-industries-q2-17-earnings-conference-call-at-730-am-et-20170803-00425,Teva Pharmaceutical Industries Q2 17 Earnings Conference Call At 7:30 AM ET
TEVA,TEVA:US,BBG000C0CD58,Buy GoPro Inc (GPRO) Stock for Its Attractive Risk-Reward Ahead of Q2 Earnings,2017-08-02 21:55:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2If5Vzt-D4Q/buy-gopro-inc-gpro-stock-for-its-attractive-risk-reward-ahead-of-q2-earnings-cm826117,InvestorPlace Stock Market News Stock Advice amp Trading Tips GoPro Inc 160 NASDAQ GPRO stockholders are desperate to hear some good news when the action camera specialist reports second quarter 2017 earnings results after Thursday s closing bell While I don t
TEVA,TEVA:US,BBG000C0CD58,Realty Income Corp (O) Stock Isn’t Convincing,2017-08-02 21:54:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kOHxxfXtFlg/realty-income-corp-o-stock-isnt-convincing-cm826109,InvestorPlace Stock Market News Stock Advice amp Trading Tips Of all the investments I ve covered and I ve covered quite a few Realty Income Corp NYSE O is one of the most difficult to analyze In my opinion O stock features well balanced pros and cons What it boils
TEVA,TEVA:US,BBG000C0CD58,Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?,2017-08-02 19:54:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T2SURedh-3I/will-teva-pharmaceutical-industries-ltd-adr-teva-stock-catch-a-break-cm826043,InvestorPlace Stock Market News Stock Advice amp Trading Tips When Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA reports quarterly earnings results on Aug 3 before market open good sales numbers may not do enough to give TEVA stock a boost Source Open
TEVA,TEVA:US,BBG000C0CD58,What's in Store for Arena (ARNA) this Earnings Season?,2017-08-02 18:55:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uCQQ0qYoZjA/whats-in-store-for-arena-arna-this-earnings-season-cm825957,We expect Arena Pharmaceuticals Inc ARNA to beat estimates when it reports second quarter 2017 earnings on Aug 7 after the market closes Year to date Arena s shares have significantly soared 69 7 compared with the industry s 9 increase Arena s earnings performance is a
TEVA,TEVA:US,BBG000C0CD58,"IEFA, TEVA, CHKP, MBLY: Large Inflows Detected at ETF",2017-08-02 16:57:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8htVqn6S9Eg/iefa-teva-chkp-mbly-large-inflows-detected-at-etf-cm825860,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 50 3 million dollar inflow that s a 0 2 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,What&apos;s in Store for Arena (ARNA) this Earnings Season?,2017-08-02 16:41:04 +0000,https://finance.yahoo.com/news/apos-store-arena-arna-earnings-164104913.html?.tsrc=rss,"Although Belviq, the only approved product in Arena&apos;s (ARNA) portfolio, has an unimpressive performance so far, the company&apos;s efforts to improve the drug&apos;s performance might drive the stock in Q2."
TEVA,TEVA:US,BBG000C0CD58,Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?,2017-08-02 15:41:02 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-154102281.html?.tsrc=rss,"Investors will demand more details on Teva Pharmaceutical’s strategy in absorbing Actavis.  TEVA stock has strong fundamentals, a robust pipeline and has the flexibility to adjust for the upheaval in healthcare policies imposed by governments around the world.  Teva Pharmaceutical will need to show growth in operating cash flow in the quarter."
TEVA,TEVA:US,BBG000C0CD58,Earnings Preview: What To Expect From Teva Pharmaceutical On Thursday,2017-08-02 15:01:00 +0000,http://finance.yahoo.com/r/bc26a670-734a-3d54-b14a-9ade4004e343/earnings-preview-what-to-expect-from-teva-pharmaceutical-on-thursday?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Teva is expected to report earnings of $1.06 per share on $5.85 billion in revenue. Meanwhile, the so-called Whisper number is $1.08."
TEVA,TEVA:US,BBG000C0CD58,3 Pharma Stocks That Will Inject New Life Into Your Portfolio,2017-08-01 22:53:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BLUqL3NHOjI/3-pharma-stocks-that-will-inject-new-life-into-your-portfolio-cm825352,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pharmacy stocks are a risky bunch right now as lawmakers argue over how to lower healthcare costs and whether ultra high drug prices are fair However if you have a stomach for risk there are a few great pharma stocks
TEVA,TEVA:US,BBG000C0CD58,Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Before Q2 Earnings,2017-08-01 19:55:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l4sWnsk5mo8/buy-teva-pharmaceutical-industries-ltd-adr-teva-stock-before-q2-earnings-cm825280,InvestorPlace Stock Market News Stock Advice amp Trading Tips Specialty pharma company Teva Pharmaceutical Industries Ltd ADR NYSE TEVA is set to report second quarter fiscal 2017 earnings results Thursday before the opening bell Down more than 11 year to date and almost
TEVA,TEVA:US,BBG000C0CD58,Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Before Q2 Earnings,2017-08-01 15:21:17 +0000,https://finance.yahoo.com/news/buy-teva-pharmaceutical-industries-ltd-152117983.html?.tsrc=rss,"Specialty pharma company Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is set to report second-quarter fiscal 2017 earnings results Thursday before the opening bell.  Despite the punishment TEVA stock has taken, the Israel-based company, which has beaten Wall Street’s earnings estimates for 10 straight quarters, has operated far better.  Investors have had to absorb the recent departures of both Teva’s CEO and CFO."
TEVA,TEVA:US,BBG000C0CD58,Is a Surprise in the Cards for Teva (TEVA) in Q2 Earnings?,2017-07-31 16:57:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/skGl8UOq5L0/is-a-surprise-in-the-cards-for-teva-teva-in-q2-earnings-cm824347,Teva Pharmaceutical Industries Ltd TEVA will be reporting second quarter 2017 earnings on Aug 3 before the market opens Last quarter the company delivered in line earnings This generic drug maker s shares have lost 10 8 so far this year while the industry witnessed an increase of 0
TEVA,TEVA:US,BBG000C0CD58,Is a Surprise in the Cards for Teva (TEVA) in Q2 Earnings?,2017-07-31 14:37:02 +0000,https://finance.yahoo.com/news/surprise-cards-teva-teva-q2-143702491.html?.tsrc=rss,"While the inclusion of sales from Actavis Generics acquisition may continue to pull up Teva Pharmaceutical Industries Ltd.&apos;s (TEVA) sales, its generic segment may see weakness."
TEVA,TEVA:US,BBG000C0CD58,U.S. FDA to review Teva and Celltrion's cancer biosimilar drug,2017-07-31 12:59:27 +0000,https://finance.yahoo.com/news/u-fda-review-teva-celltrions-125927873.html?.tsrc=rss,Teva Pharmaceutical Industries and South Korea's Celltrion said on Monday the U.S. Food and Drug Administration has accepted for review a biologics application for a biosimilar drug to treat breast cancer. ...
TEVA,TEVA:US,BBG000C0CD58,Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar to Herceptin® (trastuzumab),2017-07-31 12:00:00 +0000,https://finance.yahoo.com/news/celltrion-teva-announce-u-fda-120000339.html?.tsrc=rss,"Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application for CT-P6, a proposed Monoclonal Antibody biosimilar to Herceptin®1 which is used for the treatment of Human Epidermal growth factor Receptor 2 -overexpressing breast cancer and metastatic gastric cancer."
TEVA,TEVA:US,BBG000C0CD58,Celltrion And Teva Say FDA Accepts BLA For Proposed Biosimilar To Herceptin,2017-07-31 08:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s_JkxvfGFGg/celltrion-and-teva-say-fda-accepts-bla-for-proposed-biosimilar-to-herceptin-20170731-00591,Celltrion And Teva Say FDA Accepts BLA For Proposed Biosimilar To Herceptin
TEVA,TEVA:US,BBG000C0CD58,Ignore the Obamacare fight in Congress and buy these 5 health-care stocks,2017-07-29 12:08:26 +0000,http://finance.yahoo.com/r/21245a54-0139-3044-b78c-c4cfe62696e7/Story.aspx?guid=A3D5BCF6-720E-11E7-9E70-77DD8B13BB6F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Regardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Epiduo® in the United States,2017-07-28 12:00:00 +0000,https://finance.yahoo.com/news/teva-announces-launch-generic-epiduo-120000362.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the launch of generic Epiduo®1 gel, 0.1%/2.5% in the U.S."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch Of Generic Epiduo In U.S.,2017-07-28 08:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k9gI14jm0PM/teva-announces-launch-of-generic-epiduo-in-us-20170728-00649,Teva Announces Launch Of Generic Epiduo In U.S.
TEVA,TEVA:US,BBG000C0CD58,Benzinga's Option Alert Recap From July 27,2017-07-27 20:05:03 +0000,https://finance.yahoo.com/news/benzingas-option-alert-recap-july-200503562.html?.tsrc=rss,"Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity. Here's a recap of the option alerts from Thursday, July 27, 2017. All timestamps are in Eastern ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] AstraZeneca shares tumble 15% on big drug trial setback,2017-07-27 16:55:44 +0000,"http://finance.yahoo.com/r/f0f5b254-bbd3-3de4-9300-8015141e6ca7/eee32de4-627f-11e7-91a7-502f7ee26895,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","A treatment AstraZeneca hoped would replace chemotherapy for some lung cancer patients was no better at preventing the disease from getting worse in clinical tests, dealing a major blow for one of the ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] AstraZeneca: transcendental agitation,2017-07-27 16:24:47 +0000,"http://finance.yahoo.com/r/fe409344-18fe-3c87-9c88-6c8e10eb0c91/2b7a6e30-72dd-11e7-aca6-c6bd07df1a3c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss",Philosopher Blaise Pascal never faced proof he was wrong to believe in God. AstraZeneca's Pascal Soriot has discovered his faith in the Mystic cancer drug trial really was misplaced. A failure of a key ...
TEVA,TEVA:US,BBG000C0CD58,Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis,2017-07-27 14:51:00 +0000,http://finance.yahoo.com/r/203db846-909b-3719-968c-7e95ffff4fee/top-ranking-democrat-expands-probe-into-opioid-crisis.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,McCaskill requested that four more drug companies and three drug distributors turn over documents.
TEVA,TEVA:US,BBG000C0CD58,[$$] McCaskill Expands Probe Into Opioid Addiction Crisis,2017-07-27 14:05:12 +0000,http://finance.yahoo.com/r/b330179a-d776-31ab-bd9d-6f10414362c5/senator-expands-probe-into-opioid-addiction-crisis-1501158600?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Sen. Claire McCaskill asked four more drug companies and three distributors to provide documents and explain steps they have taken to stop prescription painkillers from being diverted to the black market....
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Interest Takes a Big Step Back,2017-07-26 12:55:19 +0000,https://finance.yahoo.com/news/major-pharma-short-interest-takes-125519696.html?.tsrc=rss,"The July 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces the Launch of Generic Vagifem® in the United States,2017-07-24 18:51:00 +0000,https://finance.yahoo.com/news/teva-announces-launch-generic-vagifem-185100844.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today announced the launch of a generic version of Vagifem®1 , 10 mcg in the U.S."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm to reduce workforce in Israel, mainly in production",2017-07-23 10:38:59 +0000,https://finance.yahoo.com/news/teva-pharm-reduce-workforce-israel-103859976.html?.tsrc=rss,"Teva Pharmaceutical Industries  said on Sunday it would lay off some of its 7,000  employees in Israel in the coming months as it reorganises in a  drive to improve competitiveness.  Teva, Israel's largest company, did not specify how many  workers would leave, but a source close to the process told  Reuters the number would be about 350, mainly in production.  ""In light of the complex business reality the entire  pharmaceutical industry and Teva in particular face, Teva has  been implementing in recent years a global reorganisation,"" it  said in a statement."
TEVA,TEVA:US,BBG000C0CD58,"Stull, Stull & Brody Announces Class Action Lawsuit on Behalf of Employee Benefit Plan Purchasers of American Depository Shares of Teva Pharmaceutical Industries Limited",2017-07-21 22:45:00 +0000,https://finance.yahoo.com/news/stull-stull-brody-announces-class-224500324.html?.tsrc=rss,"NEW YORK, July 21, 2017-- Stull, Stull & Brody announces that a class action lawsuit was commenced in the United States District Court for the Southern District of Ohio on behalf of purchasers of Teva ..."
TEVA,TEVA:US,BBG000C0CD58,7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods,2017-07-21 17:15:00 +0000,http://finance.yahoo.com/r/7d0c7a23-fc9a-31ef-962e-9fb56ff24aab/jana-partners-to-put-whole-foods-amazon-deal-windfall-to-use.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here are the activist investor's next potential targets.
TEVA,TEVA:US,BBG000C0CD58,"AstraZeneca CEO reassures staff, aims to be at September cancer meet",2017-07-21 07:28:13 +0000,https://finance.yahoo.com/news/astrazeneca-ceo-reassures-staff-aims-080051132.html?.tsrc=rss,"AstraZeneca Chief Executive Pascal Soriot, responding to rumors he might leave the drugmaker to join rival Teva Pharmaceutical Industries, has told staff he expects to work ""together"" with employees to see the company succeed.  A company spokeswoman added he was intending to attend the European Society for Medical Oncology annual meeting in Madrid in September, assuming that AstraZeneca had clinical data on its new immunotherapy medicine ready to present at the event.  Soriot did not comment on whether he had received a job offer from Teva in the internal memo to staff, which was sent out at the start of this week."
TEVA,TEVA:US,BBG000C0CD58,"Mount Vernon Associates Inc Buys Energy Transfer Partners LP, Teva Pharmaceutical Industries",2017-07-20 20:38:04 +0000,https://finance.yahoo.com/news/mount-vernon-associates-inc-buys-203804123.html?.tsrc=rss,"Investment company Mount Vernon Associates Inc buys Energy Transfer Partners LP, Teva Pharmaceutical Industries during the 3-months ended 2017-06-30, according to the most recent filings of the investment ..."
TEVA,TEVA:US,BBG000C0CD58,3 Stocks the Smartest Investors Are Buying Right Now,2017-07-20 19:02:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w5L6Ut6C718/3-stocks-the-smartest-investors-are-buying-right-now-cm818862,Investing wisely can lead investors down a number of paths in today s market There are value plays growth plays and stocks that are downright misunderstood by the market We asked some of the Motley Fool s investors for their favorite stocks for smart investors to buy this
TEVA,TEVA:US,BBG000C0CD58,NICE Recommends CINQAERO® (reslizumab) for the Treatment of Severe Eosinophilic Asthma,2017-07-20 09:00:00 +0000,https://finance.yahoo.com/news/nice-recommends-cinqaero-reslizumab-treatment-090000727.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. today announced that the National Institute for Health and Care Excellence in England has recommended CINQAERO® in its Final Appraisal Determination .
TEVA,TEVA:US,BBG000C0CD58,Teva  Reveals NICE Recommendation For Cinqaero In Severe Asthma Patients,2017-07-20 05:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1MqldOlCXVo/teva--reveals-nice-recommendation-for-cinqaero-in-severe-asthma-patients-20170720-00190,Teva  Reveals NICE Recommendation For Cinqaero In Severe Asthma Patients
TEVA,TEVA:US,BBG000C0CD58,Nektar's NKTR-181 Positive in Human Abuse Potential Study,2017-07-19 23:03:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HVfO3K_hWQE/nektars-nktr-181-positive-in-human-abuse-potential-study-cm818400,Nektar Therapeutics NKTR shares increased more than 4 on Tuesday after the company announced positive top line results from an oral human abuse potential HAP study evaluating its opioid analgesic candidate NKTR 181 to assess the abuse potential compared with oxycodone NKTR 181 is a
TEVA,TEVA:US,BBG000C0CD58,"AstraZeneca (AZN) CEO Rumor Reportedly Ends, Shares Rise",2017-07-17 23:45:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GSmj_EGVESY/astrazeneca-azn-ceo-rumor-reportedly-ends-shares-rise-cm817195,AstraZeneca plc s AZN shares rose almost 5 on Friday after the company reportedly confirmed that its chief executive officer CEO Pascal Soriot is not quitting the company to join the generic drug maker Teva Pharmaceutical Industries Limited TEVA AstraZeneca s shares have
TEVA,TEVA:US,BBG000C0CD58,"AstraZeneca (AZN) CEO Rumor Reportedly Ends, Shares Rise",2017-07-17 21:47:09 +0000,https://finance.yahoo.com/news/astrazeneca-azn-ceo-rumor-reportedly-214709044.html?.tsrc=rss,"AstraZeneca plc shares rose after the company reportedly confirmed that its CEO is not quitting the company to join the generic drug-maker, Teva Pharmaceutical Industries Limited (TEVA)."
TEVA,TEVA:US,BBG000C0CD58,Facebook Inc (FB) Stock’s Growth Will Be Rooted in Instagram,2017-07-17 20:48:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BPzwOHQdPtk/facebook-inc-fb-stocks-growth-will-be-rooted-in-instagram-cm817169,InvestorPlace Stock Market News Stock Advice amp Trading Tips Snap Inc NYSE SNAP may have won the market s attention in recent months since its IPO but investors looking for value in technology stock should watch Facebook Inc NASDAQ FB instead
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back,2017-07-17 19:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-t9IHkiSJk/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-coming-back-cm817133,InvestorPlace Stock Market News Stock Advice amp Trading Tips If you have even a hint of a contrarian personality you should look no further than the pharmaceutical industry Thanks to various scandals and controversies like the one impacting Valeant Pharmaceuticals Intl Inc
TEVA,TEVA:US,BBG000C0CD58,[$$] EU accuses Teva Pharmaceutical of anti-competitive behaviour,2017-07-17 18:00:19 +0000,"http://finance.yahoo.com/r/cf04ddad-2c63-3c28-b4ca-cb85138f1c05/3c9e9ae8-6b07-11e7-b9c7-15af748b60d0,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss",The European Commission has accused Teva Pharmaceutical Industries of anti-competitive behaviour over an agreement it made with US-based rival Cephalon. The complaint centres on an agreement by Israel-based ...
TEVA,TEVA:US,BBG000C0CD58,U.S. court upholds Takeda patent on cancer drug Velcade,2017-07-17 17:55:54 +0000,https://finance.yahoo.com/news/u-court-upholds-takeda-patent-175554767.html?.tsrc=rss,"A U.S. appeals court ruled on Monday  that a patent on Takeda Pharmaceutical Co Ltd's cancer  treatment Velcade is valid, pushing back the date when generic  drug makers including Teva Pharmaceutical Industries Ltd  and Mylan NV will be allowed to launch  lower-cost versions of the drug in the United States.  The U.S. Court of Appeals for the Federal Circuit rejected  arguments by a dozen generic drug companies that the Velcade  patent was obvious and should not have been granted.  The ruling,  which reversed a lower court, will allow Takeda to sell Velcade  exclusively until the patent expires in 2022."
TEVA,TEVA:US,BBG000C0CD58,"IEFA, IBML: Big ETF Inflows",2017-07-17 16:50:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M814lBuCmuw/iefa-ibml-big-etf-inflows-cm816979,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF which added 27 000 000 units or a 5 5 increase week over week Among the largest underlying components of IEFA in morning trading
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back,2017-07-17 15:41:28 +0000,https://finance.yahoo.com/news/why-teva-pharmaceutical-industries-ltd-154128683.html?.tsrc=rss,"Under this condition, I believe Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is a compelling opportunity.  TEVA stock is a classic case of a good investment struggling with poor, and in this case, confounding decisions.  The woes surrounding Teva Pharmaceuticals have been broadcast ad-nauseam."
TEVA,TEVA:US,BBG000C0CD58,Valeant Unloads Yet Another Unit,2017-07-17 15:30:00 +0000,http://finance.yahoo.com/r/341b0be9-5e6f-31eb-be40-2fa9c3ae61c7/valeant-pharmaceuticals-the-fire-sale-continues-1500305414?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are climbing Monday after the drug maker announced the $190 million sale of Obagi Medical Products to Shonghua Finance Acquisition Fund.  The deal is the latest asset sale by the beleaguered drug maker as it labors to meet its goal of $5 billion in debt reduction by February 2018.  The company has shed its iNova division, as well as cancer treatment maker Dendreon, and sold some skin care lines to L’Oreal, and is throwing the proceeds at its debt load."
TEVA,TEVA:US,BBG000C0CD58,EU regulators charge Teva over pay-for-delay drug deal,2017-07-17 11:36:58 +0000,https://finance.yahoo.com/news/eu-regulators-charge-teva-over-101442934.html?.tsrc=rss,"EU antitrust regulators charged Israeli drugmaker Teva (TEVA.TA) (TEVA.N) on Monday with doing an illegal deal with Cephalon to delay selling a cheaper generic version of the latter's sleep disorder drug, putting it at risk of a fine.  The crackdown by the European Commission follows fines against scores of companies including Denmark's Lundbeck, U.S. giant Johnson & Johnson and France's Servier in recent years over similar deals.  Teva, the world's biggest generic drugmaker, reached the deal with Cephalon as part of a settlement to end a lawsuit over alleged infringement of Cephalon's patents on the blockbuster  drug."
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca Shares Top FTSE 100 After Drugmaker Says CEO Will Host Late-July Earnings Call,2017-07-17 07:36:00 +0000,http://finance.yahoo.com/r/9a4dc8d3-6815-3cd8-8179-d7aa900cf14a/astrazeneca-shares-top-ftse-100-after-drugmaker-says-ceo-will-host-late-july-earnings-call.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,AstraZeneca shares rose after the group said its CEO would host an earnings call later this month following speculation he was to take up a similar role Teva Pharmaceuticals.
TEVA,TEVA:US,BBG000C0CD58,Here Are The 5 Stories Europe Was Talking About This Week,2017-07-15 01:45:00 +0000,http://finance.yahoo.com/r/493fabe2-3569-3fcd-abca-4c637b610778/here-are-the-5-stories-europe-was-talking-about-this-week.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"From Aramco's IPO to the mystery surrounding AstraZeneca's CEO, here are the stories making headlines in Europe"
TEVA,TEVA:US,BBG000C0CD58,[$$] AstraZeneca CEO's Future Remains Shrouded in Mystery,2017-07-14 22:19:04 +0000,http://finance.yahoo.com/r/1dd3cee1-0148-355b-b70e-81442689292d/astrazenecas-ceo-we-still-dont-know-if-hes-staying-or-going-1500070741?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"The mystery surrounding the intentions of the chief executive of AstraZeneca PLC, one of the world’s largest pharmaceutical firms, remains…a mystery."
TEVA,TEVA:US,BBG000C0CD58,[$$] Pascal Soriot to remain at AstraZeneca,2017-07-14 21:47:48 +0000,"http://finance.yahoo.com/r/935f50ec-ee55-3ebc-9bb4-5fcc107de4ea/16dad442-68ce-11e7-8526-7b38dcaef614,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Pascal Soriot is to remain as chief executive of AstraZeneca, scotching two days of rumours that he was leaving to head rival drugmaker Teva Pharmaceutical Industries and pushing AstraZeneca's US-listed ..."
TEVA,TEVA:US,BBG000C0CD58,"Why Cyberark Software Ltd (CYBR), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Wynn Resorts, Limited (WYNN) Are 3 of Today’s Worst Stocks",2017-07-14 20:45:20 +0000,https://finance.yahoo.com/news/why-cyberark-software-ltd-cybr-204520577.html?.tsrc=rss,"In fact, Cyberark Software Ltd (NASDAQ:CYBR), Wynn Resorts, Limited (NASDAQ:WYNN) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) were all noteworthy losers.  What was good news for AstraZeneca plc (ADR) (NYSE:AZN) shareholders today ended up being bad news for Teva Pharmaceutical Industries.  As it turns out, AstraZeneca’s CEO Pascal Soriot will be staying put rather than defecting to Teva."
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca Pops On Report CEO Won&apos;t Jump Ship For Teva Pharma,2017-07-14 20:42:44 +0000,http://finance.yahoo.com/r/b83e77ee-8157-3b71-8794-e33da1b0ffac/astrazeneca-pops-on-report-ceo-wont-jump-ship-for-teva-pharma?src=A00220&yptr=yahoo&.tsrc=rss,"AstraZeneca stock rallied Friday on reports CEO Pascal Soriot will remain on board, defying rumors he would leave to take the top job at Teva Pharmaceutical."
TEVA,TEVA:US,BBG000C0CD58,Potential AstraZeneca C-Suite Shuffle Rekindles Takeover Chatter,2017-07-14 20:05:00 +0000,http://finance.yahoo.com/r/2c94c8ae-5002-346b-9f48-f243c2e55439/potential-astrazeneca-c-suite-shuffle-rekindles-takeover-chatter.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,CEO Pascal Soriot may be on his way to Israel's Teva Pharmaceuticals ahead of key drug trial information release.
TEVA,TEVA:US,BBG000C0CD58,"Valeant Pharmaceuticals’ Overall Trajectory Remains on Edge, Teva Pharmaceutical May Face Difficulty Beating Consensus",2017-07-14 12:22:06 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-122206565.html?.tsrc=rss,"Valeant Pharmaceuticals Intl Inc (NYSE:VRX) may have lessened its net debt, easing liquidity concerns, but as far as Piper Jaffray analyst David Amsellem sees the biotech giant, troubled waters have not ceased just yet.  With projected EBITDA for 2017 well beyond seven times over and domestic segment trends appearing less than robust, the analyst is not swayed by confidence from the stock's rally following April dips- nor by asset sales.  In reaction, the analyst reiterates an Underweight rating on shares of VRX with a $10 price target, which represents a 42% downside from where the shares last closed."
TEVA,TEVA:US,BBG000C0CD58,[$$] Mystery at AstraZeneca: Is CEO Pascal Soriot Staying or Going?,2017-07-14 04:34:06 +0000,http://finance.yahoo.com/r/83ce3c70-ce69-359e-a25f-c78060bea230/mystery-at-astrazeneca-is-ceo-pascal-soriot-staying-or-going-1499945355?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Shares in the U.K. drug giant fell sharply after a news outlet reported he was moving to lead Teva Pharmaceuticals, an Israeli generics drugmaker that has been looking for a new chief for months."
TEVA,TEVA:US,BBG000C0CD58,Teva Shareholders Approve All Proposals,2017-07-14 00:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ktNXcA7luoM/teva-shareholders-approve-all-proposals-20170714-00008,Teva Shareholders Approve All Proposals
TEVA,TEVA:US,BBG000C0CD58,Why AstraZeneca&apos;s Rumored Chief Executive Exit Is Bad Timing,2017-07-13 20:15:28 +0000,http://finance.yahoo.com/r/0736b30a-871c-3a84-a64d-2d89beade90b/why-astrazenecas-rumored-chief-executive-exit-is-bad-timing?src=A00220&yptr=yahoo&.tsrc=rss,Rumors that Chief Executive Pascal Soriot could leave AstraZeneca for Teva may hurt AstraZeneca ahead of a key readout in an immuno-oncology trial.
TEVA,TEVA:US,BBG000C0CD58,Will AstraZeneca's CEO Leave for Teva? Credit Suisse Doesn't Think So,2017-07-13 20:14:00 +0000,http://finance.yahoo.com/r/d078e812-5504-35e9-b4e6-f344f2a8f74d/will-astrazeneca-s-ceo-leave-for-teva-credit-suisse-doesn-t-think-so.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Neither company has confirmed Pascal Soriot's move.
TEVA,TEVA:US,BBG000C0CD58,"Airlines, pharma, financials & more in the blitz",2017-07-13 18:49:00 +0000,https://finance.yahoo.com/video/airlines-pharma-financials-more-blitz-184900576.html?.tsrc=rss,The &quot;Halftime Report&quot; traders take investors through some of the day's biggest movers.
TEVA,TEVA:US,BBG000C0CD58,[$$] AstraZeneca shares hit by report on chief's departure,2017-07-13 17:04:49 +0000,"http://finance.yahoo.com/r/1f217488-6a3b-3166-91f1-ce6cbe3def14/11b5b1ee-6752-11e7-8526-7b38dcaef614,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Shares in AstraZeneca fell on Thursday following a report that its chief executive, Pascal Soriot, was leaving the Anglo-Swedish drugmaker after almost five years to take the top job at Teva Pharmaceutical ..."
TEVA,TEVA:US,BBG000C0CD58,Will AstraZeneca's CEO Leave For Teva?,2017-07-13 17:01:00 +0000,http://finance.yahoo.com/r/7b82e835-bf2f-30ea-876f-9158b300f5c7/will-astrazenecas-ceo-leave-for-teva-1499965315?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"According to reports today from Israeli business news site Calcalist, AstraZeneca's (AZN) CEO Pascal Soriot may leave the company to take the helm at Teva Pharmaceuticals (TEVA).  Credit Suisse's Vamil Divan writes that the move, if it does happen (both firms declined to comment on the report), would be surprising to him, given Soriot's background in branded pharma, which at first blush isn't an obvious fit for generics-maker Teva.  Here are his thoughts on the move from each company's perspective:  Thoughts from an AZN perspective: As CEO Soriot has been very focused on moving AZN away from relying largely on relatively undifferentiated primary care drugs and back to a focus on novel oncology products, whilst also keeping the company's strong emerging markets presence."
TEVA,TEVA:US,BBG000C0CD58,Interesting TEVA Put And Call Options For September 1st,2017-07-13 15:51:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SVEYQaRpudE/interesting-teva-put-and-call-options-for-september-1st-cm815573,Investors in Teva Pharmaceutical Industries Ltd Symbol TEVA saw new options begin trading today for the September 1st expiration At Stock Options Channel our YieldBoost formula has looked up and down the TEVA options chain for the new September 1st contracts and identified one put and
TEVA,TEVA:US,BBG000C0CD58,Report: AstraZeneca CEO in running for Teva chief executive job,2017-07-13 15:45:11 +0000,http://finance.yahoo.com/r/ee0b4d33-5272-3a26-a069-826f1fd4b798/astrazeneca-azn-teva-ceo-pascal-soriot.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"AstraZeneca's stock was trading down Thursday after reports surfaced that the company’s CEO, Pascal Soriot, has emerged as the leading candidate to become the new chief executive of Teva Pharmaceutical Industries.  Teva, based in Israel, has its North American headquarters in North Wales, Pa. London-based AstraZeneca has its North American commercial headquarters in Wilmington, Del.  A story published late Wednesday on Calcalist, a financial news web site, said Soriot — AstraZeneca’s CEO since 2012 — is expected to be named CEO of Teva."
TEVA,TEVA:US,BBG000C0CD58,Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders,2017-07-13 15:38:00 +0000,https://finance.yahoo.com/news/teva-enhances-board-directors-proposals-153800266.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd.  announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. Shareholders voted to approve the elections of Murray Goldberg, Roberto Mignone, Dr."
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Sellers Become More Selective,2017-07-13 13:20:36 +0000,https://finance.yahoo.com/news/major-pharma-short-sellers-become-132036257.html?.tsrc=rss,"The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed."
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Jul 13, 2017 :  YNDX, FOLD, SNAP, MT, ALDR, ARNA, TEF, QAT, DAL, TGT, QQQ, TEVA",2017-07-13 12:54:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xOqWnJJFg5Q/pre-market-most-active-for-jul-13-2017-yndx-fold-snap-mt-aldr-arna-tef-qat-dal-tgt-qqq-teva-cm815385,The NASDAQ 100 Pre Market Indicator is up 6 24 to 5 785 19 The total Pre Market volume is currently 4 422 128 shares traded The following are the most active stocks for the pre market session Yandex N V YNDX is 5 18 at 32 51 with 2 639 346 shares traded As
TEVA,TEVA:US,BBG000C0CD58,"Early movers: DAL, TGT, YNDX, STX, SNAP, AZN, TRNC, AAL & more",2017-07-13 11:52:17 +0000,http://finance.yahoo.com/r/0ca54be4-f873-36c3-982a-a811e35bf907/104584046?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104584046&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca Falls After Report Says Its CEO Is Leaving for Teva,2017-07-13 11:07:00 +0000,http://finance.yahoo.com/r/9562f037-c08e-38fd-8cd5-923bbc9011c9/astrazeneca-falls-after-report-says-ceo-leaving-teva?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Shares in AstraZeneca took a hammering after word spread that its CEO, Pascal Soriot, is set to take the reins at Israel-based Teva."
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca slumps on report CEO is heading to Teva,2017-07-13 09:11:52 +0000,https://finance.yahoo.com/news/astrazeneca-slumps-report-ceo-heading-091152795.html?.tsrc=rss,"Shares in AstraZeneca fell more than 5 percent on Thursday after the company declined to deny a media report that Chief Executive Pascal Soriot was about to defect to Israel-based Teva Pharmaceutical Industries.  Soriot, who has led the Anglo-Swedish company since 2012, met with Teva's search committee and its chairman to express his agreement to serve as its next CEO, the Calcalist financial news website said late on Wednesday.  Teva was left without a permanent CEO in February after Erez Vigodman stepped down, leaving new management to try to restore confidence in the world's biggest generic drugmaker after a series of missteps."
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca Shares Slump On Reports Teva Courting CEO Pascal Soriot,2017-07-13 07:51:00 +0000,http://finance.yahoo.com/r/8bfed4e6-7fd2-381f-bf2c-3a6ecd97c89a/astrazeneca-shares-slump-on-reports-teva-courting-ceo-pascal-soriot.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,AstraZeneca shares dropped in the first hours of trading Thursday after it was reported that Teva Pharmaceuticals was courting its CEO.
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca Stock Dips After Report Says CEO Pascal Soriot Plans To Move To Teva,2017-07-13 05:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FDC4iJfwCdE/astrazeneca-stock-dips-after-report-says-ceo-pascal-soriot-plans-to-move-to-teva-20170713-00170,AstraZeneca Stock Dips After Report Says CEO Pascal Soriot Plans To Move To Teva
TEVA,TEVA:US,BBG000C0CD58,Teva Stock Jumps as New CEO Expected to Be Named,2017-07-12 20:03:00 +0000,http://finance.yahoo.com/r/5804ecab-d837-31f3-94b7-951daf887f1c/teva-stock-jumps-as-new-ceo-expected-to-be-named.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,AstraZeneca CEO Pascal Sorio will reportedly take over at Teva.
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report,2017-07-12 19:47:28 +0000,https://finance.yahoo.com/news/astrazenecas-ceo-soriot-join-israeli-192430308.html?.tsrc=rss,"Israel-based Teva Pharmaceutical Industries (TEVA.TA) is expected to name Anglo-Swedish group AstraZeneca's (AZN.L) Chief Executive Pascal Soriot as Teva's next CEO, the Calcalist financial news website said on Wednesday.  Soriot has met with Teva's (TEVA.N) search committee and its chairman and expressed his agreement to serve as its next CEO, Calcalist said.  Teva was left without a permanent CEO in February after Erez Vigodman stepped down, leaving new management to try to restore confidence in the world's biggest generic drugmaker after a series of missteps."
TEVA,TEVA:US,BBG000C0CD58,Health Care Sector Update for 07/11/2017: TEVA,2017-07-11 14:04:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pGJv1EXyepo/health-care-sector-update-for-07112017-teva-cm814338,Top Health care stocks Top Health care stocks JNJ 0 2 JNJ 0 2 PFE flatPFE flat ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on Tuesday Health care shares were mainly unchanged in pre market trade on Tuesday
TEVA,TEVA:US,BBG000C0CD58,"Teva to Report Second Quarter 2017 Financial Results on August 3, 2017",2017-07-11 14:00:00 +0000,https://finance.yahoo.com/news/teva-report-second-quarter-2017-140000185.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. announced today that it will release its second quarter 2017 financial results on Thursday, August 3, 2017 at 6:30 a.m. ET."
TEVA,TEVA:US,BBG000C0CD58,Teva and the Huntington Study Group Announce Publication of Data for AUSTEDO™ (deutetrabenazine) Tablets in Huntington Disease from ARC-HD Study in JAMA Neurology,2017-07-11 12:00:00 +0000,https://finance.yahoo.com/news/teva-huntington-study-group-announce-120000870.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. and the Huntington Study Group today announced results from the Phase III open-label, single-arm switch cohort of the ARC-HD study were published in JAMA Neurology."
TEVA,TEVA:US,BBG000C0CD58,5 Top Stocks for July,2017-07-11 11:45:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/49waNw68hDQ/5-top-stocks-for-july-cm814198,We asked five of our Motley Fool investors which stocks they believe savvy investors should be adding to their portfolios this month In their views now is the perfect time to pick up Waste Connections Inc NYSE WCG Boston Beer Co NYSE SAM Duluth Holdings
TEVA,TEVA:US,BBG000C0CD58,"Illinois Looks for Kudos for Passing a Budget, Doesn’t Get it",2017-07-11 11:44:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LY8zP896EnY/illinois-looks-for-kudos-for-passing-a-budget-doesnt-get-it-cm814215,Illinois passed a budget and its bonds may still be headed toward junk according to rating agency Moody s Springfield the state s capitol is shocked Balanced or not Illinois was expecting its credit rating not to be lowered to junk just because a budget was passed Illinois passed a
TEVA,TEVA:US,BBG000C0CD58,5 Top Stocks for July,2017-07-11 10:00:00 +0000,http://finance.yahoo.com/r/70a02816-1a57-3ace-af86-4a51cd5ef0ac/5-top-stocks-for-july.aspx?yptr=yahoo&.tsrc=rss,"Adding Waste Connections Inc., Boston Beer Co., Duluth Holdings, Teva Pharmaceutical Industries, and SunPower Corp. to your portfolio this summer could heat up your returns long term."
TEVA,TEVA:US,BBG000C0CD58,Lilly Gets Favorable Ruling in Alimta Patent Lawsuit in UK,2017-07-10 15:52:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xMu7Cfg6emk/lilly-gets-favorable-ruling-in-alimta-patent-lawsuit-in-uk-cm813829,Eli Lilly and Company LLY announced that it has received favorable ruling from the UK Supreme Court in a patent lawsuit against generic drugmaker Actavis related to its key cancer drug Alimta pemetrexed disodium Per the court s verdict alternative salt forms of Alimta launched by
TEVA,TEVA:US,BBG000C0CD58,Lilly Gets Favorable Ruling in Alimta Patent Lawsuit in UK,2017-07-10 13:14:01 +0000,https://finance.yahoo.com/news/lilly-gets-favorable-ruling-alimta-131401094.html?.tsrc=rss,"Eli Lilly and Company (LLY) announced that it has received favorable ruling from the UK Supreme Court in a patent lawsuit against generic drugmaker, Actavis related to its key cancer drug, Alimta (pemetrexed disodium)."
TEVA,TEVA:US,BBG000C0CD58,[$$] U.K. Court Says Generics Infringe on Lilly’s Alimta Patents,2017-07-10 04:29:28 +0000,http://finance.yahoo.com/r/3fc9692e-6e7f-3a76-b24f-a85827e93d12/u-k-court-says-generics-infringe-on-lillys-alimta-patents-1499439663?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Lilly said the U.K. Supreme Court ruled that a rival’s product infringes on its patents for cancer-treatment drug Alimta in several European countries.
TEVA,TEVA:US,BBG000C0CD58,Two cancer drug prices have already been hiked by 8% this year,2017-07-08 14:44:21 +0000,http://finance.yahoo.com/r/2f541064-be4a-3cd0-a9be-8ef63c114613/Story.aspx?guid=8F314C68-5FF6-11E7-8632-80EE0C2E325F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The move provides fodder “for those who argue drug companies raise prices ‘because they can,’” an analyst said."
TEVA,TEVA:US,BBG000C0CD58,"Needelman Asset Management Inc Buys NCR Corp, Sells Teva Pharmaceutical Industries",2017-07-07 21:38:01 +0000,https://finance.yahoo.com/news/needelman-asset-management-inc-buys-213801227.html?.tsrc=rss,"Irvine, CA, based Investment company Needelman Asset Management Inc buys NCR Corp, sells Teva Pharmaceutical Industries during the 3-months ended 2017-06-30, according to the most recent filings of the ..."
TEVA,TEVA:US,BBG000C0CD58,"IEFA, IBML: Big ETF Inflows",2017-07-07 16:48:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tfqonXM6hJs/iefa-ibml-big-etf-inflows-cm813109,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF IEFA which added 29 000 000 units or a 6 3 increase week over week Among the largest underlying components of IEFA in
TEVA,TEVA:US,BBG000C0CD58,[$$] U.K. Court Says Generics Infringe on Lilly's Alimta Patents,2017-07-07 16:47:09 +0000,http://finance.yahoo.com/r/3fc9692e-6e7f-3a76-b24f-a85827e93d12/u-k-court-says-generics-infringe-on-lillys-alimta-patents-1499439663?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Lilly said the U.K. Supreme Court ruled that a rival’s product infringes on its patents for cancer-treatment drug Alimta in several European countries.
TEVA,TEVA:US,BBG000C0CD58,Analysts Predict 10% Gains Ahead For PID,2017-07-07 14:46:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gi7U9eBUlkE/analysts-predict-10-gains-ahead-for-pid-cm812919,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
TEVA,TEVA:US,BBG000C0CD58,[$$] Maryland Sued by Generic-Drug Trade Group Over New Pricing Law,2017-07-07 05:09:18 +0000,http://finance.yahoo.com/r/33560d46-6ab3-339a-9ae4-22c95466097e/maryland-sued-by-generic-drug-trade-group-over-new-pricing-law-1499370135?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,A trade group for the generic-drug industry filed a lawsuit seeking to block Maryland’s new law aimed at curbing steep price increases for generic drugs.
TEVA,TEVA:US,BBG000C0CD58,4 Reasons Teva Pharmaceutical Industries Ltd. Gained 21% in June,2017-07-06 21:45:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mYN7heQi3C8/4-reasons-teva-pharmaceutical-industries-ltd-gained-21-in-june-cm812717,What happened Shares of Teva Pharmaceutical Industries NYSE TEVA an Israeli based developer of brand name and generic drugs catapulted 21 during the month of June according to data from S amp P Global Market Intelligence putting an end to a steady downtrend
TEVA,TEVA:US,BBG000C0CD58,[$$] Maryland Sued by Generic-Drug Trade Group Over New Pricing Law,2017-07-06 20:50:33 +0000,http://finance.yahoo.com/r/33560d46-6ab3-339a-9ae4-22c95466097e/maryland-sued-by-generic-drug-trade-group-over-new-pricing-law-1499370135?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,A trade group for the generic-drug industry filed a lawsuit seeking to block Maryland’s new law aimed at curbing steep price increases for generic drugs.
TEVA,TEVA:US,BBG000C0CD58,4 Reasons Teva Pharmaceutical Industries Ltd. Gained 21% in June,2017-07-06 19:41:00 +0000,http://finance.yahoo.com/r/5cdc7365-a34c-3157-aa88-b306dafb91b6/4-reasons-teva-pharmaceutical-industries-ltd-gaine.aspx?yptr=yahoo&.tsrc=rss,"Sometimes, no news is good news for a troubled drugmaker."
TEVA,TEVA:US,BBG000C0CD58,VIVUS Settles with Teva on Weight Management Drug Generic,2017-07-06 15:45:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lOu-XycPBV4/vivus-settles-with-teva-on-weight-management-drug-generic-cm812369,VIVUS Inc VVUS announced that it has entered into a settlement agreement with Actavis Laboratories a subsidiary of generic company Teva Pharmaceutical Industries Limited TEVA thereby resolving a three year old patent litigation related to its weight management drug Qsymia Shares of
TEVA,TEVA:US,BBG000C0CD58,VIVUS Settles with Teva on Weight Management Drug Generic,2017-07-06 14:06:02 +0000,https://finance.yahoo.com/news/vivus-settles-teva-weight-management-140602451.html?.tsrc=rss,"VIVUS, Inc. (VVUS) announced that it has entered into a settlement agreement with Teva Pharmaceutical Industries Limited (TEVA), thereby resolving a three-year old patent litigation related to its weight management drug Qsymia."
TEVA,TEVA:US,BBG000C0CD58,Options say this pharma name could break out,2017-07-05 17:46:00 +0000,https://finance.yahoo.com/video/options-pharma-name-could-break-174600922.html?.tsrc=rss,The Najarian brothers spot heavy call-buying in shares of Teva Pharmaceuticals & Energy Transfer Equity.
TEVA,TEVA:US,BBG000C0CD58,United Therapeutics’ Orenitram May Show Revenue Growth in 2017,2017-07-04 11:38:50 +0000,http://finance.yahoo.com/r/7c33e622-55c2-33ce-b9bc-895ada9ee839/united-therapeutics-orenitram-may-show-revenue-growth-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, United Therapeutics’ (UTHR) Orenitram reported revenues of ~$157.0 million, which reflected ~33.0% growth year-over-year."
TEVA,TEVA:US,BBG000C0CD58,Use Alibaba Group Holding Ltd (BABA) Stock’s ‘Buy Now’ Option,2017-07-03 19:43:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YznKFmx1JKk/use-alibaba-group-holding-ltd-baba-stocks-buy-now-option-cm811450,InvestorPlace Stock Market News Stock Advice amp Trading Tips You ve certainly heard it before but on this occasion the bullish echo is for the massive disruptor Alibaba Group Holding Ltd NYSE BABA And for investors interested in riding BABA stock
TEVA,TEVA:US,BBG000C0CD58,3 Top High-Yield Pharmaceutical Stocks to Buy Now,2017-07-03 19:11:00 +0000,http://finance.yahoo.com/r/a9365adc-2b41-3ac8-9fb3-24dbef45c6b8/3-top-high-yield-pharmaceutical-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"AstraZeneca, GlaxoSmithKline, and Teva Pharmaceutical Industries sport some of the highest dividend yields among drugmakers today. Here&apos;s why their rewards could outweigh their risks."
TEVA,TEVA:US,BBG000C0CD58,"The Zacks Analyst Blog Highlights: Merck, Sanofi, Roche, Esperion and Teva",2017-07-03 15:50:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/25ag6e4wWog/the-zacks-analyst-blog-highlights-merck-sanofi-roche-esperion-and-teva-cm811240,For Immediate Release Chicago IL July 03 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Reach $40,2017-07-03 15:46:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_32ZHTcr3pQ/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-reach-40-cm811309,InvestorPlace Stock Market News Stock Advice amp Trading Tips Despite what appears to be an unhealthy market for drug stocks weighed by political pressures on pricing Teva Pharmaceutical Industries Ltd ADR NYSE TEVA still could be compelling trade With TEVA stock down
TEVA,TEVA:US,BBG000C0CD58,"The Zacks Analyst Blog Highlights: Merck, Sanofi, Roche, Esperion and Teva",2017-07-03 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-merck-133001364.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Merck, Sanofi, Roche, Esperion and Teva"
TEVA,TEVA:US,BBG000C0CD58,How Is United Therapeutics’ Remodulin Positioned in 2017?,2017-07-03 13:10:54 +0000,http://finance.yahoo.com/r/54cac33d-ddc4-3b15-b9fc-008e1a50e5de/how-is-united-therapeutics-remodulin-positioned-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, United Therapeutics’ (UTHR) Remodulin reported revenues of ~$602.3 million, which reflected ~5.0% year-over-year growth."
TEVA,TEVA:US,BBG000C0CD58,Pharma Firms Hit With Lawsuit From Oklahoma AG Over Opioid Marketing,2017-06-30 21:21:00 +0000,http://finance.yahoo.com/r/44702e48-5608-3539-8250-b85c16f8c386/pharma-firms-hit-with-lawsuit-from-oklahoma-ag-over-opioid-marketing.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Oklahoma Attorney General Mike Hunter alleged that the firms engaged in misleading marketing practices and ""waged a fraudulent, decade-long marketing campaign to profit from the anguish of thousands ..."
TEVA,TEVA:US,BBG000C0CD58,Teva's (TEVA) Filing for Biosimilar Rituxan Accepted by FDA,2017-06-30 17:41:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7fYHmfThxNU/tevas-teva-filing-for-biosimilar-rituxan-accepted-by-fda-cm810646,Teva Pharmaceutical Industries Ltd TEVA and Korean partner Celltrion Inc announced that the FDA has accepted for review their Biologics License Application BLA for CT P10 a proposed biosimilar to Roche Holding AG s RHHBY Rituxan rituximab The regulatory action by the FDA is expected
TEVA,TEVA:US,BBG000C0CD58,Teva&apos;s (TEVA) Filing for Biosimilar Rituxan Accepted by FDA,2017-06-30 16:04:04 +0000,https://finance.yahoo.com/news/teva-apos-teva-filing-biosimilar-160404759.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. (TEVA) and Korean partner Celltrion, Inc., announced that the FDA has accepted for review their Biologics License Application (BLA) for CT-P10, a proposed biosimilar to Roche Holding AG&apos;s (RHHBY) Rituxan (rituximab)."
TEVA,TEVA:US,BBG000C0CD58,"CARA In Pain, ALKS Enlightened, FDA Expands Approved Use Of AMGN's Vectibix",2017-06-30 02:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WnQXnBoQVo0/cara-in-pain-alks-enlightened-fda-expands-approved-use-of-amgns-vectibix-20170630-00064,"CARA In Pain, ALKS Enlightened, FDA Expands Approved Use Of AMGN's Vectibix"
TEVA,TEVA:US,BBG000C0CD58,iQ100 index up 20% for one year,2017-06-29 17:31:00 +0000,https://finance.yahoo.com/video/iq100-index-20-one-173100328.html?.tsrc=rss,"Today's leaders in the CNBC iQ100 include Bank of America, J.P. Morgan, Nabors Industries, Metlife Inc, and Teva."
TEVA,TEVA:US,BBG000C0CD58,"IEFA, RFDI: Big ETF Inflows",2017-06-29 16:06:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zYjVxqWl_MI/iefa-rfdi-big-etf-inflows-cm809982,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF IEFA which added 20 000 000 units or a 4 5 increase week over week Among the largest underlying components of IEFA in
TEVA,TEVA:US,BBG000C0CD58,Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar to Rituxan® (rituximab),2017-06-29 12:30:00 +0000,https://finance.yahoo.com/news/celltrion-teva-announce-u-fda-123000202.html?.tsrc=rss,"Celltrion, Inc., a global biopharmaceutical company, and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application for CT-P10, a proposed Monoclonal Antibody biosimilar to Rituxan®1 , which is used to treat patients with non-Hodgkin’s lymphoma , chronic lymphocytic leukemia , rheumatoid arthritis , granulomatosis ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Publication of AIM-TD Study Results in The Lancet Psychiatry for the Investigational Use of Deutetrabenazine in Tardive Dyskinesia,2017-06-29 12:00:00 +0000,https://finance.yahoo.com/news/teva-announces-publication-aim-td-120000461.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today announced the publication of results from the Phase III study, AIM-TD , in the medical journal, The Lancet Psychiatry."
TEVA,TEVA:US,BBG000C0CD58,Teva And Celltrion Say FDA Accepts BLA For Proposed Biosimilar To Rituxan,2017-06-29 08:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SZvzKXNAJa8/teva-and-celltrion-say-fda-accepts-bla-for-proposed-biosimilar-to-rituxan-20170629-00555,Teva And Celltrion Say FDA Accepts BLA For Proposed Biosimilar To Rituxan
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Publication Of Results From Phase III Study AIM-TD,2017-06-29 08:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zD_fpF8K8KQ/teva-announces-publication-of-results-from-phase-iii-study-aimtd-20170629-00471,Teva Announces Publication Of Results From Phase III Study AIM-TD
TEVA,TEVA:US,BBG000C0CD58,Today's iQ100 leaders,2017-06-28 19:07:00 +0000,https://finance.yahoo.com/video/todays-iq100-leaders-190700471.html?.tsrc=rss,"The CNBC iQ100 is up more than twenty percent for one year. It's an index tracking the one hundred big cap companies that get most of their revenue from their own intellectual property. Today's leaders include Bank of America, General Mills, Prudential..."
TEVA,TEVA:US,BBG000C0CD58,Alder's Shares Dip Despite Positive Migraine Trial Results,2017-06-28 17:03:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ibP6RWPrkMM/alders-shares-dip-despite-positive-migraine-trial-results-cm809487,Alder Biopharmaceuticals Inc s ALDR shares plummeted almost 28 despite the announcement of positive top line results from phase III PROMISE I study evaluating its lead pipeline candidate eptinezumab ALD403 for prevention of frequent episodic migraine Though the study has met both
TEVA,TEVA:US,BBG000C0CD58,Teva/Xenon Nerve Pain Candidate Fails in Phase II Study,2017-06-28 14:07:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/InXgU7yB8uA/tevaxenon-nerve-pain-candidate-fails-in-phase-ii-study-cm809347,Teva Pharmaceutical Industries Ltd TEVA and partner Xenon Pharmaceuticals Inc XENE announced that a mid stage study evaluating their pipeline candidate topical TV 45070 for post herpetic neuralgia PNH did not meet the primary endpoint Shares of Xenon were down 21 on Tuesday while that
TEVA,TEVA:US,BBG000C0CD58,Teva/Xenon Nerve Pain Candidate Fails in Phase II Study,2017-06-28 12:24:12 +0000,https://finance.yahoo.com/news/teva-xenon-nerve-pain-candidate-122412190.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. (TEVA) announced that a mid-stage study evaluating their pipeline candidate, topical TV-45070 for post-herpetic neuralgia (PNH) did not meet the primary endpoint."
TEVA,TEVA:US,BBG000C0CD58,World's largest generic drugmaker warns health-care industry faces 'huge disruption',2017-06-28 05:04:27 +0000,http://finance.yahoo.com/r/fd9ccfd9-ee92-3a02-967e-5c8b9baf9911/104555332?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104555332&yptr=yahoo&.tsrc=rss,"Yitzhak Peterburg, interim president and CEO of Teva Pharmaceutical, talks about the disruption facing the traditional health care industry."
TEVA,TEVA:US,BBG000C0CD58,World&apos;s largest generic drugmaker warns health-care industry faces &apos;huge disruption&apos;,2017-06-28 05:04:27 +0000,https://finance.yahoo.com/news/world-apos-largest-generic-drugmaker-050427966.html?.tsrc=rss,"Yitzhak Peterburg, interim president and CEO of Teva Pharmaceutical, talks about the disruption facing the traditional health care industry."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma CEO on health-care bill and disruption,2017-06-28 01:16:00 +0000,https://finance.yahoo.com/video/teva-pharma-ceo-health-care-011600892.html?.tsrc=rss,"Yitzhak Peterburg, Teva Pharmaceutical Industries, says uncertainty over policies have impacted the industry, but digital disruption is unlikely to be hampered."
TEVA,TEVA:US,BBG000C0CD58,This Biotech Crashed 28% Despite Positive Migraine Drug Tests,2017-06-27 20:08:49 +0000,http://finance.yahoo.com/r/b239eb6d-e316-3223-99f0-30a46fc0ef96/this-biotech-crashed-20-despite-positive-migraine-drug-tests?src=A00220&yptr=yahoo&.tsrc=rss,"Alder stock dove to a nearly three-year low Tuesday despite strong data in a Phase 3 migraine trial, making it competitive with Lilly, Amgen and Teva."
TEVA,TEVA:US,BBG000C0CD58,"Health Care Sector Update for 06/27/2017: XENE,TEVA,APDN,RARX",2017-06-27 18:29:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U8gu12a82kE/health-care-sector-update-for-06272017-xenetevaapdnrarx-cm808996,Top Health Care StocksTop Health Care Stocks JNJ 0 59 JNJ 0 59 PFE 0 34 PFE 0 34 ABT 0 09 ABT 0 09 MRK 0 26 MRK 0 26 AMGN 0 71 AMGN 0 71 Health care stocks were lower Tuesday with the NYSE Health Care Index declining almost 0 3 while shares of health care companies in the S amp
TEVA,TEVA:US,BBG000C0CD58,"Valeant: Out of the Frying Pan, Into the Fire",2017-06-27 18:02:00 +0000,http://finance.yahoo.com/r/f21aaf46-59a6-384d-9213-77b33b3d2a43/valeant-out-of-the-frying-pan-into-the-fire-1498586566?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) spiked yesterday on speculation regarding a possible debt-to-equity swap by the troubled drug maker.  Wells Fargo analyst David Maris weighed in on the notion today, arguing that even if a swap does happen, it does not repair poor business trends or the increasingly unlikelihood that Valeant can deliver the strong earnings growth promised by consensus forecasts.  As Maris writes: Based on our experience and feedback from our high yield debt analyst, we think that most debt holders do not have the ability or interest to take cross structure risk."
TEVA,TEVA:US,BBG000C0CD58,"Midday Update: Market Averages Under Pressure on Tech Sell-Off, Fed VC Fischer's Warning on Asset Valuations",2017-06-27 17:51:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s5KHObfN5Ck/midday-update-market-averages-under-pressure-on-tech-sell-off-fed-vc-fischers-warning-on-asset-valuations-cm808967,The Dow surrendered its modest gain at midday and joined the other benchmark averages in negative territory as Fed Vice Chairman Stanley Fischer cautioned investors of the notable uptick in risk appetites in asset markets The Dow surrendered its modest gain at midday and joined the
TEVA,TEVA:US,BBG000C0CD58,"John Paulson Buys T-Mobile US Inc, DISH Network Corp, Mead Johnson Nutrition Co, Sells Teva ...",2017-06-27 17:50:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bs7Z9rS0m-o/john-paulson-buys-t-mobile-us-inc-dish-network-corp-mead-johnson-nutrition-co-sells-teva-cm808988,John Paulson New Purchases TMUS DISH BKD ARNC PANW XENT FGL WBMD AMZN Z Added Positions MJN NXPI ALXN TWX FDX STE SD GSK ESPR PFE Reduced Positions TEVA STAY AGN MYL SHPG MNK AIG AEM BIIB GOOG Sold Out BEAV VMW HPE
TEVA,TEVA:US,BBG000C0CD58,"UPDATED: Xenon and Teva say mid-stage nerve pain drug missed primary, secondary endpoints",2017-06-27 12:51:58 +0000,http://finance.yahoo.com/r/39d85ef7-a083-3cdb-b7c4-b9bb726569ed/Story.aspx?guid=506EE7F8-C1F6-4618-9069-63CDA5EFF755&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Xenon Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. said premarket Tuesday that their mid-stage nerve pain drug missed its primary endpoint and secondary endpoints. Xenon shares plummeted ...
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Run for Cover From Major Pharma,2017-06-27 12:45:26 +0000,https://finance.yahoo.com/news/short-sellers-run-cover-major-124526926.html?.tsrc=rss,"The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank."
TEVA,TEVA:US,BBG000C0CD58,Teva and Xenon Announce Phase II Study of Topical TV-45070 in Patients with Post-Herpetic Neuralgia (PHN) Did Not Meet Primary Endpoint,2017-06-27 12:15:00 +0000,https://finance.yahoo.com/news/teva-xenon-announce-phase-ii-121500466.html?.tsrc=rss,"JERUSALEM and BURNABY, British Columbia, June 27, 2017-- Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announce top-line results in a Phase II study of topical TV-45070 in patients ..."
TEVA,TEVA:US,BBG000C0CD58,Teva : Phase II Study Of Topical TV-45070 In PHN Fails To Meet Primary Endpoint,2017-06-27 08:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/md_iNMGypaE/teva--phase-ii-study-of-topical-tv45070-in-phn-fails-to-meet-primary-endpoint-20170627-00492,Teva : Phase II Study Of Topical TV-45070 In PHN Fails To Meet Primary Endpoint
TEVA,TEVA:US,BBG000C0CD58,iQ100 up over twenty percent this year,2017-06-26 18:38:00 +0000,https://finance.yahoo.com/video/iq100-over-twenty-percent-183800339.html?.tsrc=rss,"The CNBC iQ100 up more than 20 percent in one year. It's an index tracking 100 big cap companies that get most of their revenue from their own intellectual property. Today's leaders include Micron, HP inc, Teva Pharmaceuticals Industries, Johnson Contr..."
TEVA,TEVA:US,BBG000C0CD58,Valeant Pharma: A Debt Swap?,2017-06-26 18:17:00 +0000,http://finance.yahoo.com/r/776a7947-bc63-3e80-9dcb-7c540131cbc6/valeant-pharma-a-debt-swap-1498501031?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Why are shares of Valeant Pharmaceuticals International (VRX) rising and does the market have it right?  According to Evercore ISI analyst Umer Raffat, anytime the market receives a signal of some sort that the embattled drug maker has value beyond its pile of debt, the stock price rises and short sellers cover their positions.  Today, a 7.8% spike in Valeant’s share price is linked to speculation that a debt-to-equity swap could be on the horizon, Raffat says."
TEVA,TEVA:US,BBG000C0CD58,Allergan Continues to Focus on Acquisitions and Branded Unit,2017-06-26 15:54:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BVusu62u1nc/allergan-continues-to-focus-on-acquisitions-and-branded-unit-cm808129,We issued an updated research report on Allergan plc AGN on Jun 23 Acquisitions form an integral part of Allergan s expansion strategy Allergan is reshaping its portfolio through strategic acquisitions With the Allergan Inc acquisition the company finds itself among the top 10
TEVA,TEVA:US,BBG000C0CD58,Allergan Continues to Focus on Acquisitions and Branded Unit,2017-06-26 13:15:01 +0000,https://finance.yahoo.com/news/allergan-continues-focus-acquisitions-branded-131501124.html?.tsrc=rss,We issued an updated research report on Allergan plc (AGN) on Jun 23.
TEVA,TEVA:US,BBG000C0CD58,"What You Don't Know About Generic Drugs, and How It Can Hurt You",2017-06-26 09:00:00 +0000,http://finance.yahoo.com/r/695d747f-69a9-3cab-ab6b-e4545ea3d0f7/what-you-don-t-know-about-generic-drugs-and-how-it-can-hurt-you?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"To keep his anxiety under control, Peter, a 35-year-old government employee, relied for nine years on a blue-and-white pill he popped every night before bed: Cymbalta, made by Eli Lilly & Co. When a generic ..."
TEVA,TEVA:US,BBG000C0CD58,These 3 Stocks Are Up Over 500% in the Last 3 Years,2017-06-25 15:50:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RLBeL88Fy7Q/these-3-stocks-are-up-over-500-in-the-last-3-years-cm807850,Image seeing your investment of 10 000 grow to more than 60 000 in just three years That would be awesome wouldn t it Investors who bought big enough stakes in three stocks in mid 2014 and held on don t have to imagine that scenario Eagle Pharmaceuticals NASDAQ
TEVA,TEVA:US,BBG000C0CD58,These 3 Stocks Are Up Over 500% in the Last 3 Years,2017-06-25 13:42:00 +0000,http://finance.yahoo.com/r/b3f0fdd1-6dcc-31fa-8deb-e538bed1cd6a/these-3-stocks-are-up-over-500-in-the-last-3-years.aspx?yptr=yahoo&.tsrc=rss,"How Eagle Pharmaceuticals, Exelixis, and NVIDIA stocks have made some investors rich."
TEVA,TEVA:US,BBG000C0CD58,"Facebook, Baidu, Coach And 5 Other Blue-Chip Stocks To Buy For Second-Half 2017",2017-06-24 14:01:00 +0000,http://finance.yahoo.com/r/235a0f96-395f-334d-8a17-a8bd0f772041/facebook-baidu-coach-and-5-other-blue-chip-stocks-to-buy-for-second-half-2017?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The bull market that kicked off in March 2009 should be on the front cover of AARP magazine. At age 8, the S&P 500 bull run is very old and very overvalued compared to its historical ratios. Given the less than stellar circumstances, how should you invest now?"
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Geron Corporation and Teva Pharmaceutical,2017-06-23 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000999.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 23, 2017 / It was a disappointing day for Teva Pharmaceutical Industries on Thursday, but judging by the gains the stock saw yesterday nobody would have known it. The pharmaceutical ..."
TEVA,TEVA:US,BBG000C0CD58,The Long Case For Taro Pharmaceutical,2017-06-22 22:20:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vq8cOU9r0MA/the-long-case-for-taro-pharmaceutical-cm807125,By Alessandro Villadei ByAlessandro Villadei Target Price and Rationale Target Price and RationaleTarget Price and Rationale Taro Pharmaceutical TARO is a recommended buy with a price target of 175 Taro Pharmaceutical TARO is a recommended buy with a price target of 175
TEVA,TEVA:US,BBG000C0CD58,Glaxo's (GSK) Shingles Candidate Phase III Data Positive,2017-06-22 16:24:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FDaAJrW7Wn4/glaxos-gsk-shingles-candidate-phase-iii-data-positive-cm806943,GlaxoSmithKline plc GSK announced positive top line results from a phase III revaccination study on its shingles vaccine candidate Shingrix in older patients The Zoster 048 study administered Shingrix in patients aged 50 years or older who have been vaccinated against shingles with
TEVA,TEVA:US,BBG000C0CD58,Glaxo&apos;s (GSK) Shingles Candidate Phase III Data Positive,2017-06-22 14:06:02 +0000,https://finance.yahoo.com/news/glaxo-apos-gsk-shingles-candidate-140602662.html?.tsrc=rss,"GlaxoSmithKline plc (GSK) announced positive top-line results from a phase III revaccination study on its shingles vaccine candidate, Shingrix, in older patients."
TEVA,TEVA:US,BBG000C0CD58,GSK wins $235 million from Teva in Coreg patent trial,2017-06-21 22:41:52 +0000,https://finance.yahoo.com/news/gsk-wins-235-million-teva-224152421.html?.tsrc=rss,"A U.S. jury has ordered Teva  Pharmaceutical Industries Ltd to pay GlaxoSmithKline  Plc more than $235 million for infringing a patent  covering its blood pressure drug Coreg, court documents showed.  A federal jury in Wilmington, Delaware on Tuesday found that  Teva willfully infringed the patent in connection with its sales  of a generic version of the drug with a label indicating it  could be used for treating chronic heart failure.  The jury rejected Teva's contention that the patent was  invalid."
TEVA,TEVA:US,BBG000C0CD58,"IEFA, TEVA, CHKP, MBLY: Large Inflows Detected at ETF",2017-06-21 17:20:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2ZO-RWiVIB8/iefa-teva-chkp-mbly-large-inflows-detected-at-etf-cm806344,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 335 3 million dollar inflow that s a 1 2 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Israeli credit card firm Isracard names outgoing Teva CFO as chairman,2017-06-21 11:25:59 +0000,https://finance.yahoo.com/news/israeli-credit-card-firm-isracard-112559333.html?.tsrc=rss,"Israel's biggest credit card  company Isracard on Wednesday named Eyal Desheh, the outgoing  chief financial officer of Teva Pharmaceutical Industries  , as its new chairman.  Teva in April said Desheh would step down at  end-June after nearly a decade in the job, the second top  official to resign from the Israel-based company this year.  Isracard is a unit of Bank Hapoalim, Israel's  largest lender."
TEVA,TEVA:US,BBG000C0CD58,"ETFs with exposure to Teva Pharmaceutical Industries Ltd. : June 20, 2017",2017-06-20 19:18:34 +0000,http://finance.yahoo.com/r/78281263-1e8b-3659-8c3e-3b4c8ededfb8/etfs-with-exposure-to-teva-pharmaceutical-industries-ltd-june-20-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Teva Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TEVA-US. Comparing the performance and risk of Teva Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
<b>(Read more...)</b>"
TEVA,TEVA:US,BBG000C0CD58,Dupixent May Prove Effective in Multiple Diseases,2017-06-20 18:06:09 +0000,http://finance.yahoo.com/r/54a23092-8e5b-3fbf-9847-c11a49caed5c/dupixent-may-prove-effective-multiple-diseases-caused-overactivity-il-4-il-13-pathway?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Regeneron plans to discuss Dupixent’s innovative mechanism-based treatment approach with regulatory authorities.
TEVA,TEVA:US,BBG000C0CD58,Label Expansion May Boost Regeneron’s Dupixent in the Future,2017-06-20 16:20:50 +0000,http://finance.yahoo.com/r/8ab8524c-dda7-36c1-ab70-31624ea9bef1/label-expansion-may-boost-dupixents-sales-future-years?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Regeneron (REGN) and Sanofi (SNY) are exploring the use of Dupixent in other indications such as asthma, pediatric AD, nasal polyps, and eosinophilic esophagitis."
TEVA,TEVA:US,BBG000C0CD58,Should Investors Steer Clear of Opioid Drug Stocks?,2017-06-20 13:20:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Hmy_4-Djcs/should-investors-steer-clear-of-opioid-drug-stocks-cm805463,More than 50 000 Americans died as a result of opioid overdoses last year The opioid epidemic is taking a huge toll on families across the country It s also placing a heavy burden on state and local governments that must bear the added costs of healthcare and law enforcement And many
TEVA,TEVA:US,BBG000C0CD58,Should Investors Steer Clear of Opioid Drug Stocks?,2017-06-20 12:04:00 +0000,http://finance.yahoo.com/r/2cbd48db-9df5-3ae2-bcf6-0729b26669c9/should-investors-steer-clear-of-opioid-drug-stocks.aspx?yptr=yahoo&.tsrc=rss,"State and local governments are targeting Johnson & Johnson, Teva, and other opioid drugmakers and distributors. Could their stocks be at risk?"
TEVA,TEVA:US,BBG000C0CD58,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 22:19:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Itsgu_jwGQI/valeant-pharmaceuticals-intl-inc-vrx-stock-isnt-healed-by-paulsons-presence-cm805395,InvestorPlace Stock Market News Stock Advice amp Trading Tips It remains to be seen if John Paulson s presence on the board of directors of Valeant Pharmaceuticals Intl Inc NYSE VRX will make a positive difference for the beleaguered company But as far as owners of VRX
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Time to Go Contrarian?,2017-06-19 20:19:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YxM29o3La_c/teva-pharmaceutical-industries-ltd-adr-teva-stock-time-to-go-contrarian-cm805346,InvestorPlace Stock Market News Stock Advice amp Trading Tips The pharmaceutical business is a love hate affair Right now Wall Street is feeling the latter for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA Although the Israeli pharma is one of the most respected names
TEVA,TEVA:US,BBG000C0CD58,Valeant Pharmaceuticals Intl Inc (VRX) Stock Isn’t Healed by Paulson’s Presence,2017-06-19 17:47:28 +0000,https://finance.yahoo.com/news/valeant-pharmaceuticals-intl-inc-vrx-174728345.html?.tsrc=rss,"It remains to be seen if John Paulson’s presence on the board of directors of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) will make a positive difference for the beleaguered company.  John Paulson is the chief of hedge fund Paulson & Co., which rose to infamy after making a (very) correct bearish call on the U.S. housing market in 2007."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Time to Go Contrarian?,2017-06-19 15:52:13 +0000,https://finance.yahoo.com/news/teva-pharmaceutical-industries-ltd-adr-155213099.html?.tsrc=rss,"The pharmaceutical business is a love-hate affair.  Right now, Wall Street is feeling the latter for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).  Although the Israeli pharma is one of the most respected names in the industry, TEVA stock plays the opposite role."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017",2017-06-19 15:47:26 +0000,http://finance.yahoo.com/r/8c1fcf73-5e78-357e-9a22-9bb02135c6e1/teva-pharmaceutical-industries-ltd-teva-us-earnings-analysis-q1-2017-by-the-numbers-june-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Teva Pharmaceutical Industries Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Teva Pharmaceutical Industries Ltd. – Mylan N.V., Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Pfizer Inc., Dr. Reddy’s ... Read more
<b>(Read more...)</b>"
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks in Healthcare,2017-06-16 14:10:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GtNVYqGiDqk/3-dividend-stocks-in-healthcare-cm804267,The healthcare sector can be an enormously profitable area to hunt for dividend stocks Top healthcare companies after all often sport ginormous free cash flows and sustainable levels of growth Based on this insight we turned to our contributors to ask them which
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals Upgraded at Mizuho,2017-06-16 13:33:00 +0000,http://finance.yahoo.com/r/e0085d09-6153-3d4e-9f00-c98c3e6876b4/teva-pharmaceuticals-upgraded-at-mizuho.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Positive subscription trends and less downside risk this year have the company well positioned, Mizuho says."
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks in Healthcare,2017-06-16 12:07:00 +0000,http://finance.yahoo.com/r/b15e3865-02c4-3adc-a7a0-d6d2bd0b83a2/3-dividend-stocks-in-healthcare.aspx?yptr=yahoo&.tsrc=rss,These top healthcare dividend stocks might be great long-term buys.
TEVA,TEVA:US,BBG000C0CD58,Futures Slip as Wall Street Braces For More Political Turmoil,2017-06-15 14:06:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q-HpdYVgVJ8/futures-slip-as-wall-street-braces-for-more-political-turmoil-cm803763,Stock futures were losing ground ahead of Thursday s open as political turmoil weighs on Wall Street and as Wednesday s Federal Open Market Committee statement continues to reverberate The Washington Post reported late Wednesday that special counsel Robert Mueller is opening an
TEVA,TEVA:US,BBG000C0CD58,CTI BioPharma Gets $10 Mln Milestone Payment For TRISENOX From Teva,2017-06-15 01:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RRW0bdKYJRg/cti-biopharma-gets-10-mln-milestone-payment-for-trisenox-from-teva-20170615-00032,CTI BioPharma Gets $10 Mln Milestone Payment For TRISENOX From Teva
TEVA,TEVA:US,BBG000C0CD58,States Launch Bipartisan Probe of Opioid Marketing and Addiction,2017-06-15 00:58:43 +0000,http://finance.yahoo.com/r/bb831a15-bae6-3d37-9caa-781ecd1c70f4/states-launch-bipartisan-probe-of-opioid-marketing-and-addiction-1497474841?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"A bipartisan group of state attorneys general is jointly investigating the marketing of prescription painkillers and the causes of widespread opioid addiction, according to people familiar with the matter, ..."
TEVA,TEVA:US,BBG000C0CD58,Pfizer & Lilly Get Fast Track Designation for Pain Candidate,2017-06-14 17:08:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r96pw6frSEc/pfizer-lilly-get-fast-track-designation-for-pain-candidate-cm803406,Pfizer Inc PFE and Eli Lilly and Company LLY announced that the FDA has granted fast track designation to their pipeline candidate tanezumab for the treatment of chronic pain in patients with osteoarthritis OA and chronic low back pain CLBP We note that the FDA s fast track
TEVA,TEVA:US,BBG000C0CD58,Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space,2017-06-13 16:07:00 +0000,http://finance.yahoo.com/r/4d1c14dd-91d4-30d7-9f0c-899a8503826d/struggling-generic-drugmakers-face-ma-dilemma-expand-and-complicate-or-stand-pat-and-risk-it-all.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Celgene and Teva Pharmaceutical Industries,2017-06-13 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000865.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 13, 2017 / U.S. markets dipped Monday as the Tech sector's sell-off continued for the second consecutive session. The Dow Jones Industrial Average declined 0.17 percent ..."
TEVA,TEVA:US,BBG000C0CD58,Teva launches generic version of Merck cholesterol-lowering medicine,2017-06-13 11:55:09 +0000,http://finance.yahoo.com/r/cbd5ab33-7f25-3134-ac5d-6fa2361dce41/teva-launches-generic-version-of-merck-cholesterol.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. said Monday it has launched a generic version of the cholesterol-lowering medication Zetia.  Zetia, which contains the active ingredient ezetimibe, is a prescription medicine made by Merck (MRK) used to lower levels of total cholesterol and low-density lipoprotein (LDL) cholesterol in the blood.  Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet and exercise alone."
TEVA,TEVA:US,BBG000C0CD58,[$$] Nassau County Sues Drugmakers Over Opioid Epidemic,2017-06-13 05:08:39 +0000,http://finance.yahoo.com/r/0b4b3cd9-661d-3c0e-a1a5-210ab6d91868/nassau-county-sues-drug-makers-over-opioid-epidemic-1497298701?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Nassau County filed a lawsuit Monday against several pharmaceutical companies, alleging their prescription painkillers helped fuel the opioid epidemic that costs the county millions of dollars annually ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] Nassau County Sues Drugmakers Over Opioid Epidemic,2017-06-12 23:18:22 +0000,http://finance.yahoo.com/r/0b4b3cd9-661d-3c0e-a1a5-210ab6d91868/nassau-county-sues-drug-makers-over-opioid-epidemic-1497298701?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Nassau County filed a lawsuit Monday against several pharmaceutical companies, alleging their prescription painkillers helped fuel the opioid epidemic that costs the county millions of dollars annually ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Zetia® in the United States,2017-06-12 19:16:00 +0000,https://finance.yahoo.com/news/teva-announces-launch-generic-zetia-191600339.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the launch of generic Zetia®1 tablets, 10 mg, in the U.S."
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Grow More Selective on Major Pharma,2017-06-12 12:55:03 +0000,https://finance.yahoo.com/news/short-sellers-grow-more-selective-125503838.html?.tsrc=rss,"The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed."
TEVA,TEVA:US,BBG000C0CD58,Opioid Stocks Feel the Pressure of FDA Measures,2017-06-11 18:27:00 +0000,http://finance.yahoo.com/r/4c7bb277-eae6-3d97-b692-e7273b96a4f0/opioid-stocks-threatened-fda-steps-endp-depo-insy?partner=YahooSA&yptr=yahoo&.tsrc=rss,Recent FDA measures to curb the alarming U.S. opioid epidemic is hurting some drug stocks.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm looks to refresh board with four new nominees,2017-06-11 07:52:37 +0000,https://finance.yahoo.com/news/teva-pharm-looks-refresh-board-075237187.html?.tsrc=rss,* Israel's Teva Pharmaceutical Industries is looking to refresh its board of directors with four new members as it tries to restore investor confidence after a series of missteps. * Teva's stock price ...
TEVA,TEVA:US,BBG000C0CD58,Pharmaceutical Stocks Gain on Promising Migraine Drugs with Hefty Price Tags,2017-06-09 17:43:00 +0000,http://finance.yahoo.com/r/d9884dd8-aa72-3975-a4cc-820c24fa4865/pharmaceutical-stocks-gain-on-promising-migraine-drugs-with-hefty-price-tags.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Newly released neurotransmitter research could open up a $8 - $10 billion market as early as next year.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Stock Rising on Generic Eye Drop Launch,2017-06-09 13:30:00 +0000,http://finance.yahoo.com/r/923f399b-6cf0-340d-b0af-768d90baf884/teva-pharmaceutical-stock-rising-on-generic-eye-drop-launch.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The drops are used to treat itchy eyes associated with allergies.
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Exclusive Launch of Generic Pataday® in the United States,2017-06-09 12:53:00 +0000,https://finance.yahoo.com/news/teva-announces-exclusive-launch-generic-125300523.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the launch of generic Pataday®1 0.2%, in the U.S."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Pharmaceutical to Nominate Four New Directors,2017-06-09 05:21:00 +0000,http://finance.yahoo.com/r/82557ebb-8b99-34c4-92b2-efe43f2b3b79/teva-pharmaceutical-to-nominate-four-new-directors-1496952181?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical will seek to overhaul its board by nominating four new directors, the latest step toward remaking the struggling drug company."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Pharmaceutical to Nominate Four New Directors,2017-06-08 20:03:07 +0000,http://finance.yahoo.com/r/82557ebb-8b99-34c4-92b2-efe43f2b3b79/teva-pharmaceutical-to-nominate-four-new-directors-1496952181?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical will seek to overhaul its board by nominating four new directors, the latest step toward remaking the struggling drug company."
TEVA,TEVA:US,BBG000C0CD58,Teva Migraine Candidate Succeeds in Second Phase III Study,2017-06-08 16:31:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qckKAoLJf5o/teva-migraine-candidate-succeeds-in-second-phase-iii-study-cm800670,Teva Pharmaceutical Industries Ltd TEVA announced that its experimental migraine prevention drug fremanezumab met all the primary and secondary endpoints in a second late stage study Pivotal data from the second phase III HALO study in episodic migraine prevention showed that patients
TEVA,TEVA:US,BBG000C0CD58,Interesting TEVA Put And Call Options For July 28th,2017-06-08 16:31:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RXPlY6pOaQg/interesting-teva-put-and-call-options-for-july-28th-cm800644,Investors in Teva Pharmaceutical Industries Ltd Symbol TEVA saw new options become available today for the July 28th expiration At Stock Options Channel our YieldBoost formula has looked up and down the TEVA options chain for the new July 28th contracts and identified one put and one
TEVA,TEVA:US,BBG000C0CD58,Teva Migraine Candidate Succeeds in Second Phase III Study,2017-06-08 14:06:02 +0000,https://finance.yahoo.com/news/teva-migraine-candidate-succeeds-second-140602147.html?.tsrc=rss,"Teva announced that its experimental migraine prevention candidate, fremanezumab, met all the primary and secondary endpoints in a second late-stage study."
TEVA,TEVA:US,BBG000C0CD58,Teva Signals It's Seeking New Chief With Experience at Helm,2017-06-08 08:28:45 +0000,http://finance.yahoo.com/r/624aec77-74e6-3254-aa68-d46304eb08f2/teva-signals-it-s-seeking-new-chief-with-experience-at-the-helm?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd., the world’s largest maker of copycat medicines, signaled its intent to hire a new chief executive officer with prior experience in that role."
TEVA,TEVA:US,BBG000C0CD58,"ABBV Hits A High Note, AGN Opens Wallet, TEVA's HALO Does An Encore",2017-06-08 03:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7pOA0o3GXxI/abbv-hits-a-high-note-agn-opens-wallet-tevas-halo-does-an-encore-20170608-00112,"ABBV Hits A High Note, AGN Opens Wallet, TEVA's HALO Does An Encore"
TEVA,TEVA:US,BBG000C0CD58,"People Shouldn't Be Surprised by Mylan's Desperate Attempt to Distort the Facts, Says Official",2017-06-07 21:47:00 +0000,http://finance.yahoo.com/r/5c54a77b-87f7-31c6-baed-585351f5e333/mylan-in-another-spat-this-time-with-iss.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Shareholders will vote on a ""Just vote no"" campaign at Mylan's June 22 meeting."
TEVA,TEVA:US,BBG000C0CD58,"Teva's migraine drug clears another hurdle, aims for launch in 2018",2017-06-07 14:38:20 +0000,https://finance.yahoo.com/news/tevas-migraine-drug-clears-another-143820490.html?.tsrc=rss,"Teva Pharmaceutical Industries  Ltd said on Wednesday its experimental drug to prevent  migraines cleared another late-stage study, setting it on course  for U.S regulatory approval and launch in the second half of  2018.  The drug's success would be a much needed boost for Teva,  Israel's biggest company and the world's largest generic  drugmaker.  Teva's stock price has plummeted over the past few months  after a series of costly acquisitions and delayed drug launches,  while its best-selling multiple sclerosis drug Copaxone faces  new generic competition."
TEVA,TEVA:US,BBG000C0CD58,Health Care Sector Update for 06/07/2017: TEVA,2017-06-07 13:56:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O2-mWas0BAQ/health-care-sector-update-for-06072017-teva-cm799937,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 3 PFE 0 3 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on Wednesday Health care shares were mainly unchanged in pre market trade on Wednesday
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical To Present At Jefferies Conference; Webcast At 2:30 PM ET,2017-06-07 13:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WU7fD1csyuo/teva-pharmaceutical-to-present-at-jefferies-conference-webcast-at-230-pm-et-20170607-01012,Teva Pharmaceutical To Present At Jefferies Conference; Webcast At 2:30 PM ET
TEVA,TEVA:US,BBG000C0CD58,Teva's Fremanezumab Meets all Primary & Secondary Endpoints Across Both Monthly and Quarterly Dosing Regimens in Phase III Study in Episodic Migraine Prevention,2017-06-07 12:00:00 +0000,https://finance.yahoo.com/news/tevas-fremanezumab-meets-primary-secondary-120000559.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today announced positive results from the second Phase III HALO study of fremanezumab , an investigational treatment for the prevention of migraine."
TEVA,TEVA:US,BBG000C0CD58,Teva: Fremanezumab Meets All 25 Endpoints In Migraine Studies - Quick Facts,2017-06-07 08:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jxz8aGZo6y4/teva-fremanezumab-meets-all-25-endpoints-in-migraine-studies--quick-facts-20170607-00443,Teva: Fremanezumab Meets All 25 Endpoints In Migraine Studies - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,3 Reasons Teva Pharmaceutical Industries Ltd. Nosedived 12% in May,2017-06-06 19:18:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NVPyz7pES-E/3-reasons-teva-pharmaceutical-industries-ltd-nosedived-12-in-may-cm799589,What happened Shares of Teva Pharmaceutical Industries NYSE TEVA a developer of branded drugs and the current largest manufacturer of generic drugs in the world continued its yearlong plus tumble in May according to data from S amp P Global Market Intelligence
TEVA,TEVA:US,BBG000C0CD58,3 Reasons Teva Pharmaceutical Industries Ltd. Nosedived 12% in May,2017-06-06 17:55:00 +0000,http://finance.yahoo.com/r/48d8db22-48e3-3e8a-8cca-8637bf95b66f/3-reasons-teva-pharmaceutical-industries-ltd-nosed.aspx?yptr=yahoo&.tsrc=rss,Teva&apos;s rough year continues to get worse. Is there light at the end of the tunnel?
TEVA,TEVA:US,BBG000C0CD58,Teva to Present at the Jefferies 2017 Global Healthcare Conference,2017-06-06 12:00:00 +0000,https://finance.yahoo.com/news/teva-present-jefferies-2017-global-120000794.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the Jefferies 2017 Global Healthcare Conference in New York, NY."
TEVA,TEVA:US,BBG000C0CD58,Apple Inc. (AAPL) HomePod “Siri Speaker” Will Battle With Amazon’s Echo,2017-06-06 09:59:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RGruj7o0Xto/apple-inc-aapl-homepod-siri-speaker-will-battle-with-amazons-echo-cm799104,InvestorPlace Stock Market News Stock Advice amp Trading Tips Apple Inc NASDAQ A APL just wrapped up its WWDC 2017 keynote and as expected one of the highlights of the event the company s new smart speaker Source Apple Apple s HomePod is the rumored Siri
TEVA,TEVA:US,BBG000C0CD58,Microsoft Corporation (MSFT) Stock Looks Even MORE Overvalued,2017-06-06 00:00:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I8dMnkluFec/microsoft-corporation-msft-stock-looks-even-more-overvalued-cm799064,InvestorPlace Stock Market News Stock Advice amp Trading Tips So far I ve been a small brick in the wall of worry being climbed by Microsoft Corporation NASDAQ MSFT stock I argued in March for instance that Microsoft was worth about 100 billion too much MSFT stock
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Nibble on Its Dividend and Wait,2017-06-05 22:00:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fxo3gwbQRik/teva-pharmaceutical-industries-ltd-adr-teva-nibble-on-its-dividend-and-wait-cm799037,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors have yet to warm to embattled generic drug maker Teva Pharmaceutical Industries Ltd ADR NYSE TEVA So far this year Teva stock is down close to 20 which is a far cry from the market s return of
TEVA,TEVA:US,BBG000C0CD58,Regeneron Announces Positive Data on Carcinoma Candidate,2017-06-05 17:03:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/94WLixHoRbs/regeneron-announces-positive-data-on-carcinoma-candidate-cm798814,Regeneron Pharmaceuticals Inc REGN and partner Sanofi SNY announced positive results related to its experimental candidate REGN2810 a checkpoint inhibitor targeting PD 1 programmed death 1 in patients with advanced cutaneous squamous cell carcinoma CSCC The data was presented at
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : June 05th, 2017 (record date) : By the numbers : June 5, 2017",2017-06-05 16:40:49 +0000,http://finance.yahoo.com/r/b33858ed-7173-3915-af02-b1f4f3859586/teva-pharmaceutical-industries-ltd-teva-us-dividend-analysis-june-05th-2017-record-date-by-the-numbers-june-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Our analysis is based on comparing Teva Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Sanofi Sponsored ADR, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Pfizer Inc., Dr. Reddy’s Laboratories Ltd. Sponsored ADR, Astrazeneca PLC Sponsored ADR and Takeda Pharmaceutical ... Read more
<b>(Read more...)</b>"
TEVA,TEVA:US,BBG000C0CD58,iShares Core MSCI EAFE ETF Experiences Big Inflow,2017-06-05 16:03:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TVZbXZo8lus/ishares-core-msci-eafe-etf-experiences-big-inflow-cm798698,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 150 1 million dollar inflow that s a 0 6 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Implied PPH Analyst Target Price: $64,2017-06-05 14:01:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l-QGm57ExMA/implied-pph-analyst-target-price-64-cm798545,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Positive Data from Lilly & Teva, BMY&apos;s Deals & More",2017-06-02 12:12:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-positive-data-121212412.html?.tsrc=rss,Lilly (LLY) posted positive data on Cyramza while Teva&apos;s migraine drug delivered positive results in a late-stage study.
TEVA,TEVA:US,BBG000C0CD58,Mylan Launches Generic Version Of Teva's Azilect Tablets - Quick Facts,2017-06-02 08:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nmKgJ6YWSB4/mylan-launches-generic-version-of-tevas-azilect-tablets--quick-facts-20170602-00334,Mylan Launches Generic Version Of Teva's Azilect Tablets - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,State Sues Big Pharma For Opioid Carnage,2017-06-02 06:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YV9Ux8kb_uU/state-sues-big-pharma-for-opioid-carnage-20170602-00169,State Sues Big Pharma For Opioid Carnage
TEVA,TEVA:US,BBG000C0CD58,Teva's Migraine Candidate TEV-48125 Positive in Phase III,2017-06-02 00:31:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xe4bHKT3Ol0/tevas-migraine-candidate-tev-48125-positive-in-phase-iii-cm797744,Teva Pharmaceutical Industries Limited TEVA announced positive top line results from a phase III study HALO evaluating its pipeline candidate fremanezumab TEV 48125 for prevention of chronic migraine CM The study met both its primary and secondary end points The company will
TEVA,TEVA:US,BBG000C0CD58,Teva to Present Data from 18 Abstracts in Tardive Dyskinesia and Huntington Disease at the 21st International Congress of Parkinson’s Disease and Movement Disorders,2017-06-01 12:00:00 +0000,https://finance.yahoo.com/news/teva-present-data-18-abstracts-120000930.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced data for deutetrabenazine tablets for the treatment of tardive dyskinesia and chorea associated with Huntington disease , and pridopidine for the treatment HD will be presented in 18 poster presentations at the 21st International Congress of Parkinson’s Disease and Movement Disorders in Vancouver, BC, Canada from June 4-8."
TEVA,TEVA:US,BBG000C0CD58,"FDA Greenlights Novo Nordisk's Rebinyn, TEVA's HALO Shines, LUCY Walks The Talk",2017-06-01 02:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZSL3n-VW7QM/fda-greenlights-novo-nordisks-rebinyn-tevas-halo-shines-lucy-walks-the-talk-20170601-00063,"FDA Greenlights Novo Nordisk's Rebinyn, TEVA's HALO Shines, LUCY Walks The Talk"
TEVA,TEVA:US,BBG000C0CD58,How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover,2017-05-31 22:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPvHKLuZacc/how-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-recover-cm797145,InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been an awful awful run for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA And the lousy performance in TEVA stock is showing no signs of giving up this week Source Open Grid Scheduler
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharma Ran A Migraine Trial — And Lilly, Amgen Benefited",2017-05-31 20:25:30 +0000,http://finance.yahoo.com/r/2ac45023-0f45-3ce6-9202-458c3e2a655b/teva-pharma-ran-a-migraine-trial-and-lilly-amgen-benefited?src=A00220&yptr=yahoo&.tsrc=rss,Eli Lilly and Amgen stocks got a boost Wednesday after rival Teva unveiled strong results of a trial in chronic migraines.
TEVA,TEVA:US,BBG000C0CD58,[$$] Ohio sues drugmakers over US opioid addiction crisis,2017-05-31 18:43:05 +0000,"http://finance.yahoo.com/r/29795244-17b2-3645-8795-603437747006/24027d0e-4629-11e7-8d27-59b4dd6296b8,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Ohio's attorney-general has become the latest US official to sue drugmakers for their alleged role in fuelling the country's painkiller addiction crisis, opening a new front in the legal battle to force ..."
TEVA,TEVA:US,BBG000C0CD58,5 Drug Stocks in Focus on World MS Day,2017-05-31 16:36:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WraSAmDK038/5-drug-stocks-in-focus-on-world-ms-day-cm796902,Since 2009 World MS Day is officially marked on the last Wednesday of May with events and campaigns focused on bringing the worldwide multiple sclerosis MS community together and raising awareness about the disease Life with MS This World MS Day the theme is Life with MS
TEVA,TEVA:US,BBG000C0CD58,"EFA, HEWL: Big ETF Inflows",2017-05-31 16:35:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QnPEvKI0bnQ/efa-hewl-big-etf-inflows-cm796893,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares MSCI EAFE ETF EFA which added 21 600 000 units or a 1 9 increase week over week Among the largest underlying components of EFA in morning
TEVA,TEVA:US,BBG000C0CD58,"Johnson and Johnson, other drug companies accused of viol...",2017-05-31 16:10:00 +0000,https://finance.yahoo.com/video/johnson-johnson-other-drug-companies-161000339.html?.tsrc=rss,CNBC's Meg Tirrell reports on the drug companies being sued by the Ohio attorney general for Medicaid fraud.
TEVA,TEVA:US,BBG000C0CD58,5 Drug Stocks in Focus on World MS Day,2017-05-31 14:08:02 +0000,https://finance.yahoo.com/news/5-drug-stocks-focus-world-140802344.html?.tsrc=rss,"Life with MS -- this world MS day, here&apos;s a look at 5 stocks including Biogen (BIIB) that are key players in the multiple sclerosis (MS) market."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for June 01, 2017",2017-05-31 13:22:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o6RzBbuWn1I/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-june-01-2017-cm796693,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on June 01 2017 A cash dividend payment of 0 289 per share is scheduled to be paid on June 22 2017 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend payment
TEVA,TEVA:US,BBG000C0CD58,"Investment funds urge shareholders to vote down Mylan board, pay",2017-05-31 12:48:01 +0000,https://finance.yahoo.com/news/investment-funds-urge-shareholders-vote-124801519.html?.tsrc=rss,"The New York City and State  pension funds and the California State Teachers' Retirement  System are fighting the re-election of six board members at  drugmaker Mylan Inc and its 2016 executive pay including  Chairman Robert Coury's compensation of more than $97 million.  The funds, along with Netherlands-based pension fund PGGM,  said they control 4.3 million shares of the company and are  urging shareholders to vote against the company at Mylan's June  22 annual meeting.  The letter noted the decline in Mylan shares, which now  trade for around $40, less than half the $82 that rival Teva  Pharmaceuticals had offered to buy the company for in  April of 2015."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Positive Results for Phase III Study of Fremanezumab for the Prevention of Chronic Migraine,2017-05-31 12:22:00 +0000,https://finance.yahoo.com/news/teva-announces-positive-results-phase-122200795.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today announced positive results from a Phase III HALO study of fremanezumab, an investigational treatment for the prevention of migraine."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Positive Results For Phase III Study Of Fremanezumab,2017-05-31 08:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tpuveB-Mzrc/teva-announces-positive-results-for-phase-iii-study-of-fremanezumab-20170531-00575,Teva Announces Positive Results For Phase III Study Of Fremanezumab
TEVA,TEVA:US,BBG000C0CD58,"Ex-Dividend Reminder: McKesson, Teva Pharmaceutical Industries and Baxter International",2017-05-30 16:37:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H1TXwvusIu4/ex-dividend-reminder-mckesson-teva-pharmaceutical-industries-and-baxter-international-cm796281,Looking at the universe of stocks we cover at Dividend Channel on 6 1 17 McKesson Corp Symbol MCK Teva Pharmaceutical Industries Ltd Symbol TEVA and Baxter International Inc Symbol BAX will all trade ex dividend for their respective upcoming dividends McKesson Corp will pay
TEVA,TEVA:US,BBG000C0CD58,Paulson & Co. Hedge Fund Cuts Back on Health Care in Q1,2017-05-30 16:13:00 +0000,http://finance.yahoo.com/r/bba6c52e-a921-3fcb-b56a-45520f8fbfbb/paulson-co-hedge-fund-cuts-back-health-care-q1-agn-shpg?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Paulson & Co. reduced its number of holdings in Q1, lightening its positions in several health care companies."
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Gain 30%,2017-05-26 20:33:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hUnDM6fu580/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-gain-30-cm795591,InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a rough year for Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA with net income down some 80 since 2015 despite robust global sales that pushed the top line 15 in the other
TEVA,TEVA:US,BBG000C0CD58,3 Top Dividend Stocks in Generic Drugs,2017-05-26 19:02:00 +0000,http://finance.yahoo.com/r/c1cdeb46-8ed1-384b-afe0-af26791b8111/3-top-dividend-stocks-in-generic-drugs.aspx?yptr=yahoo&.tsrc=rss,"Why Pfizer, Novartis, and Sanofi rank at the top of all dividend stocks in the generic-drug industry."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharma, Eagle Pharma, Depomed Among Slew Getting Price Haircuts",2017-05-25 20:10:12 +0000,http://finance.yahoo.com/r/d2fbc5b5-3c18-37df-8ab3-8875aa07c38d/teva-pharma-eagle-pharma-depomed-among-a-slew-getting-pt-haircuts?src=A00220&yptr=yahoo&.tsrc=rss,Depomed and Eagle stocks plunged Thursday after a Mizuho analyst slashed her price targets on a slew of drugmakers.
TEVA,TEVA:US,BBG000C0CD58,How Teva Is Fighting (and Losing) the Big Pharma Battle,2017-05-25 20:04:00 +0000,http://finance.yahoo.com/r/8a6b87c9-7626-3c97-bd14-034b5dd59adb/teva-fighting-losing-big-pharma-battle?partner=YahooSA&yptr=yahoo&.tsrc=rss,Teva is still the largest generics drugmaker in the world but struggles to catch up with big pharmaceutical companies boosted by brand name drugs.
TEVA,TEVA:US,BBG000C0CD58,"3 Naked Puts for $1,000 in Summertime Cash",2017-05-25 18:33:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a1aLRfnxytM/3-naked-puts-for-1000-in-summertime-cash-cm794786,InvestorPlace Stock Market News Stock Advice amp Trading Tips Need some extra cash for the summer Then considering selling some naked puts These are options trades and they usually require Level 4 options approval but most brokers shouldn t stonewall on getting this option added
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Interest Surges,2017-05-25 13:45:19 +0000,https://finance.yahoo.com/news/major-pharma-short-interest-surges-134519988.html?.tsrc=rss,"The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly upward."
TEVA,TEVA:US,BBG000C0CD58,Cramer Remix: The market is not ready for this Trump scen...,2017-05-24 23:00:00 +0000,https://finance.yahoo.com/video/cramer-remix-market-not-ready-230000369.html?.tsrc=rss,Jim Cramer says Wall Street isn’t ready for this very possible Presidential event.
TEVA,TEVA:US,BBG000C0CD58,Did Neurocrine Just Leave The Door Open For Teva In Tourette&apos;s?,2017-05-24 20:21:00 +0000,http://finance.yahoo.com/r/547aef74-c4c9-3315-8f47-418c27885737/did-neurocrine-just-leave-the-door-open-for-teva-in-tourettes?src=A00220&yptr=yahoo&.tsrc=rss,"Neurocrine may have left the door open for Teva to get an early lead in Tourette&apos;s syndrome, an analyst said Wednesday."
TEVA,TEVA:US,BBG000C0CD58,3 Reasons Sprint Corp (S) Stock Is Juicy Buyout Bait,2017-05-24 19:32:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/govn0OQXrYQ/3-reasons-sprint-corp-s-stock-is-juicy-buyout-bait-cm794160,InvestorPlace Stock Market News Stock Advice amp Trading Tips According to a report from Bloomberg it looks like that there are preliminary 160 discussions regarding a merger between Sprint Corp NYSE S and T Mobile US Inc NASDAQ TMUS 160 While such rumors
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Going to $40,2017-05-24 18:31:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QfOwHOmZD7g/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-going-to-40-cm794106,InvestorPlace Stock Market News Stock Advice amp Trading Tips Beaten down pharma specialist Teva Pharmaceutical Industries Ltd ADR NYSE TEVA which has seen its value plummet some 45 over the past year remains an intriguing option for risk
TEVA,TEVA:US,BBG000C0CD58,"Amazon.com, Inc. (AMZN) Stock Is Still a Buy at All-Time Highs",2017-05-24 18:30:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/icpWDuFaFVc/amazoncom-inc-amzn-stock-is-still-a-buy-at-all-time-highs-cm794090,InvestorPlace Stock Market News Stock Advice amp Trading Tips E commerce juggernaut Amazon com Inc NASDAQ AMZN has seen its share price surge 30 so far this year The company has been on fire with exciting new products and a fiercely competitive cloud computing arm
TEVA,TEVA:US,BBG000C0CD58,Neupogen and Enbrel Could See Falling Revenues in 2017,2017-05-24 14:37:07 +0000,http://finance.yahoo.com/r/3a4d55e9-aae8-3009-ac17-98341fc7a411/neupogen-and-enbrel-could-see-falling-revenues-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Neupogen generated revenues of ~$148 million, a significant drop from the drug’s 1Q16 revenues of ~$213 million."
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva and Cerus Corporation,2017-05-24 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000721.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 24, 2017 / Teva is still not with a CEO but the company has made some decisions at least and that a foreigner would be the front-runner to lead the Israeli Company. Cerus ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Reaches New Lows – Will It Bottom Out?,2017-05-23 20:23:00 +0000,http://finance.yahoo.com/r/145d684d-c188-3b90-9eec-25f25d52dc3e/teva-breaks-down-fresh-lows-will-it-bottom-out-teva?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Teva Pharmaceuticals has experienced a rough year, but the stock could be bottoming out at current levels."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Enters Oversold Territory,2017-05-23 17:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JFlVXmVaqtU/teva-pharmaceutical-industries-enters-oversold-territory-cm793382,The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics strong fundamentals and a valuation that looks inexpensive
TEVA,TEVA:US,BBG000C0CD58,"EFA, IPK: Big ETF Inflows",2017-05-23 16:14:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/odIpp4--hS4/efa-ipk-big-etf-inflows-cm793299,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares MSCI EAFE ETF which added 18 600 000 units or a 1 7 increase week over week Among the largest underlying components of EFA in morning trading today
TEVA,TEVA:US,BBG000C0CD58,"It's Easy To Be Skeptical Of Mylan, But Don't Ignore This Pending PDUFA Date",2017-05-22 16:25:45 +0000,https://finance.yahoo.com/news/easy-skeptical-mylan-dont-ignore-162545056.html?.tsrc=rss,"Commenting on Mylan N.V. (NASDAQ: MYL ), Barclays said there's understandably reason to be skeptical that the company will win approval for its generic version of Copaxone now after years of promises. ..."
TEVA,TEVA:US,BBG000C0CD58,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 14:14:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iIrH_ODdBGw/3-drug-stocks-billionaire-money-managers-dumped-big-time-in-the-first-quarter-cm792533,Monday May 15 was an important day for Wall Street and investors It was the last day for money managers with more than 100 million in assets under management to file 13F paperwork with the Securities and Exchange Commission that in effect discloses their portfolio holding as of
TEVA,TEVA:US,BBG000C0CD58,3 Drug Stocks Billionaire Money Managers Dumped Big-Time in the First Quarter,2017-05-22 12:27:00 +0000,http://finance.yahoo.com/r/3c080f35-6f74-3b88-b068-e8990e4b124f/3-drug-stocks-billionaire-money-managers-dumped-bi.aspx?yptr=yahoo&.tsrc=rss,Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
TEVA,TEVA:US,BBG000C0CD58,"John Paulson Sells VMware, Hewlett Packard, Several Other Holdings",2017-05-20 17:11:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dhoa6c2rkCk/john-paulson-sells-vmware-hewlett-packard-several-other-holdings-cm792291,John Paulson Trades Portfolio manages a portfolio composed of 97 stocks that is valued at 7 5 billion During the first quarter the guru sold shares of the following stocks John Paulson Trades Portfolio manages a portfolio composed of 97 stocks that is valued at 7 5
TEVA,TEVA:US,BBG000C0CD58,Valeant Pharmaceuticals: Intrigued…Really?,2017-05-19 17:33:00 +0000,http://finance.yahoo.com/r/316c21e1-5aae-3e85-badb-ab90d5856099/valeant-pharmaceuticals-intriguedreally-1495215191?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"This very blog has offered up no shortage of opinions on shares Valeant Pharmaceuticals International (VRX)...some good, some bad and some still undecided.  Quoting from Gilbert’s recent note, StreetInsider reported: We have been cautious/skeptical on VRX for a very long time, and uncertainties around the growth potential and durability of key franchises, the potential cost of past sins, and the heavy debt load have kept us at Hold."
TEVA,TEVA:US,BBG000C0CD58,Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA,2017-05-19 16:15:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8db26Pn_g0k/valeant-vrx-decides-to-extend-stay-on-xifaxans-anda-cm791976,Valeant Pharmaceuticals International Inc VRX and Actavis Laboratories Inc which is now a part of Teva Pharmaceuticals Inc TEVA announced that both the companies have agreed to stay outstanding litigation and extend the 30 month stay regarding the latter s Abbreviated New Drug
TEVA,TEVA:US,BBG000C0CD58,Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab,2017-05-19 16:12:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hllJAarGf7Y/amgen-amgn-submits-bla-to-fda-for-migraine-drug-erenumab-cm791923,Amgen Inc AMGN recently announced the submission of a biologics license application BLA to the FDA for its pipeline candidate erenumab AMG 334 for the prevention of migraine Shares of Amgen have outperformed the Zacks classified Medical Biomed Genetics industry so far this year
TEVA,TEVA:US,BBG000C0CD58,Valeant (VRX) Decides to Extend Stay on Xifaxan&apos;s ANDA,2017-05-19 13:48:01 +0000,https://finance.yahoo.com/news/valeant-vrx-decides-extend-stay-134801886.html?.tsrc=rss,"Valeant Pharmaceuticals International, Inc. (VRX) announced that it has decided to stay outstanding litigation and extend the 30-month stay regarding Teva&apos;s ANDA for a generic version of Xifaxan 550 mg tablets."
TEVA,TEVA:US,BBG000C0CD58,Vetr Issues Strong Buy As Teva Trends Down,2017-05-19 11:30:12 +0000,https://finance.yahoo.com/news/vetr-issues-strong-buy-teva-113012155.html?.tsrc=rss,"The Vetr crowd on Thursday upgraded its rating for Teva Pharmaceutical Industries Limited (ADR) (NYSE: TEVA ) from 3.5 stars (Buy), issued 15 days ago, to 4.5 stars (Strong Buy). Crowd sentiment at the ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Leaning Towards Foreigner as New CEO,2017-05-18 13:53:00 +0000,http://finance.yahoo.com/r/0c490d9a-ee7a-3b25-aadd-27e8244fa48e/teva-pharmaceutical-leaning-towards-foreigner-as-new-ceo.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Israel's largest firm is also searching for a chief financial officer in which three candidates are vying for the position.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical's search committee recommends foreign CEO: report,2017-05-18 11:42:55 +0000,https://finance.yahoo.com/news/teva-pharm-search-committee-recommends-104231271.html?.tsrc=rss,"Teva Pharmaceutical Industries' (TEVA.TA) search for a new chief executive has resulted in the selection of a foreigner as the leading candidate, Israeli financial news website Calcalist said on Thursday.  Separately, three candidates are vying for the position of chief financial officer (CFO) at Israel's biggest company.  Israeli members of the board of directors are demanding that an Israeli be appointed CFO if the CEO is a foreigner, Calcalist said."
TEVA,TEVA:US,BBG000C0CD58,Teva Showcases Asthma Research at the 2017 American Thoracic Society (ATS) International Conference,2017-05-17 13:00:00 +0000,https://finance.yahoo.com/news/teva-showcases-asthma-research-2017-130000947.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced that eight company-sponsored abstracts will be presented at the 2017 American Thoracic Society International Conference in Washington, D.C."
TEVA,TEVA:US,BBG000C0CD58,Teva to Present Data for Deutetrabenazine in Tardive Dyskinesia at the American Psychiatric Association 2017 Annual Meeting,2017-05-17 12:00:00 +0000,https://finance.yahoo.com/news/teva-present-data-deutetrabenazine-tardive-120000163.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced eight abstracts evaluating deutetrabenazine tablets – formerly referred to as SD-809 – for the treatment of tardive dyskinesia will be presented at the American Psychiatric Association 2017 Annual Meeting in San Diego, CA from May 20-24."
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka",2017-05-16 16:20:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZTg-U2W4p0o/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka-cm789994,Teva Pharmaceutical Industries Ltd TEVA announced the launch of a generic version of Valeant Pharmaceuticals International Inc s VRX diabetes drug Glumetza in the U S The drug will be available in 500 mg and 1000 mg tablets Teva s shares have underperformed the Zacks
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka",2017-05-16 13:54:01 +0000,https://finance.yahoo.com/news/teva-teva-launches-glumetza-generic-135401905.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.&apos;s (VRX) diabetes drug, Glumetza, in the U.S."
TEVA,TEVA:US,BBG000C0CD58,Third Time Is Not the Charm for PPG as Azko Nobel Rejects Another Offer,2017-05-16 13:18:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y01nOHAZgys/third-time-is-not-the-charm-for-ppg-as-azko-nobel-rejects-another-offer-cm789702,PPG Industries NYSE PPG has apparently taken to heart the old saying If at first you don t succeed try try again in its pursuit of coatings specialist Akzo Nobel NASDAQOTH AKZOY The suitor has now made three offers to acquire its rival the most recent for 28
TEVA,TEVA:US,BBG000C0CD58,Lilly's Migraine Drug Phase III Trials Meet Primary Endpoint,2017-05-16 01:14:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/STYoVlgLLJA/lillys-migraine-drug-phase-iii-trials-meet-primary-endpoint-cm789605,Eli Lilly and Company LLY recently announced that its migraine candidate galcanezumab met primary endpoint in phase III studies The data from the evaluation demonstrated that the galcanezumab led to statistically significant reduction in the number of migraine headaches days per month
TEVA,TEVA:US,BBG000C0CD58,Lilly&apos;s Migraine Drug Phase III Trials Meet Primary Endpoint,2017-05-15 23:06:11 +0000,https://finance.yahoo.com/news/lilly-apos-migraine-drug-phase-230611088.html?.tsrc=rss,"Eli Lilly and Company (LLY) recently announced that its migraine candidate, galcanezumab, met primary endpoint in phase III studies"
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Recover,2017-05-15 22:14:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7F9LmpzlvxI/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-can-recover-cm789567,InvestorPlace Stock Market News Stock Advice amp Trading Tips Volatile health care stocks are nothing new in fact it s a fairly mundane occurrence But Teva Pharmaceutical Industries Ltd ADR NYSE TEVA is in a class of its own Since the opening trade of 2016 TEVA stock
TEVA,TEVA:US,BBG000C0CD58,John Paulson Takes A Shine To Telecom,2017-05-15 21:59:10 +0000,http://finance.yahoo.com/r/36dda89a-f3e7-3c3c-b3df-b2bef394c4e3/paulson0515?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Hedge-fund billionaire John Paulson bought new positions in telecommunications operators T-Mobile US Inc. and Dish Network Corp. in the first quarter, according to securities filings Monday."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Glumetza® in the United States,2017-05-15 17:20:00 +0000,https://finance.yahoo.com/news/teva-announces-launch-generic-glumetza-172000111.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the launch of generic Glumetza®1 , 500 mg and 1000 mg, in the U.S."
TEVA,TEVA:US,BBG000C0CD58,"EFA, HSCZ: Big ETF Inflows",2017-05-15 16:16:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T1nQQ6bMHLo/efa-hscz-big-etf-inflows-cm789256,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares MSCI EAFE ETF which added 21 600 000 units or a 2 0 increase week over week Among the largest underlying components of EFA in morning trading today
TEVA,TEVA:US,BBG000C0CD58,Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125),2017-05-15 12:00:00 +0000,https://finance.yahoo.com/news/otsuka-teva-sign-licensing-agreement-120000365.html?.tsrc=rss,"Otsuka Pharmaceutical Co., Ltd and Teva Pharmaceutical Industries, Ltd. announce an agreement covering Japan for Otsuka to develop and commercialize Teva’s investigational drug candidate fremanezumab , an anti-calcitonin gene-related peptide monoclonal antibody for the prevention of migraine. Fremanezumab is administered monthly as a subcutaneous injection."
TEVA,TEVA:US,BBG000C0CD58,Biostime International Holdings Limited -- Moody's: Biostime's ratings unaffected by disclosure of PGT option in collaboration agreement with Swisse,2017-05-15 11:09:07 +0000,http://finance.yahoo.com/r/f03692d2-4e4b-3e6e-b57c-eda75951e7aa/viewresearchdoc.aspx?docid=PR_366688&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170515_PR_366688&yptr=yahoo&.tsrc=rss,"Announcement: Moody's: Biostime's ratings unaffected by disclosure of PGT option in collaboration agreement with Swisse. Global Credit Research- 15 May 2017. Hong Kong, May 15, 2017-- Moody's Investors ..."
TEVA,TEVA:US,BBG000C0CD58,Otsuka Secures Exclusive Rights In Japan To Fremanezumab - Quick Facts,2017-05-15 08:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WnrpNisjTJ4/otsuka-secures-exclusive-rights-in-japan-to-fremanezumab--quick-facts-20170515-00529,Otsuka Secures Exclusive Rights In Japan To Fremanezumab - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,"Francis Chou Buys Endo International PLC, Teva Pharmaceutical Industries, Valeant ...",2017-05-13 13:14:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jJeb9mzmntA/francis-chou-buys-endo-international-plc-teva-pharmaceutical-industries-valeant-cm788894,Francis Chou New Purchases ENDP TEVA Added Positions VRX SD SD Reduced Positions NOK Sold Out AZN GSK New Purchases ENDP TEVA New Purchases ENDP TEVA Added Positions VRX SD SD Added Positions
TEVA,TEVA:US,BBG000C0CD58,Can Teva Hold Its Own In Bringing Migraine Drugs To Market?,2017-05-12 20:20:16 +0000,http://finance.yahoo.com/r/0c80360d-ceac-374a-ad04-a77e44d33a28/can-teva-hold-its-own-in-migraine-vs-lilly-amgen-alder?src=A00220&yptr=yahoo&.tsrc=rss,"Teva will square off with Eli Lilly, Amgen, Novartis and Alder next month when it unveils the results of a Phase 3 study in migraines."
TEVA,TEVA:US,BBG000C0CD58,Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets,2017-05-12 16:29:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/POc9_Lfx6L8/heres-how-much-teva-pharmaceutical-could-net-from-the-sale-of-non-core-assets-cm788603,On Wednesday May 10 we looked at four of the most pressing questions shareholders including yours truly had heading into Teva Pharmaceutical Industries NYSE TEVA first quarter earnings report By the following morning we had answers to quite a few of those
TEVA,TEVA:US,BBG000C0CD58,Here&apos;s How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets,2017-05-12 14:26:00 +0000,http://finance.yahoo.com/r/d9deca95-9ae6-3efd-8f03-4ea7977a470c/heres-how-much-teva-pharmaceutical-could-net-from.aspx?yptr=yahoo&.tsrc=rss,Teva&apos;s Women&apos;s Health operations and its European oncology and pain divisions appear to be on the chopping block.
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls",2017-05-12 14:07:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aS3gg3JZRig/teva-teva-q1-earnings-in-line-sales-lag-as-copaxone-falls-cm788375,Teva Pharmaceutical Industries Ltd TEVA reported first quarter 2017 earnings of 1 03 per share including equity compensation expenses which was in line with the Zacks Consensus Estimate The year ago adjusted earnings were 1 18 per share Revenues of 5 63 billion missed the
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceuticals and Merck & Co.,2017-05-12 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000998.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 12, 2017 / Merck & Co. just moved a step ahead after the FDA approved the company's Keyruda to be used to fight frontline lung cancer. The approval helps broaden the use ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls",2017-05-12 11:34:11 +0000,http://finance.yahoo.com/news/teva-teva-q1-earnings-line-113411474.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. (TEVA) reported first-quarter 2017 earnings of $1.03 per share (including equity compensation expenses), which was in line with the Zacks Consensus Estimate."
TEVA,TEVA:US,BBG000C0CD58,[$$] Investors Are Losing Patience With Teva,2017-05-12 04:19:16 +0000,http://finance.yahoo.com/r/510d1dd4-d3f3-331d-87c5-3095da20cd61/investors-are-losing-patience-with-teva-1494520567?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Teva Pharmaceuticals Industries has gone one quarter too many without taking the drastic action needed to reverse its decline. It risks losing investor confidence, which is a bad thing for a heavily indebted ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] Investors Are Losing Patience With Teva,2017-05-11 20:17:18 +0000,http://finance.yahoo.com/r/510d1dd4-d3f3-331d-87c5-3095da20cd61/investors-are-losing-patience-with-teva-1494520567?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Teva Pharmaceuticals Industries has gone one quarter too many without taking the drastic action needed to reverse its decline. It risks losing investor confidence, which is a bad thing for a heavily indebted ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Q1 Sales Lag As Key Multiple Sclerosis Drug Topples,2017-05-11 20:04:38 +0000,http://finance.yahoo.com/r/be9ae462-c8aa-32e7-a193-f3a1a022a222/teva-pharma-tops-q1-earnings-views-but-misses-on-revenue?src=A00220&yptr=yahoo&.tsrc=rss,"No. 1 generic drugmaker Teva earned $1.06 a share, beating by 3 cents, while revenue of $5.63 billion fell short of the $5.68 billion estimate."
TEVA,TEVA:US,BBG000C0CD58,Why Groupon Inc (GRPN) Stock Is Far Too Scary to Be a Good Bargain,2017-05-11 20:03:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPy_gx2P4kA/why-groupon-inc-grpn-stock-is-far-too-scary-to-be-a-good-bargain-cm788161,InvestorPlace Stock Market News Stock Advice amp Trading Tips The Q1 earnings report from Groupon Inc NASDAQ GRPN was a big one for the company GRPN stock traditionally has made big moves out of earnings but Q1 seemed even more important than usual Source
TEVA,TEVA:US,BBG000C0CD58,"Thursday’s Vital Data: Apple Inc. (AAPL), Advanced Micro Devices, Inc. (AMD) and Snap Inc (SNAP)",2017-05-11 19:04:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r-ZDr-ryzRY/thursdays-vital-data-apple-inc-aapl-advanced-micro-devices-inc-amd-and-snap-inc-snap-cm788124,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are trading lower once again this morning as Wall Street digests the aftermath of the surprise firing of FBI Director James Comey and President Donald Trump s unpredictable behavior If there
TEVA,TEVA:US,BBG000C0CD58,Why Apple Inc. (AAPL) Stock Can Count on the Apple Watch,2017-05-11 19:04:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zszWXKKIOmw/why-apple-inc-aapl-stock-can-count-on-the-apple-watch-cm788122,InvestorPlace Stock Market News Stock Advice amp Trading Tips Apple Inc s 160 NASDAQ AAPL Apple Watch was released in 2015 to much fanfare and analyst interaction The smartwatch has changed the market and absolutely dominated a growing industry The company doesn t
TEVA,TEVA:US,BBG000C0CD58,TEVA's Every Narrowing Margin for Error,2017-05-11 18:30:00 +0000,http://finance.yahoo.com/r/1e25612c-b25d-366a-b875-90c3fe46c452/tevas-every-narrowing-margin-error?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Teva barely topped analyst expectations in its fiscal first quarter, but it has little margin for error."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Can Bounce Now,2017-05-11 18:04:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fg8OVYwKZxo/teva-pharmaceutical-industries-ltd-adr-teva-stock-can-bounce-now-cm788081,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stockholders desperately needed good news heading into Thursday s 160 first quarter earnings report After all TEVA stock has been in
TEVA,TEVA:US,BBG000C0CD58,"3 Reasons Advanced Micro Devices, Inc. (AMD) Stock Will Rebound",2017-05-11 18:04:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mLR0bCEUy8I/3-reasons-advanced-micro-devices-inc-amd-stock-will-rebound-cm788078,InvestorPlace Stock Market News Stock Advice amp Trading Tips For a little over a year Advanced Micro Devices Inc NASDAQ AMD could do no wrong AMD stock dipped below 2 in early February 2016 Over the next twelve and a half months AMD stock rose about 700 clearing 15
TEVA,TEVA:US,BBG000C0CD58,Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher,2017-05-11 17:03:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vNxHPIh_dWQ/actavis-generics-acquisition-drives-teva-pharmaceutical-industries-ltd-first-quarter-sales-higher-cm787956,A boost from the acquisition of Actavis Generics from Allergan NYSE AGN made the difference for Teva Pharmaceutical Industries Ltd NYSE TEVA when the company reported its results for the fourth quarter of 2016 The addition of Actavis Generics drove Teva s revenue
TEVA,TEVA:US,BBG000C0CD58,"Impax (IPXL) Q1 Earnings Miss, Stock Up on Cost Savings Plan",2017-05-11 17:02:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mn7iLm49NFs/impax-ipxl-q1-earnings-miss-stock-up-on-cost-savings-plan-cm787960,Impax Laboratories Inc 160 IPXL posted first quarter 2017 adjusted earnings of 11 cents per share missing the Zacks Consensus Estimate of 12 cents Earnings were down 74 4 from 43 cents in the year ago period due to lower revenues and higher costs Total revenue decreased 18 2 year
TEVA,TEVA:US,BBG000C0CD58,"Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers",2017-05-11 16:07:00 +0000,http://finance.yahoo.com/r/a6af1829-f5f8-33d0-9a29-94ec8e3f9ecb/biotech-movers-merck-up-on-approval-for-keytruda-chemo-combo.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The approval marks the first time that an immunotherapy has been combined with another drug to kill cancer cells more effectively.
TEVA,TEVA:US,BBG000C0CD58,Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher,2017-05-11 15:43:00 +0000,http://finance.yahoo.com/r/9cfa53ce-84e5-3d01-b7d2-599d78dac6e6/actavis-generics-acquisition-drives-teva-pharmaceu.aspx?yptr=yahoo&.tsrc=rss,The specialty and generic drugmaker gets another boost from its 2016 purchase of Actavis Generics from Allergan.
TEVA,TEVA:US,BBG000C0CD58,Market Overly Negative on Teva,2017-05-11 15:27:00 +0000,http://finance.yahoo.com/news/market-overly-negative-teva-152700605.html?.tsrc=rss,The market is too harshly penalizing the company for the large challenges it faces in both its generics and branded segments over the coming years.
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Q1 Earnings In-Line, Sales Miss, Shares Up",2017-05-11 14:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ykH8Iqj3QTE/teva-teva-q1-earnings-in-line-sales-miss-shares-up-cm787807,Israel based Teva Pharmaceutical Industries Ltd TEVA is a global pharmaceutical company with a strong presence in the generics as well as branded markets The company s branded products include Copaxone multiple sclerosis MS Azilect Parkinson s disease and respiratory products like
TEVA,TEVA:US,BBG000C0CD58,"Teva Q1 profit tops estimates, revenue up on Actavis deal",2017-05-11 13:46:18 +0000,http://finance.yahoo.com/news/teva-q1-profit-tops-estimates-115310491.html?.tsrc=rss,"Israel-based Teva  Pharmaceutical Industries reported a  smaller-than-expected fall in first-quarter profit on Thursday,  with sales boosted by its $40.5 billion acquisition last year of  generics drug business Actavis.  Teva was left without a permanent chief executive in  February after Erez Vigodman stepped down, leaving new  management to try to restore confidence in the world's biggest  generic drugmaker after a series of missteps.  Teva on Thursday named Michael McClellan as interim CFO,  effective July 1."
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Q1 Earnings In-Line, Sales Miss, Shares Up",2017-05-11 12:39:12 +0000,http://finance.yahoo.com/news/teva-teva-q1-earnings-line-123912063.html?.tsrc=rss,"Teva???s first quarter earnings (including equity compensation expenses), came in at $1.03 per share, in-line with the consensus estimate."
TEVA,TEVA:US,BBG000C0CD58,"Early movers: STRP, SNAP, FOXA, WFM, KSS, TEVA, YUM & more",2017-05-11 11:54:58 +0000,http://finance.yahoo.com/news/early-movers-strp-snap-foxa-115458665.html?.tsrc=rss,These are the stocks posting the largest moves before the bell.
TEVA,TEVA:US,BBG000C0CD58,"Early movers: STRP, SNAP, FOXA, WFM, KSS, TEVA, YUM & more",2017-05-11 11:54:58 +0000,http://finance.yahoo.com/r/9f40ed98-45d9-37eb-b8f0-a4f04e7df0ae/104463244?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104463244&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
TEVA,TEVA:US,BBG000C0CD58,Teva to Sell Assets Such as Women's Health Unit to Cut Debt,2017-05-11 11:30:04 +0000,http://finance.yahoo.com/news/teva-sell-assets-including-womens-113004089.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, plans to divest some assets including its global women’s health and European cancer and pain-treatment divisions to reduce ..."
TEVA,TEVA:US,BBG000C0CD58,"Market Recon: Snapchat Is Down Sharply; Yet, I Am Not Tempted",2017-05-11 11:23:00 +0000,http://finance.yahoo.com/r/616dfc9a-115e-38f3-a88d-04a729a01ef3/market-recon-snapchat-is-down-sharply-yet-i-am-not-tempted.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Soon after its IPO, the company finds that there is no more room for error."
TEVA,TEVA:US,BBG000C0CD58,"Teva stock rises 1.6% after Q1 profit beat, revenue miss",2017-05-11 11:17:51 +0000,http://finance.yahoo.com/r/293fb162-5272-3716-9a9a-2d3a5d473f13/Story.aspx?guid=E0664592-C1FE-46B5-8C29-3EFC0A50241F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. shares rose 1.6% in premarket trade Thursday after the company reported a first-quarter profit beat and revenue miss. Earnings for the latest quarter rose to $580 million, ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva stock rises 1.6% after Q1 profit beat, revenue miss",2017-05-11 11:17:51 +0000,http://finance.yahoo.com/news/teva-stock-rises-1-6-111751765.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. shares rose 1.6% in premarket trade Thursday after the company reported a first-quarter profit beat and revenue miss. Earnings for the latest quarter rose to $580 million, ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm Q1 profit tops estimates, revenue rises",2017-05-11 11:16:54 +0000,http://finance.yahoo.com/news/teva-pharm-q1-profit-tops-111654563.html?.tsrc=rss,"Teva Pharmaceutical Industries  reported better-than- expected first-quarter profit as  sales were boosted by its $40.5 billion acquisition of  Allergan's Actavis generic drug business in August.  Israel-based Teva said on Thursday it earned $1.06 per share  excluding one-time items in the quarter, down from $1.20.  Teva was forecast to earn $1.03 excluding one-off  items on revenue of $5.68 billion, according to Thomson Reuters  I/B/E/S."
TEVA,TEVA:US,BBG000C0CD58,Teva Reports First Quarter 2017 Financial Results,2017-05-11 11:00:00 +0000,http://finance.yahoo.com/news/teva-reports-first-quarter-2017-110000676.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended March 31, 2017."
TEVA,TEVA:US,BBG000C0CD58,"Teva Q1 Profit Rises, Beats View; But Revenue Misses - Quick Facts",2017-05-11 07:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sxP_1grhrWY/teva-q1-profit-rises-beats-view-but-revenue-misses--quick-facts-20170511-00447,"Teva Q1 Profit Rises, Beats View; But Revenue Misses - Quick Facts"
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Limited Announces 8% Drop In Q1 Profit,2017-05-11 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uU5Jshcxl2c/teva-pharmaceutical-industries-limited-announces-8-drop-in-q1-profit-20170511-00431,Teva Pharmaceutical Industries Limited Announces 8% Drop In Q1 Profit
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Q1 17 Earnings Conference Call At 8:00 AM ET,2017-05-11 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BstMjoIeFuE/teva-pharmaceutical-industries-q1-17-earnings-conference-call-at-800-am-et-20170511-00298,Teva Pharmaceutical Industries Q1 17 Earnings Conference Call At 8:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,"Should You Buy Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock? 3 Pros, 3 Cons",2017-05-11 06:00:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Vy_mukU0dM/should-you-buy-teva-pharmaceutical-industries-ltd-adr-teva-stock-3-pros-3-cons-cm787616,InvestorPlace Stock Market News Stock Advice amp Trading Tips You would be forgiven for thinking Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has profoundly bad luck It seems everything that could go wrong for the company 160 pretty much has over the past year
TEVA,TEVA:US,BBG000C0CD58,4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning,2017-05-10 22:02:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8keeWeYmB9s/4-pressing-questions-we-want-answered-when-teva-pharmaceutical-reports-tomorrow-morning-cm787508,We re in the thick of earnings season which means some of the most prominent industry leaders are set to report their quarterly results Tomorrow morning Israel based drug developer Teva Pharmaceutical Industries NYSE TEVA is set to join the crowd and release its first
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Has a Chance,2017-05-10 22:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O_L6WypJKGQ/teva-pharmaceutical-industries-ltd-adr-teva-stock-still-has-a-chance-cm787544,InvestorPlace Stock Market News Stock Advice amp Trading Tips The year for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has certainly been awful with the shares off about 14 Yet last year was even worse TEVA stock plunged from 56 44 to 31 15 Source Open
TEVA,TEVA:US,BBG000C0CD58,4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning,2017-05-10 20:52:00 +0000,http://finance.yahoo.com/r/32142eed-40ef-341c-a5e3-f4bc101bc863/4-pressing-questions-we-want-answered-when-teva-ph.aspx?yptr=yahoo&.tsrc=rss,"From Copaxone&apos;s patents to its $35.8 billion in debt, shareholders have questions and we want answers."
TEVA,TEVA:US,BBG000C0CD58,Wednesday's ETF with Unusual Volume: GWL,2017-05-10 18:01:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L_SM1EkNJZY/wednesdays-etf-with-unusual-volume-gwl-cm787330,The SPDR S amp P World ex US ETF GWL is seeing unusually high volume in afternoon trading Wednesday with over 883 000 shares traded versus three month average volume of about 271 000 Shares of GWL were up about 0 2 on the day Components of that ETF with the highest volume
TEVA,TEVA:US,BBG000C0CD58,"IEFA, FTXL: Big ETF Inflows",2017-05-10 16:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q1u01mCH24g/iefa-ftxl-big-etf-inflows-cm787193,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF IEFA which added 11 600 000 units or a 2 9 increase week over week Among the largest underlying components of IEFA in
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries is a Top 10 SAFE International Dividend Stock (TEVA),2017-05-10 13:00:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tsBpzn_TVqA/why-teva-pharmaceutical-industries-is-a-top-10-safe-international-dividend-stock-teva-cm787006,Teva Pharmaceutical Industries Ltd Symbol TEVA has been named to the Dividend Channel International S A F E 10 list signifying an international stock with above average DividendRank statistics including a strong 4 4 yield as well as a superb track record of at least five years
TEVA,TEVA:US,BBG000C0CD58,Short Interest in Major Pharma Shrinks,2017-05-10 13:00:31 +0000,http://finance.yahoo.com/news/short-interest-major-pharma-shrinks-130031038.html?.tsrc=rss,"The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward."
TEVA,TEVA:US,BBG000C0CD58,Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?,2017-05-09 21:02:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KriMAIW_2Mo/mylan-vs-teva-which-is-the-better-generics-stock-ahead-of-earnings-cm786807,Ever since the political climate heated up in the run up to the last presidential election drug stocks have come under severe scrutiny Allegations of overpricing first from Hillary Clinton and then from her opponent now President Trump drove down prices and led to an industry wide
TEVA,TEVA:US,BBG000C0CD58,Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings?,2017-05-09 18:22:06 +0000,http://finance.yahoo.com/news/mylan-vs-teva-better-generics-182206388.html?.tsrc=rss,Mylan and Teva are scheduled to report on May 10 and May 11
TEVA,TEVA:US,BBG000C0CD58,"Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View",2017-05-09 17:03:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hayuIi7TSS4/allergan-agn-beats-q1-earnings-estimates-ups-2017-view-cm786622,Allergan plc s AGN first quarter 2017 earnings came in at 3 35 per share beating the Zacks Consensus Estimate of 3 32 by 0 9 Earnings rose 12 year over year Revenues came in at 3 57 billion up 5 1 from the year ago period and beat the Zacks Consensus Estimate of 3
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical (TEVA) Stock Can Capture 376% Returns,2017-05-08 22:00:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p3-2IQkDRnM/teva-pharmaceutical-teva-stock-can-capture-376-returns-cm786203,InvestorPlace Stock Market News Stock Advice amp Trading Tips It hasn t gotten any easier for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA in 2017 after a difficult 2016 But now more than ever I think it s time to forgive and forget or at least give TEVA stock
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Has 25% Upside,2017-05-08 18:01:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tJxZConnWDc/teva-pharmaceutical-industries-ltd-adr-teva-stock-has-25-upside-cm786031,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors who are looking for a beaten down pharma stock should consider Teva Pharmaceutical Industries Ltd ADR NYSE TEVA which has seen its value plummet nearly 40 160 over the past year including
TEVA,TEVA:US,BBG000C0CD58,"EFA, HSCZ: Big ETF Inflows",2017-05-08 16:02:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VM0hygTyk0k/efa-hscz-big-etf-inflows-cm785890,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares MSCI EAFE ETF EFA which added 9 600 000 units or a 0 9 increase week over week Among the largest underlying components of EFA in morning
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical (TEVA) Q1 Earnings: What's in the Cards?,2017-05-08 15:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y_aMSJA7PQ8/teva-pharmaceutical-teva-q1-earnings-whats-in-the-cards-cm785858,Teva Pharmaceutical Industries Ltd TEVA is scheduled to report first quarter 2017 earnings on May 11 before the market opens Last quarter the company delivered a positive earnings surprise of 3 03 This generic drug maker s shares have lost 14 1 so far this year compared with the
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical (TEVA) Q1 Earnings: What&apos;s in the Cards?,2017-05-08 13:26:01 +0000,http://finance.yahoo.com/news/teva-pharmaceutical-teva-q1-earnings-132601524.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to report first-quarter 2017 earnings on May 11
TEVA,TEVA:US,BBG000C0CD58,"TXMD All Set For D-day, IMMU Soars On Strategic Plan, CTSO On Watch",2017-05-07 12:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mtsNKh07O2g/txmd-all-set-for-dday-immu-soars-on-strategic-plan-ctso-on-watch-20170507-00007,"TXMD All Set For D-day, IMMU Soars On Strategic Plan, CTSO On Watch"
TEVA,TEVA:US,BBG000C0CD58,Teva and Active Biotech Announce CONCERTO trial of Laquinimod in RRMS Did Not Meet Primary Endpoint,2017-05-05 18:00:00 +0000,http://finance.yahoo.com/news/teva-active-biotech-announce-concerto-180000076.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. and Active Biotech today announced results from the CONCERTO trial in patients with relapsing-remitting multiple sclerosis .
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Publication of COPAXONE® (glatiramer acetate injection) Pregnancy Data in the International Journal of MS Care,2017-05-05 12:00:00 +0000,http://finance.yahoo.com/news/teva-announces-publication-copaxone-glatiramer-120000071.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. today announced that data suggests that women with relapsing forms of multiple sclerosis who were exposed to COPAXONE® 20 mg/mL daily during pregnancy are not at higher risk for congenital anomalies compared to reference rates for abnormal pregnancy outcomes reported in two large databases representing the general population.
TEVA,TEVA:US,BBG000C0CD58,Generic Drug Industry Headwinds Lead to Moat Downgrades,2017-05-05 11:00:00 +0000,http://finance.yahoo.com/r/1437b563-ae7d-30c9-8112-a6a6adb3ff5c/article.aspx?id=807269&SR=Yahoo&yptr=yahoo&.tsrc=rss,"Fear could create opportunity, but we advise investors to proceed with caution."
TEVA,TEVA:US,BBG000C0CD58,Arena Pharmaceuticals (ARNA) Q1 Earnings: What's in Store?,2017-05-04 16:14:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T5reVbvTxvo/arena-pharmaceuticals-arna-q1-earnings-whats-in-store-cm784203,Arena Pharmaceuticals Inc ARNA is expected to report first quarter 2017 on May 9 after market closes The company delivered a positive earnings surprise of 277 78 in the last quarter Over the four trailing quarters it had an average positive surprise of 79 09 Let s see how things
TEVA,TEVA:US,BBG000C0CD58,Generic Drugmakers Tumble as Perrigo Discloses DoJ Search,2017-05-04 13:13:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3vE4mQBEzIs/generic-drugmakers-tumble-as-perrigo-discloses-doj-search-cm784052,Generic drugmakers saw their shares tumbling yesterday following news that search warrants were executed at the corporate offices of Perrigo Company plc PRGO in connection with an ongoing investigation by the U S Department of Justice DoJ Antitrust Division The investigation is regarding
TEVA,TEVA:US,BBG000C0CD58,Generic Drugmakers Tumble as Perrigo Discloses DoJ Search,2017-05-04 12:23:12 +0000,http://finance.yahoo.com/news/generic-drugmakers-tumble-perrigo-discloses-122312898.html?.tsrc=rss,"With Perrigo (PRGO) disclosing that DoJ search warrants were executed at its corporate offices, industry-wide pricing practices are back in focus."
TEVA,TEVA:US,BBG000C0CD58,"Momenta Pharmaceuticals, Inc. Looks for Some Momentum",2017-05-03 20:50:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WgWUKnda0r8/momenta-pharmaceuticals-inc-looks-for-some-momentum-cm783792,Momenta Pharmaceuticals NASDAQ MNTA reported first quarter earnings on Tuesday but given the relatively small sales it was an update on the potential FDA approval of higher strength Glatopa and pipeline plans that should most interest investors Momenta Pharmaceuticals results
TEVA,TEVA:US,BBG000C0CD58,Perrigo Stock Sliding on DOJ Search,2017-05-03 12:53:00 +0000,http://finance.yahoo.com/r/badb82a7-cb93-380b-814c-c41f9a7be92a/perrigo-stock-sliding-in-pre-market-trading-on-doj-search.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The investigation is in relation to drug pricing in the pharmaceutical industry.
TEVA,TEVA:US,BBG000C0CD58,3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April,2017-05-03 12:32:00 +0000,http://finance.yahoo.com/r/53f9562d-85dc-3cb4-b9f0-f2bfa8e029af/3-reasons-teva-pharmaceutical-industries-lost-anot.aspx?yptr=yahoo&.tsrc=rss,"The hits just keep on coming for Teva and its shareholders, but relief may be around the corner."
TEVA,TEVA:US,BBG000C0CD58,"Noteworthy ETF Inflows: IEFA, NXPI, TEVA, CHKP",2017-05-02 16:26:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p0khEq0IJmA/noteworthy-etf-inflows-iefa-nxpi-teva-chkp-cm782738,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 83 2 million dollar inflow that s a 0 3 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Is Ready for a Tradable Rally,2017-05-01 18:08:00 +0000,http://finance.yahoo.com/r/ad369519-4a14-3492-b967-7b2da27b54ce/teva-pharmaceutical-ready-tradable-rally?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Prices are extended on the downside.
TEVA,TEVA:US,BBG000C0CD58,The 3 Best Pharmaceutical Stocks to Buy in 2017,2017-04-29 21:26:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1x9pMmqVuJk/the-3-best-pharmaceutical-stocks-to-buy-in-2017-cm781694,One big benefit that comes from owning pharmaceutical stocks is that their products remain in demand even during periods of economic stress That allows drugmakers to crank out profits even when the economy catches a cold So what pharmaceutical stocks should investors buy this
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Is Looking to Deal, and That's a Good Thing",2017-04-28 15:27:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x7sjk3w74PY/teva-pharmaceutical-is-looking-to-deal-and-thats-a-good-thing-cm781093,The tables have turned pretty quickly for Israeli based branded and generic drug developer Teva Pharmaceutical Industries NYSE TEVA In July 2015 shares of the company were trading north of 72 an all time high Today Teva s stock is struggling to hang onto the 30 mark which
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Is Looking to Deal, and That&apos;s a Good Thing",2017-04-28 14:21:00 +0000,http://finance.yahoo.com/r/f5e2aaf8-b8b4-33d3-9065-50ddfc8b31d8/teva-pharmaceutical-is-looking-to-deal-and-thats-a.aspx?yptr=yahoo&.tsrc=rss,Teva&apos;s oncology division could be on the chopping block.
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Publication of ARM-TD Study Results in Neurology® for the Investigational Use of Deutetrabenazine in Tardive Dyskinesia,2017-04-27 12:00:00 +0000,http://finance.yahoo.com/news/teva-announces-publication-arm-td-120000609.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today announced the publication of results from the Phase II/III study ARM-TD in Neurology®, the medical journal of the American Academy of Neurology."
TEVA,TEVA:US,BBG000C0CD58,"Merck cholesterol drug Vytorin faces competition from Impax, Teva generics",2017-04-26 21:08:07 +0000,http://finance.yahoo.com/news/merck-cholesterol-drug-vytorin-faces-210807625.html?.tsrc=rss,"Merck & Co's  cholesterol-reducing drug Vytorin faces competition for the  first time ever after two companies announced progress on their  generic versions of a drug that generated more than $1 billion  in sales last year.  The U.S. Food and Drug Administration on Wednesday approved  Impax Laboratories Inc's generic version of Vytorin,  while Teva Pharmaceutical Industries Ltd launched its  generic version of the drug in the United States.  Impax said it will immediately start commercialization for  its generic version of Vytorin."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Vytorin® in the United States,2017-04-26 20:09:00 +0000,http://finance.yahoo.com/news/teva-announces-launch-generic-vytorin-200900227.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the launch of generic Vytorin®1 tablets in the U.S."
TEVA,TEVA:US,BBG000C0CD58,Teva Confirms CFO Is Leaving,2017-04-26 17:12:00 +0000,http://finance.yahoo.com/r/f39508d2-e559-3781-b081-a4a9e580ee9a/teva-confirms-cfo-is-leaving.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Eyal Desheh became the Israel-based drugmaker's CFO in 2008.
TEVA,TEVA:US,BBG000C0CD58,"Finance chief quits drugmaker Teva, leaving another gap at top",2017-04-26 14:12:36 +0000,http://finance.yahoo.com/news/finance-chief-quits-drugmaker-teva-141236182.html?.tsrc=rss,"Teva Pharmaceutical  Industries' finance chief Eyal Desheh will step down  in the next few months after nearly a decade in the job, the  second top official to resign from the Israel-based company this  year.  Israeli media reported on Tuesday that Desheh is likely to  be appointed as chairman of Isracard, the credit card unit of  Bank Hapoalim, the country's largest bank, which said  there were a number of candidates.  Teva said it would immediately start a search for a new CFO,  but that Desheh will take part in the company's first-quarter  earnings call on May 11."
TEVA,TEVA:US,BBG000C0CD58,"Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer",2017-04-26 13:02:00 +0000,http://finance.yahoo.com/news/teva-announces-planned-departure-eyal-130200987.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. today confirmed that Eyal Desheh, Group Executive Vice President, Chief Financial Officer, will depart from Teva during the coming months."
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Can’t Make Up Their Minds on Major Pharma,2017-04-26 12:25:50 +0000,http://finance.yahoo.com/news/short-sellers-t-minds-major-122550485.html?.tsrc=rss,"The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed."
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and TG Therapeutics,2017-04-26 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000048.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 26, 2017 / Strong corporate earnings continued to drive markets higher Tuesday. The NASDAQ Composite Index topped the 6,000 mark for the first time ever, hitting a high ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Said to Consider Sale of Cancer Portfolio to Reduce Debt,2017-04-26 10:05:27 +0000,http://finance.yahoo.com/news/teva-said-consider-sale-cancer-100527600.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., the Israeli drugmaker seeking to cut debt after an acquisition spree, is exploring a sale of its specialty cancer treatments, according to people familiar with the ..."
TEVA,TEVA:US,BBG000C0CD58,Teva CFO Eyal Desheh To Step Down - Quick Facts,2017-04-26 09:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kLsQzNSUqaQ/teva-cfo-eyal-desheh-to-step-down--quick-facts-20170426-00953,Teva CFO Eyal Desheh To Step Down - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,"Express Scripts, Teva Pharmaceuticals Drop into Tuesday’s 52-Week Low Club",2017-04-25 20:04:54 +0000,http://finance.yahoo.com/news/express-scripts-teva-pharmaceuticals-drop-200454175.html?.tsrc=rss,"Express Scripts, Teva Pharmaceuticals, Range Resources, and Nielsen posted new 52-week lows on Tuesday."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical CFO Stepping Down,2017-04-25 19:08:00 +0000,http://finance.yahoo.com/r/061c61fe-707c-3ecc-b37b-9c47fd39116c/teva-pharmaceutical-cfo-reportedly-stepping-down.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,It is being reported that Teva will lose its CFO.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical CFO to step down: media,2017-04-25 18:06:36 +0000,http://finance.yahoo.com/news/teva-pharmaceutical-cfo-step-down-180636725.html?.tsrc=rss,"The chief financial officer of Teva Pharmaceutical Industries (TEVA.TA), Eyal Desheh, is stepping down and will likely be appointed chairman of Isracard, Bank Hapoalim's (POLI.TA) credit card company, Israeli news websites reported on Tuesday.  Desheh joined Teva as CFO in 2008 and briefly served as acting CEO from October 2013 to February 2014.  Teva was left without a permanent chief executive in February after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps."
TEVA,TEVA:US,BBG000C0CD58,Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,2017-04-25 17:44:54 +0000,http://finance.yahoo.com/news/mark-calendar-days-may-play-174454598.html?.tsrc=rss,"Investment in biotech stocks is fraught with risks. These stocks trade in anticipation of some ""make-or-break"" events called catalysts and therefore face the danger of seeing wild swings in the ..."
TEVA,TEVA:US,BBG000C0CD58,Teva looks to resume some production at Rimsa plant in Mexico,2017-04-25 11:23:44 +0000,http://finance.yahoo.com/news/teva-looks-resume-production-rimsa-112344587.html?.tsrc=rss,"Teva Pharmaceutical  Industries hopes to resume some production at its  newly purchased Mexican plant in the coming months, but an  overhaul needed to bring the factory up to speed will take a few  years, the company said on Tuesday.  Teva, the world's largest generic drugmaker, bought the  Rimsa plant in 2016 in a $2.3 billion deal, only to shut it down  immediately, saying the operation was overrun by improprieties.  Rimsa's previous owners, the Espinosa family, deny this, and the  two sides are locked in a legal battle."
TEVA,TEVA:US,BBG000C0CD58,Biotech Stocks Facing FDA Decision In May,2017-04-24 06:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m7nOglfsE90/biotech-stocks-facing-fda-decision-in-may-20170424-00222,Biotech Stocks Facing FDA Decision In May
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks That Retirees Should Avoid,2017-04-22 18:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sUMqKi3X0fg/3-dividend-stocks-that-retirees-should-avoid-cm777529,Sometimes the most tempting stocks can be some of the most dangerous That appears to be the case for three stocks with seemingly attractive dividend yields CenturyLink NYSE CTL GlaxoSmithKline NYSE GSK and Teva Pharmaceutical Industries NYSE TEVA Here s
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks That Retirees Should Avoid,2017-04-22 16:03:00 +0000,http://finance.yahoo.com/r/0b024976-bd14-367c-b517-dc50c8bbb525/3-dividend-stocks-that-retirees-should-avoid.aspx?yptr=yahoo&.tsrc=rss,"High dividend yields for CenturyLink, GlaxoSmithKline, and Teva look great, but there&apos;s more to the story for these stocks."
TEVA,TEVA:US,BBG000C0CD58,Teva's new asthma inhaler poses first competition for GSK's Advair,2017-04-20 22:43:39 +0000,http://finance.yahoo.com/news/teva-launches-copy-asthma-inhaler-191218937.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd  on Thursday launched an asthma inhaler that  will be the first direct competition to GlaxoSmithKline's  best-selling Advair.  Teva, which won U.S. approval in January to make an inhaler  similar to Advair, also launched a generic version of its own  inhaler, AirDuo RespiClick.  AirDuo is not a true generic of Advair, but contains the  same two active ingredients, fluticasone propionate and  salmeterol."
TEVA,TEVA:US,BBG000C0CD58,Teva launches copy of asthma inhaler Advair,2017-04-20 17:34:20 +0000,http://finance.yahoo.com/news/teva-launches-copy-asthma-inhaler-173420564.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd  launched its asthma inhaler and the  authorized generic of the drug on Thursday, nearly three months  after it got U.S. approval to market a copy of GlaxoSmithKline's  best-selling Advair.  Teva did not disclose the pricing of the inhalers.  Bernstein  analyst Erica Kazlow said the branded inhaler was priced at $285  wholesale acquisition cost, while the authorized generic was  priced at $90."
TEVA,TEVA:US,BBG000C0CD58,PID's Holdings Could Mean 10% Gain Potential,2017-04-20 17:05:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j-T9VPKGY0M/pids-holdings-could-mean-10-gain-potential-cm776563,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
TEVA,TEVA:US,BBG000C0CD58,"Teva Launches AirDuo™ RespiClick® and its Authorized Generic, Two Inhalers Containing Fluticasone Propionate and Salmeterol",2017-04-20 12:42:00 +0000,http://finance.yahoo.com/news/teva-launches-airduo-respiclick-authorized-124200983.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced the simultaneous launch of AirDuo™ RespiClick® inhalation powder and its authorized generic for the treatment of asthma in patients aged 12 years and older who are uncontrolled on an inhaled corticosteroid or whose disease severity clearly warrants the use of an ICS/long-acting beta2-adrenergic agonist combination."
TEVA,TEVA:US,BBG000C0CD58,Teva Showcases CNS Portfolio at 69th Annual Meeting of the American Academy of Neurology,2017-04-19 12:00:00 +0000,http://finance.yahoo.com/news/teva-showcases-cns-portfolio-69th-120000480.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd., today announced data for five of the Company’s innovative therapies for central nervous system disorders will be presented at the 69th Annual Meeting of the American Academy of Neurology in Boston, MA from April 22-28, 2017."
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Valeant Pharmaceuticals,2017-04-19 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000692.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 19, 2017 / U.S. markets were dragged down by the Banking and Healthcare sectors Tuesday after Goldman Sachs and Johnson & Johnson reported earnings that fell short of ..."
TEVA,TEVA:US,BBG000C0CD58,"Trade Micron Technology, Inc. (MU) Stock and Let Time Do the Work",2017-04-18 19:03:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BVNjVl1Q0nE/trade-micron-technology-inc-mu-stock-and-let-time-do-the-work-cm775470,InvestorPlace Stock Market News Stock Advice amp Trading Tips I ve recently had some luck trading the price action in Micron Technology Inc 160 NASDAQ MU both bearish and bullish In late March I shared a bearish trade that paid quickly Two weeks prior to that I
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Enters Oversold Territory,2017-04-18 17:04:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PyqrW_adOJs/teva-pharmaceutical-industries-enters-oversold-territory-cm775337,The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics strong fundamentals and a valuation that looks inexpensive
TEVA,TEVA:US,BBG000C0CD58,The Billionaire And The Drug Price-Fixing Scandal,2017-04-18 11:11:00 +0000,http://finance.yahoo.com/r/53930245-e358-3515-b1fc-8f489607f061/the-billionaire-and-the-drug-price-fixing-scandal?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag&yptr=yahoo&.tsrc=rss,"From Valeant to Martin Shkreli, populists have raged at exorbitant prices in the pharmaceutical industry. Now, amid a collusion scandal, there may finally be a major fall guy: generics billionaire Satish Mehta."
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Double,2017-04-17 22:54:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9EyjUrRMIiw/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-could-double-cm774920,InvestorPlace Stock Market News Stock Advice amp Trading Tips Price fixing allegations in the generic drug industry A backlash against drug price increases Costly past acquisitions that piled on debt Management turnover and fines for bribing officials for business 160 If
TEVA,TEVA:US,BBG000C0CD58,"Neurocrine's Stock Up, FDA Nod for Tardive Dyskinesia Drug",2017-04-13 23:54:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PS7I00Rmc_w/neurocrines-stock-up-fda-nod-for-tardive-dyskinesia-drug-cm774133,Shares of Neurocrine Biosciences Inc NBIX soared 25 on Tuesday after announcing the FDA approval ofIngrezza valbenazine capsules a day before for the treatment of adults with tardive dyskinesia TD Ingrezza is the first and the only drug approved by the FDA for the treatment of adults
TEVA,TEVA:US,BBG000C0CD58,U.S. FDA raises concerns over Teva's plant in China,2017-04-13 13:58:00 +0000,http://finance.yahoo.com/news/u-fda-raises-concerns-over-135800849.html?.tsrc=rss,"The U.S. Food and Drug Administration  (FDA) has raised concerns over manufacturing controls at a Teva  Pharmaceutical Industries plant in China, Israel's  biggest company said in a regulatory filing on Thursday.  Teva said the FDA's warning letter, which it  received on April 10, stemmed from a regulatory inspection of  the plant in September."
TEVA,TEVA:US,BBG000C0CD58,Neurocrine Avoids Suicide Warning In Teva-Rivaling Drug; Stock Pops,2017-04-12 20:54:00 +0000,http://finance.yahoo.com/r/b63f4b89-9204-3735-a7d5-546431d7c5e3/neurocrine-avoids-suicide-warning-in-teva-rivaling-drug-stock-pops?src=A00220A&yptr=yahoo&.tsrc=rss,"Neurocrine has a lead on Teva, grabbing FDA approval late Tuesday for the first drug in tardive dyskinesia."
TEVA,TEVA:US,BBG000C0CD58,"Cenovus  Energy, DryShips Dip into Wednesday’s 52-Week Low Club",2017-04-12 20:04:05 +0000,http://finance.yahoo.com/news/cenovus-energy-dryships-dip-wednesday-200405948.html?.tsrc=rss,"Cenovus Energy, DryShips, Teva Pharmaceuticals, and OncoMed Pharmaceuticals all posted new 52-week lows Wednesday."
TEVA,TEVA:US,BBG000C0CD58,Why Neurocrine Biosciences Stock Is Soaring Higher Today,2017-04-12 17:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8cbob6Fh7sY/why-neurocrine-biosciences-stock-is-soaring-higher-today-cm773358,What happened Shares of the mid cap biotech Neurocrine Biosciences NASDAQ NBIX rocketed higher today as a result of the Food and Drug Administration FDA approving the company s first drug Ingrezza as a treatment for adults with tardive dyskinesia TD Tardive dyskinesia is
TEVA,TEVA:US,BBG000C0CD58,"Approval For Neurocrine's Ingrezza Was No Surprise, But Lack Of Warning Label A Big Advantage Over Teva",2017-04-12 17:40:41 +0000,http://finance.yahoo.com/news/approval-neurocrines-ingrezza-no-surprise-174041057.html?.tsrc=rss,"Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) investors got a pleasant surprise when the FDA approved the company’s Ingrezza drug for treatment of tardive dyskinesia (TD). While the approval itself was ..."
TEVA,TEVA:US,BBG000C0CD58,Neurocrine Outperforms Even Bullish Estimates Of Ingrezza Approval Upside,2017-04-12 16:57:44 +0000,http://finance.yahoo.com/news/neurocrine-outperforms-even-bullish-estimates-165744778.html?.tsrc=rss,"Shares of Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) soared by more than 20 percent Wednesday after the U.S. Food and Drug Administration granted approval for the company's Ingrezza therapy. Ingrezza ..."
TEVA,TEVA:US,BBG000C0CD58,Why Neurocrine Biosciences Stock Is Soaring Higher Today,2017-04-12 16:43:46 +0000,http://finance.yahoo.com/r/d6eed183-a8b7-3714-a5a8-26fedffe9a32/why-neurocrine-biosciences-stock-is-soaring-higher.aspx?yptr=yahoo&.tsrc=rss,"The biotech struck regulatory gold with its tardive dyskinesia drug, Ingrezza."
TEVA,TEVA:US,BBG000C0CD58,"FDA Approves 1st Drug For Tardive Dyskinesia, AGRX On Track, ITEK, AZRX On Watch",2017-04-11 22:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3U2UdDfuC1I/fda-approves-1st-drug-for-tardive-dyskinesia-agrx-on-track-itek-azrx-on-watch-20170411-01284,"FDA Approves 1st Drug For Tardive Dyskinesia, AGRX On Track, ITEK, AZRX On Watch"
TEVA,TEVA:US,BBG000C0CD58,What Will Make Man Smarter?,2017-04-10 23:18:16 +0000,http://finance.yahoo.com/news/man-smarter-231816142.html?.tsrc=rss,Companies are increasingly investing in smart drugs
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Said to Be Exploring Sale of Women's Health Unit,2017-04-07 19:19:00 +0000,http://finance.yahoo.com/r/631a673b-688e-3966-84a4-351f2eb465b8/teva-pharmaceutical-said-to-be-exploring-sale-of-women-s-health-unit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Teva Pharmaceutical's women's health business could sell for $2 billion.
TEVA,TEVA:US,BBG000C0CD58,3 Stocks the Smartest Investors Are Buying Right Now,2017-04-07 15:56:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gDKl6JE-irU/3-stocks-the-smartest-investors-are-buying-right-now-cm771393,Keeping tabs on the quarterly activity of elite billionaire investors like George Soros and David Tepper can be a good way to drum up worthwhile investing ideas However everyday investors should never buy a stock simply because a so called super investor added it to their
TEVA,TEVA:US,BBG000C0CD58,Allergan (AGN) Presents Mixed Depression Data on Botox,2017-04-06 17:53:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/elMXlAN1JVg/allergan-agn-presents-mixed-depression-data-on-botox-cm770907,Allergan plc AGN announced mixed top line data from a mid stage study evaluating its key drug Botox for the treatment of major depressive disorder MDD Allergan s share price is up 13 2 this year so far while the Zacks classified Medical Generics Drug industry declined 3 4 Botox
TEVA,TEVA:US,BBG000C0CD58,"Acorda (ACOR) to Reduce Workforce, Focus on Product Pipeline",2017-04-06 15:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6FzIEtVW7vg/acorda-acor-to-reduce-workforce-focus-on-product-pipeline-cm770742,Acorda Therapeutics Inc ACOR recently announced plans to reduce its workforce by approximately 20 The workforce reduction which is expected to be completed in Apr 2017 is part of the company s strategy to significantly lower its operating expenses The company expects this move
TEVA,TEVA:US,BBG000C0CD58,"Noteworthy ETF Inflows: EFA, NXPI, TEVA, CHKP",2017-04-06 15:55:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dHfw0LHIG98/noteworthy-etf-inflows-efa-nxpi-teva-chkp-cm770750,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 1 5 billion dollar inflow that s a 2 3 increase week over week in outstanding
TEVA,TEVA:US,BBG000C0CD58,"Teva to Report First Quarter 2017 Financial Results on May 11, 2017",2017-04-06 12:30:00 +0000,http://finance.yahoo.com/news/teva-report-first-quarter-2017-123000658.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. announced today that it will release its first quarter 2017 financial results on Thursday, May 11, 2017 at 7:00 a.m. ET."
TEVA,TEVA:US,BBG000C0CD58,Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst,2017-04-05 21:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/biWDpxO9Yx4/celgene-celg-gets-paragraph-iv-notice-letter-for-pomalyst-cm770413,Celgene Corporation CELG recently received a Paragraph IV Notice Letter advising that Teva Pharmaceutical Industries Ltd TEVA submitted an Abbreviated New Drug Application ANDA to the FDA seeking an approval to manufacture and market a generic version of Pomalyst pomalidomide 1 mg 2 mg
TEVA,TEVA:US,BBG000C0CD58,Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst,2017-04-05 19:36:07 +0000,http://finance.yahoo.com/news/celgene-celg-gets-paragraph-iv-193607894.html?.tsrc=rss,Celgene Corporation (CELG) recently received a Paragraph IV Notice Letter advising that Teva Pharmaceutical Industries Limited (TEVA) submitted an ANDA to the FDA seeking an approval to manufacture and market a generic version of Pomalyst.
TEVA,TEVA:US,BBG000C0CD58,5 Reasons to Invest in Eli Lilly (LLY) Stock Right Now,2017-04-05 15:27:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sZRcWR8_Pe8/5-reasons-to-invest-in-eli-lilly-lly-stock-right-now-cm770127,Indianapolis IN based Eli Lilly and Company LLY is a global healthcare company which enjoys presence across a wide range of therapeutic areas including neuroscience oncology endocrinology immunology and cardiovascular which are all high growth areas and represent significant
TEVA,TEVA:US,BBG000C0CD58,"History Comes Back to Haunt Teva Pharmaceutical Industries, Sending Shares Down 8% in March",2017-04-05 14:25:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GRR1PCs4dgA/history-comes-back-to-haunt-teva-pharmaceutical-industries-sending-shares-down-8-in-march-cm770030,What happened Shares of Teva Pharmaceutical Industries NYSE TEVA an Israeli based producer of generic and branded drugs sank another 8 in March according to data from S amp P Global Market Intelligence Shares of Teva have now lost half their value since the
TEVA,TEVA:US,BBG000C0CD58,"History Comes Back to Haunt Teva Pharmaceutical Industries, Sending Shares Down 8% in March",2017-04-05 13:20:00 +0000,http://finance.yahoo.com/r/3c8d77b5-4b3b-3471-adf5-59eaec44d56d/history-comes-back-to-haunt-teva-pharmaceutical-in.aspx?yptr=yahoo&.tsrc=rss,"Worries over Copaxone, drug price reform, and its debt continue to weigh on Teva&apos;s share price."
TEVA,TEVA:US,BBG000C0CD58,Why Teva stock isn’t moving on its major Huntington’s disease drug approval,2017-04-05 12:47:09 +0000,http://finance.yahoo.com/r/19cd6dee-9fbb-3a4a-a51c-bca0887bb40f/Story.aspx?guid=CF47D388-1944-11E7-ACE9-1B88A12ADC17&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"For once, it seems to have nothing to do with price."
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and Neurocrine Biosciences,2017-04-05 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-113000430.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 5, 2017 / Teva Pharmaceutical Industries and Neurocrine Biosciences will be racing for the FDA approval for their treatments of tardive dyskinesia, revealed an analyst ..."
TEVA,TEVA:US,BBG000C0CD58,An Israeli pharma firm has found a way to make drugs longer lasting and more effective,2017-04-05 11:24:16 +0000,http://finance.yahoo.com/r/d7f0a3db-1378-3dfc-a87b-4366ecf425a1/austedo-for-huntingtons-disease-teva-pharmaceuticals-has-found-a-nifty-way-to-keep-drugs-in-your-body-for-longer?utm_source=YPL&yptr=yahoo&.tsrc=rss,"Your body treats drugs much like a sandwich. As soon you ingest something, enzymes and acids start breaking down its various chemical components. That’s bad news for most drugs, because the active ingredient can’t do its job if it is quickly broken down. (A metabolized drug is often eliminated when you pee.) Pharma companies have…"
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Gets Good News but Still Needs a Head,2017-04-05 11:13:00 +0000,http://finance.yahoo.com/r/c601f326-449b-3a1c-afde-ebcfc736944d/teva-gets-good-news-but-still-needs-a-head-1491390807?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries (TEVA:NYSE)  By Credit Suisse ($32.19, April 3, 2017) Teva Pharmaceutical Industries announced approval of Austedo (SD-809) for the treatment of patients with chorea associated with Huntington’s Disease (HD).  The approval does not materially change our revenue numbers and our target price remains $42, but we see this as an important piece of good news for TEVA given the steady stream of negative news the company has had to deal with over the past several months and given it helps set the stage for approval in the more commercially important indication of tardive dyskinesia (TD) later this year.  Teva has been under pressure over the last several months following a challenging 2016."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva: Starting to Pierce the Gloom,2017-04-05 04:26:32 +0000,http://finance.yahoo.com/r/84b2cf2e-0eb0-3b05-863b-d4d752c60afc/teva-starting-to-pierce-the-gloom-1491323754?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Regulatory approval for Teva Pharmaceutical Industries’ new treatment for Huntington’s disease offers some much-needed good news.
TEVA,TEVA:US,BBG000C0CD58,3 Stocks That Give Us Heartburn,2017-04-04 23:24:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oGcxrFCe5lo/3-stocks-that-give-us-heartburn-cm769906,No one ever said investing was easy Over the long run we as investors are bound to run into companies that may look enticing but wind up doing nothing more than giving us heartburn with their business troubles and the antics of management Sometimes it can be worth taking an antacid
TEVA,TEVA:US,BBG000C0CD58,3 Stocks That Give Us Heartburn,2017-04-04 21:32:00 +0000,http://finance.yahoo.com/r/9e609663-9198-31b0-8fa5-382b437a9179/3-stocks-that-give-us-heartburn.aspx?yptr=yahoo&.tsrc=rss,Someone pass the antacid.
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharma, Neurocrine Do Battle Over Neurological Treatments",2017-04-04 20:36:45 +0000,http://finance.yahoo.com/r/ba691c1d-93a3-33be-9082-1bf8eb0bcdcc/teva-pharma-neurocrine-prep-for-donnybrook-in-tourettes?src=A00220A&yptr=yahoo&.tsrc=rss,"Teva and Neurocrine look likely to compete this year as the FDA mulls drugs from them to treat involuntary movements, an analyst said Tuesday."
TEVA,TEVA:US,BBG000C0CD58,Huge Royals logo takes three strikes but wins approval in OP,2017-04-04 19:19:45 +0000,http://finance.yahoo.com/r/04e02cff-0bc1-3407-9521-56f4aa7566cb/teva-building-raised-royal-logo.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"The Overland Park City Council on Monday approved a special event permit allowing Teva Pharmaceuticals to show its Kansas City Royals pride in a big way.  The permit will allow the firm to apply a 40-foot-diameter copy of the Royal's 2017 logo — a crown and the words ""Raised Royal"" — on the glass facade of Teva's high-profile office building at College Boulevard and Nall Avenue.  The ""Raised Royal"" logo, however, raised concerns with some members of the City Council, which voted 8-3 to allow it to be displayed through the entire Royals season, which hopefully will extend into November."
TEVA,TEVA:US,BBG000C0CD58,Teva's Austedo Gets FDA Nod for Huntington Disease Treatment,2017-04-04 16:26:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WlIGGR2Brwk/tevas-austedo-gets-fda-nod-for-huntington-disease-treatment-cm769624,Teva Pharmaceutical Industries Ltd TEVA recently announced that the FDA has approved its investigational drug Austedo deutetrabenazine tablets previously referred to as SD 809 for the treatment of chorea associated with Huntington disease HD We note that Austedo became part
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Receives FDA Approval For Huntington's Drug,2017-04-04 15:44:00 +0000,http://finance.yahoo.com/r/3f454bdd-aa7f-3a1c-875f-c9997813012e/teva-pharmaceutical-receives-fda-approval-for-huntington-s-drug.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Austedo is the second drug to be approved for the treatment of chorea.
TEVA,TEVA:US,BBG000C0CD58,"Teva's Huntington's disease drug approved Monday, second drug ever approved for chorea",2017-04-04 14:39:54 +0000,http://finance.yahoo.com/r/a663b35f-e6fb-3246-aa0b-3b6d54a0b35d/Story.aspx?guid=8F657078-04C9-4665-B3A4-7D57588B1924&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Teva Pharmaceutical Industries Ltd. got its Huntington's disease drug approved by the Food and Drug Administration late Monday. The drug, Austedo, is the second drug ever approved for chorea, the writhing ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Huntington's Drug Wins FDA Nod,2017-04-04 14:29:00 +0000,http://finance.yahoo.com/r/625875e1-74c4-3442-a5e6-21a3ddb5e7ce/teva-huntingtons-drug-wins-fda-nod-teva?partner=YahooSA&yptr=yahoo&.tsrc=rss,Teva’s Austedo got FDA approval to treat chorea linked to Huntington’s disease.
TEVA,TEVA:US,BBG000C0CD58,Teva&apos;s Austedo Gets FDA Nod for Huntington Disease Treatment,2017-04-04 14:24:02 +0000,http://finance.yahoo.com/news/teva-apos-austedo-gets-fda-142402695.html?.tsrc=rss,"Teva Pharmaceutical Industries Ltd. (TEVA) recently announced that the FDA has approved its investigational drug, Austedo (deutetrabenazine) tablets for the treatment of chorea associated with Huntington disease (HD)."
TEVA,TEVA:US,BBG000C0CD58,Teva gets FDA OK for rare disease treatment,2017-04-04 12:45:09 +0000,http://finance.yahoo.com/r/a6822ef3-2c1f-337a-a5b2-70d528135653/teva-gets-fda-ok-chorea-huntingdons-treatement.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"The Food and Drug Administration approved Austedo, a drug developed by Teva Pharmaceutical Industries Ltd. to treat chorea associated with Huntington’s disease.  Huntington’s disease is a rare and fatal neurodegenerative disorder that affects more than 35,000 people in the United States.  Chorea, a condition characterized by involuntary, random and sudden, twisting and/or writhing movements, is a physical manifestation of the disease that occurs in about 90 percent of Huntingdon’s disease patients."
TEVA,TEVA:US,BBG000C0CD58,"FDA Nod For TEVA, Cheers For PRTK, SRNE Hits Goal, SNY Launches Kids Toothpaste",2017-04-03 23:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2lMh_CDwmvU/fda-nod-for-teva-cheers-for-prtk-srne-hits-goal-sny-launches-kids-toothpaste-20170403-01547,"FDA Nod For TEVA, Cheers For PRTK, SRNE Hits Goal, SNY Launches Kids Toothpaste"
TEVA,TEVA:US,BBG000C0CD58,Teva wins FDA approval for Huntington's drug,2017-04-03 22:02:02 +0000,http://finance.yahoo.com/news/teva-wins-fda-approval-huntingtons-220202632.html?.tsrc=rss,"Israel-based Teva Pharmaceutical  Industries Ltd  said the U.S. Food and Drug  Administration had approved its drug to treat chorea stemming  from Huntington's disease, a fatal degenerative disorder.  Chorea is an abnormal, involuntary writhing movements  disorder that occur in 90 percent of Huntington's disease  patients at some point in the course of their illness.  The company said on Monday that the FDA approval was based  on results from a late-stage study of the drug, Austedo, in  reducing chorea in patients with Huntington's disease."
TEVA,TEVA:US,BBG000C0CD58,Teva wins FDA approval for Huntington's drug,2017-04-03 22:02:02 +0000,http://finance.yahoo.com/news/teva-wins-fda-approval-huntingtons-220202632.html,Teva wins FDA approval for Huntington's drug
TEVA,TEVA:US,BBG000C0CD58,5:08 pm Teva Pharma announces FDA approval of AUSTEDO (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease,2017-04-03 21:08:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#teva,5:08 pm Teva Pharma announces FDA approval of AUSTEDO (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease
TEVA,TEVA:US,BBG000C0CD58,Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease,2017-04-03 21:04:00 +0000,http://finance.yahoo.com/news/teva-announces-fda-approval-austedo-210400280.html?.tsrc=rss,Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AUSTEDO™ tablets for the treatment of chorea associated with Huntington’s disease .
TEVA,TEVA:US,BBG000C0CD58,Teva Announces FDA Approval of AUSTEDO™ (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease,2017-04-03 21:04:00 +0000,http://finance.yahoo.com/news/teva-announces-fda-approval-austedo-210400280.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AUSTEDO™ tablets for the treatment of chorea associated with Huntington’s disease .
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Risky,2017-04-03 18:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4def1eYGQQE/why-teva-pharmaceutical-industries-ltd-adr-teva-stock-is-risky-cm769213,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock is down 40 over the past year and down more than 50 since August 2015 Admittedly the past year and a half hasn t been great
TEVA,TEVA:US,BBG000C0CD58,BlackBerry Ltd (BBRY) Stock Is Being Underestimated by Investors,2017-04-03 18:35:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lH7VBCYyv-c/blackberry-ltd-bbry-stock-is-being-underestimated-by-investors-cm769205,InvestorPlace Stock Market News Stock Advice amp Trading Tips Even after BlackBerry Ltd s NASDAQ BBRY 160 results beat expectations on Friday morning most investors and pundits still seem to be lost in the trees of the company s financial results and near term outlook
TEVA,TEVA:US,BBG000C0CD58,United Therapeutics loses challenge to its drug patent,2017-04-03 14:07:09 +0000,http://www.bizjournals.com/washington/news/2017/04/03/united-therapeutics-loses-rules-in-challenge.html?ana=yahoo,United Therapeutics loses challenge to its drug patent
TEVA,TEVA:US,BBG000C0CD58,United Therapeutics loses challenge to its drug patent,2017-04-03 14:07:09 +0000,http://finance.yahoo.com/r/d03b5d41-ff5f-34ad-a1af-797c27472f22/united-therapeutics-loses-rules-in-challenge.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Silver Spring-based biotech United Therapeutics Corp. (UTHR) lost a recent challenge to one of its lead patents for its flagship drugs.  The U.S. Patent and Trademark Office's Patent Trial and Appeal Board found that all of the company's claims for the particular patent — which impacts its lead products for treating pulmonary arterial hypertension such as Remodulin, Tyvaso and Orenitram — are not patentable.  In a statement, United Therapeutics officials said they are evaluating all of their options, including possibly appealing the decision in the U.S. Court of Appeals for the Federal Circuit or requesting a rehearing before the patent board."
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva investor warns of rebellion as pressure mounts,2017-04-03 13:47:21 +0000,"http://www.ft.com/cms/s/133847c0-1734-11e7-a53d-df09f373be87,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[$$] Teva investor warns of rebellion as pressure mounts
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Looks Vulnerable to Further Losses,2017-04-03 13:47:00 +0000,http://realmoney.thestreet.com/articles/04/03/2017/teva-pharmaceutical-looks-vulnerable-further-losses?puc=yahoo&cm_ven=YAHOO,Teva Pharmaceutical Looks Vulnerable to Further Losses
TEVA,TEVA:US,BBG000C0CD58,Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe,2017-04-03 06:00:00 +0000,http://uk.finance.yahoo.com/news/teva-receives-positive-outcome-copaxone-060000268.html,Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe
TEVA,TEVA:US,BBG000C0CD58,Teva Gets Positive Outcome For COPAXONE 40 Mg/ml 3 Times Weekly Label In Europe,2017-04-03 02:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t-P3jQ_wFPw/teva-gets-positive-outcome-for-copaxone-40-mgml-3-times-weekly-label-in-europe-20170403-00072,Teva Gets Positive Outcome For COPAXONE 40 Mg/ml 3 Times Weekly Label In Europe
TEVA,TEVA:US,BBG000C0CD58,Alan Knuckman's Teva Trade,2017-04-01 15:05:12 +0000,http://finance.yahoo.com/news/alan-knuckmans-teva-trade-150512633.html,Alan Knuckman's Teva Trade
TEVA,TEVA:US,BBG000C0CD58,Hat Tip: 5 Dividend Stocks that Should Hold Up if Market Tanks,2017-03-31 20:32:00 +0000,http://blogs.barrons.com/incomeinvesting/2017/03/31/hat-tip-5-dividend-stocks-that-should-hold-up-if-market-tanks/?mod=yahoobarrons&ru=yahoo,Hat Tip: 5 Dividend Stocks that Should Hold Up if Market Tanks
TEVA,TEVA:US,BBG000C0CD58,How to Trade Teva Pharmaceutical,2017-03-31 19:54:11 +0000,http://finance.yahoo.com/video/trade-teva-pharmaceutical-195411619.html,How to Trade Teva Pharmaceutical
TEVA,TEVA:US,BBG000C0CD58,How to Trade Teva Pharmaceutical,2017-03-31 19:54:06 +0000,https://www.bloomberg.com/news/videos/2017-03-31/how-to-trade-teva-pharmaceutical-video?cmpid=yhoo.headline,How to Trade Teva Pharmaceutical
TEVA,TEVA:US,BBG000C0CD58,These Popular Stocks Could Prove Toxic for Your Portfolio,2017-03-31 19:00:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GUclaYigTTY/these-popular-stocks-could-prove-toxic-for-your-portfolio-cm768461,Sometimes stocks that seem like great investments can go bad Companies with good numbers or a strong story can have flaws that aren t 160 readily visible to most investors Even good companies can hit roadblocks or situations where there s a lot more at risk than is apparent
TEVA,TEVA:US,BBG000C0CD58,These Popular Stocks Could Prove Toxic for Your Portfolio,2017-03-31 17:21:00 +0000,https://www.fool.com/investing/2017/03/31/these-popular-stocks-could-prove-toxic-portfolio.aspx,These Popular Stocks Could Prove Toxic for Your Portfolio
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : March 02nd, 2017 (record date) : By the numbers : March 31, 2017",2017-03-31 16:25:33 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-us-dividend-analysis-march-02nd-2017-record-date-by-the-numbers-march-31-2017/,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : March 02nd, 2017 (record date) : By the numbers : March 31, 2017"
TEVA,TEVA:US,BBG000C0CD58,TEVA May 12th Options Begin Trading,2017-03-30 16:02:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hmux649gs-o/teva-may-12th-options-begin-trading-cm767775,Investors in Teva Pharmaceutical Industries Ltd Symbol TEVA saw new options become available today for the May 12th expiration At Stock Options Channel our YieldBoost formula has looked up and down the TEVA options chain for the new May 12th contracts and identified one put and one
TEVA,TEVA:US,BBG000C0CD58,"EFA, SYG: Big ETF Inflows",2017-03-30 16:01:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d3s2Wwc_iLE/efa-syg-big-etf-inflows-cm767771,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares MSCI EAFE ETF which added 11 400 000 units or a 1 1 increase week over week Among the largest underlying components of EFA in morning trading today
TEVA,TEVA:US,BBG000C0CD58,Viagra May Be Soon Be Sold Without a Prescription in the UK,2017-03-30 13:16:00 +0000,http://www.investopedia.com/news/viagra-may-be-soon-be-sold-without-prescription-uk-pfe-teva/?partner=YahooSA,Viagra May Be Soon Be Sold Without a Prescription in the UK
TEVA,TEVA:US,BBG000C0CD58,5 rock-solid dividend stocks to protect you from a stock-market retreat,2017-03-30 11:57:18 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=09A246FE-1539-11E7-A301-E0E2E4BCD1B0&siteid=yhoof2,5 rock-solid dividend stocks to protect you from a stock-market retreat
TEVA,TEVA:US,BBG000C0CD58,Performance of GlaxoSmithKline’s HIV Business in 2016,2017-03-29 14:36:23 +0000,http://marketrealist.com/2017/03/performance-of-glaxosmithklines-hiv-business-in-2016/?utm_source=yahoo&utm_medium=feed,Performance of GlaxoSmithKline’s HIV Business in 2016
TEVA,TEVA:US,BBG000C0CD58,GlaxoSmithKline’s Pharmaceuticals Segment Performance,2017-03-29 11:37:09 +0000,http://marketrealist.com/2017/03/glaxosmithklines-pharmaceuticals-segment-performance/?utm_source=yahoo&utm_medium=feed,GlaxoSmithKline’s Pharmaceuticals Segment Performance
TEVA,TEVA:US,BBG000C0CD58,"Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen",2017-03-29 00:45:00 +0000,https://www.thestreet.com/story/14062067/1/roche-wins-fda-backing-for-new-multiple-sclerosis-therapy-competition-could-crimp-biogen.html?puc=yahoo&cm_ven=YAHOO,"Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen"
TEVA,TEVA:US,BBG000C0CD58,Valeant Pharmaceuticals Intl Inc (VRX) Stock May Be Healthy for Long-Term Investors,2017-03-28 18:58:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JM-pbo1x6ao/valeant-pharmaceuticals-intl-inc-vrx-stock-may-be-healthy-for-long-term-investors-cm766847,InvestorPlace Stock Market News Stock Advice amp Trading Tips Since reporting quarterly earnings that showed significant deterioration in sales for its Salix and Bausch amp Lomb unit Valeant Pharmaceuticals Intl Inc NYSE VRX is still a compelling turnaround story The
TEVA,TEVA:US,BBG000C0CD58,Allergan Acne Candidate Meets Endpoints in Phase III Studies,2017-03-28 17:59:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZcgY9SP6U28/allergan-acne-candidate-meets-endpoints-in-phase-iii-studies-cm766765,Allergan plc AGN in collaboration with Paratek Pharmaceuticals Inc PRTK has announced positive results from two phase III studies on sarecycline The companies are developing sarecycline for the treatment of moderate to severe acne The companies said the studies met their 12 week
TEVA,TEVA:US,BBG000C0CD58,Why Impax Labs Soared 37.3% Today,2017-03-27 23:58:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rYvXtZXrIRc/why-impax-labs-soared-373-today-cm766257,What happened After the company reported it has hired Allergan s NYSE AGN former executive chairman as its new president and CEO investors sent shares in Impax Laboratories NASDAQ IPXL 160 surging 37 3 today So what Impax Labs shareholders have
TEVA,TEVA:US,BBG000C0CD58,Risk-Reward With Teva Pharmaceutical,2017-03-27 23:00:15 +0000,http://finance.yahoo.com/news/risk-reward-teva-pharmaceutical-230015395.html,Risk-Reward With Teva Pharmaceutical
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote,2017-03-27 12:35:12 +0000,http://finance.yahoo.com/news/major-pharma-short-sellers-couldn-123512794.html,Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Denies Rumors of Global Workforce Reduction,2017-03-24 17:01:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AMw8s-wHGuo/teva-pharma-denies-rumors-of-global-workforce-reduction-cm765298,According to recent reports Teva Pharmaceutical Industries Ltd TEVA is likely lay off almost 11 of its global workforce to cut costs and improve growth prospects The news which was first reported by Israeli newspaper Calcalist mentioned that the company may cut 6 000 jobs or about
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Denies Rumors of Global Workforce Reduction,2017-03-24 14:54:02 +0000,http://finance.yahoo.com/news/teva-pharma-denies-rumors-global-145402506.html,Teva Pharma Denies Rumors of Global Workforce Reduction
TEVA,TEVA:US,BBG000C0CD58,3 Israeli ETFs to Play the ‘Start-Up Nation’,2017-03-23 21:00:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RKvgvTZDk44/3-israeli-etfs-to-play-the-start-up-nation-cm764936,InvestorPlace Stock Market News Stock Advice amp Trading Tips With the move last week by Intel Corporation NASDAQ INTC to purchase Israel s Mobileye NV NYSE MBLY investors began taking a fresh look at Start Up Nation fund opportunities Source Shutterstock
TEVA,TEVA:US,BBG000C0CD58,TEVA Layoffs? Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Denies Job Cut Rumors,2017-03-23 21:00:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8DUV2Bdpr7I/teva-layoffs-teva-pharmaceutical-industries-ltd-adr-teva-denies-job-cut-rumors-cm764935,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA is denying reports that it plans to lay off up to 6 000 employees Source Open Grid Scheduler Modified The TEVA layoffs reports came from two
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Industries Ltd (ADR) Stock Has Staying Power,2017-03-23 19:02:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AMWBNz3Lx28/why-teva-pharmaceutical-industries-ltd-adr-stock-has-staying-power-cm764877,InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a rough few years for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock TEVA stock has declined by half from mid 2015 levels nearing a three plus year low in the process The loss of patents for
TEVA,TEVA:US,BBG000C0CD58,Allergan's Restasis Now Available in Multidose Bottle in U.S.,2017-03-23 17:00:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1c-jRUmNJKo/allergans-restasis-now-available-in-multidose-bottle-in-us-cm764765,Allergan plc AGN recently announced that its marketed drug Restasis cyclosporine ophthalmic emulsion 0 05 is now available in multidose bottles in the U S It is the first and only prescription medication approved by the FDA to help patients with a type of chronic dry eye Restasis
TEVA,TEVA:US,BBG000C0CD58,"Mylan Stock Dips On Recall Of 81,000 EpiPens Outside U.S.",2017-03-23 14:16:30 +0000,http://www.investors.com/news/technology/mylan-stock-dips-on-81000-epipen-recall-outside-u-s-citing-failures/?src=A00220A,"Mylan Stock Dips On Recall Of 81,000 EpiPens Outside U.S."
TEVA,TEVA:US,BBG000C0CD58,Teva Denies Reports About 11% Global Workforce Reduction (TEVA),2017-03-23 13:06:00 +0000,http://www.investopedia.com/news/teva-denies-reports-about-11-global-workforce-reduction-teva-agn/?partner=YahooSA,Teva Denies Reports About 11% Global Workforce Reduction (TEVA)
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm says media reports of up to 6,000 layoffs incorrect",2017-03-23 10:52:42 +0000,http://finance.yahoo.com/news/teva-pharm-says-media-reports-105242583.html,"Teva Pharm says media reports of up to 6,000 layoffs incorrect"
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm may fire 6,000 workers: Israeli media report",2017-03-23 08:30:53 +0000,http://finance.yahoo.com/news/teva-pharm-may-fire-6-083053768.html,"Teva Pharm may fire 6,000 workers: Israeli media report"
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm may fire 6,000 workers - Israeli media report",2017-03-23 08:21:22 +0000,http://sg.finance.yahoo.com/news/teva-pharm-may-fire-6-082122988.html,"Teva Pharm may fire 6,000 workers - Israeli media report"
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm may fire 6,000 workers -Israeli media report",2017-03-23 08:19:13 +0000,http://finance.yahoo.com/news/teva-pharm-may-fire-6-081913506.html,"Teva Pharm may fire 6,000 workers -Israeli media report"
TEVA,TEVA:US,BBG000C0CD58,"Teva to Cut as Many as 6,000 Jobs, Calcalist Newspaper Reports",2017-03-23 07:33:25 +0000,http://finance.yahoo.com/news/teva-cut-many-6-000-073325009.html,"Teva to Cut as Many as 6,000 Jobs, Calcalist Newspaper Reports"
TEVA,TEVA:US,BBG000C0CD58,Teva to Cut Undisclosed Number of Jobs as It Seeks to Pare Costs,2017-03-23 07:33:25 +0000,https://www.bloomberg.com/news/articles/2017-03-23/teva-to-cut-as-many-as-6-000-jobs-calcalist-newspaper-reports?cmpid=yhoo.headline,Teva to Cut Undisclosed Number of Jobs as It Seeks to Pare Costs
TEVA,TEVA:US,BBG000C0CD58,Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod,2017-03-21 21:08:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s3huNu9biqI/allergans-dermal-filler-for-wrinkle-correction-gets-fda-nod-cm763764,Allergan plc AGN announced yesterday that the FDA has approved its Juvederm Vollure XC dermal filler for correction of facial wrinkles and folds in adults over the age of 21 The approval was based on the data from a U S pivotal clinical trial It showed that 59 of patients under test
TEVA,TEVA:US,BBG000C0CD58,"EFA, TEVA, NXPI, CHKP: Large Inflows Detected at ETF",2017-03-21 17:09:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QP9BJVt73M4/efa-teva-nxpi-chkp-large-inflows-detected-at-etf-cm763607,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 261 1 million dollar inflow that s a 0 4 increase week over week in outstanding
TEVA,TEVA:US,BBG000C0CD58,Nektar's Pain Drug Positive in Phase III Study; Shares Gain,2017-03-21 17:09:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PxmxpyDhFrY/nektars-pain-drug-positive-in-phase-iii-study-shares-gain-cm763605,Nektar Therapeutics NKTR shares surged 42 6 after the company announced positive results from SUMMIT 07 phase III efficacy study evaluating its investigational opioid analgesic candidate NKTR 181 in patients with moderate to severe chronic low back pain The opioid based drug was studied
TEVA,TEVA:US,BBG000C0CD58,Nektar's Pain Drug Positive in Phase III Study; Shares Gain,2017-03-21 14:53:02 +0000,http://finance.yahoo.com/news/nektars-pain-drug-positive-phase-145302660.html,Nektar's Pain Drug Positive in Phase III Study; Shares Gain
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States,2017-03-21 00:10:28 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-teva-launches-minastrin-generic-in-the-united-states-567607/,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (TEVA) Stock Is a Deep Value Play,2017-03-20 22:06:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/miIRKbZc2hA/teva-pharmaceutical-industries-ltd-teva-stock-is-a-deep-value-play-cm763188,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd NYSE TEVA came on my radar around 1996 when a friend who had just been diagnosed with multiple sclerosis mentioned that TEVA had a drug called Copaxone that treated the
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal,2017-03-20 17:08:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VD0jEST0MYE/astrazeneca-azn-gets-another-crl-for-zs-9-inks-copd-deal-cm763005,London based AstraZeneca plc AZN received a second Complete Response Letter CRL from the FDA for its new drug application NDA for investigational drug ZS 9 The company is looking to get ZS 9 sodium zirconium cyclosilicate approved for the treatment of hyperkalemia high potassium level
TEVA,TEVA:US,BBG000C0CD58,AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal,2017-03-20 14:32:02 +0000,http://finance.yahoo.com/news/astrazeneca-azn-gets-another-crl-143202137.html,AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
TEVA,TEVA:US,BBG000C0CD58,"Andreas Halvorsen Sells Amazon, MasterCard in 4th Quarter",2017-03-18 16:05:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-OS8IlOArsM/andreas-halvorsen-sells-amazon-mastercard-in-4th-quarter-cm762579,Andreas Halvorsen Trades Portfolio is a founding partner of Viking Global Investors LP and serves as its CIO During the fourth quarter he sold shares in the following stocks Andreas Halvorsen Trades Portfolio is a founding partner of Viking Global Investors LP and serves as
TEVA,TEVA:US,BBG000C0CD58,3 Companies That Need to Kick Their CEO to the Curb,2017-03-17 20:05:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G0Jo8Z6YBjM/3-companies-that-need-to-kick-their-ceo-to-the-curb-cm762386,Immunomedics NASDAQ IMMU Sears Holdings NASDAQ SHLD and Community Health Systems NYSE CYH could benefit from a change at the top according to Motley Fool contributors All three companies are struggling to overcome obstacles that may be holding down their
TEVA,TEVA:US,BBG000C0CD58,Teva Launches Authorized Generic of Allergan's Minastrin,2017-03-17 16:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8JN7jomG8eQ/teva-launches-authorized-generic-of-allergans-minastrin-cm762270,Teva Pharmaceutical Industries Ltd TEVA recently launched an authorized generic version of Allergan plc s AGN oral contraceptive Minastrin 24 Fe1 in the U S Minastrin norethindrone acetate ethinyl estradiol tablets and ferrous fumarate tablets 1 mg 20 mcg had annual sales
TEVA,TEVA:US,BBG000C0CD58,Teva Launches Authorized Generic of Allergan's Minastrin,2017-03-17 13:58:01 +0000,http://finance.yahoo.com/news/teva-launches-authorized-generic-allergans-135801409.html,Teva Launches Authorized Generic of Allergan's Minastrin
TEVA,TEVA:US,BBG000C0CD58,Valeant: It's Not a Game of Chess- Part I,2017-03-17 13:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9pQ8wPUK4cE/valeant-its-not-a-game-of-chess-part-i-cm762050,I have always been interested in extreme successes and failures as case studies No doubt Valeant Pharmaceuticals VRX has been the most fascinating story I have followed in the investing world over the past few years What started as a promising business model designed by an ambitious
TEVA,TEVA:US,BBG000C0CD58,"Camber Capital Management LLC Buys Allergan PLC, Myriad Genetics, Vertex Pharmaceuticals, Sells ...",2017-03-17 11:05:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oyy1s9Bn6Ss/camber-capital-management-llc-buys-allergan-plc-myriad-genetics-vertex-pharmaceuticals-sells-cm762022,Camber Capital Management LLC New Purchases AGN MYGN VRTX LIVN BIIB ABT ATHN CNC BIOL Added Positions NKTR TEVA GILD BKD ELGX MYL ALKS Reduced Positions CSII ARNA UAM ENDP NVTA Sold Out MDCO CYH VRX PTCT PLX New Purchases
TEVA,TEVA:US,BBG000C0CD58,Migdal Insurance & Financial Holdings Ltd. ...,2017-03-17 09:05:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TiTWkRALjwk/migdal-insurance-financial-holdings-ltd-cm762015,Migdal Insurance Financial Holdings Ltd New Purchases RSX EPI DBEM IYT BAC REZ CSCO DLPH ACWI JNPR Added Positions XLV MYL EWZ FB AMZN TEVA V VCSH MA MBLY Reduced Positions FXI VOO AAXJ ITB PRGO OPK CHKP USB GILD DAL
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Authorized Generic of Minastrin® 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) in the United States,2017-03-16 17:58:00 +0000,http://finance.yahoo.com/news/teva-announces-launch-authorized-generic-175800896.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced the launch of the Authorized Generic of Minastrin® 24 Fe1 1 mg/20 mcg in the U.S.
TEVA,TEVA:US,BBG000C0CD58,Why Halliburton Company (HAL) Stock Is Rally-Ready!,2017-03-16 17:08:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-vYG_0V6zvs/why-halliburton-company-hal-stock-is-rally-ready-cm761812,InvestorPlace Stock Market News Stock Advice amp Trading Tips Investors witnessed a broad based rally on Wednesday following the Federal Reserve s decision to hike interest rates and signaling further hikes to come later this year However the rally wasn t just confined
TEVA,TEVA:US,BBG000C0CD58,Forget Teva Pharmaceutical Industries Ltd (ADR) (TEVA). Buy This Instead.,2017-03-16 16:09:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/No-OfZvyvYw/forget-teva-pharmaceutical-industries-ltd-adr-teva-buy-this-instead-cm761790,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA is the world s leading generic pharmaceutical company however it happens to make most of its profits from specialty drugs related to multiple sclerosis
TEVA,TEVA:US,BBG000C0CD58,PPH's Underlying Holdings Imply 13% Gain Potential,2017-03-16 15:07:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4d-XlMo_Kac/pphs-underlying-holdings-imply-13-gain-potential-cm761567,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
TEVA,TEVA:US,BBG000C0CD58,Teva To Present At Barclays Global Healthcare Conference; Webcast At 9:00 AM ET,2017-03-15 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RFZQdZB_Kw8/teva-to-present-at-barclays-global-healthcare-conference-webcast-at-900-am-et-20170315-00406,Teva To Present At Barclays Global Healthcare Conference; Webcast At 9:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,3 High-Yield Investments in Healthcare,2017-03-14 12:05:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g2LqhdEiB50/3-high-yield-investments-in-healthcare-cm760315,Are you looking for great high yield investment alternatives We asked three of our top healthcare contributors to weigh in on which dividend stocks were solid picks in the sector Their responses included a biotech AbbVie NYSE ABBV a real estate investment trust
TEVA,TEVA:US,BBG000C0CD58,3 High-Yield Investments in Healthcare,2017-03-14 11:02:00 +0000,http://www.fool.com/investing/2017/03/14/3-high-yield-investments-in-healthcare.aspx,3 High-Yield Investments in Healthcare
TEVA,TEVA:US,BBG000C0CD58,"Noteworthy ETF Inflows: EFA, NXPI, TEVA, CHKP",2017-03-13 16:08:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/alm_r59lA7s/noteworthy-etf-inflows-efa-nxpi-teva-chkp-cm759991,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 146 2 million dollar inflow that s a 0 2 increase week over week in outstanding
TEVA,TEVA:US,BBG000C0CD58,Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks,2017-03-13 15:18:39 +0000,http://www.insidermonkey.com/blog/billionaire-david-tepper-makes-huge-investments-in-these-4-drug-stocks-565903/,Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks
TEVA,TEVA:US,BBG000C0CD58,Teva to Present at the Barclays Global Annual Healthcare Conference,2017-03-13 15:00:00 +0000,http://finance.yahoo.com/news/teva-present-barclays-global-annual-150000872.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the Barclays Global Healthcare Conference in Miami, Florida."
TEVA,TEVA:US,BBG000C0CD58,"IEFA, FTXO: Big ETF Inflows",2017-03-11 00:15:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5kuXYsaBHNA/iefa-ftxo-big-etf-inflows-cm759457,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF IEFA which added 12 200 000 units or a 3 5 increase week over week Among the largest underlying components of IEFA in
TEVA,TEVA:US,BBG000C0CD58,"3 Value Stock Naked Puts to Make a Quick $1,000",2017-03-09 20:15:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uKLlleUyRBw/3-value-stock-naked-puts-to-make-a-quick-1000-cm758813,InvestorPlace Stock Market News Stock Advice amp Trading Tips I m mostly a value stock investor Value stocks offer greater returns over the long haul than growth stocks and there is a greater margin of error should you choose poorly One of the great things about value stocks and
TEVA,TEVA:US,BBG000C0CD58,Why Battered Biotech Teva Is a Smart Contrarian Buy Right Now,2017-03-09 17:00:00 +0000,https://www.thestreet.com/story/14033238/1/battered-biotech-teva-is-a-smart-contrarian-buy-now.html?puc=yahoo&cm_ven=YAHOO,Why Battered Biotech Teva Is a Smart Contrarian Buy Right Now
TEVA,TEVA:US,BBG000C0CD58,7 Cheap Dividend Stocks to Buy Now,2017-03-09 11:12:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nMMHq7oKVGI/7-cheap-dividend-stocks-to-buy-now-cm758300,InvestorPlace Stock Market News Stock Advice amp Trading Tips Finding cheap dividend stocks that are actually buy worthy is tough On the one hand you re looking for significant dividend yield On the other hand you d also like to invest in a business that s still growing And on
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is a Good Spec Buy,2017-03-08 20:12:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zwr74n8XdAc/teva-pharmaceutical-industries-ltd-adr-teva-is-a-good-spec-buy-cm758096,InvestorPlace Stock Market News Stock Advice amp Trading Tips Lately InvestorPlace writers have been busy pounding the table for the stock of Teva Pharmaceutical Industries Ltd ADR NYSE TEVA Source Open Grid Scheduler Modified Teva is based in Israel
TEVA,TEVA:US,BBG000C0CD58,The Tepper blitz on The Halftime Report,2017-03-08 18:52:00 +0000,http://finance.yahoo.com/video/tepper-blitz-halftime-report-185200631.html,The Tepper blitz on The Halftime Report
TEVA,TEVA:US,BBG000C0CD58,David Tepper's big bet in pharma,2017-03-08 12:50:00 +0000,http://finance.yahoo.com/video/david-teppers-big-bet-pharma-125000611.html,David Tepper's big bet in pharma
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma. To Present At Cowen Healthcare Conference;webcast At 9:20 AM ET,2017-03-08 08:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DhkaH6C4WAU/teva-pharma-to-present-at-cowen-healthcare-conferencewebcast-at-920-am-et-20170308-00503,Teva Pharma. To Present At Cowen Healthcare Conference;webcast At 9:20 AM ET
TEVA,TEVA:US,BBG000C0CD58,These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet,2017-03-07 21:25:44 +0000,http://www.investors.com/news/technology/supernus-valeant-endo-stocks-lose-big-after-trump-drug-pricing-tweet/?src=A00220A,These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet
TEVA,TEVA:US,BBG000C0CD58,TD Ameritrade's Investor Movement Index (IMX) For February 2017,2017-03-06 17:49:01 +0000,http://finance.yahoo.com/news/td-ameritrades-investor-movement-index-174901625.html,TD Ameritrade's Investor Movement Index (IMX) For February 2017
TEVA,TEVA:US,BBG000C0CD58,Teva to Present at the Cowen & Company 37th Annual Healthcare Conference,2017-03-06 15:56:00 +0000,http://finance.yahoo.com/news/teva-present-cowen-company-37th-155600567.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the Cowen & Company 37th Annual Healthcare Conference in Boston, MA."
TEVA,TEVA:US,BBG000C0CD58,3 Tempting Stocks to Avoid,2017-03-05 18:12:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bFXk3r5yAKM/3-tempting-stocks-to-avoid-cm756383,Stocks that appear to be ridiculously cheap based on various valuation metrics or potential market opportunities all too often turn out to be capital destroying sinkholes Fortunately with a little foresight these potential landmines can generally be avoided With this in
TEVA,TEVA:US,BBG000C0CD58,3 Tempting Stocks to Avoid,2017-03-05 16:41:00 +0000,http://www.fool.com/investing/2017/03/05/3-tempting-stocks-to-avoid.aspx,3 Tempting Stocks to Avoid
TEVA,TEVA:US,BBG000C0CD58,Perrigo Joins Firms With Generic Drugs Under U.S. Glare,2017-03-03 15:25:46 +0000,https://www.bloomberg.com/news/articles/2017-03-03/perrigo-joins-list-of-firms-with-generic-drugs-under-u-s-glare?cmpid=yhoo.headline,Perrigo Joins Firms With Generic Drugs Under U.S. Glare
TEVA,TEVA:US,BBG000C0CD58,Mylan's Governance May Be the Root of Its Problems,2017-03-03 11:00:00 +0000,https://www.thestreet.com/story/14025059/1/mylan-s-governance-may-be-the-root-of-its-problems.html?puc=yahoo&cm_ven=YAHOO,Mylan's Governance May Be the Root of Its Problems
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States",2017-03-02 18:15:12 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-teva-mylan-n-v-myl-accused-of-price-fixing-by-20-more-states-563298/,"Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States"
TEVA,TEVA:US,BBG000C0CD58,"IEFA, ISCF: Big ETF Inflows",2017-03-02 17:14:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4IL3gFxKrVc/iefa-iscf-big-etf-inflows-cm755476,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF which added 12 800 000 units or a 3 9 increase week over week Among the largest underlying components of IEFA in morning trading
TEVA,TEVA:US,BBG000C0CD58,"Notable ETF Outflow Detected - EFG, NXPI, CHKP, TEVA",2017-03-02 17:13:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vQRD0fAgfC0/notable-etf-outflow-detected-efg-nxpi-chkp-teva-cm755457,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE Growth ETF Symbol EFG where we have detected an approximate 54 1 million dollar outflow that s a 2 1 decrease week over week from 38 400
TEVA,TEVA:US,BBG000C0CD58,"Twenty More States Accuse Mylan, Teva and Others of Price Collusion",2017-03-01 21:53:00 +0000,https://www.thestreet.com/story/14022831/1/twenty-more-states-accuse-mylan-teva-and-others-of-price-collusion.html?puc=yahoo&cm_ven=YAHOO,"Twenty More States Accuse Mylan, Teva and Others of Price Collusion"
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Pristiq® in the United States,2017-03-01 15:56:00 +0000,http://finance.yahoo.com/news/teva-announces-launch-generic-pristiq-155600516.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced the launch of generic Pristiq®1 extended-release tablets, 25, 50 and 100 mg, in the U.S."
TEVA,TEVA:US,BBG000C0CD58,Priority Review Granted To Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Tardive Dyskinesia Drug,2017-03-01 15:10:49 +0000,http://www.insidermonkey.com/blog/priority-review-granted-to-teva-pharmaceutical-industries-ltd-adr-teva-tardive-dyskinesia-drug-563006/,Priority Review Granted To Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Tardive Dyskinesia Drug
TEVA,TEVA:US,BBG000C0CD58,"Teva Downgraded On Lost MS Drug Patents, DOJ Probe",2017-02-28 21:33:27 +0000,http://www.investors.com/news/technology/teva-plagued-by-problems-downgraded-on-lost-ms-drug-patents-doj-probe/,"Teva Downgraded On Lost MS Drug Patents, DOJ Probe"
TEVA,TEVA:US,BBG000C0CD58,Why Short Sellers Are Making a Massive Bet in Major Pharma,2017-02-28 13:55:54 +0000,http://finance.yahoo.com/news/why-short-sellers-making-massive-135554141.html,Why Short Sellers Are Making a Massive Bet in Major Pharma
TEVA,TEVA:US,BBG000C0CD58,"Drug Stocks Q4 Earnings Lineup for Mar 1: MYL, KERX & More",2017-02-28 13:51:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G_ZaqJbYxoY/drug-stocks-q4-earnings-lineup-for-mar-1-myl-kerx-more-cm754034,With the curtains almost down on the Q4 earnings season we believe this quarter has turned out to be a good one with growth on track to be the highest in the last two years As of Feb 17 2017 411 S amp P 500 members accounting for 88 4 of the index s total market capitalization have
TEVA,TEVA:US,BBG000C0CD58,FDA to expedite review of Teva drug for movement disorder,2017-02-28 13:35:02 +0000,http://finance.yahoo.com/news/fda-expedite-review-teva-drug-133502944.html,"[Reuters] - Israel-based Teva Pharmaceutical Industries said on Tuesday the U.S. Food and Drug Administration (FDA) has granted ""priority review"" for its SD-809 drug to treat tardive dyskinesia with a target date for approval by Aug. 30. A priority, or expedited, review allows for a faster evaluation of drug applications. Tardive dyskinesia, a condition for which there are no approved therapies in the United States, is a disorder characterised by repetitive and uncontrollable movements."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Priority Review Granted by FDA for SD-809 for Treatment of Tardive Dyskinesia,2017-02-28 13:00:00 +0000,http://finance.yahoo.com/news/teva-announces-priority-review-granted-130000375.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced the U.S. Food and Drug Administration has accepted the New Drug Application and granted Priority Review for SD-809 for the treatment of tardive dyskinesia .
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma downgraded by Argus,2017-02-28 12:58:24 +0000,http://finance.yahoo.com/q/ud?s=TEVA,Teva Pharma downgraded by Argus
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma: FDA Grants Priority Review For SD-809 - Quick Facts,2017-02-28 08:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UEQZgdvMhEI/teva-pharma-fda-grants-priority-review-for-sd809--quick-facts-20170228-00774,Teva Pharma: FDA Grants Priority Review For SD-809 - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals Industries Ltd (ADR) (TEVA): Be Cautious and Earn a Double-Digit Return,2017-02-27 21:50:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XOk2MfPqu4Y/teva-pharmaceuticals-industries-ltd-adr-teva-be-cautious-and-earn-a-double-digit-return-cm753860,InvestorPlace Stock Market News Stock Advice amp Trading Tips There s little doubt 2016 was a downer for Teva Pharmaceuticals Industries Ltd ADR NYSE TEVA shareholders Nevertheless there s reason to believe 2017 could be time to forgive and forget or at least give
TEVA,TEVA:US,BBG000C0CD58,"No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn’t Doomed",2017-02-27 21:50:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tc7pzab88pE/no-teva-pharmaceutical-industries-ltd-adr-teva-stock-isnt-doomed-cm753855,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pharmaceutical giant Teva Pharmaceutical Industries Ltd ADR NYSE TEVA got a much needed break this week Source Open Grid Scheduler Modified After being told in late January the company s patent protection
TEVA,TEVA:US,BBG000C0CD58,3 Surprising Big-Brand Stocks Billionaires Sold Heavily Last Quarter,2017-02-27 15:53:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nHHsO_XSYvY/3-surprising-big-brand-stocks-billionaires-sold-heavily-last-quarter-cm753524,We re a little more than a week removed from Valentine s Day which for investors had a completely different meaning than amore this year Feb 14 2017 was the deadline for institutional and hedge fund managers with more than 100 million in assets under management to complete and
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for February 28, 2017",2017-02-27 14:19:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CRgO1X5Zv5Y/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-february-28-2017-cm753442,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on February 28 2017 A cash dividend payment of 0 289 per share is scheduled to be paid on March 20 2017 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend payment
TEVA,TEVA:US,BBG000C0CD58,3 Surprising Big-Brand Stocks Billionaires Sold Heavily Last Quarter,2017-02-27 13:55:06 +0000,http://www.fool.com/investing/2017/02/27/3-surprising-big-brand-stocks-billionaires-sold-he.aspx,3 Surprising Big-Brand Stocks Billionaires Sold Heavily Last Quarter
TEVA,TEVA:US,BBG000C0CD58,These 3 Big Pharma Stocks Are Ridiculously Cheap,2017-02-27 12:57:12 +0000,http://www.fool.com/investing/2017/02/26/these-3-big-pharma-stocks-are-ridiculously-cheap.aspx,These 3 Big Pharma Stocks Are Ridiculously Cheap
TEVA,TEVA:US,BBG000C0CD58,These 3 Big Pharma Stocks Are Ridiculously Cheap,2017-02-26 13:49:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZmyjmEsisvk/these-3-big-pharma-stocks-are-ridiculously-cheap-cm753262,It s not the easiest of task to find large biopharmaceutical companies with stocks trading at low valuations But there are some relatively inexpensive alternatives out there Teva Pharmaceutical NYSE TEVA Mylan Pharmaceuticals NASDAQ MYL and Gilead
TEVA,TEVA:US,BBG000C0CD58,3 Cheap Healthcare Stocks You Can Buy Right Now,2017-02-24 20:01:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5wlR1l8pkGo/3-cheap-healthcare-stocks-you-can-buy-right-now-cm752950,Looking for some quality healthcare stocks trading at a discount Teva Pharmaceutical Industries Ltd ADR NYSE TEVA 160 and CVS Health Corp NYSE CVS are two highly profitable companies at the top of their respective industries but their shares have fallen into what
TEVA,TEVA:US,BBG000C0CD58,3 Cheap Healthcare Stocks You Can Buy Right Now,2017-02-24 17:57:13 +0000,http://www.fool.com/investing/2017/02/24/3-cheap-healthcare-stocks-you-can-buy-right-now.aspx,3 Cheap Healthcare Stocks You Can Buy Right Now
TEVA,TEVA:US,BBG000C0CD58,"Ex-Dividend Reminder: Teva Pharmaceutical Industries, First Financial Bancorp and FNB Corp",2017-02-24 16:52:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dQBm4exlBxc/ex-dividend-reminder-teva-pharmaceutical-industries-first-financial-bancorp-and-fnb-corp-cm752802,Looking at the universe of stocks we cover at Dividend Channel on 2 28 17 Teva Pharmaceutical Industries Ltd Symbol TEVA First Financial Bancorp Symbol FFBC and FNB Corp Symbol FNB will all trade ex dividend for their respective upcoming dividends Teva Pharmaceutical Industries
TEVA,TEVA:US,BBG000C0CD58,3 Stocks the Market Is Wrong About,2017-02-24 02:23:33 +0000,http://www.fool.com/investing/2017/02/23/3-stocks-the-market-is-wrong-about-2.aspx,3 Stocks the Market Is Wrong About
TEVA,TEVA:US,BBG000C0CD58,Teva Is Expected to See a Fall in Its Profit Margins in 2017,2017-02-23 22:06:29 +0000,http://marketrealist.com/2017/02/teva-pharmaceutical-expected-witness-drop-profit-margins-2017/?utm_source=yahoo&utm_medium=feed,Teva Is Expected to See a Fall in Its Profit Margins in 2017
TEVA,TEVA:US,BBG000C0CD58,Teva Is Expected to Witness a Modest Revenue Rise in 2017,2017-02-23 20:36:46 +0000,http://marketrealist.com/2017/02/teva-pharmaceutical-expected-witness-modest-rise-revenues-2017/?utm_source=yahoo&utm_medium=feed,Teva Is Expected to Witness a Modest Revenue Rise in 2017
TEVA,TEVA:US,BBG000C0CD58,What Analysts Recommend for Teva Pharmaceutical in 2017,2017-02-23 18:50:57 +0000,http://marketrealist.com/2017/02/analyst-recommendations-teva-pharmaceutical-2017/?utm_source=yahoo&utm_medium=feed,What Analysts Recommend for Teva Pharmaceutical in 2017
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap,2017-02-23 17:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJWUEwQ_m9A/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-crazy-cheap-cm752236,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA desperately needed some good news heading into its fourth quarter earnings report TEVA stock hit its lowest level in over a decade the week before after its
TEVA,TEVA:US,BBG000C0CD58,"Billionaire Andreas Halvorsen’s Viking Global Cuts Losses and Dumps Southwestern Energy and Teva Pharmaceutical, Still Bullish on Bank of America",2017-02-23 17:03:42 +0000,http://www.insidermonkey.com/blog/billionaire-andreas-halvorsens-viking-global-cuts-losses-and-dumps-southwestern-energy-and-teva-pharmaceutical-still-bullish-on-bank-of-america-561876/,"Billionaire Andreas Halvorsen’s Viking Global Cuts Losses and Dumps Southwestern Energy and Teva Pharmaceutical, Still Bullish on Bank of America"
TEVA,TEVA:US,BBG000C0CD58,3 Stocks the Market Is Wrong About,2017-02-23 16:53:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EfrT-D7krGQ/3-stocks-the-market-is-wrong-about-cm752077,Every time a stock jumps or crashes investors want to believe that the market is correctly pricing the stock That may not always be the case as the market s shortsightedness can sometimes push an undeserving stock into overbought territory or punish one that s worthy of more
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Fading Fast,2017-02-23 08:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/okoeyTjuOYg/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-fading-fast-cm751738,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has enjoyed a solid run during the past week with TEVA stock up more than 12 since Feb 10 A strong showing in the earnings
TEVA,TEVA:US,BBG000C0CD58,Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA),2017-02-22 19:02:19 +0000,http://www.insidermonkey.com/blog/manufacturing-delay-of-generic-drug-from-pfizer-inc-pfe-a-relief-for-teva-pharmaceutical-industries-ltd-adr-teva-561521/,Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
TEVA,TEVA:US,BBG000C0CD58,TEVA PHARMACEUTICAL INDUSTRIES LTD Financials,2017-02-22 18:04:20 +0000,http://finance.yahoo.com/q/is?s=teva&annual,TEVA PHARMACEUTICAL INDUSTRIES LTD Financials
TEVA,TEVA:US,BBG000C0CD58,"Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More",2017-02-22 15:12:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KcgF6FkWn34/drug-stocks-q4-earnings-slated-for-feb-23-bmrn-icpt-more-cm751080,The fourth quarter earnings season is drawing to a close with results from 411 S amp P 500 members or 82 2 of the index s total membership already out as of Feb 22 2017 according to the latest Earnings Preview report Total earnings for these 411 index members were up 8 from the year
TEVA,TEVA:US,BBG000C0CD58,"Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More",2017-02-22 13:29:01 +0000,http://finance.yahoo.com/news/drug-stocks-q4-earnings-slated-132901558.html,"Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More"
TEVA,TEVA:US,BBG000C0CD58,"Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today",2017-02-21 19:09:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FIwBBq3AWBs/why-momenta-pharmaceuticals-inc-shares-got-crushed-today-cm750788,What happened Momenta Pharmaceuticals NASDAQ MNTA 160 stock is down 15 4 at 11 50 a m EST Tuesday after the company announced on Friday after the closing bell that its three times weekly version of Glatopa is unlikely to be approved this quarter due to a manufacturing
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Looks Strong,2017-02-21 19:07:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bcv7XuqV3Qg/teva-pharmaceutical-industries-ltd-adr-teva-stock-still-looks-strong-cm750819,InvestorPlace Stock Market News Stock Advice amp Trading Tips I m a big fan of Israeli stocks First and foremost Israelis are essentially the world s most educated people You can t progress as a society unless rationality and science reigns and they have it in droves I also love
TEVA,TEVA:US,BBG000C0CD58,Prepare for the Twilio Inc (TWLO) Stock Bounce,2017-02-21 19:06:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Il_YwK7-Fgo/prepare-for-the-twilio-inc-twlo-stock-bounce-cm750805,InvestorPlace Stock Market News Stock Advice amp Trading Tips It seems I underestimated Twilio Inc NYSE TWLO when I last checked in on the stock in mid January ahead of earnings I set a target just shy of 30 per share for TWLO stock and the
TEVA,TEVA:US,BBG000C0CD58,"Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug",2017-02-21 17:37:27 +0000,http://www.investors.com/news/technology/momenta-pfizer-give-teva-pharma-breathing-room-on-generic-ms-drug/,"Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug"
TEVA,TEVA:US,BBG000C0CD58,"Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today",2017-02-21 17:26:26 +0000,http://www.fool.com/investing/2017/02/21/why-momenta-pharmaceuticals-inc-shares-got-crushed.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Momenta Pharmaceuticals, Inc. Shares Got Crushed Today"
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Get a Boost in Early Trading,2017-02-21 14:36:00 +0000,http://www.investopedia.com/news/teva-pops-early-trading-teva/?partner=YahooSA,Teva Shares Get a Boost in Early Trading
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Feb 21, 2017 :  UN, UL, TRVN, TEVA, KHC, VALE, AZN, WMT, ERIC, VOD, AAPL, TVIX",2017-02-21 13:52:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q9v2U5C0AcE/pre-market-most-active-for-feb-21-2017-un-ul-trvn-teva-khc-vale-azn-wmt-eric-vod-aapl-tvix-cm750362,The NASDAQ 100 Pre Market Indicator is up 18 34 to 5 343 06 The total Pre Market volume is currently 17 568 028 shares traded The following are the most active stocks for the pre market session Unilever NV UN is 4 03 at 44 76 with 2 292 899 shares traded following
TEVA,TEVA:US,BBG000C0CD58,Billionaire Value Investor Michael Price Adds Specialty Retailer and a REIT to Its 13F Portfolio,2017-02-20 21:40:01 +0000,http://www.insidermonkey.com/blog/billionaire-value-investor-michael-price-adds-specialty-retailer-and-a-reit-to-its-13f-portfolio-560797/,Billionaire Value Investor Michael Price Adds Specialty Retailer and a REIT to Its 13F Portfolio
TEVA,TEVA:US,BBG000C0CD58,3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter,2017-02-20 14:54:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mBuvdy6qDvo/3-top-drug-stocks-that-can-be-purchased-on-the-cheap-this-winter-cm750193,Drug stocks have been a volatile group since the beginning of 2016 with many selling off and still more than a year later struggling to recover what they lost Meanwhile the broad based S amp P 500 has moved substantially higher It s not hard to understand why investors view
TEVA,TEVA:US,BBG000C0CD58,"Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS",2017-02-20 13:52:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HZDGy-X13Nw/drug-stocks-q4-earnings-lineup-for-feb-21-irwd-mnta-exas-cm750167,As the Q4 earnings season enters the last leg we believe this quarter is on track to witness the highest growth momentum in the last two years As of Feb 17 2017 411 S amp P 500 members accounting for 88 4 of the index s total market capitalization have reported results according to
TEVA,TEVA:US,BBG000C0CD58,3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter,2017-02-20 13:24:10 +0000,http://www.fool.com/investing/2017/02/20/3-top-drug-stocks-that-can-be-purchased-on-the-che.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter
TEVA,TEVA:US,BBG000C0CD58,This Keeps Driving Sanofi’s Growth,2017-02-20 12:37:20 +0000,http://marketrealist.com/2017/02/this-keeps-driving-sanofis-growth/?utm_source=yahoo&utm_medium=feed,This Keeps Driving Sanofi’s Growth
TEVA,TEVA:US,BBG000C0CD58,Qorvo Inc (QRVO) Stock Prone to Air Pockets But Worth the Wait,2017-02-17 21:53:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TKemXJN92_8/qorvo-inc-qrvo-stock-prone-to-air-pockets-but-worth-the-wait-cm749881,InvestorPlace Stock Market News Stock Advice amp Trading Tips Qorvo Inc NASDAQ QRVO is a longtime favorite stock of mine I ve talked about it on my show Making Money with Charles Payne many times dating all the way back to when it was RF
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is Turning Around,2017-02-17 20:54:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H-QVWdYjaQ8/teva-pharmaceutical-industries-ltd-adr-teva-is-turning-around-cm749851,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR 160 NYSE TEVA has been dealing with a lot challenges over the past 12 18 months Source Open Grid Scheduler Modified It has been trying to incorporate its
TEVA,TEVA:US,BBG000C0CD58,"If You're in Your 30s, Consider Buying These Stocks",2017-02-17 16:54:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T_Lwp-3NVeg/if-youre-in-your-30s-consider-buying-these-stocks-cm749661,Investors in their 30s have several 160 decades ahead of them before they reach retirement age which gives them a huge advantage over older investors For that reason they shouldn t shy away from adding a few high risk growth stocks to their portfolios Knowing that we asked
TEVA,TEVA:US,BBG000C0CD58,Amgen Is Managing the Life Cycle of Its Mature Nephrology Drugs in 2017,2017-02-17 15:36:59 +0000,http://marketrealist.com/2017/02/amgen-effectively-managing-lifecycle-mature-nephrology-drugs-2017/?utm_source=yahoo&utm_medium=feed,Amgen Is Managing the Life Cycle of Its Mature Nephrology Drugs in 2017
TEVA,TEVA:US,BBG000C0CD58,"If You're in Your 30s, Consider Buying These Stocks",2017-02-17 15:35:05 +0000,http://www.fool.com/investing/2017/02/17/if-youre-in-your-30s-consider-buying-these-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"If You're in Your 30s, Consider Buying These Stocks"
TEVA,TEVA:US,BBG000C0CD58,Parsabiv Is Expected to Boost Amgen’s Revenues in 2017,2017-02-17 14:07:12 +0000,http://marketrealist.com/2017/02/parsabiv-expected-boost-amgens-revenues-2017/?utm_source=yahoo&utm_medium=feed,Parsabiv Is Expected to Boost Amgen’s Revenues in 2017
TEVA,TEVA:US,BBG000C0CD58,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks,2017-02-16 23:55:26 +0000,http://www.fool.com/investing/2017/02/16/why-this-billionaire-just-shelled-out-11-billion-o.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
TEVA,TEVA:US,BBG000C0CD58,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks,2017-02-16 21:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cLW2Vs0vmNU/why-this-billionaire-just-shelled-out-11-billion-on-4-drug-stocks-cm749190,A billion here a billion there and pretty soon you re talking about real money It s debatable who first uttered that phrase What isn t debatable though is that David Tepper and Appaloosa Management are accustomed to throwing around plenty of real money The multi billion
TEVA,TEVA:US,BBG000C0CD58,David Tepper Invests Heavily in Pharma in 4th Quarter,2017-02-16 17:06:55 +0000,http://finance.yahoo.com/news/david-tepper-invests-heavily-pharma-170655363.html,David Tepper Invests Heavily in Pharma in 4th Quarter
TEVA,TEVA:US,BBG000C0CD58,What's Driving Lilly's (LLY) Shares after 2016 Decline?,2017-02-16 16:57:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EmzsWHW3tFw/whats-driving-lillys-lly-shares-after-2016-decline-cm748996,After a rather difficult 2016 share price of pharma giant Eli Lilly amp Company LLY has picked up in 2017 What Hurt Shares in 2016 In 2016 Lilly s shares were hurt due to soft earnings and some negative pipeline updates including the failure of its high profile
TEVA,TEVA:US,BBG000C0CD58,Allergan's Roll-Up Is Not Breaking Even (SEC Letter Response),2017-02-16 16:55:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kjVip28BQj8/allergans-roll-up-is-not-breaking-even-sec-letter-response-cm748857,By SigmaCap BySigmaCap On February 13 The Wall Street Journal broke news of a recent letter from the SEC to Allergan AGN highlighting its concerns about AGN s non GAAP earnings practices This letter corroborates my concerns about AGN s approach In its earnings AGN excludes
TEVA,TEVA:US,BBG000C0CD58,"Polaris Capital Management, LLC Buys Verint Systems, Web. ...",2017-02-16 15:53:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t9dfejzHr8c/polaris-capital-management-llc-buys-verint-systems-web-cm748941,Polaris Capital Management LLC Added Positions VRNT WEB WBS JPM MPC INDB ALE COF IBOC ANTM Reduced Positions VZ BBL SBRCY OKSB RH SWFT GBX MEOH Sold Out HPQ FRP IMAX TREX TPC PZZA BDN HT CATM IGT Added Positions
TEVA,TEVA:US,BBG000C0CD58,What's Driving Lilly's (LLY) Shares after 2016 Decline?,2017-02-16 14:31:02 +0000,http://finance.yahoo.com/news/whats-driving-lillys-lly-shares-143102361.html,What's Driving Lilly's (LLY) Shares after 2016 Decline?
TEVA,TEVA:US,BBG000C0CD58,Multinationals learn the limits of being big,2017-02-16 08:25:01 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=8FC807FE-F3BB-11E6-A916-C2E7F0B39F6D&siteid=yhoof2,Multinationals learn the limits of being big
TEVA,TEVA:US,BBG000C0CD58,Teva Files 2016 Annual Report on Form 20-F,2017-02-15 23:10:00 +0000,http://finance.yahoo.com/news/teva-files-2016-annual-report-231000563.html,"[Business Wire] - In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva Pharmaceutical Industries Ltd. announced today that it has filed its 2016 Annual Report on Form 20-F with the U.S."
TEVA,TEVA:US,BBG000C0CD58,"Acorda Must Stave Off Mylan, Teva Generics To Protect Ampyra: RBC",2017-02-15 21:45:00 +0000,http://www.investors.com/news/technology/acorda-must-stave-off-mylan-teva-generics-to-protect-ampyra-rbc/,"Acorda Must Stave Off Mylan, Teva Generics To Protect Ampyra: RBC"
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: 2016 By the Numbers : February 15, 2017",2017-02-15 17:35:01 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-us-earnings-analysis-2016-by-the-numbers-february-15-2017/,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: 2016 By the Numbers : February 15, 2017"
TEVA,TEVA:US,BBG000C0CD58,Some of biotech's biggest names have acquired this Md. company,2017-02-14 20:10:20 +0000,http://www.bizjournals.com/washington/news/2017/02/14/roivant-sciences.html?ana=yahoo,Some of biotech's biggest names have acquired this Md. company
TEVA,TEVA:US,BBG000C0CD58,"Company News for February 14, 2017",2017-02-14 17:20:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zBylkROh1z0/company-news-for-february-14-2017-cm747720,Shares of Apple AAPL gained 0 9 160 to end at a record level of 133 29 after Goldman Sachs Group Inc GS increased its target price for the stock Verizon Communications Inc VZ shares declined 0 9 after the largest wireless carrier in the U S recommenced the sale
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance",2017-02-14 15:22:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZYais-jvJ_I/teva-teva-tops-on-q4-earnings-maintains-2017-guidance-cm747557,Teva Pharmaceutical Industries Ltd TEVA reported fourth quarter 2016 earnings of 1 34 per share including equity compensation expenses which beat the Zacks Consensus Estimate of 1 28 Excluding stock based compensation expenses earnings were 1 38 per share up 7 8 year over
TEVA,TEVA:US,BBG000C0CD58,"Company News for February 14, 2017",2017-02-14 15:10:03 +0000,http://finance.yahoo.com/news/company-news-february-14-2017-151003154.html,"Company News for February 14, 2017"
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 14, 2017",2017-02-14 14:45:17 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-us-earnings-analysis-q4-2016-by-the-numbers-february-14-2017/,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q4, 2016 By the Numbers : February 14, 2017"
TEVA,TEVA:US,BBG000C0CD58,Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan,2017-02-14 14:45:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-144500824.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 14, 2017 / Promises of a ""phenomenal"" tax plan by President Trump continued to push markets to new record highs on Monday. The Dow Jones industrial Average ..."
TEVA,TEVA:US,BBG000C0CD58,"Top Analyst Upgrades and Downgrades: Intuitive Surgical, Restaurant Brands, Scorpio Tankers, Teva, Under Armour, Zillow and Many More",2017-02-14 13:55:47 +0000,http://finance.yahoo.com/news/top-analyst-upgrades-downgrades-intuitive-135547669.html,"Top Analyst Upgrades and Downgrades: Intuitive Surgical, Restaurant Brands, Scorpio Tankers, Teva, Under Armour, Zillow and Many More"
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance",2017-02-14 13:20:01 +0000,http://finance.yahoo.com/news/teva-teva-tops-q4-earnings-132001714.html,"Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance"
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Swings to Loss on Write-Down But Beats Expectations,2017-02-14 05:42:18 +0000,https://www.wsj.com/articles/teva-swings-to-loss-on-write-downs-but-beats-expectations-1486991412?ru=yahoo?mod=yahoo_itp,[$$] Teva Swings to Loss on Write-Down But Beats Expectations
TEVA,TEVA:US,BBG000C0CD58,9 Top Pharmaceutical Stocks to Buy for the Dividends,2017-02-14 04:17:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vOX7JeqtEYM/9-top-pharmaceutical-stocks-to-buy-for-the-dividends-cm747392,InvestorPlace Stock Market News Stock Advice amp Trading Tips When investors are on the hunt for income driving dividend stocks they often gravitate toward utilities or consumer staples names And well they should Those businesses are essentially recession proof so the income in
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal,2017-02-14 04:17:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r66XKcWpZ8k/teva-pharmaceutical-industries-ltd-reports-q4-improvement-thanks-to-actavis-deal-cm747384,Teva Pharmaceutical Industries NYSE TEVA hasn t had much good news lately Shares of the Israel based drugmaker were hit hard in the second half of 2016 However the company had a chance to report good news with the announcement of its fourth quarter and full year 2016
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal,2017-02-14 03:40:51 +0000,http://www.fool.com/investing/2017/02/13/teva-pharmaceutical-industries-ltd-reports-q4-impr.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal
TEVA,TEVA:US,BBG000C0CD58,Mid-Afternoon Market Update: Dow Rises 150 Points; Zeltiq Aesthetics Shares Surge Following Acquisition News,2017-02-13 21:19:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Af9mHymCRIo/mid-afternoon-market-update-dow-rises-150-points-zeltiq-aesthetics-shares-surge-following-acquisition-news-cm747281,Toward the end of trading Monday the Dow traded up 0 76 percent to 20 423 25 while the NASDAQ gained 0 57 percent to 5 766 58 The S amp P also rose gaining 0 56 percent to 2 329 09 Leading and Lagging Sectors Basic materials shares climbed by 1 29 percent in trading on
TEVA,TEVA:US,BBG000C0CD58,Teva Maintains 2017 Guidance Despite Copaxone Patent Losses; Q4 Tops,2017-02-13 21:01:38 +0000,http://www.investors.com/news/technology/teva-maintains-2017-guidance-despite-copaxone-patent-losses-q4-tops/,Teva Maintains 2017 Guidance Despite Copaxone Patent Losses; Q4 Tops
TEVA,TEVA:US,BBG000C0CD58,Troubling Trends Seen in Teva's FY16 Results,2017-02-13 19:53:00 +0000,http://www.investopedia.com/articles/investing/021317/teva-reports-full-year-and-fourth-quarter-results-teva.asp?partner=YahooSA,Troubling Trends Seen in Teva's FY16 Results
TEVA,TEVA:US,BBG000C0CD58,3 Bargain-Bin High-Yield Dividend Stocks You've Overlooked This Winter,2017-02-13 19:19:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H33Xk4sQh1I/3-bargain-bin-high-yield-dividend-stocks-youve-overlooked-this-winter-cm747207,Regardless of how well or poorly the stock market is performing one thing is for certain Dividend stocks are always in style I ve often said that dividend stocks are the foundation of a great retirement portfolio and for good reason For starters companies that pay
TEVA,TEVA:US,BBG000C0CD58,"3 Stocks to Watch on Monday: Tesla Inc (TSLA), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Verizon Communications Inc. (VZ)",2017-02-13 19:18:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0qKFl5xBp0E/3-stocks-to-watch-on-monday-tesla-inc-tsla-teva-pharmaceutical-industries-ltd-adr-teva-and-verizon-communications-inc-vz-cm747253,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The earnings calendar is slowly thinning out with just a couple more weeks of heavy reporting before we reach the unofficial offseason Still there s plenty out there to move the
TEVA,TEVA:US,BBG000C0CD58,"How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More",2017-02-13 18:26:00 +0000,https://www.thestreet.com/story/13999935/1/how-to-trade-monday-s-most-active-stocks-bofa-vale-zeltiq-teva-and-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More"
TEVA,TEVA:US,BBG000C0CD58,3 Bargain-Bin High-Yield Dividend Stocks You've Overlooked This Winter,2017-02-13 18:02:06 +0000,http://www.fool.com/retirement/2017/02/13/3-bargain-bin-high-yield-dividend-stocks-youve-ove.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Bargain-Bin High-Yield Dividend Stocks You've Overlooked This Winter
TEVA,TEVA:US,BBG000C0CD58,Teva Tries Out 'Alternative Guidance',2017-02-13 17:37:08 +0000,http://www.bloomberg.com/gadfly/articles/2017-02-13/teva-earnings-trying-out-alternative-guidance?cmpid=yhoo.headline,Teva Tries Out 'Alternative Guidance'
TEVA,TEVA:US,BBG000C0CD58,Markets Climb Amid Solid Q4 Earnings,2017-02-13 17:17:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LAJ5ggLOhRk/markets-climb-amid-solid-q4-earnings-cm747070,Monday February 13 2017 Q4 earnings season even performed better than analysts had hoped for Of course we re not completely through the entire cycle retailers have yet to report en masse and we see industry leaders like Cisco CSCO Pepsi PEP and AIG AIG on the docket for this
TEVA,TEVA:US,BBG000C0CD58,Mid-Morning Market Update: Markets Open Higher; Teva Tops Q4 Estimates,2017-02-13 16:47:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B62vx8OUoYQ/mid-morning-market-update-markets-open-higher-teva-tops-q4-estimates-cm747146,Following the market opening Monday the Dow traded up 0 50 percent to 20 371 05 while the NASDAQ gained 0 48 percent to 5 761 38 The S amp P also rose gaining 0 42 percent to 2 325 74 Leading and Lagging Sectors Basic materials shares climbed by 1 15 percent in trading on
TEVA,TEVA:US,BBG000C0CD58,Teva Said to Consider Options for Branded Generics Unit,2017-02-13 16:35:21 +0000,http://www.bloomberg.com/news/articles/2017-02-13/teva-said-to-weigh-options-for-branded-generics-to-reduce-debt?cmpid=yhoo.headline,Teva Said to Consider Options for Branded Generics Unit
TEVA,TEVA:US,BBG000C0CD58,Teva Said to Weigh Options for Branded Generics to Reduce Debt,2017-02-13 16:35:21 +0000,http://finance.yahoo.com/news/teva-said-weigh-options-branded-163521581.html,Teva Said to Weigh Options for Branded Generics to Reduce Debt
TEVA,TEVA:US,BBG000C0CD58,Analysts See 18% Gains Ahead For The Holdings of PPH,2017-02-13 16:20:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GYPOvYrPr44/analysts-see-18-gains-ahead-for-the-holdings-of-pph-cm746963,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
TEVA,TEVA:US,BBG000C0CD58,Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq,2017-02-13 16:11:00 +0000,https://www.thestreet.com/story/13999813/1/allergan-in-2-5b-deal-for-body-sculptor-zeltiq.html?puc=yahoo&cm_ven=YAHOO,Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
TEVA,TEVA:US,BBG000C0CD58,Teva Faces Uncertainty,2017-02-13 16:00:00 +0000,http://finance.yahoo.com/news/teva-faces-uncertainty-160000524.html,Teva Faces Uncertainty
TEVA,TEVA:US,BBG000C0CD58,Teva seeks CEO with pharma background to lead recovery efforts,2017-02-13 15:36:04 +0000,http://sg.finance.yahoo.com/news/teva-pharma-fourth-quarter-profit-121328169.html,Teva seeks CEO with pharma background to lead recovery efforts
TEVA,TEVA:US,BBG000C0CD58,Markets Climb Amid Solid Q4 Earnings,2017-02-13 15:27:03 +0000,http://finance.yahoo.com/news/markets-climb-amid-solid-q4-152703555.html,Markets Climb Amid Solid Q4 Earnings
TEVA,TEVA:US,BBG000C0CD58,"Teva Climbs On Upbeat Q4 Earnings, Reaffirmed Guidance",2017-02-13 15:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/13/teva-climbs-on-upbeat-q4-earnings-reaffirmed-guidance/?mod=yahoobarrons&ru=yahoo,"Teva Climbs On Upbeat Q4 Earnings, Reaffirmed Guidance"
TEVA,TEVA:US,BBG000C0CD58,"Teva Claws Its Way Back With Earnings, Revenue Beat",2017-02-13 15:02:00 +0000,https://www.thestreet.com/story/13999649/1/teva-claws-its-way-back-with-earnings-revenue-beat.html?puc=yahoo&cm_ven=YAHOO,"Teva Claws Its Way Back With Earnings, Revenue Beat"
TEVA,TEVA:US,BBG000C0CD58,"Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters",2017-02-13 14:39:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/13/morning-movers-verizon-falls-teva-jumps-hain-celestial-craters/?mod=yahoobarrons&ru=yahoo,"Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters"
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA) Tops Q4 Earnings & Sales Estimates; Shares Up,2017-02-13 14:17:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5jAn7xZoIww/teva-teva-tops-q4-earnings-sales-estimates-shares-up-cm746916,Israel based Teva Pharmaceutical Industries Ltd TEVA is a global pharmaceutical company with a strong presence in the generics as well as branded markets Teva s main branded products include Copaxone multiple sclerosis and Azilect Parkinson s disease Besides this Teva s branded
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Feb 13, 2017 :  TEVA, CLF, VALE, IMMU, ZLTQ, MT, FCX, RIO, TVIX, AAPL, QQQ, ERIC",2017-02-13 13:57:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7yHUR5ej_UQ/pre-market-most-active-for-feb-13-2017-teva-clf-vale-immu-zltq-mt-fcx-rio-tvix-aapl-qqq-eric-cm746880,The NASDAQ 100 Pre Market Indicator is up 10 32 to 5 237 01 The total Pre Market volume is currently 8 369 971 shares traded The following are the most active stocks for the pre market session Teva Pharmaceutical Industries Limited TEVA is 1 26 at 33 45 with 1 359
TEVA,TEVA:US,BBG000C0CD58,"[$$] Teva Swings to Loss, But Beats Expectations",2017-02-13 13:53:52 +0000,https://www.wsj.com/articles/teva-swings-to-loss-on-write-downs-but-beats-expectations-1486991412?mod=yahoo_hs,"[$$] Teva Swings to Loss, But Beats Expectations"
TEVA,TEVA:US,BBG000C0CD58,"Teva Gets Actavis Boost, Q4 Results Top Estimates",2017-02-13 13:44:38 +0000,http://finance.yahoo.com/news/teva-gets-actavis-boost-q4-134438505.html,"Teva Gets Actavis Boost, Q4 Results Top Estimates"
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA) Tops Q4 Earnings & Sales Estimates; Shares Up,2017-02-13 13:34:01 +0000,http://finance.yahoo.com/news/teva-teva-tops-q4-earnings-133401966.html,Teva (TEVA) Tops Q4 Earnings & Sales Estimates; Shares Up
TEVA,TEVA:US,BBG000C0CD58,How Rosy Is the Outlook for Teva Pharmaceutical?,2017-02-13 12:55:23 +0000,http://finance.yahoo.com/news/rosy-outlook-teva-pharmaceutical-125523823.html,How Rosy Is the Outlook for Teva Pharmaceutical?
TEVA,TEVA:US,BBG000C0CD58,Market Recon: The Foundation Is Laid to Support This Rally,2017-02-13 12:17:00 +0000,https://www.thestreet.com/story/13999224/1/market-recon-the-foundation-is-laid-to-support-this-rally.html?puc=yahoo&cm_ven=YAHOO,Market Recon: The Foundation Is Laid to Support This Rally
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm Q4 profit, revenue beat expectations",2017-02-13 12:02:52 +0000,http://finance.yahoo.com/news/teva-pharm-q4-profit-revenue-120252612.html,[Reuters] - Teva Pharmaceutical Industries reported better-than- expected fourth-quarter profit as sales were boosted by its $40.5 billion acquisition of Allergan's Actavis generic drug business on Aug. 2. Israel-based ...
TEVA,TEVA:US,BBG000C0CD58,Teva Reports Full Year and Fourth Quarter 2016 Financial Results,2017-02-13 11:42:00 +0000,http://finance.yahoo.com/news/teva-reports-full-fourth-quarter-114200178.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. today reported results for the year and the quarter ended December 31, 2016."
TEVA,TEVA:US,BBG000C0CD58,U.S. stocks on pace to continue their run of records,2017-02-13 10:45:29 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1C35C6FC-F1CF-11E6-9546-7567D09D9D1E&siteid=yhoof2,U.S. stocks on pace to continue their run of records
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Q4 Profit Beats Estimates; Reaffirms 2017 Non-GAAP Guidance,2017-02-13 07:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FuZHIAkbGJQ/teva-pharma-q4-profit-beats-estimates-reaffirms-2017-nongaap-guidance-20170213-00348,Teva Pharma Q4 Profit Beats Estimates; Reaffirms 2017 Non-GAAP Guidance
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Q4 16 Earnings Conference Call At 8:00 AM ET,2017-02-13 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IJRLR9xR9JI/teva-pharmaceutical-industries-q4-16-earnings-conference-call-at-800-am-et-20170213-00326,Teva Pharmaceutical Industries Q4 16 Earnings Conference Call At 8:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Limited Profit Advances 30% In Q4,2017-02-13 06:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ypsy1fIucYc/teva-pharmaceutical-industries-limited-profit-advances-30-in-q4-20170213-00256,Teva Pharmaceutical Industries Limited Profit Advances 30% In Q4
TEVA,TEVA:US,BBG000C0CD58,Earnings Preview: What To Expect From Teva Pharmaceutical On Monday,2017-02-11 13:24:00 +0000,http://www.forbes.com/sites/adamsarhan/2017/02/11/earnings-preview-what-to-expect-from-teva-pharmaceutical-on-monday/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Earnings Preview: What To Expect From Teva Pharmaceutical On Monday
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Will the Slump End?,2017-02-11 00:17:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RrWtt2xIKGc/teva-pharmaceutical-industries-ltd-adr-teva-stock-will-the-slump-end-cm746621,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Value investors are familiar with pain They endure pain when the stock hits a low then falls some more The markets are hammering 160 Teva Pharmaceutical Industries Ltd ADR NYSE TEVA because it
TEVA,TEVA:US,BBG000C0CD58,Cramer’s game plan: Spotting the perfect combination for ...,2017-02-10 23:52:00 +0000,http://finance.yahoo.com/video/cramer-game-plan-spotting-perfect-235200183.html,Cramer’s game plan: Spotting the perfect combination for ...
TEVA,TEVA:US,BBG000C0CD58,[video]Game Plan for the Week Ahead: Cramer's 'Mad Money' Recap (Friday 2/10/17),2017-02-10 23:42:00 +0000,https://www.thestreet.com/story/13998649/1/game-plan-for-the-week-ahead-cramer-s-mad-money-recap-friday-2-10-17.html?puc=yahoo&cm_ven=YAHOO,[video]Game Plan for the Week Ahead: Cramer's 'Mad Money' Recap (Friday 2/10/17)
TEVA,TEVA:US,BBG000C0CD58,iShares MSCI EAFE ETF Experiences Big Inflow,2017-02-10 17:17:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pLKqsNynIfM/ishares-msci-eafe-etf-experiences-big-inflow-cm746343,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 214 9 million dollar inflow that s a 0 3 increase week over week in outstanding
TEVA,TEVA:US,BBG000C0CD58,Is More Downside Ahead For Teva Pharmaceutical?,2017-02-10 17:00:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/10/is-more-downside-ahead-for-teva-pharmaceutical/?mod=yahoobarrons&ru=yahoo,Is More Downside Ahead For Teva Pharmaceutical?
TEVA,TEVA:US,BBG000C0CD58,Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?,2017-02-10 13:35:53 +0000,http://finance.yahoo.com/news/short-sellers-doubting-trump-hiking-133553363.html,Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi",2017-02-10 11:44:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-allergan-gsk-114411776.html,"Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi"
TEVA,TEVA:US,BBG000C0CD58,Bartosiak: Trading Teva Pharmaceutical's (TEVA) Earnings with Options,2017-02-09 04:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OGuAp8zhNfo/bartosiak-trading-teva-pharmaceuticals-teva-earnings-with-options-cm745253,On Monday February 13th Teva Pharmaceutical TEVA 160 will release its fourth quarter earnings results after the bell The company is a Zacks Rank 4 Sell and have a Value Growth and Momentum score of C Dave will look at Teva Pharmaceutical past earnings looks at what is currently
TEVA,TEVA:US,BBG000C0CD58,Bartosiak: Trading Teva Pharmaceutical's (TEVA) Earnings with Options,2017-02-09 02:13:02 +0000,http://finance.yahoo.com/news/bartosiak-trading-teva-pharmaceuticals-teva-021302694.html,Bartosiak: Trading Teva Pharmaceutical's (TEVA) Earnings with Options
TEVA,TEVA:US,BBG000C0CD58,"Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club",2017-02-08 21:08:04 +0000,http://finance.yahoo.com/news/gilead-sciences-fitbit-plunge-wednesday-210804910.html,"Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva under police investigation in home market of Israel,2017-02-08 18:21:35 +0000,"http://www.ft.com/cms/s/70b24da4-ee14-11e6-930f-061b01e23655,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Teva Pharmaceuticals, the world's biggest maker of generic drugs, said on Wednesday that it was being investigated by Israeli police in connection with a bribery case it settled with US authorities last ..."
TEVA,TEVA:US,BBG000C0CD58,Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat,2017-02-08 17:22:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a64GforZF5Y/allergan-agn-tops-q4-earnings-2017-sales-view-upbeat-cm744964,Allergan plc s AGN fourth quarter 2016 earnings came in at 3 90 per share beating the Zacks Consensus Estimate of 3 79 by 2 9 Earnings also soared 16 1 year over year and 17 5 sequentially on the back of strong revenues FindTheCompany Graphiq Revenues came in
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA) Q4 Earnings: What's in Store for the Stock?,2017-02-08 15:21:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0HOHTC-kiDs/teva-teva-q4-earnings-whats-in-store-for-the-stock-cm744860,Teva Pharmaceutical Industries Ltd TEVA will be reporting fourth quarter 2016 and full year earnings on Feb 13 before the market opens Last quarter the company delivered in line earnings This generic drug maker s shares have lost 11 3 so far this year while the Zacks classified
TEVA,TEVA:US,BBG000C0CD58,"After Copaxone, Is Teva's Future Bleak?",2017-02-08 15:20:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZqLXjkQBxSg/after-copaxone-is-tevas-future-bleak-cm744769,Teva Pharmaceutical NYSE TEVA has its hands full Its peers are challenging patents protecting its best selling drug Copaxone and that puts billions of dollars at risk However Teva Pharmaceutical s shares may already be pricing in a lot of that bad news and there could be
TEVA,TEVA:US,BBG000C0CD58,Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat,2017-02-08 14:57:02 +0000,http://finance.yahoo.com/news/allergan-agn-tops-q4-earnings-145702292.html,Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat
TEVA,TEVA:US,BBG000C0CD58,[$$] Darkest Before the Dawn at Teva,2017-02-08 14:08:18 +0000,https://www.wsj.com/articles/darkest-before-the-dawn-at-teva-1486485532?mod=yahoo_hs,[$$] Darkest Before the Dawn at Teva
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA) Q4 Earnings: What's in Store for the Stock?,2017-02-08 13:59:01 +0000,http://finance.yahoo.com/news/teva-teva-q4-earnings-whats-135901699.html,Teva (TEVA) Q4 Earnings: What's in Store for the Stock?
TEVA,TEVA:US,BBG000C0CD58,"After Copaxone, Is Teva's Future Bleak?",2017-02-08 13:23:59 +0000,http://www.fool.com/investing/2017/02/08/after-copaxone-is-tevas-future-bleak.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"After Copaxone, Is Teva's Future Bleak?"
TEVA,TEVA:US,BBG000C0CD58,Drugmaker Teva says Israel probing kickback allegations,2017-02-08 13:15:20 +0000,http://uk.finance.yahoo.com/news/drugmaker-teva-says-israel-probing-131520771.html,Drugmaker Teva says Israel probing kickback allegations
TEVA,TEVA:US,BBG000C0CD58,[$$] Darkest Before the Dawn at Teva,2017-02-08 06:00:59 +0000,https://www.wsj.com/articles/darkest-before-the-dawn-at-teva-1486485532?ru=yahoo?mod=yahoo_itp,[$$] Darkest Before the Dawn at Teva
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical CEO Erez Vigodman Departs,2017-02-07 22:45:03 +0000,http://www.investopedia.com/stock-analysis/020717/teva-pharmaceutical-ceo-erez-vigodman-departs.aspx?partner=YahooSA,Teva Pharmaceutical CEO Erez Vigodman Departs
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Decline After Company's CEO Exits,2017-02-07 22:32:00 +0000,https://www.thestreet.com/story/13993673/1/teva-shares-decline-after-company-s-ceo-exits.html?puc=yahoo&cm_ven=YAHOO,Teva Shares Decline After Company's CEO Exits
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Falls on CEO Departure,2017-02-07 22:17:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GlE5Amot9is/teva-pharmaceutical-industries-ltd-adr-teva-stock-falls-on-ceo-departure-cm744556,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock was down Tuesday on news that CEO 160 Erez Vigodman is leaving the company Source Open Grid Scheduler Modified Teva
TEVA,TEVA:US,BBG000C0CD58,"After Hours Most Active for Feb 7, 2017 :  BAC, FCX, GILD, SCOR, GE, MSFT, QQQ, TEVA, HBAN, T, TWLO, MTCH",2017-02-07 21:57:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HZgKxz7MvAU/after-hours-most-active-for-feb-7-2017-bac-fcx-gild-scor-ge-msft-qqq-teva-hban-t-twlo-mtch-cm744538,The NASDAQ 100 After Hours Indicator is down 4 03 to 5 181 85 The total After hours volume is currently 31 756 338 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is unchanged at 22 90 with 11 774
TEVA,TEVA:US,BBG000C0CD58,Teva shares plummet amid CEO departure and bribery reports,2017-02-07 21:53:06 +0000,http://www.cnbc.com/id/104267355?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104267355,Teva shares plummet amid CEO departure and bribery reports
TEVA,TEVA:US,BBG000C0CD58,Levin: Immigration fears will inhibit the 'best of the be...,2017-02-07 21:50:00 +0000,http://finance.yahoo.com/video/levin-immigration-fears-inhibit-best-215000958.html,Levin: Immigration fears will inhibit the 'best of the be...
TEVA,TEVA:US,BBG000C0CD58,"Teva, Kors Stagger into Tuesday’s 52-Week Low Club",2017-02-07 21:09:01 +0000,http://finance.yahoo.com/news/teva-kors-stagger-tuesday-52-210901533.html,"Teva, Kors Stagger into Tuesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,"Teva CEO Steps Down After Patent Losses, Bribery Settlement; Stock Dives",2017-02-07 21:01:32 +0000,http://www.investors.com/news/technology/teva-ceo-steps-down-after-patent-losses-bribery-settlement-stock-dives/,"Teva CEO Steps Down After Patent Losses, Bribery Settlement; Stock Dives"
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical: 'Short-Term CEO Lease Program Continues in Earnest',2017-02-07 20:29:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/07/teva-pharmaceutical-short-term-ceo-lease-program-continues-in-earnest/?mod=yahoobarrons&ru=yahoo,Teva Pharmaceutical: 'Short-Term CEO Lease Program Continues in Earnest'
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceuticals Industries Just Lost $1.5 Billion In Market Value,2017-02-07 19:19:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YKy7KrvvW74/why-teva-pharmaceuticals-industries-just-lost-15-billion-in-market-value-cm744390,What happened After announcing the sudden departure of its CEO shares of Teva Pharmaceuticals NYSE TEVA 160 an Israeli based manufacturer of generic and branded drugs 160 fell by more than 5 in early afternoon trading on Tuesday The move has erased more than 1 5
TEVA,TEVA:US,BBG000C0CD58,Teva CEO exits in ongoing crisis of confidence at drugmaker,2017-02-07 18:45:59 +0000,http://finance.yahoo.com/news/teva-ceo-exits-amid-crisis-121514635.html,Teva CEO exits in ongoing crisis of confidence at drugmaker
TEVA,TEVA:US,BBG000C0CD58,Teva CEO exits in ongoing crisis of confidence at drugmaker,2017-02-07 18:44:15 +0000,http://in.finance.yahoo.com/news/teva-ceo-exits-ongoing-crisis-184415184.html,Teva CEO exits in ongoing crisis of confidence at drugmaker
TEVA,TEVA:US,BBG000C0CD58,Is Teva's 4% Dividend Yield Safe?,2017-02-07 18:42:07 +0000,http://finance.yahoo.com/news/tevas-4-dividend-yield-safe-184207950.html,Is Teva's 4% Dividend Yield Safe?
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceuticals Industries Just Lost $1.5 Billion In Market Value,2017-02-07 18:00:44 +0000,http://www.fool.com/investing/2017/02/07/why-teva-pharmacetuicals-just-lost-15-billion-in-m.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Teva Pharmaceuticals Industries Just Lost $1.5 Billion In Market Value
TEVA,TEVA:US,BBG000C0CD58,Teva says Israel probing same issues as U.S. bribery case,2017-02-07 17:41:50 +0000,http://sg.finance.yahoo.com/news/teva-says-israel-probing-same-174150787.html,Teva says Israel probing same issues as U.S. bribery case
TEVA,TEVA:US,BBG000C0CD58,Is Teva’s CEO Departure Long Overdue?,2017-02-07 17:40:14 +0000,http://finance.yahoo.com/news/teva-ceo-departure-long-overdue-174014998.html,Is Teva’s CEO Departure Long Overdue?
TEVA,TEVA:US,BBG000C0CD58,The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva,2017-02-07 17:25:14 +0000,http://www.bloomberg.com/news/articles/2017-02-07/the-pharma-job-from-hell-low-salary-to-fix-a-sinking-giant?cmpid=yhoo.headline,The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva
TEVA,TEVA:US,BBG000C0CD58,The Pharma Job From Hell: Low Salary to Fix a Sinking Giant,2017-02-07 17:25:14 +0000,http://finance.yahoo.com/news/pharma-job-hell-low-salary-172514359.html,The Pharma Job From Hell: Low Salary to Fix a Sinking Giant
TEVA,TEVA:US,BBG000C0CD58,Teva Set to Bounce Despite Bad News,2017-02-07 16:44:00 +0000,http://www.investopedia.com/stock-analysis/cotd/020717/teva-set-bounce-despite-bad-news-teva-teva.aspx?partner=YahooSA,Teva Set to Bounce Despite Bad News
TEVA,TEVA:US,BBG000C0CD58,JIm Cramer: Investors Should Be Cautious With Teva Pharmaceutical,2017-02-07 16:37:00 +0000,http://www.thestreet.com/video/13993088/jim-cramer-says-here-s-why-investors-should-be-cautious-on-teva-pharmaceuticals.html?puc=yahoov&cm_ven=YAHOOV,JIm Cramer: Investors Should Be Cautious With Teva Pharmaceutical
TEVA,TEVA:US,BBG000C0CD58,"CEO of Teva Steps Down, Shares Fall",2017-02-07 15:49:00 +0000,http://www.investopedia.com/news/teva-shares-fall-ceo-resigns-teva/?partner=YahooSA,"CEO of Teva Steps Down, Shares Fall"
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals CEO Steps Down After a Series of Missteps,2017-02-07 15:26:00 +0000,http://www.thestreet.com/video/13992787/teva-pharmaceuticals-ceo-steps-down-after-a-series-of-missteps.html?puc=yahoov&cm_ven=YAHOOV,Teva Pharmaceuticals CEO Steps Down After a Series of Missteps
TEVA,TEVA:US,BBG000C0CD58,"In an Ironic Twist, Generics Take Aim at Teva Pharmaceutical",2017-02-07 15:19:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kOpN-ZWPHb4/in-an-ironic-twist-generics-take-aim-at-teva-pharmaceutical-cm744098,Teva Pharmaceutical s NYSE TEVA top selling drug is the long standing multiple sclerosis therapy Copaxone The drug racks up billions of dollars in annual sales for the generic drug powerhouse but that could change because Teva Pharmaceutical s generic rivals are
TEVA,TEVA:US,BBG000C0CD58,Teva's Dividend Should Follow Its CEO Out,2017-02-07 14:58:49 +0000,http://www.bloomberg.com/gadfly/articles/2017-02-07/teva-ceo-resigns-dividend-cut-should-be-next?cmpid=yhoo.headline,Teva's Dividend Should Follow Its CEO Out
TEVA,TEVA:US,BBG000C0CD58,A Conversation With Teva's Interim CEO And Chair,2017-02-07 14:49:38 +0000,http://finance.yahoo.com/news/conversation-tevas-interim-ceo-chair-144938820.html,A Conversation With Teva's Interim CEO And Chair
TEVA,TEVA:US,BBG000C0CD58,Faber Report: Pharma fumbles,2017-02-07 14:43:00 +0000,http://finance.yahoo.com/video/faber-report-pharma-fumbles-144300386.html,Faber Report: Pharma fumbles
TEVA,TEVA:US,BBG000C0CD58,"Teva: Vigodman Steps Down, Peterburg Hired as Interim CEO",2017-02-07 14:20:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mUmRy03u4nU/teva-vigodman-steps-down-peterburg-hired-as-interim-ceo-cm744119,Teva Pharmaceutical Industries Ltd TEVA recently announced that its present chief executive officer CEO Erez Vigodman is stepping down The company has named Dr Yitzhak Peterburg as the interim president and CEO effective immediately Peterburg has served as the chairman of Teva s
TEVA,TEVA:US,BBG000C0CD58,"In an Ironic Twist, Generics Take Aim at Teva Pharmaceutical",2017-02-07 13:30:15 +0000,http://www.fool.com/investing/2017/02/07/in-an-ironic-twist-generics-take-aim-at-teva-pharm.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"In an Ironic Twist, Generics Take Aim at Teva Pharmaceutical"
TEVA,TEVA:US,BBG000C0CD58,"Teva, CEO part ways",2017-02-07 13:25:25 +0000,http://www.bizjournals.com/philadelphia/news/2017/02/07/teva-ceo-erez-vigodman-resigns.html?ana=yahoo,"Teva, CEO part ways"
TEVA,TEVA:US,BBG000C0CD58,"Teva: Vigodman Steps Down, Peterburg Hired as Interim CEO",2017-02-07 13:15:01 +0000,http://finance.yahoo.com/news/teva-vigodman-steps-down-peterburg-131501803.html,"Teva: Vigodman Steps Down, Peterburg Hired as Interim CEO"
TEVA,TEVA:US,BBG000C0CD58,UPDATE 2-Teva Pharm's CEO Vigodman steps down amid crisis of confidence,2017-02-07 10:21:45 +0000,http://finance.yahoo.com/news/teva-pharms-ceo-vigodman-steps-093653256.html,UPDATE 2-Teva Pharm's CEO Vigodman steps down amid crisis of confidence
TEVA,TEVA:US,BBG000C0CD58,PRESS DIGEST- Financial Times - Feb 7,2017-02-07 00:30:29 +0000,http://finance.yahoo.com/news/press-digest-financial-times-feb-003029982.html,[Reuters] - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines Metro shareholders in big vote to support split in two ...
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva CEO Erez Vigodman to Step Down,2017-02-06 23:42:19 +0000,https://www.wsj.com/articles/teva-ceo-erez-vigodman-to-step-down-1486424535?mod=yahoo_hs,[$$] Teva CEO Erez Vigodman to Step Down
TEVA,TEVA:US,BBG000C0CD58,"Teva names interim CEO, new chairman as Vigodman steps down",2017-02-06 23:14:03 +0000,http://in.finance.yahoo.com/news/teva-names-interim-ceo-chairman-230120375.html,"Teva names interim CEO, new chairman as Vigodman steps down"
TEVA,TEVA:US,BBG000C0CD58,Teva Searches for a New CEO,2017-02-06 22:51:00 +0000,https://www.thestreet.com/story/13991848/1/teva-searches-for-a-new-ceo.html?puc=yahoo&cm_ven=YAHOO,Teva Searches for a New CEO
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma shares slide on CEO departure,2017-02-06 22:05:00 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=EF19DDA3-363E-4AA0-B67F-3CDF587272E1&siteid=yhoof2,Teva Pharma shares slide on CEO departure
TEVA,TEVA:US,BBG000C0CD58,"Teva Loses CEO, Leaving Investors to Guess What’s Next",2017-02-06 22:02:26 +0000,http://www.bloomberg.com/news/articles/2017-02-06/teva-ceo-vigodman-stepping-down-after-three-years-atop-drugmaker?cmpid=yhoo.headline,"Teva Loses CEO, Leaving Investors to Guess What’s Next"
TEVA,TEVA:US,BBG000C0CD58,"Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman",2017-02-06 21:53:00 +0000,http://finance.yahoo.com/news/teva-appoints-dr-yitzhak-peterburg-215300575.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced that Dr. Yitzhak Peterburg, who has served as Chairman of the Teva Board of Directors since January 2015, has been appointed Interim President and Chief Executive Officer, effective immediately."
TEVA,TEVA:US,BBG000C0CD58,Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Finally Stabilize,2017-02-06 21:17:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CyOppkdnL50/why-valeant-pharmaceuticals-intl-inc-vrx-stock-will-finally-stabilize-cm743858,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When the President of the United States lightens his focus on high drug prices and instead looks at the whole Medicare system and its pricing structure for patient care as a whole well generic drug
TEVA,TEVA:US,BBG000C0CD58,Naltrexone Showing More Potential in Drug Addiction Treatment Market,2017-02-06 20:16:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gr9PrOu4n3E/naltrexone-showing-more-potential-in-drug-addiction-treatment-market-cm743812,In the on going debate of which drug addiction treatment is more effective naltrexone is showing more potential than buprenorphine according to the latest study by researchers from Columbia University In the on going debate of which drug addiction treatment is more effective naltrexone
TEVA,TEVA:US,BBG000C0CD58,10 Dividend Growth Stocks That Simply Print Money,2017-02-06 19:30:01 +0000,http://portal.kiplinger.com/slideshow/investing/T018-S015-10-dividend-growth-stocks-that-simply-print-money/index.html?rid=SYN-yahoo&rpageid=16086,10 Dividend Growth Stocks That Simply Print Money
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Appoints Yitzhak Peterburg As Interim CEO; Sol Barer Named Chairman,2017-02-06 17:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mMgdld8tfmc/teva-pharma-appoints-yitzhak-peterburg-as-interim-ceo-sol-barer-named-chairman-20170206-01293,Teva Pharma Appoints Yitzhak Peterburg As Interim CEO; Sol Barer Named Chairman
TEVA,TEVA:US,BBG000C0CD58,Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3,2017-02-06 16:20:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xqlni1yVH7s/dr-reddys-rdy-earnings-revenues-decline-yy-in-q3-cm743571,Dr Reddy s Laboratories Ltd RDY reported third quarter fiscal 2017 earnings per American Depositary Share ADS of 42 cents down 16 year over year While quarterly revenues declined 6 5 year over year to 546 million they were up by 3 on a sequential basis Dr Reddy s share price
TEVA,TEVA:US,BBG000C0CD58,"Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet",2017-02-03 18:29:00 +0000,https://www.thestreet.com/story/13982370/1/acadia-pops-on-takeout-rumors-but-don-t-buy-on-m-amp-a-just-yet.html?puc=yahoo&cm_ven=YAHOO,"Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet"
TEVA,TEVA:US,BBG000C0CD58,Why the Majority of Analysts Deem Novartis a ‘Buy’,2017-02-03 14:06:16 +0000,http://marketrealist.com/2017/02/why-the-majority-of-analysts-deem-novartis-a-buy/?utm_source=yahoo&utm_medium=feed,Why the Majority of Analysts Deem Novartis a ‘Buy’
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling",2017-02-03 11:54:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pfizer-merck-115411134.html,"Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling"
TEVA,TEVA:US,BBG000C0CD58,iShares MSCI EAFE ETF Experiences Big Inflow,2017-02-02 17:34:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8CUDrdt2zQ/ishares-msci-eafe-etf-experiences-big-inflow-cm742312,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 143 3 million dollar inflow that s a 0 2 increase week over week in outstanding
TEVA,TEVA:US,BBG000C0CD58,"Advair, Armonair From Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Gets FDA Approval",2017-02-02 16:03:31 +0000,http://www.insidermonkey.com/blog/advair-armonair-from-teva-pharmaceutical-industries-ltd-adr-teva-gets-fda-approval-530510/,"Advair, Armonair From Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Gets FDA Approval"
TEVA,TEVA:US,BBG000C0CD58,Allergan (AGN) Q4 Earnings: What's in Store for the Stock?,2017-02-02 13:34:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z0lNC851xb8/allergan-agn-q4-earnings-whats-in-store-for-the-stock-cm741983,Allergan plc AGN will be reporting fourth quarter 2016 earnings on Feb 8 before the market opens Last quarter the company delivered a negative earnings surprise of 7 00 Allergan s share price was up 9 1 this year so far while the Zacks classified Medical Generics Drug industry
TEVA,TEVA:US,BBG000C0CD58,Teva Confirms Generic Victoza® Patent Challenge in the United States,2017-02-02 13:00:00 +0000,http://finance.yahoo.com/news/teva-confirms-generic-victoza-patent-130000247.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced that it has filed an abbreviated new drug application with the U.S. Food and Drug Administration seeking approval to market the generic version of Novo Nordisk's Victoza® injection, in the U.S."
TEVA,TEVA:US,BBG000C0CD58,Are Teva Pharmaceutical's Best Days Behind It?,2017-02-01 23:32:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BE_s28LAP2A/are-teva-pharmaceuticals-best-days-behind-it-cm741902,After losing a patent challenge in U S District Court it s become increasingly likely that Teva Pharmaceutical Industries NYSE TEVA top selling Copaxone will face generic competition soon Since Copaxone accounts for 16 of Teva Pharmaceutical s sales and over 40 of its
TEVA,TEVA:US,BBG000C0CD58,Are Teva Pharmaceutical's Best Days Behind It?,2017-02-01 21:40:05 +0000,http://www.fool.com/investing/2017/02/01/are-teva-pharmaceuticals-best-days-behind-it.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Are Teva Pharmaceutical's Best Days Behind It?
TEVA,TEVA:US,BBG000C0CD58,"Teva to Report Fourth Quarter 2016 Financial Results on February 13, 2017",2017-02-01 20:01:00 +0000,http://finance.yahoo.com/news/teva-report-fourth-quarter-2016-200100752.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. announced today that it will release its fourth quarter 2016 financial results on Monday, February 13, 2017 at 7:00 a.m. ET."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical: Not Going Down Without a Fight,2017-02-01 18:45:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/01/teva-pharmaceutical-not-going-down-without-a-fight/?mod=yahoobarrons&ru=yahoo,Teva Pharmaceutical: Not Going Down Without a Fight
TEVA,TEVA:US,BBG000C0CD58,Momenta Says District of Delaware Invalidates Teva's MS Drug,2017-02-01 17:34:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ki_5fxc60Ok/momenta-says-district-of-delaware-invalidates-tevas-ms-drug-cm741652,Shares of Momenta Pharmaceuticals Inc MNTA shot up 25 2 after Mylan N V MYL announced that the U S District Court for the District of Delaware has issued a decision in favor of the latter pertaining to claims related to Teva Pharmaceutical s TEVA Copaxone 40mg mL This news is a
TEVA,TEVA:US,BBG000C0CD58,Momenta Says District of Delaware Invalidates Teva's MS Drug,2017-02-01 15:11:03 +0000,http://finance.yahoo.com/news/momenta-says-district-delaware-invalidates-151103352.html,Momenta Says District of Delaware Invalidates Teva's MS Drug
TEVA,TEVA:US,BBG000C0CD58,"Fail, win and then fail some more to become a winning trader",2017-02-01 14:50:33 +0000,http://finance.yahoo.com/tumblr/blog-fail-win-and-then-fail-some-more-to-become-a-145045350.html,"Fail, win and then fail some more to become a winning trader"
TEVA,TEVA:US,BBG000C0CD58,Asian shares mostly higher on strong manufacturing data,2017-02-01 04:50:11 +0000,http://sg.finance.yahoo.com/news/weak-quarterly-reports-push-stocks-151240776.html,Asian shares mostly higher on strong manufacturing data
TEVA,TEVA:US,BBG000C0CD58,"Why Momenta Pharmaceuticals, Ally Financial, and Thermo Fisher Scientific Jumped Today",2017-02-01 01:31:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M7ybwgnHMRw/why-momenta-pharmaceuticals-ally-financial-and-thermo-fisher-scientific-jumped-today-cm741238,The stock market finished mixed on Tuesday and although the Dow Jones Industrials still finished with a loss of more than 100 points other major market benchmarks finished very close to the unchanged level on the day Geopolitical pressure continued to hurt investor sentiment and
TEVA,TEVA:US,BBG000C0CD58,Weak quarterly reports push stocks to small losses,2017-01-31 20:25:17 +0000,http://finance.yahoo.com/news/weak-quarterly-reports-push-stocks-lower-second-day-151240263--finance.html,Weak quarterly reports push stocks to small losses
TEVA,TEVA:US,BBG000C0CD58,"Why Momenta Pharmaceuticals, Inc. Stock Skyrocketed Higher Today",2017-01-31 19:33:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3VdNbzq2O3E/why-momenta-pharmaceuticals-inc-stock-skyrocketed-higher-today-cm741050,Image source Getty Images What happened Shares of Momenta Pharmaceuticals NASDAQ MNTA 160 are up over 20 at 12 28 p m EST after the company announced that the U S District Court invalidated four of Teva Pharmaceutical s NYSE TEVA patents on the three times
TEVA,TEVA:US,BBG000C0CD58,Tuesday's ETF with Unusual Volume: PPH,2017-01-31 19:31:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/autjheTRc_A/tuesdays-etf-with-unusual-volume-pph-cm741029,The Pharmaceutical ETF PPH is seeing unusually high volume in afternoon trading Tuesday with over 2 2 million shares traded versus three month average volume of about 193 000 Shares of PPH were up about 0 6 on the day Components of that ETF with the highest volume on Tuesday
TEVA,TEVA:US,BBG000C0CD58,Instant Analysis: Is Teva Pharmaceutical Industries a Buy on the Dip?,2017-01-31 18:33:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AZT_OQ3H9v0/instant-analysis-is-teva-pharmaceutical-industries-a-buy-on-the-dip-cm741010,Image source The Motley Fool What happened Teva Pharmaceutical Industries NYSE TEVA 160 took another stock market hit after a U S District Court invalidated four method of use patents protecting a long acting version of Teva s multiple sclerosis drug Copaxone
TEVA,TEVA:US,BBG000C0CD58,All The Bad News For Teva (TEVA) Is Now Priced In,2017-01-31 18:05:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tiW11Y3LK00/all-the-bad-news-for-teva-teva-is-now-priced-in-cm741016,"Most of us have, at some time in our lives, experienced a sequence of events when it seems that nothing can go right. Bad news piles on bad news and we seem to go through a run of making bad decisions, albeit for all the right reasons.  Corporations, as Mitt Romney once famously reminded us, are people too, and it"
TEVA,TEVA:US,BBG000C0CD58,"Why Momenta Pharmaceuticals, Inc. Stock Skyrocketed Higher Today",2017-01-31 18:03:40 +0000,http://www.fool.com/investing/2017/01/31/why-momenta-pharmaceuticals-inc-skyrocketed-higher.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Momenta Pharmaceuticals, Inc. Stock Skyrocketed Higher Today"
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Gets Favorable Verdict for Copaxone in the US,2017-01-31 17:32:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hGH6rS_Ry7E/mylan-myl-gets-favorable-verdict-for-copaxone-in-the-us-cm740903,Mylan N V MYL announced that the United States District Court for the District of Delaware has issued a decision in favor of the company pertaining to claims related to Teva Pharmaceutical s TEVA Copaxone 40mg mL The court declared all claims of four Orange Book listed patents relating
TEVA,TEVA:US,BBG000C0CD58,A U.S Court Will Hear Nothing Of Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Claims Of Patent Infringement,2017-01-31 17:24:53 +0000,http://www.insidermonkey.com/blog/a-u-s-court-will-hear-nothing-of-teva-pharmaceutical-industries-ltd-adr-teva-claims-of-patent-infringement-529333/,A U.S Court Will Hear Nothing Of Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Claims Of Patent Infringement
TEVA,TEVA:US,BBG000C0CD58,Instant Analysis: Is Teva Pharmaceutical Industries a Buy on the Dip?,2017-01-31 16:58:08 +0000,http://www.fool.com/investing/2017/01/31/instant-analysis-is-teva-pharmaceutical-industries.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Instant Analysis: Is Teva Pharmaceutical Industries a Buy on the Dip?
TEVA,TEVA:US,BBG000C0CD58,Teva Is Losing Credibility,2017-01-31 16:48:46 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-31/teva-copaxone-patent-ruling-debt-situation-gets-scary?cmpid=yhoo.headline,Teva Is Losing Credibility
TEVA,TEVA:US,BBG000C0CD58,Copaxone Patent Ruling Will Hurt Teva,2017-01-31 16:22:00 +0000,http://www.investopedia.com/news/teva-plummets-early-trading-teva/?partner=YahooSA,Copaxone Patent Ruling Will Hurt Teva
TEVA,TEVA:US,BBG000C0CD58,Mylan's Shares Rise Despite FTC Investigation,2017-01-31 16:16:00 +0000,https://www.thestreet.com/story/13972921/1/mylan-s-shares-rise-despite-ftc-investigation.html?puc=yahoo&cm_ven=YAHOO,Mylan's Shares Rise Despite FTC Investigation
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Gets Favorable Verdict for Copaxone in the US,2017-01-31 15:45:03 +0000,http://finance.yahoo.com/news/mylan-myl-gets-favorable-verdict-154503824.html,Mylan (MYL) Gets Favorable Verdict for Copaxone in the US
TEVA,TEVA:US,BBG000C0CD58,Allergan (AGN) Avycaz Label to Include New Phase III Data,2017-01-31 14:36:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CZknADxbpIw/allergan-agn-avycaz-label-to-include-new-phase-iii-data-cm740656,Allergan plc AGN announced that its supplemental new drug application sNDA for antibiotic Avycaz ceftazidime and avibactam ex U S trade name Zavicefta has been approved by the FDA Allergan is looking to include new data from two phase III trials RECAPTURE and REPRISE in the drug
TEVA,TEVA:US,BBG000C0CD58,"Premarket Biotech Movers: Mylan, Momenta Pharmaceuticals, Seres Therapeutics",2017-01-31 14:27:00 +0000,https://www.thestreet.com/story/13972592/1/premarket-biotech-movers-mylan-momenta-pharmaceuticals-seres-therapeutics.html?puc=yahoo&cm_ven=YAHOO,"Premarket Biotech Movers: Mylan, Momenta Pharmaceuticals, Seres Therapeutics"
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Jan 31, 2017 :  NRZ, UAA, UA, TEVA, SDRL, TEF, TVIX, XIV, QQQ, ARIA, VOD, AAPL",2017-01-31 13:51:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d9jaIZSnlP8/pre-market-most-active-for-jan-31-2017-nrz-uaa-ua-teva-sdrl-tef-tvix-xiv-qqq-aria-vod-aapl-cm740670,The NASDAQ 100 Pre Market Indicator is down 7 07 to 5 122 26 The total Pre Market volume is currently 20 492 506 shares traded The following are the most active stocks for the pre market session New Residential Investment Corp NRZ is 0 49 at 15 17 with 4 942
TEVA,TEVA:US,BBG000C0CD58,Blog Coverage Teva Announced FDA Approval for Two Asthma Products; Plans to Appeal Court Decision on COPAXONE,2017-01-31 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-teva-announced-fda-131500248.html,"[Accesswire] - Upcoming AWS Coverage on Dr. Reddy's Laboratories Post-Earnings Results LONDON, UK / ACCESSWIRE / January 31, 2017 / Active Wall St. blog coverage looks at the headline from Teva Pharmaceutical Industries ..."
TEVA,TEVA:US,BBG000C0CD58,"AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch",2017-01-31 03:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gUAgYE_P7wI/aezs-inches-closer-to-dday-eyeg-catches-investors-eyes-mcrb-on-watch-20170131-00111,"AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch"
TEVA,TEVA:US,BBG000C0CD58,Teva Dives To 10-Year Low After 4 Copaxone Patents Invalidated,2017-01-31 00:55:23 +0000,http://www.investors.com/news/teva-dives-to-10-year-low-after-4-copaxone-patents-invalidated/,Teva Dives To 10-Year Low After 4 Copaxone Patents Invalidated
TEVA,TEVA:US,BBG000C0CD58,U.S. court rejects Teva's patent-infringement claims on Copaxone,2017-01-31 00:46:16 +0000,http://finance.yahoo.com/news/u-court-rejects-tevas-patent-004616001.html,U.S. court rejects Teva's patent-infringement claims on Copaxone
TEVA,TEVA:US,BBG000C0CD58,Teva shares fall as court invalidates patent infringement claims,2017-01-31 00:15:18 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=103D35E2-BDB1-4D68-B90A-A4D31DE45292&siteid=yhoof2,Teva shares fall as court invalidates patent infringement claims
TEVA,TEVA:US,BBG000C0CD58,Teva Confirms District Court Decision in COPAXONE® 40 mg/mL Patent Trial,2017-01-30 23:52:00 +0000,http://finance.yahoo.com/news/teva-confirms-district-court-decision-235200138.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. today confirmed the U.S. District Court for the District of Delaware ruling invalidating all asserted claims of the ‘250, ‘413, ‘776 and ‘302 patents for COPAXONE® 40 mg/mL."
TEVA,TEVA:US,BBG000C0CD58,Teva’s Patent Loss Marks Second Blow in Weeks as New Year Begins,2017-01-30 22:36:42 +0000,http://www.bloomberg.com/news/articles/2017-01-30/teva-loses-ruling-invalidating-patents-on-copaxone-drug?cmpid=yhoo.headline,Teva’s Patent Loss Marks Second Blow in Weeks as New Year Begins
TEVA,TEVA:US,BBG000C0CD58,Mylan Wins U.S. Court Ruling On Copaxone 40 Mg/mL Patents,2017-01-30 20:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JaaDYiOvt5U/mylan-wins-us-court-ruling-on-copaxone-40-mgml-patents-20170130-01390,Mylan Wins U.S. Court Ruling On Copaxone 40 Mg/mL Patents
TEVA,TEVA:US,BBG000C0CD58,"IEFA, EFU: Big ETF Inflows",2017-01-30 17:35:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sfpmhIn2NuM/iefa-efu-big-etf-inflows-cm740257,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF IEFA which added 14 000 000 units or a 4 5 increase week over week Among the largest underlying components of IEFA in
TEVA,TEVA:US,BBG000C0CD58,"As Teva wins U.S. approval for GSK Advair copy, main fight yet to come",2017-01-30 16:33:32 +0000,http://sg.finance.yahoo.com/news/teva-wins-u-approval-gsk-163332660.html,"As Teva wins U.S. approval for GSK Advair copy, main fight yet to come"
TEVA,TEVA:US,BBG000C0CD58,"As Teva wins US approval for GSK Advair copy, main fight yet to come",2017-01-30 16:24:50 +0000,http://uk.finance.yahoo.com/news/teva-wins-us-approval-gsk-162450130.html,"[Reuters - UK Focus] - Israel's Teva Pharmaceutical Industries has won U.S. approval to market a copy of GlaxoSmithKline (Other OTC: GLAXF - news) 's best-selling Advair inhaler, although the real battle is still to come. Teva's version of GSK's blockbuster medicine, called AirDuo RespiClick, is not directly substitutable for Advair and is only approved for asthma, while Advair is also widely used for chronic obstructive pulmonary disease (COPD)."
TEVA,TEVA:US,BBG000C0CD58,Health Care Sector Update for 01/30/2017: TEVA,2017-01-30 14:31:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MF1W34oSHjU/health-care-sector-update-for-01302017-teva-cm740024,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 4 MRK 0 4 AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on Monday Health care shares were mainly unchanged in pre market trade on Monday
TEVA,TEVA:US,BBG000C0CD58,Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma,2017-01-30 13:00:00 +0000,http://finance.yahoo.com/news/teva-announces-fda-approval-two-130000751.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced that the U.S. Food and Drug Administration approved two products for adolescent and adult patients with asthma."
TEVA,TEVA:US,BBG000C0CD58,Here's the Best Dividend Stock in Big Pharma,2017-01-30 12:43:33 +0000,http://www.fool.com/investing/2017/01/29/heres-the-best-dividend-stock-in-big-pharma.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's the Best Dividend Stock in Big Pharma
TEVA,TEVA:US,BBG000C0CD58,Teva Announces FDA Approval Of Two New RespiClick Maintenance Inhalers,2017-01-30 08:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m3v8YZS4f10/teva-announces-fda-approval-of-two-new-respiclick-maintenance-inhalers-20170130-00407,Teva Announces FDA Approval Of Two New RespiClick Maintenance Inhalers
TEVA,TEVA:US,BBG000C0CD58,Here's the Best Dividend Stock in Big Pharma,2017-01-29 14:31:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lafqQ0VdCnY/heres-the-best-dividend-stock-in-big-pharma-cm739862,Many big pharma companies pay attractive dividends But which is the best big pharma dividend stock of all There s a strong case to be made that the distinction belongs to AbbVie NYSE ABBV Here s why Image source Getty Images Criteria What s the best way
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : December 05th, 2016 (record date) : By the numbers : January 27, 2017",2017-01-27 17:42:40 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-us-dividend-analysis-december-05th-2016-record-date-by-the-numbers-january-27-2017/,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : December 05th, 2016 (record date) : By the numbers : January 27, 2017"
TEVA,TEVA:US,BBG000C0CD58,Teva Settles Antitrust Case,2017-01-27 16:51:00 +0000,http://www.investopedia.com/news/teva-seeing-dead-cat-bounce-probably-teva/?partner=YahooSA,Teva Settles Antitrust Case
TEVA,TEVA:US,BBG000C0CD58,Teva's Barr Labs settles Cipro antitrust case for $225 mln,2017-01-27 03:23:52 +0000,http://finance.yahoo.com/news/tevas-barr-labs-settles-cipro-032352438.html,"[Reuters] - Teva Pharmaceutical Industries Ltd's Barr Laboratories Inc has reached a $225 million settlement in an antitrust class action that accused the drugmaker of keeping a generic version of Bayer AG's antibiotic Cipro off the market, court documents showed. The case, which began in 2000 in California state court, centers on a series of settlements in the late 1990s under which Bayer allegedly paid Barr Pharmaceuticals, since bought by Teva, $398 million not to market Cipro's generic version. Bayer had earlier sued Barr claiming that generic Cipro would infringe a Bayer patent."
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Run for Cover From Major Pharma,2017-01-26 14:50:10 +0000,http://finance.yahoo.com/news/short-sellers-run-cover-major-145010014.html,Short Sellers Run for Cover From Major Pharma
TEVA,TEVA:US,BBG000C0CD58,How Will Eli Lilly’s Neuroscience Franchise Fare in 4Q16?,2017-01-26 12:37:11 +0000,http://marketrealist.com/2017/01/how-will-eli-lilys-neuroscience-franchise-fare-in-4q16/?utm_source=yahoo&utm_medium=feed,How Will Eli Lilly’s Neuroscience Franchise Fare in 4Q16?
TEVA,TEVA:US,BBG000C0CD58,Here’s Why Teva Pharmaceuticals Industries Ltd (ADR) (TEVA) Is Bullish on 2017,2017-01-25 21:32:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sfPdwokpBO4/heres-why-teva-pharmaceuticals-industries-ltd-adr-teva-is-bullish-on-2017-cm738310,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceuticals Industries Ltd ADR NYSE TEVA has had a tough 2016 with TEVA stock off 44 plus for the year Source Open Grid Scheduler Modified Some of it Teva brought on itself
TEVA,TEVA:US,BBG000C0CD58,Will Eli Lilly's (LLY) Earnings Surpass Estimates in Q4?,2017-01-25 17:35:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YtmLGFJ0mU8/will-eli-lillys-lly-earnings-surpass-estimates-in-q4-cm738127,We expect Eli Lilly and Company LLY to beat expectations when it reports fourth quarter and full year 2016 earnings results on Jan 31 before market opens So far this year Lilly s share price has improved 1 7 as against a decrease of 1 6 for the Zacks classified Large Cap Pharma
TEVA,TEVA:US,BBG000C0CD58,"Notable ETF Inflow Detected - EFA, TEVA, NXPI, CHKP",2017-01-25 17:33:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jwjPXZlqHH8/notable-etf-inflow-detected-efa-teva-nxpi-chkp-cm738108,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 142 5 million dollar inflow that s a 0 2 increase week over week in outstanding
TEVA,TEVA:US,BBG000C0CD58,Benzinga's Option Alert Recap From January 24,2017-01-24 22:26:25 +0000,http://finance.yahoo.com/news/benzingas-option-alert-recap-january-222625811.html,Benzinga's Option Alert Recap From January 24
TEVA,TEVA:US,BBG000C0CD58,"Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club",2017-01-23 21:04:30 +0000,http://finance.yahoo.com/news/teva-gilead-sciences-tumble-monday-210430441.html,"Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,"FTC, Endo propose agreement to resolve pay-for-delay dispute",2017-01-23 20:55:07 +0000,http://www.bizjournals.com/philadelphia/news/2017/01/23/endo-fed-trade-commission-ftc-pay-delay-dispute.html?ana=yahoo,"FTC, Endo propose agreement to resolve pay-for-delay dispute"
TEVA,TEVA:US,BBG000C0CD58,Canada Wants Painkiller Warnings as Deaths Soar,2017-01-23 16:10:00 +0000,http://www.investopedia.com/news/canada-seeks-painkiller-warnings-amid-deaths-teva-mnk/?partner=YahooSA,Canada Wants Painkiller Warnings as Deaths Soar
TEVA,TEVA:US,BBG000C0CD58,3 Incredibly Cheap High-Yield Dividend Stocks,2017-01-22 13:37:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fSzfWmdIvFI/3-incredibly-cheap-high-yield-dividend-stocks-cm736410,Who says stocks that pay great dividends have to be expensive While investors often do pay a premium price for stocks that boast high dividend yields that s not always the case In fact three healthcare stocks with attractive yields are incredibly cheap right now If you re
TEVA,TEVA:US,BBG000C0CD58,3 Incredibly Cheap High-Yield Dividend Stocks,2017-01-22 11:42:20 +0000,http://www.fool.com/investing/2017/01/22/3-incredibly-cheap-high-yield-dividend-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Incredibly Cheap High-Yield Dividend Stocks
TEVA,TEVA:US,BBG000C0CD58,JP Morgan Downgrades Teva,2017-01-20 17:59:00 +0000,http://www.investopedia.com/news/jp-morgan-cuts-tevas-price-target-teva-agn/?partner=YahooSA,JP Morgan Downgrades Teva
TEVA,TEVA:US,BBG000C0CD58,"IEFA, SVXY: Big ETF Inflows",2017-01-20 17:38:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rXoLjAj9EgA/iefa-svxy-big-etf-inflows-cm736086,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF IEFA which added 8 000 000 units or a 2 6 increase week over week Among the largest underlying components of IEFA in
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Secures FDA Approval For Vantreal ER,2017-01-19 19:13:56 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-teva-secures-fda-approval-for-vantreal-er-520713/,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Secures FDA Approval For Vantreal ER
TEVA,TEVA:US,BBG000C0CD58,Lilly to Boost Migraine Pipeline with $960M CoLucid Buyout,2017-01-19 15:41:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HuTTxIy3wBA/lilly-to-boost-migraine-pipeline-with-960m-colucid-buyout-cm735316,Eli Lilly and Company LLY announced that it plans to buy Cambridge MA based biotech firm CoLucid Pharmaceuticals Inc CLCD for approximately 960 million in cash The deal will enhance Lilly s pain management portfolio for migraine The announcement sent CoLucid s soaring over 32
TEVA,TEVA:US,BBG000C0CD58,Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval,2017-01-19 15:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tq63KL0w5Ww/tevas-teva-pain-drug-vantrela-er-receives-fda-approval-cm735298,Teva Pharmaceutical Industries Ltd TEVA announced that the FDA has approved Vantrela ER for the treatment of pain which is severe enough to require daily around the clock long term opioid treatment and for which alternative treatment options are inadequate Teva s share price has declined
TEVA,TEVA:US,BBG000C0CD58,Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval,2017-01-19 13:51:01 +0000,http://finance.yahoo.com/news/tevas-teva-pain-drug-vantrela-135101164.html,Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval
TEVA,TEVA:US,BBG000C0CD58,"DERM Delights With A Hat-trick, Shot In The Arm For APRI, FDA Nod For TEVA",2017-01-19 03:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MGyqv56qtxs/derm-delights-with-a-hattrick-shot-in-the-arm-for-apri-fda-nod-for-teva-20170119-00163,"DERM Delights With A Hat-trick, Shot In The Arm For APRI, FDA Nod For TEVA"
TEVA,TEVA:US,BBG000C0CD58,Teva's Pain Drug Gets Approved By The FDA,2017-01-18 16:02:00 +0000,http://www.investopedia.com/news/teva-announces-fda-approval-teva/?partner=YahooSA,Teva's Pain Drug Gets Approved By The FDA
TEVA,TEVA:US,BBG000C0CD58,FDA approves Teva's abuse-deterrent painkiller,2017-01-18 16:00:09 +0000,http://www.bizjournals.com/philadelphia/news/2017/01/18/fda-teva-abuse-deterrent-painkiller-vantrela.html?ana=yahoo,FDA approves Teva's abuse-deterrent painkiller
TEVA,TEVA:US,BBG000C0CD58,Orphan Drugs Among 2015's Top 10 Best-Selling Medications,2017-01-18 15:40:29 +0000,http://finance.yahoo.com/news/orphan-drugs-among-2015s-top-154029638.html,Orphan Drugs Among 2015's Top 10 Best-Selling Medications
TEVA,TEVA:US,BBG000C0CD58,Teva Receives FDA Approval for VANTRELATM ER (Hydrocodone Bitartrate) Extended-Release Tablets Formulated with Proprietary Abuse Deterrence Technology,2017-01-18 13:00:00 +0000,http://finance.yahoo.com/news/teva-receives-fda-approval-vantrelatm-130000247.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced the U.S. Food and Drug Administration approved VANTRELATM ER extended-release tablets formulated with Teva’s proprietary abuse deterrence technology.
TEVA,TEVA:US,BBG000C0CD58,Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended,2017-01-16 14:39:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J0q2VXUFt7o/lilly-incyte-rheumatoid-arthritis-drug-pdufa-date-extended-cm733817,Eli Lilly and Company LLY and partner Incyte Corporation INCY announced that the FDA has extended the time to review the company s New Drug Application NDA seeking approval of its pipeline candidate baricitinib for the treatment of rheumatoid arthritis RA Previously the FDA was
TEVA,TEVA:US,BBG000C0CD58,5 Trump-Proof Pharma Dividends Up To 5.3%,2017-01-16 13:38:00 +0000,http://www.forbes.com/sites/brettowens/2017/01/16/5-trump-proof-pharma-dividends-up-to-5-3/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,5 Trump-Proof Pharma Dividends Up To 5.3%
TEVA,TEVA:US,BBG000C0CD58,Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended,2017-01-16 12:39:12 +0000,http://finance.yahoo.com/news/lilly-incyte-rheumatoid-arthritis-drug-123912305.html,Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended
TEVA,TEVA:US,BBG000C0CD58,Friday's ETF with Unusual Volume: GWL,2017-01-13 19:37:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rmJQURM-23A/fridays-etf-with-unusual-volume-gwl-cm733433,The SPDR S amp P World ex US ETF GWL is seeing unusually high volume in afternoon trading Friday with over 1 5 million shares traded versus three month average volume of about 239 000 Shares of GWL were up about 0 2 on the day Components of that ETF with the highest volume on
TEVA,TEVA:US,BBG000C0CD58,Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit,2017-01-13 14:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VzUn73dxtJE/lilly-wins-appeal-against-teva-in-alimta-patent-lawsuit-cm733160,Eli Lilly and Company LLY announced that it has received a favorable ruling in a lawsuit against generic drugmaker Teva Pharmaceutical Industries Limited TEVA related to the infringement of a vitamin regimen patent for its cancer drug Alimta by the U S Court of Appeals for the Federal
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Trump Targets Pharma Again, Merck Up on Keytruda News",2017-01-13 13:39:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cwbyLAch2ws/pharma-stock-roundup-trump-targets-pharma-again-merck-up-on-keytruda-news-cm733130,The sector was once again slammed by president elect Donald Trump s comments this week regarding drug pricing and other issues Read more Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again The drug pricing issue in fact overshadowed guidance updates and pipeline news presented at
TEVA,TEVA:US,BBG000C0CD58,Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit,2017-01-13 12:09:12 +0000,http://finance.yahoo.com/news/lilly-wins-appeal-against-teva-120912846.html,Lilly Wins Appeal Against Teva in Alimta Patent Lawsuit
TEVA,TEVA:US,BBG000C0CD58,Teva Loses Alimta Appeal Against Eli Lilly,2017-01-12 23:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pr-k3yyV6iw/teva-loses-alimta-appeal-against-eli-lilly-20170112-01002,Teva Loses Alimta Appeal Against Eli Lilly
TEVA,TEVA:US,BBG000C0CD58,10 Dividend Growth Stocks That Simply Print Money,2017-01-12 21:58:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9et4IdmsvAw/10-dividend-growth-stocks-that-simply-print-money-cm733007,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips History has taught us that dividend growth stocks are the absolute best way to grow both your income and wealth over time Source StockSnap io One such group of dividend stocks is known as the S amp P
TEVA,TEVA:US,BBG000C0CD58,Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva,2017-01-12 21:18:57 +0000,http://www.investors.com/news/technology/eli-lilly-rebounds-on-chemo-drug-patent-win-vs-generic-teva/,Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva
TEVA,TEVA:US,BBG000C0CD58,Patent Victory Secures Lilly Hold on Cancer Drug Until 2022,2017-01-12 20:39:00 +0000,https://www.thestreet.com/story/13952863/1/patent-victory-secures-lilly-hold-on-cancer-drug-until-2022.html?puc=yahoo&cm_ven=YAHOO,Patent Victory Secures Lilly Hold on Cancer Drug Until 2022
TEVA,TEVA:US,BBG000C0CD58,Eli Lilly's stock rallies after appeals court upholds favorable patent ruling,2017-01-12 17:26:27 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=7C41CABF-ACF7-4EAF-BDA8-9ED561B3EBEC&siteid=yhoof2,Eli Lilly's stock rallies after appeals court upholds favorable patent ruling
TEVA,TEVA:US,BBG000C0CD58,"IEFA, XTL: Big ETF Inflows",2017-01-12 16:59:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ibh5VS5xuN4/iefa-xtl-big-etf-inflows-cm732779,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF IEFA which added 9 800 000 units or a 3 3 increase week over week Among the largest underlying components of IEFA in
TEVA,TEVA:US,BBG000C0CD58,March 3rd Options Now Available For Teva Pharmaceutical Industries (TEVA),2017-01-12 16:58:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zVOMBcAythw/march-3rd-options-now-available-for-teva-pharmaceutical-industries-teva-cm732758,Investors in Teva Pharmaceutical Industries Ltd Symbol TEVA saw new options begin trading today for the March 3rd expiration At Stock Options Channel our YieldBoost formula has looked up and down the TEVA options chain for the new March 3rd contracts and identified one put and one
TEVA,TEVA:US,BBG000C0CD58,Lilly Jumps After Lung Cancer Drug Patent Upheld,2017-01-12 14:36:52 +0000,http://www.bloomberg.com/news/articles/2017-01-12/lilly-wins-appeal-upholding-patent-on-alimta-cancer-drug-ixuhatta?cmpid=yhoo.headline,Lilly Jumps After Lung Cancer Drug Patent Upheld
TEVA,TEVA:US,BBG000C0CD58,These 3 stocks may be the only true value plays left,2017-01-12 12:45:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=360A67EA-D820-11E6-AD98-6CAA2260FD2A&siteid=yhoof2,These 3 stocks may be the only true value plays left
TEVA,TEVA:US,BBG000C0CD58,Drug Stocks Tank As Trump Vows To Attack High Drug Prices,2017-01-11 21:21:47 +0000,http://www.investors.com/news/technology/drug-stocks-tank-as-trump-vows-to-attack-high-drug-prices/,Drug Stocks Tank As Trump Vows To Attack High Drug Prices
TEVA,TEVA:US,BBG000C0CD58,"Macy’s, Teva Join Wednesday’s 52-Week Low Club",2017-01-11 21:04:47 +0000,http://finance.yahoo.com/news/macy-teva-join-wednesday-52-210447359.html,"Macy’s, Teva Join Wednesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,New Strong Sell Stocks for January 11th,2017-01-11 17:56:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wb3xryJRfyY/new-strong-sell-stocks-for-january-11th-cm732262,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today Barrick Gold Corporation ABX is a leading international gold producer 160 The Zacks Consensus Estimate for its current year earnings has been revised 5 6 downward over the last 30 days Cisco Systems Inc CSCO
TEVA,TEVA:US,BBG000C0CD58,New Strong Sell Stocks for January 11th,2017-01-11 16:05:04 +0000,http://finance.yahoo.com/news/strong-sell-stocks-january-11th-160504520.html,New Strong Sell Stocks for January 11th
TEVA,TEVA:US,BBG000C0CD58,What's behind surge of puts in Teva,2017-01-10 12:45:51 +0000,http://finance.yahoo.com/news/whats-behind-surge-puts-teva-124551220.html,What's behind surge of puts in Teva
TEVA,TEVA:US,BBG000C0CD58,Merrimack (MACK) Sells Onivyde Rights to Ipsen for $1B,2017-01-10 01:48:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cop7aofBs0k/merrimack-mack-sells-onivyde-rights-to-ipsen-for-1b-cm731377,Merrimack Pharmaceuticals Inc MACK announced that it has entered into a definitive asset purchase and sale agreement with Ipsen for 1 0 billion along with milestone payment of up to 33 million Notably Merrimack has underperformed the Zacks classified 160 Medical Biomed
TEVA,TEVA:US,BBG000C0CD58,Teva Stock Gets Axed By Analysts,2017-01-09 23:21:00 +0000,http://www.investopedia.com/news/analysts-slash-tevas-ratings-teva/?partner=YahooSA,Teva Stock Gets Axed By Analysts
TEVA,TEVA:US,BBG000C0CD58,3 Top Dividend Stocks Selling for a Discount This Winter,2017-01-09 19:50:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y1xYk4u4Umo/3-top-dividend-stocks-selling-for-a-discount-this-winter-cm731237,Image source Getty Images Dividend stocks are often the driving force of a well rounded retirement portfolio They 160 offer three key advantages that can be quite attractive to long term investors 160 First they are a sign of a company s proven long term track record A
TEVA,TEVA:US,BBG000C0CD58,Merrimack Pharmaceuticals Inc (MACK) Stock Soars on Ipsen Deal,2017-01-09 19:49:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WzBnMTBlZwo/merrimack-pharmaceuticals-inc-mack-stock-soars-on-ipsen-deal-cm731236,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Merrimack Pharmaceuticals Inc NASDAQ MACK stock was up on Monday following news that it will sell some of its drugs to Ipsen The
TEVA,TEVA:US,BBG000C0CD58,"Kempner Capital Management Inc. Buys XL Group Ltd, Teva Pharmaceutical Industries Ltd, Gilead ...",2017-01-09 19:48:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KrUO80gTk5w/kempner-capital-management-inc-buys-xl-group-ltd-teva-pharmaceutical-industries-ltd-gilead-cm731269,Kempner Capital Management Inc New Purchases XLGILDZBHHPTMAIN Added Positions TEVA Reduced Positions WU BA DOW AMAT MRK WMT DOV C ALL UNP Sold Out IBM ERIC RTN ESV ADM DGX WPC New Purchases XLGILDZBHHPTMAINNew Purchases XLGILDZBHHPTMAIN Added Positions TEVA
TEVA,TEVA:US,BBG000C0CD58,Analysts Slash Teva Targets Following Disappointing Guidance,2017-01-09 18:56:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/09/analysts-slash-teva-targets-following-disappointing-guidance/?mod=yahoobarrons&ru=yahoo,Analysts Slash Teva Targets Following Disappointing Guidance
TEVA,TEVA:US,BBG000C0CD58,3 Top Dividend Stocks Selling for a Discount This Winter,2017-01-09 18:03:05 +0000,http://www.fool.com/investing/2017/01/09/3-top-dividend-stocks-selling-for-a-discount-this.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Dividend Stocks Selling for a Discount This Winter
TEVA,TEVA:US,BBG000C0CD58,"Stock Market News for January 09, 2017",2017-01-09 17:51:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mi6UPOwguXc/stock-market-news-for-january-09-2017-cm731142,Benchmarks posted modest gains on Friday following a solid December U S jobs report While job additions were steady last month workers pay surged at the fastest pace since the Great Recession This rise in hiring was spearheaded by health care providers financial firms
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd -- Moody's: Operating Headwinds Weigh On Teva's 2017 Deleveraging Plans -- A Credit Negative,2017-01-09 16:21:03 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_360436&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX1JhdGluZyBOZXdzX0FsbF9Fbmc=~20170109_PR_360436,Teva Pharmaceutical Industries Ltd -- Moody's: Operating Headwinds Weigh On Teva's 2017 Deleveraging Plans -- A Credit Negative
TEVA,TEVA:US,BBG000C0CD58,"Stock Market News for January 09, 2017",2017-01-09 15:10:03 +0000,http://finance.yahoo.com/news/stock-market-news-january-09-151003265.html,"Stock Market News for January 09, 2017"
TEVA,TEVA:US,BBG000C0CD58,Teva Falls on Disappointing 2017 Sales & Earnings Guidance,2017-01-09 14:53:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3B3GGPYOZl4/teva-falls-on-disappointing-2017-sales-earnings-guidance-cm730924,Teva Pharmaceutical Industries Ltd TEVA provided a weaker than expected sales and earnings guidance for 2017 seeing that its blockbuster multiple sclerosis drug Copaxone is reeling under competitive pressures Following the announcement shares of the Israeli generic pharmaceuticals
TEVA,TEVA:US,BBG000C0CD58,Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit,2017-01-09 14:52:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pp9f7lZbji0/impax-ipxl-applies-for-generic-aubagio-sanofi-files-lawsuit-cm730897,Impax Laboratories Inc IPXL announced that it has filed an Abbreviated New Drug application ANDA with the FDA for a generic version of Sanofi s Aubagio teriflunomide tablets 14 mg Aubagio has been approved for the treatment of relapsing forms of multiple sclerosis MS Impax s
TEVA,TEVA:US,BBG000C0CD58,Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit,2017-01-09 13:11:01 +0000,http://finance.yahoo.com/news/impax-ipxl-applies-generic-aubagio-131101999.html,Impax (IPXL) Applies for Generic Aubagio; Sanofi Files Lawsuit
TEVA,TEVA:US,BBG000C0CD58,Teva Falls on Disappointing 2017 Sales & Earnings Guidance,2017-01-09 12:39:12 +0000,http://finance.yahoo.com/news/teva-falls-disappointing-2017-sales-123912913.html,Teva Falls on Disappointing 2017 Sales & Earnings Guidance
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Completion of Sale of UK and Ireland Actavis Assets and Operations Following European Commission Approval,2017-01-09 12:30:00 +0000,http://uk.finance.yahoo.com/news/teva-announces-completion-sale-uk-123000607.html,Teva Announces Completion of Sale of UK and Ireland Actavis Assets and Operations Following European Commission Approval
TEVA,TEVA:US,BBG000C0CD58,"EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data",2017-01-08 22:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WoouSJVRzBk/exas-abuzz-mack-makes-deal-with-ipsen-xene-awaits-data-20170108-00044,"EXAS Abuzz, MACK Makes Deal With Ipsen, XENE Awaits Data"
TEVA,TEVA:US,BBG000C0CD58,"How to Trade the Week's Most Active Stocks -- Apple, AT&T, Chesapeake Energy and More",2017-01-07 14:00:00 +0000,https://www.thestreet.com/story/13945708/1/how-to-trade-the-week-s-most-active-stocks-apple-at-amp-t-chesapeake-energy-and-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade the Week's Most Active Stocks -- Apple, AT&T, Chesapeake Energy and More"
TEVA,TEVA:US,BBG000C0CD58,Here's Why Teva Pharmaceuticals is Plunging Today,2017-01-06 22:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_rONE72zsn0/heres-why-teva-pharmaceuticals-is-plunging-today-cm730605,On Friday shares of Teva Pharmaceuticals Industries TEVA are plunging down almost 7 7 in late afternoon trading after the company announced weaker than expected 2017 guidance The Israel based company now expects earnings per share in the range of 4 90 and 5 30 for fiscal 2017
TEVA,TEVA:US,BBG000C0CD58,Teva to Present at the 35th Annual J.P. Morgan Healthcare Conference,2017-01-06 21:01:00 +0000,http://finance.yahoo.com/news/teva-present-35th-annual-j-210100549.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the 35th Annual J.P. Morgan Healthcare Conference. Teva’s management will present on Monday, January 9, 2017 at 9:30 AM PST."
TEVA,TEVA:US,BBG000C0CD58,Here's Why Teva Pharmaceuticals is Plunging Today,2017-01-06 20:46:08 +0000,http://finance.yahoo.com/news/heres-why-teva-pharmaceuticals-plunging-204608642.html,Here's Why Teva Pharmaceuticals is Plunging Today
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical: What the Heck Does 'Focused on Execution' Mean Anyway?,2017-01-06 20:26:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/06/teva-pharmaceutical-what-the-heck-does-focused-on-execution-mean-anyway/?mod=yahoobarrons&ru=yahoo,Teva Pharmaceutical: What the Heck Does 'Focused on Execution' Mean Anyway?
TEVA,TEVA:US,BBG000C0CD58,Is Teva a Value Trap?,2017-01-06 20:26:00 +0000,http://www.investopedia.com/news/teva-plummets-weak-guidance-teva/?partner=YahooSA,Is Teva a Value Trap?
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceuticals Shares Are Losing Steam,2017-01-06 17:35:00 +0000,http://www.thestreet.com/video/13945394/here-is-why-teva-pharmaceuticals-shares-are-losing-steam.html?puc=yahoov&cm_ven=YAHOOV,Why Teva Pharmaceuticals Shares Are Losing Steam
TEVA,TEVA:US,BBG000C0CD58,Teva's Weak Forecast Leads to Fair Value Estimate Cut,2017-01-06 17:00:00 +0000,http://finance.yahoo.com/news/tevas-weak-forecast-leads-fair-170000635.html,Teva's Weak Forecast Leads to Fair Value Estimate Cut
TEVA,TEVA:US,BBG000C0CD58,Here's Why Teva Shares Are Plummeting,2017-01-06 16:26:00 +0000,https://www.thestreet.com/story/13945243/1/here-s-why-teva-shares-are-plummeting.html?puc=yahoo&cm_ven=YAHOO,Here's Why Teva Shares Are Plummeting
TEVA,TEVA:US,BBG000C0CD58,"Teva's 2017 revenue, profit forecasts miss as launch delays weigh",2017-01-06 16:19:38 +0000,http://finance.yahoo.com/news/tevas-2017-revenue-profit-forecasts-161938364.html,"Teva's 2017 revenue, profit forecasts miss as launch delays weigh"
TEVA,TEVA:US,BBG000C0CD58,Teva provides financial forecast – with a caveat,2017-01-06 16:00:08 +0000,http://www.bizjournals.com/philadelphia/news/2017/01/06/teva-revenue-projection-copaxone-patent-generic.html?ana=yahoo,Teva provides financial forecast – with a caveat
TEVA,TEVA:US,BBG000C0CD58,"UPDATE 1-Teva forecasts 2017 revenue, profit below estimates",2017-01-06 14:48:39 +0000,http://finance.yahoo.com/news/teva-forecasts-2017-revenue-profit-125804480.html,"UPDATE 1-Teva forecasts 2017 revenue, profit below estimates"
TEVA,TEVA:US,BBG000C0CD58,"Teva forecasts 2017 revenue, profit below estimates",2017-01-06 14:47:57 +0000,http://finance.yahoo.com/news/teva-forecasts-2017-revenue-profit-124546777.html,"Teva forecasts 2017 revenue, profit below estimates"
TEVA,TEVA:US,BBG000C0CD58,4 Factors That Sent Teva Pharmaceutical Industries Ltd. Sliding 45% in 2016,2017-01-06 14:40:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jn-BQsm0mIc/4-factors-that-sent-teva-pharmaceutical-industries-ltd-sliding-45-in-2016-cm730232,Image source Getty Images What happened Shares of Teva Pharmaceutical Industries NYSE TEVA an Israeli based developer of branded and generic drugs sank a mind numbing 45 in 2016 according to data from S amp P Global Market Intelligence The reason for the drop
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Jan 6, 2017 :  JCP, NOK, TEVA, BAC, SUM, FCAU, TLT, TVIX, OREX, QQQ, XIV, REGN",2017-01-06 13:56:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DkG3LWXaDgg/pre-market-most-active-for-jan-6-2017-jcp-nok-teva-bac-sum-fcau-tlt-tvix-orex-qqq-xiv-regn-cm730253,The NASDAQ 100 Pre Market Indicator is up 4 59 to 4 969 54 The total Pre Market volume is currently 7 043 418 shares traded The following are the most active stocks for the pre market session J C Penney Company Inc Holding Company JCP is 0 31 at 7 55 with 1 825
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Gives Downbeat Earnings Forecast,2017-01-06 13:12:39 +0000,http://www.wsj.com/articles/teva-gives-downbeat-earnings-forecast-1483708033?mod=yahoo_hs,[$$] Teva Gives Downbeat Earnings Forecast
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical issues 2017 guidance that is below expectations,2017-01-06 12:51:03 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=E9517CDD-FFD8-4130-8AA7-EC5D57AB6923&siteid=yhoof2,Teva Pharmaceutical issues 2017 guidance that is below expectations
TEVA,TEVA:US,BBG000C0CD58,4 Factors That Sent Teva Pharmaceutical Industries Ltd. Sliding 45% in 2016,2017-01-06 12:41:07 +0000,http://www.fool.com/investing/2017/01/06/4-factors-that-sent-teva-pharmaceutical-industries.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Factors That Sent Teva Pharmaceutical Industries Ltd. Sliding 45% in 2016
TEVA,TEVA:US,BBG000C0CD58,Teva Provides 2017 Financial Outlook,2017-01-06 12:30:00 +0000,http://finance.yahoo.com/news/teva-provides-2017-financial-outlook-123000638.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. provides its current outlook for non-GAAP financial performance for the year ending December 31, 2017."
TEVA,TEVA:US,BBG000C0CD58,Teva Sees FY17 Results Below View; Stock Down,2017-01-06 07:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/si5DlbYB-BY/teva-sees-fy17-results-below-view-stock-down-20170106-00165,Teva Sees FY17 Results Below View; Stock Down
TEVA,TEVA:US,BBG000C0CD58,Teva Sees FY17 Results Below View; Stock Down,2017-01-06 07:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AJujQKrzg5Q/teva-sees-fy17-results-below-view-stock-down-20170106-00164,Teva Sees FY17 Results Below View; Stock Down
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Business Outlook Conference Call At 8:00 AM ET,2017-01-06 07:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GlmFMZq8LAA/teva-pharmaceutical-industries-business-outlook-conference-call-at-800-am-et-20170106-00079,Teva Pharmaceutical Industries Business Outlook Conference Call At 8:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Business Outlook Conference Call At 8:00 AM ET,2017-01-06 06:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hNq53Jpi-NQ/teva-pharmaceutical-industries-business-outlook-conference-call-at-800-am-et-20170106-00078,Teva Pharmaceutical Industries Business Outlook Conference Call At 8:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,"Mylan, Novartis, Hikma Take On GSK In Generic Asthma Battle",2017-01-05 21:41:32 +0000,http://www.investors.com/news/technology/mylan-novartis-hikma-take-on-gsk-in-generic-asthma-battle/,"Mylan, Novartis, Hikma Take On GSK In Generic Asthma Battle"
TEVA,TEVA:US,BBG000C0CD58,"Teva to Host 2017 Business Outlook Conference Call and Webcast on January 6, 2017",2017-01-05 21:01:00 +0000,http://finance.yahoo.com/news/teva-host-2017-business-outlook-210100421.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. announced today that it will host a conference call and live webcast on Friday, January 6, 2017 at 8:00 a.m. ET."
TEVA,TEVA:US,BBG000C0CD58,Interesting TEVA Put And Call Options For February 24th,2017-01-05 17:39:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TmSvQmv3ADg/interesting-teva-put-and-call-options-for-february-24th-cm729897,Investors in Teva Pharmaceutical Industries Ltd Symbol TEVA saw new options begin trading today for the February 24th expiration At Stock Options Channel our YieldBoost formula has looked up and down the TEVA options chain for the new February 24th contracts and identified one put and
TEVA,TEVA:US,BBG000C0CD58,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare,2017-01-05 15:30:00 +0000,https://www.thestreet.com/story/13942819/1/six-happenings-you-won-t-want-to-miss-when-frisco-takes-center-stage-in-healthcare.html?puc=yahoo&cm_ven=YAHOO,Six Happenings You Won't Want to miss when 'Frisco Takes Center Stage in Healthcare
TEVA,TEVA:US,BBG000C0CD58,"Teva's Range of Products, Reach Make It a Solid Value Play in the Drug Sector",2017-01-05 12:15:00 +0000,https://www.thestreet.com/story/13942070/1/teva-s-range-of-products-reach-make-it-a-solid-value-play-in-the-drug-sector.html?puc=yahoo&cm_ven=YAHOO,"Teva's Range of Products, Reach Make It a Solid Value Play in the Drug Sector"
TEVA,TEVA:US,BBG000C0CD58,What Pharma and Healthcare Investors Should Watch For at JPM Next Week,2017-01-05 11:45:00 +0000,https://www.thestreet.com/story/13942732/1/what-pharma-and-healthcare-investors-should-watch-for-at-jpm-next-week.html?puc=yahoo&cm_ven=YAHOO,What Pharma and Healthcare Investors Should Watch For at JPM Next Week
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva: Tempering the 2017 Outlook,2017-01-04 19:06:00 +0000,http://www.barrons.com/articles/teva-tempering-the-2017-outlook-1483556806?mod=yahoobarrons&ru=yahoo,[$$] Teva: Tempering the 2017 Outlook
TEVA,TEVA:US,BBG000C0CD58,"IEFA, FDIV: Big ETF Inflows",2017-01-04 17:40:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4r6qPZjqjFc/iefa-fdiv-big-etf-inflows-cm729369,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the iShares Core MSCI EAFE ETF which added 7 200 000 units or a 2 5 increase week over week Among the largest underlying components of IEFA in morning trading
TEVA,TEVA:US,BBG000C0CD58,These Indicators Show the Bull Market Has More Room to Run in —…–7,2017-01-04 14:37:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WrJ9FZ8u1CM/these-indicators-show-the-bull-market-has-more-room-to-run-in-7-cm729160,Although the S amp P 500 is overvalued by P E current 25 76 average 15 63 and Shiller P E current 27 9 average 16 7 measures the market still has more upside according to the two economic indicators that I monitor the Chemical Activity Barometer CAB and the Chicago Fed
TEVA,TEVA:US,BBG000C0CD58,"Teva: Good Value, Questionable Management?",2017-01-04 14:36:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BROb7sU_3vQ/teva-good-value-questionable-management-cm729155,One of the few sectors that has the potential to offer returns in our opinion is the pharmaceutical sector Political claims sent pharma stocks into tailspin Both Hillary Clinton and President elect Donald Trump repeatedly campaigned that they wanted to lower drug prices It is difficult
TEVA,TEVA:US,BBG000C0CD58,Now's the Time to Embrace This Unloved Drug Stock,2017-01-04 12:28:00 +0000,https://www.thestreet.com/story/13939784/1/now-s-the-time-to-embrace-this-unloved-drug-stock.html?puc=yahoo&cm_ven=YAHOO,Now's the Time to Embrace This Unloved Drug Stock
TEVA,TEVA:US,BBG000C0CD58,Guggenheim Removes Teva From Best Ideas List,2017-01-03 21:06:00 +0000,http://www.investopedia.com/news/teva-and-healthcare-bounce-start-2017-teva/?partner=YahooSA,Guggenheim Removes Teva From Best Ideas List
TEVA,TEVA:US,BBG000C0CD58,GPM Reminds Investors of the January 5 Deadline in the Class Action Lawsuit Against Teva Pharmaceutical Industries Limited,2017-01-03 20:44:00 +0000,http://finance.yahoo.com/news/gpm-reminds-investors-january-5-204400797.html,"[Business Wire] - Glancy Prongay & Murray LLP reminds investors of the January 5, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased Teva Pharmaceutical Industries Limited securities between February 10, 2014 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Migraine Biologics Drugs Has Blockbuster Potential,2017-01-03 15:14:00 +0000,http://www.investopedia.com/news/blockbuster-potential-migraine-drugs-amgn-aldr/?partner=YahooSA,Migraine Biologics Drugs Has Blockbuster Potential
TEVA,TEVA:US,BBG000C0CD58,Meet Miami's Renaissance Billionaire,2017-01-03 14:15:00 +0000,http://www.forbes.com/sites/schifrin/2017/01/03/meet-miamis-renaissance-billionaire/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahoofeed&partner=yahoomag,Meet Miami's Renaissance Billionaire
TEVA,TEVA:US,BBG000C0CD58,"Teva: Good Value, Questionable Management?",2017-01-02 22:58:03 +0000,http://finance.yahoo.com/news/teva-good-value-questionable-management-225803280.html,"Teva: Good Value, Questionable Management?"
TEVA,TEVA:US,BBG000C0CD58,4 Stocks Reach Their ‘-Year Low Prices,2017-01-01 18:56:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bdV4ppBU6Mw/4-stocks-reach-their-year-low-prices-cm728284,Teva Pharmaceutical Industries Ltd TEVA Fomento Economico Mexicano SAB de CV FMX VF Corp VFC and Cerner Corp CERN have reached their three year lows Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd TEVA Fomento Economico Mexicano SAB
TEVA,TEVA:US,BBG000C0CD58,4 Stocks Reach Their 3-Year Low Prices,2016-12-31 22:02:46 +0000,http://finance.yahoo.com/news/4-stocks-reach-3-low-220246162.html,4 Stocks Reach Their 3-Year Low Prices
TEVA,TEVA:US,BBG000C0CD58,3 Sleeper Biotechs That Could Bounce Back Strong in 2017,2016-12-30 16:15:37 +0000,http://finance.yahoo.com/news/3-sleeper-biotechs-could-bounce-161537373.html,3 Sleeper Biotechs That Could Bounce Back Strong in 2017
TEVA,TEVA:US,BBG000C0CD58,January 5 Deadline Alert: Law Offices of Howard G. Smith Reminds Teva Pharmaceutical Industries Limited Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm,2016-12-30 15:30:00 +0000,http://finance.yahoo.com/news/january-5-deadline-alert-law-153000875.html,"[Business Wire] - Law Offices of Howard G. Smith reminds investors of the upcoming January 5, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Teva Pharmaceutical Industries Limited securities between February 10, 2014 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Securities Law Firms Seeking Lead Plaintiffs In Class Action Suit Against Teva Pharmaceutical Industries Ltd (ADR) (TEVA),2016-12-30 13:57:21 +0000,http://www.insidermonkey.com/blog/securities-law-firms-seeking-lead-plaintiffs-in-class-action-suit-against-teva-pharmaceutical-industries-ltd-adr-teva-513735/,Securities Law Firms Seeking Lead Plaintiffs In Class Action Suit Against Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
TEVA,TEVA:US,BBG000C0CD58,10 Good Stocks That Are Flying Under the Radar,2016-12-30 13:30:02 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S015-the-10-best-under-the-radar-stocks-to-buy-for-2017/index.html?rid=SYN-yahoo&rpageid=15875,10 Good Stocks That Are Flying Under the Radar
TEVA,TEVA:US,BBG000C0CD58,"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors with Losses in Excess of $1,000,000 of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-12-29 15:34:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-153400514.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 29, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,"DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) & Lead Plaintiff Deadline - January 5, 2017",2016-12-29 15:10:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-151000042.html,"[GlobeNewswire] - NEW YORK, Dec. 29, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited and certain ..."
TEVA,TEVA:US,BBG000C0CD58,Healthcare: What Does a Trump Administration Mean for Healthcare Stocks?,2016-12-29 12:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=784804&SR=Yahoo,Healthcare: What Does a Trump Administration Mean for Healthcare Stocks?
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $250,000 Investing in Teva Pharmaceutical Industries Ltd. to Contact the Firm Before Imminent Lead Plaintiff Deadline",2016-12-28 21:44:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-214400566.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 28, 2016 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teva Pharmaceutical Industries Ltd. (""Teva"" or the ""Company"") ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Agrees To Settle With The SEC Over Corruption Charges,2016-12-28 20:40:53 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-teva-agrees-to-settle-with-the-sec-over-corruption-charges-513572/,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Agrees To Settle With The SEC Over Corruption Charges
TEVA,TEVA:US,BBG000C0CD58,"DEADLINE ALERT: Brower Piven Reminds Investors Of The January 5, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Teva Pharmaceutical Industries Limited To Contact The Firm ",2016-12-28 20:06:34 +0000,http://finance.yahoo.com/news/deadline-alert-brower-piven-reminds-200634348.html,"[GlobeNewswire] - STEVENSON, Md., Dec. 28, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
TEVA,TEVA:US,BBG000C0CD58,Short Interest Rises in Major Pharma,2016-12-28 15:25:59 +0000,http://finance.yahoo.com/news/short-interest-rises-major-pharma-152559380.html,Short Interest Rises in Major Pharma
TEVA,TEVA:US,BBG000C0CD58,Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited,2016-12-27 23:34:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-llp-files-233400727.html,"[Business Wire] - Glancy Prongay & Murray LLP announces that it has filed a class action lawsuit in the United States District Court for the Central District of California on behalf of a class consisting of persons and entities that purchased or otherwise acquired Teva Pharmaceutical Industries Limited securities between February 10, 2014 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Teva Agrees to Pay Over $500 Million for FCPA Violations,2016-12-27 17:40:42 +0000,http://finance.yahoo.com/news/teva-agrees-pay-over-500-174042462.html,Teva Agrees to Pay Over $500 Million for FCPA Violations
TEVA,TEVA:US,BBG000C0CD58,"TEVA REMINDER: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important January 5 Deadline in Class Action Filed by Firm- TEVA",2016-12-27 14:00:00 +0000,http://finance.yahoo.com/news/teva-reminder-investors-losses-excess-140000920.html,"[GlobeNewswire] - NEW YORK, Dec. 27, 2016-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Shares of Teva Pharmaceutical Industries Limited between February 10, 2015 and ..."
TEVA,TEVA:US,BBG000C0CD58,December Delivers Again for FCPA Enforcement Watchers,2016-12-23 21:54:44 +0000,http://blogs.wsj.com/riskandcompliance/2016/12/23/december-delivers-again-for-fcpa-enforcement-watchers/?mod=yahoo_hs,December Delivers Again for FCPA Enforcement Watchers
TEVA,TEVA:US,BBG000C0CD58,US Accelerates Pursuit Of Companies For FCPA Violations,2016-12-23 19:20:00 +0000,http://www.forbes.com/sites/erikakelton/2016/12/23/us-accelerates-pursuit-of-companies-for-fcpa-violations/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,US Accelerates Pursuit Of Companies For FCPA Violations
TEVA,TEVA:US,BBG000C0CD58,Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse,2016-12-23 15:11:28 +0000,http://www.investors.com/news/technology/allergan-outlook-improves-on-good-trial-for-colon-drug-credit-suisse/,Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse
TEVA,TEVA:US,BBG000C0CD58,Teva Settles Foreign Bribery Charges with U.S. Government,2016-12-23 15:00:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TBW9cCfqG4c/teva-settles-foreign-bribery-charges-with-us-government-cm725579,Pharmaceutical giant Teva Pharmaceuticals Industries Ltd TEVA announced that it has completed negotiations with the U S government over violations of the Foreign Corrupt Practices Act FCPA A look at Teva s year to date share price movement shows that the company has underperformed
TEVA,TEVA:US,BBG000C0CD58,Teva Settles Foreign Bribery Charges with U.S. Government,2016-12-23 13:16:01 +0000,http://finance.yahoo.com/news/teva-settles-foreign-bribery-charges-131601518.html,Teva Settles Foreign Bribery Charges with U.S. Government
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Settles Foreign Corruption Probe for $519 Million,2016-12-23 05:10:29 +0000,http://www.wsj.com/articles/teva-settles-foreign-corruption-probe-for-519-million-1482418901?ru=yahoo?mod=yahoo_itp,[$$] Teva Settles Foreign Corruption Probe for $519 Million
TEVA,TEVA:US,BBG000C0CD58,Teva Settles Charges in U.S. -- WSJ,2016-12-23 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YQHyE8PJxiM/teva-settles-charges-in-us--wsj-20161223-00054,Teva Settles Charges in U.S. -- WSJ
TEVA,TEVA:US,BBG000C0CD58,"Drastic Drug-Price Action No Trump Card, Says Needham",2016-12-22 21:08:05 +0000,http://www.investors.com/news/technology/drastic-drug-price-action-no-trump-card-says-needham/,"Drastic Drug-Price Action No Trump Card, Says Needham"
TEVA,TEVA:US,BBG000C0CD58,Thursday's ETF with Unusual Volume: IXUS,2016-12-22 19:57:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YwD1LGsosDQ/thursdays-etf-with-unusual-volume-ixus-cm725313,The iShares Core MSCI Total International Stock ETF IXUS is seeing unusually high volume in afternoon trading Thursday with over 1 9 million shares traded versus three month average volume of about 415 000 Shares of IXUS were off about 0 3 on the day Components of that ETF with
TEVA,TEVA:US,BBG000C0CD58,Teva Spikes After Settling On Corruption Probe,2016-12-22 18:56:00 +0000,http://www.investopedia.com/news/teva-pay-519m-connection-probe-teva/?partner=YahooSA,Teva Spikes After Settling On Corruption Probe
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical: It Ain't Over 'Til It's Over,2016-12-22 18:52:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/22/teva-pharmaceutical-it-aint-over-til-its-over/?mod=yahoobarrons&ru=yahoo,Teva Pharmaceutical: It Ain't Over 'Til It's Over
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva agrees $519m settlement of anti-bribery charges,2016-12-22 18:21:08 +0000,"http://www.ft.com/cms/s/4ca96a8e-c865-11e6-8f29-9445cac8966f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Teva, the world's largest maker of generic drugs, has agreed to pay more than $519m to settle charges that it violated US anti-bribery laws by making improper payments to government officials in Russia, ..."
TEVA,TEVA:US,BBG000C0CD58,Teva to pay U.S. government $519 million over foreign bribery charges,2016-12-22 17:59:20 +0000,http://finance.yahoo.com/news/teva-pay-u-government-519-145933181.html,"[Reuters] - Teva Pharmaceutical Industries (TEVA.TA) agreed to pay more than $519 million to settle U.S. criminal and civil allegations that the company bribed overseas officials to gain business for its medications, the U.S. Department of Justice said on Thursday. The company paid millions of dollars in bribes to officials in Mexico, Russia and Ukraine to promote its products such as its blockbuster multiple sclerosis drug Copaxone, the Justice Department said. Teva will pay a $283 million penalty to settle Foreign Corrupt Practices Act allegations with the Justice Department."
TEVA,TEVA:US,BBG000C0CD58,Teva to pay U.S. government $519 mln over foreign bribery charges,2016-12-22 17:54:26 +0000,http://finance.yahoo.com/news/teva-pay-us-government-519-153658254.html,"[Reuters] - Teva Pharmaceutical Industries agreed to pay more than $519 million to settle U.S. criminal and civil allegations that the company bribed overseas officials to gain business for its medications, the U.S. Department of Justice said on Thursday. The company paid millions of dollars in bribes to officials in Mexico, Russia and Ukraine to promote its products such as its blockbuster multiple sclerosis drug Copaxone, the Justice Department said. Teva will pay a $283 million penalty to settle Foreign Corrupt Practices Act allegations with the Justice Department."
TEVA,TEVA:US,BBG000C0CD58,These Billionaire Michael Price’s Stock Picks Can Destroy Your Portfolio,2016-12-22 16:44:52 +0000,http://www.insidermonkey.com/blog/these-billionaire-michael-prices-stock-picks-can-destroy-your-portfolio-512650/,These Billionaire Michael Price’s Stock Picks Can Destroy Your Portfolio
TEVA,TEVA:US,BBG000C0CD58,Israeli drugmaker Teva fined $519 mn in US for foreign bribes,2016-12-22 16:40:04 +0000,http://uk.finance.yahoo.com/news/israeli-drugmaker-teva-fined-519-161140864.html,Israeli drugmaker Teva fined $519 mn in US for foreign bribes
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Settles Foreign Corruption Probe for $519 Million,2016-12-22 16:35:11 +0000,http://www.wsj.com/articles/teva-settles-foreign-corruption-probe-for-519-million-1482418901?mod=yahoo_hs,[$$] Teva Settles Foreign Corruption Probe for $519 Million
TEVA,TEVA:US,BBG000C0CD58,Teva Will Pay $519 Million to Settle Foreign Bribery Charges; Shares Jump,2016-12-22 16:30:00 +0000,https://www.thestreet.com/story/13935581/1/teva-will-pay-519-million-to-settle-foreign-bribery-charges-shares-jump-on-news.html?puc=yahoo&cm_ven=YAHOO,Teva Will Pay $519 Million to Settle Foreign Bribery Charges; Shares Jump
TEVA,TEVA:US,BBG000C0CD58,Teva to pay $519M to resolve bribery allegations,2016-12-22 16:00:09 +0000,http://www.bizjournals.com/philadelphia/news/2016/12/22/teva-bribery-russia-sec-justice-department.html?ana=yahoo,Teva to pay $519M to resolve bribery allegations
TEVA,TEVA:US,BBG000C0CD58,"SEC, DOJ fine Teva Pharmaceutical $519 million to settle foreign bribery charges",2016-12-22 15:55:24 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=2C4E44DB-4047-4ED7-B699-C78A6C38DAA3&siteid=yhoof2,"SEC, DOJ fine Teva Pharmaceutical $519 million to settle foreign bribery charges"
TEVA,TEVA:US,BBG000C0CD58,Teva agrees to pay more than $519 million to settle bribe allegations: DoJ,2016-12-22 15:51:51 +0000,http://finance.yahoo.com/news/teva-agrees-pay-more-519-155151486.html,"[Reuters] - Teva Pharmaceutical Industries agreed to pay more than $519 million to settle criminal and civil allegations that the company paid bribes to officials in Mexico, Ukraine and Russia to bolster sales of ..."
TEVA,TEVA:US,BBG000C0CD58,Teva agrees to pay more than $519 mln to settle bribe allegations - DoJ,2016-12-22 15:49:46 +0000,http://finance.yahoo.com/news/teva-agrees-pay-more-519-154946467.html,"[Reuters] - Teva Pharmaceutical Industries agreed to pay more than $519 million to settle criminal and civil allegations that the company paid bribes to officials in Mexico, Ukraine and Russia to bolster sales of ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Settles Foreign Corruption Probe for $519 Million -- 2nd Update,2016-12-22 15:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qAtreSCEbc0/teva-settles-foreign-corruption-probe-for-519-million--2nd-update-20161222-00642,Teva Settles Foreign Corruption Probe for $519 Million -- 2nd Update
TEVA,TEVA:US,BBG000C0CD58,Teva to pay US government $519 mln over foreign bribery charges,2016-12-22 14:57:15 +0000,http://finance.yahoo.com/news/teva-pay-us-government-519-145715688.html,"[Reuters] - Israel's Teva Pharmaceutical Industries Ltd , said on Thursday it had agreed to pay $519 million to resolve charges related to the U.S. Foreign Corrupt Practices Act. The settlement with the Department of Justice and the Securities and Exchange Commission relates to conduct in Ukraine, Mexico and a guilty plea by a subsidiary in Russia, and followed a voluntary investigation, Teva said. Details of the misconduct, which Teva said ended several years ago, were not disclosed."
TEVA,TEVA:US,BBG000C0CD58,Teva Reaches Settlement with Government on FCPA,2016-12-22 14:15:00 +0000,http://finance.yahoo.com/news/teva-reaches-settlement-government-fcpa-141500650.html,"[Business Wire] - Teva Pharmaceuticals Industries Ltd., announced today the conclusion of negotiations with the United States government over violations of the Foreign Corrupt Practices Act ."
TEVA,TEVA:US,BBG000C0CD58,Teva Settles Foreign Corruption Probe for $519 Million--Update,2016-12-22 11:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6povFS8DqSk/teva-settles-foreign-corruption-probe-for-519-millionupdate-20161222-00495,Teva Settles Foreign Corruption Probe for $519 Million--Update
TEVA,TEVA:US,BBG000C0CD58,Teva Settles Foreign Corruption Probe for $519 million,2016-12-22 10:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VQiDjHqYd-U/teva-settles-foreign-corruption-probe-for-519-million-20161222-00440,Teva Settles Foreign Corruption Probe for $519 million
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Settlement For Violation Of Foreign Corrupt Practices Act,2016-12-22 10:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EthtRbRb9MU/teva-announces-settlement-for-violation-of-foreign-corrupt-practices-act-20161222-00430,Teva Announces Settlement For Violation Of Foreign Corrupt Practices Act
TEVA,TEVA:US,BBG000C0CD58,Allergan: Why LifeCell Deal is a 'Christmas Miracle!',2016-12-21 18:06:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/21/allergan-why-lifecell-deal-is-a-christmas-miracle/?mod=yahoobarrons&ru=yahoo,Allergan: Why LifeCell Deal is a 'Christmas Miracle!'
TEVA,TEVA:US,BBG000C0CD58,Allergan to Buy LifeCell to Boost Regenerative Medicine Suite,2016-12-21 14:59:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yzdaDHK4aVQ/allergan-to-buy-lifecell-to-boost-regenerative-medicine-suite-cm724428,Allergan plc AGN announced that it has signed a definitive agreement to acquire LifeCell the regenerative medicine unit of Texas based privately held company Acelity for 2 9 billion in cash Allergan s share price was up 1 3 in the past one month outperforming the 0 6 increase for the
TEVA,TEVA:US,BBG000C0CD58,5 Steps To Buying Biotech Stocks,2016-12-21 14:58:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PhgbFj4OlDY/5-steps-to-buying-biotech-stocks-cm724431,Image source Getty Images Biotech investing is risky Very risky Historically only 10 of drugs in clinical trials make it to market and with steep odds like that it s easy to understand why biotech stocks are more prone to significant pops and drops than stocks in
TEVA,TEVA:US,BBG000C0CD58,Impax Searches for a New CEO,2016-12-20 15:55:00 +0000,https://www.thestreet.com/story/13932722/1/impax-searches-for-a-new-ceo.html?puc=yahoo&cm_ven=YAHOO,Impax Searches for a New CEO
TEVA,TEVA:US,BBG000C0CD58,3 Stocks the Smartest Investors are Buying Right Now,2016-12-20 13:57:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nWpY-zNc_6Q/3-stocks-the-smartest-investors-are-buying-right-now-cm723750,Image source Getty Images The stock market can be a tricky place for both seasoned and novice investors from time to time Sometimes stock valuations head lower for perfectly valid reasons such as a series of poor earnings reports a delayed product launch or growing
TEVA,TEVA:US,BBG000C0CD58,3 Stocks the Smartest Investors are Buying Right Now,2016-12-20 12:36:20 +0000,http://www.fool.com/investing/2016/12/20/3-stocks-the-smartest-investors-are-buying-right-n.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks the Smartest Investors are Buying Right Now
TEVA,TEVA:US,BBG000C0CD58,Analysts Mixed on Health Care Stocks in the New Year,2016-12-19 22:31:00 +0000,https://www.thestreet.com/story/13931642/1/analysts-mixed-on-healthcare-stocks-in-the-new-year.html?puc=yahoo&cm_ven=YAHOO,Analysts Mixed on Health Care Stocks in the New Year
TEVA,TEVA:US,BBG000C0CD58,Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks,2016-12-19 21:16:15 +0000,http://www.investors.com/news/technology/supernus-pharmaceuticls-breaks-out-on-up-day-for-biotech-stocks/,Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks
TEVA,TEVA:US,BBG000C0CD58,ANTARES PHARMA ANNOUNCES THE SUCCESSFUL COMPLETION OF TEVA’S DECENTRALIZED PROCEDURE FOR TERIPARATIDE INJECTION IN EUROPE READ,2016-12-19 19:51:07 +0000,http://www.publicnow.com/view/F83236B0C5EDEEEF9EC54CCB365C855E6574FB20,[at noodls] - NEWS RELEASE ANTARES PHARMA ANNOUNCES THE SUCCESSFUL COMPLETION OF TEVA'S DECENTRALIZED PROCEDURE FOR TERIPARATIDE INJECTION IN EUROPE Teriparatide Injection Represents the First Product Approved in Europe ...
TEVA,TEVA:US,BBG000C0CD58,iShares Core MSCI EAFE ETF Experiences Big Inflow,2016-12-19 17:59:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hpn0jzWaRjw/ishares-core-msci-eafe-etf-experiences-big-inflow-cm723404,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 430 2 million dollar inflow that s a 2 9 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Launches Authorized Generic EpiPen at $300,2016-12-19 16:02:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kuo_sdpFYV8/mylan-myl-launches-authorized-generic-epipen-at-300-cm723235,Mylan N V MYL announced the launch of the first generic version of its life saving allergy treatment EpiPen auto injector at more than 50 discount on the branded product s price The generic EpiPen will have a list price of 300 for a pack of two and will reach pharmacies beginning this
TEVA,TEVA:US,BBG000C0CD58,3 Large-Cap Stocks Worth Buying in 2017,2016-12-19 16:00:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DOSOL5CHQzg/3-large-cap-stocks-worth-buying-in-2017-cm723227,Image source Getty Images 2016 began about as ugly as imaginable for investors but it sure looks to be ending on a high note After opening with the worst two week losses in history to begin a year all three major U S indexes are seemingly knocking on the door of new all time
TEVA,TEVA:US,BBG000C0CD58,3 Large-Cap Stocks Worth Buying in 2017,2016-12-19 14:20:06 +0000,http://www.fool.com/retirement/2016/12/19/3-large-cap-stocks-worth-buying-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Large-Cap Stocks Worth Buying in 2017
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Most Active for Dec 19, 2016 :  BAC, AZN, VEDL, DB, SDRL, TEVA, TVIX, QQQ, XIV, NVDA, MU, AAPL",2016-12-19 13:57:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mDExsPexcP0/pre-market-most-active-for-dec-19-2016-bac-azn-vedl-db-sdrl-teva-tvix-qqq-xiv-nvda-mu-aapl-cm723099,The NASDAQ 100 Pre Market Indicator is up 2 63 to 4 917 49 The total Pre Market volume is currently 3 849 192 shares traded The following are the most active stocks for the pre market session Bank of America Corporation BAC is 0 03 at 22 63 with 415 390 shares
TEVA,TEVA:US,BBG000C0CD58,The Drug Price-Fixing Probe Is Just the Beginning,2016-12-19 08:00:00 +0000,http://www.investopedia.com/news/drug-pricefixing-probe-just-beginning-myl-teva/?partner=YahooSA,The Drug Price-Fixing Probe Is Just the Beginning
TEVA,TEVA:US,BBG000C0CD58,Why You Should Avoid These Stock Picks of Billionaire John Paulson,2016-12-18 03:18:53 +0000,http://www.insidermonkey.com/blog/why-you-should-avoid-these-stock-picks-of-billionaire-john-paulson-511583/,Why You Should Avoid These Stock Picks of Billionaire John Paulson
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Teva Pharmaceutical Industries Ltd. To Contact The Firm Before Lead Plaintiff Deadline",2016-12-17 12:05:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-120500099.html,"[PR Newswire] - NEW YORK, Dec. 17, 2016 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teva Pharmaceutical Industries Ltd. (""Teva"" or the ""Company"") (TEVA) of the January 2, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased American Depositary Shares (""ADSs"") of Teva between February 10, 2015 and November 3, 2016 (the ""Class Period""). The case, Galmi v. Teva Pharmaceutical Industries Limited et al, No. 2:16-cv-08259 was filed on November 6, 2016."
TEVA,TEVA:US,BBG000C0CD58,"TEVA SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $500,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited – TEVA",2016-12-17 03:50:00 +0000,http://finance.yahoo.com/news/teva-shareholder-alert-former-louisiana-035000652.html,"[Business Wire] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 5, 2017 to file lead plaintiff applications in securities class action lawsuits against Teva Pharmaceutical Industries Limited , if they purchased the Company’s American Depositary Shares between February 10, 2014 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Mylan Launching Cheaper EpiPen Generic Amid Drug Pricing Saga,2016-12-16 21:06:43 +0000,http://www.investors.com/news/technology/mylan-launching-cheaper-epipen-generic-amid-drug-pricing-saga/,Mylan Launching Cheaper EpiPen Generic Amid Drug Pricing Saga
TEVA,TEVA:US,BBG000C0CD58,[$$] Generic Drug Price-Fixing Case May Grow in Scope,2016-12-16 16:51:00 +0000,http://www.barrons.com/articles/generic-drug-price-fixing-case-may-grow-in-scope-1481907074?mod=yahoobarrons&ru=yahoo,[$$] Generic Drug Price-Fixing Case May Grow in Scope
TEVA,TEVA:US,BBG000C0CD58,"20 States Sue Teva, Mylan & Other Drug Companies for Price Fixing",2016-12-16 15:01:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v83RDLUqEq8/20-states-sue-teva-mylan-other-drug-companies-for-price-fixing-cm722378,Just a day after the first charges were filed by the U S Department of Justice DoJ Antitrust Division in an investigation related to generic drug pricing Read more Generic Stocks Feel Pricing Heat 1st Charges Filed in DoJ Antitrust Probe New York Attorney General A G Eric
TEVA,TEVA:US,BBG000C0CD58,Local generic drug company is 1 of 6 accused by 20 states in price-fixing lawsuit,2016-12-16 13:40:11 +0000,http://www.bizjournals.com/philadelphia/news/2016/12/16/local-generic-drug-company-is-1-of-6-accused-by-20.html?ana=yahoo,Local generic drug company is 1 of 6 accused by 20 states in price-fixing lawsuit
TEVA,TEVA:US,BBG000C0CD58,"20 States Sue Teva, Mylan & Other Drug Companies for Price Fixing",2016-12-16 12:34:12 +0000,http://finance.yahoo.com/news/20-states-sue-teva-mylan-123412271.html,"20 States Sue Teva, Mylan & Other Drug Companies for Price Fixing"
TEVA,TEVA:US,BBG000C0CD58,"Actavis UK raised drug prices 12,000 pct, watchdog finds",2016-12-16 11:20:42 +0000,http://uk.finance.yahoo.com/news/actavis-uk-raised-drug-prices-112042495.html,"[Reuters - UK Focus] - Dec (Shanghai: 600875.SS - news) 16 (Reuters) - Drug maker Actavis UK broke competition law by raising prices of hydrocortisone tablets by more than 12,000 percent, Britain's competition watchdog said in a provisional ruling on Friday. ""Although the pricing of the acquired Actavis product, Hydrocortisone, under investigation was never under Teva's effective control, Teva believes that intervention by the CMA in prices for generic medicines raises serious policy concerns regarding the roles of both the CMA and the Department of Health,"" the company said in an emailed statement."
TEVA,TEVA:US,BBG000C0CD58,5 Fairly Valued Dividend Growth Stocks In The Healthcare Sector,2016-12-15 23:57:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f2spy4F0nn4/5-fairly-valued-dividend-growth-stocks-in-the-healthcare-sector-cm722218,By Chuck Carnevale ByChuck Carnevale Introduction IntroductionIntroduction President elect Donald Trump recently commented in a Time magazine interview that he ll bring down drug prices Apparently the president elect s remarks were not well received by the market because they led to
TEVA,TEVA:US,BBG000C0CD58,"Mylan, Teva Among 6 Pharmas Sued In Alleged Price-Fixing Scheme",2016-12-15 21:43:11 +0000,http://www.investors.com/news/technology/mylan-teva-among-6-pharmas-sued-in-alleged-price-fixing-scheme/,"Mylan, Teva Among 6 Pharmas Sued In Alleged Price-Fixing Scheme"
TEVA,TEVA:US,BBG000C0CD58,"Mylan, Teva Sued Over Drug Pricing",2016-12-15 21:18:38 +0000,http://finance.yahoo.com/video/mylan-teva-sued-over-drug-211838733.html,"Mylan, Teva Sued Over Drug Pricing"
TEVA,TEVA:US,BBG000C0CD58,"U.S. states sue Mylan, Teva, others for fixing drug prices",2016-12-15 19:06:32 +0000,http://finance.yahoo.com/news/u-states-sue-mylan-teva-164431362.html,"[Reuters] - Two years after high generic drug prices became a public controversy, legal cases are starting to land. Twenty states filed a lawsuit Thursday against Mylan NV , Teva Pharmaceuticals and four other generic drug makers, saying they conspired over steak dinners and ""girls nights out"" on pricing of two common generic drugs, according to a copy of the complaint."
TEVA,TEVA:US,BBG000C0CD58,20 state attorneys general are suing 6 generic drugmakers over collusion and price fixing,2016-12-15 16:35:00 +0000,http://finance.yahoo.com/news/20-state-attorneys-general-suing-161830475.html,20 state attorneys general are suing 6 generic drugmakers over collusion and price fixing
TEVA,TEVA:US,BBG000C0CD58,"Generic Stocks Feel Pricing Heat, 1st Charges Filed in DoJ Antitrust Probe",2016-12-15 13:59:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_orgWFweJ98/generic-stocks-feel-pricing-heat-1st-charges-filed-in-doj-antitrust-probe-cm721758,Key generic drugmakers saw their shares sliding on news that the first charges have been brought by the antitrust division in the investigation related to generic drug pricing The Department of Justice DoJ said that two former senior executives Jeffrey Glazer the erstwhile CEO of a
TEVA,TEVA:US,BBG000C0CD58,Wednesday's ETF with Unusual Volume: EFG,2016-12-14 21:57:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eMbox-nI76I/wednesdays-etf-with-unusual-volume-efg-cm721555,The iShares MSCI EAFE Growth ETF EFG is seeing unusually high volume in afternoon trading Wednesday with over 1 1 million shares traded versus three month average volume of about 236 000 Shares of EFG were down about 1 5 on the day Components of that ETF with the highest volume
TEVA,TEVA:US,BBG000C0CD58,"DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall",2016-12-14 21:22:02 +0000,http://www.investors.com/news/technology/doj-charges-pharma-execs-with-price-fixing-teva-mylan-stocks-topple/,"DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall"
TEVA,TEVA:US,BBG000C0CD58,Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceuticals Investors and Encourages Investors to Contact the Firm,2016-12-14 19:28:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-llp-announces-192800024.html,"[Business Wire] - Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Teva Pharmaceuticals securities between February 10, 2015 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,DOJ Files Charges in Generic Drug Price-Fixing Investigation,2016-12-14 17:51:00 +0000,https://www.thestreet.com/story/13925956/1/doj-files-charges-in-generic-drug-fixing-investigation.html?puc=yahoo&cm_ven=YAHOO,DOJ Files Charges in Generic Drug Price-Fixing Investigation
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks That Won't Be This Discounted for Long,2016-12-13 19:57:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PI0QjpEAp3M/3-dividend-stocks-that-wont-be-this-discounted-for-long-cm720910,Getting paid to invest by earning a steady stream of income through dividend payments is a valuable component of any portfolio strategy Image source Getty Images Dividends are a great way for investors to see a steady stream of returns on their investments and many companies strive
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks That Won't Be This Discounted for Long,2016-12-13 18:40:00 +0000,http://www.fool.com/investing/2016/12/13/3-dividend-stocks-that-wont-be-this-discounted-for.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Dividend Stocks That Won't Be This Discounted for Long
TEVA,TEVA:US,BBG000C0CD58,Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA,2016-12-12 23:23:48 +0000,http://finance.yahoo.com/news/rosen-law-firm-announces-filing-232348803.html,"[GlobeNewswire] - NEW YORK, Dec. 12, 2016-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the American Depositary Shares of Teva Pharmaceutical ..."
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Back Way Off Major Pharma Stocks,2016-12-12 13:44:06 +0000,http://247wallst.com/healthcare-business/2016/12/12/short-sellers-back-way-off-major-pharma-stocks/,Short Sellers Back Way Off Major Pharma Stocks
TEVA,TEVA:US,BBG000C0CD58,Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents,2016-12-09 21:12:00 +0000,https://www.thestreet.com/story/13921090/1/allergan-unhappy-with-patent-office-decision-to-allow-mylan-challenge-to-restasis-patents.html?puc=yahoo&cm_ven=YAHOO,Allergan Unhappy with Patent Office Decision to Allow Mylan Challenge to Restasis Patents
TEVA,TEVA:US,BBG000C0CD58,Don't Give Up on Battered Teva Stock; a Turnaround Is Coming,2016-12-09 14:38:00 +0000,https://www.thestreet.com/story/13919805/1/don-t-give-up-on-battered-teva-stock-a-turnaround-is-coming.html?puc=yahoo&cm_ven=YAHOO,Don't Give Up on Battered Teva Stock; a Turnaround Is Coming
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Are Jumping Over 3%,2016-12-08 16:39:00 +0000,http://www.investopedia.com/news/teva-gets-boost-ceos-positive-comments-teva/?partner=YahooSA,Teva Shares Are Jumping Over 3%
TEVA,TEVA:US,BBG000C0CD58,"Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Teva Pharmaceutical Industries Limited (NYSE: TEVA) Securities Case",2016-12-08 16:07:31 +0000,http://finance.yahoo.com/news/scott-scott-attorneys-law-llp-160731494.html,"[GlobeNewswire] - NEW YORK, Dec. 08, 2016-- Scott+ Scott, Attorneys at Law, LLP, a national investor rights law firm, reminds investors that January 5, 2017 is the last day to file lead plaintiff papers in the securities ..."
TEVA,TEVA:US,BBG000C0CD58,Why Biotech is Getting Killed…And Why It WIll Bounce Back,2016-12-08 15:44:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/08/why-biotech-is-getting-killed-and-why-it-will-bounce-back/?mod=yahoobarrons&ru=yahoo,Why Biotech is Getting Killed…And Why It WIll Bounce Back
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma To Present At Citi Global Healthcare Conference; Webcast At 10:15 AM,2016-12-08 09:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nk8rACa0JEo/teva-pharma-to-present-at-citi-global-healthcare-conference-webcast-at-1015-am-20161208-00544,Teva Pharma To Present At Citi Global Healthcare Conference; Webcast At 10:15 AM
TEVA,TEVA:US,BBG000C0CD58,"DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited To Contact The Firm",2016-12-08 03:00:00 +0000,http://finance.yahoo.com/news/deadline-alert-brower-piven-alerts-030000631.html,"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of Teva Pharmaceutical Industries Limited American Depositary Shares during the period between February 10, 2015 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Exclusive - Teva investigating allegations by tipster of bribery in Romania,2016-12-07 23:30:43 +0000,http://sg.finance.yahoo.com/news/exclusive-teva-investigating-allegations-tipster-233043364.html,Exclusive - Teva investigating allegations by tipster of bribery in Romania
TEVA,TEVA:US,BBG000C0CD58,Why Teva's Selloff Could Be A Buying Opportunity,2016-12-07 18:56:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/07/why-tevas-selloff-could-be-a-buying-opportunity/?mod=yahoobarrons&ru=yahoo,Why Teva's Selloff Could Be A Buying Opportunity
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s End-Of-Year Switch Of Generics CEO Surprises Investors,2016-12-07 18:36:58 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-tevas-end-of-year-switch-of-generics-ceo-surprises-investors-500807/,Teva Pharmaceutical Industries Ltd (ADR) (TEVA)’s End-Of-Year Switch Of Generics CEO Surprises Investors
TEVA,TEVA:US,BBG000C0CD58,"3 Stocks to Watch on Wednesday: Anthera Pharmaceuticals Inc (ANTH), Mastercard Inc (MA) and Western Digital Corp (WDC)",2016-12-07 17:57:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xgfe8NchL2w/3-stocks-to-watch-on-wednesday-anthera-pharmaceuticals-inc-anth-mastercard-inc-ma-and-western-digital-corp-wdc-cm718105,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It was a good day for U S stocks as gold prices fell and the financial sector was booming once again up 1 on Tuesday The 160 S amp P 500 Index grew 0 3 the 160 Dow
TEVA,TEVA:US,BBG000C0CD58,Win With This Teva Pharmaceuticals Industries Ltd (TEVA) Stock Trade,2016-12-07 16:56:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UAHQ6DYU2ww/win-with-this-teva-pharmaceuticals-industries-ltd-teva-stock-trade-cm718000,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceuticals Industries Ltd ADR 160 NYSE TEVA shares continue to circle the drain The latest setback came following news that the President and CEO of Global Generic
TEVA,TEVA:US,BBG000C0CD58,Teva Copaxone EU Label to Omit Pregnancy Contraindication,2016-12-07 16:00:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qH8ieVntLC4/teva-copaxone-eu-label-to-omit-pregnancy-contraindication-cm717944,Teva Pharmaceutical Industries Ltd TEVA announced that it has received a positive outcome to remove the pregnancy contraindication from the label of its key drug Copaxone in the EU The latest label update will improve the safety and tolerability profile of the multiple sclerosis drug
TEVA,TEVA:US,BBG000C0CD58,Teva Copaxone EU Label to Omit Pregnancy Contraindication,2016-12-07 14:05:02 +0000,http://finance.yahoo.com/news/teva-copaxone-eu-label-omit-140502061.html,Teva Copaxone EU Label to Omit Pregnancy Contraindication
TEVA,TEVA:US,BBG000C0CD58,Teva to Present at the Citi 2016 Global Healthcare Conference,2016-12-07 14:05:00 +0000,http://finance.yahoo.com/news/teva-present-citi-2016-global-140500880.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the Citi 2016 Global Healthcare Conference.
TEVA,TEVA:US,BBG000C0CD58,Blog Coverage Teva Reports Positive Outcome for the European Label for COPAXONE®; Replaces Generics Head,2016-12-07 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-teva-reports-positive-131500622.html,"[Accesswire] - Upcoming AWS Coverage on Pernix Therapeutics Holdings Post-Earnings Results LONDON, UK / ACCESSWIRE / December 7, 2016 / Active Wall St. blog coverage looks at the headline from Teva Pharmaceutical Industries ..."
TEVA,TEVA:US,BBG000C0CD58,"Stock Market Roundup Dec. 6: CMG, TEVA, Oil Futures Fall",2016-12-06 23:55:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lVGJ_RLjuo4/stock-market-roundup-dec-6-cmg-teva-oil-futures-fall-cm717712,Although it was a relatively sound trading day overall Tuesday was marred by nervousness and hesitation for some struggling companies including Chipotle CMG and Teva Pharmaceutical Industries TEVA Oil closed down the day 2 as traders grow increasingly cautious on OPEC s ability to
TEVA,TEVA:US,BBG000C0CD58,"Stock Market Roundup Dec. 6: CMG, TEVA, Oil Futures Fall",2016-12-06 22:19:10 +0000,http://finance.yahoo.com/news/stock-market-roundup-dec-6-221910370.html,"Stock Market Roundup Dec. 6: CMG, TEVA, Oil Futures Fall"
TEVA,TEVA:US,BBG000C0CD58,3 Beaten-Down Generic Drugmakers to Buy,2016-12-06 21:27:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eme2rex36mo/3-beaten-down-generic-drugmakers-to-buy-cm717611,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Earlier in November some of the largest firms in the generic drugs firm space received subpoenas from the U S Justice Department The Justice Department is alleging that certain generic drugmakers may
TEVA,TEVA:US,BBG000C0CD58,Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today,2016-12-06 21:20:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IYEMPdp1iM8/heres-why-teva-pharmaceuticals-teva-stock-is-down-today-cm717403,Shares of Teva Pharmaceutical Industries TEVA slipped over 5 8 in morning trading Tuesday after the company announced a change in upper level management Teva is replacing the chief executive of its global generics group Siggi Olafsson with Dipankar Bhattacharjee the current chief of
TEVA,TEVA:US,BBG000C0CD58,"Teva, FitBit Settle into Tuesday’s 52-Week Low Club",2016-12-06 21:04:50 +0000,http://finance.yahoo.com/news/teva-fitbit-settle-tuesday-52-210450401.html,"Teva, FitBit Settle into Tuesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today,2016-12-06 18:39:06 +0000,http://finance.yahoo.com/news/heres-why-teva-pharmaceuticals-teva-183906140.html,Here's Why Teva Pharmaceutical's (TEVA) Stock Is Down Today
TEVA,TEVA:US,BBG000C0CD58,Teva's Generics CEO Departure Cause for Concern,2016-12-06 18:15:00 +0000,http://finance.yahoo.com/news/tevas-generics-ceo-departure-cause-181500121.html,Teva's Generics CEO Departure Cause for Concern
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical: 'Uniquely Qualified'…And Now He's Gone,2016-12-06 16:40:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/06/teva-pharmaceutical-uniquely-qualified-and-now-hes-gone/?mod=yahoobarrons&ru=yahoo,Teva Pharmaceutical: 'Uniquely Qualified'…And Now He's Gone
TEVA,TEVA:US,BBG000C0CD58,Teva shares plummet after key departure in generics business,2016-12-06 16:11:33 +0000,http://www.cnbc.com/id/104149679?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104149679,Teva shares plummet after key departure in generics business
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Is Down to Key Support. Did I Say Key?,2016-12-06 16:04:00 +0000,http://realmoney.thestreet.com/articles/12/06/2016/teva-pharmaceutical-down-key-support.-did-i-say-key?puc=yahoo&cm_ven=YAHOO,Teva Pharmaceutical Is Down to Key Support. Did I Say Key?
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Slide on Management Change,2016-12-06 15:50:17 +0000,http://finance.yahoo.com/news/teva-shares-slide-management-change-155017903.html,Teva Shares Slide on Management Change
TEVA,TEVA:US,BBG000C0CD58,Questions Mount at Teva as Generics Head Quits Without Explanation,2016-12-06 15:05:00 +0000,https://www.thestreet.com/story/13915892/1/questions-mount-at-teva-amid-c-suite-change.html?puc=yahoo&cm_ven=YAHOO,Questions Mount at Teva as Generics Head Quits Without Explanation
TEVA,TEVA:US,BBG000C0CD58,TherapeuticsMD Soars On Positive Menopause Drug Clinical Trial Results,2016-12-06 12:11:25 +0000,http://www.investors.com/news/technology/therapeuticsmd-soars-on-positive-menopause-drug-trial-results/,TherapeuticsMD Soars On Positive Menopause Drug Clinical Trial Results
TEVA,TEVA:US,BBG000C0CD58,Teva Receives Positive Outcome for COPAXONE® Label in Europe,2016-12-06 07:00:00 +0000,http://uk.finance.yahoo.com/news/teva-receives-positive-outcome-copaxone-070000834.html,Teva Receives Positive Outcome for COPAXONE® Label in Europe
TEVA,TEVA:US,BBG000C0CD58,Wall Street Points To Higher Opening,2016-12-06 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SmO0i7A9-Vk/wall-street-points-to-higher-opening-20161206-00169,Wall Street Points To Higher Opening
TEVA,TEVA:US,BBG000C0CD58,Teva Gets Positive Outcome For COPAXONE Label In Europe,2016-12-06 02:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zZwMJjCGGtw/teva-gets-positive-outcome-for-copaxone-label-in-europe-20161206-00040,Teva Gets Positive Outcome For COPAXONE Label In Europe
TEVA,TEVA:US,BBG000C0CD58,Teva Names Bhattacharjee As CEO Global Generic Medicines; Backs 2016 Outlook,2016-12-05 22:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fiuga6XacC4/teva-names-bhattacharjee-as-ceo-global-generic-medicines-backs-2016-outlook-20161205-01186,Teva Names Bhattacharjee As CEO Global Generic Medicines; Backs 2016 Outlook
TEVA,TEVA:US,BBG000C0CD58,"Teva names Bhattacharjee as generics group head, replacing Olafsson",2016-12-05 22:38:18 +0000,http://in.finance.yahoo.com/news/teva-names-bhattacharjee-generics-group-223818111.html,"Teva names Bhattacharjee as generics group head, replacing Olafsson"
TEVA,TEVA:US,BBG000C0CD58,"FitBit, Teva Slide into Monday’s 52-Week Low Club",2016-12-05 21:04:18 +0000,http://247wallst.com/investing/2016/12/05/fitbit-teva-slide-into-mondays-52-week-low-club/,"FitBit, Teva Slide into Monday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,"Teva Appoints Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson",2016-12-05 21:01:00 +0000,http://finance.yahoo.com/news/teva-appoints-dipankar-bhattacharjee-president-210100468.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced that Dipankar Bhattacharjee has been appointed President and Chief Executive Officer, Global Generic Medicines Group, effective today."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-12-05 15:04:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150400214.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 5, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,2 Stocks That Could Soar Under a Donald Trump Presidency,2016-12-05 14:48:38 +0000,http://www.fool.com/investing/2016/12/05/2-stocks-that-could-soar-under-a-donald-trump-pres.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,2 Stocks That Could Soar Under a Donald Trump Presidency
TEVA,TEVA:US,BBG000C0CD58,"TEVA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds INSTITUTIONAL Investors with Losses in Excess of $500,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries ",2016-12-03 03:07:00 +0000,http://finance.yahoo.com/news/teva-shareholder-alert-former-louisiana-030700397.html,"[PR Newswire] - NEW ORLEANS, Dec. 2, 2016 /PRNewswire/ -- Kahn Swick & Foti, LLC (""KSF"") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until ..."
TEVA,TEVA:US,BBG000C0CD58,The Sole Reason Teva Pharmaceutical Industries Ltd. Sank 12% in November,2016-12-02 22:34:55 +0000,http://www.fool.com/investing/2016/12/02/the-sole-reason-teva-pharmaceutical-industries-ltd.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Sole Reason Teva Pharmaceutical Industries Ltd. Sank 12% in November
TEVA,TEVA:US,BBG000C0CD58,Analysts Are Bullish on Valeant,2016-12-02 16:04:40 +0000,http://marketrealist.com/2016/11/analysts-are-bullish-on-valeant/?utm_source=yahoo&utm_medium=feed,Analysts Are Bullish on Valeant
TEVA,TEVA:US,BBG000C0CD58,Should You Avoid Suncor Energy Inc. (USA) (SU)?,2016-12-01 20:48:34 +0000,http://www.insidermonkey.com/blog/should-you-avoid-suncor-energy-inc-usa-su-494529/,Should You Avoid Suncor Energy Inc. (USA) (SU)?
TEVA,TEVA:US,BBG000C0CD58,Corruption Currrents: Tracking Trump's Conflicts of Interest,2016-12-01 19:51:38 +0000,http://blogs.wsj.com/riskandcompliance/2016/12/01/corruption-currrents-tracking-trumps-conflicts-of-interest/?mod=yahoo_hs,Corruption Currrents: Tracking Trump's Conflicts of Interest
TEVA,TEVA:US,BBG000C0CD58,"Notable ETF Inflow Detected - IEFA, TEVA, NXPI, CHKP",2016-12-01 17:17:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NtNKIJAAUWs/notable-etf-inflow-detected-iefa-teva-nxpi-chkp-cm716376,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 179 0 million dollar inflow that s a 1 3 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-12-01 16:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-160300071.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / December 1, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,The 10 Best Under-the-Radar Stocks to Buy for 2017,2016-12-01 12:50:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JkQHnoSIiZU/the-10-best-under-the-radar-stocks-to-buy-for-2017-cm716099,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips In my years of trading and investing I ve always found that the headlines can lead you to a few good opportunities but the best stocks to buy are those that are underappreciated and underloved and
TEVA,TEVA:US,BBG000C0CD58,Inside the Double-Digit Fall for Mallinckrodt’s Specialty Generics Business in 2016,2016-11-30 21:04:13 +0000,http://marketrealist.com/2016/11/inside-the-double-digit-fall-for-mallinckrodts-specialty-generics-business-in-2016/?utm_source=yahoo&utm_medium=feed,Inside the Double-Digit Fall for Mallinckrodt’s Specialty Generics Business in 2016
TEVA,TEVA:US,BBG000C0CD58,Teva Is a Hold,2016-11-30 17:08:07 +0000,http://finance.yahoo.com/news/teva-hold-170807001.html,Teva Is a Hold
TEVA,TEVA:US,BBG000C0CD58,What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?,2016-11-30 16:17:42 +0000,http://www.fool.com/investing/2016/11/29/what-happens-when-your-biotech-stock-faces-generic.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for December 01, 2016",2016-11-30 14:14:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0fUCDRKhl2I/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-december-01-2016-cm715609,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on December 01 2016 A cash dividend payment of 0 289 per share is scheduled to be paid on December 20 2016 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend
TEVA,TEVA:US,BBG000C0CD58,Israeli Cannabis Inhaler May Get Tested With Opium Poppy Next,2016-11-30 13:02:44 +0000,http://www.bloomberg.com/news/articles/2016-11-30/israeli-cannabis-inhaler-may-get-tested-with-opium-poppy-next?cmpid=yhoo.headline,Israeli Cannabis Inhaler May Get Tested With Opium Poppy Next
TEVA,TEVA:US,BBG000C0CD58,Teva to Present Oncology Data at the 2016 American Society of Hematology (ASH) Annual Meeting & Exposition,2016-11-30 13:00:00 +0000,http://finance.yahoo.com/news/teva-present-oncology-data-2016-130000238.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced that data on GRANIX® Injection, TREANDA® Injection and TRISENOX® Injection will be presented during poster sessions at the 2016 ASH Annual Meeting to be held at the San Diego Convention Center in San Diego, CA on December 3-6, 2016."
TEVA,TEVA:US,BBG000C0CD58,What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?,2016-11-29 17:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8E40uMN9Euw/what-happens-when-your-biotech-stock-faces-generic-competition-lawsuits-cm715218,Image source Getty Images Few things are as inevitable and frustrating as generic competition in the pharma industry After overcoming the high risks of failure in drug development and pouring money into sales and marketing the owner of a successful drug can see its revenue
TEVA,TEVA:US,BBG000C0CD58,Teva drugs help boost Mayne revenue,2016-11-29 04:15:32 +0000,http://au.finance.yahoo.com/news/teva-drugs-help-boost-mayne-041532505.html,"[AAP] - The $US652 million acquisition of a suite of generic drugs from Teva Pharmaceutical Industries has helped Mayne Pharma to a strong start to the financial year. Mayne Pharma chief executive Scott Richards told shareholders at the company's annual general meeting on Tuesday that group revenue to the end of October had more than doubled to $172 million compared to a year ago. ""In summary, our business has had a strong start to the financial year,"" Mr Richards said."
TEVA,TEVA:US,BBG000C0CD58,Teva drugs help Mayne to strong start,2016-11-29 02:29:00 +0000,http://au.finance.yahoo.com/news/teva-drugs-help-mayne-strong-022900209.html,"[AAP] - Mayne Pharma says it has had a strong start to the current financial year, partly boosted by its $US652 million acquisition of a suite of generic drugs from Teva Pharmaceutical Industries and Allergan. Mayne Pharma chief executive Scott Richards told shareholders at the company's annual general meeting on Tuesday that group revenue to the end of October had more than doubled to $172 million compared to a year ago. Mr Richards said there was strong growth across Mayne's Generic Products, Contract Services and Mayne Pharma International businesses."
TEVA,TEVA:US,BBG000C0CD58,Mallinckrodt’s Greater Dependence on Acthar and Generic Business,2016-11-28 23:25:02 +0000,http://marketrealist.com/2016/11/mallinckrodts-greater-dependence-on-acthar-and-generic-business/?utm_source=yahoo&utm_medium=feed,Mallinckrodt’s Greater Dependence on Acthar and Generic Business
TEVA,TEVA:US,BBG000C0CD58,Teva to Market Medical Marijuana Inhaler in Israel,2016-11-28 21:23:00 +0000,http://www.investopedia.com/news/teva-market-medical-marijuana-inhaler-israel-teva/?partner=YahooSA,Teva to Market Medical Marijuana Inhaler in Israel
TEVA,TEVA:US,BBG000C0CD58,Marijuana News: Teva Pharmaceuticals Industries Ltd (ADR) Signs Cannabis Inhaler Deal,2016-11-28 18:58:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/29ULNrv13sQ/marijuana-news-teva-pharmaceuticals-industries-ltd-adr-signs-cannabis-inhaler-deal-cm714600,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has some good marijuana news for those living in Israel Source MarihuanayMedicina via Flickr This new bit of marijuana news
TEVA,TEVA:US,BBG000C0CD58,3 Stocks That Had Billionaires Running for the Exit in Q3,2016-11-28 18:31:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A8DyPw0NoN8/3-stocks-that-had-billionaires-running-for-the-exit-in-q3-cm714582,Image source Getty Images A little more than a week ago the 13F filing deadline with the Securities and Exchange Commission came and passed These filings allow Wall Street and investors to get an under the hood look at what institutional money managers with 100 million or more
TEVA,TEVA:US,BBG000C0CD58,3 Stocks That Had Billionaires Running for the Exit in Q3,2016-11-28 17:01:00 +0000,http://www.fool.com/investing/2016/11/28/3-stocks-that-had-billionaires-running-for-the-exi.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Stocks That Had Billionaires Running for the Exit in Q3
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-11-28 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000298.html,"[GlobeNewswire] - NEW YORK, Nov. 28, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited and certain ..."
TEVA,TEVA:US,BBG000C0CD58,How to buy the biggest losers,2016-11-28 12:51:00 +0000,http://finance.yahoo.com/video/buy-biggest-losers-125100982.html,How to buy the biggest losers
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Hike Their Bets in Most Major Pharma Stocks,2016-11-28 12:15:13 +0000,http://finance.yahoo.com/news/short-sellers-hike-bets-most-121513877.html,Short Sellers Hike Their Bets in Most Major Pharma Stocks
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm to market medical cannabis inhaler in Israel,2016-11-28 09:32:31 +0000,http://finance.yahoo.com/news/teva-pharm-market-medical-cannabis-093231773.html,Teva Pharm to market medical cannabis inhaler in Israel
TEVA,TEVA:US,BBG000C0CD58,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/behind-mallinckrodts-performance-based-ev-ebitda/?utm_source=yahoo&utm_medium=feed,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit – TEVA",2016-11-27 11:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-110000287.html,"[GlobeNewswire] - STEVENSON, Md., Nov. 27, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceutical Industries Ltd. of Class Action Lawsuit and Upcoming Deadline – TEVA,2016-11-26 01:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-010000957.html,"[GlobeNewswire] - NEW YORK, Nov. 25, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. and certain of its officers. The class action, filed in United States ..."
TEVA,TEVA:US,BBG000C0CD58,Is Petroleo Brasileiro SA Petrobras (ADR) (PBR) A Good Stock to Buy? Top Investors Think So,2016-11-25 23:52:20 +0000,http://www.insidermonkey.com/blog/is-petroleo-brasileiro-sa-petrobras-adr-pbr-a-good-stock-to-buy-top-investors-think-so-491986/,Is Petroleo Brasileiro SA Petrobras (ADR) (PBR) A Good Stock to Buy? Top Investors Think So
TEVA,TEVA:US,BBG000C0CD58,Do Hedge Funds Love Teva Pharmaceutical Industries Ltd (ADR) (TEVA)?,2016-11-25 21:12:33 +0000,http://www.insidermonkey.com/blog/do-hedge-funds-love-teva-pharmaceutical-industries-ltd-adr-teva-490131/,"[at Insider Monkey] - Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players […]"
TEVA,TEVA:US,BBG000C0CD58,3 Stocks That Have Been Cut in Half in the Last 12 Months,2016-11-25 18:06:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qbVLxVCsKLw/3-stocks-that-have-been-cut-in-half-in-the-last-12-months-cm714030,It s not likely 2016 is going to go down as one of the best years the S amp P 500 has ever had but with a nearly 7 gain over the last 12 months the index is sporting a respectable return Pity then those poor stocks that haven t fared even half as well or worse the three
TEVA,TEVA:US,BBG000C0CD58,Patent Litigations to Delay Teva’s New Product Launches,2016-11-24 16:04:34 +0000,http://marketrealist.com/2016/11/patent-litigations-delay-teva-pharmaceuticals-new-product-launches-future-years/?utm_source=yahoo&utm_medium=feed,Patent Litigations to Delay Teva’s New Product Launches
TEVA,TEVA:US,BBG000C0CD58,Teva’s Research Pipeline to Culminate in Many New Drug Launches?,2016-11-24 15:04:40 +0000,http://marketrealist.com/2016/11/teva-pharmaceuticals-research-pipeline-expected-culminate-multiple-new-drug-launches/?utm_source=yahoo&utm_medium=feed,Teva’s Research Pipeline to Culminate in Many New Drug Launches?
TEVA,TEVA:US,BBG000C0CD58,Teva Leads the Industry in First-to-File Applications in 2016,2016-11-24 13:04:47 +0000,http://marketrealist.com/2016/11/teva-pharmaceutical-leads-u-s-generic-pharmaceutical-industry-first-file-applications-2016/?utm_source=yahoo&utm_medium=feed,Teva Leads the Industry in First-to-File Applications in 2016
TEVA,TEVA:US,BBG000C0CD58,Biosimilar Business May Be a Strong Growth Opportunity for Teva,2016-11-23 20:04:10 +0000,http://marketrealist.com/2016/11/biosimilar-business-may-prove-strong-growth-opportunity-teva-pharmaceutical/?utm_source=yahoo&utm_medium=feed,Biosimilar Business May Be a Strong Growth Opportunity for Teva
TEVA,TEVA:US,BBG000C0CD58,Targeted Acquisitions Have Strengthened Teva’s Generic Business,2016-11-23 18:04:21 +0000,http://marketrealist.com/2016/11/targeted-acquisitions-strengthened-teva-pharmaceuticals-generic-business-2016/?utm_source=yahoo&utm_medium=feed,Targeted Acquisitions Have Strengthened Teva’s Generic Business
TEVA,TEVA:US,BBG000C0CD58,"IEFA, TEVA, CHKP, MPEL: Large Inflows Detected at ETF",2016-11-23 17:05:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s9VlT1eTsqg/iefa-teva-chkp-mpel-large-inflows-detected-at-etf-cm713329,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 367 7 million dollar inflow that s a 2 7 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical’s Financial Guidance for 2016,2016-11-23 16:25:22 +0000,http://marketrealist.com/2016/11/teva-pharmaceuticals-financial-guidance-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical’s Financial Guidance for 2016
TEVA,TEVA:US,BBG000C0CD58,"AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case",2016-11-23 16:05:37 +0000,http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-ranbaxy-laboratories-limited-adr-rbxly-wins-over-illegal-deal-case-490092/,"AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case"
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-11-23 15:05:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150500636.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 23, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Limited Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important Deadline in Class Action Filed by Firm - TEVA",2016-11-23 14:58:00 +0000,http://finance.yahoo.com/news/teva-pharmaceutical-industries-limited-investors-145800475.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Shares of Teva Pharmaceutical Industries Limited between February 10, 2015 and November 3, 2016, both dates inclusive of the important January 5, 2017 lead plaintiff deadline in the class action filed by the firm."
TEVA,TEVA:US,BBG000C0CD58,Alder Keels For Sixth Day After EU Upholds Teva Migraine Patent,2016-11-22 21:53:38 +0000,http://www.investors.com/news/technology/alder-keels-for-sixth-day-after-eu-upholds-teva-migraine-patent/,Alder Keels For Sixth Day After EU Upholds Teva Migraine Patent
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Faces Multiple Challenges in 2016,2016-11-22 16:04:50 +0000,http://marketrealist.com/2016/11/teva-pharmaceutical-faces-multiple-challenges-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical Faces Multiple Challenges in 2016
TEVA,TEVA:US,BBG000C0CD58,Teva's Leukemia Drug Gets EU Approval in First-Line Setting,2016-11-22 15:22:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fa9RVWjLN1g/tevas-leukemia-drug-gets-eu-approval-in-first-line-setting-cm712595,Teva Pharmaceutical Industries Ltd TEVA announced that the European Commission EC has approved a label expansion of Trisenox Now Trisenox in combination with retinoic acid can be used for the first line treatment of low to intermediate risk Acute Promyelocytic Leukemia APL Trisenox
TEVA,TEVA:US,BBG000C0CD58,Allergan's Fibristal Approved in Canada for Label Expansion,2016-11-22 15:22:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xW5ZJPej1cw/allergans-fibristal-approved-in-canada-for-label-expansion-cm712589,Allergan plc AGN announced that it has received approval from Health Canada to expand the label of its drug Fibristal for the long term treatment of signs and symptoms of uterine fibroids Fibristal is already approved for the treatment of signs and symptoms of uterine fibroids However now
TEVA,TEVA:US,BBG000C0CD58,"The Latest on Fasinumab, a Teva-Regeneron Collaborative Drug",2016-11-22 15:04:52 +0000,http://marketrealist.com/2016/11/teva-pharmaceutical-regeneron-continue-develop-ngf-antibody-fasinumab-2016/?utm_source=yahoo&utm_medium=feed,"The Latest on Fasinumab, a Teva-Regeneron Collaborative Drug"
TEVA,TEVA:US,BBG000C0CD58,Teva's Leukemia Drug Gets EU Approval in First-Line Setting,2016-11-22 13:09:01 +0000,http://finance.yahoo.com/news/tevas-leukemia-drug-gets-eu-130901705.html,Teva's Leukemia Drug Gets EU Approval in First-Line Setting
TEVA,TEVA:US,BBG000C0CD58,SD-809 Could Be a Strong Growth Driver for Teva Pharmaceutical,2016-11-22 13:05:01 +0000,http://marketrealist.com/2016/11/sd-809-may-strong-growth-driver-teva-pharmaceutical-future-years/?utm_source=yahoo&utm_medium=feed,SD-809 Could Be a Strong Growth Driver for Teva Pharmaceutical
TEVA,TEVA:US,BBG000C0CD58,Copaxone May Face Competitive Pressures in the Future,2016-11-21 22:04:14 +0000,http://marketrealist.com/2016/11/copaxone-franchise-may-face-competitive-pressures-future-years/?utm_source=yahoo&utm_medium=feed,Copaxone May Face Competitive Pressures in the Future
TEVA,TEVA:US,BBG000C0CD58,"Top Research Reports for 21st November, 2016",2016-11-21 21:22:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LRW7AsYC9KA/top-research-reports-for-21st-november-2016-cm712329,Monday November 21 2016 Today s Research Daily features new research reports on 16 major stocks including Coca Cola KO Disney DIS and Danaher DHR Coca Cola shares have struggled this year with the stock down more than 4 in the year to date period compared to the roughly
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Expects Mid-Single-Digit Growth for Generics,2016-11-21 21:04:06 +0000,http://marketrealist.com/2016/11/teva-pharmaceutical-expects-mid-single-digit-growth-generic-business-future-years/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical Expects Mid-Single-Digit Growth for Generics
TEVA,TEVA:US,BBG000C0CD58,Mallinckrodt: The Rebound Continues,2016-11-21 19:06:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/21/mallinckrodt-the-rebound-continues/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: The Rebound Continues
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Expected to Report Robust Revenue in 2016,2016-11-21 18:35:57 +0000,http://marketrealist.com/2016/11/teva-pharmaceutical-expected-report-robust-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical Expected to Report Robust Revenue in 2016
TEVA,TEVA:US,BBG000C0CD58,"Top Research Reports for 21st November, 2016",2016-11-21 17:44:05 +0000,http://finance.yahoo.com/news/top-research-reports-21st-november-174405965.html,"Top Research Reports for 21st November, 2016"
TEVA,TEVA:US,BBG000C0CD58,Cardinal Health Inc (CAH) Stock Looks Healthy in the Long Term,2016-11-21 13:56:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/it7dq2IFSwo/cardinal-health-inc-cah-stock-looks-healthy-in-the-long-term-cm711794,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When the polls suggested Hillary Clinton would take the election pharmaceutical stocks felt the pressure and Cardinal Health Inc NYSE CAH was no exception Near
TEVA,TEVA:US,BBG000C0CD58,Teva Secures European Approval of Trisenox® for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia (APL),2016-11-21 07:00:00 +0000,http://finance.yahoo.com/news/teva-secures-european-approval-trisenox-070000639.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced it has obtained approval from the European Commission for an indication extension of Trisenox® ."
TEVA,TEVA:US,BBG000C0CD58,Wall Street May Bounce Back,2016-11-21 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KbljkAAg7QA/wall-street-may-bounce-back-20161121-00148,Wall Street May Bounce Back
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Announces Indication Extension Of Trisenox In EU - Quick Facts,2016-11-21 02:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zoj85xOVSGk/teva-pharma-announces-indication-extension-of-trisenox-in-eu--quick-facts-20161121-00039,Teva Pharma Announces Indication Extension Of Trisenox In EU - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,"Drug Makers Sued for Price Collusion (NVS, TEVA)",2016-11-20 17:30:00 +0000,http://www.investopedia.com/news/unions-drug-makers-colluded-prices-nvs-teva/?partner=YahooSA,"Drug Makers Sued for Price Collusion (NVS, TEVA)"
TEVA,TEVA:US,BBG000C0CD58,Ready to Get In on Biotech? Check Out These 3 Stocks,2016-11-20 12:50:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9gaEmWvHvzM/ready-to-get-in-on-biotech-check-out-these-3-stocks-cm711663,There 160 are plenty of reasons for investors to avoid the biotechnology sector altogether The majority of companies from the industry are unprofitable forcing them to constantly raise additional capital Bringing a new drug through the regulatory approval process is
TEVA,TEVA:US,BBG000C0CD58,"INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",2016-11-19 04:45:00 +0000,http://finance.yahoo.com/news/investor-alert-brower-piven-encourages-044500334.html,"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of Teva Pharmaceutical Industries Limited American Depositary Shares during the period between February 10, 2015 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,"TEVA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds INSTITUTIONAL Investors with Losses in Excess of $500,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries ",2016-11-19 03:07:00 +0000,http://finance.yahoo.com/news/teva-shareholder-alert-former-louisiana-030700124.html,"[Marketwired] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 5, 2017 to file lead plaintiff applications in securities ..."
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceutical Industries Ltd. of Class Action Lawsuit and Upcoming Deadline - TEVA,2016-11-19 01:12:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-011200809.html,"[PR Newswire] - NEW YORK, Nov. 18, 2016 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. (""Teva"" or the ""Company"") (NYSE: TEVA) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-08747, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Teva securities between February 10, 2014 and November 2, 2016, both dates inclusive (the ""Class Period""), seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934. If you are a shareholder who purchased Teva securities during the Class Period, you have until January 5, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext."
TEVA,TEVA:US,BBG000C0CD58,"Mylan 2018 EPS Target In Jeopardy Without M&A, Says Mizuho",2016-11-18 21:03:17 +0000,http://www.investors.com/news/technology/mylan-2018-eps-target-in-jeopardy-without-ma-says-mizuho/,"Mylan 2018 EPS Target In Jeopardy Without M&A, Says Mizuho"
TEVA,TEVA:US,BBG000C0CD58,3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3,2016-11-18 15:51:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3RyrNMN2fdU/3-big-drug-stocks-that-billionaire-money-managers-dumped-in-q3-cm711210,Image source Getty Images It s that time of the quarter again folks the filing of 13Fs with the Securities and Exchange Commission by institutional money managers with more than 100 million under management The release of 13Fs is highly anticipated because it gives Wall Street
TEVA,TEVA:US,BBG000C0CD58,Novartis/Amgen Migraine Drug Positive in Phase III Study,2016-11-18 15:50:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nl33DJdNgqY/novartisamgen-migraine-drug-positive-in-phase-iii-study-cm711157,Novartis AG NVS and partner Amgen Inc AMGN announced positive top line data from the second pivotal phase III study STRIVE on their calcitonin gene related peptide CGRP receptor AMG 334 erenumab for the prevention of episodic migraine The multicenter randomized 24 week double
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016",2016-11-18 14:23:17 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-us-earnings-analysis-q3-2016-by-the-numbers-november-18-2016/,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016"
TEVA,TEVA:US,BBG000C0CD58,3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3,2016-11-18 14:03:00 +0000,http://www.fool.com/investing/2016/11/18/3-big-drug-stocks-that-billionaire-money-managers.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Big Drug Stocks That Billionaire Money Managers Dumped in Q3
TEVA,TEVA:US,BBG000C0CD58,Novartis/Amgen Migraine Drug Positive in Phase III Study,2016-11-18 13:54:01 +0000,http://finance.yahoo.com/news/novartis-amgen-migraine-drug-positive-135401165.html,Novartis/Amgen Migraine Drug Positive in Phase III Study
TEVA,TEVA:US,BBG000C0CD58,"Amgen On Track For 2018 Migraine-Drug Launch, Beating 'Crowded Field'",2016-11-17 21:18:05 +0000,http://www.investors.com/news/technology/amgen-on-track-for-2018-migraine-drug-launch-beating-crowded-field/,"Amgen On Track For 2018 Migraine-Drug Launch, Beating 'Crowded Field'"
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Takes a Tumble,2016-11-17 18:15:00 +0000,http://www.barrons.com/articles/teva-takes-a-tumble-1479406538?mod=yahoobarrons&ru=yahoo,[$$] Teva Takes a Tumble
TEVA,TEVA:US,BBG000C0CD58,Amgen's Migraine Drug Hits Primary Endpoint in STRIVE Study,2016-11-17 17:50:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SDkDXfPWt00/amgens-migraine-drug-hits-primary-endpoint-in-strive-study-cm710685,Amgen Inc AMGN announced top line data from a phase III study STRIVE which showed that its calcitonin gene related peptide CGRP receptor erenumab significantly reduced monthly migraine days in patients with episodic migraine Erenumab is being evaluated in two phase III studies for
TEVA,TEVA:US,BBG000C0CD58,"Nokia, Teva Pharmaceutical and Vodafone Are Volatile; Here's Why",2016-11-17 17:40:00 +0000,https://www.thestreet.com/story/13897442/1/nokia-teva-pharmaceutical-and-vodafone-are-volatile-here-s-why.html?puc=yahoo&cm_ven=YAHOO,"Nokia, Teva Pharmaceutical and Vodafone Are Volatile; Here's Why"
TEVA,TEVA:US,BBG000C0CD58,NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe,2016-11-17 16:00:00 +0000,http://www.bloomberg.com/news/articles/2016-11-17/nypd-union-goes-after-drug-prices-amid-doj-pharma-investigation?cmpid=yhoo.headline,NYPD Union Goes After Drug Prices Amid DOJ Pharma Probe
TEVA,TEVA:US,BBG000C0CD58,Cramer Remix: The premier stock to own post-Trump,2016-11-17 00:00:00 +0000,http://finance.yahoo.com/video/cramer-remix-premier-stock-own-000000465.html,Cramer Remix: The premier stock to own post-Trump
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharma Outplays Peers Despite Light Q3 Sales, Lacking 2017 Views",2016-11-16 21:40:05 +0000,http://www.investors.com/news/technology/teva-pharma-outplays-peers-despite-light-q3-sales-lacking-2017-views/,"Teva Pharma Outplays Peers Despite Light Q3 Sales, Lacking 2017 Views"
TEVA,TEVA:US,BBG000C0CD58,Here's Why I Just Bought These 4 Stocks,2016-11-16 20:01:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3UsEn1cGzLI/heres-why-i-just-bought-these-4-stocks-cm710137,Image source Getty Images I admit it Even though the evidence is overwhelmingly in favor of investing regularly and holding high quality stocks over the long term I m a picky investor Despite 35 stock market corrections of at least 10 when rounded that have been completely
TEVA,TEVA:US,BBG000C0CD58,The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceuticals Investors and Encourages Investors to Contact the Firm,2016-11-16 19:40:00 +0000,http://finance.yahoo.com/news/law-offices-howard-g-smith-194000994.html,"[Business Wire] - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Teva Pharmaceuticals securities between February 10, 2015 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision,2016-11-16 18:38:50 +0000,http://finance.yahoo.com/news/teva-pharmaceuticals-hit-slew-downgrades-183850146.html,Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Falls Despite Q3 Earnings Beat,2016-11-16 17:52:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CADo1ePASZ8/teva-pharmaceutical-industries-ltd-adr-teva-stock-falls-despite-q3-earnings-beat-cm709597,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock was down on Tuesday despite an earnings beat in the third quarter of 2016 Teva
TEVA,TEVA:US,BBG000C0CD58,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings,2016-11-16 16:53:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yUaQOZ1jNrg/6-things-you-need-to-know-about-tevas-teva-q3-earnings-cm710056,Israel based Teva Pharmaceutical Industries Limited TEVA reported third quarter results yesterday With the company missing revenue estimates and lowering its outlook for the year shares were down 8 4 Here is a look at some key points from the company s conference call
TEVA,TEVA:US,BBG000C0CD58,Teva Posts 3Q Profit Amid Bribery Charges (TEVA),2016-11-16 15:59:00 +0000,http://www.investopedia.com/news/tevas-3q-net-131share-beats-street-teva/?partner=YahooSA,Teva Posts 3Q Profit Amid Bribery Charges (TEVA)
TEVA,TEVA:US,BBG000C0CD58,Here's Why I Just Bought These 4 Stocks,2016-11-16 15:41:06 +0000,http://www.fool.com/investing/2016/11/16/heres-why-i-just-bought-these-4-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why I Just Bought These 4 Stocks
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) May Settle Bribery Allegations For $520 Million,2016-11-16 15:36:44 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-teva-may-settle-bribery-allegations-for-520-million-488454/,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) May Settle Bribery Allegations For $520 Million
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-11-16 15:03:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150300449.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 16, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva to Pay $520M in DOJ, SEC Bribery Case (TEVA)",2016-11-16 14:55:00 +0000,http://www.investopedia.com/news/teva-pay-520m-settle-bribery-claims-teva/?partner=YahooSA,"Teva to Pay $520M in DOJ, SEC Bribery Case (TEVA)"
TEVA,TEVA:US,BBG000C0CD58,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings,2016-11-16 14:43:02 +0000,http://finance.yahoo.com/news/6-things-know-tevas-teva-144302626.html,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings
TEVA,TEVA:US,BBG000C0CD58,Jefferies Warns Of 'Too Many Headwinds' For Teva,2016-11-16 14:42:22 +0000,http://finance.yahoo.com/news/jefferies-warns-too-many-headwinds-144222058.html,Jefferies Warns Of 'Too Many Headwinds' For Teva
TEVA,TEVA:US,BBG000C0CD58,"Top Analyst Upgrades and Downgrades: Bank of America, Fitbit, Teva Pharma, Disney, Regions Financial, Noble, Sysco and More",2016-11-16 13:55:11 +0000,http://247wallst.com/investing/2016/11/16/top-analyst-upgrades-and-downgrades-bank-of-america-fitbit-teva-pharma-disney-regions-financial-noble-sysco-and-more/,"Top Analyst Upgrades and Downgrades: Bank of America, Fitbit, Teva Pharma, Disney, Regions Financial, Noble, Sysco and More"
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical (TEVA) Beats on Q3 Earnings, Cuts View",2016-11-16 13:51:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z1bL4GeFYyI/teva-pharmaceutical-teva-beats-on-q3-earnings-cuts-view-cm709844,Teva Pharmaceutical Industries Ltd TEVA reported third quarter earnings of 1 28 per share including equity compensation expenses which beat the Zacks Consensus Estimate of 1 27 However revenues of 5 6 billion missed the Zacks Consensus Estimate of 5 90 billion On a year over
TEVA,TEVA:US,BBG000C0CD58,Morgan Stanley Cuts Teva's Price Target By 33%,2016-11-16 13:23:20 +0000,http://finance.yahoo.com/news/morgan-stanley-cuts-tevas-price-132320244.html,Morgan Stanley Cuts Teva's Price Target By 33%
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical (TEVA) Beats on Q3 Earnings, Cuts View",2016-11-16 11:19:11 +0000,http://finance.yahoo.com/news/teva-pharmaceutical-teva-beats-q3-111911598.html,"Teva Pharmaceutical (TEVA) Beats on Q3 Earnings, Cuts View"
TEVA,TEVA:US,BBG000C0CD58,[$$] Investors’ Prognosis for Teva Seems Overly Bleak,2016-11-16 04:52:50 +0000,http://www.wsj.com/articles/investors-prognosis-for-teva-seems-overly-bleak-1479228166?ru=yahoo?mod=yahoo_itp,[$$] Investors’ Prognosis for Teva Seems Overly Bleak
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA) Q3 Earnings Top but Revenues Lag Estimates,2016-11-16 01:51:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MCnEf4y29I/teva-teva-q3-earnings-top-but-revenues-lag-estimates-cm709461,Israel based Teva Pharmaceutical Industries Limited TEVA is a global pharmaceutical company with a strong presence in the generics as well as branded markets Teva s main branded products include Copaxone multiple sclerosis and Azilect Parkinson s disease Besides this Teva s branded
TEVA,TEVA:US,BBG000C0CD58,"Why Stratasys, Dick's Sporting Goods, and Teva Pharmaceutical Slumped Today",2016-11-15 23:49:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XqywxAdQgGk/why-stratasys-dicks-sporting-goods-and-teva-pharmaceutical-slumped-today-cm709746,Tuesday was another solid day for the stock market with all major market benchmarks posting gains on the day A rebound in some hard hit areas of the market including the energy sector and emerging market stocks internationally helped restore some confidence in the long term
TEVA,TEVA:US,BBG000C0CD58,"Why Stratasys, Dick's Sporting Goods, and Teva Pharmaceutical Slumped Today",2016-11-15 22:39:06 +0000,http://www.fool.com/investing/2016/11/15/why-stratasys-dicks-sporting-goods-and-teva-pharma.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Stratasys, Dick's Sporting Goods, and Teva Pharmaceutical Slumped Today"
TEVA,TEVA:US,BBG000C0CD58,"Nokia, Teva Plunge into Tuesday’s 52-Week Low Club",2016-11-15 21:04:01 +0000,http://247wallst.com/investing/2016/11/15/nokia-teva-plunge-into-tuesdays-52-week-low-club/,"Nokia, Teva Plunge into Tuesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Teva's Scale Needs to Start Paying Off Soon,2016-11-15 20:29:25 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-15/teva-earnings-scale-needs-to-pay-off-soon?cmpid=yhoo.headline,Teva's Scale Needs to Start Paying Off Soon
TEVA,TEVA:US,BBG000C0CD58,Robbins Arroyo LLP: Teva Pharmaceutical Industries Ltd. (TEVA) Misled Shareholders According to a Recently Filed Class Action,2016-11-15 19:18:00 +0000,http://finance.yahoo.com/news/robbins-arroyo-llp-teva-pharmaceutical-191800935.html,[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Teva Pharmaceutical Industries Ltd. in the U.S. District Court for the Central District of California.
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough,2016-11-15 17:29:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/npTz-Z4o0pc/teva-pharmaceutical-industries-ltds-q3-helped-by-actavis-generics-deal-but-not-quite-enough-cm709497,It s been a tough year for generic drugmakers Teva Pharmaceutical NYSE TEVA 160 is no exception with its stock down nearly 40 year to date Teva announced its third quarter earnings results before the market opened on Tuesday Unfortunately those results weren t enough to
TEVA,TEVA:US,BBG000C0CD58,iShares Core MSCI EAFE ETF Experiences Big Inflow,2016-11-15 17:27:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k5cCBk3gqv0/ishares-core-msci-eafe-etf-experiences-big-inflow-cm709481,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core MSCI EAFE ETF Symbol IEFA where we have detected an approximate 168 1 million dollar inflow that s a 1 3 increase week over week in
TEVA,TEVA:US,BBG000C0CD58,Why Teva is Tanking,2016-11-15 17:02:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/15/why-teva-is-tanking/?mod=yahoobarrons&ru=yahoo,Why Teva is Tanking
TEVA,TEVA:US,BBG000C0CD58,[$$] Investors' Prognosis for Teva Seems Overly Bleak,2016-11-15 16:42:49 +0000,http://www.wsj.com/articles/investors-prognosis-for-teva-seems-overly-bleak-1479228166?mod=yahoo_hs,[$$] Investors' Prognosis for Teva Seems Overly Bleak
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough,2016-11-15 16:10:47 +0000,http://www.fool.com/investing/2016/11/15/teva-pharmaceutical-industries-ltd-q3-helped-by-ac.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough
TEVA,TEVA:US,BBG000C0CD58,Teva trims 2016 outlook on drug launch delays,2016-11-15 15:49:34 +0000,http://sg.finance.yahoo.com/news/teva-pharm-third-quarter-beats-124337588.html,Teva trims 2016 outlook on drug launch delays
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Revenue Rises on Allergan Deal,2016-11-15 14:31:29 +0000,http://www.wsj.com/articles/teva-revenue-rises-on-allergan-deal-but-its-specialty-drugs-saw-pressure-1479215460?mod=yahoo_hs,[$$] Teva Revenue Rises on Allergan Deal
TEVA,TEVA:US,BBG000C0CD58,Why Teva Sank Despite Solid Earnings and Guidance,2016-11-15 14:15:02 +0000,http://247wallst.com/healthcare-business/2016/11/15/why-teva-sank-despite-solid-earnings-and-guidance/,Why Teva Sank Despite Solid Earnings and Guidance
TEVA,TEVA:US,BBG000C0CD58,Teva Shares Lower on Third-Quarter Results,2016-11-15 14:10:00 +0000,https://www.thestreet.com/story/13893483/1/teva-shares-lower-on-third-quarter-results.html?puc=yahoo&cm_ven=YAHOO,Teva Shares Lower on Third-Quarter Results
TEVA,TEVA:US,BBG000C0CD58,"The Market In 5 Minutes: Carl Icahn, Mary Jo White And Rudy Giuliani Making News",2016-11-15 13:57:48 +0000,http://finance.yahoo.com/news/market-5-minutes-carl-icahn-135748500.html,"The Market In 5 Minutes: Carl Icahn, Mary Jo White And Rudy Giuliani Making News"
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA) Q3 Earnings Top but Revenues Lag Estimates,2016-11-15 13:50:01 +0000,http://finance.yahoo.com/news/teva-teva-q3-earnings-top-135001348.html,Teva (TEVA) Q3 Earnings Top but Revenues Lag Estimates
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals Under Pressure On Disappointing Q3 Revenues,2016-11-15 12:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wwe_4T_5ATU/teva-pharmaceuticals-under-pressure-on-disappointing-q3-revenues-20161115-01026,Teva Pharmaceuticals Under Pressure On Disappointing Q3 Revenues
TEVA,TEVA:US,BBG000C0CD58,Teva misses Street 3Q forecasts,2016-11-15 12:28:35 +0000,http://sg.finance.yahoo.com/news/teva-misses-street-3q-forecasts-122835382.html,Teva misses Street 3Q forecasts
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm Q3 beats estimates as acquisition lifts revenue,2016-11-15 12:25:42 +0000,http://finance.yahoo.com/news/teva-pharm-q3-beats-estimates-122542304.html,Teva Pharm Q3 beats estimates as acquisition lifts revenue
TEVA,TEVA:US,BBG000C0CD58,Teva Reports Third Quarter 2016 Results,2016-11-15 12:00:00 +0000,http://finance.yahoo.com/news/teva-reports-third-quarter-2016-120000725.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended September 30, 2016."
TEVA,TEVA:US,BBG000C0CD58,Israeli billionaire Nacht bets big money on another Teva in healthcare,2016-11-15 10:14:35 +0000,http://sg.finance.yahoo.com/news/israeli-billionaire-nacht-bets-big-101435045.html,Israeli billionaire Nacht bets big money on another Teva in healthcare
TEVA,TEVA:US,BBG000C0CD58,Teva Revenue Rises on Allergan Deal -- Update,2016-11-15 09:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ruk-ebBxkUI/teva-revenue-rises-on-allergan-deal--update-20161115-00784,Teva Revenue Rises on Allergan Deal -- Update
TEVA,TEVA:US,BBG000C0CD58,Correction to Teva Earnings Story,2016-11-15 09:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SoNMeMRGkt8/correction-to-teva-earnings-story-20161115-00774,Correction to Teva Earnings Story
TEVA,TEVA:US,BBG000C0CD58,Teva Revenue Rises on Allergan Deal,2016-11-15 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oecTvL7-mWg/teva-revenue-rises-on-allergan-deal-20161115-00564,Teva Revenue Rises on Allergan Deal
TEVA,TEVA:US,BBG000C0CD58,"Teva Revenue Rises on Allergan Deal, But Its Specialty Drugs Saw Pressure",2016-11-15 08:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HYS2txWVSzE/teva-revenue-rises-on-allergan-deal-but-its-specialty-drugs-saw-pressure-20161115-00502,"Teva Revenue Rises on Allergan Deal, But Its Specialty Drugs Saw Pressure"
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Q3 16 Earnings Conference Call At 8:00 AM ET,2016-11-15 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hQQA5eo0-6A/teva-pharmaceutical-industries-q3-16-earnings-conference-call-at-800-am-et-20161115-00192,Teva Pharmaceutical Industries Q3 16 Earnings Conference Call At 8:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,5 Stocks to Watch that Report Earnings Tomorrow,2016-11-14 21:30:12 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-that-report-earnings-tomorrow-213021033.html,5 Stocks to Watch that Report Earnings Tomorrow
TEVA,TEVA:US,BBG000C0CD58,"Pre-Market Earnings Report for November 15, 2016 :  HD, TJX, TEVA, JD, ARMK, MBLY, DKS, SBH, DBD, TSEM, SSYS, KLIC",2016-11-14 21:17:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C9NKo9nLZQ4/pre-market-earnings-report-for-november-15-2016-hd-tjx-teva-jd-armk-mbly-dks-sbh-dbd-tsem-ssys-klic-cm708978,The following companies are expected to report earnings prior to market open on 11 15 2016 Visit our Earnings Calendar for a full list of expected earnings releases Home Depot Inc HD is reporting for the quarter ending October 31 2016 The
TEVA,TEVA:US,BBG000C0CD58,Could Trump 'Make Drug Development Great Again'?,2016-11-14 21:06:56 +0000,http://www.investors.com/news/technology/could-trump-make-drug-development-great-again-biotechs-see-rally/,Could Trump 'Make Drug Development Great Again'?
TEVA,TEVA:US,BBG000C0CD58,What to Look for in Teva Pharmaceuticals Earnings,2016-11-14 17:25:31 +0000,http://247wallst.com/healthcare-business/2016/11/14/what-to-look-for-in-teva-earnings/,What to Look for in Teva Pharmaceuticals Earnings
TEVA,TEVA:US,BBG000C0CD58,Fidelity Healthcare Fund: 5 Things You Should Know,2016-11-14 14:30:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-AguBvxurhg/fidelity-healthcare-fund-5-things-you-should-know-cm708469,Image source Getty Images The Fidelity Select Health Care Fund NASDAQMUTFUND FSPHX is one of the best performing Fidelity mutual funds helped by the strong performance of healthcare stocks and stock selection that puts it among the top healthcare mutual funds on the market
TEVA,TEVA:US,BBG000C0CD58,Top 11 Earnings for the Week Ahead,2016-11-13 15:10:15 +0000,http://247wallst.com/investing/2016/11/13/top-11-earnings-for-the-week-ahead/,Top 11 Earnings for the Week Ahead
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-12 00:51:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-005100135.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 11, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA,2016-11-11 23:46:00 +0000,http://finance.yahoo.com/news/rosen-law-firm-announces-filing-234600210.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the American Depositary Shares of Teva Pharmaceutical Industries Limited between February 10, 2015 and November 3, 2016, both dates inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Trouble Developing for Generic Pharma Stocks?,2016-11-11 19:50:39 +0000,http://finance.yahoo.com/tumblr/blog-trouble-developing-for-generic-pharma-stocks-195047922.html,Trouble Developing for Generic Pharma Stocks?
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-11 17:09:00 +0000,http://finance.yahoo.com/news/important-investor-alert-khang-khang-170900802.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / November 11, 2016 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited (""Teva"" or ..."
TEVA,TEVA:US,BBG000C0CD58,"Merrimack (MACK) Q3 Loss Lower than Expected, Stock Up",2016-11-11 16:17:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ydWD6mmGFBU/merrimack-mack-q3-loss-lower-than-expected-stock-up-cm707788,Merrimack Pharmaceuticals Inc MACK reported a loss of 23 cents per share in the third quarter of 2016 narrower than the Zacks Consensus Estimate of 30 cents FindTheCompany Graphiq Quarterly revenues came in at 28 1 million down 16 7 sequentially Revenues
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Teva Pharmaceutical Industries Ltd. and Certain Officers – TEVA,2016-11-11 02:29:12 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-022912060.html,"[GlobeNewswire] - NEW YORK, Nov. 10, 2016-- Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. and certain of its officers. The class action, filed in United States ..."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-10 18:23:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-182300916.html,"[Accesswire] - LOS ANGELES, CA / ACCESSWIRE / November 10, 2016 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit has been filed against Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,December 30th Options Now Available For Teva Pharmaceutical Industries (TEVA),2016-11-10 17:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YDMjM5oFgP4/december-30th-options-now-available-for-teva-pharmaceutical-industries-teva-cm707209,Investors in Teva Pharmaceutical Industries Ltd Symbol TEVA saw new options become available today for the December 30th expiration At Stock Options Channel our YieldBoost formula has looked up and down the TEVA options chain for the new December 30th contracts and identified one put
TEVA,TEVA:US,BBG000C0CD58,War and Peace in Trumpland: Here Is Why You Buy These 4 Stocks Now,2016-11-10 15:28:00 +0000,https://www.thestreet.com/story/13887716/1/war-and-peace-in-trumpland-here-is-why-to-buy-these-4-stocks-now.html?puc=yahoo&cm_ven=YAHOO,War and Peace in Trumpland: Here Is Why You Buy These 4 Stocks Now
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-11-10 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000485.html,"[GlobeNewswire] - NEW YORK, Nov. 10, 2016-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited and certain ..."
TEVA,TEVA:US,BBG000C0CD58,Short Interest Bets Increase on Major Pharma,2016-11-10 12:40:14 +0000,http://finance.yahoo.com/news/short-interest-bets-increase-major-124014934.html,Short Interest Bets Increase on Major Pharma
TEVA,TEVA:US,BBG000C0CD58,ISS Mexico wins contract with Teva Pharmaceuticals,2016-11-10 12:21:07 +0000,http://www.publicnow.com/view/47063886495C034FE7939F6E1F3796539F0D57B3,"[at noodls] - The new contract includes sanitation and cleaning at Teva Pharmaceuticals plants to ensure the facilities are run efficiently and sustainably. ISS Mexico commenced the contract in July 2016, and it is ..."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-09 16:57:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-165700380.html,"[Business Wire] - Khang & Khang LLP announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited . Investors who purchased or otherwise acquired shares between February 10, 2015 and November 3, 2016 inclusive , are encouraged to contact the Firm prior to the January 5, 2017 lead plaintiff motion deadline."
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA): Can it Keep the Earnings Streak Alive in Q3?,2016-11-09 16:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83DGZSqKNog/teva-teva-can-it-keep-the-earnings-streak-alive-in-q3-cm706520,Teva Pharmaceutical Industries Ltd TEVA will be reporting third quarter 2016 earnings on Nov 15 before market open Last quarter the company delivered a positive earnings surprise of 5 93 The generic drug maker has been consistently beating earnings expectations The company s
TEVA,TEVA:US,BBG000C0CD58,"Here’s Why Investors Are Buzzing about Teva, Amazon, Exxon, and Two Other Stocks",2016-11-09 16:36:57 +0000,http://www.insidermonkey.com/blog/heres-why-investors-are-buzzing-about-teva-amazon-exxon-and-two-other-stocks-486208/,"Here’s Why Investors Are Buzzing about Teva, Amazon, Exxon, and Two Other Stocks"
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Teva Pharmaceuticals Investors Concerning Recent Revelations Regarding An Alleged Illegal Conspiracy To Fix Drug Prices,2016-11-09 15:30:00 +0000,http://finance.yahoo.com/news/investor-alert-law-offices-howard-153000738.html,[Business Wire] - Law Offices of Howard G. Smith announces an investigation on behalf of investors of Teva Pharmaceuticals concerning recent reports that the Company has unlawfully colluded with other pharmaceutical companies to fix generic drug prices.
TEVA,TEVA:US,BBG000C0CD58,Teva (TEVA): Can it Keep the Earnings Streak Alive in Q3?,2016-11-09 14:26:02 +0000,http://finance.yahoo.com/news/teva-teva-keep-earnings-streak-142602057.html,Teva (TEVA): Can it Keep the Earnings Streak Alive in Q3?
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries a Top Ranked SAFE Dividend Stock With 3.5% Yield (TEVA),2016-11-09 13:52:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RmCAD4Es1Ks/teva-pharmaceutical-industries-a-top-ranked-safe-dividend-stock-with-35-yield-teva-cm706190,Teva Pharmaceutical Industries Ltd Symbol TEVA has been named to the Dividend Channel International S A F E 10 list signifying an international stock with above average DividendRank statistics including a strong 3 5 yield as well as a superb track record of at least five years
TEVA,TEVA:US,BBG000C0CD58,"TEVA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Institutional Investors with Losses in Excess of $500,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries ",2016-11-09 03:07:00 +0000,http://finance.yahoo.com/news/teva-shareholder-alert-former-louisiana-030700080.html,"[GlobeNewswire] - NEW ORLEANS, Nov. 08, 2016-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 5, 2017 to file lead plaintiff ..."
TEVA,TEVA:US,BBG000C0CD58,"Regeneron Pharmaceuticals, Inc. Dropped 14.3% in October -- Here's Why",2016-11-09 00:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OFEzXrHn1XI/regeneron-pharmaceuticals-inc-dropped-143-in-october-heres-why-cm706044,Image source Getty Images What happened Investors in Regeneron Pharmaceuticals NASDAQ REGN had a rough October Shares of the biotech giant fell 14 3 during the month according to data from S amp P Global Market Intelligence
TEVA,TEVA:US,BBG000C0CD58,"Regeneron Pharmaceuticals, Inc. Dropped 14.3% in October -- Here's Why",2016-11-08 22:30:35 +0000,http://www.fool.com/investing/2016/11/08/regeneron-pharmaceuticals-inc-dropped-14-in-octob.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Regeneron Pharmaceuticals, Inc. Dropped 14.3% in October -- Here's Why"
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited To Contact Brower Piven Before The Lead Plaintif",2016-11-08 21:32:20 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-notifies-213220099.html,"[GlobeNewswire] - STEVENSON, Md., Nov. 08, 2016-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-08 16:35:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-163500692.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces a class action lawsuit has been filed against Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws between February 10, 2015 and November 3, 2016 inclusive ."
TEVA,TEVA:US,BBG000C0CD58,"Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming Deadline to File Lead Plaintiff Papers in Teva Pharmaceutical Industries Limited (NYSE: TEVA) Securities Case",2016-11-08 15:54:19 +0000,http://finance.yahoo.com/news/scott-scott-attorneys-law-llp-155419548.html,"[GlobeNewswire] - NEW YORK, Nov. 08, 2016-- Scott+ Scott, Attorneys at Law, LLP, a national investor rights law firm, reminds investors that January 5, 2017 is the last day to file lead plaintiff papers in the securities ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Appointment of New Chief Legal Officer,2016-11-08 14:00:00 +0000,http://finance.yahoo.com/news/teva-announces-appointment-chief-legal-140000343.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced the appointment of Mr. David Stark to the position of Chief Legal Officer. Stark is joining the Company’s executive leadership team and will replace Mr.
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-08 01:08:00 +0000,http://finance.yahoo.com/news/investor-alert-goldberg-law-pc-010800543.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited ."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Teva Pharmaceutical Industries Ltd. To Contact The Firm Before Lead Plaintiff Deadline",2016-11-08 00:07:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-000700711.html,"[GlobeNewswire] - NEW YORK, Nov. 07, 2016-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Teva Pharmaceutical Industries Ltd. of the January 2, 2017 deadline to seek the role of lead ..."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-07 21:58:00 +0000,http://finance.yahoo.com/news/important-investor-alert-khang-khang-215800342.html,"[Business Wire] - Khang & Khang LLP announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited . Investors who purchased or otherwise acquired shares between February 10, 2015 and November 3, 2016 inclusive , are encouraged to contact the Firm prior to the January 5, 2017 lead plaintiff motion deadline."
TEVA,TEVA:US,BBG000C0CD58,Drugmaker Mylan Slated For Q3 Growth Following Price-Fixing Fracas,2016-11-07 21:05:01 +0000,http://www.investors.com/news/technology/drugmaker-mylan-slated-for-q3-growth-following-price-fixing-fracas/,Drugmaker Mylan Slated For Q3 Growth Following Price-Fixing Fracas
TEVA,TEVA:US,BBG000C0CD58,Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceuticals Investors and Encourages Investors to Contact the Firm,2016-11-07 20:34:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-announces-filing-203400902.html,"[Business Wire] - Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Teva Pharmaceuticals securities between February 10, 2015 and November 3, 2016, inclusive ."
TEVA,TEVA:US,BBG000C0CD58,Why Valeant Has Been in the News Recently,2016-11-07 19:04:13 +0000,http://marketrealist.com/2016/11/why-valeant-has-been-making-news-recently/?utm_source=yahoo&utm_medium=feed,Why Valeant Has Been in the News Recently
TEVA,TEVA:US,BBG000C0CD58,Buy Health Care Now? It All Depends on the Election,2016-11-07 16:56:07 +0000,http://finance.yahoo.com/news/buy-health-care-now-depends-165607235.html,Buy Health Care Now? It All Depends on the Election
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-07 16:53:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-165300861.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces a class action lawsuit has been filed against Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws between February 10, 2015 and November 3, 2016 inclusive ."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline - January 5, 2017",2016-11-07 15:30:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-153000114.html,"[PR Newswire] - NEW YORK, Nov. 7, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Teva Pharmaceutical Industries ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Approval of Generic Tribenzor® in the United States,2016-11-07 14:00:00 +0000,http://finance.yahoo.com/news/teva-announces-approval-generic-tribenzor-140000435.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced approval of generic Tribenzor®1 tablets in the U.S."
TEVA,TEVA:US,BBG000C0CD58,"Top Analyst Upgrades and Downgrades: GoPro, Randgold, Teva Pharma, Time Warner, Waste Management and More",2016-11-07 13:50:37 +0000,http://247wallst.com/investing/2016/11/07/top-analyst-upgrades-and-downgrades-gopro-randgold-teva-pharma-time-warner-waste-management-and-more/,"Top Analyst Upgrades and Downgrades: GoPro, Randgold, Teva Pharma, Time Warner, Waste Management and More"
TEVA,TEVA:US,BBG000C0CD58,"Teva Highlights Growing Respiratory Portfolio at the 2016 American College of Allergy, Asthma & Immunology Annual Scientific Meeting",2016-11-07 13:00:00 +0000,http://finance.yahoo.com/news/teva-highlights-growing-respiratory-portfolio-130000617.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced that ten company-sponsored abstracts will be presented at the 2016 American College of Allergy, Asthma & Immunology Annual Scientific Meeting in San Francisco, California on November 10-14, 2016."
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-07 11:40:00 +0000,http://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-114000205.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited ."
TEVA,TEVA:US,BBG000C0CD58,Rosen Law Firm Files Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA,2016-11-07 00:46:00 +0000,http://finance.yahoo.com/news/rosen-law-firm-files-securities-004600371.html,"[PR Newswire] - NEW YORK, Nov. 6, 2016 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of the American Depositary Shares (""ADSs"") ..."
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Shares Dropped 7% in October,2016-11-05 16:49:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pxGrBaiB_Wc/why-teva-pharmaceutical-shares-dropped-7-in-october-cm704519,Image source Getty Images What happened After U S patent regulators invalidated the third of five patents protecting Copaxone sales shares in Teva Pharmaceutical NYSE TEVA fell steadily throughout October to finish down 7 1 on the month 160 according to S amp
TEVA,TEVA:US,BBG000C0CD58,Why Teva Pharmaceutical Shares Dropped 7% in October,2016-11-05 15:43:06 +0000,http://www.fool.com/investing/2016/11/05/why-teva-pharmaceutical-shares-dropped-7-in-octobe.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Teva Pharmaceutical Shares Dropped 7% in October
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of Teva Pharmaceutical Industries Limited and Advises Investors with Losses to Contact the Firm,2016-11-04 22:56:00 +0000,http://finance.yahoo.com/news/important-investor-alert-lundin-law-225600810.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws."
TEVA,TEVA:US,BBG000C0CD58,"After Big Drop in Generics, Ride the Rebound",2016-11-04 22:02:00 +0000,https://www.thestreet.com/story/13882195/1/after-big-drop-in-generics-ride-the-rebound.html?puc=yahoo&cm_ven=YAHOO,"After Big Drop in Generics, Ride the Rebound"
TEVA,TEVA:US,BBG000C0CD58,"Momenta Pharmaceuticals, Inc. Continues Its Wait for Higher Sales",2016-11-04 21:48:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8aVPQLr9OTM/momenta-pharmaceuticals-inc-continues-its-wait-for-higher-sales-cm704411,Image source Getty Images Momenta Pharmaceuticals NASDAQ MNTA released third quarter earnings on Wednesday The drug company is producing solid sales for what it has to work with but next year and beyond offer larger opportunities for investors to look forward to
TEVA,TEVA:US,BBG000C0CD58,Incyte Recoups Losses After Price-Fixing Fracas On Strong Chemo Results,2016-11-04 21:18:59 +0000,http://www.investors.com/news/technology/incyte-recoups-losses-after-price-fixing-fracas-on-strong-chemo-results/,Incyte Recoups Losses After Price-Fixing Fracas On Strong Chemo Results
TEVA,TEVA:US,BBG000C0CD58,"Teva, Allergan, Mylan Rally Following Sell-Off On DOJ Antitrust Probe",2016-11-04 20:24:10 +0000,http://www.investors.com/news/technology/teva-allergan-mylan-rally-following-sell-off-on-doj-antitrust-probe/,"Teva, Allergan, Mylan Rally Following Sell-Off On DOJ Antitrust Probe"
TEVA,TEVA:US,BBG000C0CD58,"Week In Review: Stocks Fall As Facebook Faceplants, Oil Drilled, Drugs Poisoned",2016-11-04 20:21:54 +0000,http://www.investors.com/news/week-in-review-2/,"Week In Review: Stocks Fall As Facebook Faceplants, Oil Drilled, Drugs Poisoned"
TEVA,TEVA:US,BBG000C0CD58,"Momenta Pharmaceuticals, Inc. Continues Its Wait for Higher Sales",2016-11-04 20:09:26 +0000,http://www.fool.com/investing/2016/11/04/momenta-pharmaceuticals-inc-continues-its-wait-for.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Momenta Pharmaceuticals, Inc. Continues Its Wait for Higher Sales"
TEVA,TEVA:US,BBG000C0CD58,"GoPro, Qorvo PTs Slashed; Teva Downgraded; 3D Systems A Buy",2016-11-04 20:03:49 +0000,http://www.investors.com/news/analysts-change-their-minds-on-gopro-teva-apple-chip-suppliers/,"GoPro, Qorvo PTs Slashed; Teva Downgraded; 3D Systems A Buy"
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Teva Pharmaceutical Industries Limited (TEVA)",2016-11-04 18:30:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-183000723.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 4, 2016 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Teva Pharmaceutical Industries Limited (""Teva"" ..."
TEVA,TEVA:US,BBG000C0CD58,"Generic drug stocks bounce, but analysts warn not to jump in",2016-11-04 18:24:57 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=6E0BD336-A297-11E6-A1B9-23844945BD4B&siteid=yhoof2,"Generic drug stocks bounce, but analysts warn not to jump in"
TEVA,TEVA:US,BBG000C0CD58,"Credit Suisse: Allergan Selloff 'Inappropriate,' Teva an 'Overreaction'",2016-11-04 17:57:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/04/credit-suisse-allergan-selloff-inappropriate-teva-an-overreaction/?mod=yahoobarrons&ru=yahoo,"Credit Suisse: Allergan Selloff 'Inappropriate,' Teva an 'Overreaction'"
TEVA,TEVA:US,BBG000C0CD58,INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm,2016-11-04 16:20:00 +0000,http://finance.yahoo.com/news/investor-alert-khang-khang-llp-162000368.html,[Business Wire] - Khang & Khang LLP announces that it is investigating claims against Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws.
TEVA,TEVA:US,BBG000C0CD58,Mylan's Troubles Just Won't Stop Showing Up,2016-11-04 16:10:00 +0000,https://www.thestreet.com/story/13881767/1/mylan-s-troubles-just-won-t-stop-showing-up.html?puc=yahoo&cm_ven=YAHOO,Mylan's Troubles Just Won't Stop Showing Up
TEVA,TEVA:US,BBG000C0CD58,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teva Pharmaceuticals Industries Limited - TEVA,2016-11-04 15:45:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-154500331.html,"[PR Newswire] - NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teva Pharmaceuticals Industries Limited (""Teva"" or the ""Company"") (NYSE: TEVA) ..."
TEVA,TEVA:US,BBG000C0CD58,"Here’s Why ENSCO PLC (ESV), Yum! Brands, Inc. (YUM), and Three Other Stocks Are Trending Today",2016-11-04 15:10:49 +0000,http://www.insidermonkey.com/blog/heres-why-ensco-plc-esv-yum-brands-inc-yum-and-three-other-stocks-are-trending-today-484941/,"Here’s Why ENSCO PLC (ESV), Yum! Brands, Inc. (YUM), and Three Other Stocks Are Trending Today"
TEVA,TEVA:US,BBG000C0CD58,This Generic-Drug-Stock Bloodbath Provides an Early Holiday Gift,2016-11-04 15:02:00 +0000,https://www.thestreet.com/story/13881112/1/this-generic-drug-stock-bloodbath-provides-an-early-holiday-gift.html?puc=yahoo&cm_ven=YAHOO,This Generic-Drug-Stock Bloodbath Provides an Early Holiday Gift
TEVA,TEVA:US,BBG000C0CD58,EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Teva Pharmaceutical Industries Ltd. - TEVA,2016-11-04 14:59:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-145900703.html,"[PR Newswire] - NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Teva Pharmaceutical Industries ..."
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Teva Pharmaceutical Industries Limited and Advises Investors with Losses to Contact the Firm,2016-11-04 14:42:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-lundin-law-144200774.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Teva Pharmaceutical Industries Limited concerning possible violations of federal securities laws."
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Teva Pharmaceutical Industries Limited (TEVA)",2016-11-04 14:15:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-141500967.html,"[PR Newswire] - NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Teva Pharmaceutical Industries ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical (TEVA) Stock Rating Cut at HSBC,2016-11-04 12:47:00 +0000,https://www.thestreet.com/story/13881311/1/teva-pharmaceutical-teva-stock-rating-cut-at-hsbc.html?puc=yahoo&cm_ven=YAHOO,Teva Pharmaceutical (TEVA) Stock Rating Cut at HSBC
TEVA,TEVA:US,BBG000C0CD58,"Generic Drug Stocks Tumble, DoJ Probe to Remain an Overhang",2016-11-04 11:45:11 +0000,http://finance.yahoo.com/news/generic-drug-stocks-tumble-doj-114511964.html,"Generic Drug Stocks Tumble, DoJ Probe to Remain an Overhang"
TEVA,TEVA:US,BBG000C0CD58,"SHAREHOLDER ALERT: Investigation of Teva Pharmaceutical Announced by Holzer & Holzer, LLC",2016-11-04 11:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-investigation-teva-pharmaceutical-110000578.html,"[Business Wire] - Holzer & Holzer, LLC is investigating whether certain statements made by Teva Pharmaceutical Industries LTD regarding its business and operations complied with federal securities laws."
TEVA,TEVA:US,BBG000C0CD58,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson,2016-11-04 06:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mNbvi-Fa7J0/big-hit-on-drug-stocks-caps-26-billion-decline-for-john-paulson-20161104-00162,Big Hit on Drug Stocks Caps $26 Billion Decline for John Paulson
TEVA,TEVA:US,BBG000C0CD58,DoJ Investigation Wipes $8.5B Off Generic Drug Makers: Buy On Dip?,2016-11-04 06:07:00 +0000,http://blogs.barrons.com/asiastocks/2016/11/04/generic-drug-pharmas-slammed-by-doj-investigation-buy-on-dip/?mod=yahoobarrons&ru=yahoo,DoJ Investigation Wipes $8.5B Off Generic Drug Makers: Buy On Dip?
TEVA,TEVA:US,BBG000C0CD58,[$$] Generic-Drug Firms Face Possible Collusion Charges,2016-11-04 03:57:43 +0000,http://www.wsj.com/articles/generic-drug-makers-shares-drop-on-report-of-possible-probe-1478209036?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Federal prosecutors, after a lengthy probe, are nearing possible criminal charges for price-collusion in the generic-drug industry, according to a person familiar with the matter."
TEVA,TEVA:US,BBG000C0CD58,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark",2016-11-04 03:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WBMAZAXetGU/achn-tanks-innls-acts-fail-lci-in-the-crosshair-of-law-once-loses-its-spark-20161104-00065,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark"
TEVA,TEVA:US,BBG000C0CD58,Generic Drug Firms Face Possible Collusion Charges -- WSJ,2016-11-04 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/78-5RUwZImE/generic-drug-firms-face-possible-collusion-charges--wsj-20161104-00491,Generic Drug Firms Face Possible Collusion Charges -- WSJ
TEVA,TEVA:US,BBG000C0CD58,IMPORTANT SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Teva Pharmaceutical Industries Limited and Advises Investors with Losses to Contact the Firm,2016-11-04 02:44:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-goldberg-law-024400762.html,[Business Wire] - Goldberg Law PC announces that it is investigating Teva Pharmaceutical Industries Limited concerning reports that the Company unlawfully colluded with other companies to fix generic drug prices.
TEVA,TEVA:US,BBG000C0CD58,Generic-Drug Firms Face Possible Collusion Charges,2016-11-04 00:42:00 +0000,http://finance.yahoo.com/news/generic-drug-firms-face-possible-004200451.html,Generic-Drug Firms Face Possible Collusion Charges
TEVA,TEVA:US,BBG000C0CD58,Generics Hit by Report on Pending DOJ Price Fixing Charges,2016-11-03 23:17:00 +0000,https://www.thestreet.com/story/13880923/1/generics-hit-by-report-on-pending-doj-price-fixing-charges.html?puc=yahoo&cm_ven=YAHOO,Generics Hit by Report on Pending DOJ Price Fixing Charges
TEVA,TEVA:US,BBG000C0CD58,Glancy Prongay & Murray LLP Commences Investigation on Behalf of Teva Pharmaceuticals Investors Concerning Recent Revelations Regarding an Alleged Illegal Conspiracy to Fix Drug Prices,2016-11-03 23:16:00 +0000,http://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-231600538.html,[Business Wire] - Glancy Prongay & Murray LLP announces an investigation on behalf of Teva Pharmaceuticals investors concerning recent reports that the Company has unlawfully colluded with other pharmaceutical companies to fix generic drug prices.
TEVA,TEVA:US,BBG000C0CD58,[$$] Generic-Drug Makers' Shares Drop on Report of Possible Probe,2016-11-03 21:59:32 +0000,http://www.wsj.com/articles/generic-drug-makers-shares-drop-on-report-of-possible-probe-1478209036?mod=yahoo_hs,[$$] Generic-Drug Makers' Shares Drop on Report of Possible Probe
TEVA,TEVA:US,BBG000C0CD58,Health Sector Down As Report of Industry Price Collusion Surfaces,2016-11-03 21:03:00 +0000,https://www.thestreet.com/story/13880341/1/health-sector-down-as-report-of-industry-price-collusion-surfaces.html?puc=yahoo&cm_ven=YAHOO,Health Sector Down As Report of Industry Price Collusion Surfaces
TEVA,TEVA:US,BBG000C0CD58,Generic-Drug Makers Crash On Report DOJ Plans Collusion Charges,2016-11-03 20:59:43 +0000,http://www.investors.com/news/technology/generic-drugmakers-crash-on-report-doj-plans-collusion-charges/,Generic-Drug Makers Crash On Report DOJ Plans Collusion Charges
TEVA,TEVA:US,BBG000C0CD58,Generic-Drug Firms Face Possible Collusion Charges -- 1st update,2016-11-03 20:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-bOvVSAKTss/genericdrug-firms-face-possible-collusion-charges--1st-update-20161103-01236,Generic-Drug Firms Face Possible Collusion Charges -- 1st update
TEVA,TEVA:US,BBG000C0CD58,"Eagle Pharma, Teva Pharma Diverge On 'Surprise' Leukemia Drug Win",2016-11-03 20:13:53 +0000,http://www.investors.com/news/technology/eagle-pharma-teva-pharma-diverge-on-surprise-leukemia-drug-win/,"Eagle Pharma, Teva Pharma Diverge On 'Surprise' Leukemia Drug Win"
TEVA,TEVA:US,BBG000C0CD58,"Fitbit, Frontier Communications Tumble into Thursday’s 52-Week Low Club",2016-11-03 20:04:55 +0000,http://247wallst.com/investing/2016/11/03/fitbit-frontier-communications-tumble-into-thursdays-52-week-low-club/,"Fitbit, Frontier Communications Tumble into Thursday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Generic drug probe charges to be filed by year end: Repor...,2016-11-03 18:19:00 +0000,http://finance.yahoo.com/video/generic-drug-probe-charges-filed-181900702.html,Generic drug probe charges to be filed by year end: Repor...
TEVA,TEVA:US,BBG000C0CD58,Generic-Drug Firms Face Possible Collusion Charges,2016-11-03 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q_BrV9vSKks/genericdrug-firms-face-possible-collusion-charges-20161103-01241,Generic-Drug Firms Face Possible Collusion Charges
TEVA,TEVA:US,BBG000C0CD58,Generic Drug Firms Face Possible Collusion Charges,2016-11-03 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kn4Mp2kihCw/generic-drug-firms-face-possible-collusion-charges-20161103-01234,Generic Drug Firms Face Possible Collusion Charges
TEVA,TEVA:US,BBG000C0CD58,Generic-Drug Makers' Shares Drop on Report of Possible Probe,2016-11-03 17:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qi3HbUrZ900/genericdrug-makers-shares-drop-on-report-of-possible-probe-20161103-01235,Generic-Drug Makers' Shares Drop on Report of Possible Probe
TEVA,TEVA:US,BBG000C0CD58,Generic-Drug Makers'' Shares Drop on Report of Possible Probe,2016-11-03 17:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hdznyXa-NO0/genericdrug-makers-shares-drop-on-report-of-possible-probe-20161103-01155,Generic-Drug Makers'' Shares Drop on Report of Possible Probe
TEVA,TEVA:US,BBG000C0CD58,3 Things You Really Need to Know About Allergan's Q3 Results,2016-11-03 10:23:39 +0000,http://www.fool.com/investing/2016/11/02/3-things-you-really-need-to-know-about-allergans-q.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Things You Really Need to Know About Allergan's Q3 Results
TEVA,TEVA:US,BBG000C0CD58,These 5 Mega-Cap Stocks Are Breaking Out in November,2016-11-03 10:01:00 +0000,https://www.thestreet.com/story/13878662/1/these-5-mega-cap-stocks-are-breaking-out-in-november.html?puc=yahoo&cm_ven=YAHOO,These 5 Mega-Cap Stocks Are Breaking Out in November
TEVA,TEVA:US,BBG000C0CD58,"CEMP Loses Big As D-Day Nears, AVXS Catches Investors'' Eyes, No Respite For OPXA",2016-11-03 02:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HYQ7fJGCKSc/cemp-loses-big-as-dday-nears-avxs-catches-investors-eyes-no-respite-for-opxa-20161103-00039,"CEMP Loses Big As D-Day Nears, AVXS Catches Investors'' Eyes, No Respite For OPXA"
TEVA,TEVA:US,BBG000C0CD58,3 Things You Really Need to Know About Allergan's Q3 Results,2016-11-02 22:08:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JPtftckG-Q8/3-things-you-really-need-to-know-about-allergans-q3-results-cm702857,You might think that nothing has gone right for Allergan plc NYSE AGN this year Its share price has declined over 30 since January as the potential acquisition by Pfizer fell apart However Allergan actually has seen some positive developments in 2016 The
TEVA,TEVA:US,BBG000C0CD58,3 Beaten-Down Healthcare Stocks to Buy,2016-11-02 22:07:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/98JH4uilX-c/3-beaten-down-healthcare-stocks-to-buy-cm702843,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips So far this year the S amp P 500 has returned about 3 Surprisingly and uncharacteristically the healthcare sector has fallen 7 which qualifies it as the worst performer this year Source Will
TEVA,TEVA:US,BBG000C0CD58,"Why Eagle Pharmaceuticals, Inc. Is Soaring 21.6% Today",2016-11-02 18:09:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E-Qb-vVyfmA/why-eagle-pharmaceuticals-inc-is-soaring-216-today-cm702682,Image source Getty Images What happened After reporting that its Bendeka has received a unique J code from the Centers for Medicare and Medicaid Services or CMS Eagle Pharmaceuticals NASDAQ EGRX shares are soaring 21 6 as of 12 00 p m EDT today So
TEVA,TEVA:US,BBG000C0CD58,Teva call buyers look for quick pop,2016-11-02 18:02:35 +0000,http://finance.yahoo.com/news/teva-call-buyers-look-quick-173033073.html,Teva call buyers look for quick pop
TEVA,TEVA:US,BBG000C0CD58,"Why Eagle Pharmaceuticals, Inc. Is Soaring 21.6% Today",2016-11-02 16:30:21 +0000,http://www.fool.com/investing/2016/11/02/why-eagle-pharmaceuticals-inc-skyrocketed-216-toda.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Eagle Pharmaceuticals, Inc. Is Soaring 21.6% Today"
TEVA,TEVA:US,BBG000C0CD58,"Allergan (AGN) Lags Q3 Earnings, Cuts View, Ups Buyback",2016-11-02 15:09:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ghT4RNqEA_o/allergan-agn-lags-q3-earnings-cuts-view-ups-buyback-cm702532,Allergan plc s AGN third quarter 2016 earnings came in at 3 32 per share missing the Zacks Consensus Estimate of 3 57 by 7 Earnings declined 2 6 from the year ago period and almost 1 sequentially FindTheCompany Graphiq Lower revenues and higher research
TEVA,TEVA:US,BBG000C0CD58,What Allergan Is Buying and Shedding to Gain a Better Position,2016-11-02 15:05:25 +0000,http://marketrealist.com/2016/11/what-allergan-is-buying-and-shedding-to-gain-a-better-position/?utm_source=yahoo&utm_medium=feed,What Allergan Is Buying and Shedding to Gain a Better Position
TEVA,TEVA:US,BBG000C0CD58,CMS Establishes Unique J-Code for BENDEKA® (Bendamustine Hydrochloride) Injection,2016-11-02 13:33:00 +0000,http://finance.yahoo.com/news/cms-establishes-unique-j-code-110000041.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. and Eagle Pharmaceuticals, Inc. announced today that the Centers for Medicare & Medicaid Services has established a unique, product-specific billing code, or J-code , for BENDEKA® Injection."
TEVA,TEVA:US,BBG000C0CD58,5 Stocks to Watch Before the Market Opens Tomorrow,2016-11-01 20:10:21 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-tomorrow-201025824.html,5 Stocks to Watch Before the Market Opens Tomorrow
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Requests Stricter Approval Requirements For Copaxone Generics,2016-11-01 17:38:00 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-adr-teva-requests-stricter-approval-requirements-for-copaxone-generics-484492/,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Requests Stricter Approval Requirements For Copaxone Generics
TEVA,TEVA:US,BBG000C0CD58,Regeneron (REGN) Q3 Earnings: Will the Stock Surprise?,2016-11-01 14:16:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/icvMyO34wCM/regeneron-regn-q3-earnings-will-the-stock-surprise-cm701666,Regeneron Pharmaceuticals Inc REGN is scheduled to release third quarter 2016 results on Nov 4 before the opening bell The company s performance has been mixed so far In the last four reported quarters it has surpassed earnings estimates on two occasions and missed the same twice
TEVA,TEVA:US,BBG000C0CD58,"After Hours Most Active for Oct 31, 2016 :  ADNT, BAC, TEVA, AAPL, MSFT, GE, CSCO, T, INTC, KO, ASNA, BEAV",2016-10-31 21:04:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LzkHQTtdu_k/after-hours-most-active-for-oct-31-2016-adnt-bac-teva-aapl-msft-ge-csco-t-intc-ko-asna-beav-cm701393,The NASDAQ 100 After Hours Indicator is up 2 04 to 4 803 31 The total After hours volume is currently 71 890 922 shares traded The following are the most active stocks for the after hours session Adient plc ADNT is 0 005 at 45 52 with 4 124 816 shares traded
TEVA,TEVA:US,BBG000C0CD58,Monday's ETF with Unusual Volume: GWL,2016-10-31 20:13:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5bqUS8ZtCtk/mondays-etf-with-unusual-volume-gwl-cm701329,The SPDR S amp P World ex US ETF GWL is seeing unusually high volume in afternoon trading Monday with over 441 000 shares traded versus three month average volume of about 93 000 Shares of GWL were trading flat on the day Components of that ETF with the highest volume on Monday
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Has Generic 'Tricks' Ahead But Valuation 'A Treat',2016-10-31 20:10:40 +0000,http://www.investors.com/news/technology/teva-pharma-has-generic-tricks-ahead-but-valuation-a-treat/,Teva Pharma Has Generic 'Tricks' Ahead But Valuation 'A Treat'
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals Could Be Poised For A Turnaround,2016-10-31 18:46:34 +0000,http://finance.yahoo.com/news/teva-pharmaceuticals-could-poised-turnaround-184634250.html,Teva Pharmaceuticals Could Be Poised For A Turnaround
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals (TEVA) Stock Upgraded at Credit Suisse,2016-10-31 14:37:00 +0000,https://www.thestreet.com/story/13873523/1/teva-pharmaceuticals-teva-stock-upgraded-at-credit-suisse.html?puc=yahoo&cm_ven=YAHOO,Teva Pharmaceuticals (TEVA) Stock Upgraded at Credit Suisse
TEVA,TEVA:US,BBG000C0CD58,"Teva to Report Third Quarter 2016 Financial Results on November 15, 2016",2016-10-31 12:30:00 +0000,http://finance.yahoo.com/news/teva-report-third-quarter-2016-123000498.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. announced today that it will release its third quarter 2016 financial results on Tuesday, November 15, 2016 at 7:00 a.m. ET."
TEVA,TEVA:US,BBG000C0CD58,3 Top Healthcare Stocks to Own If Hillary Clinton Becomes President,2016-10-30 14:00:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AeLfvIBoV7s/3-top-healthcare-stocks-to-own-if-hillary-clinton-becomes-president-cm700732,If the polls are right the odds of Hillary Clinton becoming president of the United States are pretty good right now The conventional wisdom is that many healthcare stocks could suffer under her presidency While that might be true healthcare companies like Centene NYSE
TEVA,TEVA:US,BBG000C0CD58,3 Top Healthcare Stocks to Own If Hillary Clinton Becomes President,2016-10-30 13:18:45 +0000,http://www.fool.com/investing/2016/10/30/3-best-healthcare-stocks-to-own-if-hillary-clinton.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Healthcare Stocks to Own If Hillary Clinton Becomes President
TEVA,TEVA:US,BBG000C0CD58,How The Parts Add Up: ADRD Headed For $22,2016-10-28 14:32:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_d_Tnp9_KFI/how-the-parts-add-up-adrd-headed-for-22-cm700086,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
TEVA,TEVA:US,BBG000C0CD58,Can Allergan (AGN) Keep the Earnings Streak Alive in Q3?,2016-10-27 17:43:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1-d8lgEeapE/can-allergan-agn-keep-the-earnings-streak-alive-in-q3-cm699587,Allergan plc AGN will be reporting third quarter 2016 earnings on Nov 2 before market open Last quarter the company delivered a positive earnings surprise of 2 13 Allergan s performance has been pretty impressive with consistent positive surprises The average earnings beat over the
TEVA,TEVA:US,BBG000C0CD58,"Teva, IBM Expand Drug Repurposing Plan (TEVA, IBM)",2016-10-27 12:53:00 +0000,http://www.investopedia.com/news/teva-and-ibm-broaden-drug-partnership-teva-ibm/?partner=YahooSA,[at Investopedia] - Teva and IBM expanded their disease management and drug repurposing alliance.
TEVA,TEVA:US,BBG000C0CD58,Allergan CEO Brent Saunders Succeeds Paul Bisaro as Chairman,2016-10-26 20:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4wrasAdpF_Q/allergan-ceo-brent-saunders-succeeds-paul-bisaro-as-chairman-20161026-01342,Allergan CEO Brent Saunders Succeeds Paul Bisaro as Chairman
TEVA,TEVA:US,BBG000C0CD58,Exactly How Bad Is Regeneron's Latest News?,2016-10-26 15:29:32 +0000,http://www.fool.com/investing/2016/10/26/exactly-how-bad-is-regenerons-latest-news.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Exactly How Bad Is Regeneron's Latest News?
TEVA,TEVA:US,BBG000C0CD58,"Teva, IBM expand Watson supercomputer partnership",2016-10-26 15:20:12 +0000,http://www.bizjournals.com/philadelphia/news/2016/10/26/teva-ibm-watson-supercomputer-health-cloud-pharma.html?ana=yahoo,"[at American City Business Journals] - Teva Pharmaceutical Industries Ltd. and IBM said Wednesday they are ""significantly expanding"" their Watson Health alliance. Watson is IBM's supercomputer that combines artificial intelligence and sophisticated analytical software. The expansion of Teva (TEVA) and IBM's three-year partnership will focus on two key health care challenges: the discovery of new treatment options and improving chronic disease management."
TEVA,TEVA:US,BBG000C0CD58,"Why Toyota, IBM, Teva, and Two Other Stocks Are in Spotlight Today",2016-10-26 15:17:59 +0000,http://www.insidermonkey.com/blog/why-toyota-ibm-teva-and-two-other-stocks-are-in-spotlight-today-483286/,"Why Toyota, IBM, Teva, and Two Other Stocks Are in Spotlight Today"
TEVA,TEVA:US,BBG000C0CD58,Exactly How Bad Is Regeneron's Latest News?,2016-10-26 14:50:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tEWH54rcxtI/exactly-how-bad-is-regenerons-latest-news-cm698435,Image source Getty Images Are Regeneron Pharmaceuticals NASDAQ REGN and partner Teva Pharmaceuticals NYSE TEVA experiencing a case of deja vu 160 In 2011 and 2012 the FDA placed clinical holds on investigational drug fasinumab that were eventually lifted Now the
TEVA,TEVA:US,BBG000C0CD58,Short-term calls target upside in Teva,2016-10-26 14:22:30 +0000,http://finance.yahoo.com/news/short-term-calls-target-upside-142230051.html,Short-term calls target upside in Teva
TEVA,TEVA:US,BBG000C0CD58,4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall,2016-10-26 12:27:59 +0000,http://www.fool.com/investing/2016/10/25/4-top-drug-stocks-that-can-be-purchased-on-the-che.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall
TEVA,TEVA:US,BBG000C0CD58,Short Sellers Grow More Selective on Major Pharma Stocks,2016-10-26 11:40:58 +0000,http://247wallst.com/healthcare-business/2016/10/26/short-sellers-grow-more-selective-on-major-pharma-stocks/,Short Sellers Grow More Selective on Major Pharma Stocks
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson,2016-10-26 11:00:00 +0000,http://finance.yahoo.com/news/teva-pharmaceuticals-ibm-expand-global-110000821.html,"[Business Wire] - IBM and Teva Pharmaceutical Industries Ltd., today announce a significant expansion of their existing global e-Health alliance with a focus on two key healthcare challenges: the discovery of new treatment options and improving chronic disease management."
TEVA,TEVA:US,BBG000C0CD58,GlaxoSmithKline’s 3Q16 Revenues Are Expected to Rise,2016-10-25 17:04:08 +0000,http://marketrealist.com/2016/10/glaxosmithklines-3q16-revenues-are-expected-to-rise/?utm_source=yahoo&utm_medium=feed,GlaxoSmithKline’s 3Q16 Revenues Are Expected to Rise
TEVA,TEVA:US,BBG000C0CD58,Do Emerging Market Face Plethora Of Risks?,2016-10-25 16:02:00 +0000,http://blogs.barrons.com/emergingmarketsdaily/2016/10/25/do-emerging-market-face-plethora-of-risks/?mod=yahoobarrons&ru=yahoo,Do Emerging Market Face Plethora Of Risks?
TEVA,TEVA:US,BBG000C0CD58,4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall,2016-10-25 14:25:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F3nBd9-FyfI/4-top-drug-stocks-that-can-be-purchased-on-the-cheap-this-fall-cm697683,Some great drug stocks could be hiding in plain view Image source Getty Images U S stocks have been taken for a wild ride in 2016 but at least most long term investors can relish the fact that despite the volatility the broader market indexes are all higher year to date The
TEVA,TEVA:US,BBG000C0CD58,Allergan's Nocturia Drug Gets FDA Advisory Committee's Nod,2016-10-21 15:25:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wG3EBvwGlpA/allergans-nocturia-drug-gets-fda-advisory-committees-nod-cm696526,Allergan plc AGN and partner Serenity Pharmaceuticals announced that the FDA s Advisory Committee of Bone Reproductive and Urologic Drugs recommended approval for its pipeline candidate SER120 desmopressin nasal spray for the treatment of nocturia Nocturia is a very common
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : August 22nd, 2016 (record date) : By the numbers : October 20, 2016",2016-10-20 15:12:50 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-us-dividend-analysis-august-22nd-2016-record-date-by-the-numbers-october-20-2016/,"Teva Pharmaceutical Industries Ltd. : TEVA-US: Dividend Analysis : August 22nd, 2016 (record date) : By the numbers : October 20, 2016"
TEVA,TEVA:US,BBG000C0CD58,7 Drug Stocks to Consider as Biosimilars Pick Up Pace,2016-10-20 14:29:02 +0000,http://finance.yahoo.com/news/7-drug-stocks-consider-biosimilars-142902130.html,7 Drug Stocks to Consider as Biosimilars Pick Up Pace
TEVA,TEVA:US,BBG000C0CD58,Teva’s Banned Hungarian Plant Warned by FDA (TEVA),2016-10-20 13:22:00 +0000,http://www.investopedia.com/news/teva-hungary-facility-gets-fda-warning-teva/?partner=YahooSA,Teva’s Banned Hungarian Plant Warned by FDA (TEVA)
TEVA,TEVA:US,BBG000C0CD58,Teva Announces FDA Acceptance of Resubmitted New Drug Application for SD-809 for Treatment of Chorea Associated with Huntington Disease,2016-10-20 13:00:00 +0000,http://finance.yahoo.com/news/teva-announces-fda-acceptance-resubmitted-130000437.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has accepted the resubmission of the New Drug Application for SD-809 for the treatment of chorea associated with Huntington disease .
TEVA,TEVA:US,BBG000C0CD58,Teva: FDA To Review Resubmitted NDA For SD-809 - Quick Facts,2016-10-20 09:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CVk-kk8CrIU/teva-fda-to-review-resubmitted-nda-for-sd809--quick-facts-20161020-00689,Teva: FDA To Review Resubmitted NDA For SD-809 - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,Allergan (AGN) Brings Juvederm Voluma XC to U.S. Market,2016-10-19 14:50:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w_7WzCU21ns/allergan-agn-brings-juvederm-voluma-xc-to-us-market-cm695256,Allergan plc AGN announced that it has launched Juvéderm Voluma XC in the U S The product is a new addition to the Juvéderm range of fillers for lip augmentation and for correcting perioral rhytids or lipstick lines in adults aged 21 and above In one year of clinical trials the
TEVA,TEVA:US,BBG000C0CD58,"Mylan: 'Ouch, That Hurt'",2016-10-19 14:16:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/19/mylan-ouch-that-hurt/?mod=yahoobarrons&ru=yahoo,"Mylan: 'Ouch, That Hurt'"
TEVA,TEVA:US,BBG000C0CD58,Is Teva Pharmaceutical Industries Ltd (TEVA) Planning Celltrion Takeover To Bolster Biosimilar Portfolio?,2016-10-19 04:01:00 +0000,http://www.insidermonkey.com/blog/is-teva-pharmaceutical-industries-ltd-teva-planning-celltrion-takeover-to-bolster-biosimilar-portfolio-482064/,Is Teva Pharmaceutical Industries Ltd (TEVA) Planning Celltrion Takeover To Bolster Biosimilar Portfolio?
TEVA,TEVA:US,BBG000C0CD58,Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia,2016-10-18 15:51:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fL0RKd9hzrU/teva-trisenox-wins-chmp-nod-for-expanded-use-in-leukemia-cm694767,Teva Pharmaceutical Industries Ltd TEVA announced that the European Medicines Agency s EMA Committee for Medicinal Products for Human Use CHMP has recommended expanding Trisenox s label in the EU The company is looking to get Trisenox approved in combination with retinoic acid for
TEVA,TEVA:US,BBG000C0CD58,Regeneron & Teva Hit by Clinical Hold on Chronic Pain Study,2016-10-18 15:51:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zZCQ0HNnb8c/regeneron-teva-hit-by-clinical-hold-on-chronic-pain-study-cm694765,Both Regeneron Pharmaceuticals Inc REGN and its partner Teva Pharmaceutical Industries Ltd TEVA suffered a setback with the FDA placing a clinical hold on a phase IIb study evaluating their experimental nerve growth factor NGF antibody fasinumab for chronic low back pain While
TEVA,TEVA:US,BBG000C0CD58,"FDA Holds Regeneron, Teva Pain Study (REGN, TEVA)",2016-10-18 15:40:00 +0000,http://www.investopedia.com/news/regeneron-teva-study-hold-fda-regn-teva/?partner=YahooSA,"FDA Holds Regeneron, Teva Pain Study (REGN, TEVA)"
TEVA,TEVA:US,BBG000C0CD58,Regeneron & Teva Hit by Clinical Hold on Chronic Pain Study,2016-10-18 13:25:01 +0000,http://finance.yahoo.com/news/regeneron-teva-hit-clinical-hold-132501243.html,Regeneron & Teva Hit by Clinical Hold on Chronic Pain Study
TEVA,TEVA:US,BBG000C0CD58,Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia,2016-10-18 13:23:01 +0000,http://finance.yahoo.com/news/teva-trisenox-wins-chmp-nod-132301590.html,Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia
TEVA,TEVA:US,BBG000C0CD58,"Why Lannett Company, Inc. Shares Got Pummeled Today",2016-10-17 21:47:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ild-MKO2UV0/why-lannett-company-inc-shares-got-pummeled-today-cm694461,Image source Getty Images What happened Lannett Company Inc NYSE LCI ended the day down almost 13 after the Food and Drug Administration proposed withdrawing a generic version of Johnson amp Johnson s NYSE JNJ Concerta sold by Lannett s subsidiary Kremers
TEVA,TEVA:US,BBG000C0CD58,"Why Lannett Company, Inc. Shares Got Pummeled Today",2016-10-17 20:33:55 +0000,http://www.fool.com/investing/2016/10/17/why-lannett-company-inc-shares-got-pummeled-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Lannett Company, Inc. Shares Got Pummeled Today"
TEVA,TEVA:US,BBG000C0CD58,"Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing",2016-10-17 20:13:21 +0000,http://www.investors.com/news/technology/eli-lilly-abbvie-top-2017-rankings-pfizer-astrazeneca-flailing/,"Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing"
TEVA,TEVA:US,BBG000C0CD58,"Nike, Bristol-Myers Drop into Monday’s 52-Week Low Club",2016-10-17 20:04:42 +0000,http://247wallst.com/investing/2016/10/17/nike-bristol-myers-drop-into-mondays-52-week-low-club/,"Nike, Bristol-Myers Drop into Monday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs,2016-10-17 12:13:03 +0000,http://www.publicnow.com/view/5152D44A935DEC4EC667BA348A904F3C06903851,"[at noodls] - October 17, 2016 TARRYTOWN, N.Y. and JERUSALEM, Oct. 17, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today provided ..."
TEVA,TEVA:US,BBG000C0CD58,"News Of Clinical Hold For Fasinumab Weighs On Regeneron, Teva Shares",2016-10-17 12:09:51 +0000,http://finance.yahoo.com/news/news-clinical-hold-fasinumab-weighs-120951685.html,"News Of Clinical Hold For Fasinumab Weighs On Regeneron, Teva Shares"
TEVA,TEVA:US,BBG000C0CD58,FDA places Regeneron and Teva's pain-drug study on hold,2016-10-17 11:27:32 +0000,http://finance.yahoo.com/news/fda-places-regeneron-tevas-pain-112732960.html,"[Reuters] - Regeneron Pharmaceuticals Inc and partner Teva Pharmaceutical Industries Ltd said the U.S. health regulator has placed a clinical hold on a mid-stage study of their experimental drug for chronic lower back pain. The Food and Drug Administration (FDA) imposed the hold after observing a case of a type of joint inflammation in an advanced osteoarthritis patient, who was given a high dose of the drug, fasinumab. Following the FDA decision, Regeneron has completed an unplanned interim review of data and has stopped dosing patients, the company said on Monday."
TEVA,TEVA:US,BBG000C0CD58,Regeneron stock slumps nearly 2% after FDA puts hold on midstage clinical trial,2016-10-17 11:23:22 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B539644D-A557-4A15-AEA8-371660F6EB1D&siteid=yhoof2,Regeneron stock slumps nearly 2% after FDA puts hold on midstage clinical trial
TEVA,TEVA:US,BBG000C0CD58,"Regeneron, Teva: FDA Places Phase 2b Fasinumab Back Pain Trial On Clinical Hold",2016-10-17 07:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HbMs08LV3vE/regeneron-teva-fda-places-phase-2b-fasinumab-back-pain-trial-on-clinical-hold-20161017-00252,"Regeneron, Teva: FDA Places Phase 2b Fasinumab Back Pain Trial On Clinical Hold"
TEVA,TEVA:US,BBG000C0CD58,Wall Street Points To Lower Opening,2016-10-17 06:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pfdQt3ErtC8/wall-street-points-to-lower-opening-20161017-00144,Wall Street Points To Lower Opening
TEVA,TEVA:US,BBG000C0CD58,Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox® for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL),2016-10-17 06:00:00 +0000,http://uk.finance.yahoo.com/news/teva-receives-positive-opinion-european-060000648.html,Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox® for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma: CHMP Adopts Positive Opinion For Extended Indication Of Trisenox,2016-10-17 02:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tg_RP8Rs4J4/teva-pharma-chmp-adopts-positive-opinion-for-extended-indication-of-trisenox-20161017-00999,Teva Pharma: CHMP Adopts Positive Opinion For Extended Indication Of Trisenox
TEVA,TEVA:US,BBG000C0CD58,"Teva, Celltion Enter $160M Biosimilar Deal (TEVA)",2016-10-14 20:08:00 +0000,http://www.investopedia.com/news/teva-and-celltrion-biosimilar-drug-pact-teva/?partner=YahooSA,"Teva, Celltion Enter $160M Biosimilar Deal (TEVA)"
TEVA,TEVA:US,BBG000C0CD58,"Staples, Teva Join Friday’s 52-Week Low Club",2016-10-14 20:04:27 +0000,http://247wallst.com/investing/2016/10/14/staples-teva-join-fridays-52-week-low-club/,"Staples, Teva Join Friday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Teva Launches Generic Version of Beyaz (TEVA),2016-10-14 19:04:00 +0000,http://www.investopedia.com/news/teva-rolls-out-generic-birth-control-rajani-teva/?partner=YahooSA,Teva Launches Generic Version of Beyaz (TEVA)
TEVA,TEVA:US,BBG000C0CD58,Four Key Deals: Analyzing Pfizer’s Impending Growth,2016-10-14 12:04:53 +0000,http://marketrealist.com/2016/10/four-key-deals-analyzing-pfizers-impending-growth/?utm_source=yahoo&utm_medium=feed,Four Key Deals: Analyzing Pfizer’s Impending Growth
TEVA,TEVA:US,BBG000C0CD58,Allergan Gets Priority Review for Avycaz Label Expansion,2016-10-13 20:41:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MJy8Y2ahVOc/allergan-gets-priority-review-for-avycaz-label-expansion-cm693134,Allergan plc AGN announced that its supplemental new drug application for antibiotic Avycaz ceftazidime and avibactam ex U S trade name Zavicefta has been accepted for review by the FDA Allergan is looking to include data from a phase III study in Avycaz s existing label The phase
TEVA,TEVA:US,BBG000C0CD58,"Ericsson, Gilead Tumble into Wednesday’s 52-Week Low Club",2016-10-12 20:04:57 +0000,http://247wallst.com/?p=357824,"Ericsson, Gilead Tumble into Wednesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,"Ericsson, Gilead Tumble Into Wednesday’s 52-Week Low Club",2016-10-12 20:04:57 +0000,http://247wallst.com/investing/2016/10/12/ericsson-gilead-tumble-into-wednesdays-52-week-low-club/,"Ericsson, Gilead Tumble Into Wednesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Beyaz® in the United States,2016-10-12 14:00:00 +0000,http://finance.yahoo.com/news/teva-announces-launch-generic-beyaz-140000581.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced the launch of RAJANITM in the United States."
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Sellers Grow More Selective,2016-10-12 11:35:07 +0000,http://247wallst.com/healthcare-business/2016/10/12/major-pharma-short-sellers-grow-more-selective/,Major Pharma Short Sellers Grow More Selective
TEVA,TEVA:US,BBG000C0CD58,Teva Launches Generic Beyaz In U.S.,2016-10-12 10:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mweec1UaA98/teva-launches-generic-beyaz-in-us-20161012-00652,Teva Launches Generic Beyaz In U.S.
TEVA,TEVA:US,BBG000C0CD58,"Why Momenta Pharmaceuticals, Inc. Jumped Higher Today",2016-10-11 22:18:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5GiECRYKDk0/why-momenta-pharmaceuticals-inc-jumped-higher-today-cm692083,Image source Getty Images What happened Momenta Pharmaceuticals NASDAQ MNTA ended Tuesday up 12 5 after an analyst at Barclays upgraded the biotech and increased the price target So what The next big event for Momenta Pharmaceuticals is likely to be the launch of
TEVA,TEVA:US,BBG000C0CD58,"Why Momenta Pharmaceuticals, Inc. Jumped Higher Today",2016-10-11 20:29:38 +0000,http://www.fool.com/investing/2016/10/11/why-momenta-pharmaceuticals-inc-jumped-higher-toda.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Momenta Pharmaceuticals, Inc. Jumped Higher Today"
TEVA,TEVA:US,BBG000C0CD58,"Momenta Pharmaceuticals (MNTA) Stock Surges, Barclays Upgrades",2016-10-11 18:45:00 +0000,https://www.thestreet.com/story/13849323/1/momenta-pharmaceuticals-mnta-stock-surges-barclays-upgrades.html?puc=yahoo&cm_ven=YAHOO,"Momenta Pharmaceuticals (MNTA) Stock Surges, Barclays Upgrades"
TEVA,TEVA:US,BBG000C0CD58,Punishment For This Healthcare ETF Could Create Opportunity,2016-10-11 18:13:24 +0000,http://finance.yahoo.com/news/punishment-healthcare-etf-could-create-181324943.html,Punishment For This Healthcare ETF Could Create Opportunity
TEVA,TEVA:US,BBG000C0CD58,Teva Acquires Rights to Oncology Biosimilar Candidates,2016-10-11 15:22:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BOkBUoVdxco/teva-acquires-rights-to-oncology-biosimilar-candidates-cm691786,Generic drug maker Teva Pharmaceutical Industries Ltd TEVA has entered into an exclusive biosimilar commercial partnership with Korean biopharmaceutical company Celltrion Inc and its distribution partner Celltrion Healthcare Per the deal Teva gets exclusive rights to commercialize two
TEVA,TEVA:US,BBG000C0CD58,Teva Acquires Rights to Oncology Biosimilar Candidates,2016-10-11 13:25:01 +0000,http://finance.yahoo.com/news/teva-acquires-rights-oncology-biosimilar-132501925.html,Teva Acquires Rights to Oncology Biosimilar Candidates
TEVA,TEVA:US,BBG000C0CD58,Mylan Jumps As DOJ Settlement Removes 'Lingering Concerns',2016-10-10 20:03:36 +0000,http://www.investors.com/news/technology/mylan-jumps-as-doj-settlement-removes-lingering-concerns/,Mylan Jumps As DOJ Settlement Removes 'Lingering Concerns'
TEVA,TEVA:US,BBG000C0CD58,"Mylan’s $465 million settlement boosts stock, but benefit may be short-lived",2016-10-10 18:51:33 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D366E8AA-8EED-11E6-94B4-A9EAC68D0F98&siteid=yhoof2,"Mylan’s $465 million settlement boosts stock, but benefit may be short-lived"
TEVA,TEVA:US,BBG000C0CD58,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System",2016-10-09 18:28:54 +0000,http://www.fool.com/investing/2016/10/08/dont-blame-mylans-ceo-for-epipens-soaring-price-bl.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System"
TEVA,TEVA:US,BBG000C0CD58,"Don't Blame Mylan's CEO for EpiPen's Soaring Price, Blame the U.S. Healthcare System",2016-10-08 19:43:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A3j-ISPYg1M/dont-blame-mylans-ceo-for-epipens-soaring-price-blame-the-us-healthcare-system-cm690719,Image source Getty Images No your eyes or wallet aren t deceiving you the perception of pharmaceutical price gouging has certainly become more commonplace over the past year Last September Martin Shkreli the Bad Boy of Pharma increased the price of a 62 year
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. (TEVA), Celltrion, Team Up To Market mAb Biosimilars",2016-10-07 18:11:50 +0000,http://www.insidermonkey.com/blog/teva-pharmaceutical-industries-ltd-teva-celltrion-team-up-to-market-mab-biosimilars-479429/,"Teva Pharmaceutical Industries Ltd. (TEVA), Celltrion, Team Up To Market mAb Biosimilars"
TEVA,TEVA:US,BBG000C0CD58,3 Value Stocks Near 52-Week Lows Worth Buying,2016-10-06 16:45:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UQEGdoBIV08/3-value-stocks-near-52-week-lows-worth-buying-cm689854,Image source Getty Images While many companies shares are rising 160 past their fair values now others are trading at potentially bargain prices The difficulty with bargain shopping though is that you may be understandably hesitant to buy stocks wallowing near their 52 week
TEVA,TEVA:US,BBG000C0CD58,Teva to Divest Actavis Generics' UK & Ireland Operations,2016-10-06 15:48:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tE8fkFH2seg/teva-to-divest-actavis-generics-uk-ireland-operations-cm689783,Teva Pharmaceutical Industries Ltd TEVA announced that it has agreed to divest the UK and Ireland assets of Actavis Generics to Accord Healthcare a subsidiary of Intas Pharmaceuticals Ltd subject to a final approval from the European Commission EC The deal has been settled with
TEVA,TEVA:US,BBG000C0CD58,3 Value Stocks Near 52-Week Lows Worth Buying,2016-10-06 14:59:06 +0000,http://www.fool.com/retirement/2016/10/06/3-value-stocks-near-52-week-lows-worth-buying.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Value Stocks Near 52-Week Lows Worth Buying
TEVA,TEVA:US,BBG000C0CD58,Teva to Divest Actavis Generics' UK & Ireland Operations,2016-10-06 13:16:01 +0000,http://finance.yahoo.com/news/teva-divest-actavis-generics-uk-131601527.html,Teva to Divest Actavis Generics' UK & Ireland Operations
TEVA,TEVA:US,BBG000C0CD58,Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership,2016-10-06 12:00:00 +0000,http://au.finance.yahoo.com/news/teva-celltrion-announce-exclusive-biosimilar-120000339.html,"[Business Wire] - JERUSALEM and INCHEON, South Korea--(BUSINESSWIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA), Celltrion, Inc. and Celltrion Healthcare today announce that the companies have entered into an exclusive partnership to commercialize two of Celltrion’s mAb biosimilar candidates in the U.S. and Canada. CT-P10 is a proposed mAb biosimilar to Rituxan® (rituximab), which is used to treat patients with Non-Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Wegener’s Granulomatosis and Microscopic Polyangiitis (MPA). “This commercial partnership with Celltrion enables Teva to expand into the upcoming wave of biosimilars and build on its strong position in the biosimilar space,” said Siggi Olafsson, President & CEO of Global Generic Medicines, Teva Pharmaceuticals."
TEVA,TEVA:US,BBG000C0CD58,"Teva, Celltrion Announce Biosimilar Commercial Partnership",2016-10-06 08:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m0EoQyDiXo0/teva-celltrion-announce-biosimilar-commercial-partnership-20161006-00336,"Teva, Celltrion Announce Biosimilar Commercial Partnership"
TEVA,TEVA:US,BBG000C0CD58,Deals of the day- Mergers and acquisitions,2016-10-05 21:30:33 +0000,http://sg.finance.yahoo.com/news/deals-day-mergers-acquisitions-213033177.html,Deals of the day- Mergers and acquisitions
TEVA,TEVA:US,BBG000C0CD58,"Kroger, Teva Slip into Wednesday’s 52-Week Low Club",2016-10-05 20:04:21 +0000,http://247wallst.com/investing/2016/10/05/kroger-teva-slip-into-wednesdays-52-week-low-club/,"Kroger, Teva Slip into Wednesday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Teva Divests More Assets to Win EC Approval for Allergan Generics Deal,2016-10-05 19:03:00 +0000,https://www.thestreet.com/story/13842947/1/teva-divests-more-assets-to-win-ec-approval-for-allergan-generics-deal.html?puc=yahoo&cm_ven=YAHOO,Teva Divests More Assets to Win EC Approval for Allergan Generics Deal
TEVA,TEVA:US,BBG000C0CD58,"Teva to sell Allergan's generics business in UK, Ireland for $769 million",2016-10-05 18:40:01 +0000,http://sg.finance.yahoo.com/news/teva-sell-allergans-generics-business-163832469.html,"Teva to sell Allergan's generics business in UK, Ireland for $769 million"
TEVA,TEVA:US,BBG000C0CD58,[$$] Teva Sells Actavis Generics European Assets to Accord Healthcare,2016-10-05 16:29:11 +0000,http://www.wsj.com/articles/teva-sells-actavis-generics-european-assets-to-accord-healthcare-1475684946?mod=yahoo_hs,[$$] Teva Sells Actavis Generics European Assets to Accord Healthcare
TEVA,TEVA:US,BBG000C0CD58,"Teva to sell Allergan's generics business in UK, Ireland for $769 mln",2016-10-05 16:04:45 +0000,http://finance.yahoo.com/news/teva-sell-allergans-generics-business-160445195.html,"[Reuters] - Teva Pharmaceutical Industries Ltd said on Wednesday it would sell Allergan Plc's generics business in the UK and Ireland to India's Intas Pharmaceuticals Ltd for 603 million pounds ($769.37 million). The sale was part of Teva's deal with the European Commission to get approval for the acquisition of Allergan's generics business, called Actavis Generics. Teva completed the $40.5-billion acquisition of Allergan's generics business in August."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Sale of UK and Ireland Actavis Assets and Operations,2016-10-05 15:00:00 +0000,http://uk.finance.yahoo.com/news/teva-announces-sale-uk-ireland-150000508.html,Teva Announces Sale of UK and Ireland Actavis Assets and Operations
TEVA,TEVA:US,BBG000C0CD58,Teva To Sell UK And Ireland Actavis Assets And Operations For GBP 603 Mln,2016-10-05 11:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bwYwkf683YY/teva-to-sell-uk-and-ireland-actavis-assets-and-operations-for-gbp-603-mln-20161005-00694,Teva To Sell UK And Ireland Actavis Assets And Operations For GBP 603 Mln
TEVA,TEVA:US,BBG000C0CD58,Teva Boosts Generic Business with Allergan Anda Takeover,2016-10-04 23:43:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r19uRrJGq_0/teva-boosts-generic-business-with-allergan-anda-takeover-cm688847,Teva Pharmaceutical Industries Limited TEVA announced that it has completed the acquisition of Allergan plc s AGN U S generic distribution business Anda Inc Teva entered into a definitive agreement to acquire Anda the 4th largest distributor of generic pharmaceuticals in the U S for
TEVA,TEVA:US,BBG000C0CD58,Teva Boosts Generic Business with Allergan Anda Takeover,2016-10-04 21:59:09 +0000,http://finance.yahoo.com/news/teva-boosts-generic-business-allergan-215909803.html,Teva Boosts Generic Business with Allergan Anda Takeover
TEVA,TEVA:US,BBG000C0CD58,"Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club",2016-10-03 20:04:20 +0000,http://247wallst.com/investing/2016/10/03/wells-fargo-bristol-myers-drop-in-on-mondays-52-week-low-club/,"Wells Fargo, Bristol-Myers Drop in on Monday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Allergan PLC’s Charm-and-Merger Offensive (AGN),2016-10-03 19:44:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/itzx__LEK3E/allergan-plcs-charm-and-merger-offensive-agn-cm688064,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Since losing in his effort to take out Pfizer Inc NYSE PFE in a huge tax inversion deal this past spring Allergan Plc NYSE AGN CEO Brent Saunders has hatched a new strategy with the
TEVA,TEVA:US,BBG000C0CD58,"Teva Stock Down, Wells Fargo: Few Near-Term Positive Catalysts",2016-10-03 19:07:00 +0000,https://www.thestreet.com/story/13839436/1/teva-stock-down-wells-fargo-few-near-term-positive-catalysts.html?puc=yahoo&cm_ven=YAHOO,"Teva Stock Down, Wells Fargo: Few Near-Term Positive Catalysts"
TEVA,TEVA:US,BBG000C0CD58,"Teva Completes Acquisition of Anda, Inc.",2016-10-03 13:57:00 +0000,http://finance.yahoo.com/news/teva-completes-acquisition-anda-inc-135700388.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced that it has completed its acquisition of Anda, Inc., a leading distributor of generic pharmaceuticals in the U.S., from Allergan plc."
TEVA,TEVA:US,BBG000C0CD58,Bulls are playing for a rebound in Teva,2016-10-03 11:47:00 +0000,http://finance.yahoo.com/news/bulls-playing-rebound-teva-114700013.html,Bulls are playing for a rebound in Teva
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks to Buy in October,2016-10-01 14:21:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPpudRVzG5U/3-dividend-stocks-to-buy-in-october-cm687456,Image source Getty Images Investors who simply look at the broader markets will probably assume that there aren t a whole lot of great buys out there today because we re either at or approaching all time highs for the various indexes If you dig deeper though you will find
TEVA,TEVA:US,BBG000C0CD58,3 Dividend Stocks to Buy in October,2016-10-01 13:02:07 +0000,http://www.fool.com/investing/2016/10/01/3-dividend-stocks-to-buy-in-october.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Dividend Stocks to Buy in October
TEVA,TEVA:US,BBG000C0CD58,"Wells Fargo, Cognizant in Friday’s 52-Week Low Club",2016-09-30 20:04:48 +0000,http://finance.yahoo.com/news/wells-fargo-cognizant-friday-52-200448560.html,"Wells Fargo, Cognizant in Friday’s 52-Week Low Club"
TEVA,TEVA:US,BBG000C0CD58,Traders are betting big against this biotech stock,2016-09-30 19:04:27 +0000,http://www.cnbc.com/id/103983884?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103983884,Traders are betting big against this biotech stock
TEVA,TEVA:US,BBG000C0CD58,Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint,2016-09-30 16:24:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rKvo6B6iSSE/amgen-amgn-migraine-drug-hits-phase-iii-primary-endpoint-cm687174,Amgen Inc AMGN announced positive top line data from a phase III study ARISE on calcitonin gene related peptide CGRP receptor erenumab AMG 334 for the prevention of episodic migraine The multi center randomized 12 week double blind placebo controlled study evaluated the safety
TEVA,TEVA:US,BBG000C0CD58,Teva’s Research Pipeline and Generic Product Launches in 2016,2016-09-30 15:04:28 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-research-pipeline-may-result-multiple-generic-product-launches-2016/?utm_source=yahoo&utm_medium=feed,Teva’s Research Pipeline and Generic Product Launches in 2016
TEVA,TEVA:US,BBG000C0CD58,Allergan Generics Has Strengthened Teva’s Research Pipeline,2016-09-30 14:04:24 +0000,http://marketrealist.com/2016/09/acquisition-allergan-generics-strengthened-teva-pharmaceuticals-research-pipeline-2016/?utm_source=yahoo&utm_medium=feed,Allergan Generics Has Strengthened Teva’s Research Pipeline
TEVA,TEVA:US,BBG000C0CD58,Teva Has a Targeted Strategy to Expand in Major Growth Markets,2016-09-30 12:04:27 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-developed-targeted-strategy-expanding-major-growth-markets/?utm_source=yahoo&utm_medium=feed,Teva Has a Targeted Strategy to Expand in Major Growth Markets
TEVA,TEVA:US,BBG000C0CD58,"Amgen Migraine Drug Likely To Beat Eli Lilly, Alder, Teva To Market",2016-09-29 20:09:25 +0000,http://www.investors.com/news/technology/amgen-migraine-drug-likely-to-beat-eli-lilly-alder-teva-to-market/,"Amgen Migraine Drug Likely To Beat Eli Lilly, Alder, Teva To Market"
TEVA,TEVA:US,BBG000C0CD58,"Deutsche Bank, Wells Fargo Tumble into 52-Week Low Clubs",2016-09-29 20:04:49 +0000,http://finance.yahoo.com/news/deutsche-bank-wells-fargo-tumble-200449120.html,"Deutsche Bank, Wells Fargo Tumble into 52-Week Low Clubs"
TEVA,TEVA:US,BBG000C0CD58,Why Teva and Regeneron Entered Collaboration Agreement,2016-09-29 18:04:10 +0000,http://marketrealist.com/2016/09/teva-and-regenerons-global-collaboration-agreement-for-fasinumab/?utm_source=yahoo&utm_medium=feed,Why Teva and Regeneron Entered Collaboration Agreement
TEVA,TEVA:US,BBG000C0CD58,Strong Brand Positioning Expected to Strengthen Teva’s Position,2016-09-29 15:04:42 +0000,http://marketrealist.com/2016/09/strong-brand-positioning-expected-strengthen-teva-pharmaceuticals-position-growth-markets/?utm_source=yahoo&utm_medium=feed,Strong Brand Positioning Expected to Strengthen Teva’s Position
TEVA,TEVA:US,BBG000C0CD58,Teva Expects Significant Value Addition from Growth Markets,2016-09-29 14:04:45 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-expects-significant-value-addition-growth-markets-future-years/?utm_source=yahoo&utm_medium=feed,Teva Expects Significant Value Addition from Growth Markets
TEVA,TEVA:US,BBG000C0CD58,Teva’s Generic Business and Its Transformation in Europe,2016-09-29 12:04:57 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-generic-business-witnessed-significant-transformation-europe/?utm_source=yahoo&utm_medium=feed,Teva’s Generic Business and Its Transformation in Europe
TEVA,TEVA:US,BBG000C0CD58,Teva’s Commercial Strategy May Be Successful across Europe,2016-09-28 15:05:25 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-commercial-strategy-may-prove-successful-across-market-structures-europe/?utm_source=yahoo&utm_medium=feed,Teva’s Commercial Strategy May Be Successful across Europe
TEVA,TEVA:US,BBG000C0CD58,Teva’s Share of the US Generics Market Could Boost Its Stock,2016-09-28 15:04:46 +0000,http://marketrealist.com/2016/09/tevas-share-u-s-generics-market-boost-stock/?utm_source=yahoo&utm_medium=feed,Teva’s Share of the US Generics Market Could Boost Its Stock
TEVA,TEVA:US,BBG000C0CD58,Teva Is Well Placed to Dominate the European Generics Market,2016-09-28 14:05:19 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-well-placed-dominate-european-generics-market/?utm_source=yahoo&utm_medium=feed,Teva Is Well Placed to Dominate the European Generics Market
TEVA,TEVA:US,BBG000C0CD58,Is Teva Positioned to Compete with the Likes of Mylan and Novartis?,2016-09-28 14:04:16 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-expected-witness-limited-pricing-pressures-generics-business-2016/?utm_source=yahoo&utm_medium=feed,Is Teva Positioned to Compete with the Likes of Mylan and Novartis?
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Epzicom® Tablets in the United States,2016-09-28 13:00:00 +0000,http://finance.yahoo.com/news/teva-announces-launch-generic-epzicom-130000564.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced the launch of a generic equivalent of Epzicom®1 tablets, 600 mg/300 mg, in the United States ."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Still Dominates the Generic Market in Europe,2016-09-28 12:06:17 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-continues-dominate-generic-market-europe-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical Still Dominates the Generic Market in Europe
TEVA,TEVA:US,BBG000C0CD58,A Look at Teva’s Dominance in the Biosimilar Space,2016-09-28 12:04:22 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-continues-dominant-player-biosimilar-business-2016/?utm_source=yahoo&utm_medium=feed,A Look at Teva’s Dominance in the Biosimilar Space
TEVA,TEVA:US,BBG000C0CD58,Teva Launches Generic Epzicom Tablets In US,2016-09-28 09:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IPQrjzIIcXw/teva-launches-generic-epzicom-tablets-in-us-20160928-00458,Teva Launches Generic Epzicom Tablets In US
TEVA,TEVA:US,BBG000C0CD58,Teva Is Well Positioned for New Trends in the US Generic Market,2016-09-27 22:10:31 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-well-positioned-face-new-trends-u-s-generic-market/?utm_source=yahoo&utm_medium=feed,Teva Is Well Positioned for New Trends in the US Generic Market
TEVA,TEVA:US,BBG000C0CD58,"The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alphabet and Qualcomm",2016-09-27 15:25:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lLyj2L1DyQk/the-zacks-analyst-blog-highlights-teva-pharmaceutical-industries-intel-sanofi-alphabet-and-qualcomm-cm685315,For Immediate Release Chicago IL September 27 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
TEVA,TEVA:US,BBG000C0CD58,Teva’s OTC Business Is Playing out to Be a Key Growth Driver,2016-09-27 15:04:59 +0000,http://marketrealist.com/2016/09/otc-business-expected-become-key-growth-driver-teva-pharmaceutical-2016/?utm_source=yahoo&utm_medium=feed,Teva’s OTC Business Is Playing out to Be a Key Growth Driver
TEVA,TEVA:US,BBG000C0CD58,This Strategy Could Boost Teva’s Growth Prospects Even More,2016-09-27 14:04:36 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-geographic-diversification-strategy-may-boost-growth-prospects-2016/?utm_source=yahoo&utm_medium=feed,This Strategy Could Boost Teva’s Growth Prospects Even More
TEVA,TEVA:US,BBG000C0CD58,"The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alphabet and Qualcomm",2016-09-27 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-teva-133001440.html,"The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alphabet and Qualcomm"
TEVA,TEVA:US,BBG000C0CD58,Teva’s Generic Value Chain Differentiates It from Its Peers,2016-09-27 12:04:45 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-generic-value-chain-may-differentiate-company-peers-2016/?utm_source=yahoo&utm_medium=feed,Teva’s Generic Value Chain Differentiates It from Its Peers
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Continues to See Rising Tide in Short Interest,2016-09-27 11:40:49 +0000,http://247wallst.com/healthcare-business/2016/09/27/major-pharma-continues-to-see-rising-tide-in-short-interest/,Major Pharma Continues to See Rising Tide in Short Interest
TEVA,TEVA:US,BBG000C0CD58,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says",2016-09-26 19:42:00 +0000,https://www.thestreet.com/story/13752208/1/clinton-trump-share-big-pharma-attack-goals-andrew-left-says.html?puc=yahoo&cm_ven=YAHOO,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says"
TEVA,TEVA:US,BBG000C0CD58,The Internet of Medical Things: 6 Stocks in Focus,2016-09-26 15:24:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lzQhfP0_jp4/the-internet-of-medical-things-6-stocks-in-focus-cm684443,The Internet of Medical Things IoMT is fast gaining pace as pharma companies look to innovate and keep up with technology to help patients and physicians better monitor and track diseases With a couple of deals being announced this month IoMT seems like the future of healthcare IoMT
TEVA,TEVA:US,BBG000C0CD58,Winning? We Review How Teva Dominates Generic Drug Space,2016-09-26 15:05:19 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-implemented-winning-formula-dominate-generic-pharmaceutical-space/?utm_source=yahoo&utm_medium=feed,Winning? We Review How Teva Dominates Generic Drug Space
TEVA,TEVA:US,BBG000C0CD58,The Implied Analyst 12-Month Target For ADRD,2016-09-26 14:21:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hnUODnBKdgU/the-implied-analyst-12-month-target-for-adrd-cm684448,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Leads in Global Generic Pharmaceutical Space,2016-09-26 14:05:59 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-continues-leader-global-generic-pharmaceutical-industry/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical Leads in Global Generic Pharmaceutical Space
TEVA,TEVA:US,BBG000C0CD58,The Internet of Medical Things: 6 Stocks in Focus,2016-09-26 13:33:01 +0000,http://finance.yahoo.com/news/internet-medical-things-6-stocks-133301649.html,The Internet of Medical Things: 6 Stocks in Focus
TEVA,TEVA:US,BBG000C0CD58,How Teva’s Analysts Suggest Investors Play Its Stock,2016-09-26 12:06:28 +0000,http://marketrealist.com/2016/09/analyst-recommendations-teva-pharmaceutical-peers-2016/?utm_source=yahoo&utm_medium=feed,How Teva’s Analysts Suggest Investors Play Its Stock
TEVA,TEVA:US,BBG000C0CD58,3 Dirt-Cheap Dividend Stocks You Can Buy Right Now,2016-09-24 13:21:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u9V_MhwUems/3-dirt-cheap-dividend-stocks-you-can-buy-right-now-cm684151,There aren t a whole lot of compelling bargains these days when it comes to income generating stocks but there are a select few flying under the radar at the moment AbbVie NYSE ABBV Gilead Sciences NASDAQ GILD and Teva Pharmaceutical Industries NYSE TEVA
TEVA,TEVA:US,BBG000C0CD58,Teva’s Valuation Multiples Compared to Other Generic Drug Players,2016-09-23 21:25:53 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-valuation-multiples-compare-generic-pharmaceutical-players/?utm_source=yahoo&utm_medium=feed,Teva’s Valuation Multiples Compared to Other Generic Drug Players
TEVA,TEVA:US,BBG000C0CD58,"Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest",2016-09-23 20:46:44 +0000,http://www.investors.com/research/ibd-industry-themes/amgen-biogen-pitted-in-ma-scenario-adamas-acadia-draw-interest/,"Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest"
TEVA,TEVA:US,BBG000C0CD58,Teva Reports Positive Phase III Tardive Dyskinesia Data,2016-09-23 18:24:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bs1ITqCBVBA/teva-reports-positive-phase-iii-tardive-dyskinesia-data-cm683737,Teva Pharmaceutical Industries Ltd TEVA announced encouraging top line data from the second phase III study AIM TD on SD 809 deutetrabenazine which is being evaluated for the treatment of tardive dyskinesia TD The randomized double blinded placebo controlled parallel
TEVA,TEVA:US,BBG000C0CD58,Teva: This Is No Generic Downtrend,2016-09-23 14:16:00 +0000,http://realmoney.thestreet.com/articles/09/23/2016/teva-no-generic-downtrend?puc=yahoo&cm_ven=YAHOO,Teva: This Is No Generic Downtrend
TEVA,TEVA:US,BBG000C0CD58,Teva Reports Positive Phase III Tardive Dyskinesia Data,2016-09-23 13:33:01 +0000,http://finance.yahoo.com/news/teva-reports-positive-phase-iii-133301225.html,Teva Reports Positive Phase III Tardive Dyskinesia Data
TEVA,TEVA:US,BBG000C0CD58,"Negative impact largely priced into shares of EpiPen-maker Mylan, analyst says",2016-09-22 20:06:30 +0000,http://www.cnbc.com/id/103962110?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103962110,"Negative impact largely priced into shares of EpiPen-maker Mylan, analyst says"
TEVA,TEVA:US,BBG000C0CD58,"[$$] Teva, Allergan Pump Up the Pipelines",2016-09-22 15:17:00 +0000,http://www.barrons.com/articles/teva-allergan-pump-up-the-pipelines-1474557432?mod=yahoobarrons&ru=yahoo,"[$$] Teva, Allergan Pump Up the Pipelines"
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia (TD),2016-09-22 12:00:00 +0000,http://finance.yahoo.com/news/teva-announces-positive-top-line-120000931.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced SD-809 showed statistically significant results in the second Phase III registration trial studying the potential of SD-809 for the treatment of tardive dyskinesia .
TEVA,TEVA:US,BBG000C0CD58,Teva Reports Positive Top-Line Data From Second Phase III Study Of SD-809,2016-09-22 08:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HxrdFqFrjE4/teva-reports-positive-topline-data-from-second-phase-iii-study-of-sd809-20160922-00373,Teva Reports Positive Top-Line Data From Second Phase III Study Of SD-809
TEVA,TEVA:US,BBG000C0CD58,Teva Reports Positive Top-Line Data From Second Phase III Study Of SD-809,2016-09-22 08:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wDcpZgT6y2Y/teva-reports-positive-topline-data-from-second-phase-iii-study-of-sd809-20160922-00372,Teva Reports Positive Top-Line Data From Second Phase III Study Of SD-809
TEVA,TEVA:US,BBG000C0CD58,"Regeneron, Teva Collaborate to Develop Chronic Pain Drug",2016-09-21 21:21:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/otPtxX_AqwM/regeneron-teva-collaborate-to-develop-chronic-pain-drug-cm682870,Regeneron Pharmaceuticals Inc REGN and Teva Pharmaceutical Industries Ltd TEVA announced a global agreement for the development and commercialization of the former s experimental nerve growth factor NGF antibody fasinumab Fasinumab is in phase III development for the treatment
TEVA,TEVA:US,BBG000C0CD58,"Regeneron, Teva Collaborate to Develop Chronic Pain Drug",2016-09-21 19:08:07 +0000,http://finance.yahoo.com/news/regeneron-teva-collaborate-develop-chronic-190807956.html,"Regeneron, Teva Collaborate to Develop Chronic Pain Drug"
TEVA,TEVA:US,BBG000C0CD58,Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma,2016-09-21 11:21:53 +0000,http://finance.yahoo.com/news/allergans-tobira-acquisition-represents-highest-112153149.html,Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma
TEVA,TEVA:US,BBG000C0CD58,Mylan CEO Faces Tough Questioning in EpiPen Hearing,2016-09-21 10:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1kW6pAZhodM/mylan-ceo-faces-tough-questioning-in-epipen-hearing-20160921-01033,Mylan CEO Faces Tough Questioning in EpiPen Hearing
TEVA,TEVA:US,BBG000C0CD58,"Regeneron to Collaborate With Teva for Fasinumab Drug (REGN, TEVA)",2016-09-21 04:30:00 +0000,http://www.investopedia.com/news/regeneron-collaborate-teva-fasinumab-drug-regn-teva/?partner=YahooSA,"Regeneron to Collaborate With Teva for Fasinumab Drug (REGN, TEVA)"
TEVA,TEVA:US,BBG000C0CD58,"West Virginia Investigating EpiPen Maker Mylan for Alleged Medicaid Fraud, Antitrust Violations",2016-09-20 20:29:31 +0000,http://finance.yahoo.com/news/west-virginia-investigating-epipen-maker-202933335.html,"West Virginia Investigating EpiPen Maker Mylan for Alleged Medicaid Fraud, Antitrust Violations"
TEVA,TEVA:US,BBG000C0CD58,"Teva, Eli Lilly Have Migraine Treatments in Trial Phases",2016-09-20 15:04:57 +0000,http://marketrealist.com/2016/09/teva-pharmaceutical-eli-lilly-continue-explore-opportunities-migraine-segment/?utm_source=yahoo&utm_medium=feed,"Teva, Eli Lilly Have Migraine Treatments in Trial Phases"
TEVA,TEVA:US,BBG000C0CD58,Teva Presents Top-Line Data from Huntington Disease Study,2016-09-20 14:25:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QDXhiNnAIhs/teva-presents-top-line-data-from-huntington-disease-study-cm681876,Generic drug maker Teva Pharmaceutical Industries Ltd TEVA announced top line results from a phase II trial evaluating its pipeline candidate pridopidine for the treatment of patients with Huntington disease HD Pridopidine is an oral small molecule dopamine stabilizer which is
TEVA,TEVA:US,BBG000C0CD58,Teva Presents Top-Line Data from Huntington Disease Study,2016-09-20 12:00:12 +0000,http://finance.yahoo.com/news/teva-presents-top-line-data-120012571.html,Teva Presents Top-Line Data from Huntington Disease Study
TEVA,TEVA:US,BBG000C0CD58,"Regeneron and Teva Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain",2016-09-20 11:28:04 +0000,http://www.publicnow.com/view/4C7F3C94DCFB697CC9B994E4F351683E600FED45,"[at noodls] - September 20, 2016 Novel Nerve Growth Factor (NGF) Antibody Has Potential to Address Limitations of Current Non- Steroidal Anti-Inflammatory Drugs (NSAIDs) and Opioid Therapies TARRYTOWN, N.Y. and JERUSALEM, ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain",2016-09-20 11:00:00 +0000,http://finance.yahoo.com/news/teva-regeneron-announce-global-collaboration-110000860.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. and Regeneron Pharmaceuticals, Inc. announced today a global1 agreement to develop and commercialize fasinumab, Regeneron’s investigational NGF antibody in Phase 3 clinical development for osteoarthritis pain and in Phase 2 development for chronic low back pain."
TEVA,TEVA:US,BBG000C0CD58,Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal,2016-09-20 09:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KICoivIhBEk/allergan-to-buy-tobira-therapeutics-in-17-billion-deal-20160920-00338,Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal
TEVA,TEVA:US,BBG000C0CD58,Regeneron Pharma And Teva Pharma Reach Agreement To Commercialize Fasinumab,2016-09-20 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hH7I7S7WUT4/regeneron-pharma-and-teva-pharma-reach-agreement-to-commercialize-fasinumab-20160920-00861,Regeneron Pharma And Teva Pharma Reach Agreement To Commercialize Fasinumab
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study of Pridopidine in Huntington Disease,2016-09-19 11:00:00 +0000,http://finance.yahoo.com/news/teva-announces-results-exploratory-52-110000390.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announces top-line results from the exploratory Phase 2 PRIDE-HD study. This was a 52-week, dose-ranging trial of pridopidine twice daily versus placebo, in the treatment of Huntington disease ."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Reports Encouraging Results From Exploratory Phase 2 PRIDE-HD Study,2016-09-19 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/woJm5hx8pkc/teva-pharma-reports-encouraging-results-from-exploratory-phase-2-pridehd-study-20160919-00203,Teva Pharma Reports Encouraging Results From Exploratory Phase 2 PRIDE-HD Study
TEVA,TEVA:US,BBG000C0CD58,Intel and Teva Partner on Cloud-based Healthcare Solutions,2016-09-16 16:19:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ng8Q3v8cKFI/intel-and-teva-partner-on-cloud-based-healthcare-solutions-cm680567,Chip giant Intel Corporation INTC has joined forces with Israeli pharmaceutical company Teva Pharmaceutical Industries Limited TEVA to develop mechanisms that will better comprehend and examine the progress of still incurable Huntington s disease 160 As part of this collaboration Intel
TEVA,TEVA:US,BBG000C0CD58,Teva/Intel Tie up for Huntington's Disease Technology Platform,2016-09-16 15:22:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XPPC0LDaxtw/tevaintel-tie-up-for-huntingtons-disease-technology-platform-cm680525,Generic drug maker Teva Pharmaceutical Industries Limited TEVA announced that it is collaborating with Intel Corporation INTC to develop a wearable device and machine learning platform that can be used for the treatment of Huntington s disease HD To improve understanding of
TEVA,TEVA:US,BBG000C0CD58,Intel and Teva Partner on Cloud-based Healthcare Solutions,2016-09-16 14:13:02 +0000,http://finance.yahoo.com/news/intel-teva-partner-cloud-based-141302275.html,Intel and Teva Partner on Cloud-based Healthcare Solutions
TEVA,TEVA:US,BBG000C0CD58,Blog Coverage Allergan Boosts its RandD Expenditure and Pours 639m Dollars in the New Merger,2016-09-16 13:19:25 +0000,http://news.investornetwork.com/2016/09/16/blog-coverage-allergan-boosts-its-randd-expenditure-and-pours-639m-dollars-in-the-new-merger/?1=1&1474031965,Blog Coverage Allergan Boosts its RandD Expenditure and Pours 639m Dollars in the New Merger
TEVA,TEVA:US,BBG000C0CD58,Blog Coverage Teva Expands its Injectables Portfolio and Banks on Merck Cubicin,2016-09-16 13:19:25 +0000,http://news.investornetwork.com/2016/09/16/blog-coverage-teva-expands-its-injectables-portfolio-and-banks-on-merck-cubicin/?1=1&1474031965,Blog Coverage Teva Expands its Injectables Portfolio and Banks on Merck Cubicin
TEVA,TEVA:US,BBG000C0CD58,Teva/Intel Tie up for Huntington's Disease Technology Platform,2016-09-16 13:01:01 +0000,http://finance.yahoo.com/news/teva-intel-tie-huntingtons-disease-130101305.html,Teva/Intel Tie up for Huntington's Disease Technology Platform
TEVA,TEVA:US,BBG000C0CD58,A Decades-Old Drug Technology Finally Nears Its Big Breakthrough,2016-09-16 06:55:10 +0000,http://www.bloomberg.com/news/articles/2016-09-16/a-decades-old-drug-technology-finally-nears-its-big-breakthrough?cmpid=yhoo.headline,A Decades-Old Drug Technology Finally Nears Its Big Breakthrough
TEVA,TEVA:US,BBG000C0CD58,More Pharma and Tech Collaborations to Follow the Teva-Intel Wearable Device,2016-09-15 18:23:00 +0000,https://www.thestreet.com/story/13741670/1/more-pharma-and-tech-collaborations-to-follow-the-teva-intel-wearable-device.html?puc=yahoo&cm_ven=YAHOO,More Pharma and Tech Collaborations to Follow the Teva-Intel Wearable Device
TEVA,TEVA:US,BBG000C0CD58,"Intel (INTC) Stock Up, Developing Wearable Device with Teva Pharmaceuticals",2016-09-15 17:00:00 +0000,https://www.thestreet.com/story/13741788/1/intel-intc-stock-up-developing-wearable-device-with-teva-pharmaceuticals.html?puc=yahoo&cm_ven=YAHOO,[at TheStreet] - Intel (INTC) is working with Teva Pharmaceuticals (TEVA) to develop a wearable that can track patients' functioning and movement as a means of studying Huntington's disease.
TEVA,TEVA:US,BBG000C0CD58,"Teva, Intel to develop wearable tech for Huntington's disease",2016-09-15 16:19:45 +0000,http://sg.finance.yahoo.com/news/teva-intel-develop-wearables-monitor-134626120.html,"Teva, Intel to develop wearable tech for Huntington's disease"
TEVA,TEVA:US,BBG000C0CD58,"Teva, Intel to develop wearable technology for Huntington's disease",2016-09-15 16:15:46 +0000,http://sg.finance.yahoo.com/news/teva-intel-develop-wearables-monitor-134503616.html,"Teva, Intel to develop wearable technology for Huntington's disease"
TEVA,TEVA:US,BBG000C0CD58,Energy and Tech: Here’s Why Traders Are Buzzing about These Five Stocks Today,2016-09-15 15:12:11 +0000,http://www.insidermonkey.com/blog/energy-and-tech-heres-why-traders-are-buzzing-about-these-five-stocks-today-474812/,Energy and Tech: Here’s Why Traders Are Buzzing about These Five Stocks Today
TEVA,TEVA:US,BBG000C0CD58,Teva teaming up with Intel for wearable device study with Huntingdon's disease patients,2016-09-15 14:55:23 +0000,http://www.bizjournals.com/philadelphia/news/2016/09/15/teva-intel-wearable-device-study-huntingdons.html?ana=yahoo,"[at American City Business Journals] - Teva Pharmaceutical Industries Ltd. has formed a partnership with Intel Corp. to develop a unique wearable device and machine learning platform to continuously monitor and analyze key symptoms in patient’s with Huntingdon’s disease. Huntingdon’s disease is rare and fatal neurodegenerative disease characterized by uncoordinated and uncontrollable movements, cognitive deterioration and behavioral and/or psychological problems. According to the World Health Organization, Huntington disease affects about five to seven people per 100,000 in Western countries."
TEVA,TEVA:US,BBG000C0CD58,Teva and UGG Unveil Hybrid Collection,2016-09-15 13:28:09 +0000,http://www.publicnow.com/view/58DB98E6D4F71848987F4305E83D73434FD0BE79,[at noodls] - http://www.businesswire.com/news/home/20160915005175/en/ (Photo: Business Wire) 'The Teva x UGG collaboration allows us to celebrate expression of freedom while showcasing the innovation that is infused ...
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharm, Intel to study Huntington disease progression",2016-09-15 13:01:51 +0000,http://finance.yahoo.com/news/teva-pharm-intel-study-huntington-130151696.html,"[Reuters] - Teva Pharmaceutical Industries is collaborating with Intel Corp to develop a wearable device and machine learning platform for Huntington disease patients, Teva said on Thursday. The platform will monitor and analyse key symptoms that impact daily living to better understand disease progression and improve treatment evaluation, Israel-based Teva, the world's largest generic drugmaker, said. Huntington is a fatal neurodegenerative disease characterised by uncoordinated and uncontrollable movements, cognitive deterioration and behavioural and/or psychological problems."
TEVA,TEVA:US,BBG000C0CD58,Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin® (Daptomycin for Injection) in the United States,2016-09-15 13:00:00 +0000,http://finance.yahoo.com/news/teva-strengthens-injectables-portfolio-launch-130000407.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announced the launch of an authorized generic of Cubicin®1 500 mg per vial in the United States."
TEVA,TEVA:US,BBG000C0CD58,Buy These 5 Breakout Stocks,2016-09-15 12:31:00 +0000,https://www.thestreet.com/story/13740708/1/buy-these-5-breakout-stocks.html?puc=yahoo&cm_ven=YAHOO,Buy These 5 Breakout Stocks
TEVA,TEVA:US,BBG000C0CD58,Teva to Develop Unique Wearable Tech and Machine Learning Platform for Continuous Measurement & Analysis of Huntington Disease Symptoms in Collaboration with Intel,2016-09-15 12:00:00 +0000,http://finance.yahoo.com/news/teva-develop-unique-wearable-tech-120000761.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd., today announces a collaboration with Intel Corporation to develop a unique wearable device and machine learning platform for use in Huntington disease ."
TEVA,TEVA:US,BBG000C0CD58,Teva Launches Generic Of Cubicin - Quick Facts,2016-09-15 09:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DCs7ukE6I_U/teva-launches-generic-of-cubicin--quick-facts-20160915-00578,Teva Launches Generic Of Cubicin - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,[$$] Governance Change Needed at Mylan,2016-09-14 23:50:45 +0000,http://online.wsj.com/article/SB20710306698016174760704582314210938334008.html?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - It is time for Mylan NV to look at bringing itself into the mainstream of corporate governance.
TEVA,TEVA:US,BBG000C0CD58,4 Jefferies Stealth Stock Picks for a Very Volatile Market,2016-09-14 16:15:12 +0000,http://247wallst.com/investing/2016/09/14/4-jefferies-stealth-stock-picks-for-a-very-volatile-market/,4 Jefferies Stealth Stock Picks for a Very Volatile Market
TEVA,TEVA:US,BBG000C0CD58,Why Allergan Should Start Paying a Dividend,2016-09-13 23:46:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CpoumXdcSQ8/why-allergan-should-start-paying-a-dividend-cm679116,Image source Getty Images Raise your hand if you think big pharma Allergan s NYSE AGN s recent stock performance has been 160 dismal 160 Every hand raised I thought so The company s stock 160 has dropped 24 this year 160 while the S amp P has gained 4 2 And that
TEVA,TEVA:US,BBG000C0CD58,Why Allergan Should Start Paying a Dividend,2016-09-13 21:47:16 +0000,http://www.fool.com/investing/2016/09/13/why-allergan-should-start-paying-a-dividend.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Allergan Should Start Paying a Dividend
TEVA,TEVA:US,BBG000C0CD58,3 Reasons to Buy Teva Right Now,2016-09-13 15:09:00 +0000,https://www.thestreet.com/story/13725950/1/3-reasons-to-buy-teva-right-now.html?puc=yahoo&cm_ven=YAHOO,3 Reasons to Buy Teva Right Now
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Continues to See Significant Drop in Short Interest,2016-09-13 11:25:00 +0000,http://247wallst.com/healthcare-business/2016/09/13/major-pharma-continues-to-see-significant-drop-in-short-interest/,Major Pharma Continues to See Significant Drop in Short Interest
TEVA,TEVA:US,BBG000C0CD58,"Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes",2016-09-12 20:25:12 +0000,http://www.investors.com/news/technology/perrigo-jumps-as-starboard-reveals-big-stake-demands-changes/,"Perrigo Jumps As Starboard Reveals Big Stake, Demands Changes"
TEVA,TEVA:US,BBG000C0CD58,Greenhill Can 'Certainly Replenish' M&A Backlog: CEO,2016-09-12 13:06:03 +0000,http://finance.yahoo.com/video/greenhill-certainly-replenish-m-backlog-130603102.html,Greenhill Can 'Certainly Replenish' M&A Backlog: CEO
TEVA,TEVA:US,BBG000C0CD58,"Why Investors Are Buzzing About Apple, Ford, Teva, Mylan, and Southwest Airlines This Morning",2016-09-12 12:00:06 +0000,http://www.insidermonkey.com/blog/why-investors-are-buzzing-about-apple-ford-teva-mylan-and-southwest-airlines-this-morning-473853/,"Why Investors Are Buzzing About Apple, Ford, Teva, Mylan, and Southwest Airlines This Morning"
TEVA,TEVA:US,BBG000C0CD58,Researchers Have Identified This as the Primary Reason Why Drug Prices Are Soaring,2016-09-10 17:30:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ae-rz7wThOI/researchers-have-identified-this-as-the-primary-reason-why-drug-prices-are-soaring-cm677404,Image source Getty Images If you ve filled a prescription at any point recently you probably don t need me to tell you that drug prices are soaring According to an analysis released in January by healthcare data tracking company Truveris prescription drug prices jumped by
TEVA,TEVA:US,BBG000C0CD58,Researchers Have Identified This as the Primary Reason Why Drug Prices Are Soaring,2016-09-10 15:54:51 +0000,http://www.fool.com/investing/2016/09/10/researchers-have-identified-this-as-the-primary-re.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Researchers Have Identified This as the Primary Reason Why Drug Prices Are Soaring
TEVA,TEVA:US,BBG000C0CD58,Teva says aims to launch EpiPen-like device by 2018 in U.S.,2016-09-09 20:41:39 +0000,http://finance.yahoo.com/news/teva-says-hoping-launch-epipen-160950124.html,"[Reuters] - Teva Pharmaceutical Industries Ltd said Friday it aims to win U.S. approval by late 2017 or early 2018 for its version of Mylan NV's EpiPen device for treating severe allergic reactions, a move that would challenge the branded product's overwhelming market dominance. EpiPen's list price has soared from less than $100 when Mylan acquired the product in 2007, to more than $600 now, sparking outrage from patients, consumers and politicians."
TEVA,TEVA:US,BBG000C0CD58,Teva Discusses EpiPen Comps as Host of Generics Unveiled,2016-09-09 20:34:00 +0000,https://www.thestreet.com/slideshow/13700288/1/teva-discusses-epipen-comps-as-host-of-generics-unveiled.html?puc=yahoo&cm_ven=YAHOO,Teva Discusses EpiPen Comps as Host of Generics Unveiled
TEVA,TEVA:US,BBG000C0CD58,Sen. Grassley: Mylan's EpiPen response 'incomplete',2016-09-09 18:08:00 +0000,http://finance.yahoo.com/video/sen-grassley-mylans-epipen-response-180800668.html,Sen. Grassley: Mylan's EpiPen response 'incomplete'
TEVA,TEVA:US,BBG000C0CD58,"Why the Spotlight is Shining on Amazon, Teva, Bank of America, and More Today",2016-09-09 16:51:41 +0000,http://www.insidermonkey.com/blog/why-the-spotlight-is-shining-on-amazon-teva-bank-of-america-and-more-today-473308/,"Why the Spotlight is Shining on Amazon, Teva, Bank of America, and More Today"
TEVA,TEVA:US,BBG000C0CD58,Will Teva Pharmaceuticals (TEVA) Stock Be Helped by Planned Launch of Generic EpiPen?,2016-09-09 16:50:00 +0000,https://www.thestreet.com/story/13700176/1/will-teva-pharmaceuticals-teva-stock-be-helped-by-planned-launch-of-generic-epipen.html?puc=yahoo&cm_ven=YAHOO,Will Teva Pharmaceuticals (TEVA) Stock Be Helped by Planned Launch of Generic EpiPen?
TEVA,TEVA:US,BBG000C0CD58,Why Eagle Pharmaceuticals Inc. Flew 38.5% Higher in August,2016-09-09 15:34:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8jb1VQOtZgw/why-eagle-pharmaceuticals-inc-flew-385-higher-in-august-cm676881,Image source Getty What Shares of specialty pharmaceutical company Eagle Pharmaceuticals NASDAQ EGRX 160 jumped by more than 38 during August according to data from S amp P Global Market Intelligence EGRX data by
TEVA,TEVA:US,BBG000C0CD58,Teva says hoping to launch EpiPen-like device by 2018 in U.S.,2016-09-09 15:23:58 +0000,http://finance.yahoo.com/news/teva-says-hoping-launch-epipen-152358445.html,"[Reuters] - Teva Pharmaceutical Industries Ltd on Friday said it hopes to win U.S. approval by late 2017 or early 2018 for its version of Mylan NV's EpiPen device to treat severe allergic reactions, a move that could challenge the branded product's overwhelming dominance. The Israeli drugmaker, in a webcast overview of its generics medicines business, said it plans to meet with the U.S. Food and Drug Administration about potentially re-submitting Teva's U.S. marketing application for the device. Sigurdur Olafsson, Teva's head of global generic medicines, said the company had been attempting to secure a meeting with FDA officials after its product was rejected, and that agency officials reached out to the company in recent weeks."
TEVA,TEVA:US,BBG000C0CD58,Why Eagle Pharmaceuticals Inc. Flew 38.5% Higher in August,2016-09-09 14:03:06 +0000,http://www.fool.com/investing/2016/09/09/why-eagle-pharmaceuticals-inc-flew-385-higher-in-a.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Eagle Pharmaceuticals Inc. Flew 38.5% Higher in August
TEVA,TEVA:US,BBG000C0CD58,Did Mylan Purposefully Delay Generic Competition's Entry Into The Market?,2016-09-09 12:55:00 +0000,https://www.thestreet.com/story/13699116/1/did-mylan-purposefully-delay-generic-competition-s-entry-into-the-market.html?puc=yahoo&cm_ven=YAHOO,Did Mylan Purposefully Delay Generic Competition's Entry Into The Market?
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Investor Conference Call At 8:00 AM ET,2016-09-09 07:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/528WaeCR_SU/teva-pharmaceutical-investor-conference-call-at-800-am-et-20160909-00128,Teva Pharmaceutical Investor Conference Call At 8:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,5 Big Dividend Stocks Billionaire John Paulson Loves,2016-09-08 11:39:00 +0000,https://www.thestreet.com/story/13110189/1/john-paulsons-top-dividend-stocks.html?puc=yahoo&cm_ven=YAHOO,5 Big Dividend Stocks Billionaire John Paulson Loves
TEVA,TEVA:US,BBG000C0CD58,Teva To Participate In Wells Fargo Healthcare Conference At 1:10 PM ET,2016-09-07 12:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QD6rBhCY9qc/teva-to-participate-in-wells-fargo-healthcare-conference-at-110-pm-et-20160907-00953,Teva To Participate In Wells Fargo Healthcare Conference At 1:10 PM ET
TEVA,TEVA:US,BBG000C0CD58,Teva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in London,2016-09-07 12:00:00 +0000,http://uk.finance.yahoo.com/news/teva-present-latest-data-multiple-120000544.html,Teva to Present Latest Data in Multiple Sclerosis at 2016 ECTRIMS Congress in London
TEVA,TEVA:US,BBG000C0CD58,Teva UK Study Reveals Generational 'Digital Divide' as UK Baby Boomers Fail to Embrace Benefits of 'Digital Healthcare',2016-09-06 23:01:00 +0000,http://finance.yahoo.com/news/teva-uk-study-reveals-generational-230100085.html,"[PR Newswire] - CASTLEFORD, England, September 7, 2016 /PRNewswire/ -- Survey of 1000 UK residents shows over 55s take personal responsibility for health, but less likely to use digital technologies to manage health ..."
TEVA,TEVA:US,BBG000C0CD58,Teva to Present at the Wells Fargo 2016 Healthcare Conference,2016-09-06 12:00:00 +0000,http://finance.yahoo.com/news/teva-present-wells-fargo-2016-120000858.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. will host a live audio webcast at the Wells Fargo Healthcare Conference. Eyal Desheh will present on Wednesday, September 7, 2016 at 1:10 PM ET."
TEVA,TEVA:US,BBG000C0CD58,Billionaire Larry Robbins’ Biggest Q2 Moves in Healthcare Stocks,2016-09-03 20:15:57 +0000,http://www.insidermonkey.com/blog/billionaire-larry-robbins-biggest-q2-moves-in-healthcare-stocks-471208/,Billionaire Larry Robbins’ Biggest Q2 Moves in Healthcare Stocks
TEVA,TEVA:US,BBG000C0CD58,Is EpiPen's Price The FDA's Fault? What's Holding Up New Generics?,2016-09-03 12:00:35 +0000,http://www.investors.com/news/technology/is-epipens-price-the-fdas-fault-whats-holding-up-new-generics/,Is EpiPen's Price The FDA's Fault? What's Holding Up New Generics?
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Gets Positive Copaxone USPTO Ruling Yet Again,2016-09-02 16:21:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rh_AgRZ0jp4/mylan-myl-gets-positive-copaxone-uspto-ruling-yet-again-cm674127,In a favorable development for Mylan N V MYL the U S Patent and Trademark Office PTO once again ruled in favor of the company in its inter partes review IPR proceeding According to the company s recent announcement the PTO found that the U S Patent No 8 969 302 that covers
TEVA,TEVA:US,BBG000C0CD58,Eli Lilly’s Antidepressant and Schizophrenia Drug Sales Are Down,2016-09-02 15:04:23 +0000,http://marketrealist.com/2016/09/eli-lillys-antidepressant-schizophrenia-drug-sales/?utm_source=yahoo&utm_medium=feed,Eli Lilly’s Antidepressant and Schizophrenia Drug Sales Are Down
TEVA,TEVA:US,BBG000C0CD58,What's Next For Teva Pharmaceutical Following Patent Ruling?,2016-09-02 14:34:55 +0000,http://finance.yahoo.com/news/whats-next-teva-pharmaceutical-following-143455657.html,What's Next For Teva Pharmaceutical Following Patent Ruling?
TEVA,TEVA:US,BBG000C0CD58,Teva Stock Higher on Ratings Upgrade,2016-09-02 14:21:00 +0000,https://www.thestreet.com/story/13693270/1/teva-stock-higher-on-ratings-upgrade.html?puc=yahoo&cm_ven=YAHOO,Teva Stock Higher on Ratings Upgrade
TEVA,TEVA:US,BBG000C0CD58,"Pharma Stock Roundup: Mylan EpiPen Pricing in Focus, FDA Nod For Novartis Biosimilar",2016-09-02 14:18:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pLG-q-y9fZ4/pharma-stock-roundup-mylan-epipen-pricing-in-focus-fda-nod-for-novartis-biosimilar-cm674021,It was a rough week for drug stocks with focus once again shifting to the pricing policies of pharma and biotech companies Mylan s MYL pricing policy for EpiPen raised a storm with lawmakers questioning the company s pricing actions Meanwhile companies like Novartis NVS and Roche RHHBY
TEVA,TEVA:US,BBG000C0CD58,Teva Loses Decision on Validity of Third Copaxone Patent,2016-09-01 19:01:17 +0000,http://finance.yahoo.com/news/teva-loses-decision-validity-third-190117363.html,Teva Loses Decision on Validity of Third Copaxone Patent
TEVA,TEVA:US,BBG000C0CD58,Third U.S. patent on Teva's MS drug Copaxone invalidated,2016-09-01 18:58:16 +0000,http://finance.yahoo.com/news/third-u-patent-tevas-ms-185816504.html,Third U.S. patent on Teva's MS drug Copaxone invalidated
TEVA,TEVA:US,BBG000C0CD58,3 Growth Dividend Stocks to Buy in September,2016-09-01 18:57:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8WvNk-QjgXI/3-growth-dividend-stocks-to-buy-in-september-cm673323,Image source Getty Images Buying dividend stocks that can continue to raise their payouts is a great way to generate sizable returns over long periods of time As many companies are presently choosing to use their free cash flows to buy back shares instead of increasing
TEVA,TEVA:US,BBG000C0CD58,Teva Loses Decision on Validity of ’302 Copaxone Patent,2016-09-01 18:43:31 +0000,http://finance.yahoo.com/news/teva-loses-decision-validity-302-184331456.html,Teva Loses Decision on Validity of ’302 Copaxone Patent
TEVA,TEVA:US,BBG000C0CD58,"ETF’s with exposure to Teva Pharmaceutical Industries Ltd. : September 1, 2016",2016-09-01 13:59:48 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-teva-pharmaceutical-industries-ltd-september-1-2016/,"ETF’s with exposure to Teva Pharmaceutical Industries Ltd. : September 1, 2016"
TEVA,TEVA:US,BBG000C0CD58,3 Growth Dividend Stocks to Buy in September,2016-09-01 13:08:44 +0000,http://www.fool.com/investing/2016/09/01/3-growth-dividend-stocks-to-buy-in-september.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Growth Dividend Stocks to Buy in September
TEVA,TEVA:US,BBG000C0CD58,Plastic Cap Is Crux of Mylan Argument Against Teva’s EpiPen,2016-08-31 20:04:20 +0000,http://finance.yahoo.com/news/plastic-cap-crux-mylan-argument-200420116.html,Plastic Cap Is Crux of Mylan Argument Against Teva’s EpiPen
TEVA,TEVA:US,BBG000C0CD58,"Mylan’s EpiPen caught the full force of drug price outrage because it was the perfect target, not because it was the only one",2016-08-31 19:36:53 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=32F9BC24-6EDD-11E6-8E4D-E6CB5401D4DD&siteid=yhoof2,"Mylan’s EpiPen caught the full force of drug price outrage because it was the perfect target, not because it was the only one"
TEVA,TEVA:US,BBG000C0CD58,5 Health Care Stocks John Paulson Is Betting On in 2016,2016-08-31 12:33:00 +0000,https://www.thestreet.com/story/13285848/1/health-care-stocks-john-paulson-loves.html?puc=yahoo&cm_ven=YAHOO,5 Health Care Stocks John Paulson Is Betting On in 2016
TEVA,TEVA:US,BBG000C0CD58,MDxHealth and Teva Pharmaceuticals Sign Distribution Agreement for SelectMDx in Israel,2016-08-31 05:33:19 +0000,http://www.publicnow.com/view/AA857E9279658FF6030DE2ED917711EF091054F0,"[at noodls] - IRVINE, CA, and HERSTAL, BELGIUM - August 31st, 2016 - MDxHealth SA (Euronext: MDXH.BR), announced today that it has signed a distribution agreement with Teva Pharmaceuticals to offer its SelectMDx(TM) ..."
TEVA,TEVA:US,BBG000C0CD58,$1 Billion Sales Target in Place for Tyvaso,2016-08-30 22:04:06 +0000,http://marketrealist.com/2016/08/united-therapeutics-expects-tyvaso-annual-sales-reach-1-billion/?utm_source=yahoo&utm_medium=feed,$1 Billion Sales Target in Place for Tyvaso
TEVA,TEVA:US,BBG000C0CD58,Generic Competition Not a Threat to UTHR’s Remodulin,2016-08-30 20:04:21 +0000,http://marketrealist.com/2016/08/united-therapeutics-expects-safeguard-remodulin-sales-generic-competition-2016/?utm_source=yahoo&utm_medium=feed,Generic Competition Not a Threat to UTHR’s Remodulin
TEVA,TEVA:US,BBG000C0CD58,Akorn Expected to Report Strong Revenue Growth in 2016,2016-08-30 12:04:41 +0000,http://marketrealist.com/2016/08/akorn-expected-report-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Akorn Expected to Report Strong Revenue Growth in 2016
TEVA,TEVA:US,BBG000C0CD58,Allergan: An Undervalued Powerhouse,2016-08-30 11:09:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l1OkyBJYFLc/allergan-an-undervalued-powerhouse-cm671557,"Allergan ( AGN ) is one of the largest pharmaceutical powerhouses, operating in many areas including eye care, facial aesthetics, plastic surgery, skin care and neuroscience and urology. Allergan's history is quite interesting as the"
TEVA,TEVA:US,BBG000C0CD58,Teva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International Congress,2016-08-30 11:00:00 +0000,http://uk.finance.yahoo.com/news/teva-present-respiratory-data-2016-110000042.html,Teva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International Congress
TEVA,TEVA:US,BBG000C0CD58,Your Complete Guide to the Generic Drug Industry,2016-08-29 23:11:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PYxkSVeu3VI/your-complete-guide-to-the-generic-drug-industry-cm671899,"On Monday, embattled drugmaker Mylan NV MYL announced that it will launch a generic version of the EpiPen at a 50% discount to the branded version as the company continues to respond to widespread criticism surrounding the"
TEVA,TEVA:US,BBG000C0CD58,Your Complete Guide to the Generic Drug Industry,2016-08-29 21:13:09 +0000,http://finance.yahoo.com/news/complete-guide-generic-drug-industry-211309714.html,Your Complete Guide to the Generic Drug Industry
TEVA,TEVA:US,BBG000C0CD58,Mylan To Launch Its Own EpiPen Generic Rival At Half Price,2016-08-29 20:21:43 +0000,http://www.investors.com/news/technology/mylan-to-launch-its-own-generic-rival-to-epipen-at-half-price/,Mylan To Launch Its Own EpiPen Generic Rival At Half Price
TEVA,TEVA:US,BBG000C0CD58,Analyst Recommendations for Akorn in 2016,2016-08-29 19:04:10 +0000,http://marketrealist.com/2016/08/analyst-recommendations-akorn-inc-2016/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for Akorn in 2016
TEVA,TEVA:US,BBG000C0CD58,"Health Care Sector Update for 08/29/2016: MYL,TEVA,MCUR,AGLE",2016-08-29 18:47:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/txBIOTyt4B8/health-care-sector-update-for-08292016-myltevamcuragle-cm671818,"Top Health Care Stocks JNJ +0.61% PFE +0.92% MRK +1.17% ABT +0.51% AMGN +0.06% Health care stocks were edging higher this afternoon, with the NYSE Health Care Index climbing 0.6% while shares of health care companies in the S&P"
TEVA,TEVA:US,BBG000C0CD58,"The Zacks Analyst Blog Highlights: Mylan, Teva Pharmaceutical, Lannett Company, BioSpecifics Technologies and USANA Health Sciences",2016-08-29 16:16:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/To9H8QUN2ZE/the-zacks-analyst-blog-highlights-mylan-teva-pharmaceutical-lannett-company-biospecifics-technologies-and-usana-health-sciences-cm671730,"For Immediate Release  Chicago, IL   August 29, 2016   Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events"
TEVA,TEVA:US,BBG000C0CD58,"Teva to Host Generic Medicines Business Overview on September 9, 2016",2016-08-29 15:50:00 +0000,http://finance.yahoo.com/news/teva-host-generic-medicines-business-155000676.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. announced today that it will host a conference call and live webcast along with a slide presentation on Friday, September 9, 2016 at 8:00 a.m."
TEVA,TEVA:US,BBG000C0CD58,How Allergan Is Still Benefiting from Actavis Deal,2016-08-29 14:05:26 +0000,http://marketrealist.com/2016/08/how-allergan-is-still-benefiting-from-actavis-deal/?utm_source=yahoo&utm_medium=feed,How Allergan Is Still Benefiting from Actavis Deal
TEVA,TEVA:US,BBG000C0CD58,"The Zacks Analyst Blog Highlights: Mylan, Teva Pharmaceutical, Lannett Company, BioSpecifics Technologies and USANA Health Sciences",2016-08-29 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-mylan-133001376.html,"The Zacks Analyst Blog Highlights: Mylan, Teva Pharmaceutical, Lannett Company, BioSpecifics Technologies and USANA Health Sciences"
TEVA,TEVA:US,BBG000C0CD58,Mylan's authorized generic EpiPen to be identical,2016-08-29 11:14:00 +0000,http://finance.yahoo.com/video/mylans-authorized-generic-epipen-identical-111400381.html,Mylan's authorized generic EpiPen to be identical
TEVA,TEVA:US,BBG000C0CD58,"Mylan, Feeling Heat on EpiPen Price, Will Offer Cheaper Generic",2016-08-29 07:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XH7c6KF1Wac/mylan-feeling-heat-on-epipen-price-will-offer-cheaper-generic-20160829-00182,"Mylan, Feeling Heat on EpiPen Price, Will Offer Cheaper Generic"
TEVA,TEVA:US,BBG000C0CD58,[$$] Overheard: Mylan May Play Hero,2016-08-29 04:11:10 +0000,http://www.wsj.com/articles/overheard-mylan-may-play-hero-1472430783?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Mylan, which is under fire for raising prices on its EpiPen allergy treatment, won a patent victory against rival Teva over the multiple sclerosis treatment Copaxone. The result: Mylan can potentially ..."
TEVA,TEVA:US,BBG000C0CD58,[$$] Overheard,2016-08-28 23:44:31 +0000,http://online.wsj.com/article/SB20880415604996964463904582275622163786772.html?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - The pharma villain of the moment also has a project that could lower the cost of an important drug.
TEVA,TEVA:US,BBG000C0CD58,"Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan",2016-08-27 08:17:36 +0000,http://www.insidermonkey.com/blog/billionaire-john-paulsons-favorite-healthcare-stocks-include-the-latest-industry-punching-bag-mylan-470472/,"Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan"
TEVA,TEVA:US,BBG000C0CD58,FTC spells out new concerns over generic drug mergers,2016-08-26 20:49:00 +0000,https://www.thestreet.com/story/13686671/1/ftc-spells-out-new-concerns-over-generic-drug-mergers.html?puc=yahoo&cm_ven=YAHOO,FTC spells out new concerns over generic drug mergers
TEVA,TEVA:US,BBG000C0CD58,Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco,2016-08-26 18:01:00 +0000,https://www.thestreet.com/story/13686687/1/pharmacy-benefit-managers-shouldn-t-fret-initial-fallout-from-mylan-fiasco.html?puc=yahoo&cm_ven=YAHOO,Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco
TEVA,TEVA:US,BBG000C0CD58,4 Stocks That Billionaires Wanted Little to Do With in the Second Quarter,2016-08-26 17:29:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Htx2HGrZ0AQ/4-stocks-that-billionaires-wanted-little-to-do-with-in-the-second-quarter-cm670866,"Image source  Getty Images.  Whether or not you realize it, one of the most highly anticipated deadlines just passed. In mid August, 45 days after the end of the fiscal second quarter, money"
TEVA,TEVA:US,BBG000C0CD58,Novartis (NVS) Reports Positive Phase III Results on MS Drug,2016-08-26 16:31:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ubgubmalurg/novartis-nvs-reports-positive-phase-iii-results-on-ms-drug-cm670807,"Novartis AGNVS announced positive results from the phase III EXPAND study on its pipeline candidate, BAF312 (siponimod).  The randomized, double blinded, placebo controlled study was evaluating the efficacy and safety of once daily oral BAF312 in"
TEVA,TEVA:US,BBG000C0CD58,FTC Details Concerns on Generic Drug Company Mergers,2016-08-26 16:02:00 +0000,https://www.thestreet.com/story/13686819/1/ftc-details-concerns-on-generic-drug-company-mergers.html?puc=yahoo&cm_ven=YAHOO,FTC Details Concerns on Generic Drug Company Mergers
TEVA,TEVA:US,BBG000C0CD58,4 Stocks That Billionaires Wanted Little to Do With in the Second Quarter,2016-08-26 15:30:00 +0000,http://www.fool.com/investing/2016/08/26/4-stocks-that-billionaires-wanted-little-to-do-wit.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,4 Stocks That Billionaires Wanted Little to Do With in the Second Quarter
TEVA,TEVA:US,BBG000C0CD58,AbbVie Expects Investigational Drug Elagolix to Be a Blockbuster,2016-08-26 14:04:05 +0000,http://marketrealist.com/2016/08/abbvie-expects-investigational-womens-health-drug-elagolix-become-blockbuster-therapy/?utm_source=yahoo&utm_medium=feed,AbbVie Expects Investigational Drug Elagolix to Be a Blockbuster
TEVA,TEVA:US,BBG000C0CD58,"Wall Street Breakfast: HP Shares Sink Following Weak Outlook, Poor Printer Sales",2016-08-26 13:46:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_CJWmaE6uag/wall-street-breakfast-hp-shares-sink-following-weak-outlook-poor-printer-sales-cm670446,"By Wall Street Breakfast HP's shares were 5.7% premarket after the company gave a soft outlook and following weak FQ3 sales of printers, the most profitable part of its business. However, overall earnings in the quarter topped expectations even"
TEVA,TEVA:US,BBG000C0CD58,"After Mylan uproar, a generic EpiPen could hit the market in 2017",2016-08-26 12:12:48 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=E38927F4-6AD3-11E6-8915-31A2D5A5E29E&siteid=yhoof2,"After Mylan uproar, a generic EpiPen could hit the market in 2017"
TEVA,TEVA:US,BBG000C0CD58,Mylan Reacts to EpiPen Backlash,2016-08-26 11:36:21 +0000,http://www.wsj.com/articles/mylans-epipen-price-increases-highlight-its-grip-on-the-market-1472154769?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - The ability of Mylan to raise EpiPen’s list price by nearly 550% over the past eight years underscores the pricing power drug companies enjoy for iconic brands facing little competition.
TEVA,TEVA:US,BBG000C0CD58,Mylan's EpiPen Price Increases Highlight Its Grip on the Market,2016-08-26 05:22:04 +0000,http://www.wsj.com/articles/mylans-epipen-price-increases-highlight-its-grip-on-the-market-1472154769?mod=yahoo_hs,[at The Wall Street Journal] - The ability of Mylan to raise EpiPen’s list price by nearly 550% over the past eight years underscores the pricing power drug companies enjoy for iconic brands facing little competition.
TEVA,TEVA:US,BBG000C0CD58,US Patent and Trademark Office Invalidates Two Copaxone 40 Patents,2016-08-25 20:59:00 +0000,http://marketrealist.com/2016/08/u-s-patent-trademark-office-invalidates-two-patents-related-copaxone-40mgml/?utm_source=yahoo&utm_medium=feed,US Patent and Trademark Office Invalidates Two Copaxone 40 Patents
TEVA,TEVA:US,BBG000C0CD58,"Specialty Pharma: Never Mind the Pricing Controversy, Fundamentals Will Win Out",2016-08-25 17:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/25/specialty-pharma-never-mind-the-pricing-controversy-fundamentals-will-win-out/?mod=yahoobarrons&ru=yahoo,"Specialty Pharma: Never Mind the Pricing Controversy, Fundamentals Will Win Out"
TEVA,TEVA:US,BBG000C0CD58,Why Mylan's EpiPen Is Sparking &quot;Epi-Rage&quot;,2016-08-25 16:47:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fOee3pYP6UQ/why-mylans-epipen-is-sparking-epi-rage-cm670188,"Image source  Getty Images.  Forty three million Americans are at risk of suffering a life threatening allergic reaction, and the vast majority of people who suffer one turn to Mylan N.V. 's(NASDAQ"
TEVA,TEVA:US,BBG000C0CD58,Why is there no generic EpiPen?,2016-08-25 16:10:00 +0000,http://finance.yahoo.com/video/why-no-generic-epipen-161000921.html,Why is there no generic EpiPen?
TEVA,TEVA:US,BBG000C0CD58,AbbVie Expects to Launch Zinbryta in the US in August,2016-08-25 15:04:05 +0000,http://marketrealist.com/2016/08/abbvie-expects-launch-multiple-sclerosis-drug-zinbryta-u-s-august-2016/?utm_source=yahoo&utm_medium=feed,AbbVie Expects to Launch Zinbryta in the US in August
TEVA,TEVA:US,BBG000C0CD58,"Why Mylan's EpiPen Is Sparking ""Epi-Rage""",2016-08-25 14:40:00 +0000,http://www.fool.com/investing/2016/08/25/why-mylans-epipen-is-sparking-epi-rage.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Mylan's EpiPen Is Sparking ""Epi-Rage"""
TEVA,TEVA:US,BBG000C0CD58,"Teva Stock Gains, Leerink: Despite Patent Loss, No Generic Competition Until 2018",2016-08-25 14:02:00 +0000,https://www.thestreet.com/story/13685330/1/teva-stock-gains-leerink-despite-patent-loss-no-generic-competition-until-2018.html?puc=yahoo&cm_ven=YAHOO,"Teva Stock Gains, Leerink: Despite Patent Loss, No Generic Competition Until 2018"
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone,2016-08-25 13:48:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Grq4MQjpZ1I/mylan-myl-obtains-favorable-uspto-ruling-for-copaxone-cm670056,Positive news flowed in at Mylan N.V.MYL when the U.S. Patent and Trademark Office (PTO) ruled in favor of the company in its inter partes review proceeding. The PTO found that the two patents (U.S. Patent Nos.
TEVA,TEVA:US,BBG000C0CD58,Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?,2016-08-25 13:04:31 +0000,http://marketrealist.com/2016/08/teva-pharmaceutical-expected-strengthen-specialty-pipeline-3q16/?utm_source=yahoo&utm_medium=feed,Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?
TEVA,TEVA:US,BBG000C0CD58,"Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and More",2016-08-25 12:55:41 +0000,http://247wallst.com/investing/2016/08/25/top-analyst-upgrades-and-downgrades-ddr-hp-l-3-communications-salesforce-com-teva-twilio-and-more/,"Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and More"
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Interest Faces Significant Drop,2016-08-25 12:45:54 +0000,http://247wallst.com/healthcare-business/2016/08/25/major-pharma-short-interest-faces-significant-drop/,Major Pharma Short Interest Faces Significant Drop
TEVA,TEVA:US,BBG000C0CD58,Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone,2016-08-25 12:29:12 +0000,http://finance.yahoo.com/news/mylan-myl-obtains-favorable-uspto-122912655.html,Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone
TEVA,TEVA:US,BBG000C0CD58,Mylan wins round in fight with Teva over multiple sclerosis drug,2016-08-24 23:26:56 +0000,http://finance.yahoo.com/news/mylan-wins-round-fight-teva-214918858.html,Mylan wins round in fight with Teva over multiple sclerosis drug
TEVA,TEVA:US,BBG000C0CD58,Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher,2016-08-24 22:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hRlmPDPNc78/why-momenta-pharmaceuticals-shares-made-a-late-day-jump-higher-cm669815,Image source  Getty Images.  What  Momenta Pharmaceuticals (NASDAQ  MNTA) ended the day up 11% after spending most of the afternoon in negative territory. The come from behind victory for the day
TEVA,TEVA:US,BBG000C0CD58,Shares of Teva Pharmaceuticals fall after US Patent Office invalidates two patents,2016-08-24 21:54:39 +0000,http://www.cnbc.com/id/103891149?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103891149,Shares of Teva Pharmaceuticals fall after US Patent Office invalidates two patents
TEVA,TEVA:US,BBG000C0CD58,Teva Confirms PTAB’s Decisions on Two Patents in IPR Challenge to COPAXONE® 40 mg,2016-08-24 21:46:00 +0000,http://finance.yahoo.com/news/teva-confirms-ptab-decisions-two-214600255.html,[Business Wire] - Teva Pharmaceutical Industries Ltd. today confirmed the Patent Trial and Appeal Board decisions from an Inter Partes Review to invalidate all claims of the ‘250 and ‘413 patents for 40 mg COPAXONE® .
TEVA,TEVA:US,BBG000C0CD58,What's next for Mylan?,2016-08-24 21:06:00 +0000,http://finance.yahoo.com/video/whats-next-mylan-210600930.html,What's next for Mylan?
TEVA,TEVA:US,BBG000C0CD58,Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher,2016-08-24 20:49:49 +0000,http://www.fool.com/investing/2016/08/24/why-momenta-pharmaceuticals-shares-made-a-late-day.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Momenta Pharmaceuticals Shares Made a Late-Day Jump Higher
TEVA,TEVA:US,BBG000C0CD58,Teva Stock Drops After Patent Invalidated,2016-08-24 19:49:00 +0000,https://www.thestreet.com/story/13684496/1/teva-stock-drops-after-patent-invalidated.html?puc=yahoo&cm_ven=YAHOO,Teva Stock Drops After Patent Invalidated
TEVA,TEVA:US,BBG000C0CD58,Teva drug patent invalidated by US regulator,2016-08-24 19:35:00 +0000,http://finance.yahoo.com/video/teva-drug-patent-invalidated-us-193500672.html,Teva drug patent invalidated by US regulator
TEVA,TEVA:US,BBG000C0CD58,Teva Plunges After Two U.S. Copaxone Patents Invalidated,2016-08-24 19:27:52 +0000,http://www.bloomberg.com/news/articles/2016-08-24/teva-s-250-patent-on-copaxone-is-invalid-patent-office-says?cmpid=yhoo.headline,Teva Plunges After Two U.S. Copaxone Patents Invalidated
TEVA,TEVA:US,BBG000C0CD58,Litigation Has Teva Pharmaceutical’s Copaxone 40 mg All Tied Up,2016-08-24 15:04:05 +0000,http://marketrealist.com/2016/08/teva-pharmaceuticals-copaxone-franchise-expected-face-multiple-litigations-till-2018/?utm_source=yahoo&utm_medium=feed,Litigation Has Teva Pharmaceutical’s Copaxone 40 mg All Tied Up
TEVA,TEVA:US,BBG000C0CD58,Mylan: Five Reasons EpiPen Controversy Won't End Any Time Soon,2016-08-24 14:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/24/mylan-five-reasons-epipen-controversy-wont-end-any-time-soon/?mod=yahoobarrons&ru=yahoo,Mylan: Five Reasons EpiPen Controversy Won't End Any Time Soon
TEVA,TEVA:US,BBG000C0CD58,"Despite Litigation, Teva’s Copaxone Could See Robust 2016 Revenue",2016-08-24 13:04:05 +0000,http://marketrealist.com/2016/08/despite-multiple-litigations-copaxone-franchise-expected-report-robust-revenues-2016/?utm_source=yahoo&utm_medium=feed,"Despite Litigation, Teva’s Copaxone Could See Robust 2016 Revenue"
TEVA,TEVA:US,BBG000C0CD58,Have You Heard About This Generic EpiPen Maker?,2016-08-24 13:01:02 +0000,http://finance.yahoo.com/news/heard-generic-epipen-maker-130102308.html,Have You Heard About This Generic EpiPen Maker?
TEVA,TEVA:US,BBG000C0CD58,Performance of AstraZeneca’s Growth Platforms in 2Q16,2016-08-23 23:04:05 +0000,http://marketrealist.com/2016/08/performance-astrazenecas-growth-platforms-2q16/?utm_source=yahoo&utm_medium=feed,Performance of AstraZeneca’s Growth Platforms in 2Q16
TEVA,TEVA:US,BBG000C0CD58,"Tiger Management Welcomes Microsoft, Pandora to Portfolio, Chases Off Netflix, Teva",2016-08-23 18:29:21 +0000,http://www.insidermonkey.com/blog/tiger-management-welcomes-microsoft-pandora-to-portfolio-chases-off-netflix-teva-470223/,"Tiger Management Welcomes Microsoft, Pandora to Portfolio, Chases Off Netflix, Teva"
TEVA,TEVA:US,BBG000C0CD58,Mylan shares fall on EpiPen pricing,2016-08-23 16:45:00 +0000,http://finance.yahoo.com/video/mylan-shares-fall-epipen-pricing-164500424.html,Mylan shares fall on EpiPen pricing
TEVA,TEVA:US,BBG000C0CD58,A Backlash Materializes Against Soaring EpiPen Prices,2016-08-23 16:02:00 +0000,https://www.thestreet.com/story/13682931/1/a-backlash-materializes-against-soaring-epipen-prices.html?puc=yahoo&cm_ven=YAHOO,A Backlash Materializes Against Soaring EpiPen Prices
TEVA,TEVA:US,BBG000C0CD58,Will Anda Acquisition Improve Access to Teva’s Generic Drugs?,2016-08-23 15:04:05 +0000,http://marketrealist.com/2016/08/acquisition-anda-expected-improve-patient-access-teva-pharmaceuticals-generic-drugs/?utm_source=yahoo&utm_medium=feed,Will Anda Acquisition Improve Access to Teva’s Generic Drugs?
TEVA,TEVA:US,BBG000C0CD58,"Mylan: In EpiPen Controversy, Shades of Valeant",2016-08-23 14:30:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/23/mylan-in-epipen-controversy-shades-of-valeant/?mod=yahoobarrons&ru=yahoo,"Mylan: In EpiPen Controversy, Shades of Valeant"
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Expected to See Strong Revenue Growth in 2016,2016-08-23 13:04:05 +0000,http://marketrealist.com/2016/08/teva-pharmaceutical-expected-witness-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical Expected to See Strong Revenue Growth in 2016
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical: A Successful Bond Financing Program in 2016,2016-08-22 15:04:55 +0000,http://marketrealist.com/2016/08/teva-pharmaceutical-managed-complete-successful-bond-financing-program-2016/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical: A Successful Bond Financing Program in 2016
TEVA,TEVA:US,BBG000C0CD58,Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval,2016-08-22 13:48:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Lu2H8LTits/pfizers-pfe-pain-drug-troxyca-er-receives-fda-approval-cm668304,"Pfizer Inc.PFE announced that the FDA has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended release capsules, for oral use, CII, for the management of pain severe enough to require daily, around the clock, long term"
TEVA,TEVA:US,BBG000C0CD58,PPH's Holdings Imply 16% Gain Potential,2016-08-22 13:42:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hQX31cVqYY4/pphs-holdings-imply-16-gain-potential-cm668287,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
TEVA,TEVA:US,BBG000C0CD58,Can Allergan Generics Boost Teva Pharmaceutical’s 2016 Revenues?,2016-08-22 13:05:23 +0000,http://marketrealist.com/2016/08/acquisition-allergan-generics-business-expected-boost-teva-pharmaceuticals-revenues-2016/?utm_source=yahoo&utm_medium=feed,Can Allergan Generics Boost Teva Pharmaceutical’s 2016 Revenues?
TEVA,TEVA:US,BBG000C0CD58,Inside the Performance of Sanofi’s Human Vaccines Segment in 2Q16,2016-08-22 13:04:33 +0000,http://marketrealist.com/2016/08/inside-the-performance-of-sanofis-human-vaccines-segment-in-2q16/?utm_source=yahoo&utm_medium=feed,Inside the Performance of Sanofi’s Human Vaccines Segment in 2Q16
TEVA,TEVA:US,BBG000C0CD58,Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval,2016-08-22 11:45:11 +0000,http://finance.yahoo.com/news/pfizers-pfe-pain-drug-troxyca-114511107.html,Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval
TEVA,TEVA:US,BBG000C0CD58,Actavis recalls diabetes drugs made by Durham-based Patheon,2016-08-19 20:40:11 +0000,http://www.bizjournals.com/triangle/news/2016/08/19/actavis-allergan-teva-durham-patheon-diabetes-drug.html?ana=yahoo,Actavis recalls diabetes drugs made by Durham-based Patheon
TEVA,TEVA:US,BBG000C0CD58,"Top Research Reports for August 19, 2016",2016-08-19 19:45:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-wJmA-UkAlU/top-research-reports-for-august-19-2016-cm667916,"Friday, August 19, 2016  We are featuring 16 research reports in today's Research Daily, including reports on Verizon (VZ), Comcast (CMCSA) and Teva Pharmaceutical (TEVA).  Verizon shares have been weak lately, but they continued to"
TEVA,TEVA:US,BBG000C0CD58,Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma,2016-08-19 16:48:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/araLmZHvzi4/teva-cinqaero-gets-eu-nod-for-severe-eosinophilic-asthma-cm667826,Positive news flowed in at Teva Pharmaceutical Industries Ltd.TEVA when the European Commission approved its marketing authorisation application for Cinqaero (reslizumab  interleukin 5 (IL 5) antagonist monoclonal antibody) for use as add on therapy in adult
TEVA,TEVA:US,BBG000C0CD58,"Top Research Reports for August 19, 2016",2016-08-19 15:44:03 +0000,http://finance.yahoo.com/news/top-research-reports-august-19-154403902.html,"Top Research Reports for August 19, 2016"
TEVA,TEVA:US,BBG000C0CD58,What Are Analysts Recommending for Teva Pharmaceutical in 2016?,2016-08-19 15:25:35 +0000,http://marketrealist.com/2016/08/analyst-recommendations-teva-pharmaceutical-2016/?utm_source=yahoo&utm_medium=feed,What Are Analysts Recommending for Teva Pharmaceutical in 2016?
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical’s 2016 Valuation Compared to Peers,2016-08-19 15:25:24 +0000,http://marketrealist.com/2016/08/teva-pharmaceuticals-valuation-multiples-compare-peers-2016-2/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical’s 2016 Valuation Compared to Peers
TEVA,TEVA:US,BBG000C0CD58,Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma,2016-08-19 14:23:02 +0000,http://finance.yahoo.com/news/teva-cinqaero-gets-eu-nod-142302853.html,Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
TEVA,TEVA:US,BBG000C0CD58,"EARS Faces The Music, ABIO On Track, TEVA Gets EU Nod For Asthma Drug",2016-08-18 22:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-JGEs-j5DFo/ears-faces-the-music-abio-on-track-teva-gets-eu-nod-for-asthma-drug-20160818-00997,"EARS Faces The Music, ABIO On Track, TEVA Gets EU Nod For Asthma Drug"
TEVA,TEVA:US,BBG000C0CD58,European Commission Grants Marketing Authorization for Teva’s CINQAERO® (reslizumab),2016-08-18 07:00:00 +0000,http://finance.yahoo.com/news/european-commission-grants-marketing-authorization-070000830.html,"[Business Wire] - Teva Pharmaceutical Industries Ltd. today announced that the European Commission has granted marketing authorization for CINQAERO® in the 28 countries of the European Union in addition to Norway, Liechtenstein and Iceland."
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for August 18, 2016",2016-08-17 22:02:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJQpOE7-Ldw/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-august-18-2016-cm666416,"Teva Pharmaceutical Industries Limited ( TEVA ) will begin trading ex dividend on August 18, 2016. A cash dividend payment of $0.34 per share is scheduled to be paid on September 08, 2016. Shareholders who purchased TEVA prior to"
TEVA,TEVA:US,BBG000C0CD58,[$$] Four Picks for a Specialty Pharma Comeback,2016-08-17 20:21:00 +0000,http://www.barrons.com/articles/four-picks-for-a-specialty-pharma-comeback-1471465279?mod=yahoobarrons&ru=yahoo,[$$] Four Picks for a Specialty Pharma Comeback
TEVA,TEVA:US,BBG000C0CD58,What Are Analysts’ Recommendations for Mylan and Its Peers?,2016-08-17 19:10:13 +0000,http://marketrealist.com/2016/08/analysts-recommendations-mylan-peers-2016/?utm_source=yahoo&utm_medium=feed,What Are Analysts’ Recommendations for Mylan and Its Peers?
TEVA,TEVA:US,BBG000C0CD58,[$$] Lilly and Allergan Are Large-Cap Pharma Picks,2016-08-16 15:01:00 +0000,http://www.barrons.com/articles/lilly-and-allergan-are-large-cap-pharma-picks-1471359671?mod=yahoobarrons&ru=yahoo,[$$] Lilly and Allergan Are Large-Cap Pharma Picks
TEVA,TEVA:US,BBG000C0CD58,"Paulson Shifts Health-Care Stakes, Adds FedEx",2016-08-15 22:37:07 +0000,http://blogs.wsj.com/moneybeat/2016/08/15/paulson-shifts-health-care-stakes-adds-fedex/?mod=yahoo_hs,"Paulson Shifts Health-Care Stakes, Adds FedEx"
TEVA,TEVA:US,BBG000C0CD58,Why Allergan is Fine Without Large M&A,2016-08-15 15:29:00 +0000,https://www.thestreet.com/story/13675009/1/why-allergan-is-fine-without-large-m-amp-a.html?puc=yahoo&cm_ven=YAHOO,Why Allergan is Fine Without Large M&A
TEVA,TEVA:US,BBG000C0CD58,"Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline",2016-08-15 14:39:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J7m9W9nNbww/allergan-to-buy-forsight-vision5-boost-glaucoma-pipeline-cm665348,"Late last week, Allergan plcAGN announced that it will be acquiring a privately held, clinical stage biotechnology company focused on eye care. ForSight VISION5 will be acquired by Allergan for an upfront payment of $95 million as well as"
TEVA,TEVA:US,BBG000C0CD58,See Which Of The Latest 13F Filers Holds Teva Pharmaceutical Industries,2016-08-15 14:35:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L-jpj1IKV8c/see-which-of-the-latest-13f-filers-holds-teva-pharmaceutical-industries-cm665283,"At Holdings Channel , we have reviewed the latest batch of the 38 most recent 13F filings for the 06 30 2016 reporting period, and noticed that Teva Pharmaceutical Industries Ltd (Symbol TEVA) was held by 9 of these"
TEVA,TEVA:US,BBG000C0CD58,"Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline",2016-08-15 13:13:01 +0000,http://finance.yahoo.com/news/allergan-buy-forsight-vision5-boost-131301835.html,"Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline"
TEVA,TEVA:US,BBG000C0CD58,Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010,2016-08-13 17:34:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eFQyUe2mwAw/prices-for-these-4-top-selling-prescription-drugs-have-more-than-doubled-since-2010-cm665048,"Image source  Getty Images.  Don't blink, because if you do you might miss your prescription drug costs soaring.  We certainly don't have to look far to find instances of questionable drug pricing"
TEVA,TEVA:US,BBG000C0CD58,"After Hours Most Active for Aug 12, 2016 :  AMRN, BAC, FTR, TEVA, EXC, QQQ, VER, SDRL, AVP, SYMC, MSFT, MYL",2016-08-12 21:05:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O13tEwZIMrM/after-hours-most-active-for-aug-12-2016-amrn-bac-ftr-teva-exc-qqq-ver-sdrl-avp-symc-msft-myl-cm664893,"The NASDAQ 100 After Hours Indicator is down .12 to 4,806.96. The total After hours volume is currently 25,246,113 shares traded. The following are the most active stocks for the after hours session Amarin Corporation PLC ( AMRN )"
TEVA,TEVA:US,BBG000C0CD58,Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010,2016-08-12 15:41:00 +0000,http://www.fool.com/investing/2016/08/12/prices-for-these-4-top-selling-prescription-drugs.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010
TEVA,TEVA:US,BBG000C0CD58,Teva's Value Rises With Transformation Into Global Pharma Giant,2016-08-12 11:04:00 +0000,http://www.forbes.com/sites/genemarcial/2016/08/12/tevas-value-rises-with-transformation-into-global-pharma-giant/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Teva's Value Rises With Transformation Into Global Pharma Giant
TEVA,TEVA:US,BBG000C0CD58,This &quot;Cheap&quot; Stock May Not Be a Bargain,2016-08-11 23:49:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E8gu1p16d2U/this-cheap-stock-may-not-be-a-bargain-cm664380,"Image source  Getty Images.  After disappointing second quarter financials sent shares reeling, investors can buy Impax Labs (NASDAQ  IPXL)  for just nine times next year's consensus earnings per share estimate. That may"
TEVA,TEVA:US,BBG000C0CD58,"Glaucoma Treatment Maker a $95M ""Stepping Stone"" for Allergan",2016-08-11 15:16:00 +0000,https://www.thestreet.com/story/13672836/1/allergan-adds-glaucoma-treatment-maker-for-95m.html?puc=yahoo&cm_ven=YAHOO,"Glaucoma Treatment Maker a $95M ""Stepping Stone"" for Allergan"
TEVA,TEVA:US,BBG000C0CD58,Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox,2016-08-11 13:31:34 +0000,http://news.investornetwork.com/2016/08/11/post-earnings-coverage-as-allergan-tops-earnings-expectation-bolstered-by-botox/?1=1&1470922294,Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox
TEVA,TEVA:US,BBG000C0CD58,Major Pharma Short Interest Slides,2016-08-10 13:05:11 +0000,http://247wallst.com/healthcare-business/2016/08/10/major-pharma-short-interest-slides-down/,Major Pharma Short Interest Slides
TEVA,TEVA:US,BBG000C0CD58,5 Healthcare Stocks Near the Top of Cheyne Capital’s Portfolio,2016-08-10 12:48:57 +0000,http://www.insidermonkey.com/blog/5-healthcare-stocks-near-the-top-of-cheyne-capitals-portfolio-468025/,5 Healthcare Stocks Near the Top of Cheyne Capital’s Portfolio
TEVA,TEVA:US,BBG000C0CD58,"Momenta Pharmaceuticals, Inc.: Good News from Courts and the FDA Ahead?",2016-08-09 19:56:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jaF57oIO9PM/momenta-pharmaceuticals-inc-good-news-from-courts-and-the-fda-ahead-cm662801,"Image source  Getty Images.  Momenta Pharmaceuticals (NASDAQ  MNTA) released second quarter earnings last week. While the report included sales of Momenta's and partner Novartis AG 's(NYSE  NVS) Glatopa, the generic version"
TEVA,TEVA:US,BBG000C0CD58,Why Impax Labs Is Crashing 22.5% Today,2016-08-09 19:53:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tZbeN9ncm88/why-impax-labs-is-crashing-225-today-cm662767,"Image source  Getty Images.  What  After announcing second quarter results that fell short of industry watchers' estimates and lowering its guidance for the full year, shares in Impax Laboratories (NASDAQ  IPXL)"
TEVA,TEVA:US,BBG000C0CD58,Mylan Backs Year View After Sales Rise 8%,2016-08-09 17:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ymrhpu6R2jc/mylan-backs-year-view-after-sales-rise-8-20160809-01335,Mylan Backs Year View After Sales Rise 8%
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. :TEVA-IL: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016",2016-08-09 07:57:52 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-il-earnings-analysis-q2-2016-by-the-numbers-august-9-2016/,"Teva Pharmaceutical Industries Ltd. :TEVA-IL: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016"
TEVA,TEVA:US,BBG000C0CD58,"[$$] Allergan Revenue Increases, Though Loss Widens",2016-08-09 04:08:35 +0000,http://www.wsj.com/articles/allergan-revenue-increases-though-loss-widens-1470658455?ru=yahoo?mod=yahoo_itp,"[$$] Allergan Revenue Increases, Though Loss Widens"
TEVA,TEVA:US,BBG000C0CD58,"After Hours Most Active for Aug 8, 2016 :  GLW, CNP, F, TEVA, FCX, BAC, CSCO, AAPL, QCOM, MSFT, INTC, FB",2016-08-08 21:11:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j0gwyYBRzyc/after-hours-most-active-for-aug-8-2016-glw-cnp-f-teva-fcx-bac-csco-aapl-qcom-msft-intc-fb-cm662126,"The NASDAQ 100 After Hours Indicator is down .72 to 4,784.02. The total After hours volume is currently 43,881,886 shares traded. The following are the most active stocks for the after hours session Corning Incorporated ( GLW ) is"
TEVA,TEVA:US,BBG000C0CD58,"Allergan Earnings Top, But Stock Falls On Lowered Guidance",2016-08-08 20:00:44 +0000,http://www.investors.com/news/technology/allergan-stock-dips-on-lowered-guidance-though-q2-earnings-beat/,"Allergan Earnings Top, But Stock Falls On Lowered Guidance"
TEVA,TEVA:US,BBG000C0CD58,"ETF’s with exposure to Teva Pharmaceutical Industries Ltd. : August 8, 2016",2016-08-08 18:45:38 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-teva-pharmaceutical-industries-ltd-august-8-2016/,"ETF’s with exposure to Teva Pharmaceutical Industries Ltd. : August 8, 2016"
TEVA,TEVA:US,BBG000C0CD58,Changing Landscape for Generic-Drug Makers Creates Opportunities,2016-08-08 18:25:00 +0000,https://www.thestreet.com/story/13667533/1/changing-landscape-for-generic-drug-makers-creates-opportunities.html?puc=yahoo&cm_ven=YAHOO,Changing Landscape for Generic-Drug Makers Creates Opportunities
TEVA,TEVA:US,BBG000C0CD58,"Allergan (AGN) Tops Q2 Earnings, Revises '16 Outlook",2016-08-08 18:12:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MDHBxdiRxEk/allergan-agn-tops-q2-earnings-revises-16-outlook-cm661985,"Allergan plc 's AGN second quarter 2016 earnings came in at $3.35 per share, easily surpassing the Zacks Consensus Estimate of $3.28. Though up 12% sequentially, reported earnings were down 8.7% from the year ago period. Allergan Inc. (AGN)"
TEVA,TEVA:US,BBG000C0CD58,Allergan: Buy the Dip?,2016-08-08 15:21:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/08/allergan-buy-the-dip/?mod=yahoobarrons&ru=yahoo,Allergan: Buy the Dip?
TEVA,TEVA:US,BBG000C0CD58,"Health Care Sector Update for 08/08/2016: JNJ, PFE, ABT, MRK, AMGN",2016-08-08 14:28:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s8C1pQmbjRM/health-care-sector-update-for-08082016-jnj-pfe-abt-mrk-amgn-cm661766,"Top Health care stocks AMGN +0.2% ABT 0.4% JNJ 0.6% PFE 1.5% MRK 2.1% Health care shares were mostly lower in pre market trade Monday. In health care stocks news, Allergan ( AGN ) reported Q2 EPS of $3.35"
TEVA,TEVA:US,BBG000C0CD58,"Stocks to Watch: Allergan, Vail, Wal-Mart, Delta, Tyson Foods",2016-08-08 13:25:47 +0000,http://blogs.wsj.com/moneybeat/2016/08/08/stocks-to-watch-allergan-vail-wal-mart-delta-tyson-foods/?mod=yahoo_hs,"Stocks to Watch: Allergan, Vail, Wal-Mart, Delta, Tyson Foods"
TEVA,TEVA:US,BBG000C0CD58,Why Allergan Earnings Aren’t Telling the Whole Story,2016-08-08 11:55:38 +0000,http://247wallst.com/healthcare-business/2016/08/08/why-allergan-earnings-arent-telling-the-whole-story/,Why Allergan Earnings Aren’t Telling the Whole Story
TEVA,TEVA:US,BBG000C0CD58,"Allergan Revenue Increases, Though Loss Widens",2016-08-08 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8l0xeZ_HrgQ/allergan-revenue-increases-though-loss-widens-20160808-00413,"Allergan Revenue Increases, Though Loss Widens"
TEVA,TEVA:US,BBG000C0CD58,Teva to pay $125M to settle 'anticompetitive' claims against subsidiary,2016-08-05 19:55:11 +0000,http://www.bizjournals.com/philadelphia/morning_roundup/2016/08/teva-125m-settlement-anticompetive-claims-cephalon.html?ana=yahoo,Teva to pay $125M to settle 'anticompetitive' claims against subsidiary
TEVA,TEVA:US,BBG000C0CD58,"Stock Market News for August 05, 2016",2016-08-05 18:30:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jvMQvLR47CE/stock-market-news-for-august-05-2016-cm661216,Benchmarks ended mostly flat on Thursday as investors refrained from making big bets ahead of Friday's U.S. nonfarm payroll report. Hiring data will help gauge the strength of the economy and give an insight into the path of further
TEVA,TEVA:US,BBG000C0CD58,"Stock Market News for August 05, 2016",2016-08-05 14:10:02 +0000,http://finance.yahoo.com/news/stock-market-news-august-05-141002114.html,"Stock Market News for August 05, 2016"
TEVA,TEVA:US,BBG000C0CD58,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016",2016-08-05 13:37:44 +0000,http://www.capitalcube.com/blog/index.php/teva-pharmaceutical-industries-ltd-teva-us-earnings-analysis-q2-2016-by-the-numbers-august-5-2016/,"Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016"
TEVA,TEVA:US,BBG000C0CD58,"Teva (TEVA) Beats on Q2 Earnings & Revenues, Stock Gains",2016-08-05 12:56:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0rtUbx8DYIc/teva-teva-beats-on-q2-earnings-revenues-stock-gains-cm660897,"Teva Pharmaceutical Industries Ltd.'sTEVA shares were up 3.5% with the company announcing better than expected second quarter 2016 results. While earnings came in at $1.25 per share, well above the Zacks Consensus Estimate of $1.18, revenues were $5 billion,"
TEVA,TEVA:US,BBG000C0CD58,"Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More",2016-08-05 12:55:14 +0000,http://247wallst.com/investing/2016/08/05/top-analyst-upgrades-and-downgrades-fireeye-occidental-petroleum-seaworld-teva-pharma-windstream-zynga-and-more/,"Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More"
TEVA,TEVA:US,BBG000C0CD58,Specialty Drug Sales Give Teva Pharmaceutical Industries Ltd. a Boost in Q2,2016-08-04 19:57:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K38lBht1Rm8/specialty-drug-sales-give-teva-pharmaceutical-industries-ltd-a-boost-in-q2-cm660670,Image source  Getty Images.  It hasn't been the greatest year so far for Teva Pharmaceutical Industries (NYSE  TEVA) shareholders. The drugmaker's stock is down over 18% year to date and has been stuck
TEVA,TEVA:US,BBG000C0CD58,Stop Dreaming: Biogen Isn't for Sale,2016-08-04 15:57:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yssr5s9_3iQ/stop-dreaming-biogen-isnt-for-sale-cm660368,"Image source  Nguyen Hung Vu via Flickr.  Historically low lending rates are fueling record merger and acquisition activity in the pharmaceutical and biotech sectors. According to The Pharma Letter , access to cheap"
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm eyes more acquisitions after buying Allergan's generics business,2016-08-04 14:40:35 +0000,http://sg.finance.yahoo.com/news/teva-pharma-focus-integrating-allergans-124534771.html,Teva Pharm eyes more acquisitions after buying Allergan's generics business
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Q2 16 Earnings Conference Call At 8:00 AM ET,2016-08-04 08:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R-kBcye1etg/teva-pharmaceutical-q2-16-earnings-conference-call-at-800-am-et-20160804-00351,Teva Pharmaceutical Q2 16 Earnings Conference Call At 8:00 AM ET
TEVA,TEVA:US,BBG000C0CD58,Teva Profit Falls on Write-Downs,2016-08-04 08:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XRaJd5XOeIU/teva-profit-falls-on-writedowns-20160804-00609,Teva Profit Falls on Write-Downs
TEVA,TEVA:US,BBG000C0CD58,Teva Pharma Declares Cash Dividends - Quick Facts,2016-08-04 07:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GjadspLQmJo/teva-pharma-declares-cash-dividends--quick-facts-20160804-00372,Teva Pharma Declares Cash Dividends - Quick Facts
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical Industries Limited Q2 Profit Declines 6%,2016-08-04 07:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GbRqt-TyvHc/teva-pharmaceutical-industries-limited-q2-profit-declines-6-20160804-00361,Teva Pharmaceutical Industries Limited Q2 Profit Declines 6%
TEVA,TEVA:US,BBG000C0CD58,Business Watch -- WSJ,2016-08-04 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rP4bzg8wzyY/business-watch--wsj-20160804-00077,Business Watch -- WSJ
TEVA,TEVA:US,BBG000C0CD58,Business Watch -- WSJ,2016-08-04 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UWkVYCD3M6s/business-watch--wsj-20160804-00078,Business Watch -- WSJ
TEVA,TEVA:US,BBG000C0CD58,"AXGN Making News, Milestone Events Lined Up For NBIX, Cesca Plays It Cool",2016-08-04 00:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AMgKJTxU77c/axgn-making-news-milestone-events-lined-up-for-nbix-cesca-plays-it-cool-20160804-00007,"AXGN Making News, Milestone Events Lined Up For NBIX, Cesca Plays It Cool"
TEVA,TEVA:US,BBG000C0CD58,"Sensex, Nifty Erase Early Gains",2016-08-04 00:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RAvrh1rCQ1w/sensex-nifty-erase-early-gains-20160804-00004,"Sensex, Nifty Erase Early Gains"
TEVA,TEVA:US,BBG000C0CD58,Dr. Reddy’s Completes Acquisition of Product Portfolio from TEVA,2016-08-03 17:58:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-completes-acquisition-product-175800155.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J.--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) today announced that it successfully completed the previously announced acquisition ..."
TEVA,TEVA:US,BBG000C0CD58,Allergan to sell Anda drug distribution business to Teva,2016-08-03 14:07:08 +0000,http://sg.finance.yahoo.com/news/allergan-sell-anda-drug-distribution-140708189.html,Allergan to sell Anda drug distribution business to Teva
TEVA,TEVA:US,BBG000C0CD58,Teva completes $40 bn purchase of Allergan generics arm,2016-08-02 20:16:54 +0000,http://uk.finance.yahoo.com/news/teva-completes-40-bn-purchase-201654197.html,Teva completes $40 bn purchase of Allergan generics arm
TEVA,TEVA:US,BBG000C0CD58,"Teva, Allergan win U.S. antitrust approval for generics deal",2016-07-27 21:52:52 +0000,http://in.finance.yahoo.com/news/teva-allergan-win-u-antitrust-215252528.html,"Teva, Allergan win U.S. antitrust approval for generics deal"
TEVA,TEVA:US,BBG000C0CD58,Teva expect to close $40.5B Allergan generic deal next week,2016-07-27 20:31:33 +0000,http://sg.finance.yahoo.com/news/teva-expect-close-40-5b-203133173.html,Teva expect to close $40.5B Allergan generic deal next week
TEVA,TEVA:US,BBG000C0CD58,Five high-grade issuers announce deals,2016-07-20 15:39:07 +0000,http://uk.finance.yahoo.com/news/five-high-grade-issuers-announce-153907467.html,Five high-grade issuers announce deals
TEVA,TEVA:US,BBG000C0CD58,TEVA and Antares Pharma Announce Launch of Generic Imitrex in the United States,2016-06-27 13:21:03 +0000,http://www.publicnow.com/view/516155770A81E8C60CDE300BA60CA9CC8D252A85,"[at noodls] - a1256214-1441-4852-a4ba-d1f936a0eb05.pdf TEVA AND ANTARES PHARMA ANNOUNCE LAUNCH OF GENERIC IMITREX® IN THE UNITED STATES Jerusalem and Ewing, NJ, June 23, 2016 - Teva Pharmaceutical Industries Ltd., (NYSE ..."
TEVA,TEVA:US,BBG000C0CD58,Sagent Pharmaceuticals Acquires Product Portfolio From Teva Pharmaceutical Industries Ltd.,2016-06-16 12:39:02 +0000,http://www.publicnow.com/view/99687C2ECFBBDB8578E5F4DD3B7AEA6CA91229FE,"[at noodls] - SCHAUMBURG, Ill., June 16, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leading provider of affordable pharmaceuticals to the hospital market, today announced that it has entered ..."
TEVA,TEVA:US,BBG000C0CD58,Mesoblast shares tank after Teva exit,2016-06-14 07:58:14 +0000,http://au.finance.yahoo.com/news/mesoblast-shares-tank-teva-exit-075814486.html,"[AAP] - Shares in medical research specialist Mesoblast plunged 42 per cent on Tuesday on concerns about the stem cell therapy company's future after drugs giant Teva Pharmaceutical ended a long-standing research partnership. Mesoblast said on Tuesday it has regained worldwide rights to its experimental therapy for advanced chronic heart failure at no cost as a result of Teva ending its involvement in a phase three trial. With Teva out of the picture, Mesoblast said it has secured a new equity finance facility to meet the remaining funding requirements for its stem cell-based heart failure treatment program."
TEVA,TEVA:US,BBG000C0CD58,Mesoblast shares drop on outlook concerns,2016-06-14 02:33:40 +0000,http://au.finance.yahoo.com/news/mesoblast-shares-drop-outlook-concerns-023008476.html,"[AAP] - Investors have dumped Mesoblast shares on concerns about the stem cell therapy company's future after drugs giant Teva Pharmaceutical ended a long-standing research partnership. Mesoblast said on Tuesday it has regained worldwide rights to its experimental therapy for advanced chronic heart failure as a result of Teva ending its involvement in a phase three trial. With Teva out of the picture, Mesoblast said it has secured a new equity finance facility to meet the remaining funding requirements for its stem cell-based heart failure treatment program."
TEVA,TEVA:US,BBG000C0CD58,Teva stops selling migraine patch after reports of burns,2016-06-13 16:25:22 +0000,http://sg.finance.yahoo.com/news/teva-stops-selling-migraine-patch-141103726.html,Teva stops selling migraine patch after reports of burns
TEVA,TEVA:US,BBG000C0CD58,Dr. Reddy’s to acquire product portfolio from TEVA for US Market,2016-06-11 13:26:00 +0000,http://au.finance.yahoo.com/news/dr-reddy-acquire-product-portfolio-132600489.html,"[Business Wire] - HYDERABAD, India & PRINCETON, N.J--(BUSINESSWIRE)-- Dr. Reddy’s Laboratories (BSE:500124, NSE:DRREDDY, NYSE:RDY) has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd. (NYSE and ..."
TEVA,TEVA:US,BBG000C0CD58,"Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan",2016-06-11 09:56:38 +0000,http://in.finance.yahoo.com/news/dr-reddys-buy-8-u-081954765.html,"Dr Reddy's in $350 mln deal to buy 8 U.S. drugs from Teva, Allergan"
TEVA,TEVA:US,BBG000C0CD58,Teva Announces New Collaboration with GRAMMY Nominated Artist Jhené Aiko,2016-06-01 12:53:09 +0000,http://www.publicnow.com/view/376EF05E8AEAA784062B36A65629D108DCDA4C3A,"[at noodls] - http://www.businesswire.com/news/home/20160601005429/en/ (Photo: Business Wire) 'We love all that Jhené stands for in her musical career and as a creative individual,' said Erika Gabrielli, Director of ..."
TEVA,TEVA:US,BBG000C0CD58,Allergan CEO says company is 'weeks away' from closing Teva deal,2016-05-23 17:49:58 +0000,http://sg.finance.yahoo.com/news/allergan-ceo-says-company-weeks-163359525.html,Allergan CEO says company is 'weeks away' from closing Teva deal
TEVA,TEVA:US,BBG000C0CD58,"Takeda and Teva Establish ""Teva Takeda Yakuhin Ltd."" in Japan",2016-03-31 23:41:19 +0000,http://www.publicnow.com/view/1619B58D305B361C81B3D2C2C888BDA63F3C610E,"[at noodls] - Osaka, Japan and Jerusalem, April 1, 2016 - Takeda Pharmaceutical Company Limited (TSE: 4502) and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announce the establishment of Teva Takeda Yakuhin ..."
TEVA,TEVA:US,BBG000C0CD58,Takeda and Teva Establish “Teva Takeda Yakuhin Ltd.” in Japan,2016-03-31 23:30:00 +0000,http://au.finance.yahoo.com/news/takeda-teva-establish-teva-takeda-233000124.html,"[Business Wire] - JERUSALEM & OSAKA, Japan--(BUSINESSWIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Takeda Pharmaceutical Company Limited ( TSE:4502 ) announce the establishment of Teva Takeda Yakuhin ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm sees close of $40.5 billion Allergan generics deal by June,2016-03-15 13:41:07 +0000,http://sg.finance.yahoo.com/news/teva-pharm-sees-close-40-134107230.html,Teva Pharm sees close of $40.5 billion Allergan generics deal by June
TEVA,TEVA:US,BBG000C0CD58,EU approves Teva bid for Allergan's generics with conditions,2016-03-10 14:06:00 +0000,http://sg.finance.yahoo.com/news/eu-approves-teva-bid-allergans-140600906.html,EU approves Teva bid for Allergan's generics with conditions
TEVA,TEVA:US,BBG000C0CD58,Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources,2016-03-10 00:04:24 +0000,http://in.finance.yahoo.com/news/exclusive-teva-set-win-eu-000424015.html,Exclusive - Teva set to win EU okay for $40.5 billion Allergan deal: sources
TEVA,TEVA:US,BBG000C0CD58,"Exclusive - EU regulators set to clear $40.5 billion Teva, Allergan deal: sources",2016-03-09 19:38:31 +0000,http://in.finance.yahoo.com/news/exclusive-eu-regulators-set-clear-193831553.html,"Exclusive - EU regulators set to clear $40.5 billion Teva, Allergan deal: sources"
TEVA,TEVA:US,BBG000C0CD58,Teva offers EU concessions over Allergan generics deal - EU,2016-02-19 10:01:52 +0000,http://sg.finance.yahoo.com/news/teva-offers-eu-concessions-over-100152940.html,Teva offers EU concessions over Allergan generics deal - EU
TEVA,TEVA:US,BBG000C0CD58,Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine hydrochloride) Injection,2016-01-28 16:46:14 +0000,http://www.publicnow.com/view/EA0CEB4467BAAB671E42FCE62A1A978C443FCFDE,"[at noodls] - & --(BUSINESS WIRE)--Jan. 28, 2016-- (NYSE and TASE: TEVA) and (Nasdaq: EGRX) announced today the commercial availability of BENDEKA™, (bendamustine hydrochloride) injection, a liquid, low-volume (50 mL) ..."
TEVA,TEVA:US,BBG000C0CD58,"Teva to Report Fourth Quarter 2015 Financial Results on February 11, 2016",2016-01-28 13:22:07 +0000,http://www.publicnow.com/view/C9592FB00A08E4279D6697038D4697B47BA11867,"[at noodls] - --(BUSINESS WIRE)--Jan. 28, 2016-- (NYSE:TEVA) announced today that it will release its fourth quarter 2015 financial results on at . Teva will host a conference call and live webcast on the same day, ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Releases Innovation and Social Responsibility Highlights,2016-01-25 13:47:11 +0000,http://www.publicnow.com/view/BFE092FD7335F9D3EAEA08440180DDB37AB64C82,"[at noodls] - Leading Global Pharmaceutical Company Recaps Latest Milestones, from Bolstering Digital Healthcare Start-Ups to Creating Tailored Treatments --(BUSINESS WIRE)--Jan. 25, 2016-- (NYSE and TASE:TEVA) released ..."
TEVA,TEVA:US,BBG000C0CD58,Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP Inhibitor,2016-01-07 13:42:06 +0000,http://www.noodls.com/view/DF25E8E84E301BA7AE5DC1C937218D35AD196C0E,"[at noodls] - Checkpoint to and Commercialization Rights & --(BUSINESS WIRE)--Jan. 7, 2016-- (NYSE and TASE: TEVA) and ('Checkpoint'), a (NASDAQ: FBIO) Company, announced today a license agreement in which Checkpoint ..."
TEVA,TEVA:US,BBG000C0CD58,Teva to Present at the 34th Annual J.P. Morgan Healthcare Conference,2016-01-07 13:22:19 +0000,http://www.noodls.com/view/3050ADCA23BAD61B1740797197B52E710314BFD0,"[at noodls] - --(BUSINESS WIRE)--Jan. 7, 2016-- (NYSE:TEVA) will host a live audio webcast at the 34 Annual . Teva's management will present on at . ... This is an abstract of the original noodl. To continue reading ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Launch of Generic Ortho Tri-Cyclen® Lo in the United States,2016-01-05 13:09:05 +0000,http://www.noodls.com/view/29D5F5DAE8933A8EF1DDD2E6EA3B6AA113C4F0F8,"[at noodls] - --(BUSINESS WIRE)--Jan. 5, 2016-- , (NYSE:TEVA) announced the launch of a generic equivalent of Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) tablets in . Teva's Tri-Lo-Sprintec (norgestimate and ..."
TEVA,TEVA:US,BBG000C0CD58,Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials,2016-01-04 14:18:16 +0000,http://www.noodls.com/view/E684C8E130232F39F2A4F7D81345ED1628B4E045,"[at noodls] - 2016-01-04 CONCERTO and ARPEGGIO Trials Continue Study of Lower-dose Laquinimod Jerusalem & Lund, Sweden - January 4, 2016 - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Active Biotech ..."
TEVA,TEVA:US,BBG000C0CD58,Teva Announces Exercise of Underwriters’ Over-Allotment Option,2016-01-03 08:15:18 +0000,http://www.noodls.com/view/E3F8B6A3C47C8CAA46A669B1663E485246A15E33,"[at noodls] - --(BUSINESS WIRE)--Jan. 3, 2016-- (NYSE and TASE: TEVA) announced today that the underwriters for its previously announced offerings of its American Depositary Shares ('ADSs'), each representing one Teva ..."
TEVA,TEVA:US,BBG000C0CD58,CORRECTING and REPLACING Takeda Provides Further Information about Its New Business Venture with Teva,2015-12-28 02:55:00 +0000,http://au.finance.yahoo.com/news/takeda-provides-further-information-business-230000449.html,"[Business Wire] - OSAKA, Japan & JERUSALEM--(BUSINESSWIRE)-- Insert after fifth paragraph, first sentence of release: The new business venture will be instantly accretive to Teva's non GAAP EPS in 2016 and beyond. Takeda Pharmaceutical Company Limited (TOKYO:4502) and Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - News) (TASE:TEVA.TA - News) today made the below follow-up announcement regarding the overview of their new business venture in Japan, which was initially disclosed on November 30, 2015 in the press release titled, ""Teva and Takeda establish unique partnership to meet the wide-ranging needs of patients and growing importance of generic medicines use in Japan"". The new business venture, to be established in or after April 2016, will deliver Teva's high-quality generic medicines and some of Takeda's long listed products to patients and healthcare professionals in Japan, leveraging Takeda's corporate brand and unique distribution network in Japan and Teva's wide product portfolio and cutting-edge business efficiency."
TEVA,TEVA:US,BBG000C0CD58,Teva divesting $1 billion in assets to clear Allergan deal - sources,2015-12-03 16:35:43 +0000,http://sg.finance.yahoo.com/news/teva-divesting-1-billion-assets-163543026.html,Teva divesting $1 billion in assets to clear Allergan deal - sources
TEVA,TEVA:US,BBG000C0CD58,"Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine",2015-11-25 08:00:00 +0000,http://uk.finance.yahoo.com/news/teva-heptares-enter-agreement-discover-080000691.html,"Teva and Heptares Enter Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine"
TEVA,TEVA:US,BBG000C0CD58,Teva and University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New Approach in Neurodegenerative Disease,2015-11-19 14:00:00 +0000,http://uk.finance.yahoo.com/news/teva-university-college-london-embark-140000250.html,Teva and University College London Embark on Unique Brain Imaging Study Aimed at Unlocking a New Approach in Neurodegenerative Disease
TEVA,TEVA:US,BBG000C0CD58,Successful Ruling in Patent Infringement Litigation for Antiemetic Agent Aloxi in the United States,2015-11-17 07:13:00 +0000,http://au.finance.yahoo.com/news/successful-ruling-patent-infringement-litigation-071300573.html,"[ACN Newswire] - TOKYO, Nov 17, 2015 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, ""Eisai"") announced today that the U.S. District Court for the District of New Jersey has ruled in favor of Helsinn Healthcare S.A. (Headquarters: Lugano, Switzerland, CEO: Riccardo Braglia, ""Helsinn"") in the patent infringement lawsuit for antiemetic agent ALOXI (palonosetron hydrochloride) brought by Helsinn together with Roche Palo Alto LLC (Roche) against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. (collectively ""Teva"") in the United States, where it was determined that certain formulation patent claims for ALOXI are valid and infringed. Since 2011, Helsinn and Roche filed patent infringement lawsuits in the U.S. District Court for the District of New Jersey, against Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (collectively ""Dr. Reddy's""), Sandoz Inc. (Sandoz) and Teva, who were the first to submit Abbreviated New Drug Applications (ANDAs) for ALOXI."
TEVA,TEVA:US,BBG000C0CD58,"Exclusive - Beyond Valeant, U.S. payers scrutinize other drugmaker ties to pharmacies",2015-10-30 22:46:50 +0000,http://sg.finance.yahoo.com/news/exclusive-beyond-valeant-u-payers-205433594.html,"Exclusive - Beyond Valeant, U.S. payers scrutinize other drugmaker ties to pharmacies"
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm to buy Mexican drugmaker Rimsa for $2.3 bln,2015-10-01 16:29:25 +0000,http://sg.finance.yahoo.com/news/teva-pharm-buy-mexican-drugmaker-132506985.html,Teva Pharm to buy Mexican drugmaker Rimsa for $2.3 bln
TEVA,TEVA:US,BBG000C0CD58,Teva to buy Mexico's Rimsa for $2.3 bln,2015-10-01 14:39:46 +0000,http://uk.finance.yahoo.com/news/teva-buy-mexicos-rimsa-2-143946788.html,Teva to buy Mexico's Rimsa for $2.3 bln
TEVA,TEVA:US,BBG000C0CD58,Perrigo urges shareholders to reject Mylan takeover offer,2015-09-17 12:03:25 +0000,http://sg.finance.yahoo.com/news/perrigo-urges-shareholders-reject-mylan-120325424.html,Perrigo urges shareholders to reject Mylan takeover offer
TEVA,TEVA:US,BBG000C0CD58,Mylan opens $27.14 billion hostile bid for Perrigo,2015-09-15 12:29:03 +0000,http://sg.finance.yahoo.com/news/mylan-opens-27-14-billion-111208011.html,Mylan opens $27.14 billion hostile bid for Perrigo
TEVA,TEVA:US,BBG000C0CD58,Mylan says it will launch $27.14B bid for Perrigo,2015-09-08 22:51:48 +0000,http://sg.finance.yahoo.com/news/mylan-says-launch-27-14b-154549606.html,Mylan says it will launch $27.14B bid for Perrigo
TEVA,TEVA:US,BBG000C0CD58,"Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid",2015-07-27 21:27:22 +0000,http://uk.finance.yahoo.com/news/teva-buy-allergan-generic-drug-114831299.html,"Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid"
TEVA,TEVA:US,BBG000C0CD58,Chinese market dive pressures US stocks,2015-07-27 20:35:29 +0000,http://uk.finance.yahoo.com/news/chinese-market-dive-pressures-us-203529017.html,Chinese market dive pressures US stocks
TEVA,TEVA:US,BBG000C0CD58,"Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid",2015-07-27 18:32:04 +0000,http://in.finance.yahoo.com/news/teva-buy-allergan-generic-drug-100202496.html,"Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid"
TEVA,TEVA:US,BBG000C0CD58,Teva to lift bid for Mylan: report,2015-07-06 21:17:33 +0000,http://uk.finance.yahoo.com/news/teva-lift-bid-mylan-report-211733194.html,Teva to lift bid for Mylan: report
TEVA,TEVA:US,BBG000C0CD58,Exclusive - Teva poised to raise its stake in Mylan -sources,2015-06-02 23:09:44 +0000,http://in.finance.yahoo.com/news/exclusive-teva-poised-raise-stake-230944619.html,Exclusive - Teva poised to raise its stake in Mylan -sources
TEVA,TEVA:US,BBG000C0CD58,Teva to pay $1.2 bn fine to settle US antitrust case,2015-05-28 18:01:01 +0000,http://uk.finance.yahoo.com/news/teva-pay-1-2-bn-180101491.html,Teva to pay $1.2 bn fine to settle US antitrust case
TEVA,TEVA:US,BBG000C0CD58,Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy,2015-04-29 22:42:19 +0000,http://uk.finance.yahoo.com/news/mylan-raises-offer-buy-perrigo-141742730.html,Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy
TEVA,TEVA:US,BBG000C0CD58,US STOCKS-Wall St reverses course to trade lower as health stocks drag,2015-04-27 16:59:21 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-reverses-165921547.html,US STOCKS-Wall St reverses course to trade lower as health stocks drag
TEVA,TEVA:US,BBG000C0CD58,Generic drugmaker Mylan goes hostile in bid for Perrigo,2015-04-24 16:57:14 +0000,http://uk.finance.yahoo.com/news/mylan-says-start-formal-offer-152907706.html,Generic drugmaker Mylan goes hostile in bid for Perrigo
TEVA,TEVA:US,BBG000C0CD58,Generic drugmaker Teva makes $40 billion offer for rival Mylan,2015-04-21 23:16:38 +0000,http://in.finance.yahoo.com/news/generic-drugmaker-teva-makes-40-182309851.html,Generic drugmaker Teva makes $40 billion offer for rival Mylan
TEVA,TEVA:US,BBG000C0CD58,Top Mylan shareholders seek deal with Teva - sources,2015-04-21 22:51:19 +0000,http://in.finance.yahoo.com/news/exclusive-top-mylan-shareholders-seek-213630437.html,Top Mylan shareholders seek deal with Teva - sources
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical offers to buy Mylan for $40.1 bn,2015-04-21 20:49:47 +0000,http://uk.finance.yahoo.com/news/teva-pharmaceutical-offers-buy-mylan-140637167.html,Teva Pharmaceutical offers to buy Mylan for $40.1 bn
TEVA,TEVA:US,BBG000C0CD58,Teva formalises offer to acquire Mylan for $82 a share in cash and stock,2015-04-21 14:17:00 +0000,http://uk.finance.yahoo.com/news/teva-formalises-offer-acquire-mylan-141700638.html,Teva formalises offer to acquire Mylan for $82 a share in cash and stock
TEVA,TEVA:US,BBG000C0CD58,US STOCKS-Wall St edges up as results ease anxiety over earnings,2015-04-21 13:58:36 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-edges-135836733.html,US STOCKS-Wall St edges up as results ease anxiety over earnings
TEVA,TEVA:US,BBG000C0CD58,Teva Pharmaceutical offers to buy Mylan for $31 bn,2015-04-21 13:46:03 +0000,http://uk.finance.yahoo.com/news/teva-pharmaceutical-offers-buy-mylan-131018694.html,Teva Pharmaceutical offers to buy Mylan for $31 bn
TEVA,TEVA:US,BBG000C0CD58,Generic drugmaker Mylan offers $29 billion for Perrigo,2015-04-08 21:01:52 +0000,http://in.finance.yahoo.com/news/generic-drugmaker-mylan-offers-29-210152266.html,Generic drugmaker Mylan offers $29 billion for Perrigo
TEVA,TEVA:US,BBG000C0CD58,US STOCKS-Wall St rebounds from recent losses; deals help,2015-03-30 20:31:17 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-rebounds-203117647.html,US STOCKS-Wall St rebounds from recent losses; deals help
TEVA,TEVA:US,BBG000C0CD58,US STOCKS-Wall St higher as biotechs rally on M&A deals,2015-03-30 14:08:28 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-higher-140828967.html,US STOCKS-Wall St higher as biotechs rally on M&A deals
TEVA,TEVA:US,BBG000C0CD58,U.S. Supreme Court rules for Teva over MS drug patent,2015-01-20 18:14:39 +0000,http://in.finance.yahoo.com/news/u-supreme-court-rules-teva-153046378.html,U.S. Supreme Court rules for Teva over MS drug patent
TEVA,TEVA:US,BBG000C0CD58,Teva Pharm sees 2015 revenue lower than forecast,2014-12-11 13:16:50 +0000,http://uk.finance.yahoo.com/news/teva-pharm-sees-2015-revenue-131650280.html,Teva Pharm sees 2015 revenue lower than forecast
TEVA,TEVA:US,BBG000C0CD58,UK court backs Teva rival to AstraZeneca lung drug,2014-09-03 10:18:03 +0000,http://uk.finance.yahoo.com/news/uk-court-backs-teva-rival-101803442.html,UK court backs Teva rival to AstraZeneca lung drug
